Table of Contents

As filed with the Securities and Exchange Commission on April 17, 2012

Registration No. 333-                    

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM S-1

REGISTRATION STATEMENT

Under

The Securities Act of 1933

 

 

Five Below, Inc.

(Exact name of Registrant as specified in its charter)

 

 

 

Pennsylvania   5331   75-3000378

(State or other jurisdiction of

incorporation or organization)

 

(Primary Standard Industrial

Classification Code Number)

 

(I.R.S. Employer

Identification Number)

1818 Market Street

Suite 1900

Philadelphia, PA 19103

(215) 546-7909

(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)

 

 

Kenneth R. Bull

Chief Financial Officer

1818 Market Street

Suite 1900

Philadelphia, PA 19103

(215) 546-7909

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

 

Copies to:

 

Barry M. Abelson, Esq.

John P. Duke, Esq.

Pepper Hamilton LLP

3000 Two Logan Square

18 th and Arch Streets

Philadelphia, PA 19103

(215) 981-4000

 

Robert E. Buckholz, Esq.

Sullivan & Cromwell LLP

125 Broad Street

New York, New York 10004

(212) 558-4000

 

 

Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this Registration Statement.

 

 

If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box.   ¨

If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration number of the earlier effective registration statement for the same offering.   ¨

If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.   ¨

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.   ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act of 1934.

 

Large Accelerated filer   ¨      Accelerated filer   ¨
Non-accelerated filer   x  (do not check if a smaller reporting  company)      Smaller reporting company   ¨

 

 

CALCULATION OF REGISTRATION FEE

 

 

Title of Securities to be Registered   Proposed Maximum Aggregate
Offering Price(1)(2)
  Amount of Registration Fee(3)

Common Stock, $0.01 par value per share

  $150,000,000   $17,190

 

 

(1) Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended.
(2) Includes shares of common stock that may be purchased by the underwriters to cover the underwriters’ option to purchase additional shares, if any.
(3) Calculated pursuant to Rule 457(o) under the Securities Act of 1933, as amended.

The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.

 

 

 


Table of Contents

The information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

 

Subject to Completion, Dated April 17, 2012.

             Shares

LOGO

Five Below, Inc.

Common Stock

 

 

This is an initial public offering of shares of common stock of Five Below, Inc.

Five Below is offering              of the shares to be sold in the offering. The selling shareholders identified in this prospectus are offering an additional              shares. Five Below will not receive any of the proceeds from the sale of the shares being sold by the selling shareholders.

Prior to this offering, there has been no public market for the common stock. It is currently estimated that the initial public offering price per share will be between $         and $        .   Five Below intends to list the common stock on The NASDAQ Global Select Market under the symbol “            ”.

 

 

See “ Risk Factors ” beginning on page 12 to read about factors you should consider before buying shares of the common stock.

 

 

Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.

 

 

 

     Per Share      Total  

Initial public offering price

   $                    $                

Underwriting discount

   $                    $                

Proceeds, before expenses, to Five Below

   $                    $                

Proceeds, before expenses, to the selling shareholders

   $                    $                

To the extent that the underwriters sell more than              shares of common stock, the underwriters have the option to purchase up to an additional              shares from the selling shareholders at the initial price to the public less the underwriting discount.

 

 

The underwriters expect to deliver the shares against payment in New York, New York on                     , 2012.

 

Goldman, Sachs & Co.   Barclays     Jefferies   

 

Credit Suisse   Deutsche Bank Securities   UBS Investment Bank   Wells Fargo Securities

 

 

Prospectus dated                     , 2012.


Table of Contents

TABLE OF CONTENTS

 

     Page  

Prospectus Summary

     1   

Risk Factors

     12   

Special Note Regarding Forward-Looking Statements

     26   

Use of Proceeds

     28   

Dividends

     29   

Capitalization

     30   

Dilution

     32   

Selected Financial and Other Data

     34   

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     38   

Business

     52   

Management

     61   

Executive Compensation

     68   

Certain Relationships and Related Party Transactions

     86   

Principal and Selling Shareholders

     89   

Description of Capital Stock

     93   

Shares Eligible for Future Sale

     100   

Material United States Tax Considerations for Non-United States Holders of Common Stock

     103   

Underwriting

     108   

Conflicts of Interest

     110   

Validity of Common Stock

     113   

Experts

     113   

Where You Can Find Additional Information

     113   

Index to Financial Statements

     F-1   

 

 

Through and including                     , 2012 (the 25th day after the date of this prospectus), all dealers effecting transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to a dealer’s obligation to deliver a prospectus when acting as an underwriter and with respect to an unsold allotment or subscription.

 

 

We have not authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses we have prepared. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the shares offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus is current only as of its date.

Persons who come into possession of this prospectus and any such free writing prospectus in jurisdictions outside the United States are required to inform themselves about and to observe any restrictions as to this offering and the distribution of this prospectus and any such free writing prospectus applicable to that jurisdiction.

 

 

 


Table of Contents

Market and Industry Data

We obtained the industry, market and competitive position data throughout this prospectus from our own internal estimates and research, as well as from industry and general publications and research, surveys and studies conducted by third parties. Industry publications, studies and surveys generally state that they have been obtained from sources believed to be reliable, although they do not guarantee the accuracy or completeness of such information. While we believe that each of these studies and publications is reliable, we have not independently verified market and industry data from third-party sources. While we believe our internal company research is reliable and the definitions of our market and industry are appropriate, neither this research nor these definitions have been verified by any independent source.

 

 

Basis of Presentation

We operate on a fiscal calendar widely used by the retail industry that results in a given fiscal year consisting of a 52- or 53-week period ending on the Saturday closest to January 31 of the following year. References to “fiscal year 2011” or “fiscal 2011” refer to the fiscal year ended January 28, 2012, references to “fiscal year 2010” or “fiscal 2010” refer to the fiscal year ended January 29, 2011 and references to “fiscal year 2009” or “fiscal 2009” refer to the fiscal year ended January 30, 2010. Each of fiscal years 2011, 2010 and 2009 consisted of a 52-week period.

In connection with this offering, we will amend our articles of incorporation to effect a     -for-     reverse stock split of our common stock prior to the closing of this offering. Concurrent with the reverse stock split, we will adjust (x) the conversion price of our Series A 8% convertible preferred stock, (y) the number of shares subject to and the exercise price of our outstanding stock option awards under our equity incentive plan and (z) the number of shares subject to and the exercise price of our outstanding warrants, such that the holders of the preferred stock, options and warrants are in the same economic position both before and after the reverse stock split. In addition, the outstanding shares of our Series A 8% convertible preferred stock will convert into shares of our common stock. Unless otherwise indicated, all share data gives effect to the reverse stock split, the adjustment of the terms of our preferred stock, outstanding options and warrants and the conversion of our preferred stock into common stock.

 

 

Trademarks

We own or have rights to trademarks or trade names that we use in conjunction with the operation of our business, including Five Below ® and Five Below Hot Stuff. Cool Prices. ® Solely for convenience, trademarks and trade names referred to in this prospectus may appear without the ® or ™ symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensor to these trademarks and trade names. In this prospectus, we also refer to product names, trademarks, trade names and service marks that are the property of other companies. Each of the trademarks, trade names or service marks of other companies appearing in this prospectus belongs to its owners. Our use or display of other companies’ product names, trademarks, trade names or service marks is not intended to and does not imply a relationship with, or endorsement or sponsorship by us of, the product, trademark, trade name or service mark owner, unless we otherwise indicate.


Table of Contents

PROSPECTUS SUMMARY

This summary highlights information contained elsewhere in this prospectus. It does not contain all of the information that may be important to you and your investment decision. You should carefully read this entire prospectus, including the matters set forth under “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our financial statements and related notes included elsewhere in this prospectus. In this prospectus, unless the context otherwise requires, references to “Five Below,” the “Company,” “we,” “us” and “our” refer to Five Below, Inc. Numbers may not sum due to rounding.

Overview

Five Below is a rapidly growing specialty value retailer offering a broad range of trend-right, high-quality merchandise targeted at the aspirational teen and pre-teen customer. We offer a dynamic, edited assortment of exciting products, all priced at $5 and below, including select brands and licensed merchandise across a number of categories, which we refer to as “worlds”: Style , Room , Sports , Media , Crafts , Party, Candy and Seasonal (which we refer to as “Now” ). We believe we are transforming the shopping experience of our target demographic with a unique merchandising strategy and high-energy retail concept that our customers consider fun and exciting. Our compelling value proposition and the dynamic nature of our merchandise offering appeal to teens and pre-teens, as well as customers across a variety of age groups beyond our target demographic.

Five Below was founded in 2002 by our Executive Chairman, David Schlessinger, and our President and Chief Executive Officer, Thomas Vellios, who recognized a market need for a fun and affordable shopping destination aimed at our target customer. We opened the first Five Below store in 2002 and have since been expanding across the eastern half of the U.S. At the end of fiscal 2011, we operated a total of 192 locations across 16 states. Our stores average approximately 7,500 square feet and are typically located within power, community and lifestyle shopping centers across a variety of urban, suburban and semi-rural markets. We plan to open approximately 50 stores in 2012, and we believe we have the opportunity to grow our store base to more than 2,000 locations over time.

We believe our powerful business model has resulted in strong financial performance irrespective of the economic environment:

 

   

We have achieved positive comparable store sales during each of the last 23 fiscal quarters.

 

   

Our comparable store sales increased by 12.1% in fiscal 2009, 15.6% in fiscal 2010 and 7.9% in fiscal 2011 with positive comparable store sales performance across all geographic regions and store-year classes.

 

   

Over the past two fiscal years, we expanded our store base from 102 stores to 192 stores, representing a compound annual growth rate of 37.2%.

 

   

Between fiscal 2009 and 2011, our net sales increased from $125.1 million to $297.1 million, representing a 54.1% compound annual growth rate.

 

   

Over the same period, our operating income increased from $6.9 million to $26.2 million, representing a compound annual growth rate of 95.3%.

 


Table of Contents

Our Competitive Strengths

We believe the following strengths differentiate Five Below from competitors and are the key drivers of our success:

 

   

Unique Focus on the Teen and Pre-Teen Customer.     We target an attractive customer segment of teens and pre-teens with trend-right merchandise at a differentiated price point of $5 and below. Our brand concept, merchandising strategy and store ambience work in concert to create an upbeat and vibrant retail experience that is designed to appeal to our target audience. We monitor trends in the ever-changing teen and pre-teen markets and are able to quickly identify and respond to those that become mainstream. We believe our price points enable teens and pre-teens to shop independently and exercise self-expression, using their own money to make frequent purchases of items geared primarily to them.

 

   

Broad Assortment of Trend-Right, High-Quality Merchandise with Universal Appeal.     We deliver an edited assortment of trend-right, everyday products that changes frequently to create a sense of anticipation and freshness. Our unique approach encourages frequent customer visits and limits the cyclical fluctuations experienced by many other specialty retailers. The breadth, depth and quality of our product mix and the diversity of our category worlds attract shoppers across a broad range of age and socio-economic demographics.

 

   

Exceptional Value Proposition for Customers.     We believe we offer a clear value proposition to our customers with our price points of $5 and below. We are able to deliver on this value proposition through sourcing products in a manner that is designed to minimize cost, accelerate response times and maximize sell-through. We have collaborative relationships with our vendor partners and also employ an opportunistic buying strategy, which allows us to capitalize on select excess inventory opportunities. This unique and flexible sourcing strategy allows us to offer high-quality products at exceptional value across all of our category worlds.

 

   

Differentiated Shopping Experience.     We have created an in-store atmosphere that we believe our customers find easy-to-shop, fun and exciting. While we refresh our products frequently, we maintain a consistent floor layout with an easy-to-navigate racetrack flow and sight-lines across the entire store enabling customers to easily identify our category worlds. All of our stores feature a sound system playing popular music throughout the shopping day. We employ colorful and stimulating in-store fixtures and signage and also utilize dynamic product displays, which encourage hands-on interaction. We have developed a unique culture that emanates from our employees, driving a higher level of connectivity with customers. Additionally, we believe the combination of our price points and merchandising create an element of discovery, driving customer engagement and repeat visits while insulating us against e-commerce cannibalization trends.

 

   

Powerful and Consistent Store Economics.     We have a proven store model that generates strong cash flow, consistent store-level financial results and high level returns on investment. Our stores have been successful in varying geographic regions, population densities and real estate settings. Each of our stores was profitable on a four-wall basis in fiscal 2011 and our new stores have achieved average payback periods of less than one year. We believe our robust store model, reinforced by our rigorous site selection process and in-store execution, drives the strength and consistency of our comparable store sales financial performance across all geographic regions and store-year classes.

 

   

Highly Experienced and Passionate Senior Management Team with Proven Track Record.     Our senior management team has extensive experience across a broad range of disciplines, including merchandising, real estate, finance, store operations, supply chain management and information technology. Our co-founders, David Schlessinger and Thomas Vellios, have approximately 65

 

 

2


Table of Contents
 

combined years of retail experience and have set the vision and strategic direction for Five Below. Our management team drives our operating philosophy, which is based on a relentless focus on providing high-quality merchandise at exceptional value and a superior shopping experience utilizing a disciplined, low-cost operating and sourcing structure.

Growth Strategy

We believe we can grow our net sales and earnings by executing on the following strategies:

 

   

Grow Our Store Base.     We believe we have the potential to grow our store base in the U.S. from 192 locations at the end of fiscal 2011 to more than 2,000 locations over time, based on our experience and supported by research conducted for us by The Buxton Company, a customer analytics research firm. We expect most of our near-term growth will occur within our existing eastern U.S. markets. We opened 50 net new stores in fiscal 2011 and plan to open approximately 50 in fiscal 2012 and approximately 60 in fiscal 2013.

 

   

Drive Comparable Store Sales.     We expect to continue driving comparable store sales growth by maintaining our dynamic merchandising offering, supported by our flexible sourcing strategy and differentiated in-store shopping experience. We intend to increase our brand awareness through cost-effective marketing efforts and enthusiastic customer engagement.

 

   

Increase Brand Awareness.     We intend to leverage our cost-effective marketing strategy to increase awareness of our brand. Our strategy includes the use of newspaper circulars, local media and grassroots marketing to support existing and new market entries. We believe we have an opportunity to leverage our growing social media and online presence to drive brand excitement and increased store visits within existing and new markets. These platforms allow us to continue to build brand awareness and expand our new customer base.

 

   

Enhance Operating Margins.     We believe we have further opportunities to drive margin improvement over time. A primary driver of our expected margin expansion will come from leveraging our cost structure as we continue to increase our store base and drive our average net sales per store. We intend to capitalize on opportunities across our supply chain as we grow our business and achieve further economies of scale.

Our Market Opportunity

As a result of our unique merchandise offering and value proposition, we believe we have effectively targeted the teen and pre-teen markets. According to the U.S. Census Bureau, there were over 63 million people in the U.S. between the ages of 5 and 19, which represented over 20% of the U.S. population as of April 1, 2010. This segment of the population has a significant amount of disposable income as the vast majority of this age group’s basic needs are already met. According to EPM Communications, Inc., a publishing, research and consulting firm, teens and pre-teens between the ages of 8 and 19 were projected to spend over $250 billion in the U.S. in 2011.

 

 

3


Table of Contents

Risks Associated with our Business

There are a number of risks and uncertainties that may affect our financial and operating performance and our growth prospects. You should carefully consider all of the risks discussed in “Risk Factors,” which begins on page 12, before investing in our common stock. These risks include the following:

 

   

we may not be able to successfully implement our growth strategy if we are unable to identify suitable sites for store locations, obtain favorable lease terms, attract customers to our stores, hire and retain personnel and maintain sufficient levels of cash flow and financing to support our expansion;

 

   

we may not be able to effectively anticipate changes in trends or in spending patterns or shopping preferences of our customers, which could adversely impact our business;

 

   

we may face disruptions in our ability to select, obtain, distribute and market merchandise attractive to customers at prices that allow us to profitably sell such merchandise;

 

   

our business is seasonal and we may face adverse events during the holiday season, which could negatively impact our business;

 

   

we may not be able to effectively expand and improve our operations, including our distribution center capacity, or manage our existing resources to support our future growth;

 

   

we may not be able to maintain or improve levels of our comparable store sales;

 

   

we may lose key management personnel, which could adversely impact our business; and

 

   

we may face increased competition, which could adversely impact our business.

Financing Transactions

On                     , 2012, we entered into a $         million senior secured term loan facility, or term loan facility, with a syndicate of lenders. We used the proceeds from the term loan facility to pay a special dividend totaling approximately $         million on all outstanding shares of our common stock and Series A 8% convertible preferred stock, which we refer to as the 2012 Dividend. On the same day, we amended and restated our existing senior secured revolving credit facility with Wells Fargo Bank, National Association. We refer to the term loan facility, the new amended and restated senior secured revolving credit facility, or revolving credit facility, and related transactions as the “Financing Transactions.”

Principal Shareholders

Following the closing of this offering, funds managed by Advent International Corporation, or Advent, are expected to own approximately     % of our outstanding common stock, or      %, if the underwriters’ option to purchase additional shares is fully exercised. As a result, Advent will be able to exert significant voting influence over fundamental and significant corporate matters and transactions. See “Risk Factors—Risks Related to This Offering and Ownership of Our Common Stock” and “Principal and Selling Shareholders.”

Since 1984, Advent has raised $26 billion in private equity capital and completed over 270 transactions in 35 countries. Advent’s current portfolio is comprised of investments in 54 companies across five sectors—Retail, Consumer & Leisure; Financial and Business Services; Industrial; Technology, Media & Telecoms; and Healthcare. The Advent team includes more than 160 investment professionals across Western and Central Europe, North America, Latin America and Asia.

 

 

4


Table of Contents

Corporate and Other Information

Five Below was incorporated in Pennsylvania in January 2002. David Schlessinger, our Executive Chairman, and Thomas Vellios, our President and Chief Executive Officer, are the founders of Five Below. In October 2010, Advent acquired a majority interest in Five Below, which we refer to as the 2010 Transaction, with the goal of supporting the management team in accelerating our growth. Please see “Certain Relationships and Related Party Transactions—Investment by Advent” for a description of the 2010 Transaction.

Our principal executive office is located at 1818 Market Street, Suite 1900, Philadelphia, PA 19103 and our telephone number is (215) 546-7909. Our corporate website address is www.fivebelow.com . The information contained on, or accessible through, our corporate website does not constitute part of this prospectus.

 

 

5


Table of Contents

The Offering

 

Common stock offered by us

  

             shares

Common stock offered by selling shareholders

                shares (             shares if the underwriters exercise their option to purchase additional shares in full)

Common stock outstanding immediately after the offering

  

             shares

Option to purchase additional shares

   The underwriters have an option to purchase a maximum of              additional shares of common stock from the selling shareholders. The underwriters can exercise this option at any time within 30 days from the date of this prospectus.

Use of proceeds

  

We estimate that we will receive net proceeds from this offering of approximately $         million, assuming the shares are offered at $         per share (the midpoint of the price range set forth on the cover of this prospectus), after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us.

 

We will not receive any proceeds from the sale of shares by the selling shareholders.

 

We intend to use the net proceeds from this offering to pay any offering-related expenses and to repay $         million of outstanding indebtedness under our new term loan facility incurred in connection with the Financing Transactions. We intend to use the remaining proceeds (if any) for general corporate purposes, including working capital and capital expenditures. See “Use of Proceeds” and “Prospectus Summary—Financing Transactions.”

Principal shareholder

   Upon the closing of this offering, Advent will continue to own a majority interest in us. We do not intend to avail ourselves of any of the “controlled company” exemptions under the corporate governance rules of The NASDAQ Stock Market LLC.

Dividend policy

   We currently intend to retain any future earnings for use in the operation and expansion of our business. Any further determination to pay dividends on our capital stock will be at the discretion of our board of directors, subject to applicable laws, and will depend on our financial condition, results of operations, capital requirements, general business conditions and other factors that our board of directors considers relevant. In addition, the terms of our term loan facility and revolving credit facility contain restrictions on our ability to pay dividends. See “Dividends.”

 

 

6


Table of Contents

Proposed symbol for trading on The NASDAQ Global Select Market

  

            

Conflicts of interest

   As described under “Use of Proceeds,” we expect to use a portion of the net proceeds we receive from this offering to repay $         million of the outstanding indebtedness under our new term loan facility with a syndicate of lenders. Affiliates of                  are lenders under our new term loan facility and will each receive their pro rata share of such repayment. Because it is possible that                  or their affiliates could receive more than 5% of the proceeds of this offering in connection with the repayment of our new term loan facility, each of                  is deemed to have a “conflict of interest” under Rule 5121 (“Rule 5121”) of the Financial Industry Regulatory Authority. Accordingly, this offering will be conducted in accordance with Rule 5121. Rule 5121 requires that a “qualified independent underwriter,” meeting certain standards, participate in the preparation of the registration statement and prospectus and exercise the usual standards of due diligence with respect thereto.                      has served as “qualified independent underwriter” within the meaning of Rule 5121 in connection with this offering. For more information, see “Underwriting.”

 

 

7


Table of Contents

After giving effect to our              -for-              reverse stock split, the adjustment of the terms of our outstanding preferred stock, options and warrants, the conversion of our Series A 8% convertible preferred stock into common stock in connection with the closing of this offering, and the exercise of our outstanding warrants into common stock, the number of shares of common stock to be outstanding after this offering is based on              shares outstanding as of                     , 2012 and excludes:

 

   

             shares of common stock issuable upon the exercise of options to purchase common stock outstanding as of                     , 2012 at a weighted average exercise price of $         per share; and

 

   

             shares of common stock reserved for issuance under our equity incentive plan.

Except as otherwise indicated, all information in this prospectus assumes:

 

   

that the underwriters will not exercise their option to purchase additional shares;

 

   

a              for              reverse stock split of our common stock which will occur prior to the closing of this offering;

 

   

the conversion of all outstanding shares of our Series A 8% convertible preferred stock into              shares of our common stock in connection with the closing of this offering;

 

   

the exercise of all outstanding warrants to purchase              shares of our common stock; and

 

   

the adoption of our amended and restated articles of incorporation and amended bylaws to be effective upon the closing of this offering.

 

 

8


Table of Contents

Summary Financial and Other Data

The following table presents summary financial and other data for the periods and at the dates indicated. The statement of operations and cash flows data for fiscal 2009, 2010 and 2011 and the balance sheet data as of January 29, 2011 and January 28, 2012 are derived from audited financial statements included elsewhere in this prospectus. The balance sheet data as of January 30, 2010 have been derived from audited financial statements not included in this prospectus. You should read this data along with the sections of this prospectus entitled “Selected Financial and Other Data” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and our financial statements and related notes included elsewhere in this prospectus. Our historical results are not necessarily indicative of results for any future period.

 

     Fiscal Year  
     2009     2010     2011  
(in thousands, except total stores, share and per share data)  

Statement of Operations Data:

      

Net sales

   $ 125,135      $ 197,189      $ 297,113   

Cost of goods sold

     85,040        131,046        192,252   
  

 

 

   

 

 

   

 

 

 

Gross profit

     40,095        66,143        104,861   

Selling, general and administrative expenses(1)

     33,217        54,339        78,640   
  

 

 

   

 

 

   

 

 

 

Operating income

     6,878        11,804        26,221   

Interest expense (income), net

     73        28        (16
  

 

 

   

 

 

   

 

 

 

Income before income taxes

     6,805        11,776        26,237   

Income tax (benefit) expense

     (4,853     4,753        10,159   
  

 

 

   

 

 

   

 

 

 

Net income

     11,658        7,023        16,078   

Series A 8% convertible preferred stock cumulative dividends

     —          (4,507     (15,913

Accretion of redeemable convertible preferred stock

     (4,250     (3,329     —     
  

 

 

   

 

 

   

 

 

 

Net income (loss) available to shareholders

     7,408        (813     165   

Less: Net income attributable to participating securities

     (3,365     —          (109
  

 

 

   

 

 

   

 

 

 

Net income (loss) available to common shareholders

   $ 4,043      $ (813   $ 56   
  

 

 

   

 

 

   

 

 

 

Per Share Data:

      

Basic income (loss) per common share(2)

   $ 0.19      $ (0.03   $ —     

Diluted income (loss) per common share(2)

   $ 0.19      $ (0.03   $ —     

Weighted average shares outstanding:

      

Basic shares

     21,539,917        27,954,322        45,964,159   

Diluted shares

     21,539,917        27,954,322        45,965,631   

Unaudited pro forma net income

      

Unaudited pro forma basic income per common share(3)

      

Unaudited pro forma diluted income per common share(3)

      

Unaudited pro forma weighted average shares outstanding:

      

Basic shares

      

Diluted shares

      

Statement of Cash Flows Data:

      

Net cash provided by (used in):

      

Operating activities

   $ 9,227      $ 15,045      $ 46,695   

Investing activities

   $ (7,285   $ (14,883   $ (18,558

Financing activities

   $ (145   $ (445   $ 1,003   

Other Operating and Financial Data:

      

Total stores at end of period

     102        142        192   

Comparable store sales growth

     12.1     15.6     7.9

Average net sales per store(4)

   $ 1,302      $ 1,542      $ 1,658   

Adjusted EBITDA(5)

   $ 11,088      $ 25,798      $ 42,377   

Capital expenditures

   $ 7,285      $ 14,883      $ 18,558   

Adjusted EBITDA Reconciliation:

      

Net income

   $ 11,658     $ 7,023     $ 16,078  

Interest expense (income), net

     73       28       (16

Income tax (benefit) expense

     (4,853 )     4,753       10,159   

Depreciation and amortization

     3,660        4,805        7,071   
  

 

 

   

 

 

   

 

 

 

EBITDA(6)

     10,538        16,609        33,292   

Non-contractual executive bonus expense(7)

                   6,087   

Deferred rents(8)

     232        1,164        1,401   

Non-cash stock-based compensation and warrant expense(9)

     274        2,332        1,246   

Loss on disposal of assets(10)

     5        288        273   

Closed stores(11)

     39        76        78   

Transaction expense(12)

            5,329          
  

 

 

   

 

 

   

 

 

 

Adjusted EBITDA

   $ 11,088      $ 25,798      $ 42,377   
  

 

 

   

 

 

   

 

 

 

 

 

9


Table of Contents

 

(1) Fiscal 2010 includes $5.3 million of expense related to the 2010 Transaction and fiscal 2011 includes $6.1 million of non-contractual executive bonus expense, as described in Note 7 below.
(2) Please see Note 2 to our financial statements, included elsewhere in this prospectus, for an explanation of per share calculations.

 

(3) Pro forma per share data is unaudited and gives effect to: (i) the Financing Transactions, including the payment of the 2012 Dividend described below in “Dividends;” (ii) the conversion of our outstanding shares of Series A 8% convertible preferred stock into shares of common stock in connection with the closing of this offering and (iii) the exercise in full of our outstanding warrants for shares of common stock.

The following is a reconciliation of historical net income to unaudited pro forma net income for fiscal 2011:

 

Net income as reported

   $ 16,078   

Interest expense

  

Pro forma net income

  

Pro forma weighted average shares outstanding:

  

Basic shares

  

Diluted shares

  

 

(4) Only includes stores open during the full fiscal year.
(5) Adjusted EBITDA is defined as EBITDA (as defined below), further adjusted to exclude certain non-cash, non-recurring and other items not related to ongoing performance, such as non-contractual executive bonus expense, deferred rents, non-cash stock-based compensation and warrant expense, loss on disposal of assets, EBITDA for closed stores and expense related to the 2010 Transaction. We have presented Adjusted EBITDA because we believe that the exclusion of these items is appropriate to provide additional information to investors about our ongoing operating performance excluding certain non-cash and other items not related to ongoing performance and as a means to evaluate our period-to-period results. In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. Our presentation of Adjusted EBITDA should not be construed to imply that our future results will be unaffected by any such adjustments. We have provided this information as a means to evaluate the results of our ongoing operations. Other companies in our industry may calculate Adjusted EBITDA differently than we do. Adjusted EBITDA is not a measure of performance under U.S. generally accepted accounting principles, or GAAP, and should not be considered as a substitute for net income prepared in accordance with GAAP. Adjusted EBITDA has similar limitations as an analytical tool to those set forth in Note 6 below related to the use of EBITDA, and you should not consider it in isolation or as substitute for analysis of our results as reported under GAAP. Some of these additional limitations to the use of Adjusted EBITDA are:

 

  Ÿ  

Adjusted EBITDA does not reflect the non-contractual executive bonus expense, deferred rents, non-cash stock-based compensation and warrant expense, loss on disposal of assets, EBITDA for closed stores and expense related to the 2010 Transaction; and

 

  Ÿ  

Adjusted EBITDA does not reflect certain other costs that may recur in future periods.

We compensate for these limitations by relying primarily on our GAAP results and using Adjusted EBITDA only as a supplemental measure.

 

(6) EBITDA represents net income before interest expense (income), income taxes (benefit), depreciation and amortization. We have presented EBITDA because we consider it an important supplemental measure of our performance and believe it is frequently used by analysts, investors and other interested parties in the evaluation of companies in our industry. Management uses EBITDA as a measurement tool for evaluating our actual operating performance compared to budget and prior periods. Other companies in our industry may calculate EBITDA differently than we do. EBITDA is not a measure of performance under GAAP, and should not be considered as a substitute for net income prepared in accordance with GAAP. EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are:

 

  Ÿ  

EBITDA does not reflect our cash expenditures, our future requirements for capital expenditures or contractual commitments;

 

  Ÿ  

EBITDA does not reflect interest expense or the cash requirements necessary to service interest or principal payments on debt;

 

  Ÿ  

EBITDA does not reflect tax expense or the cash requirements necessary to pay tax obligations; and

 

  Ÿ  

Although depreciation and amortization are non-cash charges, the asset being depreciated and amortized will often have to be replaced in the future, and EBITDA does not reflect any cash requirements for such replacements.

 

(7) Represents a non-contractual bonus to certain executive officers for performance in fiscal 2011 and associated tax expense.
(8) Represents the non-cash portion of rent expense.
(9) Represents non-cash stock-based compensation and warrant expense.
(10) Represents asset write-offs for remodeled or closed stores.
(11) Represents the EBITDA, excluding the non-cash portion of rent expense, for stores which management has made the decision to close, from the period in which the decision was made.
(12) Represents expenses incurred in conjunction with the 2010 Transaction, including expenses related to the modification of certain stock options, professional fees and other employee compensation-related expenses.

 

 

10


Table of Contents

The following table represents a summary of our balance sheet data as of January 30, 2010, January 29, 2011 and January 28, 2012. The summary balance sheet data as of January 28, 2012 is presented:

 

   

on an actual basis, derived from our balance sheet as of January 28, 2012;

 

   

on a “pro forma” basis, giving effect to:

 

   

the Financing Transactions, including the payment of the 2012 Dividend;

 

   

the conversion of our outstanding shares of Series A 8% convertible preferred stock into shares of common stock in connection with the closing of this offering; and

 

   

the exercise of our outstanding warrants in full for shares of common stock prior to the closing of this offering.

 

   

on a “pro forma as adjusted” basis, further reflecting: (a) our receipt of the net proceeds from the sale of              shares of common stock by us at an assumed initial public offering price of $         per share, which is the mid-point of the price range set forth on the cover page of this prospectus, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us and (b) the repayment of outstanding indebtedness as described in “Use of Proceeds.” See “Capitalization” and “Use of Proceeds.”

 

    As of     As of January 28, 2012  
    January 30, 2010     January 29, 2011     Actual     Pro
Forma
    Pro Forma As
Adjusted
 
    (in thousands)  

Balance Sheet Data:

         

Cash and cash equivalents

  $    12,436      $ 12,153      $ 41,293      $                   $                

Total current assets

    35,335        45,942        92,249       

Total current liabilities

    10,983        18,215        49,942       

Total long-term debt

           250        250       

Total liabilities

    20,036        33,524        72,431       

Series A 8% convertible preferred stock

           191,855        191,855       

Series A redeemable convertible preferred stock

    18,778                     

Series A-1 redeemable convertible preferred stock

    18,510                     

Total shareholders’ (deficit) equity

    (1,049     (148,797     (129,759    

 

 

11


Table of Contents

RISK FACTORS

An investment in our common stock involves a high degree of risk. You should carefully consider the risks described below, together with all of the other information included in this prospectus, before making an investment decision. If any of the following risks actually occurs, our business, financial condition and results of operations could be materially and adversely affected. In that event, the trading price of our common stock could decline and you could lose all or part of your investment.

Risks Relating to Our Business and Industry

We may not be able to successfully implement our growth strategy on a timely basis or at all, which could harm our growth and results of operations.

Our growth is dependent on our ability to open profitable new stores. We believe we have an opportunity to continue to grow our store base from 192 stores in 16 states at the end of fiscal 2011, to more than 2,000 locations over time.

Our ability to open profitable new stores depends on many factors, including our ability to:

 

   

identify suitable markets and sites for new stores;

 

   

negotiate leases with acceptable terms;

 

   

achieve brand awareness in the new markets;

 

   

efficiently source and distribute additional merchandise;

 

   

maintain adequate distribution capacity, information systems and other operational system capabilities;

 

   

hire, train and retain store management and other qualified personnel; and

 

   

achieve sufficient levels of cash flow and financing to support our expansion.

Unavailability of attractive store locations, delays in the acquisition or opening of new stores, delays or costs resulting from a decrease in commercial development due to capital constraints, difficulties in staffing and operating new store locations or lack of customer acceptance of stores in new market areas may negatively impact our new store growth and the costs or the profitability associated with new stores.

Additionally, some of our new stores may be located in areas where we have little experience or a lack of brand recognition. Those markets may have different competitive conditions, market conditions, consumer tastes and discretionary spending patterns than our existing markets, which may cause these new stores to be less successful than stores in our existing markets. Other new stores may be located in areas where we have existing stores. Although we have experience in these markets, increasing the number of locations in these markets may result in inadvertent over-saturation of markets and temporarily or permanently divert customers and sales from our existing stores, thereby adversely affecting our overall financial performance.

Accordingly, we cannot assure you that we will achieve our planned growth or, even if we are able to grow our store base as planned, that any new stores will perform as planned. If we fail to successfully implement our growth strategy, we will not be able to sustain the rapid growth in sales and profits that we expect, which would likely have an adverse impact on the price of our common stock.

Any disruption in our ability to select, obtain, distribute and market merchandise attractive to customers at prices that allow us to profitably sell such merchandise could impact our business negatively.

We generally have been able to select and obtain sufficient quantities of attractive merchandise at prices that allow us to be profitable. If we are unable to continue to select products that are attractive to our customers, to

 

12


Table of Contents

obtain such products at costs that allow us to sell such products at a profit, or to market such products effectively to consumers, our sales or profitability could be affected adversely. In addition, the success of our business depends in part on our ability to anticipate, identify and respond promptly to evolving trends in demographics and consumer preferences, expectations and needs. If we are unable to quickly respond to developing trends or if the spending patterns or demographics of these markets change, and we do not timely and appropriately respond to such changes, then the demand for our products, which are discretionary, and our market share could be adversely affected. Failure to maintain attractive stores and to timely identify or effectively respond to changing consumer needs, preferences and spending patterns could adversely affect our relationship with customers, the demand for our products and our market share.

Any disruption in the supply or increase in pricing of our merchandise could negatively impact our ability to achieve anticipated operating results. The products we sell are sourced from a wide variety of domestic and international vendors. We have not experienced any difficulty in obtaining sufficient quantities of core merchandise and believe that, if one or more of our current sources of supply become unavailable, we would generally be able to obtain alternative sources without experiencing a substantial disruption of our business. However, such alternative sources could increase our merchandise costs and reduce the quality of our merchandise, and an inability to obtain alternative sources could affect our sales.

A significant majority of our merchandise is manufactured outside the United States, and changes in the prices and flow of these goods for any reason could have an adverse impact on our operations. The United States and other countries have occasionally proposed and enacted protectionist trade legislation, which may result in changes in tariff structures and trade policies and restrictions that could increase the cost or reduce the availability of certain merchandise. Any of these or other measures or events relating to vendors and the countries in which they are located or where our merchandise is manufactured, some or all of which are beyond our control, can negatively impact our operations, increase costs and lower our margins. Such events or circumstances include, but are not limited to:

 

   

political and economic instability;

 

   

the financial instability and labor problems of vendors;

 

   

the availability and cost of raw materials;

 

   

merchandise quality or safety issues;

 

   

changes in currency exchange rates;

 

   

inflation; and

 

   

transportation availability and cost.

These and other factors affecting our vendors and our access to products could affect our financial performance adversely.

Our new store growth is dependent upon our ability to successfully expand our distribution network capacity, and failure to achieve or sustain these plans could affect our performance adversely.

We maintain a distribution center in New Castle, Delaware and we plan to open a new distribution center in the southern United States during fiscal 2013 to support our growth objectives. Delays in opening this new distribution center (or new distribution centers in the future) could adversely affect our future operations by slowing store growth, which could in turn reduce sales growth. In addition, any distribution-related construction or expansion projects entail risks which could cause delays and cost overruns, such as: shortages of materials; shortages of skilled labor or work stoppages; unforeseen construction, scheduling, engineering, environmental or geological problems; weather interference; fires or other casualty losses; and unanticipated cost increases. The completion date and ultimate cost of future projects, including the distribution center planned for fiscal 2013, could differ significantly from initial expectations due to construction-related or other reasons. We cannot guarantee that any project will be completed on time or within established budgets.

 

13


Table of Contents

A significant disruption to our distribution network or to the timely receipt of inventory could adversely impact sales or increase our transportation costs, which would decrease our profits.

We currently rely primarily on our distribution center in New Castle, Delaware to distribute our products. Because most of our products are distributed from this center, the loss of our distribution center, due to natural disaster or otherwise, would materially affect our operations. We also rely upon independent third-party transportation to provide goods to our stores in a timely and cost-effective manner, through deliveries to our distribution center from vendors and then from the distribution center or direct ship vendors to our stores. Our use of outside delivery services for shipments is subject to risks outside of our control and any disruption, unanticipated expense or operational failure related to this process could affect store operations negatively. For example, unexpected delivery delays or increases in transportation costs (including through increased fuel costs or a decrease in transportation capacity for overseas shipments) could significantly decrease our ability to generate sales and earn profits. In addition, labor shortages or work stoppages in the transportation industry or long-term disruptions to the national and international transportation infrastructure that lead to delays or interruptions of deliveries could negatively affect our business. If we change shipping companies, we could face logistical difficulties that could adversely impact deliveries and we would incur costs and expend resources in connection with such change. Moreover, we may not be able to obtain terms as favorable as those received from the independent third-party transportation providers we currently use, which would increase our costs.

Inability to attract and retain qualified employees, particularly district, store and distribution center managers, and to control labor costs, as well as other labor issues, could adversely affect our business.

Our growth could be adversely impacted by our inability to attract, retain and motivate qualified employees at the store operations level, in distribution facilities, and at the corporate level, at costs which allow us to profitably conduct our operations. Our ability to meet our labor needs, while controlling our labor costs, is subject to many external factors, including competition for and availability of qualified personnel in a given market, unemployment levels within those markets, prevailing wage rates, minimum wage laws, health and other insurance costs, and changes in employment and labor laws (including changes in the process for our employees to join a union) or other workplace regulation. To the extent a significant portion of our employee base unionizes, or attempts to unionize, our labor costs could increase. In addition, we believe the current pricing of our healthcare costs includes the potential future impact of recently enacted comprehensive healthcare reform legislation, but such legislation may further cause our healthcare costs to increase. While significant costs of the healthcare reform legislation may occur after 2013 due to provisions of the legislation being phased in over time, changes to our healthcare costs structure could have a significant negative effect on our business. In addition, our ability to pass along any increase in labor costs to our customers is constrained by our low price model.

Our growth from existing stores is dependent upon our ability to increase sales and improve the efficiencies, costs and effectiveness of our operations, and failure to achieve or sustain these plans could affect our performance adversely.

Increases in sales in existing stores are dependent on factors such as competition, merchandise selection, store operations and customer satisfaction. If we fail to realize our goals of successfully managing our store operations and increasing our customer retention and recruitment levels, our sales may not increase and our growth may be impacted adversely.

Our success depends on our executive officers and other key personnel. If we lose our executive officers or any other key personnel, or are unable to hire additional qualified personnel, our business could be harmed.

Our future success depends to a significant degree on the skills, experience and efforts of our executive officers and other key personnel, including Messrs. Schlessinger and Vellios, our founders. The loss of the services of any of our executive officers or other key personnel could have an adverse effect on our operations. Absent the consent of the lenders under our revolving credit facility, the loss of the services of both Messrs.

 

14


Table of Contents

Schlessinger and Vellios would render our revolving credit facility unavailable. Our future success will also depend on our ability to attract, retain and motivate qualified personnel, as a failure to attract these key personnel could have an adverse effect on our operations. We do not currently maintain key person life insurance policies with respect to our executive officers or key personnel.

Our cash flows from operations may be negatively affected if we are not successful in managing our inventory balances and inventory shrinkage.

Our inventory balance represented approximately 29% of our total assets as of January 28, 2012. Efficient inventory management is a key component of our business success and profitability. To be successful, we must maintain sufficient inventory levels to meet our customers’ demands without allowing those levels to increase to such an extent that the costs to store and hold the goods unduly impacts our financial results. If our buying decisions do not accurately predict customer trends or purchasing actions, we may have to take unanticipated markdowns to dispose of excess inventory, which also can adversely impact our financial results. We also experience inventory shrinkage, and we cannot assure you that incidences of inventory loss and theft will stay at acceptable levels or decrease in the future, or that the measures we are taking will effectively address the problem of inventory shrinkage. We continue to focus on ways to reduce these risks, but we cannot assure you that we will be successful in our inventory management. If we are not successful in managing our inventory balances, our cash flows from operations may be negatively affected.

Our business requires that we lease substantial amounts of space and there can be no assurance that we will be able to continue to lease space on terms as favorable as the leases negotiated in the past.

We do not own any real estate. Instead, we lease all of our store locations, as well as our corporate headquarters and distribution facility in New Castle, Delaware. Our stores are leased from third parties, with typical initial lease terms of five to ten years. Many of our lease agreements also have additional five-year renewal options. We believe that we have been able to negotiate favorable rental rates and tenant allowances over the last few years due in large part to the state of the economy and higher than usual vacancy rates in shopping centers and regional malls. These trends may not continue, and there is no guarantee that we will be able to continue to negotiate such favorable terms. Many of our lease agreements have defined escalating rent provisions over the initial term and any extensions. Increases in our occupancy costs and difficulty in identifying economically suitable new store locations could have significant negative consequences, which include:

 

   

requiring that a greater portion of our available cash be applied to pay our rental obligations, thus reducing cash available for other purposes and reducing our profitability;

 

   

increasing our vulnerability to general adverse economic and industry conditions; and

 

   

limiting our flexibility in planning for, or reacting to changes in, our business or in the industry in which we compete.

We depend on cash flow from operations to pay our lease expenses and to fulfill our other cash needs. If our business does not generate sufficient cash flow from operating activities to fund these expenses and needs and sufficient funds are not otherwise available to us, we may not be able to service our lease expenses, grow our business, respond to competitive challenges or fund our other liquidity and capital needs, which could harm our business. Additional sites that we lease may be subject to long-term non-cancelable leases if we are unable to negotiate our current standard lease terms. If an existing or future store is not profitable, and we decide to close it, we may nonetheless be committed to perform our obligations under the applicable lease including, among other things, paying the base rent for the balance of the lease term. Moreover, even if a lease has an early cancellation clause, we may not satisfy the contractual requirements for early cancellation under that lease. In addition, if we are not able to enter into new leases or renew existing leases on terms acceptable to us, this could have an adverse effect on our results of operations.

 

15


Table of Contents

We operate in a competitive environment and, as a result, we may not be able to compete effectively or maintain or increase our sales, market shares or margins.

We operate in a highly competitive retail environment with numerous competitors, some of which have greater resources or better brand recognition than we do. We compete with respect to customers, price, store location, merchandise quality, assortment and presentation, in-stock consistency, customer service and employees. This competitive environment subjects us to various risks, including the ability to provide quality, trend-right merchandise to our customers at competitive prices that allow us to maintain our profitability. Because of our low price model, we may have limited ability to increase prices in response to increased costs without losing competitive position which may adversely affect our margins and financial performance. In addition, price reductions by our competitors may result in the reduction of our prices and a corresponding reduction in our profitability.

Consolidation among retailers, changes in pricing of merchandise or offerings of other services by competitors could have a negative impact on the relative attractiveness of our stores to consumers. We do not possess exclusive rights to many of the elements that comprise our in-store experience and product offerings. Our competitors may seek to copy our business strategy and in-store experience, which could result in a reduction of any competitive advantage or special appeal that we might possess. In addition, most of our products are sold to us on a non-exclusive basis. As a result, our current and future competitors may be able to duplicate or improve on some or all of our in-store experience or product offerings that we believe are important in differentiating our stores and our customers’ shopping experience. If our competitors were to duplicate or improve on some or all of our in-store experience or product offerings, our competitive position and our business could suffer. Our ability to provide quality, trend-right products while offering attractive, competitively-priced products could be impacted by various actions of our competitors that are beyond our control.

Our profitability is vulnerable to inflation, cost increases and energy prices.

Future increases in costs such as the cost of merchandise, shipping rates, freight costs, fuel costs and store occupancy costs may reduce our profitability, particularly given our $5 and below pricing model. These cost increases may be the result of inflationary pressures that could further reduce our sales or profitability. Increases in other operating costs, including changes in energy prices, wage rates and lease and utility costs, may increase our cost of goods sold or operating expenses. Our low price model and competitive pressures in our industry may have the effect of inhibiting our ability to reflect these increased costs in the prices of our products and therefore reduce our profitability.

Our business is seasonal, and adverse events during the holiday season could impact our operating results negatively.

Our business is seasonal, with the highest percentage of sales (approximately 42% of total annual sales over the last two fiscal years) occurring during the last fiscal quarter (November, December and January), which includes the holiday season. We purchase substantial amounts of inventory in the end of the third quarter (October) and beginning of the fourth quarter (November and December) and incur higher shipping costs and higher payroll costs in anticipation of the increased sales activity during these time periods. Adverse events, such as deteriorating economic conditions, higher unemployment, higher gas prices, public transportation disruptions or unusual weather could result in lower-than-planned sales during the holiday season which may lead to unanticipated markdowns. Since we rely on third parties for transportation and use third party warehouses when we build up inventory, a number of these factors are outside of our control. An unsuccessful fourth quarter, or holiday season, will have a substantial negative impact on our financial condition and results of operations for the entire fiscal year.

 

16


Table of Contents

Material damage to, or interruptions to, our technology systems as a result of external factors, staffing shortages and difficulties in updating our existing technology or developing or implementing new technology could have a material adverse effect on our business or results of operations.

We depend on a variety of information technology systems for the efficient functioning of our business. Such systems are subject to damage or interruption from power outages, computer and telecommunications failures, computer viruses, security breaches and natural disasters. Damage or interruption to these systems may require a significant investment to fix or replace them, and we may suffer interruptions in our operations in the interim. Any material interruptions may have a material adverse effect on our business or results of operations.

We also rely heavily on our information technology staff. Failure to meet these staffing needs may negatively affect our ability to fulfill our technology initiatives while continuing to provide maintenance on existing systems. We rely on certain vendors to maintain and periodically upgrade many of these systems so that they can continue to support our business. The software programs supporting many of our systems were licensed to us by independent software developers. The inability of these developers or us to continue to maintain and upgrade these information systems and software programs would disrupt or reduce the efficiency of our operations if we are unable to convert to alternate systems in an efficient and timely manner. In addition, costs and potential problems and interruptions associated with the implementation of new or upgraded systems and technology, or with maintenance or adequate support of existing systems could also disrupt or reduce the efficiency of our operations.

Failure to maintain adequate financial and management processes and controls could lead to errors in our financial reporting, which could harm our business and cause a decline in our stock price.

Reporting obligations as a public company and our anticipated growth are likely to place a considerable strain on our financial and management systems, processes and controls, as well as on our personnel. In addition, as a public company, in the future we will be required to document and test our internal controls over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act of 2002 so that our management can certify the effectiveness of our internal controls and our independent registered public accounting firm can render an opinion on the effectiveness of our internal control over financial reporting. As a result, we may be required to incur substantial expenses to test our systems, to make any necessary improvements, and to hire additional personnel. If our management is unable to certify the effectiveness of our internal controls or if our independent registered public accounting firm cannot render an opinion on the effectiveness of our internal control over financial reporting, or if material weaknesses in our internal controls are identified, we could be subject to regulatory scrutiny and a loss of public confidence, which could harm our business and cause a decline in our stock price. In addition, if we do not maintain adequate financial and management personnel, processes and controls, we may not be able to accurately report our financial performance on a timely basis, which could cause a decline in our stock price and harm our ability to raise capital. Failure to accurately report our financial performance on a timely basis could also jeopardize our continued listing on The NASDAQ Global Select Market or any other stock exchange on which our common stock may be listed. Delisting of our common stock on any exchange could reduce the liquidity of the market for our common stock, which could reduce the price of our stock and increase the volatility of our stock price.

Our ability to obtain additional financing on favorable terms, if needed, could be adversely affected by volatility in the capital markets.

We obtain and manage liquidity from the positive cash flow we generate from our operating activities, our access to capital markets and our revolving credit facility. There is no assurance that our ability to obtain additional financing from financial institutions or through the capital markets, if needed, will not be adversely impacted by economic conditions. Tightening in the credit markets, low liquidity and volatility in the capital markets could result in diminished availability of credit, higher cost of borrowing and lack of confidence in the equity market, making it more difficult to obtain additional financing on terms that are favorable to us.

 

17


Table of Contents

If we are unable to secure our customers’ confidential or credit card information, or other private data relating to our employees or our Company, we could be subject to negative publicity, costly government enforcement actions or private litigation, which could damage our business reputation and adversely affect our financial results.

The protection of our customer, employee and company data is critical to us. We have procedures and technology in place to safeguard our customers’ debit and credit card, and other personal information, our employees’ private data and company records and intellectual property. However, if we experience a data security breach of any kind, we could be exposed to negative publicity, government enforcement actions, private litigation or costly response measures. In addition, our reputation within the business community and with our customers may be affected, which could result in our customers discontinuing the use of debit or credit cards in our stores, or not shopping in our stores altogether. This could cause us to lose market share to our competitors and could have an adverse effect on our financial results.

We are exposed to the risk of natural disasters, unusual weather conditions, pandemic outbreaks, global political events, war and terrorism that could disrupt business and result in lower sales, increased operating costs and capital expenditures.

Our headquarters, store locations and distribution center, as well as certain of our vendors and customers, are located in areas which have been and could be subject to natural disasters such as floods, hurricanes, tornadoes, fires or earthquakes. Adverse weather conditions or other extreme changes in the weather, including resulting electrical and technological failures, may disrupt our business and may adversely affect our ability to sell and distribute products. In addition, we operate in markets that may be susceptible to pandemic outbreaks, war, terrorist acts or disruptive global political events, such as civil unrest in countries from which our vendors are located or products are manufactured. Our business may be harmed if our ability to sell and distribute products is impacted by any such events, any of which could influence customer trends and purchases and may negatively impact our net sales, properties or operations. Such events could result in physical damage to one or more of our properties, the temporary closure of some or all of our stores or distribution center, the temporary lack of an adequate work force in a market, temporary or long-term disruption in the transport of goods, delay in the delivery of goods to our distribution center or stores, disruption of our technology support or information systems, or fuel shortages or dramatic increases in fuel prices, which increase the cost of doing business. These events also can have indirect consequences such as increases in the costs of insurance if they result in significant loss of property or other insurable damage. Any of these factors, or combination thereof, could adversely affect our operations.

Current economic conditions and other economic factors could adversely impact our financial performance and other aspects of our business in various respects.

A delayed recovery in the U.S. economy or other economic factors affecting disposable consumer income, such as employment levels, inflation, business conditions, fuel and energy costs, consumer debt levels, lack of available credit, interest rates, tax rates and further erosion in consumer confidence may affect our business adversely. Such factors could reduce overall consumer spending or cause customers to shift their spending to products other than those sold by us or to products sold by us that are less profitable than other product choices, all of which could result in lower net sales, decreases in inventory turnover or a reduction in profitability due to lower margins. We have limited or no ability to control many of these factors. The current global economic uncertainty, the impact of recessions and the potential for failures or realignments of financial institutions and the related impact on available credit may impact us, our vendors and other business partners, our landlords, our customers, our service providers and our operations in an adverse manner.

 

18


Table of Contents

Changes in state or federal legislation or regulations, including the effects of legislation and regulations on product and food safety and quality, wage levels, employee rights, health care, social welfare and entitlement programs could increase our cost of doing business.

Our business is subject to numerous federal, state and local laws and regulations. We routinely incur costs in complying with these laws and regulations. We are exposed to the risk that federal, state or local legislation may negatively impact our operations. Changes in product and food safety and quality (including changes in labeling or disclosure requirements), federal or state wage requirements, employee rights (including changes in the process for our employees to join a union), health care, social welfare or entitlement programs such as health insurance, paid leave programs, or other changes in workplace regulation or tax laws could adversely impact our ability to achieve our financial targets. Changes in other regulatory areas, such as consumer credit, privacy and information security, or environmental regulation may result in significant added expenses or may require extensive system and operating changes that may be difficult to implement and/or could materially increase our costs of doing business. Untimely compliance or noncompliance with applicable laws and regulations may subject us to legal risk, including government enforcement action, significant fines and penalties and class action litigation, as well as reputational damage, which could adversely affect our results of operations.

Litigation may adversely affect our business, financial condition, results of operations or liquidity.

Our business is subject to the risk of litigation by employees, consumers, vendors, competitors, intellectual property rights holders, shareholders, government agencies and others through private actions, class actions, administrative proceedings, regulatory actions or other litigation. The outcome of litigation, particularly class action lawsuits, regulatory actions and intellectual property claims, is difficult to assess or quantify. Plaintiffs in these types of lawsuits may seek recovery of very large or indeterminate amounts, and the magnitude of the potential loss relating to these lawsuits may remain unknown for substantial periods of time. In addition, certain of these lawsuits, if decided adversely to us or settled by us, may result in liability material to our financial statements as a whole or may negatively affect our operating results if changes to our business operation are required. The cost to defend future litigation may be significant. There also may be adverse publicity associated with litigation that could negatively affect customer perception of our business, regardless of whether the allegations are valid or whether we are ultimately found liable. As a result, litigation may adversely affect our business, financial condition, results of operations or liquidity.

If we fail to protect our brand name, competitors may adopt trade names that dilute the value of our brand name.

We may be unable or unwilling to strictly enforce our trademarks in each jurisdiction in which we do business. Also, we may not always be able to successfully enforce our trademarks against competitors, or against challenges by others. Our failure to successfully protect our trademarks could diminish the value and efficacy of our brand recognition and could cause customer confusion, which could, in turn, adversely affect our sales and profitability.

Our management has limited experience managing a public company and our current resources may not be sufficient to fulfill our public company obligations.

Following the closing of this offering, we will be subject to various regulatory requirements, including those of the SEC and The NASDAQ Stock Market LLC. These requirements include record keeping, financial reporting and corporate governance rules and regulations. Our management team has limited experience in managing a public company and, historically, has not had the resources typically found in a public company. Our internal infrastructure may not be adequate to support our increased reporting obligations and we may be unable to hire, train or retain necessary staff and may be reliant on engaging outside consultants or professionals to overcome our lack of experience or employees. Our business could be adversely affected if our internal infrastructure is inadequate, we are unable to engage outside consultants or are otherwise unable to fulfill our public company obligations.

 

19


Table of Contents

Product and food safety claims and the effects of legislation and regulations on product and food safety and quality could affect our sales and results of operations adversely.

We may be subject to product liability claims from customers or actions required or penalties assessed by government agencies relating to products, including food products that are recalled, defective or otherwise alleged to be harmful. Such claims may result from tampering by unauthorized third parties, product contamination or spoilage, including the presence of foreign objects, substances, chemicals, other agents, or residues introduced during the growing, storage, handling and transportation phases. All of our vendors and their products are contractually required to comply with applicable product and food safety laws. We generally seek contractual indemnification and insurance coverage from our vendors. However, if we do not have adequate contractual indemnification and/or insurance available, such claims could have a material adverse effect on our business, financial condition and results of operations. Our ability to obtain indemnification from foreign vendors may be hindered by the manufacturers’ lack of understanding of U.S. product liability or other laws, which may make it more likely that we be required to respond to claims or complaints from customers as if we were the manufacturer of the products. Even with adequate insurance and indemnification, such claims could significantly damage our reputation and consumer confidence in our products. Our litigation expenses could increase as well, which also could have a materially negative impact on our results of operations even if a product liability claim is unsuccessful or is not fully pursued.

We purchase a portion of our products on a closeout basis. Some of these products are obtained through brokers or intermediaries rather than through manufacturers. The closeout nature of a portion of our products sometimes makes it more difficult for us to investigate all aspects of these products. We attempt to assure compliance and to test products when appropriate, and we seek to obtain indemnification through our vendors or to be listed as an additional insured, but there is no assurance that these efforts will be successful.

We will incur significant expenses as a result of being a public company, which will negatively impact our financial performance and could cause our results of operations and financial condition to suffer.

We will incur significant legal, accounting, insurance, compliance and other expenses as a result of being a public company. After this offering, we will become obligated to file annual and quarterly information and other reports with the SEC. In addition, we will also become subject to other reporting and corporate governance requirements which will impose significant compliance obligations upon us. The Sarbanes-Oxley Act of 2002, together with related rules implemented by the SEC and by The NASDAQ Stock Market LLC, have required changes in corporate governance practices of public companies. We expect that compliance with these laws, rules and regulations, including compliance with Section 404 of the Sarbanes-Oxley Act as discussed in “—Failure to maintain adequate financial and management processes and controls could lead to errors in our financial reporting, which could harm our business and cause a decline in our stock price” above, will substantially increase our expenses, including our legal and accounting costs, and make some activities more time-consuming and costly. We also expect these laws, rules and regulations to make it more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. As a result, it may be more difficult for us to attract and retain qualified persons to serve on our board of directors or as officers. As a result of the foregoing, we expect a substantial increase in legal, accounting and insurance compliance and certain other expenses in the future, which will negatively impact our financial performance and could cause our results of operations and financial condition to suffer.

The terms of our new term loan facility and our revolving credit facility may restrict our current and future operations, which could adversely affect our ability to respond to changes in our business and to manage our operations.

Our term loan facility and our revolving credit facility contain, and any additional debt financing we may incur would likely contain, covenants requiring us to maintain or adhere to certain financial ratios or limits and covenants that restrict our operations, which may include limitations on our ability to, among other things:

 

   

incur additional indebtedness;

 

20


Table of Contents
   

pay dividends and make certain distributions, investments and other restricted payments;

 

   

create certain liens or encumbrances;

 

   

enter into transactions with our affiliates;

 

   

redeem our common stock; and

 

   

engage in certain merger, consolidation or asset sale transactions.

Complying with these covenants could adversely affect our ability to respond to changes in our business and manage our operations. In addition, these covenants could affect our ability to invest capital in our new stores and fund capital expenditures for existing stores, including the costs associated with the conversion of certain stores existing before fiscal 2009 to our current prototype size. Our ability to comply with these covenants and other provisions in the term loan facility, the revolving credit facility and any future debt instruments may be affected by changes in our operating and financial performance, changes in general business and economic conditions, adverse regulatory developments, or other events beyond our control. A failure by us to comply with the financial ratios and restrictive covenants contained in our term loan facility, revolving credit facility and any future debt instruments could result in an event of default. Upon the occurrence of an event of default, the lenders could elect to declare all amounts outstanding to be due and payable and exercise other remedies as set forth in our term loan facility, revolving credit facility and any future debt instruments. In addition, if we are in default, we may be unable to borrow additional amounts under any such facilities to the extent that they would otherwise be available and our ability to obtain future financing may also be impacted negatively. If the indebtedness under our term loan facility, revolving credit facility and any future debt instruments were to be accelerated, our future financial condition could be materially adversely affected.

Risks Related to This Offering and Ownership of Our Common Stock

Our stock price may be volatile or may decline regardless of our operating performance, and you may not be able to resell your shares at or above the initial public offering price.

After this offering, the market price for our common stock is likely to be volatile, in part because our shares have not been traded publicly. In addition, broad market and industry factors, most of which we cannot control, may harm the price of our common stock, regardless of our actual operating performance. Factors that could cause fluctuation in the price of our common stock may include, among other things:

 

   

actual or anticipated fluctuations in quarterly operating results or other operating metrics, such as comparable store sales, that may be used by the investment community;

 

   

changes in financial estimates by us or by any securities analysts who might cover our stock;

 

   

speculation about our business in the press or the investment community;

 

   

conditions or trends affecting our industry or the economy generally;

 

   

stock market price and volume fluctuations of other publicly traded companies and, in particular, those that are in the retail industry;

 

   

announcements by us or our competitors of new product offerings, significant acquisitions, strategic partnerships or divestitures;

 

   

our entry into new markets;

 

   

timing of new store openings;

 

   

percentage of sales from new stores versus established stores;

 

   

additions or departures of key personnel;

 

21


Table of Contents
   

actual or anticipated sales of our common stock, including sales by our directors, officers or significant shareholders;

 

   

significant developments relating to our relationships with business partners, vendors and distributors;

 

   

customer purchases of new products from us and our competitors;

 

   

investor perceptions of the retail industry in general and our Company in particular;

 

   

major catastrophic events;

 

   

volatility in our stock price, which may lead to higher stock-based compensation expense under applicable accounting standards; and

 

   

changes in accounting standards, policies, guidance, interpretation or principles.

In the past, securities class action litigation has often been instituted against companies following periods of volatility in their stock price. This type of litigation, even if it does not result in liability for us, could result in substantial costs to us and divert management’s attention and resources.

Future sales of our common stock, or the perception in the public markets that these sales may occur, may depress our stock price.

The market price of our common stock could decline significantly as a result of sales of a large number of shares of our common stock in the market after this offering. The sales, or the perception that these sales might occur, could depress the market price of our common stock. These sales, or the possibility that these sales may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate.

Upon the closing of this offering, we will have              shares of common stock outstanding. The shares of common stock offered in this offering will be freely tradable without restriction under the Securities Act of 1933, as amended, or the Securities Act, except for any shares of common stock that may be held or acquired by our directors, executive officers and other affiliates, as that term is defined in the Securities Act, which will be restricted securities under the Securities Act. Restricted securities may not be sold in the public market unless the sale is registered under the Securities Act or an exemption from registration is available. In addition, pursuant to our amended and restated investor rights agreement that will be in effect upon the closing of this offering, certain of our investors will have rights to require us to file registration statements registering additional sales of shares of common stock or to include sales of such shares of common stock in registration statements that we may file for ourselves or other shareholders. In order to exercise these registration rights, these shareholders must satisfy certain conditions. Subject to compliance with applicable lock-up restrictions, shares of common stock sold under these registration statements can be freely sold in the public market. In the event such registration rights are exercised and a large number of shares of common stock are sold in the public market, such sales could reduce the trading price of our common stock. These sales also could impede our ability to raise future capital. Additionally, we will bear all expenses in connection with any such registrations (other than stock transfer taxes and underwriting discounts or commissions). See “Certain Relationships and Related Party Transactions—Amended and Restated Investor Rights Agreement.”

We and the holders of substantially all of our common stock outstanding on the date of this prospectus, including each of our executive officers, directors and selling shareholders, have agreed with the underwriters, that for a period of 180 days after the date of this prospectus, we or they will not offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale, or otherwise dispose of or hedge any shares of our common stock, or any options or warrants to purchase any shares of our common stock or any securities convertible into or exchangeable for shares of common stock, subject specified exceptions. The representatives of the underwriters may, in their discretion, at any time without prior notice, release all or any portion of the shares from the restrictions in any such agreement. See “Underwriting” for more information. Substantially all of

 

22


Table of Contents

our shares of common stock outstanding as of the date of this prospectus may be sold in the public market by existing shareholders 90 days after the date of this prospectus, subject to the lock-up agreement and applicable volume and other limitations imposed under federal securities laws. See “Shares Eligible for Future Sale” for a more detailed description of the restrictions on selling shares of our common stock after this offering. Sales by our existing shareholders of a substantial number of shares in the public market, or the perception that these sales might occur, could cause the market price of our common stock to decrease significantly.

In the future, we may also issue our securities in connection with investments or acquisitions. The number of shares of our common stock issued in connection with an investment or acquisition could constitute a material portion of our then-outstanding shares of our common stock. Any issuance of additional securities in connection with investments or acquisitions may result in additional dilution to you.

Insiders will continue to have substantial control over us after this offering, which could limit your ability to influence the outcome of key transactions, including a change of control.

Upon the closing of this offering, funds managed by Advent will control an aggregate of     % of the voting power of our outstanding common stock or     % if the underwriters exercise in full their option to purchase additional shares in this offering. As a result, Advent would be able to influence or control matters requiring approval by our shareholders, including the election of directors and the approval of mergers, acquisitions and other extraordinary transactions. It may also have interests that differ from yours and may vote in a way with which you disagree and which may be adverse to your interests. This concentration of ownership may have the effect of delaying, preventing or deterring a change of control of Five Below, could deprive our shareholders of an opportunity to receive a premium for their common stock as part of a sale of Five Below and might ultimately affect the market price of our common stock.

If you purchase shares of our common stock in this offering, you will experience substantial and immediate dilution.

If you purchase shares of our common stock in this offering, you will experience substantial and immediate dilution in the amount of $         per share, because the initial public offering price of $         per share is substantially greater than the net tangible book value per share of our outstanding common stock. This dilution is due in large part to the fact that our earlier investors paid substantially less than the initial public offering price when they purchased their shares of our capital stock and have received or will receive substantial dividends on their shares of capital stock. In addition, you may also experience additional dilution upon future equity issuances on the exercise of stock options to purchase common stock granted to our directors, management personnel and consultants under our equity incentive plan. See “Dilution.”

We do not expect to pay any cash dividends for the foreseeable future.

For the foreseeable future, we intend to retain any earnings to finance the development and expansion of our business, and we do not anticipate paying any cash dividends on our common stock. Any determination to pay dividends in the future will be at the discretion of our board of directors and will depend upon results of operations, financial condition, contractual restrictions, including under agreements for indebtedness we may incur, restrictions imposed by applicable law and other factors our board of directors deems relevant. Accordingly, if you purchase shares in this offering, realization of a gain on your investment will depend on the appreciation of the price of our common stock, which may never occur. Investors seeking cash dividends in the foreseeable future should not purchase our common stock.

If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline.

The trading market for our common stock will be influenced by the research and reports that industry or securities analysts publish about us or our business. We do not currently have and may never obtain research

 

23


Table of Contents

coverage by securities and industry analysts. If no securities or industry analysts commence coverage of us, the trading price for our common stock would be negatively impacted. If we obtain securities or industry analyst coverage and if one or more of these analysts ceases coverage of our Company or fails to publish reports on us regularly, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline. Moreover, if our operating results do not meet the expectations of the investor community, or one or more of the analysts who cover our Company downgrades our stock, our stock price could decline.

We will have broad discretion over the use of proceeds from this offering.

We intend to use the net proceeds to us from this offering to pay offering-related expenses and to repay a portion of outstanding indebtedness under our new term loan facility. We intend to use the remaining proceeds (if any) as determined by our management in its sole discretion, for general corporate purposes, including working capital and capital expenditures. However, we have not determined the specific allocation of the net proceeds among those additional uses. We will have broad discretion over the use of the net proceeds to us from this offering, and you will be relying on the judgment of our board of directors and management regarding the application of these proceeds. It is possible that a substantial portion of the net proceeds will be invested in a way that does not yield a favorable, or any, return for us.

No market currently exists for our common stock and we cannot assure you that an active market will develop for such stock.

Prior to this offering, there has been no public market for our common stock. The initial public offering price for our common stock will be determined through negotiations among us, the qualified independent underwriter and the representatives of the underwriters and may not be indicative of the market price of our common stock after this offering or to any other established criteria of the value of our business. If you purchase shares of our common stock, you may not be able to resell those shares at or above the initial public offering price. We cannot predict the extent to which investor interest in us will lead to the development of an active trading market on The NASDAQ Global Select Market or otherwise or how liquid that market might become. An active public market for our common stock may not develop or be sustained after the offering. If an active public market does not develop or is not sustained, it may be difficult for you to sell your shares of common stock at a price that is attractive to you or at all.

Anti-takeover provisions could delay and discourage takeover attempts that shareholders may consider to be favorable.

Certain provisions of our amended and restated articles of incorporation and amended bylaws that will be in effect upon the closing of this offering and applicable provisions of Pennsylvania law may make it more difficult or impossible for a third party to acquire control of us or effect a change in our board of directors and management.

In particular, these provisions, among other things:

 

   

provide that only the chairman of the board of directors, the chief executive officer or a majority of the board of directors may call special meetings of the shareholders;

 

   

classify our board of directors into three separate classes with staggered terms;

 

   

provide for supermajority approval requirements for amending or repealing provisions in our amended and restated articles of incorporation and amended bylaws;

 

   

establish certain advance notice procedures for nominations of candidates for election as directors and for shareholder proposals to be considered at shareholders’ meetings; and

 

   

permit the board of directors, without further action of the shareholders, to issue and fix the terms of preferred stock, which may have rights senior to those of the common stock.

 

24


Table of Contents

In addition, anti-takeover provisions in Pennsylvania law could make it more difficult for a third party to acquire control of us. These provisions could adversely affect the market price of our common stock and could reduce the amount that shareholders might receive if we are sold. For example, Pennsylvania law may restrict a third party’s ability to obtain control of us and may prevent shareholders from receiving a premium for their shares of our common stock. Pennsylvania law also provides that our shareholders are not entitled by statute to propose amendments to our articles of incorporation.

These and other provisions of Pennsylvania law and our amended and restated articles of incorporation and amended bylaws could delay, defer or prevent us from experiencing a change of control or changes in our board of directors and management and may adversely affect our shareholders’ voting and other rights. Any delay or prevention of a change of control transaction or changes in our board of directors and management could deter potential acquirors or prevent the completion of a transaction in which our shareholders could receive a substantial premium over the then current market price for their shares of our common stock.

 

25


Table of Contents

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

Some of the statements contained in this prospectus constitute forward-looking statements, including in the sections captioned “Prospectus Summary,” “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Business.” Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts, such as statements regarding our future financial condition or results of operations, our prospects and strategies for future growth, the introduction of new merchandise, and the implementation of our marketing and branding strategies. In many cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or the negative of these terms or other comparable terminology.

The forward-looking statements contained in this prospectus reflect our views as of the date of this prospectus about future events and are subject to risks, uncertainties, assumptions and changes in circumstances that may cause events or our actual activities or results to differ significantly from those expressed in any forward-looking statement. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future events, results, actions, levels of activity, performance or achievements. A number of important factors could cause actual results to differ materially from those indicated by the forward-looking statements, including, but not limited to, those factors described in “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” These factors include without limitation:

 

  Ÿ  

failure to successfully implement our growth strategy;

 

  Ÿ  

disruptions in our ability to select, obtain, distribute and market merchandise profitably;

 

  Ÿ  

our ability to successfully expand our distribution network capacity;

 

  Ÿ  

disruptions to our distribution network or the timely receipt of inventory;

 

  Ÿ  

inability to attract and retain qualified employees;

 

  Ÿ  

ability to increase sales and improve the efficiencies, costs and effectiveness of our operations;

 

  Ÿ  

our dependence on our executive officers and other key personnel or our inability to hire additional qualified personnel;

 

  Ÿ  

our ability to successfully manage our inventory balances and inventory shrinkage;

 

  Ÿ  

our lease obligations;

 

  Ÿ  

changes in our competitive environment, including increased competition from other retailers;

 

  Ÿ  

increasing costs due to inflation, increased operating costs or energy prices;

 

  Ÿ  

the seasonality of our business;

 

  Ÿ  

disruptions to our information technology systems in the ordinary course or as a result of system upgrades;

 

  Ÿ  

our failure to maintain adequate internal controls;

 

  Ÿ  

our ability to obtain additional financing;

 

  Ÿ  

failure to secure customers’ confidential or credit card information, or other private data relating to our employees or our company;

 

  Ÿ  

natural disasters, unusual weather conditions, pandemic outbreaks, global political events, war and terrorism;

 

  Ÿ  

current economic conditions and other economic factors;

 

26


Table of Contents
  Ÿ  

the impact of governmental laws and regulations and the outcomes of legal proceedings;

 

  Ÿ  

our inability to protect our brand name, trademarks and other intellectual property rights;

 

  Ÿ  

increased costs as a result of being a public company; and

 

  Ÿ  

restrictions imposed by our indebtedness on our current and future operations.

Readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on these forward-looking statements. All of the forward-looking statements we have included in this prospectus are based on information available to us on the date of this prospectus. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as otherwise required by law.

 

27


Table of Contents

USE OF PROCEEDS

We estimate that we will receive net proceeds from the sale of our common stock in this offering of approximately $         million based upon an assumed initial public offering price of $         per share (the midpoint of the price range set forth on the cover of this prospectus) and after deducting estimated underwriting discount, commissions and offering expenses payable by us. We will not receive any proceeds from the sale of shares of our common stock by the selling shareholders, which includes certain of our officers, directors and affiliates, including any shares sold by the selling shareholders in connection with the exercise of the underwriters’ option to purchase additional shares. A $1.00 increase or decrease in the assumed initial public offering price of $         per share would increase or decrease the net proceeds to us from this offering by approximately $         million, assuming the number of shares offered by us, as indicated on the cover page of this prospectus, remains the same and after deducting the estimated underwriting discount, commissions and offering expenses payable by us.

We intend to use the net proceeds to us from this offering in the following order:

 

   

to pay offering-related expenses of approximately $         million; and

 

   

to repay $         million of outstanding indebtedness under our new term loan facility which was incurred in connection with the Financing Transactions.

We intend to use the remaining proceeds (if any) for general corporate purposes, including working capital and capital expenditures.

On                     , 2012, we entered into our $                 million term loan facility with a syndicate of lenders which bears interest, at our option, at an alternate base rate which is the higher of the administrative agent’s prime rate and the federal funds effective rate plus         % (    % at                     , 2012), with a         % floor, plus a margin of         %, or a LIBOR-based rate (    % at                     , 2012) with a         % floor plus a margin of         %. At                     , 2012 our interest rate was     % and our outstanding balance was $         million. The term loan facility matures on the earlier of (i)                     , 2015 and (ii) the date on which such facility is accelerated following the occurrence of an event of default.

We used the amounts of the net proceeds from our term loan facility of approximately $         million to pay a dividend of $         million to holders of our common stock and $         million to holders of our Series A 8% convertible preferred stock.

 

28


Table of Contents

DIVIDENDS

In connection with the 2010 Transaction, we declared a special dividend to the holders of our common stock on October 13, 2010, referred to herein as the 2010 Dividend. We paid the 2010 Dividend on October 14, 2010 to all of our shareholders of record as of October 13, 2010. The aggregate amount of the 2010 Dividend was approximately $196.7 million, or $4.58 per share. Of this amount, $4.3 million was recorded as additional compensation expense. Please see “Certain Relationships and Related Party Transactions—Investment by Advent” for a description of the 2010 Transaction.

On                     , 2012, we declared and paid a dividend of $         per share on shares of our common stock and our Series A 8% convertible preferred stock totaling approximately $             million, which we refer to as the 2012 Dividend.

Other than the 2010 Dividend and the 2012 Dividend, we have not declared, and currently do not plan to declare in the foreseeable future, dividends on shares of our common stock. We currently intend to retain any future earnings for use in the operation and expansion of our business. Any further determination to pay dividends on our capital stock will be at the discretion of our board of directors, subject to applicable laws, and will depend on our financial condition, results of operations, capital requirements, general business conditions and other factors that our board of directors considers relevant. In addition, the terms of our term loan facility and revolving credit facility contain restrictions on our ability to pay dividends.

 

29


Table of Contents

CAPITALIZATION

The following table sets forth our capitalization as of January 28, 2012:

 

   

on an actual basis;

 

   

on a pro forma basis further reflecting: (1) the Financing Transactions, including the payment of the 2012 Dividend; (2) the conversion of all outstanding shares of our Series A 8% convertible preferred stock into              shares of common stock and (3) the exercise of all of our outstanding warrants to purchase a total of              shares of common stock; and

 

   

on a pro forma as adjusted basis to further reflect:

 

   

our receipt of the net proceeds from the sale of              shares of our common stock in this offering based upon an assumed initial public offering price of $         per share (the midpoint of the price range set forth on the cover of this prospectus) and after deducting estimated underwriting discount, commissions and offering expenses payable by us; and

 

   

the application of the estimated net proceeds from this offering as described under “Use of Proceeds.”

You should read this table together with the sections entitled “Use of Proceeds,” “Selected Financial and Other Data” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our financial statements and the related notes included elsewhere in this prospectus.

 

    As of January 28, 2012  
    Actual     Pro Forma     Pro Forma as
Adjusted
 
    (in thousands, except share and per share
data)
 

Cash and cash equivalents

  $ 41,293      $                       $                
 

 

 

   

 

 

   

 

 

 

Long-term debt (including current maturities)

     

Revolving line of credit(1)

  $      $        $     

Note payable

    250       
 

 

 

   

 

 

   

 

 

 

Total long-term debt

    250       

Preferred stock, $0.01 par value. Authorized 100,000,000 shares; 10,000,000 shares undesignated; 90,000,000 shares designated as Series A 8% convertible preferred stock:

    191,855       

Series A 8% convertible preferred stock, $0.01 par value. Issued and outstanding 89,291,773 shares with a liquidation preference of $214,420, actual; none authorized, none issued and outstanding, pro forma and pro forma, as adjusted(2)

     

Shareholders’ (deficit) equity:

     

Common stock, $0.01 par value. Authorized 200,000,000 shares; issued and outstanding 46,961,992 shares, actual;                  issued and outstanding shares, pro forma; and                  issued and outstanding shares on a pro forma, as adjusted basis

    470       

Additional paid-in capital

    3,383       

Accumulated deficit

    (133,612    
 

 

 

   

 

 

   

 

 

 

Total shareholders’ (deficit) equity

    (129,759    
 

 

 

   

 

 

   

 

 

 

Total capitalization(3)

  $ 134,527      $        $     
 

 

 

   

 

 

   

 

 

 

 

(1) At January 28, 2012, there were no outstanding letters of credit and excess availability was approximately $20.0 million.

 

30


Table of Contents
(2) Our outstanding Series A 8% convertible preferred stock will convert into shares of our common stock in connection with the closing of this offering.
(3) Each $1.00 increase or decrease in the assumed initial public offering price of $         per share would increase or decrease each of cash and cash equivalents, additional paid-in capital, total shareholders’ equity and total capitalization on a pro forma as adjusted basis by approximately $         million, assuming that the number of shares of common stock offered by us and the selling shareholders, as set forth on the cover page of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us.

The number of shares of common stock outstanding set forth in the table above does not include:

 

   

            shares of our common stock issuable upon the exercise of stock options outstanding as of                     , 2012 with a weighted average exercise price of $         per share; and

 

   

             shares of our common stock reserved for future issuance under our equity incentive plan.

 

31


Table of Contents

DILUTION

If you invest in our common stock in this offering, you will experience immediate and substantial dilution in the pro forma net tangible book value of your shares of our common stock. The pro forma net tangible book value of our common stock as of                     , 2012 was $         million, or approximately $         per share. Pro forma net tangible book value per share represents the amount of our total tangible assets less our total liabilities divided by the pro forma number of shares of common stock that would have been outstanding on                     , 2012 after giving pro forma effect to the conversion of all outstanding shares of our Series A 8% convertible preferred stock into a total of              shares of common stock and the exercise of all outstanding warrants to purchase a total of              shares of common stock.

Dilution in pro forma net tangible book value per share represents the difference between the amount per share paid by purchasers of shares of common stock in this offering and the pro forma net tangible book value per share of our common stock immediately after the closing of this offering. After giving effect to the sale of shares of our common stock in this offering based upon an assumed initial public offering price of $         (the midpoint of the price range set forth on the cover of this prospectus) and after deducting estimated underwriting discount, commissions and offering expenses payable by us, the conversion of all outstanding shares of our Series A 8% convertible preferred stock into a total of              shares of common stock and the exercise of all of our outstanding warrants to purchase a total of              shares of common stock, our pro forma net tangible book value as of                      would have been approximately $         million, or approximately $         per share. This represents an immediate increase in pro forma net tangible book value of $         per share to existing shareholders and an immediate dilution of $         per share to new investors purchasing shares of our common stock in this offering at the assumed initial public offering price. The following table illustrates this per share dilution:

 

Assumed initial public offering price per share

      $                
     

 

 

 

Pro forma net tangible book value as of                     , 2012

   $                   
  

 

 

    

Increase in pro forma net tangible book value per share attributable to new investors in this offering

     

Pro forma as adjusted net tangible book value per share after this offering .

     

Dilution per share to new investors

      $     
     

 

 

 

If the underwriters exercise their option to purchase additional shares in full, pro forma net tangible book value per share after the offering will be $        , and dilution in pro forma net tangible book value per share to new shareholders will be $        . A $1.00 increase (decrease) in the assumed initial public offering price of $         per share would increase (decrease) our pro forma net tangible book value by $         million, the pro forma net tangible book value per share after this offering by $         per share and the dilution in pro forma net tangible book value to new investors in this offering by $         per share, assuming the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same.

 

32


Table of Contents

The following table presents, on a pro forma basis, as of                     , 2012, the differences between the number of shares of common stock purchased from us, the total consideration paid or exchanged and the average price per share paid by existing shareholders and by new investors purchasing shares of our common stock in this offering before deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. The table assumes an initial public offering price of $         per share, as specified above.

 

     Shares Purchased     Total Consideration     Average
   Price Per  
Share
 
       Number        Percent         Amount          Percent      

Existing shareholders(1)

               $                             $                

New investors

               $                             $     
  

 

  

 

 

   

 

 

    

 

 

   

Total

        100.0   $           100.0   $     
  

 

  

 

 

   

 

 

    

 

 

   

 

(1) The total consideration paid by existing shareholders does not reflect the dividends received by them in the 2010 Dividend and 2012 Dividend.

A $1.00 increase (decrease) in the assumed initial public offering price of $         per share would increase (decrease) total consideration paid by new shareholders by $         million, assuming the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same.

Sales by the selling shareholders in this offering will reduce the number of shares held by existing shareholders to              shares, or approximately     % (             shares, or approximately     %, if the underwriters exercise their option to buy additional shares in full), and will increase the number of shares to be purchased by new investors to              shares, or approximately     % (             shares, or approximately     %, if the underwriters exercise their option to buy additional shares in full), of the total common stock outstanding after the offering.

The number of shares outstanding in the table above is based on the number of shares outstanding as of                     , 2012, after giving effect to the              -for-              reverse stock split of our common stock which will occur prior to the closing of this offering; the conversion of all outstanding shares of our Series A 8% convertible preferred stock into              shares of our common stock in connection with the closing of this offering; and the exercise of all outstanding warrants to purchase              shares of our common stock. The discussion and tables above do not include the following shares:

 

   

             shares of our common stock issuable upon the exercise of stock options outstanding as of                     , 2012 with a weighted average exercise price of $         per share; and

 

   

             shares of our common stock reserved for future issuance under our amended and restated equity incentive plan.

To the extent any such shares of common stock are issued, new investors may experience further dilution. If the underwriters exercise their option to purchase additional shares in full, the following will occur: (1) the number of shares of common stock held by existing shareholders will represent approximately     % of the total number of shares of common stock outstanding after this offering; and (2) the number of shares of common stock held by new investors will be increased to             , or approximately     % of the total number of shares of common stock outstanding after this offering.

 

33


Table of Contents

SELECTED FINANCIAL AND OTHER DATA

The following tables present selected financial and other data as of and for the periods indicated. The selected statement of operations data for fiscal 2009, 2010 and 2011 and selected balance sheet data as of January 29, 2011 and January 28, 2012 are derived from our financial statements audited by KPMG LLP, our independent registered public accounting firm, included elsewhere in this prospectus. The selected statement of operations data for the fiscal years ended February 2, 2008, which we refer to as fiscal 2007, and January 31, 2009, which we refer to as fiscal 2008, and the selected balance sheet data as of February 2, 2008, January 31, 2009 and January 30, 2010 are derived from our audited financial statements that have not been included in this prospectus. The historical results presented below are not necessarily indicative of the results to be expected for any future period. You should read this selected financial data in conjunction with the financial statements and accompanying notes and the information under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” appearing elsewhere in this prospectus.

We operate on a fiscal calendar that results in a given fiscal year consisting of a 52- or 53-week period ending on the Saturday closest to January 31 st of the following year. The reporting periods contained in our audited financial statements included in this prospectus contain 52 weeks of operations in fiscal 2007, 2008, 2009, 2010 and 2011.

 

    Fiscal Year  
    2007     2008     2009     2010     2011  
    (in thousands, except total stores, share and per share data)  

Statement of Operations Data:

         

Net sales

  $ 66,411      $ 89,466      $ 125,135      $ 197,189      $ 297,113   

Cost of goods sold

    48,758        64,155        85,040        131,046        192,252   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

    17,653        25,311        40,095        66,143        104,861   

Selling, general and administrative expenses(1)

    20,935        26,930        33,217        54,339        78,640   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating (loss) income

    (3,282     (1,619     6,878        11,804        26,221   

Interest expense (income), net

    208        131        73        28        (16
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

(Loss) income before income taxes

    (3,490     (1,750     6,805        11,776        26,237   

Income tax expense (benefit)

                  (4,853     4,753        10,159   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net (loss) income

    (3,490     (1,750     11,658        7,023        16,078   

Series A 8% convertible preferred stock cumulative dividends

    —          —          —          (4,507     (15,913

Accretion of redeemable convertible preferred stock

    (1,605     (2,881     (4,250     (3,329     —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net (loss) income available to shareholders

    (5,095     (4,631     7,408        (813     165   

Less: Net income attributable to participating securities

    —          —          (3,365     —          (109
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) available to common shareholders

  $ (5,095   $ (4,631   $ 4,043      $ (813   $ 56   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Per Share Data:

         

Basic (loss) income per common share(2)

  $ (0.23   $ (0.22   $ 0.19      $ (0.03   $ —     

Diluted (loss) income per common share(2)

  $ (0.23   $ (0.22   $ 0.19      $ (0.03   $ —     

Dividends declared per common share

  $ —        $ —        $ —        $ 4.58      $ —     

Weighted average shares outstanding:

         

Basic shares

    21,829,611        21,438,516        21,539,917        27,954,322        45,964,159   

Diluted shares

    21,829,611        21,438,516        21,539,917        27,954,322        45,965,631   

Unaudited pro forma net income

         

Unaudited pro forma basic income per common share(3)

         

Unaudited pro forma diluted income per common share(3)

         

Unaudited pro forma weighted average shares outstanding:

         

Basic shares

         

Diluted shares

         

 

34


Table of Contents
    Fiscal Year  
             2007                        2008                        2009                        2010                        2011            
    (in thousands, except total stores, share and per share data)  

Statement of Cash Flows Data:

         

Net cash (used in) provided by:

         

Operating activities

  $ (1,219   $ 3,671      $ 9,227      $ 15,045      $ 46,695   

Investing activities

  $ (5,021   $ (5,988   $ (7,285   $ (14,883   $ (18,558

Financing activities

  $ 6,641      $ 10,900      $ (145   $ (445   $ 1,003   

Other Operating and Financial Data:

         

Total stores at end of period

    67        82        102        142        192   

Comparable store sales growth

    5.4     5.8     12.1     15.6     7.9

Average net sales per store(4)

  $ 1,037      $ 1,185      $ 1,302      $ 1,542      $ 1,658   

Adjusted EBITDA(5)

  $ (285   $ 2,285      $ 11,088      $ 25,798      $ 42,377   

Capital expenditures

  $ 5,033      $ 5,991      $ 7,285      $ 14,883      $ 18,558   

Adjusted EBITDA Reconciliation:

         

Net (loss) income

  $ (3,490   $ (1,750   $ 11,658      $ 7,023      $ 16,078   

Interest expense (income), net

    208        131        73        28        (16

Income tax (benefit) expense

                  (4,853     4,753        10,159   

Depreciation and amortization

    2,115        2,799        3,660        4,805        7,071   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA(6)

    (1,167     1,180        10,538        16,609        33,292   

Non-contractual executive bonus expense(7)

                                6,087   

Deferred rents(8)

    608        297        232        1,164        1,401   

Non-cash stock-based compensation and warrant expense(9)

    199        329        274        2,332        1,246   

Loss on disposal of assets(10)

    16        169        5        288        273   

Closed stores(11)

    59        310        39        76        78   

Transaction expense(12)

                         5,329          
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted EBITDA

  $ (285   $ 2,285      $ 11,088      $ 25,798      $ 42,377   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

    As of  
    February 2,
2008
    January 31,
2009
    January 30,
2010
    January 29,
2011
    January 28,
2012
 
    (in thousands)  

Balance Sheet Data:

         

Cash and cash equivalents

  $ 2,056      $ 10,639      $ 12,436      $ 12,153      $ 41,293   

Total current assets

    15,261        26,533        35,335        45,942        92,249   

Total current liabilities

    13,303        10,522        10,983        18,215        49,942   

Total long-term debt(13)

    223        122               250        250   

Total liabilities

    19,255        18,331        20,036        33,524        72,431   

Series A 8% convertible preferred stock

                         191,855        191,855   

Series A redeemable convertible preferred stock

    16,312        17,030        18,778                 

Series A-1 redeemable convertible preferred stock

           16,008        18,510                 

Total shareholders’ deficit

    (7,343     (8,879 )       (1,049     (148,797     (129,759

 

(1) Fiscal 2010 includes $5.3 million of expense related to the 2010 Transaction and fiscal 2011 includes $6.1 million of non-contractual executive bonus expense, as described in Note 7 to the Adjusted EBITDA Reconciliation.
(2) Please see Note 2 to our financial statements, included elsewhere in this prospectus, for an explanation of per share calculations.
(3) Pro forma per share data is unaudited and gives effect to (i) the Financing Transactions, including the payment of the 2012 Dividend; (ii) the conversion of our outstanding shares of Series A 8% convertible preferred stock into shares of common stock in connection with the closing of this offering and (iii) the exercise in full of our outstanding warrants for shares of common stock.

 

35


Table of Contents

The following is a reconciliation of historical net income to unaudited pro forma net income for fiscal 2011:

 

Net income as reported

   $ 16,078   

Interest expense

  

Pro forma net income

  

Pro forma weighted average shares outstanding:

  

Basic shares

  

Diluted shares

  

 

(4) Only includes stores open during the full fiscal year.
(5) Adjusted EBITDA is defined as EBITDA (as defined below), further adjusted to exclude non-cash, non-recurring and other items not related to ongoing performance, such as non-contractual executive bonus expense, deferred rents, non-cash stock-based compensation and warrant expense, loss on disposal of assets, EBITDA for closed stores and expense related to the 2010 Transaction. We have presented Adjusted EBITDA because we believe that the exclusion of these items is appropriate to provide additional information to investors about our ongoing operating performance excluding certain non-cash and other items not related to ongoing performance and as a means to evaluate our period-to-period results. In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. Our presentation of Adjusted EBITDA should not be construed to imply that our future results will be unaffected by any such adjustments. We have provided this information as a means to evaluate the results of our ongoing operations. Other companies in our industry may calculate Adjusted EBITDA differently than we do. Adjusted EBITDA is not a measure of performance under GAAP and should not be considered as a substitute for net income prepared in accordance with GAAP. Adjusted EBITDA has similar limitations as an analytical tool to those set forth in Note 6 below related to the use of EBITDA, and you should not consider it in isolation or as substitute for analysis of our results as reported under GAAP. Some of these additional limitations to the use of Adjusted EBITDA are:

 

   

Adjusted EBITDA does not reflect the non-contractual executive bonus expense, deferred rents, non-cash stock-based compensation and warrant expense, loss on disposal of assets, EBITDA for closed stores and expense related to the 2010 Transaction; and

 

   

Adjusted EBITDA does not reflect certain other costs that may recur in future periods.

We compensate for these limitations by relying primarily on our GAAP results and using Adjusted EBITDA only as a supplemental measure.

 

(6) EBITDA represents net income before interest expense (income), income taxes (benefit), depreciation and amortization. We have presented EBITDA because we consider it an important supplemental measure of our performance and believe it is frequently used by analysts, investors and other interested parties in the evaluation of companies in our industry. Management uses EBITDA as a measurement tool for evaluating our actual operating performance compared to budget and prior periods. Other companies in our industry may calculate EBITDA differently than we do. EBITDA is not a measure of performance under GAAP, and should not be considered as a substitute for net income prepared in accordance with GAAP. EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are:

 

  Ÿ  

EBITDA does not reflect our cash expenditures, our future requirements for capital expenditures or contractual commitments;

 

   

EBITDA does not reflect interest expense or the cash requirements necessary to service interest or principal payments on debt;

 

   

EBITDA does not reflect tax expense or the cash requirements necessary to pay tax obligations; and

 

36


Table of Contents
   

Although depreciation and amortization are non-cash charges, the asset being depreciated and amortized will often have to be replaced in the future, and EBITDA does not reflect any cash requirements for such replacements.

 

(7) Represents a non-contractual bonus to certain executive officers for performance in fiscal 2011 and associated tax expense.
(8) Represents the non-cash portion of rent expense.
(9) Represents non-cash stock-based compensation and warrant expense.
(10) Represents asset write-offs for remodeled or closed stores.
(11) Represents the EBITDA, excluding the non-cash portion of rent expense, for stores which management has made the decision to close, from the period in which the decision was made.
(12) Represents expenses incurred in conjunction with the 2010 Transaction, including expenses related to the modification of certain stock options, professional fees and other employee compensation-related expense.
(13) Includes capital lease obligations, less current portion.

 

37


Table of Contents

MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion together with “Selected Financial and Other Data,” and the financial statements and related notes included elsewhere in this prospectus. The statements in this discussion regarding expectations of our future performance, liquidity and capital resources and other non-historical statements are forward-looking statements. These forward-looking statements are subject to numerous risks and uncertainties, including, but not limited to, the risks and uncertainties described in “Risk Factors” and “Special Note Regarding Forward-Looking Statements.” Our actual results may differ materially from those contained in or implied by any forward-looking statements.

We operate on a fiscal calendar widely used by the retail industry that results in a given fiscal year consisting of a 52- or 53-week period ending on the Saturday closest to January 31 of the following year. References to “fiscal year 2011” or “fiscal 2011” refer to the fiscal year ended January 28, 2012, references to “fiscal year 2010” or “fiscal 2010” refer to the fiscal year ended January 29, 2011 and references to “fiscal year 2009” or “fiscal 2009” refer to the fiscal year ended January 30, 2010. Each of fiscal years 2011, 2010 and 2009 consisted of a 52-week period.

Overview

Five Below is a rapidly growing specialty value retailer offering a broad range of trend-right, high-quality merchandise targeted at the aspirational teen and pre-teen customer. We offer a dynamic, edited assortment of exciting products, all priced at $5 and below, including select brands and licensed merchandise across our category worlds.

Five Below was founded in 2002 by our Executive Chairman, David Schlessinger, and our President and Chief Executive Officer, Thomas Vellios, who recognized a market need for a fun and affordable shopping destination aimed at teens and pre-teens aspiring to be young adults.

We believe that our powerful business model has resulted in strong financial performance irrespective of the economic environment. We increased net sales from $125.1 million in fiscal 2009 to $297.1 million in fiscal 2011, representing a 54.1% compound annual growth rate. We increased operating income from $6.9 million to $26.2 million during this same time period, representing a compound annual growth rate of 95.3%. Our comparable store sales also increased by 12.1% in fiscal 2009, 15.6% in fiscal 2010 and 7.9% in fiscal 2011 with positive comparable store sales performance across all geographic regions and store-year classes. In addition, over the past two fiscal years we expanded our store base from 102 stores to 192 stores.

We expect to continue our strong growth in the future. By offering trend-right merchandise at a differentiated price point of $5 and below, our stores have been successful in varying geographic regions, population densities and real estate settings. We believe we have the opportunity to expand our store base in the U.S. from 192 locations in the eastern half of the U.S. at the end of fiscal 2011, to more than 2,000 locations over time.

We have a proven and highly profitable store model that has produced consistent financial results and returns. All of our current stores were profitable on a four-wall basis in fiscal 2011 and our new stores have achieved average payback periods of less than one year. Our new store model anticipates a target store size of 7,500 square feet that achieves annual sales of $1.5 million to $1.6 million in the first full year of operation. Our new store model also assumes an average new store investment of approximately $300,000. Our new store investment includes our store buildout (net of tenant allowances), inventory and cash pre-opening expenses.

Our planned store expansion will place increased demands on our operational, managerial, administrative and other resources. Managing our growth effectively will require us to continue to enhance our store management systems, financial and management controls and information systems. In addition, we will be required to hire, train and retain store management and store personnel.

 

38


Table of Contents

Over the past 5 years we have invested a significant amount of capital in infrastructure and systems necessary to support our future growth and we expect to incur additional capital expenditures related to expansion of our infrastructure and systems in future periods. In fiscal 2010, we expanded our New Castle, Delaware distribution center, and in fiscal 2011, we relocated our corporate headquarters and upgraded our warehouse management and information systems. We have also identified the need to open a second distribution center in order to support our growth, which we expect to open in fiscal 2013. The timing and amount of investments in our infrastructure and systems could affect the comparability of our results of operations in future periods.

We believe our business strategy will continue to offer significant opportunity, but it also presents risks and challenges. These risks and challenges include, but are not limited to, that we may not be able to effectively identify and respond to changing trends and customer preferences, that we may not be able to find desirable locations for new stores and that we may not be able to effectively manage our future growth. In addition, our financial results can be expected to be directly impacted by substantial increases in product costs due to commodity cost increases or general inflation which could lead to a reduction in our sales as well as greater margin pressure as costs may not be able to be passed on to consumers. See “Risk Factors” for a description of these and other important factors that could adversely impact us and our results of operations.

How We Assess the Performance of Our Business

In assessing the performance of our business, we consider a variety of performance and financial measures. These key measures include net sales, comparable store sales, gross profit, selling, general and administrative expenses, operating income, EBITDA and Adjusted EBITDA.

Net Sales

Net sales constitute gross sales net of merchandise returns for damaged or defective goods. Net sales consist of sales from comparable stores and non-comparable stores. Revenue from the sale of gift cards is deferred and not included in net sales until the gift cards are redeemed to purchase merchandise.

Our business is seasonal and as a result, our net sales fluctuate from quarter to quarter. Net sales are usually highest in the fourth fiscal quarter due to the year-end holiday season.

Comparable Store Sales

Comparable store sales include net sales from stores that have been open for at least 15 full months from their opening date.

Comparable stores include the following:

 

   

Stores that have been remodeled while remaining open;

 

   

Stores that have been relocated within the same trade area, to a location that is not significantly different in size, in which the new store opens at about the same time as the old store closes; and

 

   

Stores that have expanded, but are not significantly different in size, within their current locations.

For stores that are relocated or expanded, the following periods are excluded when calculating comparable store sales:

 

   

The period of construction and pre-opening during which the store is closed through:

 

  ¡    

the last day of the fiscal year in which the store was relocated or expanded (for stores that increased significantly in size); or

 

39


Table of Contents
  ¡    

the last day of the fiscal month in which the store re-opens (for all other stores); and

 

   

The period beginning on the first anniversary of the date the store closed for construction through the first anniversary of the date the store re-opened.

There may be variations in the way in which some of our competitors and other retailers calculate comparable or “same store” sales. As a result, data in this prospectus regarding our comparable store sales may not be comparable to similar data made available by other retailers. Non-comparable store sales are comprised of new store sales, sales for stores not open for a full 15 months, and sales from existing store relocation and expansion projects that were temporarily closed and not included in comparable store sales.

Measuring the change in fiscal year-over-year comparable store sales allows us to evaluate how our store base is performing. Various factors affect comparable store sales, including:

 

   

consumer preferences, buying trends and overall economic trends;

 

   

our ability to identify and respond effectively to customer preferences and trends;

 

   

our ability to provide an assortment of high-quality, trend-right and everyday product offerings that generate new and repeat visits to our stores;

 

   

the customer experience we provide in our stores;

 

   

the level of traffic near our locations in the power, community and lifestyle centers in which we operate;

 

   

competition;

 

   

changes in our merchandise mix;

 

   

pricing;

 

   

our ability to source and distribute products efficiently;

 

   

the timing of promotional events and holidays;

 

   

the timing of introduction of new merchandise and customer acceptance of new merchandise;

 

   

our opening of new stores in the vicinity of existing stores; and

 

   

the number of items purchased per store visit.

Opening new stores is an important part of our growth strategy. As we continue to pursue our growth strategy, we expect that a significant percentage of our net sales will continue to come from new stores not included in comparable store sales. Accordingly, comparable store sales is only one measure we use to assess the success of our growth strategy.

Gross Profit

Gross profit is equal to our net sales less our cost of goods sold. Gross margin is gross profit as a percentage of our net sales. Cost of goods sold reflects the direct costs of purchased merchandise and inbound freight, as well as store occupancy, distribution and buying expenses. Store occupancy costs include rent, common area maintenance, utilities and property taxes for all store locations. Distribution costs include costs for receiving, processing, warehousing and shipping of merchandise to or from our distribution center and between store locations. Buying costs include compensation expense and other costs for our internal buying organization.

These costs are significant and can be expected to continue to increase as our company grows. The components of our cost of goods sold may not be comparable to the components of cost of goods sold or similar

 

40


Table of Contents

measures of our competitors and other retailers. As a result, data in this prospectus regarding our gross profit and gross margin may not be comparable to similar data made available by our competitors and other retailers.

The variable component of our cost of goods sold is higher in higher volume quarters because the variable component of our cost of goods sold generally increases as net sales increase. We regularly analyze the components of gross profit as well as gross margin. Any inability to obtain acceptable levels of initial markups, a significant increase in our use of markdowns, and a significant increase in inventory shrinkage or inability to generate sufficient sales leverage on the store occupancy, distribution and buying components of costs of goods sold could have an adverse impact on our gross profit and results of operations. Changes in the mix of our products may also impact our overall cost of goods sold.

Selling, General and Administrative Expenses

Selling, general and administrative, or SG&A, expenses are composed of payroll and other compensation, marketing and advertising expense, depreciation and amortization expense and other selling and administrative expenses. SG&A expenses as a percentage of net sales are usually higher in lower sales volume quarters and lower in higher sales volume quarters.

The components of our SG&A expenses may not be comparable to those of other retailers. We expect that our SG&A expenses will increase in future periods due to our continuing store growth and in part due to additional legal, accounting, insurance and other expenses we expect to incur as a result of being a public company. Among other things, we expect that compliance with the Sarbanes-Oxley Act of 2002 and related rules and regulations could result in significant incremental legal, accounting and other overhead costs. In addition, any increase in future stock option or other stock-based grants or modifications will increase our stock-based compensation expense included in SG&A.

Operating Income

Operating income equals gross profit less SG&A expenses. Operating income excludes interest expense or income and income tax expense or benefit. We use operating income as an indicator of the productivity of our business and our ability to manage SG&A expenses. Operating income percentage measures operating income as a percentage of our net sales.

EBITDA and Adjusted EBITDA

We define EBITDA as net income (loss) before interest expense (income), income taxes (benefit), depreciation and amortization. We define Adjusted EBITDA as EBITDA further adjusted to exclude certain non-cash, non-recurring items and other items not relating to ongoing performance. We caution investors that amounts presented in accordance with our definitions of EBITDA and Adjusted EBITDA may not be comparable to similar measures disclosed by other issuers, because not all issuers calculate EBITDA or Adjusted EBITDA in the same manner. We present EBITDA in this prospectus because we consider it an important supplemental measure of our performance and believe it is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry. We present Adjusted EBITDA in this prospectus as a further supplemental measure of our performance. For a discussion of our use of EBITDA and Adjusted EBITDA and a reconciliation to net income, please refer to “Prospectus Summary—Summary Financial and Other Data” and “Selected Financial and Other Data.”

 

41


Table of Contents

Results of Operations

The following tables summarize key components of our results of operations for the periods indicated, both in dollars and as a percentage of our net sales.

 

     Fiscal Year  
     2009     2010     2011  
     (in thousands, except total stores)  

Statements of Operations Data:

  

Net sales

   $ 125,135      $ 197,189      $ 297,113   

Cost of goods sold

     85,040        131,046        192,252   
  

 

 

   

 

 

   

 

 

 

Gross profit

     40,095        66,143        104,861   

Selling, general and administrative expenses(1)

     33,217        54,339        78,640   
  

 

 

   

 

 

   

 

 

 

Operating income

     6,878        11,804        26,221   

Interest expense (income), net

     73        28        (16
  

 

 

   

 

 

   

 

 

 

Income before income taxes

     6,805        11,776        26,237   

Income tax (benefit) expense

     (4,853     4,753        10,159   
  

 

 

   

 

 

   

 

 

 

Net income

   $ 11,658      $ 7,023      $ 16,078   
  

 

 

   

 

 

   

 

 

 

Percentage of Net Sales:

      

Net sales

     100.0     100.0     100.0

Cost of goods sold

     68.0     66.5     64.7
  

 

 

   

 

 

   

 

 

 

Gross profit

     32.0     33.5     35.3

Selling, general and administrative expenses(1)

     26.5     27.6     26.5
  

 

 

   

 

 

   

 

 

 

Operating income

     5.5     6.0     8.8

Interest expense (income), net

     0.1              
  

 

 

   

 

 

   

 

 

 

Income before income taxes

     5.4     6.0     8.8

Income tax (benefit) expense

     (3.9 %)      2.4     3.4
  

 

 

   

 

 

   

 

 

 

Net income

     9.3     3.6     5.4
  

 

 

   

 

 

   

 

 

 

Operational Data:

      

Total stores at end of period

     102        142        192   

Comparable stores sales growth

     12.1     15.6     7.9

Average net sales per store(2)

   $ 1,302      $ 1,542      $ 1,658   

 

(1) Fiscal 2010 includes $5.3 million of expense related to the 2010 Transaction and fiscal 2011 includes $6.1 million of non-contractual executive bonus expense, as described in Note 7 under “Selected Financial and Other Data.”
(2) Only includes stores open during the full fiscal year.

Fiscal Year 2011 Compared to Fiscal Year 2010

Net Sales

Net sales increased from $197.2 million in fiscal year 2010 to $297.1 million in fiscal year 2011, an increase of $99.9 million, or 50.7%. The increase was the result of a comparable store sales increase of $13.1 million and a non-comparable store sales increase of $86.8 million.

Comparable store sales increased 7.9% for fiscal year 2011 compared to fiscal year 2010. The increase was primarily the result of an increase in the number of transactions in our stores, as well as, a slight increase in the average dollar value of a transaction.

 

42


Table of Contents

Gross Profit

Gross profit increased from $66.1 million in fiscal year 2010 to $104.9 million in fiscal year 2011, an increase of $38.7 million, or 58.5%. Gross margin increased from 33.5% in fiscal year 2010 to 35.3% for fiscal year 2011, an increase of 180 basis points. The increase in gross margin was primarily the result of a 166 basis point increase due to the leveraging of buying and store occupancy expense.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased from $54.3 million in fiscal year 2010 to $78.6 million in fiscal year 2011, an increase of $24.3 million, or 44.7%. As a percentage of net sales, selling, general and administrative expenses decreased 110 basis points to 26.5% in fiscal year 2011 compared to 27.6% in fiscal year 2010. The increase in selling, general and administrative expense was primarily the result of increases of $17.4 million of store-related expenses to support new store growth and $6.0 million of a non-contractual bonus to certain executive officers for performance in fiscal 2011, which was partially offset by a decrease of $5.3 million in expense related to the 2010 Transaction, including compensation cost associated with the modification of certain stock options.

Income Tax Expense

Income tax expense increased from $4.8 million in fiscal year 2010 to $10.2 million in fiscal year 2011, an increase of $5.4 million, or 113.7%. This increase in income tax expense was primarily the result of a $14.5 million increase in pre-tax net income. Our effective tax rate decreased from 40.4% in fiscal year 2010 to 38.7% in fiscal year 2011. For fiscal 2012, we believe our effective tax rate will be approximately 40%.

Net Income

As a result of the foregoing, net income increased from $7.0 million in fiscal year 2010 to $16.1 million in fiscal year 2011, an increase of $9.1 million, or 128.9%.

Fiscal Year 2010 Compared to Fiscal Year 2009

Net Sales

Net sales increased from $125.1 million in fiscal year 2009 to $197.2 million in fiscal year 2010, an increase of $72.1 million, or 57.6%. The increase was the result of a comparable store sales increase of $16.8 million and a non-comparable store sales increase of $55.3 million.

Comparable store sales increased 15.6% for fiscal year 2010 compared to fiscal year 2009. The increase was primarily the result of an increase in the number of transactions in our stores, as well as a slight increase in the average dollar value of a transaction.

Gross Profit

Gross profit increased from $40.1 million in fiscal year 2009 to $66.1 million in fiscal year 2010, an increase of $26.0 million, or 65.0%. Gross margin increased from 32.0% for fiscal year 2009 to 33.5% for fiscal year 2010, an increase of 150 basis points. The increase in gross margin was primarily the result of a 137 basis point increase due to the leveraging of store occupancy expense.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased from $33.2 million in fiscal year 2009 to $54.3 million in fiscal year 2010, an increase of $21.1 million, or 63.6%. As a percentage of net sales, selling, general and administrative expenses increased 110 basis points to 27.6% in fiscal year 2010 compared to 26.5% in fiscal

 

43


Table of Contents

year 2009. The increase in selling, general and administrative expenses was primarily the result of increases of $11.3 million of store-related expense to support new store growth and $5.3 million of expense related to the 2010 Transaction, including compensation cost associated with the modification of certain stock options.

Income Tax Expense (Benefit)

Income taxes increased from a tax benefit of $4.9 million in fiscal year 2009 to a tax expense of $4.8 million in fiscal year 2010. This increase in income tax expense was primarily the result of a reversal of a $7.4 million deferred tax valuation allowance in fiscal 2009. Our effective tax rate changed from (71.3%) in fiscal year 2009 to 40.4% in fiscal year 2010.

Net Income

As a result of the foregoing, net income decreased from $11.7 million in fiscal year 2009 to $7.0 million in fiscal year 2010, a decrease of $4.6 million, or 39.8%.

Seasonality

Our business is seasonal in nature and demand is generally the highest in the fourth fiscal quarter due to the year-end holiday season. To prepare for the holiday season, we must order and keep in stock more merchandise than we carry during other parts of the year. We expect inventory levels, along with an increase in accounts payable and accrued expenses, generally to reach their highest levels in the third and fourth fiscal quarters in anticipation of the increased net sales during the year-end holiday season. As a result of this seasonality, and generally because of variation in consumer spending habits, we experience fluctuations in net sales and working capital requirements during the year.

Liquidity and Capital Resources

Overview

Our primary sources of liquidity are cash flows from operations, historical equity financings and borrowings under our revolving credit facility. Our primary cash needs are for capital expenditures and working capital.

Capital expenditures typically vary depending on the timing of new store openings and infrastructure-related investments. We plan to make capital expenditures of approximately $20.0 million in fiscal 2012 and approximately $23.0 million in fiscal 2013. We expect to devote approximately $15.0 million of our capital expenditure budget in fiscal 2012 to construct and open 50 new stores and a new distribution center, which will continue into fiscal 2013, with the remainder projected to be spent on corporate infrastructure and store relocations and remodels.

Our primary working capital requirements are for the purchase of store inventory and payment of payroll, rent, other store operating costs and distribution costs. Our working capital requirements fluctuate during the year, rising in the third and fourth fiscal quarters as we take title to increasing quantities of inventory in anticipation of our peak, year-end holiday shopping season in the fourth fiscal quarter. Fluctuations in working capital are also driven by the timing of new store openings.

Historically, we have funded our capital expenditures and working capital requirements during the fiscal year with cash on hand and borrowings under our revolving credit facility. We did not have any direct borrowings under our revolving credit facility at any point during fiscal 2011. When we have used our revolving credit facility, the amount of indebtedness outstanding under it has tended to be the highest in the beginning of the fourth quarter of each fiscal year. Over the past three fiscal years, to the extent that we have drawn on the facility, we have paid down the borrowings before the end of the fiscal year with cash generated during our peak selling season in the fourth quarter.

Based on our growth plans, we believe that our cash position, net cash provided by operating activities and availability under our revolving credit facility will be adequate to finance our planned capital expenditures and

 

44


Table of Contents

working capital requirements during fiscal 2012 and 2013. If cash flows from operations and borrowings under our revolving credit facility are not sufficient or available to meet our capital requirements, then we will be required to obtain additional equity or debt financing in the future. There can be no assurance that equity or debt financing will be available to us when we need it or, if available, that the terms will be satisfactory to us and not dilutive to our then-current shareholders.

Cash Flows

A summary of our cash flows from operating, investing and financing activities is presented in the following table:

 

     Fiscal Year  

(In millions)

   2009     2010     2011  

Net cash provided by operating activities

   $ 9.2      $ 15.0      $ 46.7   

Net cash used in investing activities

     (7.3     (14.9     (18.6

Net cash (used in) provided by financing activities

     (0.1     (0.4     1.0   
  

 

 

   

 

 

   

 

 

 

Net increase (decrease) during period in cash and cash equivalents

   $ 1.8      $ (0.3   $ 29.1   
  

 

 

   

 

 

   

 

 

 

Cash Provided by Operating Activities

Net cash provided by operating activities for fiscal 2011 was $46.7 million, an increase of $31.7 million compared to fiscal 2010. The increase in net cash provided by operating activities was primarily the result of an increase in net sales and the reclassification of certain negative cash balances as accounts payable due to the timing of bank settlement. Partially offsetting these increases were increases in cost of goods sold and store- related expenses to support our growth.

Net cash provided by operating activities for fiscal 2010 was $15.0 million, an increase of $5.8 million compared to fiscal 2009. The increase in net cash provided by operating activities was primarily the result of an increase in net sales and a decrease in payments on accounts payable due to the timing of vendor payments at fiscal 2010 year-end. Partially offsetting these increases were an increase in the cost of goods sold, as well as an increase in inventory purchases and store-related expenses to support our growth.

Cash Used in Investing Activities

Net cash used in investing activities for fiscal 2011 was $18.6 million, an increase of $3.7 million compared to fiscal 2010 and related solely to capital expenditures. The increase in capital expenditures was primarily for corporate infrastructure and our distribution facility.

Net cash used in investing activities for fiscal 2010 was $14.9 million, an increase of $7.6 million compared to fiscal 2009 and related solely to capital expenditures. The increase in capital expenditures was primarily for our new store construction and distribution facility.

Cash (Used in) Provided by Financing Activities

Net cash (used in) provided by financing activities for fiscal 2009, 2010 and 2011, was $(0.1) million, $(0.4) million and $1.0 million, respectively. Fiscal 2011 cash flows provided by financing activities was primarily the result of proceeds of $1.1 million from the issuance of common stock. Fiscal 2010 cash flows used in financing activities were primarily the result of dividends paid to our common shareholders of $192.4 million and the redemption of warrants of $10.2 million, partially offset by net proceeds from the issuance of shares of our preferred stock of $191.9 million, proceeds from the exercise and prepayment of warrants and options to purchase common stock of $6.9 million, and the related excess tax benefit of $3.2 million. The $192.4 million

 

45


Table of Contents

dividend, together with the $4.3 million classified as compensation expense, comprised the 2010 dividend. Fiscal 2009 cash flows used in financing activities were primarily the result of payments under capital lease agreements of $0.2 million, partially offset by proceeds from the exercise of warrants and options to purchase common stock of $0.1 million.

Financing Transactions

On                     , 2012, we entered into a $                 million term loan facility with                  as administrative agent for a syndicate of lenders, which we refer to as the term loan facility. We used the proceeds from the term loan facility to pay the 2012 Dividend totaling approximately $                 million on all outstanding shares of our common stock and Series A 8% convertible preferred stock. On the same day, we amended and restated our existing senior secured revolving credit facility with Wells Fargo Bank, National Association, which is described below under “—Line of Credit.” We refer to the term loan facility, the revolving credit facility, as amended and restated, and related transactions as the “Financing Transactions.”

The term loan facility provides for a term loan of $                 million and matures on the earlier of (i)                     , 2015 and (ii) the date on which such facility is accelerated following the occurrence of an event of default. The term loan facility provides for interest on borrowings, at our option, at an alternate base rate which is the higher of the administrative agent’s prime rate and the federal funds effective rate plus                  % (    % at                     , 2012) with a         % floor, plus a margin of         %, or a LIBOR-based rate (    % at                     , 2012) with a         % floor plus a margin of         %.

The credit agreement for the term loan facility includes a financial covenant of a maximum consolidated net leverage ratio.

The credit agreement for the term loan facility also includes customary negative and affirmative covenants including, among others, limitations on our ability to: (i) incur additional debt; (ii) create liens; (iii) make certain investments, loans and advances; (iv) sell assets; (v) pay dividends or make distributions or other restricted payments; (vi) engage in mergers or consolidations; or (vii) change our business.

The term loan facility is subject to repayment upon our receipt of certain proceeds, including those from the sale of certain assets, insurance proceeds and indebtedness not otherwise permitted. The term loan facility is also subject to repayment of $           million upon our receipt of proceeds from this offering.

Amounts under the credit agreement may become due upon certain events of default including, among others, failure to comply with the credit agreement’s covenants, bankruptcy, default on certain other indebtedness or a change in control. The default rate under the term loan facility is         % per annum.

All obligations under the term loan facility are secured by substantially all of our assets.

As of                     , 2012, we were in compliance with the financial covenant and other covenants applicable to us under the credit agreement.

Line of Credit

On August 18, 2006, we entered into a Loan and Security Agreement with Wachovia Bank National Association (predecessor in interest to Wells Fargo Bank, National Association) that included a revolving line of credit with advances tied to a borrowing base. The revolving credit facility was amended and restated on January 28, 2010 and later amended on October 14, 2010 and November 12, 2010. During fiscal year 2011, we had no borrowings under the revolving credit facility and we had approximately $20.0 million available on the line of credit for borrowings at January 28, 2012 based on the borrowing base. During fiscal year 2010, the maximum borrowings and weighted average interest rate under the revolving credit facility were $8.2 million and 4.85%, respectively, and interest expense was $53,267. During fiscal year 2009, we had no borrowings under the revolving credit facility.

 

46


Table of Contents

The revolving credit facility was amended and restated again on                     , 2012. The revolving credit facility allows maximum borrowings of $20.0 million and expires on                     . The revolving credit facility may be increased to $30.0 million upon certain conditions and the bank so agrees. The revolving credit facility includes a $             million sublimit for the issuance of letters of credit. The borrowing base is         % of eligible credit card receivables plus         % of the net recovery percentage of eligible inventory less established reserves.

The revolving credit facility provides for interest on borrowings, at our option, at (a) a prime rate (        % at                     , 2012) plus a margin of (i)         % if excess availability is greater than or equal to         %, (ii)         % if excess availability is less than         % but greater than or equal to         % or (iii)         % if excess availability is less than         % or (b) a LIBOR-based rate (        % at                     , 2012) plus a margin of (i)         % if excess availability is greater than or equal to         %, (ii)         % if excess availability is less than         % but greater than or equal to         % or (iii)         % if excess availability is less than         %. The revolving credit facility further provides for a letter of credit fee equal to the LIBOR-based rate plus (i)         % if excess availability is greater than or equal to         %, (ii)         % if excess availability is less         % but greater than or equal to         % or (iii)         % if excess availability is less than         %. The revolving credit facility also contains an unused credit facility fee of         % per annum and is subject to a servicing fee of $             per year.

The Second Amended and Restated Loan and Security Agreement includes a covenant which requires us to maintain minimum excess collateral availability of no less than the greater of (i)         % of the then effective maximum credit and (ii) $             million.

The Second Amended and Restated Loan and Security Agreement also includes customary negative and affirmative covenants including, among others, limitations on our ability to (i) incur additional debt; (ii) create liens; (iii) make certain investments, loans and advances; (iv) sell assets; (v) pay dividends or make distributions or other restricted payments; (vi) engage in mergers or consolidations; or (vii) change our business or certain members of our management.

Additionally, the revolving credit facility is subject to payment upon our receipt of certain proceeds, including those from the sale of certain assets, tax refunds, and insurance or settlement proceeds, and is subject to an increase in the interest rate on borrowings and the letter of credit fee of         % upon an event of default. If prior to the termination date and before                     , we elect to terminate the revolving credit facility or reduce the maximum credit then in effect, we must pay an early termination fee equal to the product of the then effective maximum credit or proposed reduction in the maximum credit, as applicable, and         %. Amounts under the Second Amended and Restated Loan and Security Agreement may become due upon certain events of default including among others, failure to comply with the Second Amended and Restated Loan and Security Agreement’s covenants, bankruptcy, default on certain other indebtedness, a change in control, or a material adverse change in our business, performance or financial conditions.

All obligations under the revolving credit facility are secured by substantially all of our assets.

As of January 28, 2012, we were in compliance with the covenants applicable to us under the Loan and Security Agreement.

2010 Transaction

On October 14, 2010, Advent and Sargent Family Investment, LLC, a limited liability company controlled by Ronald Sargent, one of our board members, invested $192.9 million and $1.1 million, respectively, in Five Below in consideration for 88,785,489 and 506,284 shares of our Series A 8% convertible preferred stock, respectively, and, as a result of such investment, Advent acquired a majority interest in us. In connection with this transaction, all of our outstanding shares of preferred stock on October 13, 2010 were converted into shares of our common stock and all of our then outstanding options and warrants were exercised or exchanged for restricted or unrestricted shares of our common stock. We used the proceeds of this investment as well as cash on

 

47


Table of Contents

hand to pay a special dividend to the holders of our common stock on October 14, 2010. The aggregate amount of such dividend was approximately $196.7 million, or $4.58 per share. Please see “Certain Relationships and Related Party Transactions—Investment by Advent” for more discussion of this transaction.

Critical Accounting Policies and Estimates

We have identified the policies below as critical to our business operations and understanding of our results of operations. The impact and any associated risks related to these policies on our business operations are discussed throughout “Management’s Discussion and Analysis of Financial Condition and Results of Operations” where such policies affect our reported and expected financial results. Our financial statements, which have been prepared in accordance with US generally accepted accounting principles, require us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures. We base our estimates on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from these estimates. For a detailed discussion on the application of these and other accounting policies, See Note 1, “Summary of Significant Accounting Policies,” in our financial statements included elsewhere in this prospectus.

Inventories

Inventories consist of finished goods purchased for resale, including freight, and are stated at the lower of cost or market value, at the individual product level. Cost is determined on a weighted average cost method, which approximates a FIFO (first-in, first-out) basis. Our management reviews inventory levels in order to identify obsolete and slow-moving merchandise and uses markdowns to clear merchandise. Inventory cost is reduced when the selling price less costs of disposal is below cost. We accrue an estimate for inventory shrink for the period between the last physical count and the balance sheet date. The shrink estimate can be affected by changes in merchandise mix and changes in actual shrink trends. These estimates are derived using available data and our historical experience. Our estimates may be impacted by changes in certain underlying assumptions and may not be indicative of future activity.

Impairment of Long-Lived Assets

Long-lived assets, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable in accordance with ASC Topic 360, Property, Plant and Equipment . Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, then an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. Based on the analysis performed, our management believes that there was no impairment of long-lived assets for each of the 2009, 2010 and 2011 fiscal years.

Income Taxes

Income taxes are accounted for under the asset-and-liability method in accordance with ASC Topic 740, Income Taxes . Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. We recognize the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.

 

48


Table of Contents

We record a valuation allowance to reduce our deferred tax assets when uncertainty regarding their realizability exists. In assessing the realizability of deferred tax assets, our management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during periods in which those temporary differences become deductible. Our management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment.

Stock-Based Compensation

We account for stock-based compensation in accordance with the provisions of ASC Topic 718, Compensation-Stock Compensation , which establishes accounting for equity instruments exchanged for employee services. Under the provisions of this statement, our stock-based compensation expense is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity grant). We recognize compensation expense based on the estimated grant date fair value using the Black-Scholes option-pricing model. The determination of the grant date fair value of options using an option-pricing model is affected by a number of assumptions, such as our estimated common stock fair value, our expected stock price volatility over the expected term of the options, stock option exercise and cancellation behaviors, risk-free interest rates and expected dividends. As a result, if any of the inputs or assumptions used in the Black-Scholes model change significantly, stock-based compensation for future awards may differ materially compared with the awards granted previously.

There are significant judgments and estimates inherent in the determination of fair value of stock-based awards. These judgments and estimates include determinations of an appropriate valuation method and the selection of appropriate inputs to be used in the valuation model. The use of alternative assumptions, including expected term, volatility, risk-free interest rate and dividend yield, could cause stock-based compensation to differ significantly from what has been recorded in the past. Future stock-based compensation cost will increase when we grant additional equity awards. Modifications, cancellations or repurchases of awards may require us to accelerate any remaining unearned stock-based compensation cost or incur additional cost.

Determination of the Fair Value of Common Stock on Grant Date.     We have been a private company with no active public market for our common stock. In connection with each grant of stock options, the fair value of the common stock underlying the stock options was determined by our board of directors, which intended all stock options granted to be exercisable at a price per share not less than the per share fair value of our common stock underlying those stock options on the date of grant. We have determined the estimated per share fair value of our common stock generally using a contemporaneous valuation consistent with the American Institute of Certified Public Accountants Practice Aid, Valuation of Privately-Held Company Equity Securities Issued as Compensation , or the Practice Aid. In conducting this valuation, we have considered all objective and subjective factors that we believed to be relevant, including our best estimate of our business condition, prospects and operating performance at the valuation date. Within this valuation performed by management, with the assistance of any third-party valuation specialists hired by us, a range of factors, assumptions and methodologies have been used. The significant factors have included:

 

   

the fact that we are a private retail company with illiquid securities;

 

   

our historical operating results;

 

   

our discounted future cash flows, based on our projected operating results;

 

   

the likelihood of achieving a liquidity event for the shares of common stock underlying these stock options, such as an initial public offering or sale of our company, given prevailing market conditions;

 

   

valuation of comparable public companies at the time of grant;

 

49


Table of Contents
   

the U.S. and global capital market conditions; and

 

   

outlook for our industry at the time of grant.

After review of the fair value analysis, our board of directors authorized the use of at least that fair value as the exercise price for options granted on the date of that valuation report.

Valuation Methodologies Used in Determining Fair Value.     To determine the estimated fair value of our common stock, we conducted valuation analyses of our common stock considering the factors noted above and, which, at times, were prepared with the assistance of a third-party valuation specialist with experience in the retail industry. We utilized a combination of valuation methods, including an income approach, using an analysis of expected future discounted cash flows and a market approach for similar private and public companies, as well as recent third party transactions. The expected future discounted cash flows analysis identified a level of annual cash flows for a finite number of years and a residual value at the end of the projection period. A discount rate reflecting estimates of investor-required rates of return for similar investments was used to calculate the present value. The market approach used valuation multiples of comparable companies which were applied to our operating results to arrive at a value. We then aggregated and analyzed the valuation results from these valuation methodologies to estimate an expected business enterprise value which was applied to our capital structure to determine a value per common share.

Contractual Obligations

The following table summarizes, as of January 28, 2012, our minimum rental commitments under operating lease agreements including assumed extensions, minimum payments for long-term debt and other obligations in future periods:

 

     Payments Due By Period  

(In millions)

   Total      Less than
1 year
     1-3 years      3-5 years      More than
5 years
 

Operating lease obligations(1)

   $ 268.0       $ 30.6       $ 66.1       $ 62.0       $ 109.3   

Purchase obligations(2)

     1.7         1.7                           

Notes payable

     0.3                 0.3                   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 270.0       $ 32.3       $ 66.4       $ 62.0       $ 109.3   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(1) Our store leases generally have initial lease terms of 5-10 years and include renewal options on substantially the same terms and conditions as the original lease. Also included in operating leases is our corporate office and distribution center leases.
(2) Purchase obligations consist primarily of inventory purchase orders. Our inventory purchase orders are cancellable with limited or no recourse available to the vendor until the inventory is shipped to us.

Since January 28, 2012, we have entered into 17 new fully executed retail leases with an average term of 10 years.

Off Balance Sheet Arrangements

As of and for the three fiscal years ended January 28, 2012, except for operating leases entered into in the normal course of business, we were not party to any material off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, net sales, expenses, results of operations, liquidity, capital expenditures or capital resources.

 

50


Table of Contents

Recently Issued Accounting Pronouncements

In May 2011, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, No. 2011-04, Fair Value Measurement ( Topic 820 ): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRS ). The amendments in ASU No. 2011-04 result in common fair value measurement and disclosure requirements in U.S. generally accepted accounting principles, or U.S. GAAP, and international financial reporting standards, or IFRS, and change the wording used to describe many of the requirements in U.S. GAAP for measuring fair value and for disclosing information about fair value measurements. The amendments do not require additional fair value measurements and are not intended to establish valuation standards or affect valuation practices outside of financial reporting. ASU No. 2011-04 is effective during interim and annual periods beginning after December 15, 2011. The adoption of the new requirements of ASU No. 2011-04 will not have a material impact on our financial position or results of operations.

Quantitative and Qualitative Disclosures about Market Risk

Interest Rate Risk

Our principal market risk relates to interest rate sensitivity, which is the risk that future changes in interest rates will reduce our net income or net assets. We have a Loan and Security Agreement which includes a revolving line of credit with advances tied to a borrowing base and which bears interest at a variable rate. Because our revolving credit facility bears interest at a variable rate, we will be exposed to market risks relating to changes in interest rates. As of January 28, 2012, we had no outstanding borrowings under our revolving credit facility, nor did we have any borrowings during fiscal year 2011. We do not use derivative financial instruments for speculative or trading purposes, but this does not preclude our adoption of specific hedging strategies in the future.

Impact of Inflation

Our results of operations and financial condition are presented based on historical cost. While it is difficult to accurately measure the impact of inflation due to the imprecise nature of the estimates required, we believe the effects of inflation, if any, on our historical results of operations and financial condition have been immaterial. We cannot assure you, however, that our results of operations and financial condition will not be materially impacted by inflation in the future.

 

51


Table of Contents

BUSINESS

Our Company

Five Below is a rapidly growing specialty value retailer offering a broad range of trend-right, high-quality merchandise targeted at the aspirational teen and pre-teen customer. We offer a dynamic, edited assortment of exciting products, all priced at $5 and below, including select brands and licensed merchandise across a number of our category worlds: Style , Room , Sports , Media , Crafts , Party, Candy and Seasonal (which we refer to as “ Now ”). We believe we are transforming the shopping experience of our target demographic with a unique merchandising strategy and high-energy retail concept that our customers consider fun and exciting. Our compelling value proposition and the dynamic nature of our merchandise offering has fostered universal appeal to teens and pre-teens, as well as customers across a variety of age groups beyond our target demographic.

Five Below was founded in 2002 by our Executive Chairman, David Schlessinger, and our President and Chief Executive Officer, Thomas Vellios, who recognized a market need for a fun and affordable shopping destination aimed at our target customer. We opened the first Five Below store in the greater Philadelphia area in 2002 and, since then, have been expanding contiguously across the eastern half of the U.S. At the end of fiscal 2011, we operated a total of 192 locations across 16 states. Our stores average approximately 7,500 square feet and are typically located within power, community and lifestyle shopping centers across a variety of urban, suburban and semi-rural markets. We plan to open approximately 50 stores in 2012, and we believe we have the opportunity to grow our store base to more than 2,000 locations over time.

We believe our powerful business model has resulted in strong financial performance irrespective of the economic environment:

 

   

We have achieved positive comparable store sales during each of the last 23 fiscal quarters.

 

   

Our comparable store sales increased by 12.1% in fiscal 2009, 15.6% in fiscal 2010 and 7.9% in fiscal 2011 with positive comparable store sales performance across all geographic regions and store-year classes.

 

   

Over the past two fiscal years, we expanded our store base from 102 stores to 192 stores, representing a compound annual growth rate of 37.2%.

 

   

Between fiscal 2009 and 2011, our net sales increased from $125.1 million to $297.1 million, representing a 54.1% compound annual growth rate.

 

   

Over the same period, our operating income increased from $6.9 million to $26.2 million, representing a compound annual growth rate of 95.3%.

Our Competitive Strengths

We believe the following strengths differentiate Five Below from competitors and are the key drivers of our success:

 

   

Unique Focus on the Teen and Pre-Teen Customer.     We target an attractive customer segment of teens and pre-teens with trend-right merchandise at a differentiated price point of $5 and below. We have built our concept to appeal to this economically influential and resilient customer base, as well as their parents and others who shop for them. Our brand concept, merchandising strategy and store ambience work in concert to create an upbeat and vibrant retail experience that is designed to appeal to our target audience, drive traffic to our stores and keep our customers engaged throughout their visits. We monitor trends in the ever-changing teen and pre-teen markets and are able to quickly identify and respond to trends that become mainstream. Our price points enable aspiring teens and pre-teens to shop independently, often using their own money to make frequent purchases of items geared primarily to them and to exercise self-expression through their independent retail purchases.

 

52


Table of Contents
   

Broad Assortment of Trend-Right, High-Quality Merchandise with Universal Appeal.     We deliver an edited assortment of trend-right as well as everyday products within each of our category worlds that changes frequently to create a sense of anticipation and freshness, which we believe provides excitement for our customers. We have a broad range of vendors, most of which are domestically-based, which enables us to shorten response lead times, maximizes our speed to market and equips us to make more informed buying decisions. Our unique approach encourages frequent customer visits and limits the cyclical fluctuations experienced by many other specialty retailers. The breadth, depth and quality of our product mix and the diversity of our category worlds attract shoppers across a broad range of age and socio-economic demographics.

 

   

Exceptional Value Proposition for Customers.     We believe we offer a clear value proposition to our customers. Our price points of $5 and below resonate both with our target demographic and also with other value-oriented customers. We are able to deliver on this value proposition through sourcing products in a manner that is designed to achieve low cost, fast response and high item velocity and sell-through. We maintain a dynamic and collaborative relationship with our vendor partners that provides us with favorable access to quality merchandise at attractive prices. We also employ an opportunistic buying strategy, capitalizing on select excess inventory opportunities with our vendors. This unique and flexible sourcing strategy allows us to offer high-quality products at exceptional value across all of our category worlds.

 

   

Differentiated Shopping Experience.     We believe we have created a unique and engaging in-store atmosphere that customers find fun and exciting. While we refresh our products frequently, we maintain a consistent floor layout, designed with an easy-to-navigate racetrack flow and featuring sight-lines across the entire store enabling customers to easily identify our category worlds. All of our stores feature a sound system playing trend-right music throughout the shopping day. We employ novel and dynamic techniques to display our products, including distinctive merchandise fixtures and colorful and stimulating signage, which attract customers, encourage hands-on interaction with our products, and convey our value pricing. We have developed a unique culture that emanates from our employees, many of whom frequently shop at Five Below, to our customers, thereby driving a higher level of connectivity and engagement. Additionally, we believe our price points of $5 and below, coupled with our dynamic merchandising approach, create an element of discovery, driving repeat visits and customer engagement while insulating us against e-commerce cannibalization trends.

 

   

Powerful and Consistent Store Economics.     We have a proven store model that generates strong cash flow, consistent store-level financial results and high level return on investment. Our stores have been successful in varying geographic regions, population densities and real estate settings. Each of our stores was profitable on a four-wall basis in fiscal 2011 and our new stores have achieved average payback periods of less than one year. We believe our robust store model, reinforced by our rigorous site selection process and in-store execution, drives the strength and consistency of our comparable store sales financial results across all geographic regions and store-year classes.

 

   

Highly Experienced and Passionate Senior Management Team with Proven Track Record.     Since our inception, our co-founders, David Schlessinger and Thomas Vellios, who have approximately 65 combined years of retail experience, have set the vision and strategic direction for Five Below. Messrs. Schlessinger and Vellios have assembled a talented senior management team averaging 24 years of retail experience across a broad range of disciplines, including merchandising, real estate, finance, store operations, supply chain management and information technology. Our management team drives our operating philosophy, which is based on a relentless focus on providing high-quality merchandise at exceptional value and a superior shopping experience utilizing a disciplined, low-cost operating and sourcing structure. We believe our management team is integral to our success and has positioned us well for long-term growth.

 

53


Table of Contents

Growth Strategy

We believe we can grow our net sales and earnings by executing on the following strategies:

 

   

Grow Our Store Base.     We believe there is significant opportunity to expand our store base in the U.S. from 192 locations at the end of fiscal 2011 to more than 2,000 locations within the U.S. over time, based on our experience and supported by research conducted for us by The Buxton Company, a customer analytics research firm. We expect most of our near-term growth will occur within our existing eastern U.S. markets as well as contiguous new markets. We opened 50 net new stores in fiscal 2011 and plan to open approximately 50 in fiscal 2012 and approximately 60 in fiscal 2013. Our stores average approximately 7,500 square feet and are primarily inline locations within power, community and lifestyle shopping centers across a variety of urban, suburban and semi-rural markets. We have a talented and disciplined real estate management team and a rigorous real estate site selection process. We analyze the demographics of the surrounding trade areas, the performance of adjacent retailers as well as traffic and specific site characteristics and other variables. As of March 31, 2012, we have executed lease agreements for the opening of 43 stores in fiscal 2012.

 

   

Drive Comparable Store Sales.     We expect to continue generating positive comparable store sales growth by continuing to hone and refine our dynamic merchandising offering and differentiated in-store shopping experience. We intend to increase our brand awareness through cost-effective marketing efforts and enthusiastic customer engagement. We believe that executing on these strategies will increase the size and frequency of purchases by our existing customers and attract new customers to our stores.

 

   

Increase Brand Awareness.     We have a cost-effective marketing strategy designed to drive store traffic and promote brand awareness. Our strategy includes the use of newspaper circulars, local media and grassroots marketing to support existing and new market entries. We believe we have an opportunity to leverage our growing social media presence to drive brand excitement and increased store visits within existing and new markets. We believe our online platform is an extension of our brand and retail stores, serving as a marketing and informational tool for us. This platform allows us to continue to build brand awareness and expand our customer base.

 

   

Enhance Operating Margins.     We believe we have further opportunities to drive margin improvement over time. A primary driver of our expected margin expansion will come from leveraging our cost structure as we continue to increase our store base and drive our average net sales per store. We intend to capitalize on opportunities across our supply chain as we grow our business and achieve further economies of scale.

Our Market Opportunity

As a result of our unique merchandise offering and value proposition, we believe we have effectively tapped the teen and pre-teen markets. According to the U.S. Census Bureau, there were over 63 million people in the U.S. between the ages of 5 and 19, which represented over 20% of the U.S. population as of April 1, 2010. This segment of the population has a significant amount of disposable income as the vast majority of this age group’s basic needs are already met. According to EPM Communications, Inc., a publishing, research and consulting firm, teens and pre-teens between the ages of 8 and 19 were projected to spend over $250 billion in the U.S. in 2011.

 

54


Table of Contents

Our Merchandise

Strategy

We offer a dynamic, edited assortment of trend-right, high-quality products, all priced at $5 or below, including select brands and licensed merchandise, targeted at the teen and pre-teen customer. We believe we are transforming the shopping experience of our target demographic with a unique merchandising strategy and high-energy retail concept that our customers consider fun and exciting. Our compelling value proposition and the dynamic nature of our merchandise offering has fostered universal appeal to customers across a variety of age groups beyond our target demographic.

Our typical store features in excess of 4,000 stock-keeping units, or SKUs, across a number of our category worlds including Style , Room , Sports , Media , Crafts , Party, Candy and Seasonal . We focus our merchandising strategy on maintaining core categories within our stores, but aim to generate high item velocity and sell-through to keep our assortment fresh and drive repeat visits. We monitor trends in our target demographic market, historical sales trends of current and prior products and the success of new product launches to ensure that our merchandise is relevant for our customers. We have a highly planned merchandise strategy focused on trend-right and everyday products supplemented by selected opportunistic purchases from our vendors to drive traffic and therefore offer our customers a consistently exciting shopping experience.

We believe we offer a compelling value proposition to our customers across all of our core product categories. The common element of our dynamic merchandise selection is the consistent delivery of exceptional value to the consumer, with all products offered at or below the $5 price point. Pricing all items at $5 or below enables us to provide an extensive range of exciting products, while maintaining the attraction of a value retailer. Many of the products we sell can also be found in mall specialty stores, department stores, mass merchandisers and drug stores; however, we offer all of these products in an exciting and easy to shop retail environment at price points of $5 and below.

Product Mix

We organize our merchandise into the following category worlds:

 

   

Style :    Consists primarily of accessories such as novelty socks, sunglasses, jewelry, scarves, gloves, hair accessories and “attitude” t-shirts. Our beauty offering includes products such as nail polish, lip gloss, fragrance and branded cosmetics.

 

   

Room :    Consists of items used to complete and personalize our customer’s living space, including glitter lamps, posters, frames, fleece blankets, pillows, candles, incense and related items. We also offer storage options for the customer’s room and locker.

 

   

Sports :    Consists of an assortment of sport balls, team sports merchandise and fitness accessories, including hand weights, jump ropes and gym balls. We also offer a variety of games, including name brand board games, puzzles, toys and plush items. In the summer season, our sports offering also includes pool, beach and outdoor toys, games and accessories.

 

   

Media :    Consists of a broad selection of accessories for PCs, cell phones, MP3 players and tablet computers. The offering includes cases, chargers, headphones and other related items. We also carry a wide range of media products including books, video games and DVDs.

 

   

Crafts :    We offer a wide assortment of craft activity kits, as well as arts and crafts supplies such as crayons, markers and stickers. We also offer trend-right items for school such as backpacks, fashion notebooks and journals, novelty pens and pencils, as well as everyday name brand items.

 

   

Party :    Consists of a variety of party supplies, decorations and greeting cards, as well as everyday and special occasion merchandise.

 

   

Candy :    Consists of a broad range of branded items that appeal to teens and pre-teens. This category includes an extensive assortment of classic and novelty candy bars and movie-size box candy as well as gum and snack food. We also sell chilled drinks via coolers.

 

55


Table of Contents
   

Seasonal :    Consists of seasonally-specific items used to celebrate and decorate for events such as Christmas, Easter, Halloween and St. Patrick’s Day. These products are most often placed at the front of the store.

As of fiscal 2011, no single category world represented more than 22% of our total sales.

Our Stores

At the end of fiscal 2011, we operated 192 stores throughout the eastern half of the U.S. In fiscal 2011, our average store size was approximately 7,500 square feet. Our stores are primarily located in power, community and lifestyle shopping centers; only approximately 5% of our stores are located in malls.

 

LOGO

Store Design and Layout

We present our products in a unique and engaging in-store atmosphere. We maintain a consistent floor layout designed with an easy-to-navigate racetrack flow and featuring sight-lines across the entire store enabling customers to easily identify our category worlds. All of our stores feature a sound system playing popular music throughout the shopping day. We employ novel and dynamic techniques to display our products, including distinctive merchandise fixtures and colorful and stimulating signage, which attract customers, encourage hands-on interaction with our products and convey our value pricing. In addition to traditional perimeter and gondola shelving, racks and tables, we utilize innovative approaches such as wheelbarrows, barrels and bins strategically placed throughout our stores. These techniques foster customer interaction with products, supporting the strong relationship we strive to develop with our customers and enhance our upbeat and vibrant shopping environment.

Each of our category worlds is strategically located within our stores in an effort to enhance the customer’s shopping experience. For example, seasonal offerings are located in the front of the store with the goal of catching customers’ attention and being “top of mind,” and specially featured value “wow” items and other key items are positioned along the center aisle. Impulse items and “dollar value” tables surround the checkout areas to capture add-on purchases.

 

56


Table of Contents

Expansion Opportunities and Site Selection

Our unique focus on the teen and pre-teen customer is supported by our real estate strategy to locate stores in high visibility locations. We seek to operate stores in high-visibility, high traffic retail venues, which reinforce our brand message, heighten brand awareness and drive customer traffic.

Our strategy is to saturate markets with clusters of stores because of the considerable benefit that stores derive from market concentration. Our store model is profitable across a variety of urban, suburban and semi-rural markets and in multiple real estate venues including power, community and lifestyle shopping centers. Our retail concept works well with a large and varied group of national co-tenants that drive customer traffic.

We select store sites for new store openings based upon certain criteria including minimum population density requirements, availability of attractive lease terms, sufficient space and strong positioning within a center. Members of our real estate team spend considerable time evaluating prospective sites before bringing a proposal to our real estate committee. Our real estate committee, which is composed of senior management including our executive officers, approves all of our locations before a lease is signed.

We believe there is a significant opportunity to expand our store base in the U.S. In fiscal 2011, we opened 50 net new stores, and in fiscal 2012, we intend to open approximately 50 new stores through expansion in existing markets and by entering new markets. We maintain a pipeline of real estate sites that have been approved by our real estate committee and have executed 43 leases through March 31, 2012 for new stores in fiscal 2012. Our recent store growth is summarized in the following table:

 

Period

   Stores at
Start of
Period
     Stores
Opened
     Stores
Closed
     Net
Store
Increase
     Stores at
End of
Period
 

Fiscal 2009

     82         20                 20         102   

Fiscal 2010

     102         40                 40         142   

Fiscal 2011

     142         51         1         50         192   

Opening stores within existing markets enables Five Below to benefit from enhanced brand awareness and to achieve advertising, operating and distribution efficiencies. Our targeted new store openings include additional locations in existing markets as well as expansion into adjacent states and markets. In existing markets, we use a store densification strategy that promotes brand awareness and leverages marketing, operating and distribution costs. When entering new markets we employ a store clustering strategy, opening multiple stores in a single market on the same day, enabling us to leverage marketing and pre-opening expenses.

Our store growth is supported by our new store economics, which we believe to be compelling. Our new store model assumes an average store size of approximately 7,500 square feet that achieves sales of approximately $1.5 million to $1.6 million in the first full year of operation and an average new store cash investment of approximately $300,000, including our store buildout (net of tenant allowances), inventory and cash pre-opening expenses. Our new store model targets an average payback period of less than one year on our initial investment.

Store Management, Culture and Training

Each of our stores is managed by a general manager and one or two assistant managers who oversee full-time and part-time team members within each store. Each general manager is responsible for the day-to-day operations of his or her store, including the unit’s operating results, maintaining a clean and appealing store environment and the hiring, training and development of personnel. We also employ district managers, who are responsible for overseeing the operations of 10 to 15 stores, on average.

We are guided by a philosophy that recognizes strong sales performance and customer service, allowing us to identify and reward team members who meet our high performance standards. Store managers and assistant

 

57


Table of Contents

managers participate in a rewarding bonus incentive program based on exceeding planned levels of sales and are paid on a monthly basis. We also recognize individual performance through internal promotions and provide extensive opportunities for advancement.

Our employees are critical to achieving our goals, and we strive to hire talented employees with high energy levels and motivation. We have well-established store operating policies and procedures and an in-store training program for new store managers, assistant managers and staff. In addition, we have a dedicated group of training and new store opening managers who are focused on ensuring a consistent new store opening process and who leverage their extensive experience and knowledge of the Five Below culture to train new store managers. Our customer service and store procedure training programs are designed to enable associates to assist customers in a friendly manner and to help to create a positive sales-driven environment and culture as well as teach successful operating practices and procedures.

Merchandise Sourcing and Distribution

We have developed a disciplined approach to buying and a dynamic inventory planning and allocation process to support our merchandising strategy.

Merchandising

Our merchandising team consists of two general merchandise managers, who report directly to our Chief Executive Officer, supported by an approximate 30-member merchandising team. Our merchandising team works directly with our central planning and allocation group to ensure a consistent delivery of products across our store base. Each of our general merchandise managers has over 20 years of experience within the retail sector.

Sourcing

We believe we have strong sourcing capabilities developed through a dynamic and collaborative relationship with our vendor partners that provides us with favorable access to quality merchandise at attractive prices. We regularly purchase core merchandise in accordance with our key categories. We also employ an opportunistic buying strategy, capitalizing on selected excess inventory opportunities, to purchase complementary merchandise based on consumer trends, product availability and favorable economic terms.

We work with approximately 700 active vendors, with no single vendor representing more than 8% of our purchases in fiscal 2011. We source approximately 90% of our purchases from domestic vendors. We typically have no long-term supply agreements or exclusive arrangements with our vendors and our top 20 vendors represent approximately 35% of total goods purchased in fiscal 2011.

Distribution

We distribute over 85% of the merchandise sold by us from our 421,000 square foot distribution center in New Castle, Delaware with the remaining merchandise shipped directly from the vendor to our stores. We realize cost savings by working with our vendors to streamline and reduce packaging to diminish shipping costs.

We generally ship merchandise from our distribution center to our stores between two and four times a week, depending on the season and the volume of a specific store. We use contract carriers to ship merchandise to our stores.

We are in the process of finalizing alternatives for a new distribution center, which we expect to open during fiscal 2013, to support our growth. From time to time, we augment our distribution facilities with third party warehousing.

 

58


Table of Contents

Marketing and Advertising

Our cost-effective marketing strategy is designed to drive store traffic and increase brand awareness with our target demographic, as well as other value-oriented customers. Our strategy includes the use of newspaper circulars focused during peak selling seasons that highlight our brand and exceptional value proposition as well as local media and grassroots marketing to support existing and new market entries. Additionally, we rely on the strong visibility and the presence of our store locations, email messaging and community and school marketing to promote and further our brand image and drive traffic.

Our marketing team works with our merchandising team to develop novel and dynamic techniques to display our products, including distinctive merchandise fixtures and colorful and stimulating signage, which attract customers, encourage hands-on interaction with our products and convey our value pricing.

For new store openings, we seek to create community awareness and consumer excitement through a mix of print advertising, public relations and radio promoting the grand opening and by creating an on-site grand opening event that includes free drinks and signature “Five Cent” hot dogs. We also aim to target multiple store openings in a given new market on the same day in order to leverage marketing efforts to produce maximum impact.

In addition to our marketing and public relations efforts described above, we also maintain a website ( www.fivebelow.com ) and, over the last year, our online following has grown substantially. We use both our website and social networking sites to highlight our value proposition, store locations, employment opportunities, featured products and grand openings.

Competition

We compete with a broad range of retailers including discount, mass merchandise, grocery, drug, convenience, variety and other specialty stores. Many of these retail companies operate stores in many of the areas where we operate, and many of them engage in extensive advertising and marketing efforts.

The principal basis upon which we compete is by offering a dynamic, edited assortment of exciting products, all priced at $5 or below and including select brands and licensed merchandise, targeted at the teen and pre-teen customer. We believe we are transforming the shopping experience of our target demographic with a unique merchandising strategy and high-energy retail concept that our customers consider fun and exciting. Our success also depends in substantial part on our ability to respond quickly to trends so that we can meet the changing demands of our customers. We believe that we compare favorably relative to many of our competitors based on our merchandising strategy, edited product assortment targeted at teens and pre-teens, store environment, flexible real estate strategy and company culture. Nonetheless, certain of our competitors have greater financial, distribution, marketing and other resources than we do.

Trademarks and Other Intellectual Property

We own several trademarks that have been registered with the U.S. Patent and Trademark Office, including Five Below ® and Five Below Hot Stuff. Cool Prices ® . We also own domain names, including www.fivebelow.com , and unregistered copyrights in our website content. We attempt to obtain registration of our trademarks whenever practicable and pursue any infringement of those marks.

Management Information Systems

Our management information systems provide a full range of business process assistance and timely information to support our merchandising strategy, warehouse management, stores and operating and financial

 

59


Table of Contents

teams. We believe our current systems provide us with operational efficiencies, scalability, management control and timely reporting that allow us to identify and respond to merchandising and operating trends in our business. We use a combination of internal and external resources to support store point-of-sale, merchandise planning and buying, inventory management, financial reporting, real estate and administrative functions. We believe that our information systems have the capacity to accommodate our growth plans.

Government Regulation

We are subject to labor and employment laws, laws governing advertising, privacy laws, safety regulations and other laws, including consumer protection regulations that regulate retailers and/or govern the promotion and sale of merchandise and the operation of stores and warehouse facilities. We monitor changes in these laws and believe that we are in material compliance with applicable laws.

Insurance

We maintain third-party insurance for a number of risk management activities including workers’ compensation, general liability, property and employee-related health care benefits. We evaluate our insurance requirements on an ongoing basis to ensure we maintain adequate levels of coverage.

Employees

As of fiscal 2011, we employed approximately 570 full-time and 2,400 part-time personnel. Of our total employees, approximately 105 were based at our corporate headquarters in Philadelphia, Pennsylvania, approximately 115 were based at our distribution center in New Castle, Delaware and approximately 2,750 were store employees. The number of part-time associates fluctuates depending on seasonal needs. We consider our relationship with our employees to be very good. None of our employees belong to a union or are party to any collective bargaining or similar agreement.

Properties

We do not own any real property. Our corporate headquarters are located in Philadelphia, Pennsylvania and are leased under a lease agreement expiring in 2022, with options to renew for two successive five-year periods. Our 421,000 square foot distribution center is located in New Castle, Delaware and is leased under a lease agreement expiring in 2016 with options to renew for two successive five-year periods. We plan to open a second distribution center in the southern U.S. in 2013. At the end of fiscal 2011, there were 192 Five Below store locations in 16 states. All of our stores are leased from third parties and the leases typically have five to ten year terms with one or more five-year renewal options, and many provide us with the option to terminate early under specified conditions. In addition to future minimum lease payments, some of our store leases provide for additional rental payments based on a percentage of net sales if sales at the respective stores exceed specified levels, as well as the payment of common area maintenance charges, real property insurance and real estate taxes. Many of our lease agreements have defined escalating rent provisions over the initial term and any extensions.

Legal Proceedings

We are subject to various legal proceedings and claims which arise in the ordinary course of our business. Although the outcome of these and other claims cannot be predicted with certainty, management does not believe that the ultimate resolution of these matters will have a material adverse effect on our financial condition or on our results of operations.

Corporate Information

Five Below was incorporated in Pennsylvania in January 2002 under the name of Cheap Holdings, Inc. We changed our name to Five Below, Inc. in July 2002.

 

60


Table of Contents

MANAGEMENT

Executive Officers, Key Employees and Directors

The following table sets forth information concerning our current executive officers, key employees and directors.

 

Name

  

Age

    

Position/Title

David Schlessinger

     57       Executive Chairman, Director

Thomas G. Vellios

     57       President and Chief Executive Officer, Director

Kenneth R. Bull

     49       Chief Financial Officer, Secretary and Treasurer

Jeffrey D. Moore

     45       General Merchandise Manager

Eugene F. Rosadino

     52       Senior Vice President, Supply Chain

Lisa Surella

     49       General Merchandise Manager

Steven J. Collins

     43       Director

Andrew W. Crawford

     33       Director

David M. Mussafer

     48       Director

Howard D. Ross

     60       Director

Thomas M. Ryan

     59       Director

Ronald L. Sargent

     56       Director

Our directors have been selected pursuant to the terms of a shareholders agreement described more fully below. That agreement will no longer be in force following the closing of this offering.

Executive Officers

David Schlessinger .    Mr. Schlessinger is the co-founder of Five Below and has served as our Executive Chairman since February 2005. Mr. Schlessinger previously served as our President from 2002 to 2005. Mr. Schlessinger has been a director of Five Below since our incorporation in 2002. Previously, Mr. Schlessinger founded Zany Brainy, Inc., a retail children’s educational products company, in 1991 and served as Zany Brainy’s Chief Executive Officer until 1996 and as its Chairman until 1998. He also founded Encore Books, a retail bookstore chain, in 1973 and served as its Chairman and Chief Executive Officer until 1986. Mr. Schlessinger previously served as a director of Destination Maternity Corporation. Mr. Schlessinger’s extensive experience in the management, operations and finance of a retail business as well as his knowledge of our company as a founder has led to the conclusion that he should serve as a director of Five Below.

Thomas G. Vellios .    Mr. Vellios is the co-founder of Five Below and has served as our President and Chief Executive Officer since 2005. Mr. Vellios has been a director of Five Below since our incorporation in 2002. Previously, Mr. Vellios served as President, Chief Executive Officer and a director of Zany Brainy, Inc. Prior to joining Zany Brainy, Mr. Vellios served as Senior Vice President, General Merchandise Manager at Caldor, a regional discount chain and a division of the May Company. Mr. Vellios currently serves as a director of Hot Topic, Inc. Mr. Vellios’ extensive experience in the retail industry, his experience with the management, operations and finance of a retail business, and his knowledge of our company as a founder has led to the conclusion that he should serve as a director of Five Below.

Kenneth R. Bull .     Mr. Bull joined Five Below as Senior Vice President, Finance in 2005 and was later appointed as our Secretary and Treasurer. In 2012, he was promoted to Chief Financial Officer. Previously, Mr. Bull was the Finance Director and Treasurer for Urban Outfitters, Inc., a specialty lifestyle merchandising retailer, from 1999 to 2003, and the Vice President, Finance and Controller for Asian American Partners d/b/a Eagle’s Eye, a wholesaler and retailer of women’s and children’s better apparel from 1991 to 1999.

 

61


Table of Contents

Key Employees

Jeffrey D. Moore.     Mr. Moore joined Five Below in 2007 as General Merchandise Manager. Prior to joining Five Below, Mr. Moore was Senior Vice President and General Merchandise Manager with David’s Bridal, a bridal retailer, from 2002 to 2007. Prior to David’s Bridal, he was Senior Vice President and General Merchandise Manager at The Bon-Ton Department Stores, a retail store chain, from 1998 to 2002.

Eugene F. Rosadino.     Mr. Rosadino joined Five Below in 2008 as Senior Vice President, Supply Chain. Prior to joining Five Below, he was Vice President, Supply Chain with Blue Tulip, Inc., a card and gift retail store, from 2005 to 2008. Prior to joining Blue Tulip, Mr. Rosadino held the roles of Chief Operating Officer with 4R Systems, an inventory management consulting firm, and Executive Vice President of inventory management with Zany Brainy, Inc.

Lisa Surella.     Ms. Surella joined Five Below in 2012 as General Merchandise Manager. Prior to joining Five Below, she was the Vice President and Divisional Merchandise Manager, Ladies Apparel with Wal-Mart Stores, Inc., a discount retailer, from 2009 to 2012. Prior to Wal-Mart, she was Senior Vice President and General Merchandise Manager at Lord & Taylor, a specialty-retail department store chain, from 1999 to 2009.

Non-Employee Directors

Steven J. Collins.     Mr. Collins has served as a director since 2010. Mr. Collins, a Managing Director of Advent International, which he joined in 1995, currently serves as a director of Party City Holdings, Inc., Kirkland’s, Inc. and several privately held businesses, including Charlotte Russe Holding, Inc., and previously served as a director of lululemon athletica inc. Mr. Collins’ experience serving as a director of public and private companies and his affiliation with Advent International, whose Series A 8% convertible preferred stock holdings entitle it to elect up to five directors (prior to the closing of this offering as described under “—Board Composition”), led to the conclusion that he should serve as a director of Five Below.

Andrew W. Crawford.     Mr. Crawford has served as a director since 2010. Mr. Crawford is a Principal with Advent International, which he joined in 2003 as an associate and rejoined as a Principal in 2008, following business school. Mr. Crawford currently serves as a director of privately held businesses, including Charlotte Russe Holding, Inc. Mr. Crawford’s experience in private equity fund management, his financial expertise and his affiliation with Advent International, led to the conclusion that he should serve as a director of Five Below.

David M. Mussafer.     Mr. Mussafer has served as a director since 2010. Mr. Mussafer, a Managing Partner of Advent International, which he joined in 1990, currently serves as a director of Party City Holdings, Inc., Vantiv, Inc. and Charlotte Russe Holding Inc. and previously served as a director of lululemon athletica inc. and a number of privately held businesses. Mr. Mussafer’s experience serving as a director of public and private businesses and his affiliation with Advent International, led to the conclusion that he should serve as a director of Five Below.

Howard D. Ross.     Mr. Ross has served as a director since 2005. Mr. Ross, a co-founder of LLR Partners Inc., which manages private equity funds, currently serves as a director of several privately held businesses. Prior to the formation of LLR Partners in 1999, Mr. Ross was a partner in Arthur Andersen LLP, an accounting firm. Mr. Ross’ background in accounting and private equity fund management, his financial expertise and roles on several boards of directors led to the conclusion that he should serve as a director of Five Below.

Thomas M. Ryan.     Mr. Ryan has served as a director since 2011. In 2011, Mr. Ryan became an operating partner of Advent International as a part of its Operating Partner Program. Prior to joining our board of directors, Mr. Ryan served as the Chairman of the board of directors, President and Chief Executive Officer of CVS Caremark Corporation, a retail pharmacy and healthcare corporation, until he retired in 2011. Mr. Ryan became

 

62


Table of Contents

the Chief Executive Officer of CVS Corporation in 1998 and he also served as the Chairman of the board of directors of CVS Corporation from 1999 to 2007. In 2007, Mr. Ryan again became the chairman of CVS Caremark Corporation’s board of directors. Mr. Ryan currently serves as a director of Yum! Brands, Inc. and Vantiv, Inc. and previously served as a director of Bank of America Corporation. Mr. Ryan’s experience in the retail industry, as both an executive officer and director of a large retail company, led to the conclusion that he should serve as a director of Five Below.

Ronald L. Sargent.     Mr. Sargent has served as a director since 2004. Mr. Sargent has served as the Chief Executive Officer of Staples, Inc., an office supply company, since 2002 and as Chairman of its board of directors since 2005. Prior to becoming Chairman and Chief Executive Officer, Mr. Sargent held a variety of executive positions at Staples, Inc. since joining the company in 1989. Mr. Sargent currently serves as a director of The Kroger Co. and The Home Depot, Inc. Mr. Sargent’s experience as an executive officer and director of Staples, Inc. as well as his extensive experience in the retail industry led to the conclusion that he should serve as a director of Five Below.

In addition to the information presented above regarding each director’s specific experiences, qualifications, attributes and skills, we believe that all of our directors have a reputation for integrity and adherence to high ethical standards. Each of our directors has demonstrated business acumen and an ability to exercise sound judgment, as well as a commitment of service to us and our board. Finally, we value our directors’ experience on other company boards and board committees.

Our executive officers are appointed by our board of directors and serve until their successors have been duly appointed and qualified or their earlier resignation or removal. There are no family relationships among any of our directors or executive officers.

Board Composition

Our business and affairs are managed under the direction of our board of directors, which currently consists of eight members. Upon the closing of this offering, our amended and restated articles of incorporation and amended bylaws will provide that our board of directors will consist of a number of directors, not less than three nor more than eleven, to be fixed exclusively by resolution of the board of directors.

As of the closing of this offering, our amended and restated articles of incorporation will provide for a staggered, or classified, board of directors consisting of three classes of directors, each serving staggered three-year terms, as follows:

 

   

the Class I directors will be Messrs. Ross and Sargent, and their terms will expire at the annual general meeting of shareholders to be held in 2013;

 

   

the Class II directors will be Messrs. Collins, Crawford and Ryan, and their terms will expire at the annual general meeting of shareholders to be held in 2014; and

 

   

the Class III directors will be Messrs. Mussafer, Schlessinger and Vellios, and their terms will expire at the annual general meeting of shareholders to be held in 2015.

Upon expiration of the term of a class of directors, directors for that class will be elected for a three-year term at the annual meeting of shareholders in the year in which that term expires. Each director’s term continues until the election and qualification of his or her successor, or his or her earlier death, resignation, retirement, disqualification or removal. Any vacancies on our board of directors will be filled only by the affirmative vote of a majority of the directors then in office. Any increase or decrease in the number of directors will be distributed among the three classes so that, as nearly as possible, each class will consist of one-third of the directors. The classification of our board of directors will make it more difficult for a third party to acquire control of us.

 

63


Table of Contents

Our shareholders agreement has provided that the holders of our capital stock must agree to vote their shares in favor of the election to our board of directors of five individuals designated by holders of our Series A 8% convertible preferred stock and three individuals designated by holders of our common stock. Messrs. Collins, Crawford, Mussafer, Ross and Ryan are the designees of holders of our Series A 8% convertible preferred stock and Messrs. Sargent, Schlessinger and Vellios are the designees of holders of our common stock. The shareholders agreement, and all of the rights and obligations of our shareholders under the agreement, will be terminated upon the closing of this offering. See “Certain Relationships and Related Party Transactions—Second Amended and Restated Shareholders Agreement.”

Director Independence and Controlled Company Status

Upon the closing of this offering, Advent will continue to own a majority interest in us and we will be a “controlled company” under the rules of The NASDAQ Stock Market LLC. We do not intend to avail ourselves of any of the “controlled company” exemptions under the corporate governance rules of The NASDAQ Stock Market LLC. As such, our board of directors will observe all applicable criteria for independence established by The NASDAQ Stock Market LLC and other governing laws and applicable regulations. No director will be deemed to be independent unless our board of directors determines that the director has no relationship which would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. Our board of directors has determined that Messrs. Collins, Crawford, Mussafer, Ross, Ryan and Sargent are independent as defined under the corporate governance rules of The NASDAQ Stock Market LLC. Of these six independent directors, our board has determined that: (i) Messrs. Ross, Ryan and Sargent, who will comprise our audit committee; (ii) Messrs. Collins, Crawford and Ryan, who will comprise our compensation committee; and (iii) Messrs. Crawford, Mussafer and Sargent, who will comprise our nominating and corporate governance committee, each satisfy the independence standards for those committees established by the applicable rules and regulations of the SEC and The NASDAQ Stock Market LLC.

Board Leadership Structure and Board’s Role in Risk Oversight

Our board of directors has no policy with respect to the separation of the offices of Chief Executive Officer and Chairman of the board of directors. It is the board of directors’ view that rather than having a rigid policy, the board of directors, with the advice and assistance of the nominating and corporate governance committee, and upon consideration of all relevant factors and circumstances, will determine, as and when appropriate, whether the two offices should be separate. Currently, our leadership structure separates the offices of Chief Executive Officer and Chairman of the board of directors with Mr. Vellios serving as our Chief Executive Officer and Mr. Schlessinger as Executive Chairman of the board. We believe this is appropriate as it provides Mr. Vellios with the ability to focus on our day-to-day operations while allowing Mr. Schlessinger to lead our board of directors in its fundamental role of providing advice to, and oversight of management. In addition, as Executive Chairman, Mr. Schlessinger remains involved in key matters affecting our business and in implementing our growth strategy.

Our board of directors plays an active role in overseeing management of our risks. Our board of directors regularly reviews information regarding our credit, liquidity and operations, as well as the risks associated with each. Effective upon the closing of this offering, our compensation committee will be responsible for overseeing the management of risks relating to our executive compensation plans and arrangements. Effective upon closing of this offering, our audit committee will oversee management of financial risks. Effective upon the closing of this offering, our nominating and corporate governance committee will be responsible for managing risks associated with the independence of the board of directors. While each committee will be responsible for evaluating certain risks and overseeing the management of such risks, our full board of directors plans to keep itself regularly informed regarding such risks through committee reports and otherwise.

 

64


Table of Contents

Committees of the Board of Directors

Our board of directors has established, or will establish prior to the closing of this offering, an audit committee, a compensation committee and a nominating and corporate governance committee. Each committee will operate under a charter that will be approved by our board of directors and will be available on our website, www.fivebelow.com , under the “                            ” section, upon the effective date of this offering.

Audit Committee

Our audit committee oversees our corporate accounting and financial reporting process. The audit committee has the following responsibilities, among others things, as set forth in the audit committee charter that will be effective upon the closing of this offering:

 

   

selecting and hiring our independent registered public accounting firm and approving the audit and non-audit services to be performed by our independent registered public accounting firm;

 

   

evaluating the qualifications, performance and independence of our independent registered public accounting firm;

 

   

monitoring the integrity of our financial statements and our compliance with legal and regulatory requirements as they relate to financial statements or accounting matters;

 

   

reviewing the adequacy and effectiveness of our internal control policies and procedures;

 

   

overseeing management of financial risks;

 

   

preparing the audit committee report required by the SEC to be included in our annual proxy statement;

 

   

discussing the scope and results of the audit with the independent registered public accounting firm and reviewing with management and the independent registered public accounting firm our interim and year-end operating results;

 

   

approving related party transactions; and

 

   

reviewing whistleblower complaints relating to accounting, internal accounting controls or auditing matters and overseeing the investigations conducted in connection with such complaints.

Our audit committee currently consists of Messrs. Collins, Crawford, Ross and Sargent. Upon the closing of this offering, our audit committee will be composed of Messrs. Ross, Ryan and Sargent. Mr. Ross will serve as the chairperson of the audit committee. All of the members of the audit committee are independent for purposes of serving on the audit committee and meet the requirements for financial literacy under the applicable rules and regulations of the SEC and The NASDAQ Stock Market LLC. Our board has determined that Mr. Ross is an audit committee financial expert as defined under the applicable rules of the SEC and has the requisite financial sophistication defined under the applicable rules of The NASDAQ Stock Market LLC. See “—Director Independence.”

Compensation Committee

Our compensation committee reviews and recommends policies relating to compensation and benefits of our officers and employees. The compensation committee has the following responsibilities, among other things, as set forth in the compensation committee’s charter that will be effective upon the closing of this offering:

 

   

reviewing and approving compensation of our executive officers, including annual base salary, annual incentive bonuses, specific goals, equity compensation, employment agreements, severance and change-in-control arrangements and any other benefits, compensation or arrangements;

 

   

reviewing and recommending the terms of employment agreements with our executive officers;

 

65


Table of Contents
   

reviewing succession planning for our executive officers;

 

   

reviewing and recommending compensation goals, bonus and stock-based compensation criteria for our employees;

 

   

reviewing and recommending the appropriate structure and amount of compensation for our directors;

 

   

overseeing the management of risks relating to our executive compensation plans and arrangements;

 

   

reviewing and discussing annually with management our “Compensation Discussion and Analysis” required by SEC rules;

 

   

preparing the compensation committee report required by the SEC to be included in our annual proxy statement; and

 

   

administering, reviewing and making recommendations with respect to our equity compensation plans.

Our compensation committee currently consists of Messrs. Collins, Mussafer, Ross and Sargent. Upon the closing of this offering, our compensation committee will be composed of Messrs. Collins, Crawford and Ryan. Mr. Collins will serve as the chairperson of the compensation committee. All of the members of the compensation committee are determined to be independent under applicable rules and regulations of the SEC and The NASDAQ Stock Market LLC. See “—Director Independence.”

Nominating and Corporate Governance Committee

The nominating and corporate governance committee is responsible for making recommendations regarding candidates for directorships and the size and composition of our board. Among other matters, the nominating and corporate governance committee is responsible for the following as set forth in their charter that will be effective upon the closing of this offering:

 

   

assisting our board of directors in identifying prospective director nominees and recommending nominees for each annual meeting of shareholders to our board of directors;

 

   

reviewing developments in corporate governance practices and developing and recommending governance principles applicable to our board of directors;

 

   

managing risks associated with the independence of the board of directors;

 

   

evaluating and determining the size and composition of the board of directors;

 

   

overseeing the evaluation of our board of directors and management; and

 

   

recommending members for each board committee of our board of directors.

Messrs. Crawford, Mussafer and Sargent have been elected to serve on our nominating and corporate governance committee upon the closing of this offering. Mr. Mussafer will serve as the chairperson of the nominating and corporate governance committee. All of the members of the nominating and corporate governance committee are determined to be independent under applicable rules and regulations of the SEC and The NASDAQ Stock Market LLC. See “—Director Independence.”

Director Compensation

In fiscal 2011, our directors did not receive compensation for their service as directors. After this offering, each of our non-employee directors will be paid:

 

   

an annual cash retainer of $        ;

 

66


Table of Contents
   

an additional retainer of $         for the audit committee chair and the compensation committee chair, $         for the nominating and corporate governance committee chair, and $         for each non-chair member of the committees; and

 

   

an annual equity grant of $         of restricted stock or restricted stock units.

Each director will have the option to receive some or all of his cash retainer in the form of equity grants. Directors will not receive a fee for attending meetings, but they will be entitled to reimbursement of travel expenses relating to their service.

Compensation Committee Interlocks and Insider Participation

Messrs. Ross and Sargent served as members of the compensation committee throughout fiscal 2011. On May 25, 2011, the board of directors also appointed Messrs. Collins and Mussafer to be members of the compensation committee. Each of Messrs. Ross, Sargent, Collins and Mussafer has relationships with us that require disclosure under Item 404 of Regulation S-K under the Exchange Act. See “Certain Relationships and Related Party Transactions” for more information.

None of these individuals was at any time during fiscal 2011 an officer or an employee of Five Below. In addition, none of our executive officers serves as a member of the board of directors or compensation committee of any entity that has one or more executive officers serving as a member of our board of directors or compensation committee.

Code of Business Conduct and Ethics

Upon the closing of this offering, we will adopt a code of business conduct and ethics that applies to all of our employees, officers and directors, including those officers responsible for financial reporting. Once it is adopted, the code of business conduct and ethics will be available on our website at www.fivebelow.com . Disclosure regarding any amendments to the code, or any waivers of its requirements, will be included in a current report on Form 8-K within four business days following the date of the amendment or waiver, unless posting such information on our website will then satisfy the rules of The NASDAQ Stock Market LLC.

Corporate Governance Guidelines

Our board of directors will adopt corporate governance guidelines that serve as a flexible framework within which our board of directors and its committees operate. These guidelines will cover a number of areas including the size and composition of the board, board membership criteria and director qualifications, director responsibilities, board agenda, roles of the Chairman of the board and Chief Executive Officer, meetings of independent directors, committee responsibilities and assignments, board member access to management and independent advisors, director communications with third parties, director compensation, director orientation and continuing education, evaluation of senior management and management succession planning. A copy of our corporate governance guidelines will be available on our website at www.fivebelow.com .

 

67


Table of Contents

EXECUTIVE COMPENSATION

Compensation Discussion and Analysis

Introduction

This compensation discussion and analysis provides an overview of our executive compensation program together with a description of the material factors underlying the decisions that resulted in the compensation provided with respect to the fiscal year that ended on January 28, 2012 to our principal executive officer, our principal financial officer and our other most highly compensated executive officer in 2011. These individuals are referred to collectively as the Named Executive Officers.

The following table identifies the Named Executive Officers, as well as the positions held by such individuals during fiscal year 2011:

 

Name

  

Position on January 28, 2012

David Schlessinger    Executive Chairman and Founder
Thomas G. Vellios    President, Chief Executive Officer and Founder
Kenneth R. Bull    Senior Vice President, Finance, Secretary and Treasurer

Overview

Our compensation philosophy for our Named Executive Officers has been driven by the need to recruit, develop, motivate and retain top talent both in the short-term and long-term, to create long-term value for the shareholders and to align each Named Executive Officer ’s interests with those of our shareholders.

Other factors affecting compensation are:

 

   

Our annual performance;

 

   

Impact of the employee’s performance on our results;

 

   

Our objective to incentivize attainment of our performance goals by providing compensation that can exceed competitive levels upon attainment of such goals; and

 

   

Internal equity and external market competitiveness.

Elements of Our Executive Compensation and Benefits Programs

Consistent with the philosophy that compensation to the Named Executive Officers should be aligned closely with our short and long-term financial performance, a portion of executive compensation is “at risk” and is tied to the completion of certain continued service thresholds with us and/or the attainment of certain financial goals. However, we believe that it is prudent to provide competitive base salaries and other benefits to attract and retain the appropriate management talent in order to achieve our strategic objectives. Accordingly, we provide compensation to our Named Executive Officers through a combination of the following:

 

   

Base salary;

 

   

Annual cash incentives;

 

   

Long-term equity incentives; and

 

   

Retirement (401(k) Plan), health and welfare benefits and limited perquisites.

 

68


Table of Contents

Purpose and Philosophy

We follow several principles in the development and administration of the above four main elements of our executive compensation program. In establishing executive compensation, we believe that:

 

   

Our executive compensation programs are aligned with and support the strategic direction of our business;

 

   

We design compensation levels to reflect the level of accountability and future potential of each executive and the achievement of outstanding individual results;

 

   

Our compensation programs link executive compensation to personal creation and maintenance of our long-term equity value (i.e., we pay for improving our overall performance);

 

   

As an executive’s level of responsibility increases, the proportion of compensation “at risk” may increase; however, executive compensation programs should not encourage excessive or unnecessary risks; and

 

   

The design and administration of our compensation programs will reflect best practices to be financially efficient, affordable and legally compliant.

Role of the Compensation Committee

As described in more detail under “Management—Committees of the Board of Directors—Compensation Committee,” the compensation committee operates under a written charter, which sets forth the roles and responsibilities of the compensation committee regarding executive compensation.

Upon the closing of the offering, Messrs. Collins, Crawford and Ryan will be appointed to the compensation committee, all of whom will be independent under the rules and regulations of the SEC and The NASDAQ Stock Market LLC.

Role of Executives in Establishing Compensation

Our board of directors has delegated administration of our executive compensation program to the compensation committee. Our Chief Executive Officer and our Executive Chairman provide recommendations regarding the design of our compensation programs to the compensation committee for all Named Executive Officers, excluding themselves. Upon the compensation committee’s approval, the execution of the elements of the executive compensation programs is the responsibility of the Chief Financial Officer and/or his delegees.

In fiscal year 2011, both our Chief Executive Officer and our Executive Chairman attended each of our compensation committee meetings, but were not present during executive sessions when matters related to them were discussed.

Compensation Consultant, Peer Group Comparison & Benchmarking

Neither we nor the compensation committee currently has any contractual relationships with any compensation consultants. The compensation committee has not utilized any benchmarking in designing or setting executive compensation during the time that we were privately held. From time to time, the compensation committee has worked internally to ascertain best practices in the design of our executive compensation programs. The compensation committee has generally been focused on incentivizing and rewarding internal results and has not generally engaged in any peer group or market review in the design of our executive compensation programs.

Relative Size of Major Compensation Elements

The combination of base salary, annual cash incentives and long-term equity incentives comprises total direct compensation. In setting executive compensation, the compensation committee considers the aggregate

 

69


Table of Contents

compensation payable to a Named Executive Officer and the form of that compensation. The compensation committee seeks to achieve the appropriate balance between immediate cash rewards and long-term financial incentives for the achievement of both annual and long-term financial and non-financial objectives.

The compensation committee may decide, as appropriate, to modify the mix of base salary, annual cash incentives, long-term equity incentives and retirement/perquisites to best fit a Named Executive Officer’s specific circumstances. For example, the compensation committee may make the decision to award more cash and not award an equity grant. This provides more flexibility to the compensation committee to reward executive officers appropriately as they near retirement, when they may only be able to partially fulfill the vesting required for equity options. The compensation committee may also increase the amount of equity option grants to an executive officer if the total number of career equity option grants does not adequately reflect the executive’s current position with us or if an above-market compensation package is necessary to attract and retain critical talent.

Base Salary

We provide Named Executive Officers with base salaries to compensate them for services rendered during the year. The compensation committee believes that competitive salaries must be paid in order to attract and retain high quality executives. The compensation committee annually reviews base salary for executive officers and makes adjustments only when necessary based on the executive’s and our performance.

In reviewing the performance of Messrs. Schlessinger and Vellios in fiscal year 2011, the compensation committee determined that the performance of these executives exceeded their respective base salaries. Accordingly, the compensation committee decided to (a) increase Mr. Schlessinger’s annual base salary from $400,000 to $600,000 and (b) increase Mr. Vellios’ annual base salary from $600,000 to $700,000, in each case, effective retroactively as of January 30, 2011. Based on these increases, it is the current intention of the compensation committee that the base salaries of each of Messrs. Schlessinger and Vellios would remain at such levels until at least 2014 (although the compensation committee reserves the right to modify such salaries if the performance of either executive so warrants). Accordingly, each executive’s employment letter agreement was amended as of September 28, 2011 to reflect these base salary increases and to provide that annual review of the base salary of Messrs. Schlessinger and Vellios would not be required to occur again until fiscal year 2014. We refer to these amendments as the Employment Letter Amendments.

In reviewing the performance of Mr. Bull in fiscal year 2011, the compensation committee determined that his performance exceeded his base salary. Accordingly, based upon the compensation committee’s evaluation of his performance, the compensation committee decided to increase Mr. Bull’s annual base salary from $275,000 to $325,000, from $257,269 to $275,000, and from $249,776 to $257,269 effective as of April 1, 2012, September 11, 2011, and March 27, 2011 respectively. The compensation committee also determined that a base salary of $325,000 was appropriate base compensation for a principal financial officer of a company of our size and type.

Annual Incentive Compensation

We provide cash incentive awards to Named Executive Officers for achieving and exceeding our annual financial goals, which are guided by a plan term sheet, but are otherwise discretionary based on the subjective determination of the compensation committee. The compensation committee does review the recommendations of our Chief Executive Officer and our Executive Chairman, but makes its own determinations on all items of executive compensation. Awards under our bonus program are designed to motivate and compensate executives for the achievement of our annual business objectives. Our performance goals are generally tied to financial performance measures as determined and approved by the compensation committee; however, in determining final annual bonuses the compensation committee retains full discretion to adjust any such bonuses.

In May 2011, the compensation committee approved our general performance goals and award schedule for fiscal 2011, based on our fiscal 2011 budget. The compensation committee chose to provide bonuses based on

 

70


Table of Contents

the attainment of certain levels of Adjusted EBITDA. The compensation committee determined to use these targets because attainment of Adjusted EBITDA objectives was deemed crucial for our growth and continued profitability. Accordingly, the compensation committee wanted to utilize our incentive compensation program to promote these goals. Pursuant to the general parameters of our bonus program the compensation committee retained the full discretion to increase or decrease awards and no executive, at the time the fiscal 2011 program was established, had a contractual right to be paid any specific bonus regardless of performance. However, on September 28, 2011, pursuant to the Employment Letter Amendments, Messrs. Schlessinger and Vellios received a contractual right to be paid an annual bonus of 40% of such executive’s base salary, if we achieved Adjusted EBITDA of $40.1 million (determined after subtracting all incentive payments made under our incentive compensation program) or 50% of such executive’s base salary, if we achieved Adjusted EBITDA of $42.6 million (determined after subtracting all incentive payments made under our incentive compensation program), in each case, during fiscal 2011.

Based on the general parameters of the annual incentive program, Mr. Bull’s annual target bonus was 20% of his base salary, if we achieved Adjusted EBITDA of $41.2 million with a maximum bonus of 25% of his base salary, if we achieved Adjusted EBITDA of $43.9 million, in each case, during fiscal year 2011. For the purpose of Mr. Bull’s bonus, Adjusted EBITDA was calculated before all incentive payments under our incentive compensation program were made.

On March 19, 2012, the compensation committee reviewed the performance of Messrs. Schlessinger and Vellios in 2011 and determined that based on our substantial growth both in size and in sales, payment of their contractual bonuses would not appropriately recognize such outstanding performance. Accordingly, the compensation committee exercised its discretion to authorize bonuses in excess of those potentially payable and granted each executive a discretionary, one-time bonus of $3.0 million.

On April 12, 2012, the compensation committee reviewed our individual incentive bonus program results for fiscal year 2011 performance and determined that because we had incurred certain expenses of a character that had not been contemplated at the time our budgeted fiscal 2011 Adjusted EBITDA was established, it would be equitable to further adjust the Adjusted EBITDA we earned in fiscal 2011 for purposes of measuring achievement by our executive officers of their bonus targets. After giving effect to such additional adjustments, the compensation committee concluded that we achieved Adjusted EBITDA (as further adjusted as described above) of $44.0 million. With respect to Mr. Bull, the compensation committee awarded Mr. Bull his maximum incentive bonus of 25% of his base salary due to our Adjusted EBITDA (as further adjusted as described above) exceeding $43.9 million.

Bonus performance targets or potential bonus payouts for fiscal 2012 have not yet been determined.

Long-term Equity Incentive Compensation

Equity awards are a vital piece of our total compensation package and are designed to support our long-term strategy, provide a mechanism to attract and retain talent and to create a commonality of interest between management and our shareholders. Awards under the Five Below, Inc. Equity Incentive Plan, or the Equity Incentive Plan, are intended to compensate Named Executive Officers for sustained long-term performance that is aligned with shareholder interests and to encourage retention through vesting schedules. Long term equity incentive awards may take a variety of forms, such as stock options and restricted stock grants. Levels and frequency of awards are determined by the compensation committee. Such awards are designed to reflect a recipient’s level of responsibility and performance.

While initial hire and promotion grants are targeted to be at competitive levels, actual award values will reflect our actual long-term performance (through stock price appreciation and achievement of long-term performance goals). Service-based restricted stock awards can also be granted as appropriate to recognize performance and provide ownership and/or retention focus. Long term incentives have the capacity to be the largest component of executive compensation, if our performance and stock price exceed our expectations.

 

71


Table of Contents

No awards were made to either Messrs. Schlessinger or Vellios in fiscal year 2011. In fiscal 2011, the compensation committee made two grants of non-qualified stock options to Mr. Bull. Accordingly, Mr. Bull was awarded 25,000 non-qualified stock options with an exercise price of $2.18 per share on May 25, 2011 and 75,000 non-qualified stock options with an exercise price of $2.41 per share on October 18, 2011, respectively. Each grant was made under the Equity Incentive Plan and the exercise price of each grant was based on the fair market value of our stock on the date of grant.

The compensation committee awarded these two grants to Mr. Bull because of our fiscal year 2010 financial review, which included our and his individual performance over such time. In general, 50% of Mr. Bull’s stock options vest and become exercisable two years after grant. The remaining 50% of the stock options vest in equal 6.25% increments, every 90 days thereafter, during the third and fourth year after grant. All vesting events are generally contingent upon continuous employment through the applicable vesting date.

Please see “Employee Benefit Plans” below and the discussion of “Five Below, Inc. Amended and Restated Equity Incentive Plan” for a more complete summary of this plan.

Retirement, Health and Welfare Benefits and Other Perquisites

Our Named Executive Officers are entitled to participate in all of our employee benefit plans, including medical, dental, vision, group life and disability insurance and the Five Below 401(k) Retirement Savings Plan. We provide vacation and paid holidays to our Named Executive Officers. Generally, our Named Executive Officers participate in these plans and programs on the same or similar basis as are offered to our other senior employees.

In addition, in connection with the 2010 Transaction, Messrs. Schlessinger and Vellios incurred legal expenses with respect to their employment agreements and other compensation arrangements. Pursuant to the terms of each executive’s employment agreement, we were obligated to reimburse for these attorney fees. We also made a gross-up payment to each of the executives to cover their respective taxes on income attributable to such reimbursement. As a result, Messrs. Schlessinger and Vellios were paid $48,062 and $47,084, respectively, on April 29, 2011. See the Summary Compensation Table for details regarding the value of perquisites received by our executive officers. The compensation committee does not intend to continue offering “gross ups” in the future, unless warranted by extraordinary circumstances.

Executive Compensation Decisions Occurring after the End of Fiscal Year 2011

On March 1, 2012, the compensation committee made a grant of non-qualified stock options to Mr. Bull because of our fiscal year 2011 financial review, which included our and Mr. Bull’s individual performance over such time. Accordingly, Mr. Bull was awarded 50,000 non-qualified stock options with an exercise price of $3.88 per share. The grant was made under the equity incentive plan and the exercise price was based on the fair market value of our stock on the date of grant.

On March 22, 2012, the compensation committee cancelled options to purchase 2,919,973 shares of common stock made to each of Messrs. Schlessinger and Vellios in exchange for an award of 2,919,973 shares of common stock (of which 1,946,648 were restricted and 973,325 were unrestricted as of the grant date). In general, the forfeiture restrictions applicable to the restricted shares will lapse as to 973,324 shares on each of March 22, 2013 and March 22, 2014, subject to such executive’s continued employment with us as of those dates, as more fully described below in the section entitled “—Option Cancellation Agreements.” The compensation committee had decided that the prior option grants did not appropriately recognize the efforts of Messrs. Schlessinger and Vellios in greatly expanding our sales and profitability, and accelerating our growth. Accordingly, to appropriately recognize those efforts and to further incentivize each of these executives to continue their efforts on behalf of us, the compensation committee granted these shares of restricted stock to each of Messrs. Schlessinger and Vellios. In addition, the compensation committee determined that this stock grant more appropriately aligned Messrs. Schlessinger’s and Vellios’ incentives with the interests of our shareholders.

 

72


Table of Contents

Additionally, effective April 1, 2012, the compensation committee increased Mr. Bull’s annual base salary to $325,000 in connection with his promotion to the position of Chief Financial Officer. Additionally, the compensation committee approved an increase in Mr. Bull’s severance benefits upon his termination by us without cause from three months to six months of base salary and health benefits continuation. The compensation committee believed that such changes were warranted due to Mr. Bull’s enhanced responsibility and his performance.

Employment Agreements

We have entered into employment letter agreements with each of Messrs. Schlessinger and Vellios. Additionally, effective as of April 16, 2012, we entered into an employment agreement with Mr. Bull. These agreements are further described below in the “Employment Agreements” section. Additionally, the benefits potentially payable under these agreements are more fully described below in the section entitled “—Potential Payments Upon Termination or Change of Control.”

Executive Compensation

The following table shows the annual compensation paid to or earned by the executive officers for the fiscal year ended January 28, 2012:

Summary Compensation Table

 

Name & Principal Position

   Year      Salary
($)
     Bonus ($)      Stock
Awards
($)
     Option
Awards
($)(2)
     All Other
Compensation
($)(3)
     Total ($)  

David Schlessinger

     2011         600,000         3,000,000         —           —           48,062         3,648,062   
Executive Chairman and Founder                     

Thomas G. Vellios

     2011         700,000         3,000,000         —           —           47,554         3,747,554   
President, Chief Executive Officer and Founder                     

Kenneth R. Bull

     2011         262,956         68,750         —           121,542         470         453,718   
Senior Vice President, Finance, Secretary and Treasurer(1)                     

 

(1) On April 12, 2012, Mr. Bull was named Chief Financial Officer.
(2) The amounts in this column, computed in accordance with current Financial Accounting Standard Board guidance for accounting for and reporting of stock-based compensation, represent the aggregate grant-date fair value of each option award. Further detail surrounding the shares awarded, the method of valuation and the assumptions made are set forth in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section under “Critical Accounting Policies and Estimates.” The actual value, if any, that may be realized will depend on the excess of the stock price over the exercise price on the date the option is exercised. Therefore, there is no assurance the value realized will be at or near the value estimated by the Black-Scholes option pricing model.
(3) The following table itemizes the components of the “All Other Compensation” column:

 

Name

   Reimbursement of Legal Fees
and Related Income Taxes ($)
   Imputed Income from
Long Term Disability
Coverage ($)
   Total ($)

David Schlessinger

   48,062       48,062

Thomas G. Vellios

   47,084    470    47,554

Kenneth R. Bull

      470    470

 

73


Table of Contents

Grants of Plan-Based Awards

The following table shows all grants of awards in fiscal year 2011 to each of the executive officers named in the Summary Compensation Table:

 

          Estimated Future Payouts
Under Non-Equity Incentive
Plan Awards
    Estimated Future Payouts
Under Equity Incentive Plan
Awards
    All
Other
Stock
Awards:
Number
of
Shares
of Stock
or Units
(#)
    All Other
Option
Awards:
Number of
Securities
Underlying
Options (#)
    Exercise
or Base
Price of
Option
Awards
$/Sh)
    Grant
Date
Fair
Value
of
Stock
and
Option
Awards
($)(1)
 

Name

  Grant
Date
    Threshold
($)
    Target
($)
    Maximum
($)
    Threshold
($)
    Target
($)
    Maximum
($)
         

David Schlessinger

                                                                            

Thomas G. Vellios

                                                                            

Kenneth R. Bull(2)

    5/25/2011                                                         25,000        2.18        27,418   
    10/18/2011                                                         75,000        2.41        94,125   

 

(1) The amounts in this column, computed in accordance with current Financial Accounting Standard Board guidance for accounting for and reporting of stock-based compensation, represent the aggregate grant-date fair value of each option award. Further detail surrounding the shares awarded, the method of valuation and the assumptions made are set forth in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section under “Critical Accounting Policies and Estimates.” The actual value, if any, that may be realized will depend on the excess of the stock price over the exercise price on the date the option is exercised. Therefore, there is no assurance the value realized will be at or near the value estimated by the Black-Scholes option pricing model.
(2) These stock options vest upon the following time-based schedule: 50% of the stock options vest and become exercisable on the second anniversary of the grant date and 6.25% every 90 days thereafter.

Outstanding Equity Awards at Year End Fiscal 2011

The following table details information concerning unexercised stock options, stock options that have not vested and stock awards that have not vested for each of the executive officers named in the Summary Compensation Table as of January 28, 2012:

 

Name

  Option Awards      Stock Awards  
  Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable
    Number of
Securities
Underlying
Unexercised
Options (#)
(Unexercisable)
    Equity
Incentive
Plan
Awards:
Number of
Securities
Underlying
Unexercised
Unearned
Options (#)
    Option
Exercise
Price
($)
    Option
Expiration
Date ($)
     Number
of
Shares
or Units
of Stock
That
Have
Not
Vested
(#)
    Market
Value
of
Shares
or
Units
of
Stock
That
Have
Not
Vested
($)
    Equity
Incentive
Plan
Awards:
Number
of
Unearned
Shares,
Units or
Other
Rights
that Have
Not
Vested
(#)
     Equity
Incentive
Plan
Awards:
Market
or Payout
Value
Unearned
of Shares,
Units or
Other
Rights
That
Have Not
Vested
($)
 

David Schlessinger

    456,246 (1)      1,003,740 (1)             2.18        10/14/2020                                 
           1,459,987 (2)             2.18        10/14/2020                                 

Thomas G. Vellios

    456,246 (1)      1,003,740 (1)             2.18        10/14/2020                                 
           1,459,987 (2)             2.18        10/14/2020                                 

Kenneth R. Bull

           25,000 (3)             2.18        5/25/2021                                 
           75,000 (3)             2.41        10/18/2021                                 
                                        3,750 (4)      10,575 (5)                
                                        6,250 (4)      17,625 (5)                
                                        30,000 (4)      84,600 (5)                

 

(1) These stock options vest upon the following time-based schedule: 25% of the stock options vest and become exercisable on October 14, 2011 and 6.25% of the stock options vest and become exercisable every January 14, April 14, July 14 and October 14 thereafter, commencing on January 14, 2012 and ending on October 14, 2014. Please note that pursuant to the Option Cancellation Agreements, these options were canceled on March 22, 2012.

 

74


Table of Contents
(2) These stock options vest upon the following performance-based schedule: 33.3%, 33.3% and 33.3% of the stock options vest and become exercisable on the date that (i) the “Purchasers” (as defined in the applicable Investment Agreement dated September 1, 2010) receive proceeds equal to 2.0, 2.5 and 3.0 times the amount of their investment in us, respectively or (ii) the applicable “IRR” interest rate (as defined in the applicable option award agreement) for the Purchasers is greater than or equal to 30%, 40% or 50%, respectively. Notwithstanding the above, these stock options also vest upon the nine month anniversary of an initial public offering, provided that certain of our market cap targets are met and that the individual is still employed on such date. Please note that pursuant to the Option Cancellation Agreements, these options were canceled on March 22, 2012.
(3) These stock options vest upon the following time-based schedule: 50% of the stock options vest and become exercisable on the second anniversary of the grant date and 6.25% of the stock options vest and become exercisable every 90 days thereafter.
(4) These shares are subject to a repurchase option exercisable by us in the event of an employment resignation or termination of employment prior to vesting.
(5) This value uses the most recent independent valuation of $2.82 on November 22, 2011.

Option Exercises and Stock Vested

During fiscal year 2011, Messrs. Schlessinger and Vellios did not exercise any previously issued stock options nor did such individuals vest in any of our stock awards. However, Mr. Bull vested in tranches of 15,000 and 13,750 shares of our stock.

 

     Option Awards      Stock Awards  

Name

   Number of Shares
Acquired on Exercise
     Value Realized
on Exercise ($)
     Number of Shares
Acquired on Vesting
    Value Realized
on Vesting ($)
 

David Schlessinger

                              

Thomas Vellios

                              

Kenneth Bull

    

 


  

  

    

 


  

  

    

 

15,000

13,750

(1) 

(2) 

   

 

42,300

38,775

(3) 

(3) 

 

(1) These shares of restricted stock vested as follows: 3,750 shares on each of April 2, 2011, July 2, 2011, October 2, 2011 and January 2, 2012, respectively.
(2) These shares of restricted stock vested as follows: 10,000 shares on March 29, 2011 and 1,250 shares on each of June 29, 2011, September 29, 2011 and December 29, 2011, respectively.
(3) This determination uses the most recent independent valuation of $2.82 on November 22, 2011.

Potential Payments Upon Termination or Change of Control

Termination Prior to a Change of Control—Mr. Schlessinger

If we terminate Mr. Schlessinger’s employment without “cause” or Mr. Schlessinger terminates his employment for “good reason” (as such terms are defined in his Employment Letter Agreement), in either case, prior to a “Change of Control Transaction” (as such term is defined in his Employment Letter Agreement), Mr. Schlessinger will be entitled to receive:

 

   

severance payments, equal to the greater of : (i) $400,000 or (ii) the greater of (x) base salary in effect on the date of termination or resignation or (y) unless Mr. Schlessinger approved a reduction in his annual base salary, such higher annual base salary in effect prior to termination or resignation, such amount under (i) or (ii), as applicable paid in monthly installments for a period of 12 months;

 

   

monthly payments equal to continued health and dental benefits for a period of up to 18 months, extended an additional 6 months following the expiration of such 18-month period if Mr. Schlessinger was still eligible to receive continued COBRA coverage as of the end of such 18-month period, which we refer to as the Medical Payments; and

 

   

monthly payments equal to a full tax gross up for federal, state and local income taxes based upon highest marginal tax rates solely with respect to each Medical Payment, which we refer to as the Medical Gross Up.

 

75


Table of Contents

Termination Following a Change of Control—Mr. Schlessinger

If we terminate Mr. Schlessinger’s employment without cause or Mr. Schlessinger terminates his employment for good reason, in either case, after a Change of Control Transaction, Mr. Schlessinger will be entitled to receive:

 

   

severance payments, equal to the greater of : (i) $800,000 or (ii) the greater of (x) base salary in effect on the date of termination or resignation or (y) unless Mr. Schlessinger approved a reduction in his annual base salary, such higher annual base salary in effect prior to termination or resignation, such amount under (i) or (ii), as applicable paid in monthly installments for a period of 24 months;

 

   

the Medical Payments; and

 

   

the Medical Gross Up.

Termination Prior to a Change of Control—Mr. Vellios

If we terminate Mr. Vellios’ employment without “cause” or Mr. Vellios terminates his employment for “good reason” (as such terms are defined in his Employment Letter Agreement), in either case, prior to a “Change of Control Transaction” (as such term is defined in his Employment Letter Agreement), Mr. Vellios will be entitled to receive:

 

   

severance payments, equal to the greater of : (i) base salary in effect on the date of termination or resignation or (ii) unless Mr. Vellios approved a reduction in annual base salary, such higher annual base salary in effect prior to termination or resignation, such amount under (i) or (ii), as applicable paid in monthly installments for a period of 12 months;

 

   

the Medical Payment; and

 

   

the Medical Gross Up.

Termination Following a Change of Control—Mr. Vellios

If we terminate Mr. Vellios’ employment without cause or Mr. Vellios terminates his employment for good reason, in either case, after a Change of Control Transaction, Mr. Vellios will be entitled to receive:

 

   

severance payments, equal to the greater of : (i) base salary in effect on the date of termination or resignation or (ii) unless Mr. Vellios approved a reduction in annual base salary, such higher annual base salary in effect prior to termination or resignation, such amount under (i) or (ii), as applicable paid in monthly installments for a period of 24 months;

 

   

the Medical Payment; and

 

   

the Medical Gross Up.

As described more fully below under “—Employment Agreements,” Messrs. Schlessinger and Vellios are also subject to certain restrictive covenants, including non-competition, non-solicitation and confidentiality.

Termination Without Cause—Mr. Bull

If we terminate Mr. Bull’s employment without “cause” (as such term is defined in his agreement), Mr. Bull will be entitled to receive:

 

   

base salary continuation for six months based on his base salary in effect on the date of termination less any amounts earned during the applicable six month post termination period, paid in monthly installments (pursuant to his agreement as in effect on the last day of the fiscal year, base salary would only have been continued for three months); and

 

   

monthly payments equal to continued health and dental benefits for a period of up to six months (pursuant to his agreement as in effect on the last day of the fiscal year, these benefits would only have been continued for three months).

 

76


Table of Contents

Potential Payments

The table below summarizes the payments and benefits that each of Messrs. Schlessinger, Vellios and Bull would have been entitled to receive if his last day of employment with us had been January 28, 2012.

 

Name

  Cash
Severance
Payment ($)
    Accelerated Option
Vesting ($)
    Health
Insurance
Coverage
    Paid Life
Insurance
Benefit (6)
    Total ($)  

David Schlessinger

         

Voluntary termination for good reason or involuntary termination without cause

    600,000        —          39,356 (4)      —          639,356   

No termination following a change in control

    —          642,394 (2)      —          —          642,394   

Voluntary termination for good reason or involuntary termination without cause following a change in control

    1,200,000        642,394 (2)      39,356 (4)      —          1,881,750   

Death of Named Executive Officer

    —          —          —          10,000        10,000   

Permanent Disability of Named Executive Officer

    —          —          —          —          —     

Thomas G. Vellios

         

Voluntary termination for good reason or involuntary termination without cause

    700,000        —          39,356 (4)      —          739,356   

No termination following a change in control

    —          642,394 (2)      —          —          642,394   

Voluntary termination for good reason or involuntary termination without cause following a change in control

    1,400,000        642,394 (2)      39,356 (4)      —          2,081,750   

Death of Named Executive Officer

    —          —          —          10,000        10,000   

Permanent Disability of Named Executive Officer

    —          —          —          —          —     

Kenneth R. Bull

         

Involuntary termination without cause

    68,750 (1)      —          4,919 (5)      —          73,669   

No termination following a change in control

    —          46,750 (3)      —          —          46,750   

Involuntary termination without cause following a change in control

    68,750 (1)      46,750 (3)      4,919 (5)      —          120,419   

Death of Named Executive Officer

    —          —          —          10,000        10,000   

Permanent Disability of Named Executive Officer

    —          —          —          —          —     

 

(1) This represents the severance payments Mr. Bull was entitled to as of January 28, 2012, the last day of the fiscal year, which were equal to 25% of his annual base salary in effect on January 28, 2012. Pursuant to his employment agreement entered into on April 16, 2012, Mr. Bull is entitled to severance payments, which are equal to 50% of his current annual base salary of $325,000 or a payment that would be equal $162,500.
(2) This represents the accelerated gain on the exercise of previously unvested time-based stock options for 1,003,740 shares, using the most recent independent valuation of $2.82 on November 22, 2011. The next independent valuation after fiscal year 2011 was concluded as of February 21, 2012 ($3.88). In addition, pursuant to the Option Cancellation Agreements, these options were canceled on March 22, 2012.
(3) This represents the accelerated gain on the exercise of previously unvested time-based stock options for 100,000 shares, using the most recent independent valuation of $2.82 on November 22, 2011. The next independent valuation after fiscal year 2011 was concluded as of February 21, 2012 ($3.88).
(4) Messrs. Schlessinger and Vellios are entitled to a continuation of their health and dental benefits for up to 24 months.
(5) Mr. Bull was entitled to a continuation of his health and dental benefits for up to three months as of January 28, 2012. Please note that pursuant to his letter agreement entered into on April 16, 2012, Mr. Bull is currently entitled to a continuation of his health and dental benefits for up to six months.
(6) This represents life insurance premiums under our life insurance program.

 

77


Table of Contents

Employee Benefit Plans

Five Below, Inc. Amended and Restated Equity Incentive Plan

We amended and restated our Equity Incentive Plan, effective May 14, 2010, to enable us and our affiliated companies to: (a) recruit and retain highly qualified employees, directors and consultants; (b) provide those individuals with an incentive for productivity; and (c) provide those individuals with an opportunity to share in our growth and value. We intend to amend and restate the Equity Incentive Plan prior to the closing of this offering; accordingly, a summary of the material terms of such version of the Equity Incentive Plan is described below.

The Equity Incentive Plan permits the grant of (i) incentive stock options, or ISOs; (ii) nonqualified stock options, or NQOs and together with ISOs, Options; (iii) restricted stock awards; and (iv) restricted stock units, or RSUs, which we refer to collectively as Awards, as more fully described below.

Prior to this offering, Options to purchase common stock and shares of our common stock were each granted to various participants under the Equity Incentive Plan.

All Awards granted under the Equity Incentive Plan are governed by separate written agreements, or Award Agreements, between us and the participants. No Awards may be granted after                 , 2022, although Awards granted before that time will remain valid in accordance with their terms.

A committee of our board of directors will administer the Equity Incentive Plan. This committee will designate each eligible individual to whom an Award is to be granted. The board will delegate the authority to the compensation committee to grant Awards upon such terms and conditions (not inconsistent with the provisions of the Equity Incentive Plan), as it may consider appropriate. Any of our employees, consultants, officers or other service providers, or those of our affiliates, are eligible to participate in the Equity Incentive Plan if selected by the compensation committee. In its discretion, the compensation committee may delegate all or part of its authority and duties with respect to granting Awards to one or more individuals, provided applicable law so permits.

Subject to certain adjustments, the maximum number of shares of common stock that may be issued under the Equity Incentive Plan in connection with Awards is              (which amount includes shares in connection with awards granted pursuant to the original Equity Incentive Plan prior to this offering). In any calendar year, no participant may receive any Award or any combination of Awards that relate to more than                  shares. In the event of any stock dividend, recapitalization, forward stock split or reverse stock split, reorganization, division, merger, consolidation, spin-off, combination, repurchase or share exchange, extraordinary or unusual cash distribution or other similar corporate transaction or event that affects our common stock, the compensation committee shall make appropriate adjustment in the number and kind of shares authorized by the Equity Incentive Plan and covered under outstanding Awards as it determines appropriate and equitable. Shares of our common stock subject to Awards that expire unexercised or are otherwise forfeited shall again be available for Awards under the Equity Incentive Plan.

An Option entitles the holder to purchase from us a stated number of shares of common stock. An ISO may only be granted to an employee of ours or our affiliates (provided applicable law so permits). The compensation committee will specify the number of shares of common stock subject to each Option and the exercise price for such Option, provided that the exercise price may not be less than the fair market value of a share of common stock on the date the Option is granted. Notwithstanding the foregoing, if ISOs are granted to any 10% shareholder, the exercise price shall not be less than 110% of the fair market value of common stock on the date the Option is granted. Generally, all or part of the exercise price may be paid (i) in cash, or (ii) with the proceeds received from a broker-dealer whom the holder has authorized to sell all or a portion of the common stock covered by the Option, or (iii) with the consent of the compensation committee, in whole or in part in common stock held by the holder and valued at fair market value on the date of exercise, or (iv) by any combination of such methods.

 

78


Table of Contents

All Options shall be exercisable in accordance with the terms of the applicable Award Agreement. The maximum term of an Option shall be determined by the compensation committee on the date of grant but shall not exceed 10 years (5 years in the case of ISOs granted to any 10% shareholder). In the case of ISOs, the aggregate fair market value (determined as of the date of grant) of common stock with respect to which such ISOs become exercisable for the first time during any calendar year cannot exceed $100,000. ISOs granted in excess of this limitation will be treated as NQOs.

If a participant terminates employment with us (or our affiliates) due to death or disability, the participant’s unexercised Options may be exercised, to the extent they were exercisable on the termination date, for a period of twelve months from the termination date or until the expiration of the original Option term, if shorter. If the participant terminates employment with us (or our affiliates) for cause (as defined in the Equity Incentive Plan), all unexercised Options (whether vested or unvested) shall terminate and be forfeited on the termination date. If the participant’s employment terminates for any other reason, any vested but unexercised Options may be exercised by the participant, to the extent exercisable at the time of termination, for a period of 90 days from the termination date (or such time as specified by the compensation committee at the time of grant) or until the expiration of the original Option term, whichever period is shorter. Unless otherwise provided by the compensation committee, any Options that are not exercisable at the time of termination of employment shall terminate and be forfeited on the termination date.

A restricted stock award is a grant of shares of common stock, which may or may not be subject to forfeiture restrictions during a restriction period. The compensation committee will determine the price, if any, to be paid by the participant for each share of common stock subject to a restricted stock award. The compensation committee may condition the expiration of the restriction period, if any, upon: (i) the participant’s continued service over a period of time with us or our affiliates; (ii) the achievement by the participant, us or our affiliates of any other performance goals set by the compensation committee; or (iii) any combination of the above conditions as specified in the Award Agreement. If the specified conditions are not attained, the participant will forfeit the portion of the restricted stock award with respect to which those conditions are not attained, and the underlying common stock will be forfeited to us. At the end of the restriction period, if the conditions, if any, have been satisfied, the restrictions imposed will lapse with respect to the applicable number of shares. During the restriction period, a participant will have the right to vote the shares underlying the restricted stock, however, unless otherwise provided by the compensation committee, all dividends will remain subject to restriction until the stock with respect to which the dividend was issued lapses. The board of directors may, in its discretion, accelerate the vesting and delivery of shares of restricted stock.

RSUs are granted in reference to a specified number of shares of common stock and entitle the holder to receive, on achievement of specific performance goals established by the compensation committee, after a period of continued service or any combination of the above as set forth in the applicable Award Agreement, one share of common stock for each such share of common stock covered by the RSU. The board may, in its discretion, accelerate the vesting of RSUs.

Performance goals may be linked to a variety of factors including the participant’s completion of a specified period of employment or service with us or an affiliated company. Additionally, performance goals can include objectives stated with respect to us, an affiliated company or a business unit and are limited to one or more of the following:

 

   

specified levels of or increases in pre-tax earnings, return on capital, equity measures/ratios (on a gross, net, pre-tax or post-tax basis), including basic earnings per share, diluted earnings per share, total earnings, operating earnings, earnings growth, earnings before interest and taxes, or EBIT, and EBITDA, as the same may be adjusted by any items determined by the compensation committee;

 

   

comparable store sales or non-comparable store sales;

 

   

comparable store sales or sales growth;

 

79


Table of Contents
   

new store sales;

 

   

store fundraising initiatives;

 

   

new store openings;

 

   

gross margin;

 

   

inventory shrink;

 

   

vendor allowances;

 

   

inventory turns;

 

   

inventory levels;

 

   

distribution center productivity levels;

 

   

customer service levels;

 

   

customer or employee satisfaction;

 

   

employee recruiting and development;

 

   

number and timing of store construction;

 

   

visual merchandising initiatives;

 

   

advertising effectiveness;

 

   

number and timing of lease negotiations;

 

   

development of new markets;

 

   

financial ratios;

 

   

strategic initiatives;

 

   

improvement in or attainment of operating expense levels;

 

   

improvement in or attainment of capital expense levels; and

 

   

individual objectives.

The compensation committee may impose restrictions on the grant, exercise or payment of an Award as it determines appropriate. Generally, Awards granted under the Equity Incentive Plan shall be nontransferable except by will or by the laws of descent and distribution. No participant shall have any rights as a shareholder with respect to shares covered by Options or RSUs, unless and until such Awards are settled in shares of common stock.

No Option shall be exercisable, no shares of common stock shall be issued, no certificates for shares of common stock shall be delivered and no payment shall be made under the Equity Incentive Plan except in compliance with all applicable laws.

The board may amend, suspend or terminate the Equity Incentive Plan and the compensation committee may amend any outstanding Award at any time; provided, however, that no such amendment or termination may adversely affect Awards then outstanding without the holder’s permission.

In the event of a change in control (as defined in the Equity Incentive Plan, or with respect to Awards granted prior to this offering under the Equity Incentive Plan before its amendment and restatement), the compensation committee may, on a participant-by-participant basis (i) accelerate the vesting of some or all outstanding Options and terminate such Options immediately prior to the change in control, provided the

 

80


Table of Contents

participant has been given prior written notice of the change in control and of the compensation committee’s intention to cancel the Options, (ii) fully vest and/or accelerate some or all of the restriction period for any Awards, (iii) terminate the Award immediately prior to the change in control, provided the participant has been given prior written notice of the change in control and the compensation committee’s intention to cancel the Award, further provided, however, that during such notice period, the participant will be able to give notice of exercise of any portion of the Award that will become vested upon the change in control (with the actual exercise being contingent on the occurrence of the change in control), (iv) after giving the participant a chance to exercise any outstanding Options, terminate any or all of such unexercised Options, (v) cancel any outstanding Awards with respect to all common stock for which the Award remains unexercised or for which the Award is subject to forfeiture in exchange for a cash payment equal to the excess (if any) of the fair market value of the Award over the exercise price of an Option, or the unpaid purchase price (if any) of Restricted Stock, (vi) require that the Award be assumed by the successor corporation or that Awards for shares or other interest in the successor corporation with equivalent value be substituted for such Award, or (vii) take such other action as the compensation committee deems reasonable under the circumstances to permit the participant to realize the value of the Award.

The compensation committee, in its sole discretion, has the authority to determine the application of the foregoing provisions.

Five Below, Inc. Performance Bonus Plan

Prior to the closing of this offering, we intend to adopt the Five Below, Inc. Performance Bonus Plan, or the Performance Bonus Plan, which will be administered by the compensation committee. The purpose of the Performance Bonus Plan will be to benefit and advance our interests, by rewarding selected employees of ours and our affiliates for their contributions to our financial success and thereby motivate them to continue to make such contributions in the future by granting performance-based awards that are fully tax deductible to us. As this Performance Bonus Plan will become effective prior to the closing of the offering, a summary of the material terms of such plan is described below

Background

Section 162(m) of the Code disallows a deduction to us for any compensation paid to certain named executive officers in excess of $1 million per year, subject to certain exceptions. Among other exceptions, the deduction limit does not apply to compensation that meets the specified requirements for “performance-based compensation.” In general, those requirements include the establishment of objective performance goals for the payment of such compensation by a committee of the board composed solely of two or more outside directors, shareholder approval of the material terms of such compensation prior to payment, and certification by the committee that the performance goals for the payment of such compensation have been achieved.

The board believes that it is in our best interests and those of our shareholders to enhance our ability to attract and retain qualified personnel through performance based incentive, while at the same time obtaining the highest level of deductibility of compensation paid to employees.

Administration

Subject to the other provisions of the Performance Bonus Plan, the compensation committee has the authority to administer, interpret and apply the Performance Bonus Plan, including the authority to select the employees (including employees who are directors) to participate in the Performance Bonus Plan, to establish the performance goals, to determine the amount of incentive compensation bonus payable to any participant, to determine the terms and conditions of any such incentive opportunity; to make all determinations and take all other actions necessary or appropriate for proper administration and operation of the Performance Bonus Plan and to establish and amend rules and regulations relating to the Performance Bonus Plan.

 

81


Table of Contents

The compensation committee may also delegate to one or more of our executive officers the authority to administer the Performance Bonus Plan with respect to any participants who are not subject to Section 162(m) of the Code.

Eligibility

The Named Executive Officers and such other of our employees as selected by the compensation committee are eligible to participate in the Performance Bonus Plan. The maximum amount of the incentive compensation bonuses payable to any participant under the Performance Bonus Plan in, or in respect of, any single fiscal year shall not exceed $                . All incentive compensation bonuses paid pursuant to the Performance Bonus Plan will be paid in cash.

Bonus Opportunity and Performance Goals

Bonuses may be payable to a participant as a result of the satisfaction of performance goals in respect of any performance period determined by the committee; provided that, to the extent a participant would be subject to Section 162(m) of the Code, the performance goals will be set in accordance with the regulations under Section 162(m) of the Code. Performance goals, which may vary among and between participants, may include objectives stated with respect to us, an affiliated company or a business unit and such objectives are limited to one or more of the following:

 

   

specified levels of or increases in pre-tax earnings, return on capital, equity measures/ratios (on a gross, net, pre-tax or post-tax basis), including basic earnings per share, diluted earnings per share, total earnings, operating earnings, earnings growth, EBIT, and EBITDA, as the same may be adjusted by any items determined by the compensation committee;

 

   

comparable store sales or non-comparable store sales;

 

   

comparable store sales or sales growth;

 

   

new store sales;

 

   

store fundraising initiatives;

 

   

new store openings;

 

   

gross margin;

 

   

inventory shrink;

 

   

vendor allowances;

 

   

inventory turns;

 

   

inventory levels;

 

   

distribution center productivity levels;

 

   

customer service levels;

 

   

customer or employee satisfaction;

 

   

employee recruiting and development;

 

   

number and timing of store construction;

 

   

visual merchandising initiatives;

 

   

advertising effectiveness;

 

   

number and timing of lease negotiations;

 

82


Table of Contents
   

development of new markets;

 

   

financial ratios;

 

   

strategic initiatives;

 

   

improvement in or attainment of operating expense levels;

 

   

improvement in or attainment of capital expense levels; and

 

   

individual objectives.

The compensation committee shall provide a threshold level of performance below which no incentive compensation bonus will be paid, as well as a maximum level of performance above which no additional incentive compensation bonus will be paid. It also may provide for the payment of differing amounts for different levels of performance, determined with regard either to a fixed monetary amount or a percentage of the participant’s base salary. The compensation committee shall make such adjustments, to the extent it deems appropriate, to established performance goals and performance thresholds to compensate for, or to reflect, any material changes which may have occurred due to an Extraordinary Event (as defined under the Performance Bonus Plan).

As soon as practicable after the end of each performance period, but before any incentive compensation bonuses are paid to the participants under the Performance Bonus Plan, the compensation committee will certify in writing (i) whether the performance goal(s) were attained and (ii) the amount of the incentive compensation bonus payable to each participant based upon the attainment of such specified performance goals. The compensation committee also may reduce, eliminate, or, with respect only to participants who are not subject to Section 162(m) of the Code, increase the amount of any incentive compensation bonus of any participant at any time prior to payment thereof, based on such criteria as the compensation committee shall determine, including but not limited to individual merit and attainment of, or the failure to attain, specified personal goals established by the compensation committee. Under no circumstances, however, may the compensation committee, with respect solely to a participant who is subject to Section 162(m) of the Code, (a) increase the amount of the incentive compensation otherwise payable to such participant beyond the amount originally established by the compensation committee, (b) waive the attainment of the performance goals established and applicable to such participant’s incentive compensation or (c) otherwise exercise its discretion so as to cause any incentive compensation bonus payable to such participant to not qualify as “performance-based compensation” under Section 162(m) of the Code.

All amounts due under the Performance Bonus Plan shall be paid within 2  1 / 2 months of the end of the year in which such incentive compensation is no longer subject to a risk of forfeiture. The Board, without the consent of any participant, may amend or terminate the Performance Bonus Plan at any time. However, no amendment that would require the consent of the shareholders pursuant to Section 162(m) of the Code shall be effective without such consent.

No awards have yet been made under the Performance Bonus Plan.

Employment Agreements

We have existing employment agreements with each of our Named Executive Officers.

Thomas G. Vellios and David Schlessinger

Our employment agreements with Thomas Vellios and David Schlessinger were each entered into on October 14, 2010 and were each subsequently amended on September 28, 2011. We refer to each of these agreements, as amended, as an Employment Letter Agreement (or collectively, as the “Employment Letter

 

83


Table of Contents

Agreements”). These Employment Letter Agreements provide Thomas Vellios and David Schlessinger with an annual base salary of $700,000 and $600,000, respectively. Commencing with fiscal year 2012, each executive is eligible to receive annual incentive bonuses as determined in the discretion of the Board. Each executive is eligible to participate in the benefit plans offered by us and has a right to participate in the most favorable health, welfare and tax-qualified retirement plans that we may offer from time to time.

Pursuant to the Employment Letter Agreements, Messrs. Vellios and Schlessinger were each granted a non-qualified option to purchase 2,919,973 shares of common stock under the Equity Incentive Plan. These options were cancelled in exchange for a grant of restricted stock to each executive pursuant to the terms of the Option Cancellation Agreement, as further described below.

If we were to terminate Thomas Vellios’ employment without “Cause” or if Thomas Vellios terminates his employment for “Good Reason” (as such terms are defined in his Employment Letter Agreement), then, subject to his execution of an effective release, he would be entitled to receive:

 

   

12 months of base salary continuation paid in accordance with our normal payroll practices (or 24 months if such termination occurs after a “Change of Control Transaction” as such term is defined in his Employment Letter Agreement); and

 

   

For as long as the executive maintains COBRA continuation coverage under our plan, 18 months of payments equal to the applicable monthly COBRA premium. Such payments would be grossed up for federal, state and local income and employment taxes (if the executive remains on our medical plan for the entire 18 month period, then the medical payments will continue for an additional 6 months and such payments would also be grossed up).

If we were to terminate David Schlessinger’s employment without “Cause” or if David Schlessinger terminates his employment for “Good Reason” (as such terms are defined in his Employment Letter Agreement), then, subject to his execution of an effective release, he would be entitled to receive:

 

   

The greater of $400,000 or 12 months of base salary continuation, in either case, paid in accordance with our normal payroll practices (or the greater of $800,000 or 24 months if such termination occurs after a “Change of Control Transaction” as such term is defined in his Employment Letter Agreement); and

 

   

For as long as the executive maintains COBRA continuation coverage under our plan, 18 months of payments equal to the applicable monthly COBRA premium. Such payments would be grossed up for federal, state and local income and employment taxes (if the executive remains on our medical plan for the entire 18 month period, then the medical payments will continue for an additional 6 months and such payments would also be grossed up).

Under the Employment Letter Agreements, each executive is subject to a non-competition provision for during the term of the executive’s employment with us until (i) the Executive no longer receives the salary continuation (as set forth above), if the executive’s employment is terminated without Cause or the executive terminates his employment for Good Reason or (ii) 18 months after any other termination of employment. Each executive is also subject to non-solicitation provisions, however, such provisions expire upon the closing of this initial public offering, as provided under the Employment Letter Agreements.

Kenneth R. Bull

On April 16, 2012, we entered into a new employment agreement with Mr. Bull. The agreement provides Mr. Bull with an annual base salary of $325,000.

Mr. Bull’s employment with us is “at-will” and can be terminated by either party at any time, for any reason, provided that if Mr. Bull’s employment is terminated by us without “Cause” (as such term is defined in Mr. Bull’s agreement), then Mr. Bull is entitled to receive six months of base salary continuation and health benefits (offset for any amount Mr. Bull would earn from outside sources during such period).

 

84


Table of Contents

Option Cancellation Agreements

On March 22, 2012, or the Grant Date, we entered into Option Cancellation Agreements with each of Thomas Vellios and David Schlessinger, which we refer to as the Option Cancellation Agreements. Pursuant to the terms of these agreements, each executive agreed to cancel his outstanding option to purchase 2,919,973 shares of common stock in exchange for which each executive received (i) a grant of 973,325 unrestricted shares of common stock and (ii) a grant of 1,946,648 restricted shares of common stock, or the Restricted Stock. The forfeiture restrictions applicable to the Restricted Stock will, subject to such executive’s continued employment with us as of the dates set forth below, lapse according to the following schedule:

 

   

973,324 of the shares of Restricted Stock shall lapse and become free from risk of forfeiture on March 22, 2013; and

 

   

973,324 of the shares of Restricted Stock shall lapse and become free from risk of forfeiture on March 22, 2014.

Notwithstanding the foregoing, upon (i) a “Change in Control Transaction,” (ii) such executive’s termination of employment by us without “Cause,” (iii) such executive’s termination of employment with us due to such executive’s death or disability or (iv) such executive’s voluntary termination of employment with us due to “Good Reason” (as such terms are defined in the Option Cancellation Agreements), the forfeiture restrictions underlying such executive’s Restricted Stock will immediately and fully lapse. Upon any other termination of employment not set forth above, all of such executive’s unvested Restricted Stock will be immediately forfeited.

The grant of the Restricted Stock to each executive was further subject to such executive making an election under Section 83(b) within 30 days of the Grant Date and the timely payment by such executive to us of all taxes due upon the making of such election.

 

85


Table of Contents

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

Subscription Agreement with Mr. Ryan

Mr. Ryan, a current member of our board of directors, purchased 460,257 shares of our common stock for an aggregate purchase price of $1.1 million in connection with his election to our board of directors (effective as of October 7, 2011). In connection with Mr. Ryan’s investment in our company, he became a party to the second amended and restated shareholders agreement, as amended, and the amended and restated investor rights agreement, as amended, each of which are described below.

Investment by Advent

On October 14, 2010, Advent and Sargent Family Investment, LLC, a limited liability company controlled by Ronald Sargent, a current member of our board of directors, invested $192.9 and $1.1 million, respectively, in Five Below in consideration for 88,785,489 and 506,284 shares of our Series A 8% convertible preferred stock, respectively, and, as a result of such investment, Advent acquired a majority interest in Five Below, which we refer to as the 2010 Transaction. In connection with the 2010 Transaction, on October 13, 2010, all of the then outstanding preferred shares were converted into shares of our common stock and all of our options and warrants were exercised or exchanged for restricted or unrestricted shares of our common stock. As of March 31, 2012, we had 89,291,773 shares of Series A 8% convertible preferred stock outstanding. Prior to the closing of the offering, each of the outstanding shares of Series A 8% convertible preferred stock will convert into 89,291,773 shares of common stock and there will be no shares of preferred stock outstanding.

Second Amended and Restated Shareholders Agreement

In connection with the 2010 Transaction, we entered into a second amended and restated shareholders agreement with the holders of our Series A 8% convertible preferred stock and common stock. In accordance with this agreement, as subsequently amended, the holders of our capital stock agreed to vote their shares in favor of the election to our board of directors of five individuals designated by holders of our Series A 8% convertible preferred stock and three designated by our holders of common stock. Accordingly, Messrs. Mussafer, Collins, Crawford, Ross and Ryan, the designees of holders of our Series A 8% convertible preferred stock, and Messrs. Sargent, Schlessinger and Vellios, the designees of holders of our common stock, have been elected to our board of directors. In addition, our shareholders agreement provides certain rights to certain of our shareholders with respect to our capital stock, including rights of first refusal and drag-along rights in respect of the sale of shares of our capital stock, as well as certain restrictions on the transfer of our shares. The rights of first refusal do not apply to issuances by us in an initial underwritten public offering of our common stock, including this offering. The shareholders agreement, and all of the rights and obligations of our shareholders under the agreement, will be terminated upon the closing of this offering.

Amended and Restated Investor Rights Agreement

In connection with the 2010 Transaction, we entered into an amended and restated investor rights agreement with the holders of our Series A 8% convertible preferred stock and certain of the holders of our common stock, which agreement was subsequently amended. Pursuant to the agreement, certain funds managed by Advent, LLR Partners, Sargent Family Investment, LLC, Blue 9 Fund I, L.P., David Schlessinger and Thomas Vellios have the right to include certain of their shares in this offering. Certain of these shareholders have requested that we include up to an aggregate of              shares of our common stock in this offering. This number may be decreased prior to the effectiveness of this offering by Goldman, Sachs & Co., Barclays Capital Inc. and Jefferies & Company, Inc., the representatives of the underwriters in this offering, in their sole discretion. We are obligated to pay all expenses in connection with such registration other than underwriting commissions or discounts resulting from the sale of shares by our shareholders in connection with this registration.

In addition, the amended and restated investor rights agreement contains registration rights that require us to register shares of our common stock held by the shareholders who are parties to the agreement in the event we

 

86


Table of Contents

register for sale, either for our own account or for the account of others, shares of our common stock in future offerings. In connection with the closing of this offering, the parties to such agreement will amend this agreement. The amended and restated investor rights agreement, as amended, will provide for substantially similar registration rights and will continue to require a shareholder to execute a lock-up agreement with the underwriters in connection with the shareholder’s exercise of his or her registration rights in future offerings. The remainder of the provisions in the amended and restated investor rights agreement, including rights of first offer, preemptive rights and information rights will terminate.

Side Letter Agreement

On September 1, 2010, LLR Partners, David Schlessinger and Thomas Vellios entered into a side letter agreement pursuant to which LLR Partners agreed to vote all of their securities of Five Below in favor of the election of Messrs. Schlessinger and Vellios to our board of directors so long as Messrs. Schlessinger and Vellios remained employed by us. This side letter, pursuant to its terms, will terminate upon the closing of this offering.

Loan to Officer

During fiscal 2009, we extended a loan of $250,000 to Thomas Vellios, which was collateralized by a pledge of shares of Five Below common stock held by Mr. Vellios. The loan accrued interest at 4.11% and was payable on an annual basis starting on March 1, 2011. In connection with the 2010 Transaction and 2010 Dividend, Mr. Vellios offset the amount of the dividend due to him by $250,000 plus approximately $7,600 of accrued interest in full satisfaction of the amounts owed under the loan. In connection with the repayment of the loan, the pledge of Mr. Vellios’ shares was released.

Agreements with Management

We and certain of our executive officers have entered into employment agreements. The terms and conditions of certain of these employment agreements are more fully described in “Executive Compensation—Employment Agreements.”

Indemnification of Officers and Directors

We have entered into indemnification agreements with each of our executive officers and directors. The indemnification agreements provide the executive officers and directors with contractual rights to indemnification, expense advancement and reimbursement, to the fullest extent permitted under Pennsylvania law. Additionally, we may enter into indemnification agreements with any new directors or executive officers that may be broader in scope than the specific indemnification provisions contained in Pennsylvania law. There is no pending litigation or proceeding naming any of our directors or officers for which indemnification is being sought, and we are not aware of any pending or threatened litigation that may result in claims for indemnification by any director or officer.

Our Policies Regarding Related Party Transactions

Upon the closing of this offering, our board of directors will adopt a related party transactions policy for us. Pursuant to the related party transactions policy, we will review all transactions with a dollar value in excess of $120,000 involving us in which any of our directors, director nominees, significant shareholders and executive officers and their immediate family members will be participants, to determine whether such person has a direct or indirect material interest in the transaction. This policy was not in effect when we entered into the transactions described above. All directors, director nominees and executive officers will be required to promptly notify our Executive Chairman of any proposed transaction involving us in which such person has a direct or indirect material interest. Such proposed transaction will then be reviewed by the nominating and corporate governance committee to determine whether the proposed transaction is a related party transaction under our policy. In

 

87


Table of Contents

reviewing any related party transaction, the nominating and corporate governance committee will determine whether or not to approve or ratify the transaction based on all relevant facts and circumstances, including the following:

 

   

the materiality and character of the related person’s interest in the transaction;

 

   

the commercial reasonableness of the terms of the transaction;

 

   

the benefit and perceived benefit, or lack thereof, to us;

 

   

the opportunity costs of alternate transactions; and

 

   

the actual or apparent conflict of interest of the related person.

In the event that any member of the nominating and corporate governance committee is not a disinterested member with respect to the related person transaction under review, that member will be excluded from the review and approval or rejection of such related party transaction and another director may be designated to join the committee for purposes of such review. Whenever practicable, the reporting, review and approval will occur prior to entering into the transaction. If advance review and approval is not practicable, the audit committee will review and may, in its discretion, ratify the related party transaction. After any such review, the audit committee will approve or ratify the transaction only if it determines that the transaction is in, or not inconsistent with, the best interests of us and our shareholders. Our related party transaction policy will be posted under the                          section of our website at www.fivebelow.com .

 

88


Table of Contents

PRINCIPAL AND SELLING SHAREHOLDERS

The following table contains information about the beneficial ownership of our common stock as of                     , 2012 and as adjusted to reflect the sale of shares of our common stock offered by this prospectus, assuming no exercise of the underwriters’ option to purchase additional shares, by:

 

   

each person, or group of persons, who beneficially owns more than 5% of our capital stock;

 

   

each executive officer named in the summary compensation table;

 

   

each of our directors;

 

   

all directors and executive officers as a group; and

 

   

each person selling common stock in connection with this public offering.

For further information regarding material transactions between us and certain of our shareholders, see “Certain Relationships and Related Party Transactions.”

Beneficial ownership and percentage ownership are determined in accordance with the rules and regulations of the SEC and include voting or investment power with respect to shares of stock. This information does not necessarily indicate beneficial ownership for any other purpose. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, shares of common stock subject to restrictions, options or warrants held by that person that are currently exercisable or exercisable within 60 days of                     , 2012 are deemed outstanding. Such shares, however, are not deemed outstanding for the purposes of computing the percentage ownership of any other person. Except as indicated in the footnotes to the following table or pursuant to applicable community property laws, each shareholder named in the table has sole voting and investment power with respect to the shares set forth opposite such shareholder’s name. Assuming the issuance of              shares of our common stock in this offering, there will be              shares of common stock outstanding after this offering. Beneficial ownership and the percentage of beneficial ownership prior to the offering is based on              shares of common stock outstanding on                     , 2012 assuming the completion of the              -for-              reverse stock split, the adjustment of the terms of our outstanding preferred stock, options and warrants, the conversion of our Series A 8% convertible preferred stock into common stock and the exercise of our outstanding warrants into common stock.

The table below assumes the underwriters do not exercise their option to purchase additional shares. Unless otherwise indicated in the footnotes, the address of each of the individuals named below is: c/o Five Below, Inc., 1818 Market Street, Suite 1900, Philadelphia, Pennsylvania 19103.

 

89


Table of Contents

Name of Beneficial Owner

   Shares
Beneficially
Owned
Prior to the
Offering
   Percentage
of Shares
Beneficially
Owned
Prior to the
Offering
    Number
of
Shares
Offered
   Shares
Beneficially
Owned
After the
Offering
   Percentage
of Shares
Beneficially
Owner
After the
Offering
 

5% Shareholders Not Listed Below:

             

Funds managed by Advent International Corporation(1)

                           

LLR Capital II, LLC(2)

                           

Named Executive Officers & Directors:

             

Kenneth R. Bull

                           

Steven J. Collins

                           

Andrew W. Crawford

                           

David M. Mussafer(3)

                           

Howard D. Ross(4)

                           

Thomas M. Ryan

                           

Ronald L. Sargent(5)

                           

David Schlessinger(6)

                           

Thomas G. Vellios(7)

                           

All executive officers and directors as a group (9 persons)

                           

Additional Selling Shareholder:

             

Blue 9 Fund I, L.P.(8)

                           

 

 * Less than 1%
(1)

The funds managed by Advent International Corporation own     % of Five Below, Inc. prior to this offering. The direct ownership of the shares of common stock consists of              shares held by Advent International GPE VI Limited Partnership,              shares held by Advent International GPE VI-A Limited Partnership,              shares held by Advent International GPE VI-B Limited Partnership,              shares held by Advent International GPE VI-C Limited Partnership,              shares held by Advent International GPE VI-D Limited Partnership,              shares held by Advent International GPE VI-E Limited Partnership,              shares held by Advent International GPE VI-F Limited Partnership,              shares held by Advent International GPE VI-G Limited Partnership,              shares held by Advent Partners GPE VI 2008 Limited Partnership,              shares held by Advent Partners GPE VI 2009 Limited Partnership,              shares held by Advent Partners GPE VI 2010 Limited Partnership,              shares held by Advent Partners GPE VI—A 2010 Limited Partnership and              shares held by Advent Partners GPE VI—A Limited Partnership. The funds managed by Advent International Corporation collectively purchased their interest in shares of our capital stock on October 14, 2010. Immediately prior to this offering, the funds managed by Advent International Corporation will beneficially own              shares (or     %) of our common stock, or     % of our common stock on a fully diluted basis. In the offering, Advent International GPE VI Limited Partnership will be entitled to sell              shares of our common stock (or a total of              shares if the underwriters exercise in full their option to purchase additional shares), Advent International GPE VI-A Limited Partnership will be entitled to sell              shares of our common stock (or a total of              shares if the underwriters exercise in full their option to purchase additional shares), Advent International GPE VI-B Limited Partnership will be entitled to sell              shares of our common stock (or a total              shares if the underwriters exercise in full their option to purchase additional shares), Advent International GPE VI-C Limited Partnership will be entitled to sell              shares of our common stock (or a total of              shares if the underwriters exercise in full their option to purchase additional shares), Advent International GPE VI-D Limited Partnership will be entitled to sell              shares of our common stock (or a total of              shares if the underwriters exercise in full their option to purchase additional shares), Advent International GPE VI-E Limited Partnership will be entitled to sell              shares of our common stock (or a total of              shares if the underwriters exercise in full their option to purchase additional shares), Advent International GPE VI-F Limited Partnership will be entitled to sell              shares of our common stock (or a total of              shares if the underwriters exercise in full their

 

90


Table of Contents
  option to purchase additional shares), Advent International GPE VI-G Limited Partnership will be entitled to sell              shares of our common stock (or a total of              shares if the underwriters exercise in full their option to purchase additional shares), Advent Partners GPE VI 2008 Limited Partnership will be entitled to sell              shares of our common stock (or a total of              shares if the underwriters exercise in full their option to purchase additional shares), Advent Partners GPE VI 2009 Limited Partnership will be entitled to sell              shares of our common stock (or a total of              shares if the underwriters exercise in full their option to purchase additional shares), Advent Partners GPE VI 2010 Limited Partnership will be entitled to sell              shares of our common stock (or a total of              shares if the underwriters exercise in full their option to purchase additional shares), Advent Partners GPE VI—A 2010 Limited Partnership will be entitled to sell              shares of our common stock (or a total of              shares if the underwriters exercise in full their option to purchase additional shares) and Advent Partners GPE VI—A Limited Partnership will be entitled to sell              shares of our common stock (or a total of              shares if the underwriters exercise in full their option to purchase additional shares). Immediately after this offering, the funds managed by Advent International Corporation will beneficially own              shares (or     %) of our common stock, or     % of our common stock on a fully diluted basis. If the underwriters exercise in full their option to purchase additional shares, the funds managed by Advent International Corporation will beneficially own              shares (or     %) of our common stock, or     % of our common stock on a fully diluted basis. Advent International Corporation is the manager of Advent International LLC, which is the general partner of: GPE VI GP Limited Partnership; GPE VI GP (Delaware) Limited Partnership; Advent Partners GPE VI 2008 Limited Partnership; Advent Partners GPE VI 2009 Limited Partnership; Advent Partners GPE VI 2010 Limited Partnership; Advent Partners A Limited Partnership and Advent Partners GPE VI—A 2010 Limited Partnership. GPE VI GP Limited Partnership is the general partner of: Advent International GPE VI Limited Partnership; Advent International GPE VI-A Limited Partnership; Advent International GPE VI-B Limited Partnership; Advent International GPE VI-F Limited Partnership and Advent International GPE VI-G Limited Partnership. GPE VI GP (Delaware) Limited Partnership is the general partner of: Advent International GPE VI-C Limited Partnership; Advent International GPE VI-D Limited Partnership and Advent International GPE VI-E Limited Partnership. Advent International Corporation exercises voting and investment power over the shares held by each of these entities and may be deemed to have beneficial ownership of these shares. With respect to the shares held by funds managed by Advent International Corporation, a group of individuals currently composed of Richard F. Kane, David M. Mussafer and Steven M. Tadler, none of whom have individual voting or investment power, exercise voting and investment power over the shares beneficially owned by Advent International Corporation. Each of Mr. Kane, Mr. Mussafer and Mr. Tadler disclaims beneficial ownership of the shares held by funds managed by Advent International Corporation, except to the extent of their respective pecuniary interest therein. The address of Advent International Corporation and each of the funds listed above is c/o Advent International Corporation, 75 State Street, Floor 29, Boston, MA 02109.
(2)

The funds managed by LLR Capital II, LLC own     % of Five Below, Inc. prior to this offering. The direct ownership of the shares of common stock consists of              shares held by LLR Equity Partners II, L.P. and              shares held by LLR Equity Partners Parallel II, L.P., collectively referred to as LLR Equity Partners, prior to the offering. Immediately prior to this offering, LLR Equity Partners will beneficially own              shares (or     %) of our common stock, or     % of our common stock on a fully diluted basis. In the offering, LLR Equity Partners II, L.P. will be entitled to sell              shares of our common stock (or a total of              shares if the underwriters exercise in full their option to purchase additional shares) and LLR Equity Partners Parallel II, L.P. will be entitled to sell              shares of our common stock (or a total of              shares if the underwriters exercise in full their option to purchase additional shares). Immediately after this offering, LLR Equity Partners will beneficially own              shares (or     %) of our common stock, or     % of our common stock on a fully diluted basis. If the underwriters exercise in full their option to purchase additional shares, LLR Equity Partners will beneficially own              shares (or     %) of our common stock, or     % of our common stock on a fully diluted basis. LLR Capital II, LLC is the general partner of LLR Capital II, L.P. which is the general partner of each of LLR Equity Partners II, L.P. and LLR Equity Partners Parallel II, L.P. LLR Capital II, LLC exercises voting and investment power over the shares held by each of these entities and may be deemed to have beneficial ownership of these shares. With respect to the shares of our common stock held by the LLR, a group of individuals currently

 

91


Table of Contents
  composed of Mitchell Hollin, Seth Lehr, Ira Lubert and Howard Ross, none of whom have individual voting or investment power, exercise voting and investment power over the shares beneficially owned by LLR Capital II, LLC and each of the funds mentioned above. Each of Messrs. Hollin, Lehr, Lubert and Ross disclaim beneficial ownership of the shares held by LLR Capital II, LLC, except to the extent of their respective pecuniary interest therein. The address of LLR Capital II, LLC is c/o LLR Capital II, LLC, Circa Centre, 2929 Arch Street, Suite 2700, Philadelphia, PA 19104.
(3) Mr. Mussafer is a member of a group of persons who exercise voting and investment power over the shares of common stock beneficially owned by the funds managed by Advent International Corporation and may be deemed to beneficially own the shares held by these funds. Mr. Mussafer disclaims beneficial ownership of the shares of common stock held by the funds managed by Advent International Corporation, except to the extent of his pecuniary interest therein. Mr. Mussafer’s address is c/o Advent International Corporation, 75 State Street, Floor 29, Boston, MA 02109.
(4) Mr. Ross is a member of a group of persons who exercise voting and investment power over the shares of common stock beneficially owned by the LLR Capital II, LLC and may be deemed to beneficially own the shares held by these funds. Mr. Ross disclaims beneficial ownership of the shares of common stock held by the funds managed by LLR Capital II, LLC, except to the extent of his pecuniary interest therein. Mr. Ross’s address is c/o LLR Capital II, LLC, Circa Centre, 2929 Arch Street, Suite 2700, Philadelphia, PA 19104.
(5) Includes              shares owned by Sargent Family Investment, LLC. Mr. Sargent, the sole member and manager of Sargent Family Investment, LLC, exercises voting and investment power over the shares beneficially owned by Sargent Family Investment, LLC.
(6) The total shares beneficially owned by Mr. Schlessinger includes              shares of common stock held by members of his family. The total shares beneficially owned by Mr. Schlessinger prior to the offering includes              shares of common stock held by certain shareholders as to which Mr. Schlessinger has sole voting power pursuant to irrevocable proxies granted by such shareholders. Mr. Schlessinger disclaims beneficial ownership of the shares of common stock subject to such proxies.
(7) Includes              shares of common stock held by certain shareholders as to which Mr. Vellios has sole voting power pursuant to irrevocable proxies granted by such shareholders. Mr. Vellios disclaims beneficial ownership of the shares of common stock subject to such proxies.
(8) Includes              shares owned by Blue 9 Fund I, L.P. prior to the offering. Immediately prior to this offering, Blue 9 Fund I, L.P. will beneficially own              shares (or     %) of our common stock, or     % of our common stock on a fully diluted basis. In the offering, Blue 9 Fund I, L.P. will be entitled to sell              shares of our common stock (or a total of              shares if the underwriters exercise in full their option to purchase additional shares). Immediately after this offering, Blue 9 Fund I, L.P. will beneficially own              shares (or     %) of our common stock, or     % of our common stock on a fully diluted basis. If the underwriters exercise in full their option to purchase additional shares, Blue 9 Fund I, L.P. will beneficially own              shares (or     %) of our common stock, or     % of our common stock on a fully diluted basis. Blue 9 Capital, LLC is the general partner of Blue 9 Fund I, L.P. Blue 9 Capital, LLC exercises voting and investment power over the shares held by Blue 9 Fund I, L.P. and may be deemed to have beneficial ownership of these shares. With respect to the shares of our common stock held by Blue 9 Fund I, L.P., Steven Tuttleman exercises voting and investment power over the shares beneficially owned by Blue 9 Capital, LLC. Mr. Tuttleman disclaims beneficial ownership of the shares held by Blue 9 Fund I, L.P., except to the extent of his pecuniary interest therein. The address of Blue 9 Fund I, L.P. is c/o Blue 9 Capital, LLC, 23 Tettemer Road, Erwinna, PA 18920.

 

92


Table of Contents

DESCRIPTION OF CAPITAL STOCK

The following description summarizes the terms of our capital stock, our second amended and restated articles of incorporation and our third amended bylaws. Because it is only a summary, it does not contain all the information that may be important to you. For a complete description, you should refer to our forms of second amended and restated articles of incorporation and third amended bylaws, to be effective upon the closing of this offering, which are included as exhibits to the registration statement of which this prospectus is part.

General

Upon the closing of this offering, our authorized capital stock will consist of              shares of common stock, par value $0.01 per share, and              shares of preferred stock, par value $0.01 per share.

As of             , 2012, there were outstanding:

 

   

             shares of our common stock held by      shareholders of record; and

 

   

             shares of our Series A 8% convertible preferred stock that are convertible into              shares of our common stock.

 

   

stock options to purchase an aggregate of              shares of our common stock with a weighted average exercise price of $     per share;

 

   

warrants to purchase up to              shares of our common stock at an exercise price of $     per share.

Prior to the closing of this offering, we will amend our articles of incorporation to effect a     -for-     reverse stock split of our common stock. Concurrent with the reverse stock split, we will adjust (x) the number of shares subject to and the conversion price of our Series A 8% convertible preferred stock, (y) the number of shares subject to and the exercise price of our outstanding stock option awards under our equity incentive plan and (z) the number of shares subject to and the exercise price of our outstanding warrants, such that the holders of the preferred stock, options and warrants will be in the same economic position both before and after the reverse stock split. The holders of our outstanding common stock will receive              shares of common stock after giving effect to the stock split.

Assuming the underwriters do not exercise their option to purchase additional shares, and after giving effect to the stock split, upon the closing of this offering:

 

   

all of the outstanding shares of our Series A 8% convertible preferred stock will convert into              shares of our common stock and

 

   

all of the warrants will be exercised into              shares of our common stock.

2012 Dividend

On                     , 2012, we declared and paid the 2012 Dividend on shares of our common stock and our Series A 8% convertible preferred stock.

 

93


Table of Contents

Common Stock

Voting rights

Holders of our common stock are entitled to one vote for each share for the election of directors and on all other matters submitted to a vote of shareholders, and do not have cumulative voting rights in the election of directors. Whenever corporate action is to be taken by vote of the shareholders, it becomes authorized upon receiving the affirmative vote of a majority of the votes cast by all shareholders present in person or by proxy and entitled to vote on the matter.

Dividend rights

Subject to the preferences applicable to any outstanding preferred stock, holders of common stock are entitled to receive ratably any dividend declared by the board of directors.

Rights upon liquidation

In the event of a liquidation, dissolution or winding up of the company, holders of common stock are entitled to share ratably in the assets remaining after payment of liabilities and the liquidation preferences of any outstanding preferred stock.

Other rights and preferences

Holders of our common stock have no preemptive, subscription, conversion, redemption or sinking fund rights. The rights, preferences and privileges of holders of our common stock will be subject to those of the holders of any shares of our preferred stock we may issue in the future.

Listing

We intend to apply to list our common stock on The NASDAQ Global Select Market under the trading symbol “               .”

Transfer Agent and Registrar

The transfer agent and registrar for our common stock is                     . Its address is                     , and its telephone number is (        )                     .

Preferred Stock

As of             , 2012, we had              shares of Series A 8% convertible preferred stock outstanding. Upon the closing of the offering, the outstanding shares of Series A 8% convertible preferred stock will convert into              shares of common stock and there will be no shares of preferred stock outstanding. Our board of directors has the authority, without further action by the shareholders, to issue up to              shares of preferred stock in one or more series and to fix the designations, powers, preferences, privileges and relative participating, optional, or special rights as well as the qualifications, limitations, or restrictions of the preferred stock, including dividend rights, conversion rights, voting rights, terms of redemption and liquidation preferences, any or all of which may be greater than the rights of the common stock. Accordingly, our board of directors, without shareholder approval, may issue preferred stock with voting, conversion, or other rights that could adversely affect the voting power and other rights of the holders of common stock. Preferred stock could be issued quickly with terms calculated to delay or prevent a change of control or make removal of management more difficult. Additionally, the issuance of preferred stock may have the effect of decreasing the market price of our common stock, may adversely affect the voting and other rights of the holders of our common stock, and could have the

 

94


Table of Contents

effect of delaying, deferring or preventing a change of control of Five Below or other corporate action. See “—Anti-Takeover Effects of Certain Provisions of Pennsylvania Law and our Second Amended and Restated Articles of Incorporation and Third Amended Bylaws.” At present, we have no plans to issue any shares of preferred stock following this offering.

Equity Incentive Awards

Options

As of                     , 2012, we had outstanding options to purchase                      shares of our common stock at a weighted-average price of $     per share, of which no options to purchase                      shares were vested at such time. We have                      shares remaining available for issuance pursuant to our equity incentive plan.

Restricted Common Stock

In addition, as of     , 2012, we had      shares of restricted common stock issued and outstanding, all of which shares were issued in connection with the 2010 Transaction and pursuant to our equity incentive plan when all of our options were exercised for common shares or restricted common shares on October 13, 2010. Of those                      restricted shares of common stock,                      were vested as of                     , 2012.

Warrants

As of     , 2012, we had      outstanding warrants to purchase up to      shares of our common stock each exercisable during a three-year term from the date of issuance. The weighted-average exercise price of the outstanding warrants is $     per share. Each warrant provides for adjustments in the event of reorganizations, reclassifications, stock dividends, stock splits or other changes in our corporate structure. The warrants also provide for cashless exercise and subject its holders to a lock-up in connection with the exercise. We expect that each of the outstanding warrants will be exercised in full prior to the closing of this offering.

Registration Rights

Pursuant to the existing amended and restated investor rights agreement, certain funds managed by Advent, LLR Partners, Sargent Family Investment, LLC, Blue 9 Fund I, L.P., David Schlessinger and Thomas Vellios have the right to include certain of their shares in this offering. Certain of these shareholders have requested that we include up to an aggregate of              shares of our common stock in this offering. This number may be decreased prior to the effectiveness of this offering by Goldman, Sachs & Co., Barclays Capital Inc. and Jefferies & Company, Inc., the representatives of the underwriters in this offering, in their sole discretion. We are obligated to pay all expenses in connection with such registration other than underwriting commissions or discounts resulting from the sale of shares by our shareholders in connection with this registration.

Upon the closing of this offering, shareholders who are parties to the amended and restated investor rights agreement, as amended, will have the right, subject to various conditions and limitations, to include their shares of our common stock in registration statements relating to our securities. The right to include shares in an underwritten registration is subject to the ability of the underwriters to limit the number of shares included in the offering. By exercising their registration rights and causing a large number of shares to be registered and sold in the public market, these holders could cause the price of the common stock to fall. In addition, any demand to include such shares in our registration statements could have a material adverse effect on our ability to raise needed capital.

 

95


Table of Contents

Anti-Takeover Effects of Certain Provisions of Pennsylvania Law and our Second Amended and Restated Articles of Incorporation and Third Amended Bylaws

Our second amended and restated articles of incorporation and our third amended bylaws will contain provisions that are intended to enhance the likelihood of continuity and stability in the composition of our board of directors and could make it more difficult to acquire control of us by means of a tender offer, open market purchases, a proxy contest or otherwise. We expect that these provisions will discourage coercive takeover practices or inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors, which we believe may result in an improvement of the terms of any such acquisition in favor of our shareholders. However, they also give our board of directors the power to discourage acquisitions that some shareholders may favor.

No Cumulative Voting

As of the closing of this offering, our only issued and outstanding shares of capital stock will be common stock. Each outstanding share of our common stock entitles the holder to one vote on all matters submitted to a vote of shareholders, including the election of directors. Our second amended and restated articles of incorporation do not allow for cumulative voting in the election of directors, therefore shareholders holding a majority of the outstanding capital stock entitled to vote will be able to elect all of our directors.

Special Shareholders’ Meetings and Right to Act by Written Consent

According to our third amended bylaws, our shareholders are not permitted to call, or to require that the board of directors call, a special meeting of shareholders. Rather, a special meeting of shareholders may only be called by the chairman of our board of directors or our Chief Executive Officer or upon a resolution adopted by a majority of our entire board of directors. In addition, the business permitted to be conducted at any special meeting of shareholders is limited to the business brought before the meeting pursuant to the notice of the meeting given by us.

Our third amended bylaws prohibit shareholder action without a meeting through the execution of a written consent or consents thereto by the shareholders, and therefore, any action of shareholders may be taken only at a meeting of the shareholders.

Amendment of Our Second Amended and Restated Articles of Incorporation and Third Amended Bylaws

Our second amended and restated articles of incorporation and third amended bylaws each provide that, unless previously approved by our board of directors, the affirmative vote of at least 80% of the voting power of all of our outstanding capital stock entitled to vote generally in the election of directors, voting together as a single class, would be required to amend or repeal the provisions of our second amended and restated articles of incorporation or third amended bylaws. Any amendment to or repeal of our second amended and restated articles of incorporation or third amended bylaws approved by our board of directors would require the affirmative vote of at least 50% of the voting power of all of our outstanding capital stock entitled to vote on such amendment or repeal.

These provisions may have the effect of deterring hostile takeovers, or delaying or preventing changes in control of our management or Five Below, such as a merger, reorganization or tender offer. These provisions are intended to enhance the likelihood of continued stability in the composition of our board of directors and its policies and to discourage certain types of transactions that may involve an actual or threatened acquisition of us. These provisions are designed to reduce our vulnerability to an unsolicited acquisition proposal and to discourage certain tactics that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our shares and, as a consequence, they also may inhibit fluctuations in the market price of our shares that could result from actual or rumored takeover attempts. Such provisions may also have the effect of preventing changes in our management.

 

96


Table of Contents

Classified Board; Removal of Directors; Size of Board

Pursuant to our second amended and restated articles of incorporation and third amended bylaws, directors will be divided into three classes, whose members will serve staggered three-year terms. Because our shareholders do not have cumulative voting rights, our shareholders holding a majority of the outstanding capital stock entitled to vote will be able to elect all of our directors. A third party may be discouraged from making a tender offer or otherwise attempting to obtain control of us as it is more difficult and time-consuming for shareholders to replace a majority of the directors on a classified board.

Our second amended and restated articles of incorporation and third amended bylaws provide that, subject to the rights of holders of any preferred stock, any director may be removed from office only for cause by the affirmative vote of the holders of at least 80% of the voting power of all of our outstanding capital stock entitled to vote generally in the election of directors, voting together as a single class.

In addition, our second amended and restated articles of incorporation and third amended bylaws provide that the number of directors on our board will consist of a number of directors, not less than three nor more than eleven, to be fixed exclusively by our board of directors. Newly created directorships resulting from any increase in the number of directors may be filled by the affirmative vote of the directors then in office. Further, any vacancies on our board of directors resulting from death, resignation, or removal from office will also be filed solely by the vote of our remaining directors. Any director elected in accordance with the preceding sentence shall be a director of the same class as the director whose vacancy he or she fills and shall hold office until the next annual meeting of shareholders, and until such director’s successor shall have been duly elected and qualified.

Undesignated Preferred Stock

Our second amended and restated articles of incorporation authorize undesignated preferred stock, which makes it possible for our board of directors to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to change the control of Five Below. This may have the effect of deterring hostile takeovers or delaying changes in control or management of Five Below.

Authorized but Unissued Shares

The authorized but unissued shares of our common stock and preferred stock are available for future issuance without shareholder approval, subject to various limitations imposed by The NASDAQ Stock Market LLC. These additional shares may be used for a variety of corporate purposes, including future public offerings to raise additional capital, corporate acquisitions and employee benefit plans. The existence of authorized but unissued shares of common stock and preferred stock could make it more difficult, or discourage an attempt, to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.

Procedures for Shareholder Nominations and Proposals

Our third amended bylaws establish advance notice procedures with respect to shareholder proposals and the nomination of candidates for election as directors, other than nominations made by or at the direction of the board of directors or a committee thereof. The advance notice provisions in our third amended bylaws could have the effect of delaying shareholder actions that are favored by the holders of a majority of our outstanding voting securities until the next shareholder meeting or may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect its own slate of directors or otherwise attempt to obtain control of us.

Pennsylvania Anti-Takeover Laws

Pursuant to our second amended and restated articles of incorporation, we have expressly elected not to be governed by a number of anti-takeover statutes available under Pennsylvania law. We are, however, subject to the following anti-takeover provisions under Pennsylvania law:

 

   

Subchapter F of Chapter 25 of the Pennsylvania Business Corporation Law, or the PBCL, prohibits a “business combination” with an “interested shareholder,” which means a person who (a) is the

 

97


Table of Contents
 

beneficial owner, directly or indirectly, of shares entitling that person to cast at least 20% of the votes entitled to be cast for the election of directors of a corporation or (b) who is an affiliate or associate of such corporation and was the beneficial owner, directly or indirectly, of shares entitling that person to cast at least 20% of the votes at any time within the five-year period immediately prior to the date in question, unless this business combination or the acquisition by the shareholder or group of shareholders of at least 20% of the voting power of the corporation is approved in advance by our board of directors or approved by a certain majority of those shareholders who are not interested shareholders nor affiliates or associates thereof. This provision may discourage open market purchases of our stock or a non-negotiated tender or exchange offer for our stock and, accordingly, may be considered disadvantageous by a shareholder who would desire to participate in any such transaction.

 

   

Pursuant to Section 1715 of the PBCL, our directors are not required to regard the interests of any particular group, including those of the shareholders, as being dominant or controlling in considering our best interests. The directors may consider, to the extent they deem appropriate, such factors as:

 

   

the effects of any action upon any group affected by such action, including our shareholders, employees, suppliers, customers and creditors, and communities in which we have stores, offices or other establishments;

 

   

our short-term and long-term interests, including benefits that may accrue to us from our long-term plans and the possibility that these interests may be best served by our continued independence;

 

   

the resources, intent and conduct of any person seeking to acquire control of us; and

 

   

all other pertinent factors.

Section 1715 further provides that any act of our board of directors, a committee of the board or an individual director relating to or affecting an acquisition or potential or proposed acquisition of control to which a majority of our disinterested directors have assented will be presumed to satisfy the standard of care set forth in the PBCL, unless it is proven by clear and convincing evidence that our disinterested directors did not consent to such act in good faith after reasonable investigation. As a result of this and the other provisions of Section 1715, our directors are provided with broad discretion with respect to actions that may be taken in response to acquisitions or proposed acquisitions of corporate control.

Indemnification and Limitation of Directors and Limitation of Liability

Pennsylvania Business Corporation Law

Sections 1741 through 1750 of Subchapter D, Chapter 17, of the PBCL, contain provisions for mandatory and discretionary indemnification of a corporation’s directors, officers and other personnel, and related matters. As described below, we intend to indemnify our directors, officers and other such personnel to the fullest extent permitted by the PBCL.

Third Amended Bylaws

Our third amended bylaws provide that we may indemnify our directors and officers for monetary damages for any action taken or failure to take any action, unless such director or officer has breached or failed to perform the duties of his or her office under the PBCL, our third amended bylaws or our second amended and restated articles of incorporation; and the breach or failure to perform constitutes self-dealing, willful misconduct or recklessness.

In addition, our third amended bylaws provide that we shall indemnify our directors and officers for expenses, attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit or proceeding if he or she has acted in good faith and in a manner

 

98


Table of Contents

he or she believed to be in our best interest, or in the case of a criminal proceeding, that he or she had no reasonable cause to believe his or her conduct was unlawful. Such indemnification as to expenses, including attorneys’ fees, is mandatory to the extent the individual is successful on the merits or otherwise in defense of the matter or in defense of any claim, issue or matter therein. Our third amended bylaws provide, however, in the case of an action or suit by or in the right of Five Below, that we will not indemnify a director or officer with respect to a matter in which such person has been adjudged to be liable in the performance of his or her duties to us, unless a court of common pleas determines that such person is fairly and reasonably entitled to indemnification. Our third amended bylaws also provide that we may advance expenses to any director or officer upon our receipt of an undertaking by the director or officer to repay those amounts if it is finally determined that he or she is not entitled to indemnification.

Pursuant to our third amended bylaws, we have the power to purchase and maintain insurance on behalf of any person who is or was a director or officer of Five Below or an employee or agent of Five Below, against any liability asserted against such person and incurred by him or her in any such capacity, or arising out of his or her status as such, whether or not we would have the power to indemnify him or her against that liability. Accordingly, we maintain directors’ and officers’ liability insurance to provide directors and officers with insurance coverage for losses, including those that arise from claims based on breaches of duty, negligence, error and other wrongful acts and for violations with respect to the Securities Act.

Indemnification Agreements

We have entered into indemnification agreements with our directors. These agreements require us to indemnify these individuals to the fullest extent permitted under Pennsylvania law against liabilities that may arise by reason of their service to us, and to advance expenses incurred as a result of any proceeding against them as to which they could be indemnified.

 

99


Table of Contents

SHARES ELIGIBLE FOR FUTURE SALE

Prior to this offering, there has been no public market for our common stock, and a liquid trading market for our common stock may not develop or be sustained after this offering. Sales of substantial amounts of our common stock in the public market, or the perception that such sales could occur, could adversely affect market prices prevailing from time to time. Furthermore, because only a limited number of shares will be available for sale shortly after this offering due to existing contractual and legal restrictions on resale as described below, there may be sales of substantial amounts of our common stock in the public market after the restrictions lapse. This may put downward pressure on the market price of our common stock and our ability to raise capital through a future sale of our securities.

Upon the closing of this offering,              shares of common stock will be outstanding. The number of shares outstanding after this offering is based on the number of shares outstanding as of                     , 2012 and assumes the conversion of all shares of preferred stock into common stock, the exercise of all outstanding warrants and no exercise of outstanding stock options. The              shares sold in this offering will be freely tradable without restriction under the Securities Act, unless those shares are purchased by affiliates as that term is defined in Rule 144 under the Securities Act. Persons who may be deemed to be affiliates generally include individuals or entities that control, are controlled by, or are under common control with, us and may include our directors and officers. The remaining              shares of common stock held by existing shareholders are “restricted securities” within the meaning of Rule 144 under the Securities Act. Restricted shares may be sold in the public market only if they are registered under the Securities Act or if they qualify for an exemption from registration, such as Rule 701 under the Securities Act, or meet the safe harbor requirements of Rule 144 under the Securities Act, which are summarized below. The remaining shares of common stock held by our existing shareholders upon the closing of this offering will be available for sale in the public market after the expiration of the lock-up agreements described below and under “Underwriting,” taking into account the provisions of Rules 144 and 701 of the Securities Act.

Sales of Restricted Shares and Shares Held by Our Affiliates

Rule 144

In general, under Rule 144, an affiliate who beneficially owns shares that were purchased from us, or any affiliate, at least six months previously, is entitled to sell, upon the expiration of the lock-up agreement described below and in “Underwriting” and within any three-month period beginning 90 days after the date of this prospectus, a number of shares that does not exceed the greater of 1% of our then-outstanding shares of common stock, which will equal approximately              shares immediately after this offering, or the average weekly trading volume of our common stock on The NASDAQ Global Select Market during the four calendar weeks preceding the filing of a notice of the sale with the SEC. Sales under Rule 144 are also subject to certain manner of sale provisions, notice requirements and the availability of current public information about us.

Under Rule 144(b)(1), a person (or persons whose shares are aggregated) who is not deemed to have been an affiliate of ours at any time during the 90 days preceding a sale, and who has beneficially owned the shares proposed to be sold for at least six months (including the holding period of any prior owner other than an affiliate), is entitled to sell its shares without complying with the volume limitation or the manner of sale or notice provisions of Rule 144 beginning 90 days after the date of this prospectus, provided current public information about us is available. Such current, public information requirement shall not apply if such shares were beneficially owned for at least twelve months.

Rule 701

Subject to certain limitations on the aggregate offering price of a transaction and other conditions, Rule 701 may be relied upon with respect to the resale of securities originally purchased from us by our employees,

 

100


Table of Contents

directors, officers, consultants or advisors prior to the date we become subject to the reporting requirements of the Securities Exchange Act. To be eligible for resale under Rule 701, shares must have been issued in connection with written compensatory benefit plans or written contracts relating to the compensation of such persons. In addition, the SEC has indicated that Rule 701 will apply to typical stock options granted by an issuer before it becomes subject to the reporting requirements of the Exchange Act, along with the shares acquired upon exercise of such options, including exercises after the date of this offering. Securities issued in reliance on Rule 701 are restricted securities and, subject to the contractual restrictions described below, beginning 90 days after the date of this prospectus, may be sold by persons other than “affiliates,” as defined in Rule 144, subject only to the manner of sale provisions of Rule 144 and by “affiliates” under Rule 144 without compliance with its one-year minimum holding period requirement. Subject to the 180-day lock-up period described below and in “Underwriting,” approximately              shares of our common stock will be eligible for sale in accordance with Rule 701.

Sales under Rules 144 and 701

No precise prediction can be made as to the effect, if any, that market sales of shares or the availability of shares for sale will have on the market price of our common stock prevailing from time to time. We are unable to estimate the number of our shares that may be sold in the public market pursuant to Rule 144 or Rule 701 (or pursuant to Form S-8, if applicable) because this will depend on the market price of our common stock, the personal circumstances of the sellers and other factors. Nevertheless, sales of significant amounts of our common stock in the public market could adversely affect the market price of our common stock.

Equity Incentive Plan

As of         , 2012, we had outstanding options to purchase          shares of our common stock, of which no options to purchase          shares were vested. In addition, we had          shares of restricted stock issued in connection with the 2010 Transaction as a result of the conversion of the options outstanding under the equity incentive plan prior to the 2010 Transaction. Of those          restricted shares,          were vested.

We intend to file one or more registration statements on Form S-8 under the Securities Act to register all shares of common stock subject to outstanding stock options and options and other awards issuable under our equity incentive plan. We expect to file the registration statement covering shares offered pursuant to our equity incentive plan shortly after the date of this prospectus, permitting the resale of such shares, subject to compliance with the resale provisions of Rule 144 applicable to affiliates, and subject to any vesting restrictions and lock-up agreements applicable to these shares. Our equity incentive plan is described in more detail under “Executive Compensation—Employee Benefit Plans.”

Lock-Up Agreements

We and the holders of substantially all of our common stock outstanding on the date of this prospectus, including each of our executive officers, directors and selling shareholders, have entered into lock-up agreements with the underwriters providing, subject to certain exceptions, that we and they will not, directly or indirectly, offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise dispose of or hedge any of our shares of common stock, any options or warrants to purchase shares of our common stock, or any securities convertible into, or exchangeable for or that represent the right to receive shares of our common stock, without the prior written consent of Goldman, Sachs & Co., Barclays Capital Inc. and Jefferies & Company, Inc. for a period of 180 days from the date of this prospectus. The 180-day lock-up period may be extended under certain circumstances where we release, or pre-announce a release of, our earnings shortly before or after the termination of the 180-day period, or we announce material news or a material event shortly before the termination of the 180-day period, unless Goldman, Sachs & Co., Barclays Capital Inc. and Jefferies & Company, Inc. waive, in writing, such extension.

 

101


Table of Contents

Our amended and restated investor rights agreement also provides that upon the request by underwriters in a registered public offering of our shares of common stock, each shareholder party to such agreement will not directly or indirectly, sell, contract to sell (including without limitation, any short sale), grant any option to purchase, dispose of or otherwise transfer any shares held by such shareholder, without the consent of the underwriters for a period of not more than 180 days following the effective date of the registration statement related to an initial public offering or 90 days following the effective date of the registration statement related to any registration other than the initial public offering. Such shareholders also agreed to execute and deliver the necessary documents to effect such restrictions. In addition, the agreement permits Five Below to impose stop-transfer instructions with respect to such securities until the end of the applicable period.

Registration Rights

Upon the closing of this offering, shareholders who are parties to the amended and restated investor rights agreement, as amended, have the right, subject to various conditions and limitations, to include their shares of our common stock in registration statements relating to our securities. The right to include shares in an underwritten registration is subject to the ability of the underwriters to limit the number of shares included in the offering. By exercising their registration rights and causing a large number of shares to be registered and sold in the public market, these holders could cause the price of the common stock to fall. In addition, any demand to include such shares in our registration statements could have a material adverse effect on our ability to raise needed capital.

 

102


Table of Contents

MATERIAL UNITED STATES TAX CONSIDERATIONS

FOR NON-UNITED STATES HOLDERS OF COMMON STOCK

This section summarizes the material U.S. federal income and estate tax considerations relating to the acquisition, ownership and disposition of our common stock by “non-U.S. holders” (defined below) pursuant to this offering. This summary does not provide a complete analysis of all potential U.S. federal income tax considerations relating thereto. The information provided below is based upon provisions of the Code, Treasury regulations promulgated thereunder, administrative rulings and judicial decisions currently in effect. These authorities may change at any time, possibly retroactively, or the Internal Revenue Service, or IRS, might interpret the existing authorities differently. In either case, the tax considerations of owning or disposing of our common stock could differ from those described below.

For purposes of this summary, a “non-U.S. holder” is any holder of our common stock, other than a partnership, that is not:

 

   

an individual who is a citizen or resident of the United States;

 

   

a corporation, or other entity taxable as a corporation, created or organized under the laws of the United States, any state therein or the District of Columbia;

 

   

a trust if it (1) is subject to the primary supervision of a U.S. court and one or more U.S. persons have authority to control all substantial decisions of the trust or (2) has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person; or

 

   

an estate whose income is subject to U.S. income tax regardless of source.

If you are an individual, you may, in many cases, be deemed to be a resident alien, as opposed to a nonresident alien, by virtue of being present in the United States for at least 31 days in the calendar year and for an aggregate of at least 183 days during a three-year period ending in the current calendar year. Such an individual is urged to consult his or her own tax advisor regarding his or her status as a resident alien for U.S. federal income tax purposes under these rules and the U.S. federal income tax consequences of the ownership or disposition of our common stock. If a partnership or other pass-through entity is a beneficial owner of our common stock, the tax treatment of a partner in the partnership or an owner of the entity will depend upon the status of the partner or other owner and the activities of the partnership or other entity. Any partner in a partnership or owner of a pass-through entity holding shares of our common stock should consult its own tax advisor. A partnership that is not formed under the laws of the United States or a state or the District of Columbia is a non-U.S. holder for purposes of the Additional Withholding Rules described below.

This discussion assumes that a non-U.S. holder will hold our common stock as a capital asset (generally, property held for investment). The summary generally does not address tax considerations that may be relevant to particular investors because of their specific circumstances, or because they are subject to special rules, including, without limitation, if the investor is a former citizen or long-term resident of the United States, “controlled foreign corporation,” “passive foreign investment company,” or partner in a partnership or beneficial owner of a pass-through entity that holds our common stock. Finally, the summary does not describe the effects of any applicable foreign, state or local laws, or, except to the extent discussed below, the effects of any applicable gift or estate tax laws.

INVESTORS CONSIDERING THE PURCHASE OF OUR COMMON STOCK SHOULD CONSULT THEIR OWN TAX ADVISORS REGARDING THE APPLICATION OF THE U.S. FEDERAL INCOME AND ESTATE TAX LAWS TO THEIR PARTICULAR SITUATIONS AND THE CONSEQUENCES OF FOREIGN, STATE OR LOCAL LAWS, AND TAX TREATIES.

 

103


Table of Contents

Dividends

We do not expect to declare or pay any dividends on our common stock in the foreseeable future. If we do pay dividends on shares of our common stock, however, such distributions will constitute dividends for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Distributions in excess of our current and accumulated earnings and profits will constitute a return of capital that is applied against and reduces, but not below zero, a non-U.S. holder’s adjusted tax basis in shares of our common stock. Any remaining excess will be treated as gain realized on the sale or other disposition of our common stock. See “—Sale of Common Stock.”

Any distribution to the extent treated for U.S. federal income tax purposes as a dividend paid to a non-U.S. holder on our common stock will generally be subject to U.S. withholding tax at a 30% rate. The withholding tax might not apply, however, or might apply at a reduced rate, under the terms of an applicable income tax treaty between the United States and the non-U.S. holder’s country of residence. You should consult your tax advisors regarding your entitlement to benefits under a relevant income tax treaty. Generally, in order for us or our paying agent to withhold tax at a lower treaty rate, a non-U.S. holder must certify its entitlement to treaty benefits. A non-U.S. holder generally can meet this certification requirement by providing a Form W-8BEN (or any successor form) or appropriate substitute form to us or our paying agent. If the non-U.S. holder holds the stock through a financial institution or other agent acting on the holder’s behalf, the holder will be required to provide appropriate documentation to the agent. The holder’s agent will then be required to provide certification to us or our paying agent, either directly or through other intermediaries. For payments made to a partnership or other pass-through entity, the certification requirements frequently apply to the partners or other owners rather than to the partnership or other entity, and the partnership or other entity may be required to provide the partners’ or other owners’ documentation to us or our paying agent. If you are eligible for a reduced rate of U.S. federal withholding tax under an income tax treaty, you may obtain a refund or credit of any excess amounts withheld by filing an appropriate claim for a refund with the IRS in a timely manner.

If you are a non-U.S. holder (including for this purpose, a partnership) and not an individual, you may be subject to a 30% withholding even if you are eligible to claim the benefits of a tax treaty if you do not comply with certain information reporting rules, described below under Additional Withholding Rules.

Dividends received by a non-U.S. holder that are effectively connected with a U.S. trade or business conducted by the non-U.S. holder are not subject to such withholding tax. To obtain this exemption, a non-U.S. holder must provide us with an IRS Form W-8ECI properly certifying such exemption. Such effectively connected dividends, although not subject to withholding tax, are taxed at the same graduated rates applicable to U.S. persons, net of certain deductions and credits, provided that, if required by an applicable income tax treaty between the United States and the non-U.S. holder’s country of residence, such dividends are attributable to a permanent establishment maintained by the non-U.S. holder in the United States. In addition to the graduated tax described above, dividends received by corporate non-U.S. holders that are effectively connected with a U.S. trade or business of the corporate non-U.S. holder may also be subject to a branch profits tax at a rate of 30% or such lower rate as may be specified by an applicable tax treaty.

Sale of Common Stock

Subject to the rules discussed under Additional Withholding Rules below, non-U.S. holders will generally not be subject to U.S. federal income tax on any gains realized on the sale, exchange or other disposition of our common stock unless:

 

   

the gain (1) is effectively connected with the conduct by the non-U.S. holder of a U.S. trade or business and (2) if required by an applicable income tax treaty between the United States and the non-U.S. holder’s country of residence, is attributable to a permanent establishment (or, in certain cases involving individual holders, a fixed base) maintained by the non-U.S. holder in the United States (in which case the special rules described below apply);

 

   

the non-U.S. holder is an individual who is present in the United States for 183 days or more in the taxable year of the sale, exchange or other disposition of our common stock, and certain other

 

104


Table of Contents
 

requirements are met (in which case the gain would be subject to a flat 30% tax, or such reduced rate as may be specified by an applicable income tax treaty, which may be offset by U.S. source capital losses, even though the individual is not considered a resident of the United States); or

 

   

the rules of the Foreign Investment in Real Property Tax Act, or FIRPTA, treat the gain as effectively connected with a U.S. trade or business.

The FIRPTA rules may apply to a sale, exchange or other disposition of our common stock if we are, or were within the shorter of the five-year period preceding the disposition and the non-U.S. holder’s holding period, a “U.S. real property holding corporation,” or USRPHC. In general, we would be a USRPHC if interests in U.S. real estate comprised at least half of our business assets. We do not believe that we are a USRPHC and we do not anticipate becoming one in the future. Even if we become a USRPHC, as long as our common stock is regularly traded on an established securities market, such common stock will be treated as U.S. real property interests only if beneficially owned by a non-U.S. holder that actually or constructively owned more than 5% of our outstanding common stock at some time within the five-year period preceding the disposition.

If any gain from the sale, exchange or other disposition of our common stock, (1) is effectively connected with a U.S. trade or business conducted by a non-U.S. holder and (2) if required by an applicable income tax treaty between the United States and the non-U.S. holder’s country of residence, is attributable to a permanent establishment (or, in certain cases involving individuals, a fixed base) maintained by such non-U.S. holder in the United States, then the gain generally will be subject to U.S. federal income tax at the same graduated rates applicable to U.S. persons, net of certain deductions and credits. If the non-U.S. holder is a corporation, under certain circumstances, that portion of its earnings and profits that is effectively connected with its U.S. trade or business, subject to certain adjustments, may also be subject to a “branch profits tax.” The branch profits tax rate is generally 30%, although an applicable income tax treaty between the United States and the non-U.S. holder’s country of residence might provide for a lower rate.

U.S. Federal Estate Tax

The estates of nonresident alien individuals generally are subject to U.S. federal estate tax on property with a U.S. situs. Because we are a U.S. corporation, our common stock will be U.S. situs property and therefore will be included in the taxable estate of a nonresident alien decedent, unless an applicable estate tax treaty between the United States and the decedent’s country of residence provides otherwise.

Backup Withholding and Information Reporting

The Code and the Treasury regulations require those who make specified payments to report the payments to the IRS. Among the specified payments are dividends and proceeds paid by brokers to their customers. The required information returns enable the IRS to determine whether the recipient properly included the payments in income. This reporting regime is reinforced by “backup withholding” rules. These rules require the payors to withhold tax from payments subject to information reporting if the recipient fails to cooperate with the reporting regime by failing to provide his taxpayer identification number to the payor, furnishing an incorrect identification number, or failing to report interest or dividends on his returns. The backup withholding tax rate is currently 28%. The backup withholding rules do not apply to payments to corporations, whether domestic or foreign.

Payments to non-U.S. holders of dividends on common stock generally will not be subject to backup withholding, so long as the non-U.S. holder certifies its nonresident status (and we or our paying agent do not have actual knowledge or reason to know the holder is a U.S. person or that the conditions of any other exemption are not, in fact, satisfied) or otherwise establishes an exemption. The certification procedures to claim treaty benefits described in “—Dividends” will satisfy the certification requirements necessary to avoid the backup withholding tax as well. We must report annually to the IRS any dividends paid to each non-U.S. holder and the tax withheld, if any, with respect to these dividends. Copies of these reports may be made available to tax authorities in the country where the non-U.S. holder resides.

 

105


Table of Contents

Under the Treasury regulations, the payment of proceeds from the disposition of shares of our common stock by a non-U.S. holder made to or through a U.S. office of a broker generally will be subject to information reporting and backup withholding unless the beneficial owner certifies, under penalties of perjury, among other things, its status as a non-U.S. holder (and the broker does not have actual knowledge or reason to know the holder is a U.S. person) or otherwise establishes an exemption. The payment of proceeds from the disposition of shares of our common stock by a non-U.S. holder made to or through a non-U.S. office of a broker generally will not be subject to backup withholding and information reporting, except as noted below. Information reporting, but not backup withholding, will apply to a payment of proceeds, even if that payment is made outside of the United States, if you sell our common stock through a non-U.S. office of a broker that is:

 

   

a U.S. person (including a foreign branch or office of such person);

 

   

a “controlled foreign corporation” for U.S. federal income tax purposes;

 

   

a foreign person 50% or more of whose gross income from certain periods is effectively connected with a U.S. trade or business; or

 

   

a foreign partnership if at any time during its tax year (a) one or more of its partners are U.S. persons who, in the aggregate, hold more than 50% of the income or capital interests of the partnership or (b) the foreign partnership is engaged in a U.S. trade or business;

unless the broker has documentary evidence that the beneficial owner is a non-U.S. holder and certain other conditions are satisfied, or the beneficial owner otherwise establishes an exemption (and the broker has no actual knowledge or reason to know to the contrary). Information reporting and backup withholding will apply if you sell our common stock through a non-U.S. office of a broker and:

 

   

the proceeds are transferred to an account maintained by you in the United States,

 

   

the payment of proceeds or the confirmation of the sale is mailed to you at a United States address, or

 

   

the sale has some other specified connection with the United States as provided in Treasury regulations,

unless the broker has documentary evidence that the beneficial owner is a non-U.S. holder and certain other conditions are satisfied, or the beneficial owner otherwise establishes an exemption (and the broker has no actual knowledge or reason to know to the contrary).

Backup withholding is not an additional tax. Any amounts withheld from a payment to a holder of common stock under the backup withholding rules can be credited against any U.S. federal income tax liability of the holder and may entitle the holder to a refund, provided that the required information is furnished to the IRS in a timely manner.

Additional Withholding Rules

A non-U.S. Holder that is an entity (including, for this purpose, a partnership) may be subject to a U.S. withholding tax at a rate of 30% on payments of dividends, if any, that we declare, and on the gross proceeds on the disposition of our common stock, unless the foreign entity has complied with various U.S. information reporting and due diligence requirements that are generally designed to identify U.S. owners or account holders in the entity. These withholding requirements are expected to be phased in for dividend payments made on or after January 1, 2014, and for payments of gross proceeds from dispositions of our common stock made on or after January 1, 2015. Non-U.S. holders should consult their tax advisors regarding the possible implications of this legislation on their investment in our common stock.

 

106


Table of Contents

THE PRECEDING DISCUSSION OF U.S. FEDERAL TAX CONSIDERATIONS IS FOR GENERAL INFORMATION ONLY. IT IS NOT TAX ADVICE. EACH PROSPECTIVE INVESTOR SHOULD CONSULT ITS OWN TAX ADVISOR REGARDING THE PARTICULAR U.S. FEDERAL, STATE, LOCAL AND FOREIGN TAX CONSEQUENCES OF PURCHASING, HOLDING AND DISPOSING OF OUR COMMON STOCK, INCLUDING THE CONSEQUENCES OF ANY PROPOSED CHANGE IN APPLICABLE LAWS.

 

107


Table of Contents

UNDERWRITING

We, the selling shareholders and the underwriters named below have entered into an underwriting agreement with respect to the shares being offered. Subject to certain conditions, each underwriter has severally agreed to purchase the number of shares indicated in the following table. Goldman, Sachs & Co., Barclays Capital Inc., Jefferies & Company, Inc., Credit Suisse Securities (USA) LLC, Deutsche Bank Securities Inc., UBS Securities LLC and Wells Fargo Securities, LLC are acting as joint book-running managers of the offering, and Goldman, Sachs & Co., Barclays Capital Inc. and Jefferies & Company, Inc. are the representatives of the underwriters.

 

Underwriters

   Number of Shares

Goldman, Sachs & Co.

  

Barclays Capital Inc.

  

Jefferies & Company, Inc.

  

Credit Suisse Securities (USA) LLC

  

Deutsche Bank Securities Inc.

  

UBS Securities LLC

  

Wells Fargo Securities, LLC

  

Total

  
  

 

The underwriters are committed to take and pay for all of the shares being offered, if any are taken, other than the shares covered by the option described below unless and until this option is exercised.

The underwriters have an option to buy up to an additional              shares from the selling shareholders to cover sales by the underwriters of a greater number of shares than the total number set forth in the table above. They may exercise that option for 30 days. If any shares are purchased pursuant to this option, the underwriters will severally purchase shares in approximately the same proportion as set forth in the table above.

The following tables show the per share and total underwriting discounts and commissions to be paid to the underwriters by us and the selling shareholders. Such amounts are shown assuming both no exercise and full exercise of the underwriters’ option to purchase              additional shares.

Paid by the Company

 

     No Exercise      Full Exercise  

Per Share

   $                    $                

Total

   $         $     

Paid by the Selling Shareholders

 

     No Exercise      Full Exercise  

Per Share

   $                    $                

Total

   $         $     

Shares sold by the underwriters to the public will initially be offered at the initial public offering price set forth on the cover of this prospectus. Any shares sold by the underwriters to securities dealers may be sold at a discount of up to $         per share from the initial public offering price. After the initial offering of the shares, the representatives may change the offering price and the other selling terms. The offering of the shares by the underwriters is subject to receipt and acceptance and subject to the underwriters’ right to reject any order in whole or in part.

We and holders of substantially all of our common stock on the date of this prospectus, including each of our executive officers, directors and selling shareholders, have agreed with the underwriters, subject to certain

 

108


Table of Contents

exceptions, not to dispose of or hedge any of their common stock or securities convertible into or exchangeable for shares of common stock during the period from the date of this prospectus continuing through the date that is 180 days after the date of this prospectus, except with the prior written consent of the representatives. This agreement does not apply to any existing employee benefit plans. See “Shares Eligible for Future Sale” for a discussion of certain transfer restrictions.

The 180-day restricted period described in the preceding paragraph will be automatically extended if: (1) during the last 17 days of the 180-day restricted period we issue an earnings release or announce material news or a material event; or (2) prior to the expiration of the 180-day restricted period, we announce that we will release earnings results during the 15-day period following the last day of the 180-day period, in which case the restrictions described in the preceding paragraph will continue to apply until the expiration of the 18-day period beginning on the issuance of the earnings release or the announcement of the material news or material event.

Prior to the offering, there has been no public market for the shares. The initial public offering price has been negotiated among us, the qualified independent underwriter and the representatives. Among the factors to be considered in determining the initial public offering price of the shares, in addition to prevailing market conditions, will be our historical performance, estimates of our business potential and earnings prospects, an assessment of our management and the consideration of the above factors in relation to market valuation of companies in related businesses.

An application will be made to list the common stock on The NASDAQ Global Select Market under the symbol “              ”. In connection with the offering, the underwriters may purchase and sell shares of common stock in the open market. These transactions may include short sales, stabilizing transactions and purchases to cover positions created by short sales. Short sales involve the sale by the underwriters of a greater number of shares than they are required to purchase in the offering, and a short position represents the amount of such sales that have not been covered by subsequent purchases. A “covered short position” is a short position that is not greater than the amount of additional shares for which the underwriters’ option described above may be exercised. The underwriters may cover any covered short position by either exercising their option to purchase additional shares or purchasing shares in the open market. In determining the source of shares to cover the covered short position, the underwriters will consider, among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase additional shares pursuant to the option described above. “Naked” short sales are any short sales that create a short position greater than the amount of additional shares for which the option described above may be exercised. The underwriters must cover any such naked short position by purchasing shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the common stock in the open market after pricing that could adversely affect investors who purchase in the offering. Stabilizing transactions consist of various bids for or purchases of common stock made by the underwriters in the open market prior to the closing of the offering.

The underwriters may also impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discount received by it because the representatives have repurchased shares sold by or for the account of such underwriter in stabilizing or short covering transactions.

Purchases to cover a short position and stabilizing transactions, as well as other purchases by the underwriters for their own accounts, may have the effect of preventing or retarding a decline in the market price of our stock, and together with the imposition of the penalty bid, may stabilize, maintain or otherwise affect the market price of the common stock. As a result, the price of the common stock may be higher than the price that otherwise might exist in the open market. The underwriters are not required to engage in these activities and may end any of these activities at any time. These transactions may be effected on The NASDAQ Global Select Market, in the over-the-counter market or otherwise.

 

109


Table of Contents

The underwriters do not expect sales to discretionary accounts to exceed five percent of the total number of shares offered.

We and the selling shareholders estimate that our share of the total expenses of the offering, excluding underwriting discounts and commissions, will be approximately $        .

We and the selling shareholders have agreed to indemnify the several underwriters and                      in its capacity as qualified independent underwriter against certain liabilities, including liabilities under the Securities Act.

Conflicts of Interest

As described under “Use of Proceeds,” we expect to use a portion of the net proceeds we receive from this offering to repay $         million of the outstanding indebtedness under our new term loan facility with a syndicate of lenders. Affiliates of                              are lenders under our new term loan facility and will each receive their pro rata share of such repayment. Because it is possible that each of                              or their affiliates could receive more than 5% of the proceeds of this offering in connection with the repayment of our new term loan facility, each of                              is deemed to have a “conflict of interest” under Rule 5121 (“Rule 5121”) of the Financial Industry Regulatory Authority. Accordingly, this offering will be conducted in accordance with Rule 5121. Rule 5121 requires that a “qualified independent underwriter,” meeting certain standards, participate in the preparation of the registration statement and prospectus and exercise the usual standards of due diligence with respect thereto.                      has served as “qualified independent underwriter” within the meaning of Rule 5121 in connection with this offering. To comply with Rule 5121,                              will not confirm any sales to any account over which it exercises discretionary authority without the specific written approval of the transaction from the account holder.

The underwriters and their respective affiliates are full service financial institutions engaged in various activities, which may include securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. Certain of the underwriters and their respective affiliates have, from time to time, performed, and may in the future perform, various financial advisory and investment banking services for us, for which they received or will receive customary fees and expenses. In particular, affiliates of                              are lead arrangers, bookrunners and lenders under our new term loan facility.

In the ordinary course of their various business activities, the underwriters and their respective affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers, and such investment and securities activities may involve our securities and/or instruments. The underwriters and their respective affiliates may also make investment recommendations and/or publish or express independent research views in respect of such securities or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments.

European Economic Area

In relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (each, a Relevant Member State), each underwriter has represented and agreed that with effect from and including the date on which the Prospectus Directive is implemented in that Relevant Member State (the Relevant Implementation Date) it has not made and will not make an offer of shares to the public in that Relevant Member State prior to the publication of a prospectus in relation to the shares which has been approved by the competent authority in that Relevant Member State or, where appropriate, approved in another Relevant Member

 

110


Table of Contents

State and notified to the competent authority in that Relevant Member State, all in accordance with the Prospectus Directive, except that it may, with effect from and including the Relevant Implementation Date, make an offer of shares to the public in that Relevant Member State at any time:

 

  (a) to any legal entity which is a qualified investor as defined in the Prospectus Directive;

 

  (b) to fewer than 100 or, if the Relevant Member State has implemented the relevant provision of the 2010 PD Amending Directive, 150, natural or legal persons (other than qualified investors as defined in the Prospectus Directive), as permitted under the Prospectus Directive, subject to obtaining the prior consent of the representatives for any such offer; or

 

  (c) in any other circumstances which do not require the publication by us of a prospectus pursuant to Article 3 of the Prospectus Directive.

For the purposes of this provision, the expression an “offer of shares to the public” in relation to any shares in any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the offer and the shares to be offered so as to enable an investor to decide to purchase or subscribe the shares, as the same may be varied in that Relevant Member State by any measure implementing the Prospectus Directive in that Relevant Member State, and the expression Prospectus Directive means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in the Relevant Member State), and includes any relevant implementing measure in each Relevant Member State and the expression “2010 PD Amending Directive” means Directive 2010/73/EU.

Each underwriter has represented and agreed that:

 

  (a) it has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the FSMA) received by it in connection with the issue or sale of the shares in circumstances in which Section 21(1) of the FSMA would not, if the Issuer was not an authorized person, apply to us; and

 

  (b) it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the shares in, from or otherwise involving the United Kingdom.

Hong Kong

The shares may not be offered or sold by means of any document other than (i) in circumstances which do not constitute an offer to the public within the meaning of the Companies Ordinance (Cap. 32, Laws of Hong Kong), or (ii) to “professional investors” within the meaning of the Securities and Futures Ordinance (Cap 571, Laws of Hong Kong) and any rules made thereunder, or (iii) in other circumstances which do not result in the document being a “prospectus” within the meaning of the Companies Ordinance (Cap 32, Laws of Hong Kong), and no advertisement, invitation or document relating to the shares may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the laws of Hong Kong) other than with respect to shares which are or are intended to be disposed of only to persons outside Hong Kong or only to “professional investors” within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder.

Singapore

This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the shares may not be circulated or distributed, nor may the shares be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i) to an institutional investor under Section 274 of the Securities

 

111


Table of Contents

and Futures Act, Chapter 289 of Singapore or the SFA, (ii) to a relevant person, or any person pursuant to Section 275(1A), and in accordance with the conditions, specified in Section 275 of the SFA or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA.

Where the shares are subscribed or purchased under Section 275 by a relevant person which is: (a) a corporation (which is not an accredited investor) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or (b) a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary is an accredited investor, shares, debentures and units of shares and debentures of that corporation or the beneficiaries’ rights and interest in that trust shall not be transferable for 6 months after that corporation or that trust has acquired the shares under Section 275 except: (1) to an institutional investor under Section 274 of the SFA or to a relevant person, or any person pursuant to Section 275(1A), and in accordance with the conditions, specified in Section 275 of the SFA; (2) where no consideration is given for the transfer; or (3) by operation of law.

Japan

The shares have not been and will not be registered under the Financial Instruments and Exchange Law of Japan (the “Financial Instruments and Exchange Law”) and each underwriter has agreed that it will not offer or sell any shares, directly or indirectly, in Japan or to, or for the benefit of, any resident of Japan (which term as used herein means any person resident in Japan, including any corporation or other entity organized under the laws of Japan), or to others for re-offering or resale, directly or indirectly, in Japan or to a resident of Japan, except pursuant to an exemption from the registration requirements of, and otherwise in compliance with, the Financial Instruments and Exchange Law and any other applicable laws, regulations and ministerial guidelines of Japan.

Switzerland

This document as well as any other material relating to the shares which are the subject of the offering contemplated by this prospectus (the “Shares”) does not constitute an issue prospectus pursuant to Articles 652a and/or 1156 of the Swiss Code of Obligations. The Shares will not be listed on the SIX Swiss Exchange and, therefore, the documents relating to the Shares, including, but not limited to, this document, do not claim to comply with the disclosure standards of the listing rules of the SIX Swiss Exchange and corresponding prospectus schemes annexed to the listing rules of the SIX Swiss Exchange. The Shares are being offered in Switzerland by way of a private placement, i.e., to a small number of selected investors only, without any public offer and only to investors who do not purchase the Shares with the intention to distribute them to the public. The investors will be individually approached by us from time to time. This document as well as any other material relating to the Shares is personal and confidential and does not constitute an offer to any other person. This document may only be used by those investors to whom it has been handed out in connection with the offering described herein and may neither directly nor indirectly be distributed or made available to other persons without our express consent. It may not be used in connection with any other offer and shall in particular not be copied and/or distributed to the public in (or from) Switzerland.

Dubai International Financial Centre

This prospectus relates to an Exempt Offer in accordance with the Offered Securities Rules of the Dubai Financial Services Authority (“DFSA”). This prospectus is intended for distribution only to persons of a type specified in the Offered Securities Rules of the DFSA. It must not be delivered to, or relied on by, any other person. The DFSA has no responsibility for reviewing or verifying any documents in connection with Exempt Offers. The DFSA has not approved this prospectus nor taken steps to verify the information set forth herein and has no responsibility for this prospectus. The shares to which this prospectus relates may be illiquid and/or subject to restrictions on their resale. Prospective purchasers of the shares offered should conduct their own due diligence on the shares. If you do not understand the contents of this prospectus you should consult an authorized financial advisor.

 

112


Table of Contents

VALIDITY OF COMMON STOCK

Pepper Hamilton LLP will pass upon the validity of the shares of common stock offered hereby for us. An attorney with the firm owns an aggregate of 70,000 shares of our common stock. Sullivan & Cromwell LLP will pass upon the validity of the shares of common stock offered hereby for the underwriters.

EXPERTS

The financial statements of Five Below, Inc. as of January 29, 2011 and January 28, 2012, and for each of the fiscal years in the three-year period ended January 28, 2012, have been included herein and in the registration statement in reliance upon the report of KPMG LLP, independent registered public accounting firm, appearing elsewhere herein, and upon the authority of said firm as experts in accounting and auditing.

WHERE YOU CAN FIND ADDITIONAL INFORMATION

We have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the shares of common stock offered by this prospectus. This prospectus does not contain all of the information set forth in the registration statement and its exhibits, certain portions of which are omitted as permitted by the rules and regulations of the SEC. For further information pertaining to us and our common stock to be sold in this offering, we refer you to the registration statement, including its exhibits and the financial statements, notes and schedules filed as a part of that registration statement. Statements contained in this prospectus regarding the contents of any contract or other document referred to in those documents are not necessarily complete, and in each instance we refer you to the copy of the contract or other document filed as an exhibit to the registration statement or other document. Each of these statements is qualified in all respects by this reference.

You may read and copy the registration statement and its exhibits and schedules at the SEC’s public reference room at 100 F Street, N.E., Washington, D.C. 20549. You also may obtain information on the operation of the public reference room by calling the commission at 1-800-SEC-0330. The SEC maintains a web site at www.sec.gov that contains reports, proxy and information statements and other information regarding registrants, such as Five Below, Inc., that file electronically with the SEC.

Upon the closing of this offering, we will be subject to the information reporting requirements of the Exchange Act, and we will file reports, proxy statements and other information with the SEC. These reports, proxy statements and other information will be available for inspection and copying at the public reference room and website of the SEC referred to above. We also maintain a web site at www.fivebelow.com , at which you may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. The information contained in, or that can be accessed through, our website is not part of this prospectus.

 

113


Table of Contents

FIVE BELOW, INC.

Index to Financial Statements

 

     Page  

Report of KPMG LLP, Independent Registered Public Accounting Firm

     F-2   

Financial Statements:

  

Balance Sheets

     F-3   

Statements of Operations

     F-4   

Statements of Changes in Redeemable Convertible Preferred Stock, Convertible Preferred Stock and Shareholders’ Deficit

     F-5   

Statements of Cash Flows

     F-6   

Notes to Financial Statements

     F-7   

 

F-1


Table of Contents

Report of Independent Registered Public Accounting Firm

The Board of Directors and Shareholders

Five Below, Inc.:

We have audited the accompanying balance sheets of Five Below, Inc. (the Company) as of January 29, 2011 and January 28, 2012, and the related statements of operations, changes in redeemable convertible preferred stock, convertible preferred stock and shareholders’ deficit, and cash flows for each of the fiscal years in the three-year period ended January 28, 2012. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Five Below, Inc. as of January 29, 2011 and January 28, 2012, and the results of its operations and its cash flows for each of the fiscal years in the three-year period ended January 28, 2012, in conformity with U.S. generally accepted accounting principles.

April 17, 2012

/s/    KPMG LLP

Philadelphia, Pennsylvania

 

F-2


Table of Contents

FIVE BELOW, INC.

Balance Sheets

(in thousands, except share and per share data)

 

     January 29, 2011     January 28, 2012     Pro Forma
January 28, 2012
 
                 Unaudited
(see note 1)
 
Assets       

Current assets:

      

Cash and cash equivalents

   $ 12,153     $ 41,293     $ 41,367  

Income taxes receivable

     20       —          —     

Inventories

     26,754       38,790       38,790  

Deferred income taxes

     2,899       4,863       4,863  

Prepaid expenses and other current assets

     4,116       7,303       7,303  
  

 

 

   

 

 

   

 

 

 

Total current assets

     45,942       92,249       92,323  

Property and equipment, net

     29,743       42,040       42,040  

Deferred income taxes

     714       —          —     

Other assets

     183       238       238  
  

 

 

   

 

 

   

 

 

 
   $ 76,582     $ 134,527     $ 134,601  
  

 

 

   

 

 

   

 

 

 
Liabilities and Shareholders’ (Deficit) Equity       

Current liabilities:

      

Line of credit

   $ —        $ —        $ —     

Accounts payable

     10,023       23,588       23,588  

Income taxes payable

     141       9,139       9,139  

Accrued salaries and wages

     2,043       9,254       9,254  

Other accrued expenses

     6,008       7,961       7,961  
  

 

 

   

 

 

   

 

 

 

Total current liabilities

     18,215       49,942       49,942  

Note payable

     250       250       250  

Deferred rent

     15,059       20,933       20,933  

Deferred income taxes

     —          1,306       1,306  
  

 

 

   

 

 

   

 

 

 

Total liabilities

     33,524       72,431       72,431  
  

 

 

   

 

 

   

 

 

 

Commitments and contingencies (note 4)

      

Preferred stock, $0.01 par value. Authorized 100,000,000 shares; 10,000,000 shares undesignated; 90,000,000 shares designated as Series A 8% Convertible Preferred Stock, $0.01 par value. Issued and outstanding 89,291,773 shares with a liquidation preference of $198,507 and $214,420, respectively

     191,855       191,855       —     
  

 

 

   

 

 

   

 

 

 

Shareholders’ (deficit) equity:

      

Common stock, $0.01 par value. Authorized 200,000,000 shares; issued and outstanding 46,486,735, 46,961,992 and 136,287,765 (pro forma) shares, respectively

     465       470       1,363  

Additional paid-in capital

     428       3,383       194,419  

Accumulated deficit

     (149,690     (133,612     (133,612
  

 

 

   

 

 

   

 

 

 

Total shareholders’ (deficit) equity

     (148,797     (129,759     62,170  
  

 

 

   

 

 

   

 

 

 
   $ 76,582     $ 134,527     $ 134,601  
  

 

 

   

 

 

   

 

 

 

See accompanying notes to financial statements.

 

F-3


Table of Contents

FIVE BELOW, INC.

Statements of Operations

(in thousands, except share and per share data)

 

     Fiscal Year  
     2009     2010     2011  

Net sales

   $ 125,135     $ 197,189     $ 297,113  

Cost of goods sold

     85,040       131,046       192,252  
  

 

 

   

 

 

   

 

 

 

Gross profit

     40,095       66,143       104,861  

Selling, general and administrative expenses

     33,217       54,339       78,640  
  

 

 

   

 

 

   

 

 

 

Operating income

     6,878       11,804       26,221  

Interest expense (income), net

     73       28       (16
  

 

 

   

 

 

   

 

 

 

Income before income taxes

     6,805       11,776       26,237  

Income tax (benefit) expense

     (4,853     4,753       10,159  
  

 

 

   

 

 

   

 

 

 

Net income

     11,658       7,023       16,078  

Series A 8% Convertible Preferred Stock cumulative dividends

     —          (4,507     (15,913

Accretion of Redeemable Convertible Preferred Stock

     (4,250     (3,329     —     
  

 

 

   

 

 

   

 

 

 

Net income (loss) available to shareholders

     7,408       (813     165  

Less: Net income attributable to participating securities

     (3,365     —          (109
  

 

 

   

 

 

   

 

 

 

Net income (loss) available to common shareholders

   $ 4,043     $ (813   $ 56  
  

 

 

   

 

 

   

 

 

 

Basic income (loss) per common share

   $ 0.19      $ (0.03   $ —     
  

 

 

   

 

 

   

 

 

 

Diluted income (loss) per common share

   $ 0.19      $ (0.03   $ —     
  

 

 

   

 

 

   

 

 

 

Dividends declared per common share

   $ —        $ 4.58      $ —     
  

 

 

   

 

 

   

 

 

 

Weighted average shares outstanding:

      

Basic shares

     21,539,917       27,954,322        45,964,159  
  

 

 

   

 

 

   

 

 

 

Diluted shares

     21,539,917        27,954,322        45,965,631  
  

 

 

   

 

 

   

 

 

 

Unaudited pro forma net income

       $ 16,078  
      

 

 

 

Unaudited pro forma basic income per common share

       $ 0.12   
      

 

 

 

Unaudited pro forma diluted income per common share

       $ 0.12   
      

 

 

 

Unaudited pro forma weighted average shares outstanding:

      

Basic shares

         135,289,932   
      

 

 

 

Diluted shares

         135,289,932   
      

 

 

 

See accompanying notes to financial statements.

 

F-4


Table of Contents

FIVE BELOW, INC.

Statements of Changes in Redeemable Convertible Preferred Stock, Convertible Preferred Stock and Shareholders’ Deficit

(in thousands, except share and per share data)

 

    Redeemable Convertible Preferred Stock     Series A  8%
Convertible
Preferred Stock
          Shareholders’ Deficit  
        Common stock     Additional
paid-in  capital
    Accumulated
deficit
    Total
shareholders’
deficit
 
            Series A                          Series A-1                         
    Shares     Amount     Shares     Amount     Shares     Amount           Shares     Amount        

Balance, January 31, 2009

    6,173,030     $ 17,030       8,006,984     $ 16,008       —        $ —              21,515,741     $ 215     $ 12,928     $ (22,022   $ (8,879

Issuance of warrants to purchase common stock to professional service providers

    —          —          —          —          —          —              —          —          24       —          24  

Stock-based compensation expense

    —          —          —          —          —          —              —          —          271       —          271  

Exercise of options and warrants to purchase common stock

    —          —          —          —          —          —              73,928       1       126       —          127  

Accretion of Series A Redeemable Convertible Preferred Stock to redemption value

    —          1,748       —          —          —          —              —          —          (1,748     —          (1,748

Accretion of Series A-1 Redeemable Convertible Preferred Stock to redemption value

    —          —          —          2,502       —          —              —          —          (2,502     —          (2,502

Net income

    —          —          —          —          —          —              —          —          —          11,658       11,658  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

       

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance, January 30, 2010

    6,173,030       18,778       8,006,984       18,510       —          —              21,589,669       216       9,099       (10,364     (1,049

Issuance of warrants to purchase common stock to professional service providers

    —          —          —          —          —          —              —          —          203       —          203  

Stock-based compensation expense

    —          —          —          —          —          —              —          —          2,104       —          2,104  

Exercise of options and warrants to purchase common stock

    —          —          —          —          —          —              3,432,538       35       4,957       —          4,992  

Redemption of warrants for common stock and cash

    —          —          —          —          —          —              3,530,989       35       (10,203     —          (10,168

Accretion of Series A Redeemable Convertible Preferred Stock to redemption value

    —          1,356       —          —          —          —              —          —          (1,356     —          (1,356

Accretion of Series A-1 Redeemable Convertible Preferred Stock to redemption value

    —          —          —          1,973       —          —              —          —          (1,973     —          (1,973

Conversion of Series A and Series A-1 Redeemable Convertible Preferred Stock to common stock and redemption of fractional shares

    (6,173,030     (20,134     (8,006,984     (20,483     —          —              17,933,539       179       40,439       —          40,618  

Issuance of Series A 8% Convertible Preferred Stock, net of issuance costs of $2,145

    —          —          —          —          89,291,773       191,855           —          —          —          —          —     

Dividend paid to common shareholders

    —          —          —          —          —          —              —          —          (46,068     (146,349     (192,417

Income tax benefit related to exercise of stock options and warrants

    —          —          —          —          —          —              —          —          3,226       —          3,226  

Net income

    —          —          —          —          —          —              —          —          —          7,023       7,023  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

       

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance, January 29, 2011

    —          —          —          —          89,291,773       191,855           46,486,735       465       428       (149,690     (148,797

Issuance of warrants to purchase common stock to professional service providers

    —          —          —          —          —          —              —          —          31       —          31  

Stock-based compensation expense

    —          —          —          —          —          —              —          —          1,197       —          1,197  

Exercise of warrants to purchase common stock

    —          —          —          —          —          —              15,000       —          33       —          33  

Vesting of restricted shares

    —          —          —          —          —          —              —          —          491       —          491  

Repurchase of unvested restricted shares

    —          —          —          —          —          —              —          —          98       —          98  

Issuance of common stock

    —          —          —          —          —          —              460,257        5       1,105       —          1,110  

Net income

    —          —          —          —          —          —              —          —          —          16,078       16,078  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

       

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance, January 28, 2012

    —        $ —          —        $ —          89,291,773     $ 191,855           46,961,992     $ 470     $ 3,383     $ (133,612   $ (129,759
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

       

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

See accompanying notes to financial statements.

 

F-5


Table of Contents

FIVE BELOW, INC.

Statements of Cash Flows

(in thousands)

 

     Fiscal Year  
     2009     2010     2011  

Operating activities:

      

Net income

   $ 11,658     $ 7,023     $ 16,078  

Adjustments to reconcile net income to net cash provided by operating activities:

      

Depreciation and amortization

     3,660       4,805       7,071  

Loss on disposal of property and equipment

     5       288       273  

Amortization of deferred financing costs

     51       28       28  

Warrant expense related to a merchandise vendor and professional service providers for services rendered

     3       228       49  

Stock-based compensation expense

     271       2,104       1,197  

Deferred income tax (benefit) expense

     (5,027     (716     56  

(Increase) decrease in assets:

      

Income taxes receivable

     —          (20     20  

Inventories

     (2,606     (10,711     (12,036

Prepaid expenses and other assets

     (645     (756     (3,270

(Decrease) increase in liabilities:

      

Accounts payable

     (1,326     3,684       12,481  

Income taxes payable

     127       2,144       8,998  

Accrued salaries and wages

     544       544       7,211  

Deferred rent

          2,204       6,295            6,997  

Other accrued expenses

     308       105       1,542  
  

 

 

   

 

 

   

 

 

 

Net cash provided by operating activities

     9,227       15,045       46,695  
  

 

 

   

 

 

   

 

 

 

Investing activities:

      

Capital expenditures

     (7,285     (14,883     (18,558
  

 

 

   

 

 

   

 

 

 

Net cash used in investing activities

     (7,285     (14,883     (18,558
  

 

 

   

 

 

   

 

 

 

Financing activities:

      

Borrowing under long term note payable

     —          250       —     

Payments under capital lease agreements

     (222     —          —     

Payment of financing costs

     (50     (43     —     

Net proceeds from issuance of preferred stock

     —          191,855       —     

Proceeds from issuance of common stock

     —          —          1,110  

Proceeds from exercise of and prepayment related to warrants and options to purchase common stock

     127       6,852       33  

Repurchase of unvested restricted shares

     —          —          (140

Dividend paid to common shareholders

     —          (192,417     —     

Redemption of warrants

     —          (10,168     —     

Excess tax benefit related to exercise of stock options and warrants

     —          3,226       —     
  

 

 

   

 

 

   

 

 

 

Net cash (used in) provided by financing activities

     (145     (445     1,003  
  

 

 

   

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

     1,797       (283     29,140  

Cash and cash equivalents at beginning of year

     10,639       12,436       12,153  
  

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of year

   $ 12,436     $ 12,153     $ 41,293  
  

 

 

   

 

 

   

 

 

 

Supplemental disclosures of cash flow information:

      

Interest paid

   $ 83     $ 53     $ 24  

Income taxes paid

     47       111       1,157  

See accompanying notes to financial statements.

 

F-6


Table of Contents

FIVE BELOW, INC.

Notes to Financial Statements

(in thousands, except store, share, per share and price data)

(1) Summary of Significant Accounting Policies

(a) Description of Business

Five Below, Inc. (the Company) is a specialty value retailer offering merchandise targeted at the aspirational teen and pre-teen demographic. The Company offers an edited assortment of products, priced at $5 and below. The Company’s edited assortment of products include select brands and licensed merchandise. The Company believes its merchandise is readily available, and that there are a number of potential vendors that could be utilized, if necessary, under approximately the same terms the Company is currently receiving; thus, it is not dependent on a single vendor or a group of vendors.

The Company is incorporated in the Commonwealth of Pennsylvania and as of January 28, 2012, operated 192 stores in Pennsylvania, New Jersey, Delaware, Maryland, Virginia, Massachusetts, New Hampshire, West Virginia, North Carolina, New York, Connecticut, Rhode Island, Ohio, Illinois, Indiana, and Michigan, each operating under the name “Five Below.” As of January 29, 2011 and January 30, 2010 the Company operated 142 stores and 102 stores, respectively.

(b) Fiscal Year

The Company operates on a 52/53-week fiscal year ending on the Saturday closest to January 31. The period from January 30, 2011 to January 28, 2012 is referred to as Fiscal 2011. The period from January 31, 2010 to January 29, 2011 is referred to as Fiscal 2010. The period from February 1, 2009 to January 30, 2010 is referred to as Fiscal 2009. Fiscal 2011, Fiscal 2010 and Fiscal 2009 included 52 weeks.

(c) Unaudited Pro Forma Balance Sheet Presentation

The unaudited pro forma balance sheet as of January 28, 2012 reflects:

 

   

The conversion of all outstanding shares of Series A 8% Convertible Preferred Stock, as of January 28, 2012, into 89,291,773 shares of common stock upon the closing of the initial public offering (IPO) contemplated by the Company’s prospectus. The shares of common stock issued in the IPO and any related estimated net proceeds are excluded from such pro forma information; and

 

   

The exercise of outstanding warrants to purchase 34,000 shares of common stock, as of January 28, 2012, prior to closing of the IPO.

(d) Cash and Cash Equivalents

The Company considers all highly liquid investments purchased with a maturity date of three months or less when purchased to be cash equivalents. The majority of payments due from banks for third-party credit card and debit card transactions resulting from customer purchases at the Company’s retail stores process within 24 to 48 hours, except for transactions occurring on a Friday, which are generally processed the following Monday. All credit card and debit card transactions that process in less than seven days are classified as cash and cash equivalents in the accompanying balance sheets. Amounts due from banks for these transactions classified as cash equivalents totaled $680 and $1,182 at January 29, 2011 and January 28, 2012, respectively. Book overdrafts, which are outstanding checks in excess of funds on deposit, are recorded within accounts payable in the accompanying balance sheets and within operating activities in the accompanying statements of cash flows.

The Company’s cash accounts are primarily maintained with one financial institution.

 

  F-7   (Continued)


Table of Contents

FIVE BELOW, INC.

Notes to Financial Statements

(in thousands, except store, share, per share and price data)

 

(e) Fair Value of Financial Instruments

The Company’s financial instruments consist primarily of cash and cash equivalents, accounts payable, and borrowings under a line of credit and a note payable. The Company believes that: (1) the carrying value of cash and cash equivalents and accounts payable are representative of their respective fair value due to the short-term nature of these instruments; (2) the carrying value of the borrowings under the line of credit approximates their fair value because the line of credit’s interest rates vary with market interest rates; and (3) the carrying value of the note payable approximates fair value because its negotiated terms and conditions are consistent with current market rates.

(f) Inventories

Inventories consist of finished goods purchased for resale, including freight, and are stated at the lower of cost or market value, at the individual product level. Cost is determined on a weighted average cost method which approximates a FIFO (first-in, first-out) basis. Management of the Company reviews inventory levels in order to identify slow-moving merchandise and uses markdowns to clear merchandise. Inventory cost is reduced when the selling price less costs of disposal is below cost. The Company accrues an estimate for inventory shrink for the period between the last physical count and the balance sheet date. The shrink estimate can be affected by changes in merchandise mix and changes in actual shrink trends.

(g) Property and Equipment

Property and equipment are stated at cost. Additions and improvements are capitalized, while repairs and maintenance are charged to expense as incurred. The straight-line method of depreciation and amortization is used for financial reporting purposes. The estimated useful lives are three to five years for furniture and fixtures and computers and equipment. Store leasehold improvements are amortized over the shorter of the useful life or the lease term plus assumed extensions, which is generally 10 years.

Property and equipment, net, consists of the following:

 

     January 29,
2011
    January 28,
2012
 

Furniture and fixtures

   $ 16,631      $ 23,354   

Leasehold improvements

     23,713        32,275   

Computers and equipment

     4,484        7,477   

Construction in process

     1,376        1,638   
  

 

 

   

 

 

 
     46,204        64,744   

Less: accumulated depreciation and amortization

     (16,461     (22,704
  

 

 

   

 

 

 
   $ 29,743      $ 42,040   
  

 

 

   

 

 

 

Depreciation and amortization expense for property and equipment, which is included in selling, general and administrative expenses in the accompanying statements of operations, was $3,660, $4,805 and $7,071 in Fiscal 2009, Fiscal 2010 and Fiscal 2011, respectively. Amortization expense applicable to property and equipment under capital leases of $73 in Fiscal 2009 is included in such expense.

 

  F-8   (Continued)


Table of Contents

FIVE BELOW, INC.

Notes to Financial Statements

(in thousands, except store, share, per share and price data)

 

(h) Impairment of Long-Lived Assets

Long-lived assets, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, then an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. Based on its most recent analysis, management believes that no impairment of long-lived assets exists as of January 28, 2012.

(i) Deferred Financing Costs

Deferred financing costs (note 3) are amortized to interest expense over the term of the related credit agreement. Amortization expense in Fiscal 2009, Fiscal 2010 and Fiscal 2011 was $51, $28 and $28, respectively.

(j) Other Accrued Expenses

Other accrued expenses consist of the following:

 

       January 29,
2011
     January 28,
2012
 

Deposit liability related to restricted shares (note 6)

   $ 1,860       $ 1,131   

Gift card liability

     1,230         1,745   

Other

     2,918         5,085   
  

 

 

    

 

 

 
   $ 6,008       $ 7,961   
  

 

 

    

 

 

 

(k) Deferred Rent

Certain of the Company’s operating leases contain either rent holidays and/or predetermined fixed escalations of minimum rentals during the original and/or extended lease terms. For these leases, the Company recognizes the related rent expense on a straight-line basis over the life of the lease and records the difference between the amounts charged to operations and amounts paid as deferred rent. The life of the lease is the initial term plus assumed extensions. Generally, the Company’s store leases have an initial term of ten years or five years and one assumed five-year extension, resulting in a ten-year life. The Company also receives certain lease incentives in conjunction with entering into operating leases. These lease incentives are recorded as deferred rent at the beginning of the lease term and recognized as a reduction of rent expense over the lease term. In addition, certain of the Company’s leases contain future contingent increases in rents. Such increases in rent expense are recorded in the period in which such contingent increases to the rents take place.

(l) Stock Option Plan

The Company measures the cost of employee services received in exchange for stock-based compensation based on the grant date fair value of the employee stock award. Incremental compensation costs arising from subsequent modifications of awards after the grant date must also be recognized. The Company recognizes compensation expense based on the estimated grant date fair value using the Black-Scholes option-pricing model recorded over the vesting period. Stock-based compensation cost recognized and included in expenses,

 

  F-9   (Continued)


Table of Contents

FIVE BELOW, INC.

Notes to Financial Statements

(in thousands, except store, share, per share and price data)

 

excluding modifications, for Fiscal 2009, Fiscal 2010 and Fiscal 2011 was $271, $2,104 and $1,197, respectively. In addition, during Fiscal 2010, the Company recognized $4,309 of additional compensation expense related to certain modifications of outstanding options (note 6).

(m) Revenue Recognition

Revenue is recognized at the point of sale. Returns are only permitted for damaged or defective goods. To date, returns have been immaterial. Accordingly, no reserve has been recorded. Gift card sales to customers are initially recorded as liabilities and recognized as sales upon redemption for merchandise. Sales tax collected from customers and remitted to governmental authorities are accounted for on a net basis, and therefore, excluded from sales in the accompanying statements of operations.

(n) Cost of Goods Sold

Cost of goods sold reflects the direct costs of purchased merchandise and inbound freight, as well as store occupancy, distribution and buying expenses. Store occupancy costs include rent, common area maintenance, utilities and property taxes for all store locations. Distribution costs include costs for receiving, processing, warehousing and shipping of merchandise to or from our distribution center and between store locations. Buying costs include compensation expense for our internal buying organization.

(o) Selling, General and Administrative Expenses

Selling, general and administrative expenses includes payroll and other compensation, marketing and advertising expense, depreciation and amortization expense, and other selling and administrative expenses.

(p) Vendor Allowances

The Company receives various incentives in the form of allowances, free product and promotional funds from its vendors based on product purchases and advertising activities. The amounts received are subject to changes in market conditions, vendor marketing strategies and changes in the profitability or sell-through of the related merchandise for the Company. Merchandise allowances are recorded in cost of goods and recognized in the period the related merchandise is sold. Marketing allowances are recorded in selling, general and administrative expenses and are recognized in the period the related advertising occurs to the extent the allowance is a reimbursement that is specific and incremental, and identifiable costs have been incurred by the Company to sell the vendor’s products. To the extent these conditions are not met, these allowances are recorded as merchandise allowances. Total vendor allowances recognized in the accompanying statements of operations during Fiscal 2009, Fiscal 2010 and Fiscal 2011 were $1,003, $1,999 and $2,908, respectively, of which, $893, $1,896 and $2,850 were recorded in cost of goods sold, respectively, and, $110, $103 and $58 were recorded in selling, general and administrative expenses, respectively.

(q) Store Pre-Opening Costs

Costs incurred between completion of a new store location’s construction and its opening (pre-opening costs) are charged to expense as incurred. Pre-opening costs were $1,216, $2,342 and $3,412 in Fiscal 2009, Fiscal 2010 and Fiscal 2011, respectively, and are recorded in the accompanying statements of operations based on the nature of the expense.

 

  F-10   (Continued)


Table of Contents

FIVE BELOW, INC.

Notes to Financial Statements

(in thousands, except store, share, per share and price data)

 

(r) Advertising Costs

Advertising costs are charged to expense the first time the advertising takes place. Advertising expenses were $3,920, $6,449 and $9,672 in Fiscal 2009, Fiscal 2010 and Fiscal 2011, respectively. Vendor marketing allowances earned to partially offset these costs were $110, $103 and $58 in Fiscal 2009, Fiscal 2010 and Fiscal 2011, respectively.

(s) Income Taxes

Income taxes are accounted for under the asset-and-liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.

The Company records a valuation allowance to reduce its deferred tax assets when uncertainty regarding their realizability exists. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment.

(t) Commitments and Contingencies

Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. Legal costs incurred in connection with loss contingencies are expensed as incurred.

(u) Use of Estimates

The preparation of financial statements requires management of the Company to make estimates and assumptions that affect the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include the carrying amount of property and equipment, valuation allowances for inventories, income taxes and stock-based compensation expense.

(v) Reclassifications

In certain instances, amounts previously reported in the Fiscal 2009 and Fiscal 2010 financial statements have been reclassified from selling, general and administrative expenses to cost of goods sold (including store occupancy, distribution costs and buying expenses) to conform with the presentation in the Fiscal 2011 financial statements. The reclassifications had no effect on net income or shareholders’ equity (deficit) as previously reported.

 

  F-11   (Continued)


Table of Contents

FIVE BELOW, INC.

Notes to Financial Statements

(in thousands, except store, share, per share and price data)

 

(w) Recent Accounting Pronouncements

In May 2011, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2011-04, Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs . The amendments in ASU No. 2011-04 result in common fair value measurement and disclosure requirements in U.S. generally accepted accounting principles (GAAP) and international financing reporting standards (IFRS) and change the wording used to describe many of the requirements in U.S. GAAP for measuring fair value and for disclosing information about fair value measurements. The amendments do not require additional fair value measurements and are not intended to establish valuation standards or affect valuation practices outside of financial reporting. ASU No. 2011-04 is effective during interim and annual periods beginning after December 15, 2011. The adoption of the new requirements of ASU No. 2011-04 will not have a material impact on the Company’s financial position or results of operations.

(2) Income (Loss) Per Common Share

Basic income per common share amounts are calculated using the weighted-average number of common shares outstanding for the period. Diluted income per common share amounts are calculated using the weighted-average number of common shares outstanding for the period and include the dilutive impact of preferred stock using the if-converted method and exercise of stock options and warrants as well as assumed lapse of restrictions on restricted stock awards using the treasury stock method.

The two-class method is used to calculate basic and diluted income (loss) per common share since preferred and restricted stock are participating securities under Accounting Standards Codification (ASC) 260 Earnings per share . The two-class method is an earnings allocation formula that determines income per share for each class of common stock and participating security according to dividends declared (or accumulated) and participation rights in undistributed earnings. Under the two-class method, basic income (loss) per common share is computed by dividing net income (loss) attributable to common shares after allocation of income to participating securities by the weighted-average number of common shares outstanding during the year. Diluted income (loss) per common share is computed using the more dilutive of the two-class method or the if-converted method. In periods of net loss, no effect is given to participating securities since they do not contractually participate in the losses of the Company. The two-class method is the more dilutive method for Fiscal 2009, Fiscal 2010 and Fiscal 2011.

 

  F-12   (Continued)


Table of Contents

FIVE BELOW, INC.

Notes to Financial Statements

(in thousands, except store, share, per share and price data)

 

The following table summarizes the potential dilution that could occur if options and warrants to acquire common stock were exercised or converted into common stock and reconciles the weighted average common shares outstanding used in the computations of basic and diluted income (loss) per share:

 

    Fiscal Year   
    2009     2010     2011  

Numerator:

     

Net income

  $ 11,658     $ 7,023     $ 16,078  

Series A 8% Convertible Preferred Stock cumulative dividends

    —         (4,507     (15,913

Accretion of Redeemable Convertible Preferred Stock

    (4,250     (3,329     —    
 

 

 

   

 

 

   

 

 

 

Net income (loss) available to shareholders

    7,408       (813     165   

Less: Net income attributable to participating securities

    (3,365     —         (109
 

 

 

   

 

 

   

 

 

 

Net income (loss) available to common shareholders

  $ 4,043     $ (813   $ 56  
 

 

 

   

 

 

   

 

 

 

Denominator:

     

Weighted average common share outstanding-basic

    21,539,917       27,954,322       45,964,159  

Option and other dilutive securities

    —          —         1,472   
 

 

 

   

 

 

   

 

 

 

Weighted average common share outstanding-diluted

    21,539,917       27,954,322       45,965,631  
 

 

 

   

 

 

   

 

 

 

Per common share:

     

Basic income (loss) per common share

  $ 0.19      $ (0.03   $ —     

Diluted income (loss) per common share

  $ 0.19      $ (0.03   $ —     

As discussed above, the Company is required to use the two-class method to compute basic and diluted income (loss) per common share. In Fiscal 2010, the adjustment to record the increase in redemption value of preferred stock as well as preferred stock dividends (note 5) reduced undistributed earnings, to be allocated between common shares and participating securities, to zero, for purposes of calculating net income per share using the two-class method. As such, net losses were solely attributable to common shareholders.

For Fiscal 2009, Fiscal 2010 and Fiscal 2011, preferred stock that could be converted to 17,933,539, 89,291,773, and 89,291,773 shares of common stock were not included in the computation of diluted earnings per share, as the effect of doing so would have been anti-dilutive.

For Fiscal 2009, Fiscal 2010 and Fiscal 2011, the effects of the assumed exercise of the combined stock options and warrants and vesting of restricted share awards of 6,060,497, 7,053,716 and 8,037,970 shares of common stock, respectively, were excluded from the calculation of diluted net income (loss) as (a) the average stock market price of the related common stock for the periods exceeded the exercise price of the options or warrants, (b) assumed proceeds determined under the treasury stock method resulted in no incremental shares for stock options or restricted stock, or (c) the effect would be antidilutive due to a net loss to common shareholders.

(3) Line of Credit and Note Payable

On August 18, 2006, the Company entered into a Loan and Security Agreement with a bank that included a revolving line of credit with advances tied to a borrowing base. The bank has the right to reduce the borrowing base by establishing reserves. The Loan and Security Agreement has been amended and/or restated several times, the latest on November 29, 2011 (as amended and restated, the Credit Agreement), generally to extend the maturity date, increase maximum borrowings, adjust the applicable interest rates and modify certain definitions.

 

  F-13   (Continued)


Table of Contents

FIVE BELOW, INC.

Notes to Financial Statements

(in thousands, except store, share, per share and price data)

 

The Credit Agreement allows maximum borrowings of $20,000 and expires on May 31, 2013. If the Company requests and the bank agrees, the maximum borrowings of $20,000 can be increased to $30,000 in $2,500 increments upon the payment of an additional closing fee of 0.25%. The Credit Agreement provides for interest on borrowings, at the option of the Company, at a prime rate (3.25% at January 28, 2012) plus a margin of 2.0% or a LIBOR-based rate (0.27% at January 28, 2012) plus a margin of 3.0% and a letter of credit fee equal to the LIBOR-based rate plus 2.0%. The Credit Agreement also contains an unused credit facility fee of 0.375% per annum and is subject to a servicing fee of $12 per year.

The borrowing base is 90.0% of eligible credit card receivables, as defined, plus 85.0% of the net recovery percentage of eligible inventory, as defined, less established reserves. The Company is required to maintain minimum excess collateral availability, as defined, of 15.0% of the then effective maximum credit. The Company had approximately $20,000 available on the line of credit for borrowings at January 28, 2012 based upon the borrowing base.

The Credit Agreement is secured by all assets of the Company and contains certain nonfinancial covenants which place restrictions on certain transactions, including, among others, the level of capital expenditures, certain distributions, the sale of certain assets, the merger or consolidation of the Company, incurring certain indebtedness and liens, and changes in the Company’s business or certain officers.

Additionally, the Credit Agreement is subject to payment upon the Company’s receipt of certain proceeds, as defined, including those from the sale of certain assets, income tax refunds, and insurance or settlement proceeds, and is subject to an increase in the interest rate on borrowings and the letter of credit fee of 2% upon an event of default, as defined. Amounts under the Credit Agreement may become due upon certain events of default including among others, failure to comply with the Credit Agreement’s covenants, bankruptcy, default on certain other indebtedness, a change in control, or a material adverse change in the business, assets or prospects of the Company, as defined.

During Fiscal 2009, there were no borrowings or interest expense under the Credit Agreement. During Fiscal 2010, the maximum borrowings and weighted average interest rate under the Credit Agreement were $8,247 and 4.85%, respectively, and interest expense was $53. During Fiscal 2011, there were no borrowings or interest expense under the Credit Agreement.

The Company has incurred costs of approximately $341 in connection with the Credit Agreement and its amendments, which are included in other assets on the accompanying balance sheets. These deferred financing costs are amortized over the term of the Credit Agreement or the related amendment and have a net balance of $66 and $38 as of January 29, 2011 and January 28, 2012, respectively.

On December 10, 2010 the Company entered into a Loan and Security Agreement (the Note) for $250 with a governmental authority. The Note accrues interest at 3.25% and interest is payable monthly. The principal amount and any unpaid and accrued interest is due on April 1, 2013. The Note is collateralized by certain assets of the Company. Additionally, a portion or all of the Note is subject to conversion to a grant upon the Company meeting certain non-financial conditions, as defined.

(4) Commitments and Contingencies

The Company leases property and equipment under non-cancelable operating leases. Certain retail store lease agreements provide for contingent rental payments if the store’s net sales exceed stated levels (percentage rents) and/or contain escalation clauses, which provide for increases in base rental for increases in future

 

  F-14   (Continued)


Table of Contents

FIVE BELOW, INC.

Notes to Financial Statements

(in thousands, except store, share, per share and price data)

 

operating costs. Many of the Company’s leases provide for one or more renewal options for periods ranging from five to seven years. The Company’s operating lease agreements, including assumed extensions which are generally those that take the lease to a ten-year term, expire through 2022.

The Company’s minimum rental commitments under operating lease agreements, including assumed extensions, as of January 28, 2012, are as follows:

 

     Retail stores      Corporate
office and
distribution
center
     Total  

Fiscal year:

        

2012

   $ 28,553       $ 2,097       $ 30,650   

2013

     30,759         2,426         33,185   

2014

     30,245         2,688         32,933   

2015

     29,654         2,953         32,607   

2016

     28,061         1,372         29,433   

Thereafter

     104,794         4,445         109,239   
  

 

 

    

 

 

    

 

 

 
   $ 252,066       $ 15,981       $ 268,047   
  

 

 

    

 

 

    

 

 

 

Rent expense, including base and contingent rent under operating leases, was $11,912, $16,871 and $23,607 in Fiscal 2009, Fiscal 2010 and Fiscal 2011, respectively. Contingent rents were $82, $349 and $490 in Fiscal 2009, Fiscal 2010 and Fiscal 2011, respectively.

The Company has employment agreements with certain key employees that provide for, among other things, salary, bonus, severance, and change-in-control provisions. The severance and change of control provisions under these agreements provide for additional payments upon employee separation of up to approximately $3,400.

From time to time, the Company is involved in certain legal actions arising in the ordinary course of business. In management’s opinion, the outcome of such actions will not have a material adverse effect on the Company’s financial condition or results of operations.

The Company has other purchase commitments of $1,739 as of January 28, 2012, consisting primarily of inventory purchase orders.

(5) Shareholders’ Equity

The Company is authorized to issue 200,000,000 shares of $0.01 par value common stock and 100,000,000 shares of $0.01 par value preferred stock. The holders of the common stock are entitled to one vote per share of common stock and are entitled to receive dividends if declared by the board of directors. The preferred stock may be issued from time to time in series as designated by the board of directors. The designations, powers, preferences, voting rights, privileges, options, conversion rights, and other special rights of the shares of each such series and the qualifications, limitations and restrictions thereof shall be designated by the board of directors. As of January 28, 2012, the board of directors has designated 90,000,000 shares of preferred stock as Series A 8% Convertible Preferred Stock.

 

  F-15   (Continued)


Table of Contents

FIVE BELOW, INC.

Notes to Financial Statements

(in thousands, except store, share, per share and price data)

 

Preferred Stock

In Fiscal 2005, Fiscal 2006 and Fiscal 2007, the Company issued an aggregate of 6,173,030 shares of Series A Redeemable Convertible Preferred Stock (the Series A Preferred Stock) for aggregate cash proceeds of $13,020, net of aggregate offering costs of $252. In connection with the offerings, the Company also issued warrants to originally purchase 399,865 shares of common stock at $2.15 per share (see below). The relative fair value of the warrants ($396 in aggregate) was recorded as additional paid-in capital and was being accreted to the Series A Preferred Stock through its earliest redemption dates. The offering costs incurred in connection with the issuances were also being accreted to the Series A Preferred Stock through its earliest redemption dates.

In Fiscal 2008, the Company issued an aggregate of 8,006,984 shares of Series A-1 Redeemable Convertible Preferred Stock (the Series A-1 Preferred Stock) for aggregate cash proceeds of $16,298, net of aggregate offering costs of $917. In connection with the offerings, the Company also issued warrants to purchase 3,037,938 shares of common stock at $1.70 per share. The relative fair value of the warrants ($1,442) was recorded as additional paid-in capital and was being accreted to the Series A-1 Preferred Stock through its earliest redemption dates. The offering costs incurred in connection with the issuances were also being accreted to the Series A-1 Preferred Stock through its earliest redemption dates.

In connection with the Fiscal 2008 offerings, the per share exercise price for warrants previously issued during the Company’s prior Series A Preferred Stock offerings was reduced from $2.15 per share to $1.70 per share and the number of shares of common stock for which such warrants were exercisable was increased by a factor of approximately 1.26 so that the aggregate exercise price of the warrants remained unchanged and the warrants were entitled to purchase 505,698 shares of common stock. Warrants to purchase 12,647 shares of common stock were exercised in July 2010.

Also in Fiscal 2008, as a result of a modification to the conversion ratio of the outstanding Series A Preferred Stock, the fair value of a beneficial conversion feature in the amount of $1,011 was recorded and was being accreted to the Series A Preferred Stock through its earliest redemption dates.

On October 13, 2010, the holders of the Series A and A-1 Preferred Stock converted all of their outstanding shares of Series A and A-1 Preferred Stock into the Company’s common stock according to the conversion ratio specified in the Company’s then amended and restated Certificates of Designations. As a result, 6,173,030 shares and 8,006,984 shares of Series A Preferred Stock and Series A-1 Preferred Stock, respectively, were converted into 17,933,539 shares of common stock.

On October 14, 2010, the holders of the warrants to purchase common stock issued in connection with the Series A and A-1 Preferred Stock exchanged their warrants for (i) the number of shares of common stock equal to the purchase of the number of shares underlying such warrants, and (ii) an amount of cash equal to $4.579622329 per share less the aggregate exercise price of such warrant. As a result, the warrants were exchanged for 3,530,989 shares of common stock and net cash of $10,168.

On October 14, 2010, the Company issued 89,291,773 shares of Series A 8% Convertible Preferred Stock for cash proceeds of $191,855, net of offering costs of $2,145.

Under the Company’s second amended and restated Certificate of Designations, each share of the Series A 8% Convertible Preferred Stock is convertible into one share of common stock, subject to adjustment as defined. The holders of the Series A 8% Convertible Preferred Stock may designate the election of five members of the

 

  F-16   (Continued)


Table of Contents

FIVE BELOW, INC.

Notes to Financial Statements

(in thousands, except store, share, per share and price data)

 

Company’s board of directors, or, if the board of directors is comprised of greater than eight directors, a majority of the directors. Upon the approval of the majority of the holders of the Series A 8% Convertible Preferred Stock or effective upon the closing of a qualified public offering, as defined, all shares of Series A 8% Convertible Preferred Stock will automatically convert into common stock. Each holder of the Series A 8% Convertible Preferred Stock is entitled to one vote for each share of common stock into which the shares of the Series A 8% Convertible Preferred Stock held are convertible. The Series A 8% Convertible Preferred Stock is entitled to receive cumulative dividends of 8% of its original issue price of $2.17 per share per year compounded annually and payable in cash when and if declared by the Company’s board of directors; however, the Company shall not pay, unless otherwise consented to by the holders of Series A 8% Convertible Preferred Stock, any dividends on common stock unless an equal amount of dividends per share (on an as converted basis) is simultaneously paid to the holders of the Series A 8% Convertible Preferred Stock. Cumulative dividends in arrears as of January 28, 2012 were $20,420 ($0.23 per share). The outstanding shares of the Series A 8% Convertible Preferred Stock are also entitled to certain anti-dilution rights, as defined.

In the event of any liquidation, dissolution, or winding up of the Company, as defined, or deemed liquidation event, as defined, the holders of the Series A 8% Convertible Preferred Stock will be entitled to receive the greater of the original issue price of $2.17 per share plus any accrued and unpaid dividends, or the amount that would have been paid if the Series A 8% Convertible Preferred Stock was converted to common stock, before any payment is made to the common shareholders. The Series A 8% Convertible Preferred Stock is presented outside of shareholders’ equity (deficit) since its redemption under certain circumstances is beyond the control of the Company’s management.

Approval of the holders of a majority of the shares of the Series A 8% Convertible Preferred Stock is required for, among other items, the authorization, issuance, or redemption of stock, changes in the Company’s Articles of Incorporation or By-laws, changes in the senior management and incurrence of debt or participation in certain transactions above a certain threshold.

Common Stock

The Company’s Executive Chairman of the Board and the CEO were co-founders of the Company and own a combined 10,223,920 shares of the Company’s outstanding common stock at January 28, 2012.

A shareholder of the Company’s common stock has executed an irrevocable proxy appointing David Schlessinger, Executive Chairman of the Board of the Company, as proxy. The proxy is empowered, and may exercise the irrevocable proxy, to vote the shares at any time and at any meeting of the shareholders of the Company, however called, including written actions by consent of shareholders. The irrevocable proxy is effective upon execution (with subscription agreement) and terminates, with respect to the designated shares, upon the earlier of (i) the longest period of time allowable under applicable law from the execution date and (ii) a transfer of such designated shares after the closing of an underwritten public offer for cash on a firm commitment basis pursuant to an effective registration statement filed pursuant to the Securities Act of 1933, as amended, covering the sale of the Company’s capital stock, as defined.

Certain shareholders of the Company’s common stock have each executed an irrevocable proxy appointing David Schlessinger as proxy, while certain other shareholders of the Company’s common stock have each executed an irrevocable proxy appointing Thomas Vellios as proxy. In each case, the proxy is empowered, and may exercise the irrevocable proxy, to vote the shares at any time and at any meeting of the shareholders of the Company, however called, including written actions by consent of shareholders. The irrevocable proxy is

 

  F-17   (Continued)


Table of Contents

FIVE BELOW, INC.

Notes to Financial Statements

(in thousands, except store, share, per share and price data)

 

effective upon execution (with subscription agreement) and terminates, with respect to the designated shares, upon the earlier of (i) the fifth (5 th ) anniversary of the date of the proxy and (ii) a transfer of such designated shares after the closing of an underwritten public offer for cash on a firm commitment basis pursuant to an effective registration statement filed pursuant to the Securities Act of 1933, as amended, covering the sale of the Company’s capital stock, as defined.

The Company and its shareholders have entered into an Amended and Restated Investors Rights Agreement and a Second Amended and Restated Shareholders Agreement, which provide for, among others, certain registration, information, first refusal, co-sale, observer, bring along and board of director voting rights. The Second Amended and Restated Shareholders Agreement also provides for certain restrictions and obligations with respect to the stock of the Company held by the Company’s shareholders, including limits on the transfer of stock held by shareholders.

In connection with a common stock sale that closed in 2004, the Company issued warrants to purchase 67,648 shares of common stock at a price of $1.70 per share. The fair value of these warrants is included in additional paid-in capital in the accompanying financial statements. The warrants were exercised in September 2009.

In January 2007, the Company granted warrants to purchase 120,000 shares of common stock at an exercise price of $2.15 per share to a merchandise vendor and professional service provider. Warrants to purchase 100,000 shares of common stock expired unexercised in January 2008 and the remaining warrants to purchase 20,000 shares of common stock were exercised in October 2010. The fair value of the warrants ($46) was recorded as expense in Fiscal 2006.

In March 2008, the Company granted warrants to purchase 126,628 shares of common stock at an exercise price of $2.15 per share to professional service providers and a merchandise vendor. Warrants to purchase 100,000 shares of common stock issued to the merchandise vendor expired unexercised in April 2009. Warrants to purchase 5,000 and 21,628 shares of common stock to professional service providers were exercised in September 2009 and October 2010, respectively. The fair value of the warrants ($41) was recorded as expense in Fiscal 2007.

In February 2009 and May 2009, the Company granted warrants to purchase 40,000 and 5,000 shares of common stock, respectively, at an exercise price of $1.70 per share to professional service providers. The warrants were exercised in October 2010. The fair value of the warrants ($21) and ($3) was recorded as expense in Fiscal 2008 and Fiscal 2009, respectively.

In May 2010, the Company granted warrants to purchase 80,000 shares of common stock at an exercise price of $3.96 per share to professional service providers that were exercised in October 2010. The fair value of the warrants ($203) was recorded as expense in Fiscal 2010.

On October 13, 2010, the board of directors declared a cash dividend of $4.58 per share, or $196,726 in the aggregate, which was paid on October 14, 2010 to shareholders of record on October 13, 2010. Of this amount, $4,309 was recorded as additional compensation expense (note 6).

In February 2011, the Company granted warrants to purchase 40,000 shares of common stock at an exercise price of $2.18 per share to professional service providers, of which 15,000 were exercised in November 2011. The fair value of the warrants ($25) was recorded as expense in Fiscal 2010.

In May 2011, the Company granted warrants to purchase 9,000 shares of common stock at an exercise price of $2.18 per share to a professional service provider. The fair value of the warrants ($6) was recorded as expense in Fiscal 2011.

 

  F-18   (Continued)


Table of Contents

FIVE BELOW, INC.

Notes to Financial Statements

(in thousands, except store, share, per share and price data)

 

As of January 28, 2012, there were warrants to purchase 34,000 shares of common stock at an exercise price of $2.18 per share outstanding.

In November 2011, the Company issued 460,257 shares of common stock for cash proceeds of $1,110 to an incoming member of the Company’s board of directors.

(6) Common Stock Options

Effective July 26, 2002, the Company adopted the 2002 Equity Incentive Plan (the Plan) pursuant to which the Company’s board of directors may grant stock options and restricted shares to officers, directors, key employees, and professional service providers. The Plan, as amended as of October 13, 2010, increases the number of shares available for issuance under the Plan to 13,632,159 shares of authorized but unissued common stock. All stock options have a term not greater than 10 years. Stock options vest and become exercisable in whole or in part, in accordance with vesting conditions set by the Company’s board of directors. Options granted to date generally vest over four years from the date of grant.

On August 25, 2010, the Company’s board of directors agreed to allow option holders, as of that date, to exercise, during a twenty day offer period, all options issued and outstanding under the Plan, regardless if those options were vested and exercisable (Vested Options) or were not currently vested and exercisable (Unvested Options). The Company recorded $4,309 of additional compensation cost in Fiscal 2010 to reflect the incremental value associated with the modification of the options (see below).

On October 13, 2010, the holders of the stock options exercised all of their outstanding Vested and Unvested Options to purchase shares of the Company’s common stock. The Unvested Options were exercised for restricted shares of common stock that have the same vesting schedule as the Unvested Options that were exercised for those shares. The restricted shares are subject to repurchase by the Company should the option holder’s employment be terminated prior to the vesting at a purchase price equal to the lesser of: (i) the exercise price paid for the restricted shares, and (ii) the fair market value of the restricted shares at the time of repurchase. For accounting purposes, as the shares remain subject to their original vesting provisions, the early exercises are being recorded as if the original options remain outstanding until the respective shares vest. Exercise proceeds received prior to the shares vesting are recorded as a deposit liability in other accrued expenses on the accompanying balance sheets. As of January 29, 2011 and January 28, 2012, $1,860 and $1,131 respectively, was recorded as a deposit liability. Due to the modification of the options to allow early exercise, dividends received by the exercisers before the original vesting date were recorded as additional compensation expense.

 

  F-19   (Continued)


Table of Contents

FIVE BELOW, INC.

Notes to Financial Statements

(in thousands, except store, share, per share and price data)

 

The following table summarizes the activity related to the restricted shares of common stock:

 

     Number of
shares
    Deposit
liability
 

Unvested, issued upon option exercises on October 13, 2010

     940,811      $ 1,933   

Vested

     (61,042     (73
  

 

 

   

 

 

 

Unvested, January 29, 2011

     879,769        1,860   

Vested

     (392,072     (491

Repurchases upon employee termination

     (77,502     (238
  

 

 

   

 

 

 

Unvested, January 28, 2012

     410,195      $ 1,131   
  

 

 

   

 

 

 

Stock option activity under the Plan was as follows:

 

     Shares
available for
grant
    Options
outstanding
    Weighted
average
exercise
price
     Weighted
average
remaining
contractual
term
 

Balance at January 31, 2009

     290,160        2,202,347      $ 1.18      

Granted

     (351,000     351,000        1.20      

Forfeited

     121,834        (121,834     1.20      

Exercised

     —          (1,280     1.20      
  

 

 

   

 

 

      

Balance at January 30, 2010

     60,994        2,430,233        1.18         6.9   

Increase in authorized shares

     10,982,159        —          —        

Granted

     (7,016,446     7,016,446        2.39      

Forfeited

     19,469        (19,469     1.34      

Exercised

     —          (3,253,263     1.96      
  

 

 

   

 

 

      

Balance at January 29, 2011

     4,046,176        6,173,947        2.18         9.7   

Granted

     (1,766,800     1,766,800        2.43      

Forfeited

     345,500        (345,500     2.21      

Exercised

     —          —          —        
  

 

 

   

 

 

      

Balance at January 28, 2012

     2,624,876        7,595,247        2.24         9.0   
  

 

 

   

 

 

      

Exercisable at January 28, 2012

       —          
    

 

 

      

Included in the options granted during Fiscal 2010 and outstanding as of January 28, 2012 are options to purchase 2,919,973 shares of common stock, which vest incrementally only upon the achievement of certain performance targets including achieving targeted internal rates of return for the Company’s preferred shareholders or the Company achieving certain market capitalization levels subsequent to an initial public offering. As of January 28, 2012, no compensation expense has been recognized for these options since the Company’s management determined that the performance targets were not probable of achievement at that date. Subsequent to January 28, 2012, these options were cancelled (note 10).

 

  F-20   (Continued)


Table of Contents

FIVE BELOW, INC.

Notes to Financial Statements

(in thousands, except store, share, per share and price data)

 

The fair value of each option award granted to employees, including outside directors, is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:

 

     Fiscal Year  
     2009     2010     2011  

Expected volatility

     50.0     50.0     50.0

Risk-free interest rate

     2.9     1.8     2.0

Expected life of options

     7.0 years        7.0 years        7.0 years   

Expected dividend yield

     —          —          —     

The Company uses the simplified method to estimate the expected term of the option. Expected volatility is based upon historical volatility analysis of public company peers, and the risk-free rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

The per-share weighted average grant-date fair value of stock options granted to employees, including outside directors, in Fiscal 2009, Fiscal 2010 and Fiscal 2011 was $0.50, $1.18 and $1.24 respectively. The total intrinsic value of stock options exercised during Fiscal 2009, Fiscal 2010 and Fiscal 2011 was zero, $15,621 and zero, respectively.

As of January 28, 2012, there was $10,624 of total unrecognized compensation costs related to nonvested share-based compensation arrangements granted under the Plan, excluding options that vest upon the achievement of performance targets. That cost is expected to be recognized over a weighted average vesting period of 2.3 years.

The Company currently uses authorized and unissued shares to satisfy option award exercises.

(7) Income Taxes

Deferred income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Through January 31, 2009, due to the uncertainty of the Company’s ability to realize the benefit of the net deferred tax asset, the net deferred tax assets were fully offset by a valuation allowance. The determination that the full valuation allowance was required was based largely on the history of losses experienced by the Company and the cumulative losses experienced for the three years ended January 31, 2009.

As of January 30, 2010, the Company re-evaluated the realizability of the deferred tax assets. Based upon significant Fiscal 2010 pretax income, the Company had net cumulative pretax income for the three years ended January 30, 2010. Based upon the achievement of the cumulative pretax income for the three years ended January 30, 2010 and the Company’s estimates of projected future profitability, management believed that it was more likely than not that the benefit of its net deferred tax assets would be realized and therefore reversed the valuation allowance against its net deferred tax assets. Accordingly, the Company recognized a deferred tax benefit of $7,419 related to the reduction of the valuation allowance in Fiscal 2009.

 

  F-21   (Continued)


Table of Contents

FIVE BELOW, INC.

Notes to Financial Statements

(in thousands, except store, share, per share and price data)

 

As of January 28, 2012, no valuation allowance has been provided for net deferred tax assets as management continues to believe that it is more likely than not that the Company will realize the deferred tax assets at January 28, 2012.

The components of the income tax (benefit) expense are as follows:

 

     Fiscal Year  
     2009     2010     2011  

Current:

      

Federal

   $ 127      $ 4,080      $ 6,979   

State

     47        1,389        3,124   
  

 

 

   

 

 

   

 

 

 
     174        5,469        10,103   
  

 

 

   

 

 

   

 

 

 

Deferred:

      

Federal

     2,078        (673     1,434   

State

     314        (43     (1,378
  

 

 

   

 

 

   

 

 

 
     2,392        (716     56   
  

 

 

   

 

 

   

 

 

 

Adjustments to the beginning-of-year valuation allowance

     (7,419     —          —     
  

 

 

   

 

 

   

 

 

 

Income tax (benefit) expense

   $ (4,853   $ 4,753      $ 10,159   
  

 

 

   

 

 

   

 

 

 

The reconciliation of the statutory federal income tax rate to the Company’s effective income tax rate is as follows:

 

     Fiscal Year  
     2009     2010     2011  

Statutory federal tax rate

           34.0         34.0         35.0

State taxes, net of federal benefit

     5.7        5.7        5.6   

Other

     (2.0     0.7        (1.9

Changes in valuation allowance

     (109.0     —          —     
  

 

 

   

 

 

   

 

 

 
     (71.3 )%      40.4     38.7
  

 

 

   

 

 

   

 

 

 

 

  F-22   (Continued)


Table of Contents

FIVE BELOW, INC.

Notes to Financial Statements

(in thousands, except store, share, per share and price data)

 

Significant components of deferred tax assets and liabilities consist of the following:

 

     January  29,
2011
    January  28,
2012
 
    

Deferred tax assets:

    

Net operating loss carryforwards

   $ 1,110      $ —     

Inventories

     1,412        1,920   

Alternative minimum tax credits

     225        —     

Deferred revenue

     56        71   

Accrued bonus

     —          2,907   

Deferred rent

     6,093        9,000   

Other

     342        381   
  

 

 

   

 

 

 

Deferred tax assets

     9,238        14,279   
  

 

 

   

 

 

 

Deferred tax liabilities:

    

Property and equipment

     (5,098     (10,404

Other

     (527     (318
  

 

 

   

 

 

 

Deferred tax liabilities

     (5,625     (10,722
  

 

 

   

 

 

 
   $ 3,613      $ 3,557   
  

 

 

   

 

 

 

The Company had no material accrual for uncertain tax positions or interest or penalties related to income taxes on the Company’s balance sheets at January 29, 2011 or January 28, 2012, and has not recognized any material uncertain tax positions or interest and/or penalties related to income taxes in the statement of operations for Fiscal 2009, Fiscal 2010 or Fiscal 2011.

The Company files a federal income tax return as well as state tax returns. The Company’s U.S. federal income tax returns for the years ended January 30, 2010 and thereafter remain subject to examination by the U.S. Internal Revenue Service (IRS). State returns are filed in various state jurisdictions, as appropriate, with varying statutes of limitation and remain subject to examination.

(8) Related-Party Transactions

During Fiscal 2009, the Company extended a loan of $250 to an officer. The loan accrued interest at 4.11% and was payable on an annual basis with the first interest payment due on March 1, 2011. The loan required mandatory prepayments of the full principal amount and unpaid accrued interest upon the occurrence of certain events as defined in the related agreement. The loan was collateralized by a pledge of common stock of the Company owned by the officer. On October 13, 2010, the principal of $250 and interest was paid in full. Interest income recognized on this loan totaled $8.

During the first six months of Fiscal 2009, the Executive Chairman of the Board of the Company provided his services to the Company on a full-time basis without receiving cash compensation. Beginning in August 2009, the Executive Chairman of the Board of the Company started to receive compensation for such services.

During Fiscal 2009, Fiscal 2010 and Fiscal 2011, the Company incurred fees of $247, $1,759 and $479, respectively, related to services provided by certain shareholders and professional service firms for which certain shareholders are partners.

 

  F-23   (Continued)


Table of Contents

FIVE BELOW, INC.

Notes to Financial Statements

(in thousands, except store, share, per share and price data)

 

(9) Employee Benefit Plan

Effective February 1, 2007, the Company implemented the Five Below 401(k) Retirement Savings Plan for all employees who have at least one year of service, worked at least 1,000 hours, and are 21 years of age. Employees can contribute up to the maximum amount allowed under law. The Company may make discretionary matching and profit sharing contributions, which vest over a period of five years from each employee’s commencement of employment with the Company. The Company did not make any discretionary contributions in Fiscal 2009, Fiscal 2010 or Fiscal 2011.

(10) Subsequent Events

From January 29, 2012 to April 17, 2012, the Company committed to 18 new store leases that were not included in the Company’s minimum rental commitments table in note 4. Minimum rental commitments under these leases are as follows:

 

     Retail stores  

Fiscal year:

  

2012

   $ 1,278   

2013

     2,651   

2014

     2,706   

2015

     2,706   

2016

     2,706   

Thereafter

     15,361   
  

 

 

 
   $ 27,408   
  

 

 

 

In February 2012, warrants to purchase 29,000 shares of common stock were exercised.

In March 2012, options to purchase 5,839,946 shares of common stock granted during Fiscal 2010, including options to purchase 2,919,973 shares that were to vest upon the achievement of performance targets (note 6), were cancelled and an equal number of restricted shares were granted. One-third of the shares vested in March 2012 and the remaining two-thirds vest in equal installments on the first and second anniversary of the grant. As a result, the Company estimates that it will record total future compensation expense of approximately $17,600 in connection with the cancellation and grant, including an estimated $5,400 on the date of the modification and the remainder on a straight-line basis over the two-year vesting period.

In March 2012, the Company granted warrants to purchase 32,500 shares of common stock at an exercise price of $3.88 per share to professional service providers.

In March 2012, the Company granted options to purchase 1,142,000 shares of common stock at an exercise price of $3.88 per share to Company employees.

In March 2012, warrants to purchase 7,500 shares of common stock were exercised.

In April 2012, warrants to purchase 20,000 shares of common stock were exercised.

The Company has evaluated subsequent events from the balance sheet date through April 17, 2012, the date at which the financial statements were available to be issued, and determined there are no other items requiring disclosure.

 

  F-24  


Table of Contents

 

 

             Shares

Five Below, Inc.

Common Stock

 

 

PROSPECTUS

 

 

Goldman, Sachs & Co.

Barclays

Jefferies

Credit Suisse

Deutsche Bank Securities

UBS Investment Bank

Wells Fargo Securities

 

 

Through and including                     , 2012 (the 25th day after the date of this prospectus), all dealers effecting transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to a dealer’s obligation to deliver a prospectus when acting as an underwriter and with respect to an unsold allotment or subscription.

 

 

 


Table of Contents

PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

Item 13. Other Expenses of Issuance and Distribution.

The following table sets forth the costs and expenses, other than the underwriting discounts and commissions, payable by us in connection with the sale of the common stock being registered. All amounts shown are estimates except the SEC registration fee, the FINRA filing fee and The NASDAQ Global Select Market listing fee.

 

     Amount
to be Paid
 

SEC registration fee

   $ 17,190   

FINRA filing fee

     15,500   

The NASDAQ Global Select Market listing fee

      

Blue sky fees and expenses

      

Printing and engraving expenses

      

Legal fees and expenses

      

Accounting fees and expenses

      

Transfer agent and registrar fees and expenses

      

Miscellaneous fees and expenses

      
  

 

 

 

Total

   $             
  

 

 

 

 

* To be updated by amendment.

Item 14. Indemnification of Officers and Directors.

Sections 1741 through 1750 of Subchapter D, Chapter 17, of the PBCL, contain provisions for mandatory and discretionary indemnification of a corporation’s directors, officers and other personnel, and related matters.

Under Section 1741 of the PBCL, subject to certain limitations, a corporation has the power to indemnify directors and officers under certain prescribed circumstances against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred in connection with an action or proceeding, whether civil, criminal, administrative or investigative (other than derivative or corporate actions), to which any such officer or director is a party or is threatened to be made a party by reason of such officer or director being a representative of the corporation or serving at the request of the corporation as a representative of another domestic or foreign corporation for profit or not-for-profit, partnership, joint venture, trust or other enterprise, so long as the director or officer acted in good faith and in a manner reasonably believed to be in, or not opposed to, the best interests of the corporation and, with respect to any criminal proceeding, such officer or director had no reasonable cause to believe his conduct was unlawful.

Section 1742 of the PBCL permits indemnification in derivative and corporate actions if the director or officer acted in good faith and in a manner he reasonably believed to be in, or not opposed to, the best interests of the corporation, except in respect of any claim, issue or matter as to which the officer or director has been adjudged to be liable to the corporation unless and only to the extent that the proper court determines upon application that, despite the adjudication of liability but in view of all the circumstances of the case, the officer or director is fairly and reasonably entitled to indemnity for the expenses that the court deems proper.

Under Section 1743 of the PBCL, indemnification is mandatory to the extent that the officer or director has been successful on the merits or otherwise in defense of any action or proceeding referred to in Section 1741 or 1742 of the PBCL.

 

II-1


Table of Contents

Section 1744 of the PBCL provides that, unless ordered by a court, any indemnification under Section 1741 or 1742 of the PBCL shall be made by the corporation only as authorized in the specific case upon a determination that the officer or director met the applicable standard of conduct, and such determination must be made by (i) the board of directors by a majority vote of a quorum of directors not parties to the action or proceeding, (ii) if a quorum is not obtainable, or if obtainable and a majority vote of a quorum of disinterested directors so directs, by independent legal counsel in a written opinion, or (iii) by the shareholders.

Section 1745 of the PBCL provides that expenses (including attorneys’ fees) incurred by a director or officer in defending any action or proceeding referred to in Subchapter D of Chapter 17 of the PBCL may be paid by the corporation in advance of the final disposition of such action or proceeding upon receipt of an undertaking by or on behalf of such person to repay such amount if it shall ultimately be determined that he is not entitled to be indemnified by the corporation. Except as otherwise provided in the corporation’s bylaws, the PBCL provides that advancement of expenses must be authorized by the board of directors.

Section 1746 of the PBCL provides generally that the indemnification and advancement of expenses provided by Subchapter D of Chapter 17 of the PBCL shall not be deemed exclusive of any other rights to which an officer or director seeking indemnification or advancement of expenses may be entitled under any bylaw, agreement, vote of shareholders or disinterested directors or otherwise, both as to action in his official capacity and as to action in another capacity while holding that office. In no event may indemnification be made in any case where the act or failure to act giving rise to the claim for indemnification is determined by a court to have constituted willful misconduct or recklessness.

Section 1747 of the PBCL grants a corporation the power to purchase and maintain insurance on behalf of any director or officer against any liability incurred by him in his capacity as officer or director, whether or not the corporation would have the power to indemnify him against that liability under Subchapter D of Chapter 17 of the PBCL.

Sections 1748 and 1749 of the PBCL extend the indemnification and advancement of expenses provisions contained in Subchapter D of Chapter 17 of the PBCL to successor corporations in fundamental changes and to officers and directors serving as fiduciaries of employee benefit plans.

Section 1750 of the PBCL provides that the indemnification and advancement of expenses provided by, or granted pursuant to, Subchapter D of Chapter 17 of the PBCL shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director or officer shall inure to the benefit of the heirs and personal representatives of such person.

The goal of the aforementioned provisions of the PBCL and those of our third amended bylaws, described below, is to limit the monetary liability of our officers and directors to us and to our shareholders and provide for indemnification of our officers and directors for liabilities and expenses that they may incur in such capacities.

Our third amended bylaws provide that we may indemnify our directors and officers for monetary damages for any action taken or failure to take any action, unless:

 

   

such director or officer has breached or failed to perform the duties of his or her office under the PBCL, our third amended bylaws or our second amended and restated articles of incorporation; and

 

   

the breach or failure to perform constitutes self-dealing, willful misconduct or recklessness.

In addition, our third amended bylaws provide that we shall indemnify our directors and officers for expenses, attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit or proceeding if he or she has acted in good faith and in a manner he or she believed to be in our best interest, or in the case of a criminal proceeding, that he or she had no reasonable cause to believe his or her conduct was unlawful. Such indemnification as to expenses, including

 

II-2


Table of Contents

attorneys’ fees, is mandatory to the extent the individual is successful on the merits or otherwise in defense of the matter or in defense of any claim, issue or matter therein. Our third amended bylaws provide, however, in the case of an action or suit by or in the right of the Company, that we will not indemnify a director or officer with respect to a matter in which such person has been adjudged to be liable in the performance of his or her duties to us, unless a court of common pleas determines that such person is fairly and reasonably entitled to indemnification. Our third amended bylaws also provide that we may advance expenses to any director or officer upon our receipt of an undertaking by the director or officer to repay those amounts if it is finally determined that he or she is not entitled to indemnification.

We maintain directors’ and officers’ liability insurance to provide directors and officers with insurance coverage for losses arising from claims based on breaches of duty, negligence, error and other wrongful acts and for violations with respect to the Securities Act.

We have entered, and intend to continue to enter, into separate indemnification agreements with our directors and executive officers to provide indemnification to our directors and executive officers under certain circumstances for acts or omissions that may not be covered by directors’ and officers’ liability insurance, and may, in some cases, be broader than the specific indemnification provisions contained under the PBCL.

At present, there is no pending litigation or proceeding involving one or more of our directors or executive officers regarding which indemnification is sought.

The form of underwriting agreement attached hereto as Exhibit 1.1 provides for indemnification by the underwriters named in this registration statement of our executive officers, directors and us, and by us of the underwriters named in this registration statement, for certain liabilities, including liabilities arising under the Securities Act, in connection with matters specifically provided in writing for inclusion in this registration statement.

Item 15. Recent Sales of Unregistered Securities.

During the three years preceding the filing of this registration statement, we issued unregistered securities in the following transactions. None of these transactions involved underwriters, underwriting discounts or commissions, or any public offering, and we believe that each transaction was exempt from the registration requirements of the Securities Act, as described below.

 

(a) Issuances of Common Stock

 

   

On October 13, 2010, we issued 2,449,080 shares of common stock to 84 holders in exchange for and in exercise of all issued and outstanding compensatory warrants and all vested options to purchase our common stock in connection with the 2010 Transaction on a one-for-one basis, offsetting the strike price for each holder. In addition, we issued 940,811 shares of common stock to 79 holders, in amounts equal to the unvested portion of such holder’s options. Also, on October 13, 2010, we issued 17,933,539 shares of common stock to 30 shareholders in connection with the conversion of 6,173,030 shares and 8,006,984 shares of Series A and Series A-1 redeemable convertible preferred stock, respectively, held by such shareholders. On October 14, 2010 we issued 3,530,989 shares to 30 shareholders in exchange for all remaining then-outstanding common stock warrants.

 

   

On November 22, 2011, we issued 460,257 shares of common stock to an incoming director at a price of $2.41 a share and a total purchase price of approximately $1.1 million.

 

   

On November 29, 2011, we issued 15,000 shares of common stock to a consultant in connection with the exercise of warrants issued to him as compensation for services he provided to the Company. The exercise price was $2.18 per share and resulted in aggregate cash proceeds to the Company equal to $32,700.

 

II-3


Table of Contents
   

On February 23, 2012, we issued 29,000 shares of common stock to a consultant in connection with the exercise of warrants issued to him as compensation for services he provided to the Company. The exercise price was $2.18 and resulted in aggregate cash proceeds to the Company equal to $63,220.

 

   

On March 22, 2012, we issued a total of 5,839,946 shares of restricted common stock to the Founders in exchange for the cancellation for each Founder’s option agreement, on a one-for-one basis.

 

(b) Issuances of Preferred Stock

 

   

On October 14, 2010, the Company issued 89,291,773 shares of Series A 8% convertible preferred stock, at a per share price of approximately $2.17, for gross cash proceeds of $194.0 million, to funds managed by Advent and to Sargent Family Investments, LLC, a limited liability company controlled by one of our directors.

 

(c) Issuances of Warrants to Purchase Common Stock

 

   

On February 26, 2009, we issued warrants to purchase a total of 40,000 shares of common stock at an exercise price of $1.70 per share to four service providers to the Company.

 

   

On May 22, 2009, we issued a warrant to purchase 5,000 shares of common stock at an exercise price of $1.70 per share to a service provider to the Company.

 

   

On May 27, 2010, we issued warrants to purchase 80,000 shares of common stock at an exercise price of $3.96 per share to six service providers to the Company.

 

   

On February 22, 2011, we issued warrants to purchase 40,000 shares of common stock at an exercise price of $2.18 per share to three service providers to the Company.

 

   

On May 25, 2011, we issued a warrant to purchase 9,000 shares of common stock at an exercise price of $2.18 per share to a service provider to the Company.

 

   

On March 1, 2012, we issued warrants to purchase 32,500 shares of common stock at an exercise price of $3.88 per share to three service providers to the Company.

 

(d) Stock Option Grants

 

   

On February 26, 2009, we granted stock options to purchase a total of 25,000 shares of common stock at an exercise price of $1.20 per share to two employees pursuant to our equity incentive plan.

 

   

On May 22, 2009, we granted stock options to purchase a total of 263,500 shares of common stock at an exercise price of $1.20 per share to 33 employees pursuant to our equity incentive plan.

 

   

On November 19, 2009, we granted stock options to purchase a total of 62,500 shares of common stock at an exercise price of $1.20 per share to 14 employees pursuant to our equity incentive plan.

 

   

On May 27, 2010, we granted stock options to purchase a total of 342,500 shares of common stock at an exercise price of $3.96 per share to 51 employees and one director pursuant to our equity incentive plan.

 

   

On June 30, 2010, we granted stock options to purchase a total of 500,000 shares of common stock at an exercise price of $3.96 per share to two employees, both of whom were also directors, pursuant to our equity incentive plan.

 

   

On October 14, 2010, we granted stock options to purchase a total of 5,839,946 shares of common stock at an exercise price of $2.18 per share to two employees, both of whom were also directors, pursuant to our equity incentive plan.

 

   

On November 23, 2010, we granted stock options to purchase a total of 334,000 shares of common stock at an exercise price of $2.18 per share to 21 employees pursuant to our equity incentive plan.

 

II-4


Table of Contents
   

On February 22, 2011, we granted stock options to purchase a total of 75,000 shares of common stock at an exercise price of $2.18 per share to nine employees pursuant to our equity incentive plan.

 

   

On May 25, 2011, we granted stock options to purchase a total of 434,250 shares of common stock at an exercise price of $2.18 per share to 81 employees pursuant to our equity incentive plan.

 

   

On September 1, 2011, we granted stock options to purchase a total of 102,750 shares of common stock at an exercise price of $2.41 per share to 28 employees pursuant to our equity incentive plan.

 

   

On October 18, 2011, we granted stock options to purchase a total of 781,800 shares of common stock at an exercise price of $2.41 per share to 120 employees pursuant to our equity incentive plan.

 

   

On November 22, 2011, we granted stock options to purchase a total of 373,000 shares of common stock at an exercise price of $2.82 per share to seven employees pursuant to our equity incentive plan.

 

   

On March 1, 2012, we granted stock options to purchase a total of 911,000 shares of common stock at an exercise price of $3.88 per share to 145 employees pursuant to our equity incentive plan.

 

   

On March 30, 2012, we granted stock options to purchase a total of 231,000 shares of common stock at an exercise price of $3.88 per share to 12 employees pursuant to our equity incentive plan.

The conversions of preferred stock and exchanges of warrants described in paragraph (a) above were exempt securities transactions pursuant to Section 3(a)(9) of the Securities Act. Each of the recipients of securities in these transactions had or were given adequate access, through employment, business or other relationships, to information about us.

The offers, sales and issuances of the securities described in paragraph (b) were exempt from registration under the Securities Act under Section 4(2) of the Securities Act and Regulation D promulgated thereunder as transactions by an issuer not involving a public offering. The recipients of these securities were accredited investors within the meaning of Rule 501 of Regulation D of the Securities Act, who were acquiring the applicable securities for investment and not distribution. Each recipient represented that they could bear the risks of the investment.

The issuances of the securities described in paragraphs (a), (c) and (d) were exempt from registration under the Securities Act in reliance on Rule 701 promulgated under Section 3(b) of the Securities Act, as transactions by an issuer not involving a public offering or transactions pursuant to compensatory benefit plans and contracts relating to compensation. The recipients of such options were our employees or directors, who received the securities under our equity incentive plan and the recipients of such warrants were service providers to the Company. Each recipient of securities in these transactions had adequate access, through employment or business relationships, to information about us.

 

II-5


Table of Contents

Item 16. Exhibits and Financial Statement Schedules.

 

  (a) Exhibits.

 

Exhibit
Number

  

Description

  1.1*   

Form of Underwriting Agreement

  3.1   

Amended and Restated Articles of Incorporation of Five Below, Inc., as currently in effect

  3.2   

Second Amended and Restated Certificate of Designations, Preferences, Limitations and Special Rights of the Series A 8% Convertible Preferred Stock of Five Below, Inc., as currently in effect

  3.3   

Second Amended Bylaws of Five Below, Inc., as amended, as currently in effect

  3.4*   

Second Amended and Restated Articles of Incorporation of Five Below, Inc., to be in effect upon the closing of this offering

  3.5*   

Third Amended Bylaws, to be in effect upon the closing of this offering

  4.1*   

Form of Specimen Stock Certificate

  5.1*   

Opinion of Pepper Hamilton LLP

10.1   

Investment Agreement, dated September 1, 2010, by and among Five Below, Inc., the Founders signatory thereto, the Significant Common Shareholders signatory thereto and the Purchasers signatory thereto

10.2   

Amendment No. 1 to the Investment Agreement, dated October 14, 2010, by and among Five Below, Inc., the Purchasers signatory to the Investment Agreement, and Sargent Family Investment, LLC

10.3   

Amended and Restated Investor Rights Agreement, dated September 1, 2010, by and among Five Below, Inc., the Significant Common Shareholders signatory thereto, the Series A Preferred Shareholders signatory thereto and the Other Holders party thereto and any other Persons signatory thereto from time to time

10.4   

First Amendment to Amended and Restated Investor Rights Agreement, dated October 14, 2010, by Five Below, Inc.

10.5   

Second Amended and Restated Shareholders Agreement, dated September 1, 2010, by and among Five Below, Inc. and the Shareholders party thereto and any other Persons signatory thereto from time to time

10.6   

First Amendment to Second Amended and Restated Shareholders Agreement, dated October 14, 2010, by Five Below, Inc.

10.7   

Second Amendment to Second Amended and Restated Shareholders Agreement, dated November 22, 2011, and among by Five Below, Inc. and the Consenting Shareholders signatory thereto

10.8   

Five Below, Inc. Equity Incentive Plan

10.9   

Amendment 2010-1 to the Five Below, Inc. Equity Incentive Plan

10.10   

Form of Non-Qualified Stock Option Agreement (Employees)

10.11   

Form of Non-Qualified Stock Option Agreement (Executives)

10.12   

Form of Award Agreement for Restricted Shares Under the Five Below, Inc. Equity Incentive Plan

10.13*   

Five Below, Inc. Amended and Restated Equity Incentive Plan

10.14*   

Form of Equity Incentive Award Agreement

10.15*   

Five Below, Inc. Performance Bonus Plan

10.16*   

Form of Director and Officer Indemnification Agreement

10.17   

Letter Employment Agreement, dated October 14, 2010, by and between David Schlessinger and Five Below, Inc.

10.18   

Amendment to Employment Agreement, dated September 28, 2011, by and between David Schlessinger and Five Below, Inc.

 

II-6


Table of Contents

Exhibit
Number

  

Description

10.19   

Letter Employment Agreement, dated October 14, 2010, by and between Thomas Vellios and Five Below, Inc.

10.20   

Amendment to Employment Agreement, dated September 28, 2011, by and between Thomas Vellios and Five Below, Inc.

10.21   

Letter Employment Agreement, dated April 16, 2012, by and between Kenneth R. Bull and Five Below, Inc.

10.22   

Non-Qualified Stock Option Agreement, dated October 14, 2010, by and between David Schlessinger and Five Below, Inc.

10.23   

Non-Qualified Stock Option Agreement, dated October 14, 2010, by and between Thomas Vellios and Five Below, Inc.

10.24   

Option Cancellation Agreement, dated March 22, 2012, by and between David Schlessinger and Five Below, Inc.

10.25   

Option Cancellation Agreement, dated March 22, 2012, by and between Thomas Vellios and Five Below, Inc.

10.26*   

Lease Agreement, dated April 1, 2007, by and between Twin Spans Business Park, LLC and Five Below, Inc., as amended

23.1   

Consent of KPMG LLP

24.1   

Power of Attorney (included on the signature page of this Registration Statement)

 

* To be filed by amendment.

Item 17. Undertakings.

(a) The undersigned Registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement, certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser.

(b) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

(c) The undersigned Registrant hereby undertakes that:

(1) For the purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.

(2) For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

II-7


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Philadelphia, Pennsylvania, on the 17 th day of April, 2012.

 

FIVE BELOW, INC.
By:  

/s/    David Schlessinger

  Name: David Schlessinger
  Title:    Executive Chairman

POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints David Schlessinger, Thomas Vellios and Kenneth R. Bull and each of them, his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities (including his capacity as a director and/or officer of Five Below, Inc.) to sign any or all amendments (including post-effective amendments) to this registration statement and any and all additional registration statements pursuant to rule 462(b) of the Securities Act of 1933, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as they or he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/    David Schlessinger

David Schlessinger

   Executive Chairman   April 17, 2012

/s/    Thomas Vellios

Thomas Vellios

   President, Chief Executive Officer and Director (Principal Executive Officer)   April 17, 2012

/s/    Kenneth R. Bull

Kenneth R. Bull

   Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)   April 17, 2012

/s/    Steven Collins

Steven Collins

   Director   April 17, 2012

/s/    Andrew Crawford

Andrew Crawford

   Director   April 17, 2012

 

II-8


Table of Contents

Signature

  

Title

 

Date

/s/    David Mussafer

David Mussafer

   Director   April 17, 2012

/s/    Howard Ross

Howard Ross

   Director   April 17, 2012

/s/    Thomas Ryan

Thomas Ryan

   Director   April 17, 2012

/s/    Ronald Sargent

Ronald Sargent

   Director   April 17, 2012

 

II-9


Table of Contents

EXHIBIT INDEX

 

Exhibit
Number

  

Description

  1.1*   

Form of Underwriting Agreement

  3.1   

Amended and Restated Articles of Incorporation of Five Below, Inc., as currently in effect

  3.2   

Second Amended and Restated Certificate of Designations, Preferences, Limitations and Special Rights of the Series A 8% Convertible Preferred Stock of Five Below, Inc., as currently in effect

  3.3   

Second Amended Bylaws of Five Below, Inc., as amended, as currently in effect

  3.4*   

Second Amended and Restated Articles of Incorporation of Five Below, Inc., to be in effect upon the closing of this offering

  3.5*   

Third Amended Bylaws, to be in effect upon the closing of this offering

  4.1*   

Form of Specimen Stock Certificate

  5.1*   

Opinion of Pepper Hamilton LLP

10.1   

Investment Agreement, dated September 1, 2010, by and among Five Below, Inc., the Founders signatory thereto, the Significant Common Shareholders signatory thereto and the Purchasers signatory thereto

10.2   

Amendment No. 1 to the Investment Agreement, dated October 14, 2010, by and among Five Below, Inc., the Purchasers signatory to the Investment Agreement and Sargent Family Investment, LLC

10.3   

Amended and Restated Investor Rights Agreement, dated September 1, 2010, by and among Five Below, Inc., the Significant Common Shareholders signatory thereto, the Series A Preferred Shareholders signatory thereto and the Other Holders party thereto and any other Persons signatory thereto from time to time

10.4   

First Amendment to Amended and Restated Investor Rights Agreement, dated October 14, 2010, by Five Below, Inc.

10.5   

Second Amended and Restated Shareholders Agreement, dated September 1, 2010, by and among Five Below, Inc. and the Shareholders party thereto and any other Persons signatory thereto from time to time

10.6   

First Amendment to Second Amended and Restated Shareholders Agreement, dated October 14, 2010, by Five Below, Inc.

10.7   

Second Amendment to Second Amended and Restated Shareholders Agreement, dated November 22, 2011, by and among Five Below, Inc. and the Consenting Shareholders signatory thereto

10.8   

Five Below, Inc. Equity Incentive Plan

10.9   

Amendment 2010-1 to the Five Below, Inc. Equity Incentive Plan

10.10   

Form of Non-Qualified Stock Option Agreement (Employees)

10.11   

Form of Non-Qualified Stock Option Agreement (Executives)

10.12   

Form of Award Agreement for Restricted Shares under the Five Below, Inc. Equity Incentive Plan

10.13*   

Five Below, Inc. Amended and Restated Equity Incentive Plan

10.14*   

Form of Equity Incentive Award Agreement

10.15*   

Five Below, Inc. Performance Bonus Plan

10.16*   

Form of Director and Officer Indemnification Agreement

10.17   

Letter Employment Agreement, dated October 14, 2010, by and between David Schlessinger and Five Below, Inc.

10.18   

Amendment to Employment Agreement, dated September 28, 2011, by and between David Schlessinger and Five Below, Inc.


Table of Contents

Exhibit
Number

  

Description

10.19   

Letter Employment Agreement, dated October 14, 2010, by and between Thomas Vellios and Five Below, Inc.

10.20   

Amendment to Employment Agreement, dated September 28, 2011, by and between Thomas Vellios and Five Below, Inc.

10.21   

Letter Employment Agreement, dated April 16, 2012, by and between Kenneth R. Bull and Five Below, Inc.

10.22   

Non-Qualified Stock Option Agreement, dated October 14, 2010, by and between David Schlessinger and Five Below, Inc.

10.23   

Non-Qualified Stock Option Agreement, dated October 14, 2010, by and between Thomas Vellios and Five Below, Inc.

10.24   

Option Cancellation Agreement, dated March 22, 2012, by and between David Schlessinger and Five Below, Inc.

10.25   

Option Cancellation Agreement, dated March 22, 2012, by and between Thomas Vellios and Five Below, Inc.

10.26*   

Lease Agreement, dated April 1, 2007, by and between Twin Spans Business Park, LLC and Five Below, Inc., as amended

23.1   

Consent of KPMG LLP

24.1   

Power of Attorney (included on the signature page of this Registration Statement)

 

* To be filed by amendment.

Exhibit 3.1

AMENDED AND RESTATED

ARTICLES OF INCORPORATION

OF

FIVE BELOW, INC.

A Business-stock domestic corporation

(15 Pa.C.S. § 1306)

ARTICLE ONE

The name of the corporation is: Five Below, Inc. (the “ Corporation ”).

ARTICLE TWO

The location and address of this Corporation’s registered office in this Commonwealth of Pennsylvania is: 1616 Walnut Street, Suite 400, Philadelphia, Pennsylvania, 19103 and the county of venue is Philadelphia County.

The corporation is incorporated under the provisions of the Business Corporation Law of 1988, as amended (the “ BCL ”).

ARTICLE THREE

 

A. AUTHORIZED SHARES

The authorized capital stock of the Corporation shall consist of the following: (i) Two Hundred Million shares (200,000,000) of common stock, $.01 par value (the “ Common Stock ”), and (ii) One Hundred Million shares (100,000,000) of undesignated preferred stock, $.01 par value (the “ Preferred Stock ”), the rights and preferences of which may be designated by the Corporation’s Board of Directors (the “ Board of Directors ”).

 

B. COMMON STOCK

 

  B.1 . Dividends, Distributions . Subject to the rights and preferences applicable to the holders of capital stock ranking senior to the Common Stock at any time, if any, the holders of shares of Common Stock shall be entitled to receive such dividends or distributions, payable in cash or otherwise, as may be declared thereon by the Board of Directors from time to time out of assets or funds of the Corporation legally available therefore, provided that the holders of outstanding shares of Common Stock, if any, shall be entitled to share equally, on a per share basis, in such dividends or distributions.

 

  B.2 . Voting Rights . Except as otherwise required by law, the holders of the Common Stock shall be entitled to one vote per share of Common Stock for the election of directors and on all other matters for which a vote of common shareholders is required.

 

C. PREFERRED STOCK

 

  C.1.

Preferred Stock Designation . The Preferred Stock may be issued from time to time in one or more series. The Board of Directors is hereby authorized to provide for the


  issuance of shares of Preferred Stock in series and, by filing a certificate pursuant to the applicable law of the Commonwealth of Pennsylvania (hereinafter referred to as a “ Preferred Stock Designation ”), to establish from time to time the number of shares to be included in each such series, and to fix the designations, powers, preferences, voting rights, privileges, options, conversion rights and other special rights of the shares of each such series and the qualifications, limitations and restrictions thereof. The authority of the Board of Directors with respect to each series shall include, but not be limited to, determination of the following:

 

  (a) the designation of the series, which may be by distinguishing number, letter or title;

 

  (b) the number of shares of the series, which number the Board of Directors may thereafter (except where otherwise provided in the Preferred Stock Designation) increase or decrease (but not below the number of shares thereof then outstanding);

 

  (c) whether dividends, if any, shall be cumulative or noncumulative and the dividend rate of the series;

 

  (d) the dates at which dividends, if any, shall be payable;

 

  (e) the redemption rights and price or prices, if any, for shares of the series;

 

  (f) the terms and amount of any sinking fund provided for the purchase or redemption of shares of the series;

 

  (g) the amounts payable on shares of the series in the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Corporation;

 

  (h) whether the shares of the series shall be convertible into shares of any other class or series, or any other security, of the Corporation or any other corporation, and, if so, the specification of such other class or series or such other security, the conversion price or prices or rate or rates, any adjustments thereof, the date or dates as of which such shares shall be convertible and all other terms and conditions upon which such conversion may be made;

 

  (i) restrictions on the issuance of shares of the same series or of any other class or series; and

 

  (j) the voting rights, if any, of the holders of shares of the series.

Except as may be provided in these Articles of Incorporation or in a Preferred Stock Designation, the Common Stock shall have the exclusive right to vote for the election of directors and for all other purposes.

 

  C.2.

Treatment of Liquidation Preference under Section 1551 of the BCL . Immediately after the filing of these Articles of Incorporation with the Pennsylvania Department of State Corporation Bureau, the Corporation shall file the Second Amended and Restated Certificate of Designations, Preferences, Limitations and Special Rights of the Series A

 

-2-


  8% Convertible Preferred Stock of the Corporation (the “ Series A 8% Preferred Designation ”) with the Pennsylvania Department of State Corporation Bureau pursuant to which the Series A 8% Convertible Preferred Stock shall be designated as a series of Preferred Stock. Notwithstanding the provisions of Section 1551 of the BCL, the liquidation preference of the Series A 8% Preferred Stock shall be excluded as a liability for purposes of Section 1551(b) of the BCL with respect to the Permitted Distribution (as defined in the Series A 8% Preferred Designation).

ARTICLE FOUR

For so long as there are shares of Series A 8% Preferred Stock issued and outstanding, in addition to any affirmative vote required by any Preferred Stock Designation, the affirmative vote of the holders of Common Stock and Preferred Stock (voting together as a single class) holding the Requisite Share Percentage shall be required to authorize any action by the Corporation involving (a) the acquisition of the Corporation by another entity by means of any transaction or series of related transactions (including, without limitation, any reorganization, merger or consolidation) that results in the Corporation’s shareholders immediately prior to such transaction not holding more than fifty percent (50%) of the voting power of the surviving or continuing entity, or (b) a sale, conveyance or disposition of all or substantially all of the assets of the Corporation in any transaction or series of related transactions, unless the Corporation’s shareholders immediately prior to such transaction or transactions will, as a result of such sale, conveyance or disposition hold more than fifty percent (50%) of the voting power of the purchasing entity.

For purposes hereof, “ Requisite Share Percentage ” means an amount equal to (i) until the first anniversary of effective date of these Articles of Incorporation, more than seventy-five percent (75%) of the voting power represented by the then issued and outstanding shares of Common Stock and Preferred Stock, (ii) following the first anniversary of the effective date of these Articles of Incorporation until the second anniversary of the effective date of these Articles of Incorporation, more than seventy percent (70%) of the voting power represented by the then issued and outstanding shares of Common Stock and Preferred Stock, and (iii) for all periods after the second anniversary of the effective date of these Articles of Incorporation, more than fifty percent (50%) of the voting power represented by the then issued and outstanding shares of Common Stock and Preferred Stock. For purposes hereof, the Requisite Share Percentage shall be calculated on an as-converted basis, assuming that all shares of Preferred Stock then issued and outstanding shall have been converted into Common Stock pursuant to the terms of the applicable Preferred Stock Designation.

ARTICLE FIVE

The Corporation shall be entitled to treat the person in whose name any share of its capital stock is registered as the owner thereof for all purposes and shall not be bound to recognize any equitable or other claim to, or interest in, such share on the part of any other person, whether or not the Corporation shall have notice thereof, except as expressly provided by applicable law.

ARTICLE SIX

The Corporation shall have perpetual existence.

 

-3-


ARTICLE SEVEN

To the fullest extent permitted by the BCL, as the same exists or may hereinafter be amended:

 

A.1. A director of this Corporation shall not be liable to the Corporation or its shareholders for monetary damages for breach of fiduciary duty as a director.

 

A.2. The Corporation shall indemnify any director or officer and may indemnify any employee or agent who was or is a party (other than a party plaintiff suing on his or her own behalf) or is threatened to be made a party to, or testifies in, any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative in nature, by reason of the fact that such person is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, employee benefit plan, trust or other enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding to the full extent permitted by law; provided, that no indemnification shall be provided in any case where the act or failure to act giving rise to the claim for indemnification by such person is determined by a court to have constituted willful misconduct or recklessness. The Corporation shall adopt bylaws and may enter into agreements with any such person for the purpose of providing for such indemnification.

 

A.3. The Corporation shall pay expenses incurred by a director or officer and may pay expenses incurred by an employee or agent in defending or testifying in any action, suit or proceeding, whether civil, criminal, administrative or investigative in nature, and such expenses shall be paid by the Corporation in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such director, officer, employee or agent to repay such amount if it shall ultimately be determined that such director, officer, employee or agent is not entitled to be indemnified by the Corporation against such expenses as authorized by this Article Seven, and the Corporation shall adopt bylaws and may enter into agreements with such persons for the purpose of providing for such advances.

 

A.4. The indemnification and advancement of expenses provided by this Article Seven shall not be deemed exclusive of any other rights to which any person may be entitled under any agreement, vote of shareholders or disinterested directors or otherwise, both as to action in such person’s official capacity and as to action in another capacity while holding an office, and shall continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors and administrators of such person. Section 1728 of the BCL, or any successor section, shall be applicable to any provision of these Articles, contract or transaction authorized by the directors under this Section A.4.

 

A.5. The Corporation shall have power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, employee benefit plan, trust or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out of such person’s status as such, whether or not the Corporation would have the power to indemnify such person against such liability under the provisions of this Article Seven or otherwise.

 

-4-


ARTICLE EIGHT

In furtherance and not in limitation of the powers conferred by statute, the Board of Directors is expressly authorized to make, alter, amend or repeal the Bylaws of the Corporation, subject to any affirmative vote that may be required by any Preferred Stock Designation.

ARTICLE NINE

The Corporation reserves the right to amend, alter, change or repeal any provision contained in these Articles of Incorporation in the manner now or hereafter prescribed herein and by the laws of the Commonwealth of Pennsylvania, and all rights conferred upon shareholders herein are granted subject to this reservation.

ARTICLE TEN

The shareholders of the Corporation shall not be entitled to cumulate their votes for the election of directors.

ARTICLE ELEVEN

The Corporation expressly elects not to be governed by Section 2538 (Adoption of Transactions with Interested Shareholders) and the provisions contained in Subchapters E (Control Transactions), G (Control-Share Acquisitions), H (Disgorgement by Certain Controlling Shareholders for Employees Terminated Following Attempts to Acquire Control), I (Severance Compensation for Employees Terminated Following Certain Control-Share Acquisitions) and J (Business Combination Transactions – Labor Contracts) of Chapter 25 of the BCL.

 

-5-

Exhibit 3.2

SECOND AMENDED AND RESTATED

CERTIFICATE OF DESIGNATIONS, PREFERENCES, LIMITATIONS

AND SPECIAL RIGHTS OF

THE SERIES A 8% CONVERTIBLE PREFERRED STOCK

OF

FIVE BELOW, INC.

(THIS “AMENDED AND RESTATED CERTIFICATE”)

Description and Designation of Series A 8% Convertible Preferred Stock.

1. Designation . A total of Ninety Million (90,000,000) shares of the Corporation’s Preferred Stock shall be designated as the “Series A 8% Convertible Preferred Stock.” The Series A 8% Convertible Preferred Stock is referred to herein as the “ Series A Preferred Stock .”

2. Cash Dividends . From and after the date of the issuance of any shares of Series A Preferred Stock, dividends at the rate of 8.0% of the Series A Original Issue Price (as defined below) per share per annum shall accrue on such shares of Series A Preferred Stock (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Series A Preferred Stock) (the “ Accruing Dividends ”). Accruing Dividends shall accrue from day to day, whether or not declared, shall be cumulative, shall compound on an annual basis and shall be paid in cash; provided however, that except as set forth in the following sentence of this Section 2 or Section 3.1 , such Accruing Dividends shall be payable only when, as, and if declared by Supermajority Board Approval and the Corporation shall be under no obligation to pay such Accruing Dividends. The Corporation shall not declare, pay or set aside any dividends on shares of any other class or series of capital stock of the Corporation (other than dividends on shares of Common Stock payable in shares of Common Stock) unless (in addition to obtaining any consents required elsewhere in the Articles of Incorporation) the holders of a majority of the Series A Preferred Stock then outstanding consent to the payment by the Corporation of such dividend(s); provided, however , no such consent shall be required with respect to any cash dividend declared, paid or set aside by the Corporation on shares of Common Stock to the extent (a) the aggregate amount of such cash dividend does not exceed the amount permitted under the Investment Agreement, dated September 1, 2010, by and among the Company, the Purchasers (as defined therein) and the other parties listed therein (the “ Investment Agreement ”), and (b) such dividend is paid within sixty (60) days after the effective date of this Certificate of Designations (the “ Permitted Dividend ”). In the event that holders of a majority of the Series A Preferred Stock then outstanding consent to such dividend(s), the holders of Series A Preferred Stock shall simultaneously receive a dividend on each outstanding share of Series A Preferred Stock in an amount at least equal to that dividend per share of Series A Preferred Stock as would equal the product of ( x ) the dividend payable on each share of such class or series determined, if applicable, as if all shares of such class or series had been converted into Common Stock and ( y ) the number of shares of Common Stock issuable upon conversion of a share of Series A Preferred Stock, in each case calculated on the record date for determination of holders entitled to receive such dividend; provided that, if the Corporation declares, pays or sets aside, on the same date, a dividend on shares of more than one class or series of capital stock of the Corporation, the dividend payable to the holders of Series A Preferred Stock pursuant to this Section 2 shall be calculated based upon the dividend on the class or series of capital stock that would result in the highest Series A Preferred Stock dividend. Notwithstanding anything to the contrary, holders of Series A Preferred Stock shall not be entitled to any dividend distribution upon the declaration or payment of the Permitted Dividend. The “ Series A Original Issue Price ” shall mean the per share price paid by the Purchasers for a share of Series A Preferred Stock pursuant to the terms of the Investment Agreement. The Series A Original Issue Price shall be subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Series A Preferred


Stock. As used herein “ Supermajority Board Approval ” means, if there are seven (7) members of the Corporation’s Board of Directors, the approval of five (5) of the seven (7) members of the Board of Directors, and if there are more or less than seven (7) members of the Corporation’s Board of Directors, the approval of that number of members representing at least two-thirds (rounded up to the nearest whole number) of the members of the Board of Directors.

3. Liquidation, Dissolution or Winding Up; Certain Mergers, Consolidations and Asset Sales .

3.1 Payments to Holders of Series A Preferred Stock . In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, the holders of shares of Series A Preferred Stock then outstanding shall be entitled to be paid out of the assets of the Corporation available for distribution to its shareholders before any payment shall be made to the holders of Common Stock by reason of their ownership thereof, an amount per share equal to the greater of (i) the Series A Original Issue Price, plus any dividends accrued but unpaid thereon, or (ii) such amount per share as would have been payable had all shares of Series A Preferred Stock been converted into Common Stock pursuant to Section 5 immediately prior to such liquidation, dissolution or winding up (the amount payable pursuant to this sentence is hereinafter referred to as the “ Series A Liquidation Amount ”). If upon any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, the assets of the Corporation available for distribution to its shareholders shall be insufficient to pay the holders of shares of Series A Preferred Stock the full amount to which they shall be entitled under this Section 3.1 , the holders of shares of Series A Preferred Stock shall share ratably in any distribution of the assets available for distribution in proportion to the respective amounts which would otherwise be payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid in full.

3.2 Payments to Holders of Common Stock . In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, after the payment of all preferential amounts required to be paid to the holders of shares of Series A Preferred Stock, the remaining assets of the Corporation available for distribution to its shareholders shall be distributed among the holders of shares of Common Stock, pro rata based on the number of shares held by each such holder.

3.3 Deemed Liquidation Events .

3.3.1 Definition . Each of the following events shall be considered a “ Deemed Liquidation Event ” unless the holders of at least a majority of the outstanding shares of Series A Preferred Stock elect otherwise by written notice sent to the Corporation at least ten (10) days prior to the effective date of any such event:

(a) an acquisition of the Corporation by an unaffiliated entity by means of any transaction or series of related transactions (including, without limitation, any reorganization, merger or consolidation), or the effectuation by the Corporation or its shareholders of a transaction or series of transactions, in each case, that results in the Corporation’s shareholders immediately prior to such transaction not holding at least fifty percent (50%) of the voting power of the surviving or continuing entity or the Corporation by reason of such transaction or series of related transactions, as applicable, except any such sale, merger or consolidation involving the Corporation in which the shares of capital stock of the Corporation outstanding immediately prior to such merger or consolidation continue to represent, or are converted into or exchanged for shares of capital stock that represent, immediately following such merger or consolidation, at least a majority, by voting power, of the capital stock of (1) the surviving or resulting corporation or (2) if the surviving or resulting corporation is a wholly owned subsidiary of another corporation immediately following such merger or

 

2


consolidation, the parent corporation of such surviving or resulting corporation ( provided that , for the purpose of this Section 3.3.1 , all shares of Common Stock issuable upon exercise of Options (as defined below) outstanding immediately prior to such merger or consolidation or upon conversion of Convertible Securities (as defined below) outstanding immediately prior to such merger or consolidation shall be deemed to be outstanding immediately prior to such merger or consolidation and, if applicable, converted or exchanged in such merger or consolidation on the same terms as the actual outstanding shares of Common Stock are converted or exchanged); or

(b) the sale, transfer, or other disposition, in a single transaction or series of related transactions, by the Corporation of all or substantially all the assets of the Corporation.

3.3.2 Effecting a Deemed Liquidation Event .

(a) The Corporation shall not have the power to effect a Deemed Liquidation Event referred to in Section 3.3.1(a) unless the agreement or plan of merger or consolidation for such transaction (the “ Merger Agreement ”) provides that the consideration payable to the shareholders of the Corporation shall be allocated among the holders of capital stock of the Corporation in accordance with Section 3.1 and 3.2 .

(b) In the event of a Deemed Liquidation Event referred to in Section 3.3.1(b) if the Corporation does not effect a dissolution of the Corporation under the Pennsylvania Business Corporation Law of 1988, as amended (“ PBCL ”) within 90 days after such Deemed Liquidation Event, then (i) the Corporation shall send a written notice to each holder of Series A Preferred Stock no later than the 90th day after the Deemed Liquidation Event advising such holders of their right (and the requirements to be met to secure such right) pursuant to the terms of the following clause (ii)  to require the redemption of such shares of Series A Preferred Stock, and (ii) if the holders of at least a majority of the then outstanding shares of Series A Preferred Stock so request in a written instrument delivered to the Corporation not later than 120 days after such Deemed Liquidation Event, the Corporation shall use the consideration received by the Corporation for such Deemed Liquidation Event (net of any retained liabilities associated with the assets sold , as determined in good faith by the Board of Directors of the Corporation), together with any other assets of the Corporation available for distribution to its shareholders (the “ Available Proceeds ”), to the extent legally available therefor, no later than the 150th day after such Deemed Liquidation Event, to redeem all outstanding shares of Series A Preferred Stock at a price per share equal to the Series A Liquidation Amount. Notwithstanding the foregoing, in the event of a redemption pursuant to the preceding sentence, if the Available Proceeds are not sufficient to redeem all outstanding shares of Series A Preferred Stock, the Corporation shall redeem a pro rata portion of each holder’s shares of Series A Preferred Stock to the fullest extent of such Available Proceeds, based on the respective amounts which would otherwise be payable in respect of the shares to be redeemed if the Available Proceeds were sufficient to redeem all such shares, and shall redeem the remaining shares to have been redeemed as soon as practicable after the Corporation has funds legally available therefor. Prior to the distribution or redemption provided for in this Section 3.3.2(b) , the Corporation shall not expend or dissipate the consideration received for such Deemed Liquidation Event, except to discharge expenses incurred in connection with such Deemed Liquidation Event or in the ordinary course of business.

3.3.3 Amount Deemed Paid or Distributed . The amount deemed paid or distributed to the holders of capital stock of the Corporation upon any such Deemed Liquidation Event shall be the cash or the value of the property, rights or securities paid or distributed to such holders by the Corporation or the acquiring person or entity. The value of such property, rights or securities shall be determined in good faith by the Board of Directors of the Corporation.

 

3


3.4 Treatment of Series A Liquidation Amount under Section 1551 of the PBCL. Notwithstanding the provisions of Section 1551 of the PBCL, the Series A Liquidation Amount shall be excluded as a liability for purposes of Section 1551(b) with respect to the Permitted Distribution.

4. Voting .

4.1 General . On any matter presented to the shareholders of the Corporation for their action or consideration at any meeting of shareholders of the Corporation (or by written consent of shareholders in lieu of meeting), each holder of outstanding shares of Series A Preferred Stock shall be entitled to cast the number of votes equal to the number of whole shares of Common Stock into which the shares of Series A Preferred Stock held by such holder are convertible as of the record date for determining shareholders entitled to vote on such matter. Except as provided by law or Section 4.1 , or as expressly set forth in any other provisions of the Articles of Incorporation, holders of Series A Preferred Stock shall vote together with the holders of Common Stock as a single class.

4.2 Election of Directors . For so long as shares of Series A Preferred Stock are outstanding, the holders of record of the shares of Series A Preferred Stock, exclusively and as a separate class, shall be entitled to elect four (4) directors of the Corporation (the “ Series A Directors ”); provided that if the size of the Corporation’s Board of Directors is not fixed at seven (7), then the holders of record of the shares of Series A Preferred Stock, exclusively and as a separate class, shall be entitled to elect the lowest number of directors that would constitute a majority of the members of the Corporation’s Board of Directors. Any director elected as provided in the preceding sentence may be removed without assigning any cause by, and only by, the affirmative vote of the holders of the shares of Series A Preferred Stock entitled to elect such director or directors, given either at a special meeting of such shareholders duly called for that purpose or pursuant to a written consent of such shareholders. If the holders of shares of Series A Preferred Stock fail to elect a sufficient number of directors to fill all directorships for which they are entitled to elect directors, voting exclusively and as a separate class, pursuant to the first sentence of this Section 4.2 , then any directorship not so filled shall remain vacant until such time as the holders of the Series A Preferred Stock elect a person to fill such directorship by vote or written consent in lieu of a meeting; and no such directorship may be filled by shareholders of the Corporation other than by the holders of the shares of Series A Preferred Stock. At any meeting held for the purpose of electing a Series A Director, the presence in person or by proxy of the holders of a majority of the outstanding shares of the Series A Preferred Stock shall constitute a quorum for the purpose of electing such director. Except as otherwise provided in this Section 4.2 , a vacancy in any directorship filled by the holders of shares of Series A Preferred shall be filled only by vote or written consent in lieu of a meeting of such holders or directors elected by the holders of shares of Series A Preferred pursuant to this Section 4.2 .

4.3 Series A Preferred Stock Protective Provisions . At any time when shares of Series A Preferred Stock are outstanding, the Corporation shall not, either directly or indirectly by amendment, merger, consolidation or otherwise, do any of the following without (in addition to any other vote required by law or the Articles of Incorporation) the written consent or affirmative vote of the holders of at least a majority of the then outstanding shares of Series A Preferred Stock, given in writing or by vote at a meeting, consenting or voting (as the case may be) separately as a class:

4.3.1 amend, change, alter, repeal or modify (i) the designations, powers, preferences, rights or qualifications, limitations or restrictions of the Series A Preferred Stock (including, but not limited to, by recapitalization, merger, consolidation or otherwise) or (ii) any provision of the Articles of Incorporation or Bylaws of the Corporation in a manner that adversely affects the powers, preferences or rights of the Series A Preferred Stock;

 

4


4.3.2 authorize or issue (a) any class or series of capital stock of the Corporation or (b) any bonds, debentures, notes or other obligations convertible into or exchangeable for, or having optional rights to purchase, capital stock of the Corporation, in the case of (a) or (b), ranking, either as to payment of dividends or distribution of assets under Section 3 , senior to or on parity with the Series A Preferred Stock;

4.3.3 incur, create, suffer to exist, issue, assume, guarantee or otherwise become directly liable, contingent or otherwise with respect to indebtedness for borrowed money of more than Ten Million Dollars ($10,000,000), individually;

4.3.4 consummate, enter into, or be party to, any transaction with a value of greater than Ten Million Dollars ($10,000,000) involving (i) the acquisition of another person, entity or asset by the Corporation using the Corporation’s cash or capital stock as consideration, or (ii) the disposition of the Corporation’s assets;

4.3.5 change, alter, repeal or modify the Corporation’s equity incentive plan or the adoption of new equity-based compensation arrangements;

4.3.6 redeem, repurchase or acquire the Corporation’s capital stock or other securities of the Corporation, except for repurchases or other acquisitions of shares of Common Stock of the Corporation from employees, consultants or directors of the Corporation upon such the termination of such person’s employment or services with the Corporation pursuant to the terms and conditions of agreements approved by the Board of Directors which provide the Corporation the right to repurchase such shares upon termination of employment or services; or

4.3.7 make any decision affecting the appointment or removal of senior officers of the Corporation.

5. Optional Conversion .

The holders of the Series A Preferred Stock shall have conversion rights as follows (the “ Conversion Rights ”):

5.1 Right to Convert .

5.1.1 Conversion Ratio . Each share of Series A Preferred Stock shall be convertible, at the option of the holder thereof, at any time and from time to time, and without the payment of additional consideration by the holder thereof, into such number of fully paid and nonassessable shares of Common Stock as is determined by dividing the Series A Original Issue Price by the Series A Conversion Price (as defined below) in effect at the time of conversion. The Series A Conversion Price shall initially be equal to the Series A Original Issue Price. Such initial Series A Conversion Price, and the rate at which shares of Series A Preferred Stock may be converted into shares of Common Stock, shall be subject to adjustment as provided below.

5.1.2 Termination of Conversion Rights . In the event of a liquidation, dissolution or winding up of the Corporation or a Deemed Liquidation Event, the Conversion Rights shall terminate at the close of business on the last full day preceding the date fixed for the payment of any such amounts distributable on such event to the holders of Series A Preferred Stock.

5.2 Cash in Lieu of Fractional Shares . No fractional shares of Common Stock shall be issued upon conversion of the Series A Preferred Stock. In lieu of any fractional shares to which the holder would otherwise be entitled, the Corporation shall pay cash equal to such fraction multiplied by the

 

5


fair market value of a share of Common Stock as determined in good faith by the Board of Directors of the Corporation. Whether or not fractional shares would be issuable upon such conversion shall be determined on the basis of the total number of shares of Series A Preferred Stock the holder is at the time converting into Common Stock and the aggregate number of shares of Common Stock issuable upon such conversion.

5.3 Mechanics of Conversion .

5.3.1 Notice of Conversion . In order for a holder of Series A Preferred Stock to voluntarily convert shares of Series A Preferred Stock into shares of Common Stock, such holder shall surrender the certificate or certificates for such shares of Series A Preferred Stock (or, if such registered holder alleges that such certificate has been lost, stolen or destroyed, a lost certificate affidavit and agreement reasonably acceptable to the Corporation to indemnify the Corporation against any claim that may be made against the Corporation on account of the alleged loss, theft or destruction of such certificate), at the office of the transfer agent for the Series A Preferred Stock (or at the principal office of the Corporation if the Corporation serves as its own transfer agent), together with written notice that such holder elects to convert all or any number of the shares of the Series A Preferred Stock represented by such certificate or certificates and, if applicable, any event on which such conversion is contingent. Such notice shall state such holder’s name or the names of the nominees in which such holder wishes the certificate or certificates for shares of Common Stock to be issued. If required by the Corporation, certificates surrendered for conversion shall be endorsed or accompanied by a written instrument or instruments of transfer, in form satisfactory to the Corporation, duly executed by the registered holder or his, her or its attorney duly authorized in writing. The close of business on the date of receipt by the transfer agent (or by the Corporation if the Corporation serves as its own transfer agent) of such certificates (or lost certificate affidavit and agreement) and notice shall be the time of conversion (the “ Conversion Time ”), and the shares of Common Stock issuable upon conversion of the shares represented by such certificate shall be deemed to be outstanding of record as of such date. The Corporation shall, as soon as practicable after the Conversion Time, (i) issue and deliver to such holder of Series A Preferred Stock, or to his, her or its nominees, a certificate or certificates for the number of full shares of Common Stock issuable upon such conversion in accordance with the provisions hereof and a certificate for the number (if any) of the shares of Series A Preferred Stock represented by the surrendered certificate that were not converted into Common Stock, and (ii) pay in cash such amount as provided in Section 5.2 in lieu of any fraction of a share of Common Stock otherwise issuable upon such conversion.

5.3.2 Reservation of Shares . The Corporation shall at all times when the Series A Preferred Stock shall be outstanding, reserve and keep available out of its authorized but unissued capital stock, for the purpose of effecting the conversion of the Series A Preferred Stock, such number of its duly authorized shares of Common Stock as shall from time to time be sufficient to effect the conversion of all outstanding Series A Preferred Stock; and if at any time the number of authorized but unissued shares of Common Stock shall not be sufficient to effect the conversion of all then outstanding shares of the Series A Preferred Stock, the Corporation shall take such corporate action as may be necessary to increase its authorized but unissued shares of Common Stock to such number of shares as shall be sufficient for such purposes, including, without limitation, engaging in best efforts to obtain the requisite shareholder approval of any necessary amendment to the Articles of Incorporation. Before taking any action which would cause an adjustment reducing the Series A Conversion Price below the then par value of the shares of Common Stock issuable upon conversion of the Series A Preferred Stock, the Corporation will take any corporate action which may, in the opinion of its counsel, be necessary in order that the Corporation may validly and legally issue fully paid and nonassessable shares of Common Stock at such adjusted Series A Conversion Price.

 

6


5.3.3 Effect of Conversion . All shares of Series A Preferred Stock which shall have been surrendered for conversion as herein provided shall no longer be deemed to be outstanding and shall not be entitled to the payment of any dividends that have accrued on such shares through the Conversion Time and remain unpaid, and all rights with respect to such shares shall immediately cease and terminate at the Conversion Time, except only the right of the holders thereof to receive shares of Common Stock in exchange therefor, and to receive payment in lieu of any fraction of a share otherwise issuable upon such conversion as provided in Section 5.2 . Any shares of Series A Preferred Stock so converted shall be retired and cancelled and may not be reissued as shares of such series, and the Corporation may thereafter take such appropriate action (without the need for shareholder action) as may be necessary to reduce the authorized number of shares of Series A Preferred Stock accordingly.

5.3.4 No Further Adjustment . Upon any such conversion, no adjustment to the Series A Conversion Price shall be made for any accrued but unpaid Accruing Dividends on the Series A Preferred Stock surrendered for conversion or on the Common Stock delivered upon conversion.

5.3.5 Taxes . The Corporation shall pay any and all issue and other similar taxes that may be payable in respect of any issuance or delivery of shares of Common Stock upon conversion of shares of Series A Preferred Stock pursuant to this Section 5 . The Corporation shall not, however, be required to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery of shares of Common Stock in a name other than that in which the shares of Series A Preferred Stock so converted were registered, and no such issuance or delivery shall be made unless and until the person or entity requesting such issuance has paid to the Corporation the amount of any such tax or has established, to the satisfaction of the Corporation, that such tax has been paid.

5.4 Adjustments to Series A Conversion Price for Diluting Issues .

5.4.1 Special Definitions . For purposes of this Section 5 , the following definitions shall apply:

(a) “ Option ” shall mean rights, options or warrants to subscribe for, purchase or otherwise acquire Common Stock or Convertible Securities.

(b) “ Series A Original Issue Date ” shall mean the date on which the first share of Series A Preferred Stock was issued.

(c) “ Convertible Securities ” shall mean any evidences of indebtedness, shares or other securities directly or indirectly convertible into or exchangeable for Common Stock, but excluding Options.

(d) “ Additional Shares of Common Stock ” shall mean all shares of Common Stock issued (or, pursuant to Section 5.4.3 , deemed to be issued) by the Corporation after the Series A Original Issue Date, other than (1) the following shares of Common Stock and (2) shares of Common Stock deemed issued pursuant to the following Options and Convertible Securities (clauses (1) and (2), collectively, “ Exempted Securities ”):

 

  (i) shares of Common Stock, Options or Convertible Securities issued as a dividend or distribution on Series A Preferred Stock;

 

  (ii) shares of Common Stock, Options or Convertible Securities issued by reason of a dividend, stock split, split-up or other distribution on shares of Common Stock that is covered by Section 5.5 , 5.6 , 5.7 or 5.8 ;

 

7


  (iii) shares of Common Stock or Options issued to employees or directors of, or consultants or advisors to, the Corporation pursuant to a plan, agreement or arrangement approved by the Board of Directors of the Corporation;

 

  (iv) shares of Common Stock or Convertible Securities actually issued upon the exercise of Options or shares of Common Stock actually issued upon the conversion or exchange of Convertible Securities, in each case provided such issuance is pursuant to the terms of such Option or Convertible Security;

 

  (v) shares of Common Stock, Options or Convertible Securities issued to suppliers or third party service providers in connection with the provision of goods or services pursuant to transactions approved by the Board of Directors of the Corporation;

 

  (vi) shares of Common Stock, Options or Convertible Securities issued pursuant to the acquisition of another corporation by the Corporation by merger, purchase of substantially all of the assets or other reorganization or to a joint venture agreement, provided, that such issuances are approved by the Board of Directors of the Corporation;

 

  (vii) shares of Common Stock, Options or Convertible Securities issued to banks or other financial institutions, pursuant to a debt financing approved with Supermajority Board Approval; or

 

  (viii) shares of Common Stock, Options or Convertible Securities issued pursuant to the acquisition of another corporation by the Corporation by merger, purchase of substantially all of the assets or other reorganization or to a joint venture agreement, provided, that such issuances are approved by the Board of Directors of the Corporation.

5.4.2 No Adjustment of Series A Conversion Price . No adjustment in the Series A Conversion Price shall be made as the result of the issuance or deemed issuance of Additional Shares of Common Stock if the Corporation receives written notice from the holders of at least a majority of the then outstanding shares of Series A Preferred Stock agreeing that no such adjustment shall be made as the result of the issuance or deemed issuance of such Additional Shares of Common Stock.

 

8


5.4.3 Deemed Issue of Additional Shares of Common Stock .

(a) If the Corporation at any time or from time to time after the Series A Original Issue Date shall issue any Options or Convertible Securities (excluding Options or Convertible Securities which are themselves Exempted Securities) or shall fix a record date for the determination of holders of any class of securities entitled to receive any such Options or Convertible Securities, then the maximum number of shares of Common Stock (as set forth in the instrument relating thereto, assuming the satisfaction of any conditions to exercisability, convertibility or exchangeability but without regard to any provision contained therein for a subsequent adjustment of such number) issuable upon the exercise of such Options or, in the case of Convertible Securities and Options therefor, the conversion or exchange of such Convertible Securities, shall be deemed to be Additional Shares of Common Stock issued as of the time of such issue or, in case such a record date shall have been fixed, as of the close of business on such record date.

(b) If the terms of any Option or Convertible Security, the issuance of which resulted in an adjustment to the Series A Conversion Price pursuant to the terms of Section 5.4.4 , are revised as a result of an amendment to such terms or any other adjustment pursuant to the provisions of such Option or Convertible Security (but excluding automatic adjustments to such terms pursuant to anti-dilution or similar provisions of such Option or Convertible Security) to provide for either (1) any increase or decrease in the number of shares of Common Stock issuable upon the exercise, conversion and/or exchange of any such Option or Convertible Security or (2) any increase or decrease in the consideration payable to the Corporation upon such exercise, conversion and/or exchange, then, effective upon such increase or decrease becoming effective, the Series A Conversion Price computed upon the original issue of such Option or Convertible Security (or upon the occurrence of a record date with respect thereto) shall be readjusted to such Series A Conversion Price as would have obtained had such revised terms been in effect upon the original date of issuance of such Option or Convertible Security. Notwithstanding the foregoing, no readjustment pursuant to this clause (b)  shall have the effect of increasing the Series A Conversion Price to an amount which exceeds the lower of (i) the Series A Conversion Price in effect immediately prior to the original adjustment made as a result of the issuance of such Option or Convertible Security, or (ii) the Series A Conversion Price that would have resulted from any issuances of Additional Shares of Common Stock (other than deemed issuances of Additional Shares of Common Stock as a result of the issuance of such Option or Convertible Security) between the original adjustment date and such readjustment date.

(c) If the terms of any Option or Convertible Security (excluding Options or Convertible Securities which are themselves Exempted Securities), the issuance of which did not result in an adjustment to the Series A Conversion Price pursuant to the terms of Section 5.4.4 (either because the consideration per share (determined pursuant to Section 5.4.5 ) of the Additional Shares of Common Stock subject thereto was equal to or greater than the Series A Conversion Price then in effect, or because such Option or Convertible Security was issued before the Series A Original Issue Date), are revised after the Series A Original Issue Date as a result of an amendment to such terms or any other adjustment pursuant to the provisions of such Option or Convertible Security (but excluding automatic adjustments to such terms pursuant to anti-dilution or similar provisions of such Option or Convertible Security) to provide for either (1) any increase in the number of shares of Common Stock issuable upon the exercise, conversion or exchange of any such Option or Convertible Security or (2) any decrease in the consideration payable to the Corporation upon such exercise, conversion or exchange, then such Option or Convertible Security, as so amended or adjusted, and the Additional Shares of Common Stock subject thereto (determined in the manner provided in Section 5.4.3(a) shall be deemed to have been issued effective upon such increase or decrease becoming effective.

(d) Upon the expiration or termination of any unexercised Option or unconverted or unexchanged Convertible Security (or portion thereof) which resulted (either upon its original issuance or upon a revision of its terms) in an adjustment to the Series A Conversion Price

 

9


pursuant to the terms of Section 5.4.4 , the Series A Conversion Price shall be readjusted to such Series A Conversion Price as would have obtained had such Option or Convertible Security (or portion thereof) never been issued.

(e) If the number of shares of Common Stock issuable upon the exercise, conversion and/or exchange of any Option or Convertible Security, or the consideration payable to the Corporation upon such exercise, conversion and/or exchange, is calculable at the time such Option or Convertible Security is issued or amended but is subject to adjustment based upon subsequent events, any adjustment to the Series A Conversion Price provided for in this Section 5.4.3 shall be effected at the time of such issuance or amendment based on such number of shares or amount of consideration without regard to any provisions for subsequent adjustments (and any subsequent adjustments shall be treated as provided in clauses (b) and (c) of this Section 5.4.3 ). If the number of shares of Common Stock issuable upon the exercise, conversion and/or exchange of any Option or Convertible Security, or the consideration payable to the Corporation upon such exercise, conversion and/or exchange, cannot be calculated at all at the time such Option or Convertible Security is issued or amended, any adjustment to the Series A Conversion Price that would result under the terms of this Section 5.4.3 at the time of such issuance or amendment shall instead be effected at the time such number of shares and/or amount of consideration is first calculable (even if subject to subsequent adjustments), assuming for purposes of calculating such adjustment to the Series A Conversion Price that such issuance or amendment took place at the time such calculation can first be made.

5.4.4 Adjustment of Series A Conversion Price Upon Issuance of Additional Shares of Common Stock . In the event the Corporation shall at any time after the Series A Original Issue Date issue Additional Shares of Common Stock (including Additional Shares of Common Stock deemed to be issued pursuant to Section 5.4.3 ), without consideration or for a consideration per share less than the Series A Conversion Price in effect immediately prior to such issue, then the Series A Conversion Price shall be reduced, concurrently with such issue, to a price (calculated to the nearest one-hundredth of a cent) determined in accordance with the following formula:

CP 2 = CP 1 * (A + B) ÷ (A + C).

For purposes of the foregoing formula, the following definitions shall apply:

(a) “CP 2 ” shall mean the Series A Conversion Price in effect immediately after such issue of Additional Shares of Common Stock

(b) “CP 1 ” shall mean the Series A Conversion Price in effect immediately prior to such issue of Additional Shares of Common Stock;

(c) “A” shall mean the number of shares of Common Stock outstanding immediately prior to such issue of Additional Shares of Common Stock (treating for this purpose as outstanding all shares of Common Stock issuable upon exercise of Options outstanding immediately prior to such issue or upon conversion or exchange of Convertible Securities (including the Series A Preferred Stock) outstanding (assuming exercise of any outstanding Options therefor) immediately prior to such issue);

(d) “B” shall mean the number of shares of Common Stock that would have been issued if such Additional Shares of Common Stock had been issued at a price per share equal to CP 1 (determined by dividing the aggregate consideration received by the Corporation in respect of such issue by CP 1 ); and

 

10


(e) “C” shall mean the number of such Additional Shares of Common Stock issued in such transaction.

5.4.5 Determination of Consideration . For purposes of this Section 5.4 , the consideration received by the Corporation for the issue of any Additional Shares of Common Stock shall be computed as follows:

(a) Cash and Property : Such consideration shall:

 

  (i) insofar as it consists of cash, be computed at the aggregate amount of cash received by the Corporation, excluding amounts paid or payable for accrued interest;

 

  (ii) insofar as it consists of property other than cash, be computed at the fair market value thereof at the time of such issue, as determined in good faith by the Board of Directors of the Corporation; and

 

  (iii) in the event Additional Shares of Common Stock are issued together with other shares or securities or other assets of the Corporation for consideration which covers both, be the proportion of such consideration so received, computed as provided in clauses (i)  and (ii)  above, as determined in good faith by the Board of Directors of the Corporation.

(b) Options and Convertible Securities . The consideration per share received by the Corporation for Additional Shares of Common Stock deemed to have been issued pursuant to Section 5.4.3 , relating to Options and Convertible Securities, shall be determined by dividing:

 

  (i) the total amount, if any, received or receivable by the Corporation as consideration for the issue of such Options or Convertible Securities, plus the minimum aggregate amount of additional consideration (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such consideration) payable to the Corporation upon the exercise of such Options or the conversion or exchange of such Convertible Securities, or in the case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities, by

 

  (ii) the maximum number of shares of Common Stock (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such number) issuable upon the exercise of such Options or the conversion or exchange of such Convertible Securities, or in the case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities.

 

11


5.4.6 Multiple Closing Dates . In the event the Corporation shall issue on more than one date Additional Shares of Common Stock that are a part of one transaction or a series of related transactions and that would result in an adjustment to the Series A Conversion Price pursuant to the terms of Section 5.4.4 , then, upon the final such issuance, the Series A Conversion Price shall be readjusted to give effect to all such issuances as if they occurred on the date of the first such issuance (and without giving effect to any additional adjustments as a result of any such subsequent issuances within such period).

5.5 Adjustment for Stock Splits and Combinations . If the Corporation shall at any time or from time to time after the Series A Original Issue Date effect a subdivision of the outstanding Common Stock, the Series A Conversion Price in effect immediately before that subdivision shall be proportionately decreased so that the number of shares of Common Stock issuable on conversion of each share of such series shall be increased in proportion to such increase in the aggregate number of shares of Common Stock outstanding. If the Corporation shall at any time or from time to time after the Series A Original Issue Date combine the outstanding shares of Common Stock, the Series A Conversion Price in effect immediately before the combination shall be proportionately increased so that the number of shares of Common Stock issuable on conversion of each share of such series shall be decreased in proportion to such decrease in the aggregate number of shares of Common Stock outstanding. Any adjustment under this Section shall become effective at the close of business on the date the subdivision or combination becomes effective.

5.6 Adjustment for Certain Dividends and Distributions . In the event the Corporation at any time or from time to time after the Series A Original Issue Date shall make or issue, or fix a record date for the determination of holders of Common Stock entitled to receive, a dividend or other distribution payable on the Common Stock in additional shares of Common Stock, then and in each such event the Series A Conversion Price in effect immediately before such event shall be decreased as of the time of such issuance or, in the event such a record date shall have been fixed, as of the close of business on such record date, by multiplying the Series A Conversion Price then in effect by a fraction:

(1) the numerator of which shall be the total number of shares of Common Stock issued and outstanding immediately prior to the time of such issuance or the close of business on such record date, and

(2) the denominator of which shall be the total number of shares of Common Stock issued and outstanding immediately prior to the time of such issuance or the close of business on such record date plus the number of shares of Common Stock issuable in payment of such dividend or distribution.

Notwithstanding the foregoing, (a) if such record date shall have been fixed and such dividend is not fully paid or if such distribution is not fully made on the date fixed therefor, the Series A Conversion Price shall be recomputed accordingly as of the close of business on such record date and thereafter the Series A Conversion Price shall be adjusted pursuant to this Section as of the time of actual payment of such dividends or distributions; and (b) that no such adjustment shall be made if the holders of Series A Preferred Stock simultaneously receive a dividend or other distribution of shares of Common Stock in a number equal to the number of shares of Common Stock as they would have received if all outstanding shares of Series A Preferred Stock had been converted into Common Stock on the date of such event.

 

12


5.7 Adjustments for Other Dividends and Distributions . In the event the Corporation at any time or from time to time after the Series A Original Issue Date shall make or issue, or fix a record date for the determination of holders of Common Stock entitled to receive, a dividend or other distribution payable in securities of the Corporation (other than a distribution of shares of Common Stock in respect of outstanding shares of Common Stock) or in other property and the provisions of Section 2 do not apply to such dividend or distribution, then and in each such event the holders of Series A Preferred Stock shall receive, simultaneously with the distribution to the holders of Common Stock, a dividend or other distribution of such securities or other property in an amount equal to the amount of such securities or other property as they would have received if all outstanding shares of Series A Preferred Stock had been converted into Common Stock on the date of such event.

5.8 Adjustment for Merger or Reorganization, etc . Subject to the provisions of Section 3.3 , if there shall occur any reorganization, recapitalization, reclassification, consolidation or merger involving the Corporation in which the Common Stock (but not the Series A Preferred Stock) is converted into or exchanged for securities, cash or other property (other than a transaction covered by Sections 5.4 , 5.6 or 5.7 ), then, following any such reorganization, recapitalization, reclassification, consolidation or merger, each share of Series A Preferred Stock shall thereafter be convertible in lieu of the Common Stock into which it was convertible prior to such event into the kind and amount of securities, cash or other property which a holder of the number of shares of Common Stock of the Corporation issuable upon conversion of one share of Series A Preferred Stock immediately prior to such reorganization, recapitalization, reclassification, consolidation or merger would have been entitled to receive pursuant to such transaction; and, in such case, appropriate adjustment (as determined in good faith by the Board of Directors of the Corporation) shall be made in the application of the provisions in this Section 5 with respect to the rights and interests thereafter of the holders of the Series A Preferred Stock, to the end that the provisions set forth in this Section 5 (including provisions with respect to changes in and other adjustments of the Series A Conversion Price) shall thereafter be applicable, as nearly as reasonably may be, in relation to any securities or other property thereafter deliverable upon the conversion of the Series A Preferred Stock.

5.9 Certificate as to Adjustments . Upon the occurrence of each adjustment or readjustment of the Series A Conversion Price pursuant to this Section 5 , the Corporation at its expense shall, as promptly as reasonably practicable but in any event not later than 10 days thereafter, compute such adjustment or readjustment in accordance with the terms hereof and furnish to each holder of Series A Preferred Stock a certificate setting forth such adjustment or readjustment (including the kind and amount of securities, cash or other property into which the Series A Preferred Stock is convertible) and showing in detail the facts upon which such adjustment or readjustment is based. The Corporation shall, as promptly as reasonably practicable after the written request at any time of any holder of Series A Preferred Stock (but in any event not later than 10 days thereafter), furnish or cause to be furnished to such holder a certificate setting forth (i) the Series A Conversion Price then in effect, and (ii) the number of shares of Common Stock and the amount, if any, of other securities, cash or property which then would be received upon the conversion of Series A Preferred Stock.

5.10 Notice of Record Date . In the event:

(a) the Corporation shall take a record of the holders of its Common Stock (or other capital stock or securities at the time issuable upon conversion of the Series A Preferred Stock) for the purpose of entitling or enabling them to receive any dividend or other distribution, or to receive any right to subscribe for or purchase any shares of capital stock of any class or any other securities, or to receive any other security; or

 

13


(b) of any capital reorganization of the Corporation, any reclassification of the Common Stock of the Corporation, or any Deemed Liquidation Event; or

(c) of the voluntary or involuntary dissolution, liquidation or winding-up of the Corporation,

then, and in each such case, the Corporation will send or cause to be sent to the holders of the Series A Preferred Stock a notice specifying, as the case may be, (i) the record date for such dividend, distribution or right, and the amount and character of such dividend, distribution or right, or (ii) the effective date on which such reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation or winding-up is proposed to take place, and the time, if any is to be fixed, as of which the holders of record of Common Stock (or such other capital stock or securities at the time issuable upon the conversion of the Series A Preferred Stock) shall be entitled to exchange their shares of Common Stock (or such other capital stock or securities) for securities or other property deliverable upon such reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation or winding-up, and the amount per share and character of such exchange applicable to the Series A Preferred Stock and the Common Stock. Such notice shall be sent at least ten (10) days prior to the record date or effective date for the event specified in such notice.

6. Mandatory Conversion .

6.1 Trigger Events . Upon either (a) the closing of the sale of shares of Common Stock to the public in a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, resulting in at least One Hundred Million Dollars ($100,000,000) of gross proceeds to the Corporation or (b) the date and time, or the occurrence of an event, specified by vote or written consent of the holders of at least majority of the then outstanding shares of Series A Preferred Stock (the time of such closing or the date and time specified or the time of the event specified in such vote or written consent is referred to herein as the “ Mandatory Conversion Time ”), (i) all outstanding shares of Series A Preferred Stock shall automatically be converted into shares of Common Stock, at the then effective conversion rate and (ii) such shares may not be reissued by the Corporation.

6.2 Procedural Requirements . All holders of record of shares of Series A Preferred Stock shall be sent written notice of the Mandatory Conversion Time and the place designated for mandatory conversion of all such shares of Series A Preferred Stock pursuant to this Section 6 . Such notice need not be sent in advance of the occurrence of the Mandatory Conversion Time. Upon receipt of such notice, each holder of shares of Series A Preferred Stock shall surrender his, her or its certificate or certificates for all such shares (or, if such holder alleges that such certificate has been lost, stolen or destroyed, a lost certificate affidavit and agreement reasonably acceptable to the Corporation to indemnify the Corporation against any claim that may be made against the Corporation on account of the alleged loss, theft or destruction of such certificate) to the Corporation at the place designated in such notice. If so required by the Corporation, certificates surrendered for conversion shall be endorsed or accompanied by written instrument or instruments of transfer, in form satisfactory to the Corporation, duly executed by the registered holder or by his, her or its attorney duly authorized in writing. All rights with respect to the Series A Preferred Stock converted pursuant to Section 6.1 , including the rights, if any, to receive notices and vote (other than as a holder of Common Stock), will terminate at the Mandatory Conversion Time (notwithstanding the failure of the holder or holders thereof to surrender the certificates at or prior to such time), except only the rights of the holders thereof, upon surrender of their certificate or certificates (or lost certificate affidavit and agreement) therefor, to receive the items provided for in the next sentence of this Section 6.2 . As soon as practicable after the Mandatory Conversion Time and the surrender of the certificate or certificates (or lost certificate affidavit and agreement) for Series A Preferred Stock, the

 

14


Corporation shall issue and deliver to such holder, or to his, her or its nominees, a certificate or certificates for the number of full shares of Common Stock issuable on such conversion in accordance with the provisions hereof, together with cash as provided in Section 5.2 in lieu of any fraction of a share of Common Stock otherwise issuable upon such conversion and the payment of any declared but unpaid dividends on the shares of Series A Preferred Stock converted. Such converted Series A Preferred Stock shall be retired and cancelled and may not be reissued as shares of such series, and the Corporation may thereafter take such appropriate action (without the need for shareholder action) as may be necessary to reduce the authorized number of shares of Series A Preferred Stock accordingly.

7. Redeemed or Otherwise Acquired Shares . Any shares of Series A Preferred Stock that are redeemed or otherwise acquired by the Corporation (including by conversion thereof) shall be automatically and immediately cancelled and retired and shall not be reissued, sold or transferred. For so long as shares of Series A Preferred Stock are issued and outstanding, neither the Corporation nor any of its subsidiaries may exercise any voting or other rights granted to the holders of Series A Preferred Stock following redemption.

8. Waiver . Any of the rights, powers, preferences and other terms of the Series A Preferred Stock set forth herein may be waived on behalf of all holders of Series A Preferred Stock by the affirmative written consent or vote of the holders of at least a majority of the shares of Series A Preferred Stock then outstanding.

9. Notices . Any notice required or permitted by the provisions of this Amended and Restated Certificate to be given to a holder of shares of Series A Preferred Stock shall be mailed, postage prepaid, to the post office address last shown on the records of the Corporation, or given by electronic communication in compliance with the provisions of the PBCL, and shall be deemed sent upon such mailing or electronic transmission.

 

15

Exhibit 3.3

SECOND AMENDED

BYLAWS OF

FIVE BELOW, INC.

ARTICLE I

OFFICES

Section 1.1. Registered Office . The registered office of FIVE BELOW, INC. (the “Corporation”) in the Commonwealth of Pennsylvania shall be as specified in the Articles of Incorporation of the Corporation as they may from time to time be amended (the “Articles”) or at such other place as the Board of Directors of the Corporation (the “Board”) may specify in a statement of change of registered office filed with the Department of State of the Commonwealth of Pennsylvania.

Section 1.2. Other Offices . The Corporation may also have an office or offices at such other place or places either within or without the Commonwealth of Pennsylvania as the Board may from time to time determine or the business of the Corporation requires.

ARTICLE II

MEETINGS OF THE SHAREHOLDERS

Section 2.1. Place . All meetings of the shareholders shall be held at such geographic location, within or without the Commonwealth of Pennsylvania, as the Board may from time to time determine. If a meeting of the shareholders is held by means of the internet or other electronic communications technology in a fashion pursuant to which the shareholders have the opportunity to read or hear the proceedings substantially concurrently with their occurrence, vote on matters submitted to the shareholders and pose questions to the directors, the meeting need not be held at a particular geographic location.

Section 2.2. Annual Meeting . A meeting of the shareholders for the election of directors and the transaction of such other business as may properly be brought before the meeting shall be held at such place, on such date, and at such time as the Board shall each year fix.

Section 2.3. Written Ballot . Unless required by a vote of the shareholders before the voting begins, elections of directors need not be by written ballot.

Section 2.4. Special Meetings . Special meetings of the shareholders, for any purpose or purposes, may be called at any time by the President of the Corporation, by shareholders entitled to cast at least twenty percent (20%) of the votes that all shareholders are entitled to cast at the particular meeting, or by the Board, upon written request delivered to the Secretary of the Corporation. Any request for a special meeting of shareholders shall state the purpose or purposes of the proposed meeting. Upon receipt of any such request, it shall be the duty of the Secretary of the Corporation to give notice, in a manner consistent with Section 2.6 of these Bylaws, of a special meeting of the shareholders to be held at such time as the Secretary


of the Corporation may fix, which time may not be, if the meeting is called pursuant to a statutory right, more than sixty (60) days after receipt of the request. If the Secretary of the Corporation shall neglect or refuse to fix the date of the meeting and give notice thereof, the person or persons calling the meeting may do so.

Section 2.5. Scope of Special Meetings . Business transacted at any special meeting shall be confined to the business stated in the notice.

Section 2.6. Notice . Notice of every meeting of the shareholders, stating the geographic location, if any, the date and hour thereof and, in the case of a special meeting of the shareholders, the general nature of the business to be transacted thereat, shall be given in a manner consistent with the provisions of Section 12.3 of these Bylaws at the direction of the Secretary of the Corporation or, in the absence of the Secretary of the Corporation, any Assistant Secretary of the Corporation, at least ten (10) days prior to the day named for a meeting called to consider a fundamental change under Chapter 19 of the Pennsylvania Business Corporation Law of 1988, as it may from time to time be amended (the “ 1988 BCL ”), or five (5) days prior to the day named for the meeting in any other case, to each shareholder entitled to vote thereat on the date fixed as a record date in accordance with Section 8.1 of these Bylaws or, if no record date be fixed, then of record at the close of business on the tenth (10th) day next preceding the day on which notice is given or, if notice is waived, at the close of business on the day immediately preceding the day of the meeting, at such address (or e-mail address, facsimile or telephone number), as appears on the transfer books of the Corporation.

Section 2.7. Quorum . The shareholders present in person or by proxy, entitled to cast at least a majority of the votes that all shareholders are entitled to cast on any particular matter to be acted upon at the meeting, shall constitute a quorum for the purposes of consideration of, and action on, such matter. The shareholders present in person or by proxy at a duly organized meeting can continue to do business until the adjournment thereof notwithstanding the withdrawal of enough shareholders to leave less than a quorum. If a meeting cannot be organized because a quorum has not attended, the shareholders present in person or by proxy may, except as otherwise provided by the 1988 BCL and subject to the provisions of Section 2.8 of these Bylaws, adjourn the meeting to such time and place as they may determine. If a proxy casts a vote on behalf of a shareholder on any issue other than a procedural motion considered at a meeting of shareholders, the shareholder shall be deemed to be present during the entire meeting for purposes of determining whether a quorum is present for consideration of any other issue.

Section 2.8. Adjournment . Adjournments of any regular or special meeting may be taken, but any meeting at which directors are to be elected shall be adjourned only from day to day, or for such longer periods not exceeding fifteen (15) days each as the shareholders present and entitled to vote shall direct, until the directors have been elected. Notice of the adjourned meeting or the business to be transacted thereat need not be given, other than announcement at the meeting at which adjournment is taken, unless the Board fixes a new record date for the adjourned meeting or the 1988 BCL requires notice of the business to be transacted and such notice has not previously been given. At any adjourned meeting at which a quorum is present, any business may be transacted that might have been transacted at the meeting as originally noticed.

 

-2-


Those shareholders entitled to vote present in person or by proxy, although less than a quorum pursuant to Section 2.7 of these Bylaws, shall nevertheless constitute a quorum for the purpose of electing directors at a meeting called for the election of directors that has been previously adjourned for lack of a quorum.

Section 2.9. Majority Voting . Any matter brought before a duly organized meeting for a vote of the shareholders shall be decided by a majority of the votes cast at such meeting by the shareholders present in person or by proxy and entitled to vote thereon, unless the matter is one for which a different vote is required by express provision of the 1988 BCL, the Articles or a bylaw adopted by the shareholders, in any of which case(s) such express provision shall govern and control the decision on such matter.

Section 2.10. Voting Rights . Except as otherwise provided in the Articles, at every meeting of the shareholders, every shareholder entitled to vote shall have the right to one vote for each share having voting power standing in his or her name on the books of the Corporation. Shares of the Corporation owned by it, directly or indirectly, and controlled by the Board, directly or indirectly, shall not be voted.

Section 2.11. Proxies . Every shareholder entitled to vote at a meeting of the shareholders or to express consent or dissent to corporate action in writing may authorize another person to act for him or her by proxy. The presence of, or vote or other action at a meeting of shareholders, or the expression of consent or dissent to corporate action in writing, by a proxy of a shareholder, shall constitute the presence of, or vote or action by, or written consent or dissent of the shareholder. Every proxy shall be executed or authenticated by the shareholder or by the shareholder’s duly authorized attorney-in-fact and filed with or transmitted to the Secretary of the Corporation or its designated agent. A shareholder or the shareholder’s duly authorized attorney-in-fact may execute or authenticate a writing or transmit an electronic message authorizing another person to act for him by proxy. A telegram, telex, cablegram, datagram, e-mail, Internet communication or other means of electronic transmission from a shareholder or attorney-in-fact, or a photographic, facsimile or similar reproduction of a writing executed by a shareholder or attorney-in-fact may be treated as properly executed or authenticated or shall be so treated if it sets forth or utilizes a confidential and unique identification number or other mark furnished by the Corporation to the shareholders for the purposes of a particular meeting or transaction. A proxy, unless coupled with an interest, shall be revocable at will, notwithstanding any other agreement or any provision in the proxy to the contrary, but the revocation of a proxy shall not be effective until written notice of revocation has been given to the Secretary of the Corporation or its designated agent in writing or by electronic transmission. No unrevoked proxy shall be valid after three (3) years from the date of its execution, authentication or transmission unless a longer time is expressly provided therein. A proxy shall not be revoked by the death or incapacity of the maker unless, before the vote is counted or the authority is exercised, written notice of such death or incapacity is given to the Secretary of the Corporation or its designated agent.

Section 2.12. Participation by Conference Telephone or other Electronic Technology . The right of any shareholder to participate in any shareholders’ meeting by conference telephone or other electronic means, including, without limitation, the internet, in which event all shareholders so participating shall be deemed present at such meeting, shall be granted solely in the discretion of the Board.

 

-3-


Section 2.13. Conduct of Shareholders Meeting . There shall be a presiding officer at every meeting of the shareholders. The presiding officer shall be appointed in the manner provided by the Board. If the Board fails to designate a presiding officer, the president shall be the presiding officer. The presiding officer shall determine the order of business and shall have the authority to establish rules for the conduct of the meeting. Any action by the presiding officer in adopting rules for, and in conducting, a meeting shall be fair to the shareholders. The presiding officer shall announce at the meeting when the polls close for each matter voted upon. If no announcement is made, the polls shall be deemed to have closed upon the final adjournment of the meeting. After the polls close, no ballots, proxies or votes, nor any revocations or changes thereto, may be accepted.

Section 2.14. Voting Lists . The officer or agent having charge of the transfer books for securities of the Corporation shall make a complete list of the shareholders entitled to vote at a meeting of the shareholders, arranged in alphabetical order, with the address of and the number of shares held by each shareholder, which list shall be produced and kept open at the time and place of the meeting and shall be subject to the inspection of any shareholder during the whole time of the meeting.

Section 2.15. Judges of Election . In advance of any meeting of the shareholders, the Board may appoint judges of election, who need not be shareholders, to act at such meeting or any adjournment thereof. If judges of election are not so appointed, the presiding officer of any such meeting may, and on the request of any shareholder shall, appoint judges of election at the meeting. The number of judges shall be one (1) or three (3), as determined by the Board to be appropriate under the circumstances. No person who is a candidate for office to be filled at the meeting shall act as a judge at the meeting. The judges of election shall do all such acts as may be proper to conduct the election or vote with fairness to all shareholders, and shall make a written report of any matter determined by them and execute a certificate of any fact found by them, if requested by the presiding officer of the meeting or any shareholder or the proxy of any shareholder. If there are three (3) judges of election, the decision, act or certificate of a majority shall be effective in all respects as the decision, act or certificate of all.

ARTICLE III

SHAREHOLDER ACTION BY CONSENT

Section 3.1. Unanimous Consent . Any action required or permitted to be taken at a meeting of the shareholders or of a class of shareholders may be taken without a meeting if a written consent thereto by all of the shareholders who would be entitled to vote at a meeting for such purpose is filed with the Secretary of the Corporation.

Section 3.2. Partial Consent . Any action required or permitted to be taken at a meeting of the shareholders or of a class of shareholders may be taken without a meeting upon the written consent of shareholders who would have been entitled to cast the minimum number of votes that would be necessary to authorize the action at a meeting at which all shareholders entitled to vote thereon were present and voting. The consents shall be filed with the Secretary

 

-4-


of the Corporation. An action taken pursuant to this section shall not become effective until after at least ten (10) days notice has been given to each shareholder entitled to vote thereon who has not consented thereto.

Section 3.3. Record Date - Consents . Except as otherwise provided in Section 8.1 of these Bylaws, the record date for determining shareholders entitled to (a) express consent or dissent to action without a meeting, when prior action by the Board is not necessary, (b) call a special meeting of the shareholders or (c) propose an amendment of the Articles, shall be at the close of business on the day on which the first consent or dissent, request for a special meeting or petition proposing an amendment of the Articles is filed with the Secretary of the Corporation. If prior action by the Board is necessary, the record date for determining such shareholders shall be at the close of business on the day on which the Board adopts the resolution relating to such action.

ARTICLE IV

DIRECTORS

Section 4.1. Number and Qualifications . Subject to any provision of the Articles and the Shareholders Agreement, the Board shall consist of one or more directors as determined from time to time by resolution of the Board. Except as provided in Section 4.4 of these Bylaws in the case of vacancies, directors shall be elected by the shareholders. Directors shall be natural persons of full age and need not be residents of the Commonwealth of Pennsylvania or security holders of the Corporation.

Section 4.2. Term . Each director shall be elected to serve a term of one (1) year and until a successor is elected and qualified or until the director’s earlier death, resignation or removal.

Section 4.3. Nominations of Directors . Subject to any provision in that certain Second Amended and Restated Shareholders Agreement dated as of September 1, 2010, by and among the Corporation and the shareholders party thereto (as amended from time to time in accordance with the terms therein, the “Shareholders Agreement”), nominees for election to the Board shall be selected by the Board or a committee of the Board to which the Board has delegated the authority to make such selections pursuant to Section 4.12 of these Bylaws. Subject to the Shareholders Agreement, the Board or such committee, as the case may be, may consider written recommendations from shareholders for nominees for election to the Board provided any such recommendation, together with (a) a written description of the proposed nominee’s qualifications and other relevant biographical information, (b) a description of any arrangements or understandings among the recommending shareholder and each nominee and any other person with respect to such nomination, and (c) the consent of each nominee to serve as a director of the Corporation if so elected, is received by the Secretary of the Corporation not later than the tenth (10th) day after the giving of notice of the meeting at which directors are to be elected.

Section 4.4. Vacancies . Subject to any provision of the Articles and the Shareholders Agreement, vacancies in the Board, including vacancies resulting from an increase in the number of directors, shall be filled by a majority vote of the remaining members of the

 

-5-


Board, even though less than a quorum, or by a sole remaining director, and each person so elected shall serve as a director for the balance of the unexpired term. Subject to any provision of the Articles and the Shareholders Agreement, if one or more directors resign from the Board effective at a future date, the directors then in office, including those who have resigned but are still in office, shall have the power to fill the vacancies by a majority vote, the vote thereon to take effect when the resignations become effective.

Section 4.5. Removal . Subject to the Shareholders Agreement, the entire Board or any one or more directors may be removed from office without assigning any cause by the vote of the shareholders.

Section 4.6. Powers . The business and affairs of the Corporation shall be managed under the direction of its Board, which may exercise all powers of the Corporation and do all such lawful acts and things as are not by statute or by the Articles or these Bylaws directed or required to be exercised and done by the shareholders.

Section 4.7. Place of Board Meetings . Meetings of the Board may be held at such geographic location within or without the Commonwealth of Pennsylvania as the Board may from time to time appoint or as may be designated in the notice of the meeting.

Section 4.8. First Meeting of Newly Elected Board . The first meeting of each newly elected Board may be held at the same place and immediately after the meeting at which such directors were elected and no notice shall be required other than announcement at such meeting. If such first meeting of the newly elected Board is not so held, notice of such meeting shall be given in the same manner as set forth in Section 4.9 of these Bylaws with respect to notice of regular meetings of the Board.

Section 4.9. Regular Board Meetings; Notice . Regular meetings of the Board may be held at such times and places as shall be determined from time to time by resolution of at least a majority of the whole Board at a duly convened meeting, or by unanimous written consent. The Secretary may, but need not, provide notice of each regular meeting of the Board, specifying the date, place and hour of the meeting in a manner consistent with Section 12.4 of these Bylaws.

Section 4.10. Special Board Meetings; Notice . Special meetings of the Board may be called by the President of the Corporation on notice to each director, specifying the date, place and hour of the meeting and given within the same time and in the same manner provided for notice of regular meetings in Section 4.9 of these Bylaws. Special meetings shall be called by the Secretary of the Corporation in like manner and on like notice on the written request of two directors.

Section 4.11. Quorum of the Board . At all meetings of the Board, the presence of a majority of the directors in office shall constitute a quorum for the transaction of business, and the acts of a majority of the directors present and voting at a meeting at which a quorum is present shall be the acts of the Board. If a quorum shall not be present at any meeting of directors, the directors present thereat may adjourn the meeting. It shall not be necessary to give any notice of the adjourned meeting or of the business to be transacted thereat other than by announcement at the meeting at which such adjournment is taken.

 

-6-


Section 4.12. Committees of Directors The Corporation shall maintain an audit committee (the “Audit Committee”) and a compensation committee (the “Compensation Committee”). The Board may, by resolution adopted by a majority of the directors in office, establish one or more other committees. Any such committee, to the extent provided in such resolution of the Board or in these Bylaws, shall have and may exercise all of the powers and authority of the Board; provided, however, that no such committee shall have any power or authority to (a) submit to the shareholders any action requiring approval of the shareholders under the 1988 BCL, (b) create or fill vacancies on the Board, (c) amend or repeal these Bylaws or adopt new bylaws, (d) amend or repeal any resolution of the Board that by its terms is amendable or repealable only by the Board, (e) act on any matter committed by these Bylaws or by resolution of the Board to another committee of the Board, (f) amend the Articles or adopt a resolution proposing an amendment to the Articles, or (g) adopt a plan or an agreement of merger or consolidation, share exchange, asset sale or division. Minutes of all meetings of any committee of the Board shall be kept by the person designated by such committee to keep such minutes. Copies of such minutes and any writing setting forth an action taken by written consent without a meeting shall be distributed to each member of the Board promptly after such meeting is held or such action is taken.

Section 4.13. Participation in Board Meetings by Conference Telephone or other Electronic Technology . One or more directors may participate in a meeting of the Board or of a committee of the Board by means of conference telephone or other electronic means including, without limitation, the internet, by means of which all persons participating in the meeting can hear each other, and all directors so participating shall be deemed present at the meeting.

Section 4.14. Action by Consent of Directors . Any action required or permitted to be taken at a meeting of the Board or of any committee designated by the Board, may be taken without a meeting, if all members of the Board or of such committee, as the case may be, consent thereto in writing and such consent or consents are filed with the Secretary of the Corporation.

Section 4.15. Compensation of Directors . The Board may, by resolution, fix the compensation of directors for their services as directors. A director may also serve the Corporation in any other capacity and receive compensation therefor.

Section 4.16. Directors’ Liability . No person who is or was a director of the Corporation shall be personally liable for monetary damages for any action taken, or any failure to take any action, unless (a) such director has breached or failed to perform the duties of his or her office under the 1988 BCL and (b) the breach or failure to perform constitutes self-dealing, willful misconduct or recklessness, or unless such liability is imposed pursuant to a criminal statute or for the payment of taxes pursuant to local, state or federal law.

 

-7-


ARTICLE V

OFFICERS

Section 5.1. Principal Officers . The officers of the Corporation shall be chosen by the Board, and shall include a President, a Secretary and a Treasurer (collectively, the “Principal Officers”). The President, all Vice Presidents and Secretary shall be natural persons of full age. The Treasurer may be a corporation, but if a natural person, shall be of full age. Any number of offices may be held by the same person.

Section 5.2. Electing Principal Officers . The Board, immediately after each annual meeting of the shareholders, shall elect the Principal Officers of the Corporation, none of whom need be members of the Board.

Section 5.3. Other Officers . The Corporation may have such other officers, assistant officers, agents and employees as the Board may deem necessary, each of whom shall hold office for such period, have such authority and perform such duties as the Board or the President may from time to time determine. The Board may delegate to any Principal Officer the power to appoint or remove any such other officers and any such agents or employees. Any number of officer positions (including the Principal Officers) may be held by the same person.

Section 5.4. Compensation . The salaries of the Executive Chairman of the Board and the President shall be fixed by the Compensation Committee. The Board shall have the power, or the Board may delegate to the Compensation Committee or any Principal Officer the power, to set the compensation of any other officers, agents or employees set forth in Section 5.3 of these Bylaws.

Section 5.5. Term of Office; Removal . Each officer of the Corporation shall hold office until his or her successor has been chosen and qualified or until his or her earlier death, resignation or removal. Vacancies of any office shall be filled by the Board. Any officer or agent may be removed by the Board with or without cause, but such removal shall be without prejudice to the contract rights, if any, of the person so removed. The election or appointment of an officer or agent shall not of itself create any contract rights.

Section 5.6. The President . The President shall be the chief executive officer of the Corporation; he or she shall preside at all meetings of the shareholders and directors, shall have general and active management of the business of the Corporation and shall see that all orders and resolutions of the Board are carried into effect.

Section 5.7. The Vice Presidents . The Vice-President or Vice-Presidents, in the order designated by the Board, shall, in the absence or disability of the President, perform the duties and exercise the powers of the President, and shall perform such other duties as the Board may prescribe or the President may delegate to them.

Section 5.8. The Secretary . The Secretary shall attend all sessions of the Board and all meetings of the shareholders and record all the votes of the Corporation and the minutes of all the transactions in a book to be kept for that purpose, and shall perform like duties for the committees of the Board when required. The Secretary shall give, or cause to be given, notice of all meetings of the shareholders and of the Board, and shall perform such other duties as may be prescribed by the Board or the President, under whose supervision the Secretary shall be. He or she shall keep in safe custody the corporate seal, if any, of the Corporation.

 

-8-


Section 5.9. The Treasurer .

(a) The Treasurer shall have the custody of the corporate funds and securities and shall keep full and accurate accounts of receipts and disbursements in books belonging to the Corporation, and shall deposit all moneys and other valuable effects in the name and to the credit of the Corporation in such depositories as shall be designated by the Board.

(b) The Treasurer shall disburse the funds of the Corporation as may be ordered by the Board, taking proper vouchers for such disbursements, and shall render to the President and directors, at the regular meetings of the Board, or whenever they may require it, an account of all his or her transactions as Treasurer.

Section 5.10. Bonds . If required by the Board, any officer shall give the Corporation a bond in such sum, and with such surety or sureties as may be satisfactory to the Board, for the faithful discharge of the duties of his or her office and for the restoration to the Corporation, in the case of his or her death, resignation, retirement or removal from office, of all books, papers, vouchers, money and other property of whatever kind in his or her possession or under his or her control belonging to the Corporation.

ARTICLE VI

CERTIFICATES FOR SHARES

Section 6.1. Share Certificates . The certificates representing shares of the Corporation shall be numbered and registered in a share register as they are issued. The share register shall exhibit the names and addresses of all registered holders and the number and class of shares and the series, if any, held by each. The Certificate shall state that the Corporation is incorporated under the laws of the Commonwealth of Pennsylvania, the name of the registered holder and the number and class of shares and the series, if any, represented thereby. If, under its Articles, the Corporation is authorized to issue shares of more than one class or series, each Certificate shall set forth, or shall contain a statement that the Corporation will furnish to any shareholder upon request and without charge, a full or summary statement of the designations, voting rights, preferences, limitations and special rights of the shares of each class or series authorized to be issued so far as they have been fixed and determined and the authority of the Board to fix and determine such rights.

Section 6.2. Execution of Certificates . Every share certificate shall be executed, by facsimile or otherwise, by or on behalf of the Corporation, by the President and the Secretary. In case any officer who has signed or whose facsimile signature has been placed upon any share certificate shall have ceased to be such officer, because of death, resignation or otherwise, before the certificate is issued, it may be issued by the Corporation with the same effect as if the officer had not ceased to be such at the time of issue.

 

-9-


ARTICLE VII

TRANSFER OF SHARES

Section 7.1. Transfer; Duty of Inquiry . Upon presentment to the Corporation or its transfer agent of a share certificate indorsed by the appropriate person or accompanied by proper evidence of succession, assignment or authority to transfer, a new certificate shall be issued to the person entitled thereto and the old certificate cancelled and the transfer registered upon the books of the Corporation, unless the Corporation or its transfer agent has a duty to inquire as to adverse claims with respect to such transfer which has not been discharged. The Corporation shall have no duty to inquire into adverse claims with respect to transfers of its securities or the rightfulness thereof unless (a) the Corporation has received written notification of an adverse claim at a time and in a manner which affords the Corporation a reasonable opportunity to act on it before the issuance of a new, reissued or re-registered share certificate and the notification identifies the claimant, the registered owner and the issue of which the share or shares are a part and provides an address for communications directed to the claimant; or (b) the Corporation has required and obtained, with respect to a fiduciary, a copy of a will, trust, indenture, articles of co-partnership, bylaws or other controlling instruments, for a purpose other than to obtain appropriate evidence of the appointment or incumbency of the fiduciary, and such documents indicate, upon reasonable inspection, the existence of an adverse claim.

Section 7.2. Discharging Duty of Inquiry . The Corporation may discharge any duty of inquiry by any reasonable means, including notifying an adverse claimant by registered or certified mail at the address furnished by the claimant or, if there is no such address, at the claimant’s residence or regular place of business, that the security has been presented for registration of transfer by a named person, and that the transfer will be registered unless within thirty (30) days from the date of mailing the notification, either (a) an appropriate restraining order, injunction or other process issues from a court of competent jurisdiction or (b) an indemnity bond, sufficient in the Corporation’s judgment to protect the Corporation and any transfer agent, registrar or other agent of the Corporation involved from any loss which it or they may suffer by complying with the adverse claim, is filed with the Corporation.

ARTICLE VIII

RECORD DATE; IDENTITY OF SHAREHOLDERS

Section 8.1. Record Date . The Board may fix a time, prior to the date of any meeting of the shareholders, as a record date for the determination of the shareholders entitled to notice of, or to vote at, the meeting, which time, except in the case of an adjourned meeting, shall not be more than ninety (90) days prior to the date of the meeting. Except as otherwise provided in Section 8.2 of these Bylaws, only the shareholders of record at the close of business on the date so fixed shall be entitled to notice of, or to vote at, such meeting, notwithstanding any transfer of securities on the books of the Corporation after any record date so fixed. The Board may similarly fix a record date for the determination of shareholders for any other purpose. When a determination of shareholders of record has been made as herein provided for purposes of a meeting, the determination shall apply to any adjournment thereof unless the Board fixes a new record date for the adjourned meeting.

 

-10-


Section 8.2. Certification of Nominee . The Board may adopt a procedure whereby a shareholder may certify in writing to the Secretary of the Corporation that all or a portion of the shares registered in the name of the shareholder are held for the account of a specified person or persons. The Board, in adopting such procedure, may specify (a) the classification of shareholder who may certify, (b) the purpose or purposes for which the certification may be made, (c) the form of certification and the information to be contained therein, (d) as to certifications with respect to a record date, the date after the record date by which the certification must be received by the Secretary of the Corporation, and (e) such other provisions with respect to the procedure as the Board deems necessary or desirable. Upon receipt by the Secretary of the Corporation of a certification complying with the procedure, the persons specified in the certification shall be deemed, for the purpose or purposes set forth in the certification, to be the holders of record of the number of shares specified instead of the persons making the certification.

ARTICLE IX

REGISTERED SHAREHOLDERS

Section 9.1. Before due presentment for transfer of any shares, the Corporation shall treat the registered owner thereof as the person exclusively entitled to vote, to receive notifications and otherwise to exercise all the rights and powers of an owner, and shall not be bound to recognize any equitable or other claim or interest in such securities, whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of the Commonwealth of Pennsylvania or Section 8.2 of these Bylaws.

ARTICLE X

LOST CERTIFICATES

Section 10.1. If the owner of a share certificate claims that it has been lost, destroyed, or wrongfully taken, the Corporation shall issue a new certificate in place of the original certificate if the owner so requests before the Corporation has notice that the certificate has been acquired by a bona fide purchaser, and if the owner has filed with the Corporation an indemnity bond (to the extent requested by the Corporation in its sole discretion) and an affidavit of the facts satisfactory to the Board or its designated agent, and has complied with such other reasonable requirements, if any, as the Board may deem appropriate.

ARTICLE XI

DISTRIBUTIONS

Section 11.1. Distributions . Distributions upon the shares of the Corporation, whether by dividend, purchase or redemption or other acquisition of its shares subject to any provisions of the Articles related thereto, may be authorized by the Board at any regular or special meeting of the Board and may be paid directly or indirectly in cash, in property or by the incurrence of indebtedness by the Corporation.

Section 11.2. Reserves . Before the making of any distributions, there may be set aside out of any funds of the Corporation available for distributions such sum or sums as the Board from time to time, in its absolute discretion, deems proper as a reserve fund to meet

 

-11-


contingencies, or for equalizing dividends, or for repairing or maintaining any property of the Corporation, or for such other purpose as the Board shall deem conducive to the interests of the Corporation, and the Board may abolish any such reserve in the manner in which it was created.

Section 11.3. Stock Dividends/Splits . Stock dividends or splits upon the shares of the Corporation, subject to any provisions of the Articles related thereto, may be authorized by the Board at any regular or special meeting of the Board.

ARTICLE XII

GENERAL PROVISIONS

Section 12.1. Checks and Notes . All checks or demands for money and notes of the Corporation shall be signed by such officer or officers as the Board may from time to time designate.

Section 12.2. Seal . The corporate seal, if any, shall have inscribed thereon the name of the Corporation, the year of its organization and the words “Corporate Seal, Pennsylvania.” Such seal may be used by causing it or a facsimile thereof to be impressed or affixed or in any manner reproduced. The affixation of the corporate seal shall not be necessary to the valid execution, assignment or endorsement of any instrument or other document by the Corporation.

Section 12.3. Notices . Whenever, under the provisions of the 1988 BCL or of the Articles or of these Bylaws or otherwise, notice is required to be given to any person, it shall be given to such person either personally or by sending a copy thereof (i) by first class or express mail, postage prepaid, courier service (with charges prepaid) to such person’s postal address appearing on the books of the Corporation for the purpose of notice (or in the case of directors, supplied by the director to the Corporation for the purpose of notice), or (ii) by facsimile transmission, e-mail or other electronic communication to such persons facsimile number or address for e-mail or other electronic communications supplied by such person to the Corporation for the purpose of notice. If the notice is sent by mail or courier service, it shall be deemed to have been given to the person entitled thereto when deposited in the United States mail or courier service for delivery to that person. A notice given by facsimile, e-mail or other electronic communication shall be deemed to have been given to the person entitled thereto when sent.

Section 12.4. Waiver of Notice . Whenever any notice is required to be given by the 1988 BCL or by the Articles or these Bylaws, a waiver thereof in writing, signed by the person or persons entitled to the notice, whether before or after the time stated therein, shall be deemed equivalent to the giving of such notice. Neither the business to be transacted at nor the purpose of a meeting need be specified in the waiver of notice of the meeting. Attendance of a person at any meeting shall constitute a waiver of notice of the meeting, except where any person attends a meeting for the express purpose of objecting to the transaction of any business because the meeting was not lawfully called or convened, and the person so objects at the beginning of the meeting.

 

-12-


ARTICLE XIII

AMENDMENTS

Section 13.1. Amendments . The Bylaws may be adopted, amended or repealed by a majority vote of the shareholders entitled to vote thereon at any regular or special meeting duly convened or, except for a bylaw on a subject expressly committed to the shareholders by the 1988 BCL or the Articles, by a majority vote of the members of the Board at any regular or special meeting duly convened, subject always to the power of the shareholders to change such action by the directors; however, whenever the Articles or Bylaws require for the taking of any action by the shareholders or a class of shareholders a specific number or percentage of votes, the provision of the Articles or Bylaws, as the case may be, setting forth that requirement shall not be amended or repealed by any lesser number or percentage of votes of such shareholders or of such class of shareholders. In the case of a meeting of shareholders, written notice shall be given to each shareholder that the purpose, or one of the purposes, of the meeting is to consider the adoption, amendment or repeal of the Bylaws. There shall be included in, or enclosed with the notice, a copy of the proposed amendment or a summary of the changes to be effected thereby. Any change in the Bylaws shall take effect when adopted unless otherwise provided in the resolution effecting the change.

ARTICLE XIV

INDEMNIFICATION

Section 14.1. Officers and Directors - Direct Actions . The Corporation shall indemnify any director or officer of the Corporation (as used herein, the phrase “director or officer of the Corporation” shall mean any person who is or was a director or officer of the Corporation, or is or was serving at the request of the Corporation as a director or officer of another domestic or foreign corporation for profit or not-for-profit, partnership, joint venture, trust or other enterprise), any person who was or is a party (other than a party plaintiff suing on his or her own behalf), or who is threatened to be made such a party to, or testifies in, any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the Corporation) by reason of the fact that he or she is or was a director or officer of the Corporation, to the greatest extent permitted by Pennsylvania law, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit or proceeding; provided, that no indemnification shall be provided in any case where the act or failure to act giving rise to the claim for indemnification by such person is determined by a court to have constituted willful misconduct or recklessness. The termination of any action or proceeding by judgment, order, settlement or conviction or upon a plea of nolo contendere or its equivalent shall not of itself create a presumption that the person (a) did not act in good faith and in a manner that he or she reasonably believed to be in, or not opposed to, the best interests of the Corporation and (b) with respect to any criminal proceeding, had reasonable cause to believe that his or her conduct was unlawful.

Section 14.2. Officers and Directors - Derivative Actions . The Corporation shall indemnify any director or officer of the Corporation who was or is a party (other than a party suing in the right of the Corporation), or is threatened to be made a party to, or testifies in, any threatened, pending or completed action, suit or proceeding by or in the right of the Corporation

 

-13-


to procure a judgment in the Corporation’s favor by reason of the fact that he or she is or was a director or officer of the Corporation, against expenses (including attorneys’ fees) actually and reasonably incurred by him or her in connection with the defense or settlement of the action, suit or proceeding if he or she met the standard of conduct of acting in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the Corporation. Indemnification shall not be made under this Section in respect of any claim, issue or matter as to which the person has been adjudged to be liable to the Corporation unless and only to the extent that the Court of Common Pleas of the judicial district embracing the county in which the registered office of the Corporation is located or the court in which the action, suit or proceeding was brought determines upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for the expenses that the Court of Common Pleas or other court deems proper.

Section 14.3. Employees and Agents . The Corporation may, to the extent permitted by the 1988 BCL, indemnify any employee or agent of the Corporation (as used in this Article XIV, the phrase “employee or agent of the Corporation shall mean any person who is or was an employee or agent of the Corporation, other than an officer, or is or was serving at the request of the Corporation as an employee or agent of another domestic or foreign corporation for profit or not-for-profit, partnership, joint venture, trust or other enterprise) who was or is a party, or who is threatened to be made such a party to, or testifies in, any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit or proceeding by reason of the fact that he or she is or was an employee or agent of the Corporation, provided he or she has met the standard of conduct set forth in Sections 14.1 and 14.2, subject to the limitations set forth in Section 14.2 in the case of an action, suit or proceeding by or in the right of the Corporation to procure a judgment in the Corporation’s favor.

Section 14.4. Mandatory Indemnification . To the extent that a director or officer of the Corporation or any employee or agent of the Corporation has been successful on the merits or otherwise in defense of any action or proceeding referred to in Sections 14.1, 14.2 or 14.3 of this Article XIV, or in defense of any claim, issue or matter therein, he or she shall be indemnified by the Corporation against expenses (including attorneys’ fees) actually and reasonably incurred by him or her in connection therewith.

Section 14.5. Advancing Expenses . Expenses (including attorneys’ fees) incurred by a director or officer of the Corporation in defending any action or proceeding referred to in this Article XIV shall be paid by the Corporation in advance of the final disposition of the action or proceeding to the greatest extent permitted by Pennsylvania law; provided, that the payment of those expenses incurred by any such persons in advance of the final disposition of such action or proceeding shall be made only upon receipt of an undertaking by or on behalf of such persons to repay such amount if it is ultimately determined that he or she is not entitled to be indemnified by the Corporation as authorized in this Article XIV. Expenses (including attorneys’ fees) incurred by an employee or agent of the Corporation in defending any action or proceeding referred to in this Article XIV may be paid by the Corporation in advance of the final disposition of the action or proceeding to the greatest extent permitted by Pennsylvania law; provided, that the payment of those expenses incurred by any such persons in advance of the

 

-14-


final disposition of such action or proceeding shall be made only upon receipt of an undertaking by or on behalf of such persons to repay such amount if it is ultimately determined that he or she is not entitled to be indemnified by the Corporation as authorized in this Article XIV. Advancement of expenses pursuant to the preceding sentence shall be authorized by the Board.

Section 14.6. Procedure .

(a) Unless ordered by a court, any indemnification under Section 14.1, 14.2 or 14.3 or advancement of expenses under Section 14.5 of this Article XIV shall be made by the Corporation only as authorized in a specific case upon a determination that indemnification of the director, officer, employee or agent is proper in the circumstances because he or she has met the applicable standard of conduct set forth in Section 14.1, 14.2 or 14.3.

(b) All determinations under this Section 14.6 shall be made:

(1) With respect to indemnification under Section 14.3 and advancement of expenses to an employee or agent of the Corporation, other than an officer, by the Board by a majority vote.

(2) With respect to indemnification under Section 14.1 or 14.2 and advancement of expenses to a director or officer of the Corporation,

(A) By the Board by a majority vote of a quorum consisting of directors who were not parties to such action or proceeding, or

(B) If such a quorum is not obtainable, or, if obtainable and if a majority vote of a quorum of disinterested directors so directs, by independent legal counsel in a written opinion, or

(C) By the shareholders.

Section 14.7. Nonexclusivity of Indemnification .

(a) The indemnification and advancement of expenses provided by, or granted pursuant to, this Article XIV shall not be deemed exclusive of any other rights to which a person seeking indemnification or advancement of expenses may be entitled under any Bylaw, agreement, vote of shareholders or disinterested directors or otherwise, both as to actions in his or her official capacity and as to actions in another capacity while holding that office. Section 1728 (relating to interested directors; quorum) of the 1988 BCL, or any successor section, shall be applicable to any Bylaw, contract or transaction authorized by the directors under this Section 14.7. The Corporation may create a fund of any nature, which may, but need not be, under the control of a trustee, or otherwise secure or insure in any manner its indemnification obligations, whether arising under or pursuant to this Article XIV or otherwise.

(b) Indemnification pursuant to Section 14.7(a) hereof shall not be made in any case where the act or failure to act giving rise to the claim for indemnification is determined by a court to have constituted willful misconduct or recklessness.

 

-15-


(c) Indemnification pursuant to Section 14.7(a) under any Bylaw, agreement, vote of shareholders or directors or otherwise, may be granted for any action taken or any failure to take any action and may be made whether or not the Corporation would have the power to indemnify the person under any other provision of law except as provided in this Section 14.7 and whether or not the indemnified liability arises or arose from any threatened or pending or completed action by or in the right of the Corporation.

Section 14.8. Insurance . The Corporation shall have power to purchase and maintain insurance on behalf of any person who is or was a director or officer of the Corporation or an employee or agent of the Corporation, against any liability asserted against such person and incurred by him or her in any such capacity, or arising out of his or her status as such, whether or not the Corporation would have the power to indemnify him or her against that liability under the provisions of this Article XIV or otherwise.

Section 14.9. Past Officers and Directors . The indemnification and advancement of expenses provided by, or granted pursuant to, this Article XIV shall continue as to a person who has ceased to be a director, officer, employee or agent of the Corporation and shall inure to the benefit of the heirs and personal representatives of that person.

Section 14.10. Surviving or New Corporations . References to “the Corporation” in this Article XIV include all constituent corporations absorbed in a consolidation, merger or division, as well as the surviving or new corporation resulting therefrom, so that any director, officer, employee or agent of the constituent, surviving or new corporation shall stand in the same position under the provisions of this Article XIV with respect to the surviving or new corporation as he or she would if he or she had served the surviving or new corporation in the same capacity.

Section 14.11. Employee Benefit Plans .

(a) References in this Article XIV to “other enterprises” shall include employee benefit plans and references to “serving at the request of the Corporation” shall include any service as a director, officer, employee or agent of the Corporation that imposes duties on, or involves services by, the person with respect to an employee benefit plan, its participants or beneficiaries.

(b) Excise taxes assessed on a person with respect to an employee benefit plan pursuant to applicable law shall be deemed “fines.”

(c) Action with respect to an employee benefit plan taken or omitted in good faith by a director, officer, employee or agent of the Corporation in a manner he or she reasonably believed to be in the interest of the participants and beneficiaries of the plan shall be deemed to be action in a manner that is not opposed to the best interests of the Corporation.

(as amended through November 22, 2011)

 

-16-

Exhibit 10.1

INVESTMENT AGREEMENT

BY AND AMONG

FIVE BELOW, INC.,

PURCHASERS

AND THE OTHER PARTIES NAMED HEREIN


TABLE OF CONTENTS

Page

 

1.

  Purchase and Sale of Shares      2   
  1.1    Sale and Issuance of Series A Preferred Stock      2   
  1.2    Closing; Delivery      3   
  1.3    Use of Proceeds; Dividend      3   
  1.4    Defined Terms Used in this Agreement      3   
  1.5    Terms Defined Elsewhere in this Agreement      7   
2.   Representations and Warranties of the Company      9   
  2.1    Organization, Good Standing, Corporate Power and Qualification      9   
  2.2    Capitalization      9   
  2.3    Subsidiaries      10   
  2.4    Authorization      10   
  2.5    Valid Issuance of Shares      11   
  2.6    Consents; Filings; Conflicts      11   
  2.7    Litigation      11   
  2.8    Intellectual Property      12   
  2.9    Agreements; Actions      12   
  2.10    Certain Transactions      14   
  2.11    Rights of Registration and Voting Rights      14   
  2.12    Real Property      15   
  2.13    Financial Statements      15   
  2.14    No Undisclosed Liabilities      16   
  2.15    Changes      16   
  2.16    Employee Matters      17   
  2.17    Tax Returns and Payments      19   
  2.18    Insurance      19   
  2.19    Employee Agreements      19   
  2.20    Compliance with Law and Regulations; Permits      19   
  2.21    Corporate Documents      20   
  2.22    Environmental and Safety Laws      20   
  2.23    Tangible Personal Property      21   
  2.24    Inventories      21   
  2.25    Suppliers      21   
  2.26    Certain Payments      21   
  2.27    Accounts and Notes Receivable and Payable      22   
  2.28    Working Capital      22   
3.   Representations and Warranties of Purchasers      22   
  3.1    Authorization      22   
  3.2    Purchase Entirely for Own Account      22   
  3.3    Disclosure of Information      22   
  3.4    Restricted Securities      22   

 

i


TABLE OF CONTENTS

(continued)

Page

 

  3.5    No Public Market      23   
  3.6    Legends      23   
  3.7    Accredited Investor      23   
  3.8    Financial Ability      23   
4.   Covenants      23   
  4.1    Access to Information; Confidentiality      23   
  4.2    Conduct of the Business Pending the Closing      24   
  4.3    Third Party Consents; Approval Documents, Disclosure Documents      27   
  4.4    Governmental Consents and Approvals      27   
  4.5    Further Assurances      28   
  4.6    No Shop      28   
  4.7    Non-Competition; Non-Solicitation; Confidentiality      29   
  4.8    Publicity      30   
  4.9    Related Party Transactions with Non-Management Affiliates      31   
  4.10    Monthly Financial Statements      31   
  4.11    Notification of Certain Matters      31   
  4.12    Section 280G Approval      31   
  4.13    Amendments to Stock Plan      32   
  4.14    SCS Revolving Loans      32   
5.   Conditions to Purchasers’ Obligations at Closing      33   
  5.1    Representations and Warranties      33   
  5.2    Performance      33   
  5.3    Compliance Certificate      33   
  5.4    Qualifications      33   
  5.5    Opinion of Company Counsel      33   
  5.6    Indemnification Agreement      33   
  5.7    Amended and Restated Bylaws      33   
  5.8    Amended and Restated Investor Rights Agreement      33   
  5.9    Second Amended and Restated Shareholders Agreement      33   
  5.10    Restated Articles      34   
  5.11    Secretary’s Certificate      34   
  5.12    No Material Adverse Effect      34   
  5.13    Conversion      34   
  5.14    Credit Agreement      34   
  5.15    Closing Date Capitalization Table      34   
6.   Conditions of the Company’s Obligations at Closing      34   
  6.1    Representations and Warranties      34   
  6.2    Performance      34   
  6.3    Compliance Certificate      34   

 

ii


TABLE OF CONTENTS

(continued)

Page

 

  6.4    Payment of Purchase Price      34   
  6.5    Qualifications      35   
  6.6    Amended and Restated Investor Rights Agreement      35   
  6.7    Second Amended and Restated Shareholders Agreement      35   
  6.8    Credit Agreement      35   
7.   Survival; Indemnification      35   
  7.1    Survival of Representations, Warranties and Covenants      35   
  7.2    Indemnification      36   
  7.3    Limitations on Indemnification      36   
  7.4    Indemnification Procedures      37   
  7.5    Determination of Losses      39   
  7.6    Exclusive Remedy      39   
8.   Termination      39   
  8.1    Termination of Agreement      39   
  8.2    Procedure Upon Termination      40   
  8.3    Effect of Termination      40   
9.   Miscellaneous      40   
  9.1    Binding Effect; Assignment; Successors and Assigns      40   
  9.2    Governing Law      40   
  9.3    Counterparts      41   
  9.4    Titles and Subtitles      41   
  9.5    Notices      41   
  9.6    No Finder’s Fees      41   
  9.7    Fees and Expenses      41   
  9.8    Amendments and Waivers      42   
  9.9    Severability      42   
  9.10    Delays or Omissions      42   
  9.11    Entire Agreement      42   
  9.12    Dispute Resolution      42   
  9.13    WAIVER OF JURY TRIAL      42   
  9.14    Non Recourse      43   
  9.15    No Commitment for Additional Financing      43   

 

iii


LIST OF EXHIBITS

 

Exhibit A    SCHEDULE OF PURCHASERS
Exhibit B    COMMON DIVIDEND FORMULA
Exhibit C    FORM OF AMENDED AND RESTATED ARTICLES OF INCORPORATION
Exhibit D    FORM OF SECOND AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS, PREFERENCES, LIMITATIONS AND SPECIAL RIGHTS OF THE SERIES A 8% CONVERTIBLE PREFERRED STOCK
Exhibit E    DISCLOSURE SCHEDULE
Exhibit F    FORM OF INDEMNIFICATION AGREEMENT
Exhibit G    FORM OF AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT
Exhibit H    FORM OF SECOND AMENDED AND RESTATED SHAREHOLDERS AGREEMENT
Exhibit I    FORM OF LEGAL OPINION OF COMPANY COUNSEL
Exhibit J    FORM OF AMENDED AND RESTATED BYLAWS

[Exhibits C through J have been omitted as certain of these exhibits have been separately filed as exhibits to the Form S-1. The Company agrees to furnish supplementally a copy of these exhibits to the Securities and Exchange Commission upon request.]

 

iv


INVESTMENT AGREEMENT

THIS INVESTMENT AGREEMENT is made as of September 1, 2010 by and among Five Below, Inc., a Pennsylvania corporation (the “ Company ”), the purchasers listed on Exhibit A attached to this Agreement (each a “ Purchaser ” and together the “ Purchasers ”), the Persons listed as “Founders” on the signature pages to this Agreement (each a “ Founder ” and together the “ Founders ”) and the Persons listed as “Significant Common Shareholders” on the signature pages to this Agreement (each a “ Significant Common Shareholder ” and together the “ Significant Common Shareholders ”).

WHEREAS, the Company desires to issue to Purchasers, and Purchasers desire to purchase from the Company, shares of Series A 8% Convertible Preferred Stock, $0.01 par value per share (the “ Series A Preferred Stock ”), for an aggregate purchase price of $194,000,000 (the “ Shares ”), upon the terms and conditions hereinafter set forth;

WHEREAS, as an inducement to Purchasers entering into and completing the transactions contemplated by this Agreement, (i) the Company, LLR Equity Partners II, L.P. and LLR Equity Partners Parallel II, L.P. (collectively, “ LLR ”), Blue 9 Fund I, L.P. and the Company have executed and delivered to the Purchasers an irrevocable waiver of the right of first offer and preemptive rights established by Section 2 of the Investor Rights Agreement, and (ii) LLR, as the holder of a majority of the outstanding shares of Existing Preferred Stock, has executed and delivered to the Company and the Purchasers an irrevocable conversion notice (the “ Conversion Notice ”) pursuant to Section 5.3.1 of the Company’s Amended and Restated Certificate of Designations, Preferences, Limitations and Special Rights of the Series A Convertible Preferred Stock and the Series A-1 Convertible Preferred Stock (the “ Existing Preferred Designation ”) to effect the conversion of all issued and outstanding shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock (collectively, the “ Existing Preferred Stock ”), effective as of the Dividend Record Date;

WHEREAS, promptly following the consummation of the sale of Shares to Purchasers, the Company intends to use proceeds from the sale of Shares and certain other funds (as described in Section 1.3 ) to pay a dividend (as calculated pursuant to Section 1.3 , the “ Common Dividend ”) to Persons who hold of record shares of the Company’s common stock, $0.01 par value per share (the “ Common Stock ”) on the later of (i) 11:59 PM EDT on the date that is thirty (30) days after the date on which notice of the record date of the Common Dividend is given to equity holders, and (ii) 11:59 PM EDT on the day immediately prior to the day of Closing (the “ Dividend Record Date ”);

WHEREAS, in connection with the Common Dividend, as soon as practicable after the date hereof,

 

  (i) the Company shall prepare and deliver a notice and information statement to holders of the Company’s options pursuant to which such holders will be given a period of twenty (20) Business Days from the mailing thereof (the “ Offer Period ”) (unless such twenty-Business Day period is extended) the opportunity to exercise all (but not less than all) of their vested and unvested options, effective as of the Dividend Record Date;

 

  (ii) the Company shall prepare and deliver a notice and information statement to holders of the Company’s Compensatory Warrants pursuant to which such holders will be given the opportunity during the Offer Period to exercise all (but not less than all) of their Compensatory Warrants, effective as of the Dividend Record Date (the offers described in the preceding clause (i) and this clause (ii) are referred to herein collectively as the “ Exercise Offer ”);


  (iii) the Company shall prepare and deliver a notice and information statement to holders of the Existing Preferred Stock and the Financing Warrants pursuant to which (A) holders of Financing Warrants will be given opportunity to exchange all (but not less than all) of their Financing Warrants for the Exchange Consideration, effective as of the Closing (the “ Exchange Offer ”), and (B) holders of Existing Preferred Stock will be given notice of action taken by holders of a majority of the Existing Preferred Stock regarding, among other matters, the approval of this Agreement, the other Transaction Documents, the Common Dividend, and certain other matters related thereto, and the conversion of all outstanding Existing Preferred Stock pursuant to the Conversion Notice; and

 

  (iv) the Company shall prepare and deliver a notice to holders of its Common Stock regarding, among other matters, this Agreement and certain Transaction Documents and the Common Dividend, (the notices and disclosure documents, including any exercise notice, restricted share agreement and exchange agreement executed in connection therewith, described in clauses (i) through (iv) are referred to herein collectively as the “ Disclosure Documents ”); and

WHEREAS, certain terms used in this Agreement are defined in Section 1.4 ;

NOW, THEREFORE, in consideration of the premises and the mutual covenants and agreements hereinafter contained, the parties hereby agree as follows:

1. Purchase and Sale of Shares .

1.1 Sale and Issuance of Series A Preferred Stock .

(a) The Company shall adopt and file with the Department of State of the Commonwealth of Pennsylvania on or before the Closing the Amended and Restated Articles of Incorporation of the Company in the form of Exhibit C attached to this Agreement and the Second Amended and Restated Certificate of Designations, Preferences, Limitations and Special Rights of the Series A 8% Convertible Preferred Stock of the Company in the form of Exhibit D attached to this Agreement (collectively, the “ Restated Articles ”).

(b) Subject to the terms and conditions of this Agreement, Purchasers agree to purchase at the Closing, and the Company agrees to sell and issue to Purchasers at the Closing, that number of Shares that is convertible at Closing into 65.7627%, in the aggregate, of the Post-Closing Fully Diluted Equity (the “ Total Number of Purchased Shares ”), for an aggregate purchase price of $194,000,000 (One Hundred Ninety-Four Million Dollars) (the “ Purchase Price ”). As used herein, the “ Post-Closing Fully Diluted Equity ” means that number of fully diluted shares of Common Stock outstanding immediately after Closing, (i) after giving effect to the exercise of all options and the Compensatory Warrants pursuant to Exercise Offer, the exchange of the Financing Warrants pursuant to the Exercise Offer and the conversion of the Existing Preferred Stock pursuant to the Conversion Notice, and (ii) assuming the issuance and conversion of the Shares and taking into consideration any options, Compensatory Warrants and Financing Warrants that were not exercised or exchanged pursuant to the Exercise Offer or Exchange Offer, calculated in accordance with GAAP, using the treasury stock method with the Purchase Price used in determining the fair market value per share.

(c) Each Purchaser shall purchase that number of Shares equal to the ownership percentage set forth opposite such Purchaser’s name of Exhibit A attached to this Agreement, multiplied by the Total Number of Purchased Shares and the consideration payable by such Purchaser for such Shares shall be equal to the ownership percentage set forth opposite such Purchaser’s name on Exhibit A attached to this Agreement, multiplied by the Purchase Price.

 

2


1.2 Closing; Delivery .

(a) The purchase and sale of the Shares shall take place remotely via the exchange of documents and signatures at 10:00 AM EDT on the third Business Day after the later of (i) the satisfaction or waiver of all conditions to closing set forth in Sections 5 and 6 , and (ii) the expiration of the Offer Period (as it may be extended pursuant to Subsection 4.3(b) ), or at such other time and place as the Company and Purchasers mutually agree upon in writing (which time and place are designated as the “ Closing ”).

(b) At the Closing, the Company shall deliver to Purchasers certificates representing the Shares being purchased by them at the Closing against payment of the Purchase Price by wire transfer to a bank account designated by the Company.

1.3 Use of Proceeds; Dividend . The Company will use the proceeds from the sale of the Shares, together with any other sources of cash available to the Company (including, without limitation, funds borrowed under the Company’s existing credit facility) to pay the Common Dividend concurrent with or promptly after the Closing. The amount of the Common Dividend and the Common Dividend payable per share of Common stock (the “ Per Share Dividend ”), and the sources for the Common Dividend shall be determined by the Company’s board of directors as constituted immediately prior to the Closing (the “ Pre-Closing Board ”) in good faith, provided that the aggregate amount of the Common Dividend determined by the Pre-Closing Board shall not exceed the amount determined pursuant to the formula set forth in Exhibit B attached to this Agreement. In making its determination of the Common Dividend and Per Share Dividend, the Pre-Closing Board may use such judgments as it determines in good faith and the Pre-Closing Board’s determination of the actual Common Dividend and Per Share Dividend shall be final, conclusive and binding.

1.4 Defined Terms Used in this Agreement . In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.

(a) “ Affiliate ” means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer or director of such Person or any private equity fund now or hereafter existing that is controlled by one or more general partners or managing members of, or shares the same management company with, such Person.

(b) “ Amended and Restated Bylaws ” means the amended and restated bylaws of the Company, dated as of the date of the Closing, in the form of Exhibit J attached to this Agreement.

(c) “ Amended and Restated Investor Rights Agreement ” means the agreement among the Company, Purchasers and certain other stockholders of the Company, dated as of the date of the Closing, in the form of Exhibit G attached to this Agreement.

(d) “ Amended and Restated Shareholders Agreement ” means that certain Amended and Restated Shareholders Agreement, dated April 20, 2005, as amended from time to time.

 

3


(e) “ Articles of Incorporation ” means the Company’s amended and restated articles of incorporation, dated June 27, 2008.

(f) “ Business Day ” means any day except a Saturday, Sunday or other day on which commercial banks in the City of Philadelphia, Pennsylvania are authorized by law to close.

(g) “ Change in Control ” means (a) the acquisition of the Company by another entity by means of any transaction or series of related transactions (including, without limitation, any reorganization, merger or consolidation) that results in the Company’s shareholders immediately prior to such transaction not holding more than fifty percent (50%) of the voting power of the surviving or continuing entity, or (b) a sale, conveyance or disposition of all or substantially all of the assets of the Company in a bona fide arms’ length transaction or series of related transactions with a third party, unless the Company’s shareholders immediately prior to such transaction or transactions will, as a result of such sale, lease or disposition hold more than fifty percent (50%) of the voting power of the purchasing entity.

(h) “ Code ” means the Internal Revenue Code of 1986, as amended.

(i) “ Company Intellectual Property ” means all patents, patent applications, trademarks, trademark applications, service marks, service mark applications, tradenames, copyrights, trade secrets, domain names, mask works, information and proprietary rights and processes, similar or other intellectual property rights, subject matter of any of the foregoing, tangible embodiments of any of the foregoing, licenses in to and under any of the foregoing, and any and all such cases that are owned or used by the Company in the conduct of the Company’s business as now conducted and as presently proposed to be conducted.

(j) “ Compensatory Warrants ” means the warrants to purchase Common Stock that are identified as “ Compensatory Warrants ” in Subsection 2.2(d) of the Disclosure Schedule.

(k) “ Contract ” means any contract, agreement, indenture, note, bond, mortgage, loan, instrument, lease, license, commitment or other arrangement, understanding, undertaking, commitment or obligation, whether written or oral.

(l) “ ERISA Affiliate ” means any Person which would be treated as a single employer with the Company under Section 414 of the Code.

(m) “ Event ” means any event, change, effect, development, occurrence, circumstance, condition, matter or state of facts.

(n) “ Exchange Consideration ” means, with respect to a Financing Warrant, (i) an amount in cash equal to the Common Dividend paid per share of Common Stock, multiplied by the number of shares of Common Stock underlying such Financing Warrant, minus the aggregate exercise price of such Financing Warrant, and (ii) that number of shares of Common Stock equal to the number of shares of Common Stock underlying such Financing Warrant.

(o) “ Financing Warrants ” means the warrants to purchase Common Stock that are identified as “ Financing Warrants ” in Subsection 2.2(d) of the Disclosure Schedule.

(p) “ GAAP ” means U.S. generally accepted accounting principles, consistently applied during the periods involved.

 

4


(q) “ Governmental Body ” means any government or governmental or regulatory body thereof, or political subdivision thereof, whether federal, state, local or foreign, or any agency, instrumentality or authority thereof, or any court or arbitrator (public or private).

(r) “ Indebtedness ” of any Person means, without duplication, (i) the principal, accrued and unpaid interest, prepayment and redemption premiums or penalties (if any), unpaid fees or expenses and other monetary obligations in respect of (A) indebtedness of such Person for money borrowed and (B) indebtedness evidenced by notes, debentures, bonds or other similar instruments for the payment of which such Person is responsible or liable; (ii) all obligations of such Person issued or assumed as the deferred purchase price of property, all conditional sale obligations of such Person and all obligations of such Person under any title retention agreement (but excluding trade accounts payable and other accrued current liabilities arising in the Ordinary Course of Business (other than the current liability portion of any indebtedness for borrowed money)); (iii) all obligations of such Person under leases required to be capitalized in accordance with GAAP; (iv) all obligations of such Person for the reimbursement of any obligor on any letter of credit, banker’s acceptance or similar credit transaction; (v) all obligations of such Person under interest rate or currency swap transactions (valued at the termination value thereof); (vi) all obligations of the type referred to in clauses (i) through (v) of any Persons for the payment of which such Person is responsible or liable, directly or indirectly, as obligor, guarantor, surety or otherwise, including guarantees of such obligations; and (vii) all obligations of the type referred to in clauses (i) through (vi) of other Persons secured by (or for which the holder of such obligations has an existing right, contingent or otherwise, to be secured by) any Lien on any property or asset of such Person (whether or not such obligation is assumed by such Person).

(s) “ Indemnification Agreement ” means the agreement between the Company and the director designated by any Purchaser entitled to designate a member of the Board of Directors of the Company pursuant to the Second Amended and Restated Shareholders Agreement, dated as of the date hereof and effective as of the Closing, in the form of Exhibit F attached to this Agreement.

(t) “ Investor Rights Agreement ” means that certain Investor Rights Agreement, dated April 20, 2005, as amended from time to time.

(u) “ Key Employee ” means any executive-level employee (including division director and vice president-level positions) as well as any employee or consultant who either alone or in concert with others develops, invents, programs or designs any Company Intellectual Property.

(v) “ Knowledge, ” including the phrase “ to the Company’s knowledge, ” shall mean the actual knowledge after reasonable investigation of the following officers of the Company: David Schlessinger, Thomas Vellios and Ken Bull.

(w) “ Law ” or “ Laws ” means any law, statute, Order, decree, consent decree, judgment, rule, regulation, ordinance or other pronouncement having the effect of law whether in the United States, any foreign country, or any domestic or foreign state, county, city or other political subdivision or of any Governmental Body.

(x) “ Legal Proceeding ” means any judicial, administrative or arbitral actions, suits, mediation, investigation, inquiry, proceedings or claims (including counterclaims) by or before a Governmental Body.

(y) “ Liability ” means any debt, loss, damage, adverse claim, fines, penalties, liability or obligation (whether direct or indirect, known or unknown, asserted or unasserted, absolute or contingent, accrued or unaccrued, matured or unmatured, determined or determinable,

 

5


liquidated or unliquidated, or due or to become due, and whether in contract, tort, strict liability or otherwise), and including all costs and expenses relating thereto (including all fees, disbursements and expenses of legal counsel, experts, engineers and consultants and costs of investigation).

(z) “ Lien ” means any lien, pledge, mortgage, deed of trust, security interest, claim, lease, charge, option, right of first refusal, easement, servitude, proxy, voting trust or agreement, transfer restriction under any shareholder or similar agreement, encumbrance or any other restriction or limitation whatsoever.

(aa) “ Material Adverse Effect ” means any Event that, individually or in the aggregate with all other Events, (a) has or would reasonably be expected to have a material adverse effect on the business, assets, liabilities, properties, results of operations, or financial condition of the Company other than an effect resulting from an Excluded Matter, or (b) prevents the Company from consummating the transactions contemplated by this Agreement. For purposes hereof, “ Excluded Matter ” means any one or more of the following: (i) the financial, banking, capital markets or general economic conditions, (ii) changes in the value of the Company, (iii) regulatory or political conditions, or securities markets in the United States or worldwide or any outbreak of hostilities, terrorist activities or war, or any material worsening of any such hostilities, activities or war, (iv) changes in Laws of general applicability, (v) changes in GAAP, (vi) actions and omissions of the Company taken with the prior written consent of Purchasers, or (vii) earthquakes, storms or similar catastrophes.

(bb) “ MB Letter Agreement ” means the letter agreement, dated February 11, 2010, between the Company and Miller Buckfire & Co, LLC and the supplemental letter agreement related thereto, dated of even date herewith (“ Supplemental MB Letter Agreement ”).

(cc) “ Order ” means any order, injunction, judgment, doctrine, decree, ruling, writ, assessment or arbitration award of a Governmental Body.

(dd) “ Ordinary Course of Business ” means the ordinary and usual course of day-to-day operations of the business of the Company through the date hereof consistent with past practice.

(ee) “ Permitted Exceptions ” means all (i) defects, exceptions, restrictions, easements, rights of way, encumbrances, imperfections or irregularities of title, liens, easements, building or use restrictions, prescriptive rights, protrusions, conditions, ordinances, charges or similar restrictions existing or of record or in the public records, relating to the Company Properties including, covenants, mortgages, deeds of trusts, agreements, covenants, UCC security interest filings, and similar restrictions; (ii) statutory liens for current Taxes, assessments or other governmental charges not yet delinquent or the amount or validity of which is being contested in good faith by appropriate proceedings, provided an appropriate reserve has been established therefor in the Financial Statements in accordance with GAAP; (iii) mechanics’, carriers’, workers’, and repairers’ Liens arising or incurred in the Ordinary Course of Business that are not resulting from a breach, default or violation by the Company of any Contract or Law; (iv) zoning, entitlement and other land use and environmental Laws, provided that such Laws have not been violated in any material respect; and (v) statutory and contractual landlord’s Liens under Real Property Leases pursuant to which the Company is a tenant and is not in default beyond any applicable notice and cure period.

(ff) “ Permits ” means any approvals, authorizations, consents, licenses, permits or certificates of a Governmental Body.

 

6


(gg) “ Person ” means any individual, corporation, partnership, trust, limited liability company, association or other entity.

(hh) “ Qualified Public Offering ” means an underwritten public offering of shares of Common Stock in which the Company receives aggregate gross proceeds of at least $100 million, and following which the shares of the Company are listed on a nationally recognized U.S. stock market.

(ii) “ Second Amended and Restated Shareholders Agreement ” means the agreement among the Company, Purchasers and certain other stockholders of the Company, dated as of the date hereof and effective as of the Closing, in the form of Exhibit H attached to this Agreement.

(jj) “ Securities Act ” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

(kk) “ Stock Plan ” means the Company’s Equity Incentive Plan, as amended and restated effective May 14, 2010.

(ll) “ Tax ” means (i) all taxes, charges, levies, fees or other assessments imposed by any United States federal, state, local or non-U.S. taxing authority, including net or gross income, excise, property, sales, transfer, franchise, payroll, withholding, value-added, social security or other similar taxes, including any interest, penalties or additions to tax attributable thereto, and (ii) any liability to pay amounts described in clause (i) by reason of Treasury Regulation Section 1.1502-6 or similar provision of state, local or foreign law, transferee or successor liability, contract or otherwise.

(mm) “ Tax Return ” means any return, report, information return or other document (including any related or supporting information) filed or required to be filed with any taxing authority with respect to Taxes, including all information returns relating to Taxes of third parties, any claims for refunds of Taxes and any amendments or supplements to any of the foregoing.

(nn) “ Transaction Documents ” means this Agreement, the Restated Articles, the Amended and Restated Investor Rights Agreement, the Second Amended and Restated Shareholders Agreement, the Amended and Restated Bylaws, and the Indemnification Agreement(s).

1.5 Terms Defined Elsewhere in this Agreement . For purposes of this Agreement, the following terms have means set forth in the sections indicated below:

 

Term

  

Section

280G Disclosure Statement    4.12
Acquisition Transaction    4.6(a)
Antitrust Division    4.4(a)
Antitrust Laws    4.4(b)
Closing    1.2(a)
COBRA    2.16(j)
Common Dividend    Recitals
Common Stock    Recitals
Company    Preamble
Company Plans    2.16(f)
Company Properties    2.12(a)
Confidential Information    4.1, 4.7(c)

 

7


Confidentiality Agreement    4.1
Conversion Notice    Recitals
Deductible    7.3(b)
Deductible Dividend Defense Costs    7.3(a)
Disclosure Documents    Recitals
Disclosure Documents Actions    Recitals
Disclosure Schedule    2
Dividend Record Date    Recitals
Environmental Laws    2.22
ERISA    2.16(g)
Excluded Matter    Material Adverse Effect definition
Existing Credit Facility    4.14(a)
Existing Preferred Designation    Recitals
Existing Preferred Stock    2.2(a)
Financial Statements    2.13
Founder(s)    Preamble
FTC    4.4(a)
Fundamental Representations    7.1
Hazardous Substance    2.22
HSR Act    2.6(b)
HSR Filings    4.4(a)
LLR    Recitals
Loan Agreement    5.14
Loss(es)    7.5
Material Contracts    2.9(a)
Maturity Date    4.14(b)
Most Recent Balance Sheet    2.13
New Reserve Amount    4.13
Offer Period    Recitals
Outside Termination Date    8.1(a)
PCBs    2.22
Per Share Dividend    1.3
Personal Property Leases    2.23
Post-Closing Fully Diluted Equity    1.1(b)
Potential Benefits    4.12
Pre-Closing Board    1.3
Purchase Price    1.1(b)
Purchaser(s)    Preamble
Purchaser Indemnified Parties    7.2
Real Property Lease    2.12(a)
Representatives    4.6(a)
Restated Articles    1.1(a)
Restricted Business    4.7(a)
Restriction Period    4.7(a)
SCS Loan    4.14(a)
Series A Preferred Stock    Recitals
Shares    Recitals
Significant Common Shareholder(s)    Preamble
Supplemental MB Letter Agreement    MB Letter Agreement definition
Survival Expiration Date    7.1
Third Party Claim    7.4(b)

Total Number of Purchased Shares

   1.1(c)

Working Capital Shortfall

   4.14(a)

Wells Fargo

   5.14

 

8


2. Representations and Warranties of the Company . The Company hereby represents and warrants to each Purchaser that, except as set forth on the Disclosure Schedule attached as Exhibit E to this Agreement (the “ Disclosure Schedule ”), the following representations are true and complete. The Disclosure Schedule shall be arranged in sections corresponding to the numbered and lettered sections and subsections contained in this Section 2 , and the disclosures in any section or subsection of the Disclosure Schedule shall qualify other sections and subsections in this Section 2 only to the extent it is readily apparent from a reading of the disclosure that such disclosure is applicable to such other sections and subsections.

2.1 Organization, Good Standing, Corporate Power and Qualification . The Company is a corporation duly organized, validly existing and subsisting under the laws of the Commonwealth of Pennsylvania and has all requisite corporate power and authority to carry on its business as presently conducted and as currently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would reasonably be expected to have a Material Adverse Effect.

2.2 Capitalization .

(a) The authorized capital of the Company as of the date hereof consists of:

(i) 60,000,000 shares of Common Stock, 21,632,316 shares of which are issued and outstanding; all such issued and outstanding shares of Common Stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws; and

(ii) 20,000,000 shares of Preferred Stock, of which (A) 6,990,700 shares have been designated Series A Convertible Preferred Stock pursuant to the Existing Preferred Designation, 6,173,030 shares of which are issued and outstanding, and (B) 9,300,000 shares have been designated as Series A-1 Convertible Preferred Stock pursuant to the Existing Preferred Designation, 8,006,984 shares of which are issued and outstanding.

(b) The Company holds no Common Stock in its treasury. The Company holds no Preferred Stock in its treasury.

(c) As of the date hereof:

(i) the Company has reserved 5,150,000 shares of Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to the Stock Plan.

(ii) of the shares reserved under the Stock Plan, no shares have been issued pursuant to restricted stock purchase agreements, options to purchase 3,255,982 shares have been granted and are currently outstanding, and 1,894,018 shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan.

The Company has furnished to Purchasers complete and accurate copies of the Stock Plan and forms of option award agreements used thereunder.

 

9


(d) Subsection 2.2(d) of the Disclosure Schedule sets forth the capitalization of the Company as of the date hereof, including the number of shares and the name of the holder of the following: (i) issued and outstanding Common Stock, (ii) granted and outstanding stock options, including grant date, exercise date, vesting schedule and exercise price; (iii) each series of Existing Preferred Stock; and (iv) warrants or stock purchase rights, if any. Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section 2 of the Investor Rights Agreement, (C) the securities and rights described in Subsection 2.2(c) of this Agreement and Subsection 2.2(d) of the Disclosure Schedule, and (D) the securities and rights described in the Existing Preferred Designation, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Existing Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Existing Preferred Stock. Except as set forth in Subsection 2.2(d) of the Disclosure Schedule, there are no obligations, contingent or otherwise, of the Company to (i) repurchase, redeem or otherwise acquire any shares of the Company’s capital stock, or (ii) provide material funds to, or make any material investment in (in the form of a loan or capital contribution) or provide any guarantee with respect to the obligations of, any Person. Except as set forth in Subsection 2.2(d) of the Disclosure Schedule, there are no outstanding stock appreciation, phantom stock, profit participation or similar rights with respect to the Company. There are no bonds, debentures, notes or other indebtedness of the Company having the right to vote or consent (or, convertible into, or exchangeable for, securities having the right to vote or consent) on any matters on which stockholders (or other equityholders) of the Company may vote. Except as set forth in Subsection 2.2(d) of the Disclosure Schedule, there are no voting trusts, irrevocable proxies or other Contracts or understandings to which the Company is a party or is bound with respect to the voting or consent of any shares of capital stock.

(e) The Company has obtained valid waivers with respect to the rights of first offer and preemptive rights held by any Person to purchase any of the Shares covered by this Agreement.

2.3 Subsidiaries . The Company does not currently own or control, directly or indirectly, any interest in any other corporation, partnership, trust, joint venture, limited liability company, association, or other business entity. The Company is not a participant in any joint venture, partnership or similar arrangement.

2.4 Authorization . All corporate action required to be taken by the Company’s Board of Directors and its shareholders in order to authorize the Company to enter into and perform this Agreement and the other Transaction Documents to which the Company is a party, and to issue the Shares at the Closing and the Common Stock issuable upon conversion of the Shares, has been taken or will be taken prior to the Closing. Assuming due authorization and execution by the other parties to this Agreement and the other Transaction Documents to which the Company is a party, this Agreement and such other Transaction Documents when executed and delivered by the Company, shall constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance with their respective terms except (a) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors’ rights generally, (b) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies, or (c) to the extent the indemnification provisions contained in the Amended and Restated Investor Rights Agreement, the Amended and Restated Bylaws and the Indemnification Agreement may be limited by applicable federal or state securities Laws.

 

10


2.5 Valid Issuance of Shares . The Shares, when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Documents, applicable state and federal securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of Purchasers in Section 3 of this Agreement and subject to the filings described in Subsection 2.6(b)(ii) below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares will be duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Articles, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Documents, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Based in part upon the representations of Purchasers in Section 3 of this Agreement, and subject to Subsection 2.6 below, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws.

2.6 Consents; Filings; Conflicts .

(a) Except as set forth in Subsection 2.6(a) of the Disclosure Schedule, none of the execution and delivery by the Company of this Agreement or the other Transaction Documents, the consummation of the transactions contemplated hereby or thereby, or compliance by the Company with any of the provisions hereof or thereof will conflict with, or result in any violation or breach of, conflict with or default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancellation or acceleration of any obligation or to loss of a material benefit under, or give rise to any obligation of the Company to make any payment under, or to the increased, additional, accelerated or guaranteed rights or entitlements of any Person under, or result in the creation of any Liens upon any of the properties or assets of Company under, any provision of (i) the Articles of Incorporation or Bylaws of the Company; (ii) any Material Contract or any material Permit to which the Company is a party or by which any of the properties or assets of the Company are bound; (iii) any Order applicable to the Company or any of the properties or assets of the Company; or (iv) any applicable Law.

(b) Except as set forth in Subsection 2.6(b) of the Disclosure Schedule, no consent, waiver, approval, Order, Permit or authorization of, or declaration or filing with, or notification to, any Person or Governmental Body is required on the part of the Company in connection with (i) the execution and delivery of this Agreement, the other Transaction Documents, respectively, the compliance by the Company with any of the provisions hereof and thereof, or the consummation of the transactions contemplated hereby or thereby, or (ii) the continuing validity and effectiveness immediately following the Closing of any material Permit or Material Contract of the Company, except for (A) the filing of the Restated Articles, which will have been filed as of the Closing, (B) filings pursuant to Regulation D of the Securities Act and applicable state securities laws, which have been made or will be made in a timely manner, and (C) compliance with the applicable requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the rules and regulations promulgated thereunder (the “ HSR Act ”).

2.7 Litigation . Except as set forth in Subsection 2.7 of the Disclosure Schedule, there is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company’s Knowledge, currently threatened (i) against the Company or any officer, director or Key Employee of the Company arising out of their employment or board relationship with the Company; (ii) that questions the validity of the Transaction Documents or the right of the Company to enter into them, or to consummate the transactions contemplated by the Transaction Documents; or (iii) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company’s Knowledge, any of its officers, directors or Key Employees is a party or is named as subject to the provisions of any Order (in the case of officers, directors or Key

 

11


Employees, such as would affect the Company). There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company’s employees, their services provided in connection with the Company’s business, or any information or techniques allegedly proprietary to any of their former employers, or their obligations under any agreements with prior employers.

2.8 Intellectual Property . The Company owns or possesses or can acquire on commercially reasonable terms sufficient legal rights to all Company Intellectual Property without any known conflict with, or infringement of, the rights of others. To the Company’s knowledge, no product or service marketed or sold (or proposed to be marketed or sold as of the date hereof) by the Company violates or will violate any license or infringes or will infringe any intellectual property rights of any other party. Except as set forth in Subsection 2.8 of the Disclosure Schedule, other than with respect to commercially available software products under standard end-user object code license agreements, there are no outstanding options, licenses, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company Intellectual Property, nor is the Company bound by or a party to any options, licenses or agreements of any kind with respect to the patents, trademarks, service marks, trade names, copyrights, trade secrets, licenses, information, proprietary rights and processes of any other Person. Except as set forth in Subsection 2.8 of the Disclosure Schedule, the Company has not received any written communications alleging that the Company has violated or, by conducting its business, would violate any of the patents, trademarks, service marks, tradenames, copyrights, trade secrets, mask works or other proprietary rights or processes of any other Person. The Company has obtained and possesses valid licenses to use all of the software programs present on the computers and other software-enabled electronic devices that it owns or leases or that it has otherwise provided to its employees for their use in connection with the Company’s business. To the Company’s knowledge, it will not be necessary to use any inventions of any of its employees or consultants made prior to their employment by the Company. Subsection 2.8 of the Disclosure Schedule lists all Company Intellectual Property. The Company has not embedded any open source, copy left or community source code in any of its products generally available or in development, including but not limited to any libraries or code licensed under any General Public License, Lesser General Public License or similar license arrangement. For purposes of this Subsection 2.8 , the Company shall be deemed to have knowledge of a patent right if the Company has actual knowledge of the patent right or would be found to be on notice of such patent right as determined by reference to United States patent laws.

2.9 Agreements; Actions .

(a) Subsection 2.9(a) of the Disclosure Schedule sets forth, by reference to the applicable subsection of this Subsection 2.9(a) , all of the following Contracts (other than leases for real property) to which the Company is a party or by which its assets or properties are bound (collectively, the “ Material Contracts ”):

(i) Except for stock option agreements entered into under the Stock Plan, Financing Warrants, Compensatory Warrants, Contracts entered into by the Company for the sale of Existing Preferred Stock and Financing Warrants and Disclosure Documents, Contracts with any stockholder of the Company or Affiliate thereof or any current or former officer, director, stockholder or Affiliate of the Company;

(ii) Contracts with any labor union or association representing any employee of the Company;

 

12


(iii) Contracts for the sale of any of the assets of the Company other than in the Ordinary Course of Business or for the grant to any Person of any preferential rights to purchase any of its assets;

(iv) Contracts for joint ventures, strategic alliances, partnerships, licensing arrangements, or sharing of profits or proprietary information;

(v) Contracts that limit the ability of the Company from competing in its line of business, as currently conducted; for purposes of this provision permitted use restrictions contained in a Contract for the lease of real property shall not be considered a provision that limits the Company’s ability to compete in any line of business or geographic area;

(vi) Contracts relating to the acquisition (by merger, purchase of stock or assets or otherwise) by the Company of any operating business or material assets or the capital stock of any other Person;

(vii) Contracts relating to the incurrence, assumption or guarantee of any Indebtedness by the Company or imposing a Lien on any of the assets of the Company, including indentures, guarantees, loan or credit agreements, sale and leaseback agreements, purchase money obligations incurred in connection with the acquisition of property, mortgages, pledge agreements, security agreements, or conditional sale or title retention agreements;

(viii) Contracts, other than purchase orders entered into in the Ordinary Course of Business and Contracts for the employment of any individual on a full-time, part-time or consulting or other basis, giving rise to Liabilities of the Company in excess of $150,000 during the term thereof;

(ix) Contracts (or groups of related Contracts), other than purchase orders entered into in the Ordinary Course of Business, providing for payments to the Company in excess of $50,000 in any fiscal year or $150,000 in the aggregate during the term thereof;

(x) Contracts requiring the Company to purchase a minimum volume of products from a supplier or requiring the Company to sell a minimum of its products;

(xi) Contracts under which the Company has made advances or loans to any other Person;

(xii) Contracts providing for severance, retention, change in control or other similar payments;

(xiii) Contracts for the employment of any individual on a full-time, part-time basis providing annual cash compensation in excess of $150,000;

(xiv) material Contracts with independent contractors or consultants (or similar arrangements) that (A) are not cancelable without penalty or further payment and without more than 30 days’ notice or (B) provide for annual cash compensation in excess of $150,000 per year; and

(xv) outstanding Contracts of guaranty, surety or indemnification, direct or indirect, by the Company.

 

13


(b) Except as set forth in Subsection 2.9(b) of the Disclosure Schedule, each Material Contract is a legal, valid and binding agreement and in full force and effect and enforceable by the Company in accordance with its terms except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors’ rights generally, and (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies. Except as set forth in Subsection 2.9(b) of the Disclosure Schedule, (A) upon consummation of the transactions contemplated by this Agreement, each Material Contract shall continue in full force and effect without penalty or other adverse consequence and (B) the Company is not in default under any Material Contract, nor, to the Knowledge of the Company, is any other party to any Material Contract in breach of or default thereunder, and no event has occurred that with the lapse of time or the giving of notice or both would constitute a breach or default by the Company or, to the Knowledge of the Company, any other party thereunder. No party to any of the Material Contracts has exercised any termination rights with respect thereto, and no party has given written notice of any significant dispute with respect to any Material Contract. The Company has delivered to Purchaser true, correct and complete copies of all of the Material Contracts, together with all amendments, modifications or supplements thereto.

2.10 Certain Transactions .

(a) Except as set forth in Subsection 2.10 of the Disclosure Schedule, other than (i) standard employee benefits generally made available to all employees, (ii) standard director and officer indemnification agreements approved by the Board of Directors of the Company, (iii) as set forth in the Articles of Incorporation and Bylaws of the Company, (iv) Contracts entered into in connection with prior equity financing rounds of the Company, (v) the purchase of shares of the Company’s capital stock and the issuance of options and warrants to purchase shares of Common Stock approved in the written minutes of the Board of Directors of the Company or by written consent of the Board of Directors of the Company, and (vi) as contemplated by the Disclosure Documents, there are no agreements, understandings or proposed transactions between the Company and any of its Affiliates, stockholders, officers, directors, consultants or Key Employees, or any member of his or her immediate family, or any Affiliate thereof.

(b) The Company is not indebted, directly or indirectly, to any of its directors, officers or employees or to their respective spouses or children or to any Affiliate of any of the foregoing, other than in connection with expenses or advances of expenses incurred in the Ordinary Course of Business or employee relocation expenses and for other customary employee benefits made generally available to all employees of the Company. Except as set forth in Subsection 2.10 of the Disclosure Schedule, none of the Company’s Affiliates, stockholders, directors, officers or employees, or any members of their immediate family members, or any Affiliate of the foregoing, are, directly or indirectly, indebted to the Company or, to the Company’s Knowledge, have any (i) material commercial, industrial, banking, consulting, legal, accounting, charitable or familial relationship with any of the Company’s customers, suppliers, service providers, joint venture partners, licensees and competitors, (ii) direct or indirect ownership interest in any firm or corporation with which the Company is affiliated or with which the Company has a business relationship, or any firm or corporation which directly competes with the Company except that directors, officers or employees or stockholders of the Company may own stock in (but not exceeding two percent (2%) of the outstanding capital stock of) publicly traded companies that may compete with the Company or (iii) financial interest in any Contract with the Company.

2.11 Rights of Registration and Voting Rights . Except as provided in the Investor Rights Agreement, the Company is not under any obligation to register under the Securities Act any of its currently outstanding securities or any securities issuable upon exercise or conversion of its currently

 

14


outstanding securities. To the Company’s Knowledge, except as contemplated in the Amended and Restated Shareholders Agreement and options and warrants issued by the Company and except as set forth in Subsection 2.11 of the Disclosure Schedule, no stockholder of the Company has entered into any agreements with respect to the voting of shares of capital stock of the Company.

2.12 Real Property .

(a) The Company does not, and never has, owned any real property or interests in real property, including improvements thereon and easements appurtenant thereto. Subsection 2.12(a) of the Disclosure Schedule sets forth a complete list of all real property and interests in real property leased by the Company (each a “ Real Property Lease ” and the Company’s interest in the Real Property Leases referred to herein as “ Company Properties ”) as lessee or lessor, including the name of the third party lessor or lessee and the date of the lease or sublease and all amendments thereto. The Company Properties constitute all interests in real property currently used, occupied or currently held for use in connection with the business of the Company. All of the Company Properties are adequate and sufficient, in all material respects, for the continuing conduct of the business of the Company as presently conducted. The Company has delivered to Purchaser true, correct and complete copies of the Real Property Leases, together with all amendments, modifications or supplements, if any, thereto.

(b) The Company has a valid, binding and enforceable leasehold interest against the counterparty thereto under each of the Real Property Leases under which it is a lessee, free and clear of all Liens other than Permitted Exceptions and as set forth on Subsection 2.12(b) of the Disclosure Schedule. Each of the Real Property Leases is in full force and effect. The Company is not in default under any Real Property Lease. Except as set forth on Subsection 2.12(b) of the Disclosure Schedule, to the Company’s Knowledge, no event has occurred and no circumstance exists which, if not remedied, and whether with or without notice or the passage of time or both, would result in such a default and no other party is in default thereof, and no party to any Real Property Lease has exercised any termination rights with respect thereto.

(c) There does not exist any actual or, to the Knowledge of the Company, threatened or contemplated condemnation or eminent domain proceedings that affect any of the Company Properties or any part thereof and the Company has not received any written notice of the intention of any Governmental Body or other Person to take or use all or any part thereof.

(d) The Company has not received any written notice from any insurance company that has issued a policy with respect to any of the Company Properties requiring performance of any structural or other repairs or alterations to such Company Properties.

(e) The Company does not own or hold, is not a party to, and is not obligated under, any option, right of first refusal or other contractual right to purchase, acquire, sell, assign or dispose of any real estate or any portion thereof or interest therein.

2.13 Financial Statements . The Company has delivered to each Purchaser its (a) audited financial statements as of January 31, 2009 and January 30, 2010 (the “ Audited Financial Statements ”), (b) its unaudited income statement and statement of cash flows for the 22-week period ended July 3, 2010 (the “ Interim Statements ”) and (c) its unaudited balance sheet as of July 3, 2010 (the “ Most Recent Balance Sheet ” and together with the “ Interim Statements ”, the “ Interim Financials ”, and the Audited Financials and the Interim Statements together, the “ Financials ”). Except as set forth on Subsection 2.13 of the Disclosure Schedule, the Financials (i) have been prepared in accordance with GAAP applied on a consistent basis throughout the periods indicated and (ii) fairly present in all material respects the financial condition and operating results of the Company as of the dates, and for the periods,

 

15


indicated therein, except as otherwise stated therein or, in the case of the Interim Financials, for the omission of footnotes (that, if presented, would not differ materially from those presented in the Audited Financial Statements) and subject to normal and recurring year-end adjustments The Company maintains a standard system of accounting established and administered in accordance with GAAP.

2.14 No Undisclosed Liabilities . Except as set forth on Subsection 2.14 of the Disclosure Schedule and except as and to the extent set forth in the audited balance sheet for the fiscal year ended January 30, 2010 or the Most Recent Balance Sheet, the Company has no Indebtedness or Liabilities other than those (i) incurred in the Ordinary Course of Business since January 30, 2010, (ii) under this Agreement, the other Transaction Documents and the Disclosure Documents, or (iii) that are immaterial to the Company.

2.15 Changes . Except as expressly contemplated by this Agreement, the other Transaction Documents and the Disclosure Documents and except as set forth in Subsection 2.15 of the Disclosure Schedule, since January 30, 2010 (i) the Company has conducted its business only in the Ordinary Course of Business and (ii) there has not been:

(a) any change in the assets, liabilities, financial condition or operating results of the Company from that reflected in the Financial Statements, except changes in the Ordinary Course of Business that have not caused a Material Adverse Effect;

(b) any damage, destruction or loss, whether or not covered by insurance, that would reasonably be expected to have a Material Adverse Effect;

(c) any waiver or compromise by the Company of a material debt owed to it;

(d) any satisfaction or discharge of any Lien or payment of any obligation by the Company, except in the Ordinary Course of Business;

(e) any material change to a Material Contract;

(f) any material change in any compensation arrangement or agreement with any Key Employee, officer, director or stockholder of the Company;

(g) any resignation or termination of employment of any officer or Key Employee of the Company;

(h) any Lien created by the Company with respect to any of its material properties or assets, except for Permitted Liens or Liens that arise in the Ordinary Course of Business and do not materially impair the Company’s ownership or use of its property or assets;

(i) any loans or guarantees made by the Company to or for the benefit of its employees, officers or directors, or any members of their immediate family members, other than travel advances and other advances made in the Ordinary Course of Business;

(j) any declaration, setting aside or payment or other distribution in respect of any of the Company’s capital stock, or any direct or indirect redemption, purchase, or other acquisition of any of such stock by the Company;

(k) (i) any Tax election, settlement or compromise of any Tax claim or liability, or change or revocation thereto, or entry into a settlement or compromise, or a change (or a

 

16


request to any taxing authority to change) in any material aspect of the Company’s method of accounting for Tax purposes, or (ii) preparation or filing of any Tax Return (or any amendment thereof) unless such Tax Return shall have been prepared in a manner consistent with past practice; or

(l) any arrangement or commitment by the Company to do any of the things described in this Subsection 2.15 .

2.16 Employee Matters .

(a) Subsection 2.16 of the Disclosure Schedule sets forth a description of all compensation for the fiscal year ending January 30, 2010 and projected for the fiscal year ended January 29, 2011, including salary, bonus, severance obligations and deferred compensation paid or payable for each officer, employee, consultant and independent contractor of the Company who received cash compensation from the Company in excess of $150,000 for the fiscal year ended January 30, 2010 or is anticipated to receive cash compensation from the Company in excess of $150,000 for the fiscal year ending January 29, 2011.

(b) The Company has complied in all material respects with all applicable state and federal equal employment opportunity laws and with other laws related to employment, including those related to wages, hours, worker classification, and collective bargaining. The Company has withheld and paid to the appropriate Governmental Body or is holding for payment not yet due to such Governmental Body all amounts required to be withheld from employees of the Company and is not liable for any arrears of wages, taxes, penalties, or other sums for failure to comply with any of the foregoing.

(c) To the Company’s Knowledge, no Key Employee intends to terminate employment with the Company or is otherwise likely to become unavailable to continue as a Key Employee, nor does the Company have a present intention to terminate the employment of any of the foregoing. The employment of each employee of the Company is terminable at the will of the Company. Except as set forth in Subsection 2.16 of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Subsection 2.16 of the Disclosure Schedule, the Company has no policy, practice, plan, or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.

(d) Each former executive-level employee whose employment was terminated by the Company has entered into an agreement with the Company providing for the full release of any claims against the Company or any related party arising out of such employment.

(e) The Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any Contract with any labor union, and no labor union has requested or, to the Knowledge of the Company, has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute involving the Company pending, or to the Company’s Knowledge, threatened, which would reasonably be expected to have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its current or former employees.

(f) Subsection 2.16 of the Disclosure Schedule sets forth all “employee benefit plans”, as defined in Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ ERISA ”), and all other employee benefit arrangements or payroll practices, including without limitation, retirement plans, bonus plans, employment, consulting or other compensation agreements,

 

17


incentive, equity or equity-based compensation, or deferred compensation arrangements, change in control, termination, retention or severance plans or arrangements, stock purchase, severance pay, sick leave, vacation pay, salary continuation for disability, hospitalization, medical insurance, life insurance, educational and employee assistance plans and programs maintained, established or sponsored by the Company, or which the Company participates in or contributes to thereunder for current or former employees, consultants, independent contractors or directors of the Company or any of its ERISA Affiliates (the “ Company Plans ”).

(g) True, correct and complete copies of the following documents, with respect to each of the Company Plans, have been made available or delivered to Purchasers by the Company, to the extent applicable: (i) any plans, all amendments thereto and related trust documents, and amendments thereto; (ii) the most recent Forms 5500 and all schedules thereto; (iii) the most recent Internal Revenue Service determination letter or opinion letter; (iv) the most recent summary plan descriptions; (v) written communications to employees relating to the Company Plans; and (vi) written descriptions of all non-written agreements relating to the Company Plans.

(h) All contributions, premiums and benefit payments under or in connection with the Company Plans that are required to have been made as of the date hereof in accordance with the terms of the Company Plans have been timely made (including under any valid extension) or have been reflected on the Most Recent Balance Sheet.

(i) Neither the Company nor any of its ERISA Affiliates maintains or contributes to, or has within the last six years sponsored, maintained, contributed or has been obligated to contribute to any “employee pension plans”, as defined in Section 3(2) of ERISA, subject to Title IV of ERISA or Section 412 of the “Code, including any “multiemployer plan”, as defined in Section 3(37) of ERISA.

(j) Except as set forth in Subsection 2.16 of the Disclosure Schedule, none of the Company Plans provides any retiree or post-employment life or health insurance, benefits or coverage to any current or former employees of the Company, except as may be required under the Consolidate Omnibus Budget Reconciliation Act of 1985, as amended (“ COBRA ”) and at the sole expense of such individual except as required by applicable law.

(k) The Company Plans have been established and maintained, in all material respects, in accordance with their terms and with all provisions of ERISA, the Code and other applicable federal and state laws and the Company has performed and complied in all material respects with all of its obligations under and with respect to each Company Plan. Each Company Plan that is a “nonqualified deferred compensation plan” within the meaning of Section 409A of the Code and any award thereunder, in each case that is subject to Section 409A of the Code, has been established and maintained in all material respects in accordance with the requirements of Section 409A of the Code and the regulations thereunder. Except as set forth in Subsection 2.16 of the Disclosure Schedule, (i) each stock option granted by the Company was granted with an exercise price equal to the fair market value of the Common Stock on the date of grant in compliance with Section 409A of the Code or satisfies the “grandfather” rules for stock option under Section 409A of the Code, and (ii) the Company has not adjusted or amended the exercise price of any options which are outstanding as of the date hereof. The Company has not made any representations regarding equity incentives to any officer, employees, director or consultant that are inconsistent with the share amounts and terms set forth in the minutes of meetings of the Company’s Board.

(l) Each Company Plan intended to qualify under Section 401 of the Code and the trust maintained pursuant thereto has received or may rely on a favorable determination or

 

18


opinion letter from the IRS concerning its qualification under and exemption from federal income taxation under Sections 401 and 501 of the Code, respectively, and nothing has occurred since the date of the most recent determination letter or opinion letter relating to any such Company Plan that would adversely affect the qualification of such Company Plan.

(m) Except as set forth in Subsection 2.16 of the Disclosure Schedule, the execution and delivery of this Agreement and the performance of the transactions contemplated hereby, will not (either alone or upon the occurrence of any additional or subsequent events) constitute an event under any Company Plan that will (i) result in any payment (whether of severance pay or otherwise) becoming due to any current or former employee, director of, or consultants to, the Company, (ii) result in the acceleration of the time of payment, funding or vesting of any benefits under any Company Plan, (iii) increase any amount of benefits under any Company Plan, (iv) require any contribution or payments to fund any obligations under any Company Plan, (v) result in the triggering or imposition of any restrictions or limitations on the right of the Company to amend or terminate any Company Plan or (vi) give rise to any amount that would not be deductible by the Company under Section 280G of the Code.

2.17 Tax Returns and Payments . The Company has (i) duly and timely filed (including pursuant to applicable extensions granted without penalty) all material Tax Returns required to be filed by it, and such Tax Returns are true, correct and complete in all material respects, and (ii) timely paid in full all material amounts of Taxes due and owing (whether or not shown on any Tax Return), it being understood that no representation or warranty is being made regarding the availability of any net operating loss carryovers to offset any taxes that are first due following the Closing. Except as set forth in Subsection 2.17 of the Disclosure Schedule, no material deficiencies for any Taxes have been proposed, asserted or assessed in writing against the Company. The Company has no Liability for Taxes of any other Person arising from the application of Treasury Regulation Section 1.1502-6 or any analogous provision of Law, as a transferee or successor, or by contract. Except as set forth in Subsection 2.17 of the Disclosure Schedule, all Taxes required to be withheld, collected or deposited by or with respect to the Company have been timely withheld, collected or deposited as the case may be, and to the extent required, have been paid to the relevant taxing authority. The Company is not now and has never been a “United States real property holding corporation” as defined in the Code and any applicable regulations promulgated thereunder.

2.18 Insurance . The Company has in full force and effect fire and casualty insurance policies with extended coverage, sufficient in amount (subject to reasonable deductions) to comply with applicable Law and Material Contracts to which the Company is a party or by which it is bound. The Company has insurance policies in full force and effect for such amounts as are sufficient for all Material Contracts to which the Company is a party or by which it is bound.

2.19 Employee Agreements . Each Key Employee has executed (a) an agreement with the Company regarding confidentiality and proprietary information substantially in the form or forms delivered to the counsel for Purchasers, and (b) a non-competition and non-solicitation agreement substantially in the form or forms delivered to counsel for Purchasers. To the Company’s Knowledge, no Key Employee is in violation of any agreement covered by this Subsection 2.19 .

2.20 Compliance with Law and Regulations; Permits .

(a) The operation of the business of Company since January 1, 2007, and as currently conducted, does not violate any Law or Order applicable to the Company or of its assets and properties, except where a violation would not reasonably be expected to be materially adverse to the Company. Neither the Company nor to the Company’s Knowledge, any of its directors, officers or Key Employees has violated or is currently in default or violation in any material respect under any Law or

 

19


Order applicable to the Company or any of its assets and properties. The Company has timely filed with the proper authorities all statements and reports required by all Laws or Orders to which the Company and its assets, properties and business are subject, except where noncompliance would not reasonably be expected to have a Material Adverse Effect. No claim of a violation of any such Laws or Orders by the Company has been made and the Company is not aware of any claim of violation, or of any actual violation, of any such Laws or Orders by the Company, that, in each case, would not reasonably be expected to have a Material Adverse Effect.

(b) The Company has all material Permits required by any Law or any Governmental Body for the conduct of the Company’s business as presently conducted. Each of the Company’s Permits is in full force and effect and the Company is in compliance in all material respects with the terms and requirements thereof, and no such Permit is subject to any conditions or limitations other than those applicable to permits of that kind generally. There is not pending or, to the Company’s Knowledge, threatened, any action, investigation, complaint or other proceeding by or before any Governmental Body to revoke, cancel, suspend, modify or refuse to renew, or otherwise relating to, any of the Permits.

2.21 Corporate Documents . The Articles of Incorporation and Bylaws of the Company as in effect on the date hereof are in the form provided to Purchasers. The copy of the minute books of the Company provided to Purchasers contains minutes of all meetings of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since 2007 and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders with respect to all transactions referred to in such minutes.

2.22 Environmental and Safety Laws . Except as would not reasonably be expected to have a Material Adverse Effect, the Company is and has been in compliance with all Environmental Laws. To the Company’s Knowledge, there has been no release or threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste, or petroleum or any fraction thereof, (each a “ Hazardous Substance ”) on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company. The Company has not received any written notice of any claim, allegation, investigation, judicial or administrative action or proceeding, and to the Company’s Knowledge, none are threatened or pending, in which it is alleged that the Company has failed to comply with or is subject to liability under Environmental Laws, and, to the Company’s Knowledge, the Company is not subject to any outstanding Order or agreement issued by a Governmental Body under any Environmental Laws. To the Company’s knowledge, (a) there have been no Hazardous Substances generated or otherwise used by the Company that have been disposed of or come to rest at any site that has been included in any published U.S. federal, state or local “superfund” site list or any other similar list of hazardous or toxic waste sites published by any Governmental Body in the United States; (b) no facts, circumstances or conditions exist with respect to the Company or any property currently or formerly owned, operated, leased, or otherwise used by the Company that could reasonably be expected to result in the Company incurring unbudgeted material liability; and (c) there are no underground storage tanks located on, no polychlorinated biphenyls (“ PCBs ”) or PCB-containing equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws.

For purposes of this Subsection 2.22 , “ Environmental Laws ” means any law, regulation, or other applicable requirement relating to (a) releases or threatened release of Hazardous Substance; (b) pollution or protection of employee health or safety, public health or the environment; or (c) the manufacture, handling, transport, use, treatment, storage, or disposal of Hazardous Substances.

 

20


2.23 Tangible Personal Property .

(a) The Company has good and marketable title to all of the items of tangible personal property used in the business of the Company (except as sold or disposed of subsequent to the date of acquisition thereof in the Ordinary Course of Business), free and clear of any and all Liens, other than the Permitted Exceptions and as set forth on Subsection 2.23(a) of the Disclosure Schedule. All such items of tangible personal property which, individually or in the aggregate, are material to the operation of the business of the Company are in good condition and in a state of good maintenance and repair (ordinary wear and tear excepted).

(b) None of the personal property leased by the Company for use in its business personal property involves annual payments in excess of $50,000. All of the items of personal property subject to a personal property lease (each, a “ Personal Property Lease ”) are in good condition and repair (ordinary wear and tear excepted), and such property is in all material respects in the condition required of such property by the terms of the lease applicable thereto during the term of the lease.

(c) The Company has a valid and enforceable leasehold interest under each of the Personal Property Leases under which it is a lessee. Each of the Personal Property Leases is in full force and effect and the Company has not received or given any written notice of any default or event that with notice or lapse of time, or both, would constitute a default by the Company under any of the Personal Property Leases and, to the Knowledge of the Company, no other party is in default thereof, and no party to the Personal Property Leases has exercised any termination rights with respect thereto.

2.24 Inventories . The inventories of the Company are in good and marketable condition. Adequate reserves have been reflected in the Balance Sheet for obsolete, excess, damaged, slow-moving, or otherwise unusable inventory, which reserves were calculated in a manner consistent with past practice and in accordance with GAAP. The inventories of the Company constitute sufficient quantities for the operation of business of the Company in the Ordinary Course of Business.

2.25 Suppliers . Subsection 2.25 of the Disclosure Schedule sets forth a list of the ten (10) largest merchandise suppliers of the Company, as measured by the dollar amount of purchases therefrom, during each of the fiscal years ended January 31, 2009 and January 30, 2010, showing the approximate total purchases by the Company from each such supplier during each such period. Since January 30, 2010, no supplier listed on Subsection 2.25 of the Disclosure Schedule has terminated its relationship with the Company or materially reduced or changed the pricing or other terms of its business with the Company and, to the Knowledge of the Company, no supplier listed on Subsection 2.25 of the Disclosure Schedule has notified the Company that it intends to terminate or materially reduce or change the pricing or other terms of its business with the Company.

2.26 Certain Payments . The Company has not and, to the Company’s Knowledge, none of the Company’s stockholders, directors, officers or employees or other Person associated with or acting on behalf of any of them, has directly or indirectly (a) made any contribution, gift, bribe, rebate, payoff, influence payment, kickback, entertainment or other payment to any Person, private or public (including to any foreign or domestic government officials or employees or to foreign or domestic political parties or campaigns), regardless of form, whether in money, property, or services (i) to obtain favorable treatment in securing business for the Company, (ii) to pay for favorable treatment for business secured by the Company, (iii) to obtain special concessions or for special concessions already obtained, for the benefit of the Company, or (iv) in violation of any Law in any material respect, or (b) established or maintained any fund or asset for the direct benefit of the Company that has not be recorded in the books and records of the Company.

 

21


2.27 Accounts and Notes Receivable and Payable .

(a) All accounts and notes receivable of the Company have arisen from bona fide transactions in the Ordinary Course of Business and are payable to the Company in the Ordinary Course of Business. None of the accounts or the notes receivable of the Company represent obligations for goods sold on consignment or on approval.

(b) All accounts payable of the Company reflected in the Balance Sheet or arising after the date thereof (i) are the result of bona fide transactions in the Ordinary Course of Business and (ii) have been paid (except in the case of accounts payable reflected in the Most Recent Balance Sheet) in the Ordinary Course of Business.

2.28 Working Capital . The Company has adequate working capital to conduct its business in the Ordinary Course of Business.

3. Representations and Warranties of Purchasers . Each Purchaser hereby represents and warrants to the Company, severally as to itself, and not jointly, that:

3.1 Authorization . Purchaser has full power and authority to enter into the Transaction Documents. The Transaction Documents to which Purchaser is a party, when executed and delivered by Purchaser, shall constitute valid and legally binding obligations of Purchaser, enforceable against the Purchaser in accordance with their respective terms, except (a) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors’ rights generally, (b) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies, or (c) to the extent the indemnification provisions contained in the Amended and Restated Investor Rights Agreement, the Amended and Restated Bylaws of the Company and the Indemnification Agreement may be limited by applicable federal or state securities Laws.

3.2 Purchase Entirely for Own Account . This Agreement is made with Purchaser in reliance upon Purchaser’s representation to the Company, which by Purchaser’s execution of this Agreement, Purchaser hereby confirms, that the Shares to be acquired by Purchaser will be acquired for investment for Purchaser’s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and that Purchaser has no present intention of selling, granting any participation in, or otherwise distributing the same. By executing this Agreement, Purchaser further represents that Purchaser does not presently have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to such Person or to any third Person, with respect to any of the Shares. Purchaser has not been formed for the specific purpose of acquiring the Shares.

3.3 Disclosure of Information . Purchaser has had an opportunity to discuss and review, as the case may be, the Company’s business, management, financial affairs and the terms and conditions of the offering of the Shares with the Company’s management and has had an opportunity to review the Company’s facilities. The foregoing, however, does not limit or modify the representations and warranties of the Company in Section 2 of this Agreement or the right of Purchasers to rely thereon.

3.4 Restricted Securities . Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of Purchaser’s representations as expressed herein. Purchaser understands that the Shares are “restricted securities” under applicable U.S. federal and state securities laws and that, pursuant to these laws, Purchaser must hold the Shares indefinitely unless they are

 

22


registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. Purchaser acknowledges that the Company has no obligation to register or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in the Amended and Restated Investor Rights Agreement. Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of Purchaser’s control, and which the Company is under no obligation and may not be able to satisfy.

3.5 No Public Market . Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.

3.6 Legends . Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may bear one or all of the following legends:

(a) “THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.”

(b) Any legend set forth in, or required by, the other Transaction Documents.

(c) Any legend required by the securities Laws of any state to the extent such Laws are applicable to the Shares represented by the certificate so legended.

3.7 Accredited Investor . Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.

3.8 Financial Ability . Purchasers have access to funds that will be available at Closing and sufficient to purchase the Shares. Purchasers’ obligations hereunder are not in any way contingent or otherwise subject to (a) the consummation of any financing arrangements or obtaining any financing, or (b) the availability of any financing to Purchaser or any of its Affiliates.

4. Covenants .

4.1 Access to Information; Confidentiality . The Company shall afford to Purchasers, and their accountants, counsel, financial advisors and other representatives that are bound by confidentiality terms no less restrictive than those set forth in the Confidentiality Agreement, reasonable access, during normal business hours upon reasonable notice throughout the period prior to the Closing, to the Company Property, books, financial information (including working papers and data in the possession of the Company’s or its independent public accountants, internal audit reports, and “management letters” from such accountants with respect to the Company’s systems of internal control), Contracts and records of the Company and, during such period, shall furnish promptly such information concerning the businesses, properties and personnel of the Company as Purchasers shall reasonably request; provided , however , that such investigation shall not unreasonably disrupt the Company’s operations. Prior to the Closing, the Company shall generally keep Purchasers informed as to all material matters involving the operations and businesses of the Company. The Company shall authorize and

 

23


direct the appropriate directors, officers and Key Employee to discuss matters involving the operations and business of the Company with representatives of Purchasers. All nonpublic information provided to, or obtained by, Purchasers and their accountants, counsel, financial advisors and other representatives in connection with the transactions contemplated hereby shall be “Confidential Information” (as defined in the Confidentiality Agreement) for purposes of the Confidentiality Agreement dated May 3, 2010 among Advent International Corporation and the Company (the “ Confidentiality Agreement ”), the terms of which shall continue in force for the period specified in the Confidentiality Agreement. Notwithstanding the foregoing, the Company shall not be required to disclose any information if such disclosure would contravene any applicable Law. No information provided to or obtained by Purchasers and their accountants, counsel, financial advisors and other representatives pursuant to this Subsection 4.1 shall limit or otherwise affect (a) the remedies available hereunder to Purchasers (including Purchasers’ right to seek indemnification pursuant to Section 7 ), (b) the representations or warranties of, or the conditions to the obligations of, the parties hereto, or (c) the rights and remedies of the Company under the Confidentiality Agreement.

4.2 Conduct of the Business Pending the Closing .

(a) Except as otherwise expressly provided in this Agreement or with the prior written consent of Purchasers, which consent shall not be unreasonably conditioned, withheld or delayed, between the date hereof and the Closing, the Company shall:

(i) conduct the business of the Company only in the Ordinary Course of Business;

(ii) use its commercially reasonable efforts to (A) preserve the present business operations, organization (including officers and Key Employees) and goodwill of the Company and (B) preserve the present relationships with Persons having business dealings with the Company (including suppliers);

(iii) maintain (A) all of the material assets and properties of, or used by, the Company in their current condition, ordinary wear and tear excepted, and (B) insurance upon all of the properties and assets of the Company in the Ordinary Course of Business;

(iv) (A) maintain the books, accounts and records of the Company in the Ordinary Course of Business, (B) continue to pay accounts payable in the Ordinary Course of Business, and (C) comply in all material respects with all contractual and other obligations of the Company under its Contracts;

(v) comply with the capital expenditure plan of the Company for fiscal year 2010, including making such capital expenditures in the amounts and at the times set forth in such plan; and

(vi) comply in all material respects with all applicable Laws.

(b) Without limiting the generality of the foregoing, except ( w ) as otherwise expressly provided in this Agreement, the other Transaction Documents, the Disclosure Documents or the Supplemental MB Letter Agreement, ( x ) the issuance of Common Stock in connection with the transactions contemplated by the Disclosure Documents, ( y ) as necessary to declare, pay and otherwise effect the Common Dividend and payment of expenses incurred by the Company and Purchasers in connection with the transactions contemplated by this Agreement (including, without limitation, the fees contemplated by Subsections 9.6 and 9.7 ), the other Transaction Documents or the Disclosure

 

24


Documents, or ( z ) with the prior written consent of Purchasers, which consent shall not be unreasonably conditioned, withheld or delayed, the Company shall not:

(i) declare, set aside, make or pay any dividend or other distribution in respect of the capital stock of, or other ownership interests in, the Company or repurchase, redeem or otherwise acquire any outstanding shares of the capital stock or other securities of, or other ownership interests in, the Company;

(ii) transfer, issue, sell, pledge, encumber or dispose of any shares of capital stock or other securities of, or other ownership interests in, the Company or grant options, warrants, calls or other rights to purchase or otherwise acquire shares of the capital stock or other securities of, or other ownership interests in, the Company;

(iii) effect any recapitalization, reclassification, stock split, combination or like change in the capitalization of the Company, or amend the terms of any outstanding securities of the Company;

(iv) amend the Articles of Incorporation or Bylaws of the Company except pursuant to the Restated Articles and the Amended and Restated Bylaws;

(v) except as required to comply with applicable Laws or as otherwise required under the applicable Company Plan as of the date hereof, or except as set forth in Subsection 4.2(b) of the Disclosure Schedule or in the Disclosure Documents, (A) increase the salary, wages or other compensation of any director, officer, consultant, Key Employee or, other than in the Ordinary Course of Business, employee, of the Company, (B) grant any unusual or extraordinary bonus, equity awards, fringe benefit, severance, or other direct or indirect compensation to any current or former director, officer, employee or consultant of the Company, (C) increase the coverage or benefits available under any Company Plan, or (D) adopt, enter into, terminate, amend, fund or secure any Company Plan or any other arrangement that would be a Company Plan if in effect on the date of this Agreement;

(vi) (A) issue, create, incur, assume, guarantee, endorse or otherwise become liable or responsible with respect to (whether directly, contingently or otherwise) any Indebtedness, except with respect to the payment of the Common Dividend, the fee contemplated by the Supplemental MB Letter Agreement and the fees and expenses contemplated by Subsections 9.6 and 9.7 ); (B) except in the Ordinary Course of Business, pay, repay, discharge, purchase, repurchase or satisfy any Indebtedness of the Company; or (C) modify the terms of any Indebtedness or other Liability other than as a result of the satisfaction of the condition set forth in Subsection 5.14 or in connection with the repayment and termination of the Vellios Loan;

(vii) except for Permitted Exceptions, permit, allow or suffer to be encumbered, any of the properties or assets (whether tangible or intangible) of, or used by, the Company;

(viii) acquire any material properties or assets or sell, assign, license, transfer, convey, lease or otherwise dispose of any of the material properties or assets of, or used by, the Company, other than in the Ordinary Course of Business;

(ix) enter into or agree to enter into any merger or consolidation with any corporation or other entity, and not engage in any new business or invest in, make a loan, advance or capital contribution to, or otherwise acquire the securities, of any other Person;

 

25


(x) cancel or compromise any debt or claim or waive or release any material right of the Company except in the Ordinary Course of Business;

(xi) enter into, modify or terminate any labor or collective bargaining agreement of the Company or, through negotiation or otherwise, make any commitment or incur any liability to any labor organization with respect to the Company;

(xii) except (A) as set forth in Subsection 4.2(b) of the Disclosure Schedule, and (B) for transfers of cash pursuant to normal cash management practices in the Ordinary Course of Business, make any investments in or loans to, or pay any fees or expenses to, or enter into or modify any Contract with any of the Company’s Shareholders or their respective Affiliates;

(xiii) make any change in its accounting or Tax reporting principles, methods or policies other than those required by GAAP or applicable Law;

(xiv) except with respect to the matters set forth in Subsection 4.2(b) of the Disclosure Schedule (i) make, change or revoke any Tax election, settle or compromise any Tax claim or liability or enter into a settlement or compromise, or change (or make a request to any taxing authority to change) any material aspect of its method of accounting for Tax purposes, or (ii) prepare or file any Tax Return (or any amendment thereof) unless such Tax Return shall have been prepared in a manner consistent with past practice;

(xv) except with respect to permitted use restrictions set forth in real property leases to be entered into by the Company, enter into any Contract, understanding or commitment that restrains, restricts, limits or impedes the ability of the Company to compete with or conduct any business or line of business in any geographic area or solicit the employment of any persons;

(xvi) terminate, amend, restate, supplement or waive any rights under any (A) Material Contract, other than in the Ordinary Course of Business or (B) material Permit of the Company;

(xvii) except with respect to the matters set forth in Subsection 4.2(b) of the Disclosure Schedule, settle or compromise any pending or threatened Legal Proceeding or any claim or claims for, or that would result in a loss of revenue of, an amount that could, individually or in the aggregate, reasonably be expected to be greater than $50,000; provided , that in no event shall any such settlement or compromise (including with respect to the matters set forth in Subsection 4.2(b) of the Disclosure Schedule) impose any equitable remedy on the Company that would restrict the Company from operating its business in the Ordinary Course of Business;

(xviii) fail to pay any required maintenance or other similar fees or otherwise fail to make required filings or payments required to maintain and further prosecute any applications for registration of Intellectual Property, in each case, which would reasonably be expected to be material to the Company; and

(xix) knowingly agree to do anything (A) prohibited by this Subsection 4.2 , (B) which would make any of the representations and warranties of the Company in this Agreement or any of the Transaction Documents untrue or incorrect in any material respect or would result in any of the conditions to the Closing not being satisfied or (C) that would reasonably be expected to have a Material Adverse Effect.

 

26


4.3 Third Party Consents; Approval Documents, Disclosure Documents .

(a) The Company shall use its commercially reasonable efforts to obtain at the earliest practicable date all consents, waivers, amendments and approvals, and provide all notices, listed on Subsection 4.3 of the Disclosure Schedule; provided , that , as soon as reasonably practicable, and, in any event, within three (3) Business Days following the date of this Agreement, the Company shall request from Wells Fargo a written amendment to, or written waiver under, the Loan Agreement. All such consents, waivers, approvals, amendments and notices shall be in writing and in form and substance reasonably satisfactory to Purchasers, and executed counterparts of such consents, waivers and approvals shall be delivered to Purchasers promptly after receipt thereof, and copies of such notices shall be delivered to Purchasers promptly after the making thereof. Notwithstanding anything to the contrary in this Agreement, neither Purchasers nor any of their Affiliates (which for purposes of this sentence shall include the Company) shall be required to pay any amounts in connection with obtaining any consent, waiver or approval; provided , that , in the event that a fee is payable to Wells Fargo in connection with obtaining an amendment or waiver under the Loan Agreement, the parties hereto shall discuss in good faith the payment of such fee.

(b) As soon as reasonably practicable, and, in any event, within five (5) Business Days following the date of this Agreement, the Company shall provide to Purchasers drafts of all Disclosure Documents for their review and approval, which approval shall not be unreasonably withheld, conditioned or delayed. Purchasers shall have a period of five (5) Business Days after the receipt thereof to review and provide the Company with any comments to the Disclosure Documents. As soon as reasonably practicable, and in any event, within five (5) Business Days after the expiration of the five-Business Day period in which Purchasers had an opportunity to review the Disclosure Documents, the Company shall deliver the Disclosure Documents to shareholders and holders of options and warrants, as applicable. The Company, in its sole discretion, may extend the Offer Period; provided however , that the Company may not extend the expiration date of the Offer Period to a date that is later than three (3) Business Days prior to the Outside Termination Date. Upon the Company’s election to extend the Offer Period, the Company shall give the Purchasers notice thereof.

4.4 Governmental Consents and Approvals .

(a) Each of the Purchasers and the Company shall use its commercially reasonable efforts to obtain at the earliest practical date all consents, waivers, approvals, Orders, Permits, authorizations and declarations from, make all filings with, and provide all notices to, all Governmental Bodies which are required to consummate, or in connection with, the transactions contemplated by this Agreement, including the consents, waivers, approvals, Orders, Permits, authorizations, declarations, filings and notices referred to in Subsection 2.6 . Without limiting the foregoing, Purchaser and the Company shall (i) make all filings required of each of them or any of their respective Affiliates under the HSR Act or other Antitrust Laws with respect to the transactions contemplated hereby as promptly as practicable and, in any event, within three (3) Business Days after the date of this Agreement in the case of all filings required under the HSR Act (the “ HSR Filings ”), (ii) comply at the earliest practicable date with any request under the HSR Act for additional information, documents, or other materials received by each of them or any of their respective Affiliates from the U.S. Federal Trade Commission (the “ FTC ”), the Antitrust Division of the U.S. Department of Justice (the “ Antitrust Division ”) or any other Governmental Body in respect of such filings or such transactions, and (iii) cooperate with each other in connection with any such filing (including, to the extent permitted by applicable Law, providing copies of all such documents to the non-filing parties prior to filing and considering all reasonable additions, deletions or changes suggested in connection therewith) and in connection with resolving any investigation or other inquiry of any of the FTC, the Antitrust Division with respect to any such filing or any such transaction. Each such party shall use commercially reasonable efforts to furnish to each other party hereto all information required for any application or other filing to be made pursuant to any applicable Law in connection with the transactions contemplated by this Agreement. Each such party

 

27


shall promptly inform the other parties hereto of any oral communication with, and provide copies of written communications with, any Governmental Body regarding any such filings or any such transaction and permit the other party to review in advance any proposed communication by such party to any Governmental Body. No party hereto shall independently participate in any formal meeting with any Governmental Body in respect of any such filings, investigation, or other inquiry without giving the other parties hereto prior notice of the meeting and, to the extent permitted by such Governmental Body, the opportunity to attend and/or participate. Subject to applicable Law, the parties hereto shall consult and cooperate with one another in connection with the matters described in this Subsection 4.4 , including in connection with any analyses, appearances, presentations, memoranda, briefs, arguments, opinions and proposals made or submitted by or on behalf of any party hereto relating to proceedings under the HSR Act.

(b) Each of the Purchasers and the Company shall use its commercially reasonable efforts to resolve such objections, if any, as may be asserted by any Governmental Body with respect to the transactions contemplated by this Agreement under any Law, including the HSR Act, the Sherman Act, as amended, the Clayton Act, as amended, the Federal Trade Commission Act, as amended, and any other Laws that are designed to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade (collectively, the “ Antitrust Laws ”). In connection therewith, if any Legal Proceeding is instituted (or threatened to be instituted) challenging any transaction contemplated by this Agreement as in violation of any Law, the Company shall use its commercially reasonable efforts, and Purchasers shall cooperate with the Company, to contest and resist any such Legal Proceeding, and to have vacated, lifted, reversed, or overturned any decree, judgment, injunction or other order whether temporary, preliminary or permanent, that is in effect and that prohibits, prevents, or restricts consummation of the transactions contemplated by this Agreement, including by pursuing all available avenues of administrative and judicial appeal unless, by mutual agreement, Purchasers and the Company decide that litigation is not in their respective best interests. Each of the Purchasers and the Company shall use its commercially reasonable efforts to take such action as may be required to cause the expiration of the notice periods under the HSR Act or other Antitrust Laws with respect to such transactions as promptly as possible after the execution of this Agreement; provided , however, no party shall be required to seek early termination of the waiting period applicable to the HSR Filings. Notwithstanding anything to the contrary in this Agreement, neither Purchaser nor any of its Affiliates (which for purposes of this sentence shall include the Company) shall be required, in connection with the matters covered by this Subsection 4.4 , (i) to pay any amounts (other than the payment of filing fees, which shall be paid by Purchasers, and expenses and fees of counsel), (ii) to commence or defend any litigation, (iii) to hold separate (including by trust or otherwise) or divest any of their respective businesses, product lines or assets, (iv) to agree to any limitation on the operation or conduct of their or the Company’s respective businesses or (v) to waive any of the conditions set forth in Section 5 of this Agreement.

4.5 Further Assurances . Subject to, and not in limitation of, Subsection 4.4 , each of the Company and Purchasers shall use its commercially reasonable efforts to (i) take, or cause to be taken, all actions necessary or appropriate to consummate the transactions contemplated by this Agreement, and (ii) cause the fulfillment at the earliest practicable date of all of the conditions to their respective obligations to consummate the transactions contemplated by this Agreement.

4.6 No Shop .

(a) The Significant Common Shareholders and the Company shall not, and shall not permit any of their respective Affiliates, directors, officers, employees, representatives or agents (collectively, the “ Representatives ”) to, directly or indirectly, (i) discuss, encourage, negotiate, undertake, initiate, authorize, recommend, propose or enter into, whether as the proposed surviving,

 

28


merged, acquiring or acquired corporation or otherwise, any transaction involving a merger, consolidation, business combination, purchase or disposition of any material amount of the assets of the Company or any capital stock or other ownership interests of the Company other than the transactions contemplated by this Agreement (an “ Acquisition Transaction ”), (ii) facilitate, encourage, solicit or initiate discussions, negotiations or submissions of proposals or offers in respect of an Acquisition Transaction, (iii) furnish or cause to be furnished, to any Person, any information concerning the business, operations, properties or assets of the Company in connection with an Acquisition Transaction, or (iv) otherwise cooperate in any way with, or assist or participate in, facilitate or encourage, any effort or attempt by any other Person to do or seek any of the foregoing.

(b) The Company shall notify Purchaser in writing promptly (but in no event later than 24 hours) after receipt by any of the Significant Common Shareholders, the Company or any of the Representatives thereof of any proposal or offer from any Person other than Purchasers to effect an Acquisition Transaction or any request for non-public information relating to the Company or for access to the properties, books or records of the Company by any Person other than Purchaser. Such notice shall indicate the identity of the Person making the proposal or offer, or intending to make a proposal or offer or requesting non-public information or access to the books and records of the Company, the material terms of any such proposal or offer, or modification or amendment to such proposal or offer and copies of any written proposals or offers or amendments or supplements thereto. The Significant Common Stockholders and the Company shall keep Purchasers informed, on a current basis, of any material changes in the status and any material changes or modifications in the material terms of any such proposal, offer, indication or request.

(c) The Significant Common Shareholders and the Company shall (and the Significant Common Shareholders and the Company shall cause their Representatives to) immediately cease and cause to be terminated any existing discussions or negotiations with any Persons (other than Purchasers) conducted heretofore with respect to any Acquisition Transaction. The Significant Common Shareholders and the Company agree not to release any third party from the confidentiality and standstill provisions of any agreement to which the Company is a party.

4.7 Non-Competition; Non-Solicitation; Confidentiality .

(a) For a period of four (4) years from and after the Closing Date (the “ Restriction Period ”), neither of the Founders shall, directly or indirectly, own, manage, engage in, operate, control, work for, consult with, render services for, do business with, maintain any interest in (proprietary, financial or otherwise) or participate in the ownership, management, operation or control of, any business, whether in corporate, proprietorship or partnership form or otherwise, that sells at retail products (i) predominantly to children, teens and pre-teens, (ii) that are the same as or substantially similar to products that are sold or are planned to be sold by the Company during the period in which such Founder is employed by the Company and (iii) at fixed price points of $10.00 or less anywhere in the United States or in any other country in which the Company sells or plans to sell such products at such fixed price points during the period in which such Founder is employed by the Company (a “ Restricted Business ”); provided, however, that the restrictions contained in this Subsection 4.7(a) shall not restrict the acquisition by the Founders, directly or indirectly, of less than 2% of the outstanding capital stock of any publicly traded company engaged in a Restricted Business. For the avoidance of doubt, each Founder (along with the Company and the Purchasers) acknowledges and agrees that the consideration received by such Founder in connection with the consummation of the transactions contemplated by this Agreement is good and valuable consideration in respect of the covenants contained herein, and that the covenants contained herein are distinct and separate from any covenants contained in any employment agreement between such Founder and the Company or its successors.

 

29


(b) During the Restriction Period, neither of the Founders shall, directly or indirectly, (i) cause, solicit, induce or encourage any employees of the Company to leave such employment or hire, employ or otherwise engage any such individual; or (ii) cause, induce or encourage any material actual or prospective client, supplier or licensor of the Company (including any existing or former customer of the Company and any Person that becomes a client or customer of the Company after the Closing) or any other Person who has a material business relationship with the Company, to terminate or modify any such actual or prospective relationship.

(c) From and after the Closing, neither of the Founders shall, directly or indirectly, disclose, reveal, divulge or communicate to any Person other than authorized officers, directors and employees of the Company or use or otherwise exploit for its own benefit or for the benefit of anyone other than the Company, any Confidential Information (as defined below). The Founders shall not have any obligation to keep confidential any Confidential Information if and to the extent disclosure thereof is specifically required by applicable Law; provided , however , that in the event disclosure is required by applicable Law, the Founders shall, to the extent reasonably possible, provide Purchasers with prompt notice of such requirement prior to making any disclosure so that Purchasers may seek an appropriate protective order. For purposes of this Subsection 4.7(c) , “Confidential Information” means any information with respect to the Company, including methods of operation, customer lists, products, prices, fees, costs, technology, inventions, trade secrets, know-how, Software, marketing methods, plans, personnel, suppliers, competitors, markets or other specialized information or proprietary matters. “Confidential Information” does not include, and there shall be no obligation hereunder with respect to, information that (i) is generally available to the public on the date of this Agreement or (ii) becomes generally available to the public other than as a result of a disclosure not otherwise permissible hereunder.

(d) The covenants and undertakings contained in this Subsection 4.7 relate to matters which are of a special, unique and extraordinary character and a violation of any of the terms of this Subsection 4.7 will cause irreparable injury to Purchasers, the amount of which will be impossible to estimate or determine and which cannot be adequately compensated. Accordingly, the remedy at law for any breach of this Subsection 4.7 will be inadequate. Therefore, Purchasers will be entitled to a temporary and permanent injunction, restraining order or other equitable relief from any court of competent jurisdiction in the event of any breach of this Subsection 4.7 without the necessity of proving actual damage or posting any bond whatsoever. Notwithstanding anything herein to the contrary, the rights and remedies provided by this Subsection 4.7 are cumulative and in addition to any other rights and remedies which Purchasers may have hereunder or at law or in equity.

(e) The parties hereto agree that, if any court of competent jurisdiction determines that a specified time period, a specified geographical area, a specified business limitation or any other relevant feature of this Subsection 4.7 is unreasonable, arbitrary or against public policy, then a lesser period of time, geographical area, business limitation or other relevant feature which is determined by such court to be reasonable, not arbitrary and not against public policy may be enforced against the applicable party.

4.8 Publicity .

(a) Neither Purchasers, the Significant Common Shareholders nor the Company shall issue any press release or public announcement concerning this Agreement or the transactions contemplated hereby without obtaining the prior written approval of the Company (with the consent of a supermajority of the Company’s Board of Directors) and Purchasers, which approval will not be unreasonably conditioned, withheld or delayed, unless disclosure is otherwise required by applicable Law, provided that, to the extent required by applicable Law, the party intending to make such release shall use its commercially reasonable efforts consistent with such applicable Law to consult with the other party with respect to the text thereof.

 

30


(b) Purchasers, Founders, the Significant Common Shareholders and the Company agree that the terms of this Agreement shall not be disclosed or otherwise made available to the public and that copies of this Agreement shall not be publicly filed or otherwise made available to the public, except where such disclosure, availability or filing is required by applicable Law and only to the extent required by such Law.

4.9 Related Party Transactions with Non-Management Affiliates . On or prior to the Closing, the Company shall use its commercially reasonable efforts to (a) terminate the Contracts with shareholders or their respective Affiliates listed in Subsection 4.9 of the Disclosure Schedule and (b) terminate such Contracts with the condition that the Company is not required to pay any fee or otherwise incur any expense or financial exposure with respect to any such termination or release.

4.10 Monthly Financial Statements . As soon as reasonably practicable, but in no event later than 30 days after the end of each calendar month during the period from the date hereof to the Closing, the Company shall provide Purchasers with (i) unaudited monthly financial statements and (ii) operating or management reports (such reports to be in the form prepared by the Company in the Ordinary Course of Business) of the Company for such preceding month.

4.11 Notification of Certain Matters . The Company shall give notice to Purchasers, and Purchasers shall give notice to the Company, as promptly as reasonably practicable upon becoming aware of (a) any fact, change, condition, circumstance, event, occurrence or non-occurrence that has caused or is reasonably likely to cause any representation or warranty in this Agreement made by it to be untrue or inaccurate in any material respect at any time after the date hereof and prior to the Closing, (b) any material failure on its part to comply with or satisfy any covenant, condition or agreement to be complied with or satisfied by it hereunder or (c) the institution of or the threat of institution of any Legal Proceeding against the Company related to this Agreement or the transactions contemplated hereby. Notwithstanding anything herein to the contrary, Purchasers shall be entitled to terminate this Agreement as a result of a notice provided pursuant to this Section 4.11 if the matters disclosed would cause a failure of the closing conditions set forth in Sections 5.1 and 5.2 . If Purchasers waive in writing the closing condition with respect to the matter disclosed in such notice that gives rise to a failure of such closing condition and the Closing occurs, Purchasers shall be deemed to have waived their rights to terminate this Agreement or prevent the consummation of the transactions contemplated by this Agreement and waived their right to seek indemnification pursuant to Section 7 ; provided , however , if the notice relates to a matter which was required to have been disclosed on the Disclosure Schedule as of the date hereof in order to make the representations or warranties of the Company true and correct as of such date, then after Closing the Purchasers may seek indemnification for Losses associated with such matter pursuant and subject to the terms of Section 7 hereof.

4.12 Section 280G Approval . As soon as reasonably practicable following the date of this Agreement, the Company shall solicit the approval of shareholders of the Company, in a manner intended to be compliant with the provisions of Sections 280G(b)(5)(A)(ii) and 280G(b)(5)(B) of the Code and the regulations promulgated thereunder (“ Section 280G ”) and pursuant to a disclosure statement that is reasonably acceptable to Purchasers (the “ 280G Disclosure Statement ”), of those certain payments and/or benefits set forth on Subsection 4.12 of the Disclosure Schedule (the “ Potential Benefits ”), so that such payments and/or benefits made by the Company shall not be deemed to be “excess parachute payments” (within the meaning of Section 280G). Prior to the Closing and promptly following receipt of requisite shareholder approval of the Potential Benefits, the Company shall notify the Purchasers thereof. If any of the Potential Benefits fail to be so approved by the shareholders of the Company as contemplated above, such Potential Benefits shall not be made or provided.

 

31


4.13 Amendments to Stock Plan . Prior to the Closing, the Company shall amend the Stock Plan, effective as of the Closing, to: (a) increase the number of shares of Common Stock that are issuable under the Stock Plan by an amount equal to the New Reserve Amount, (b) provide that in the event of any recapitalization, stock split, combination, stock dividend or other similar event or transaction affecting the Common Stock, equitable adjustments shall automatically be made to the equity issued or available for issuance under the Stock Plan, and (c) allow transfers of equity grants by will or the laws of descent or distribution and to a holder’s family members or trusts established for him or his family members provided that any transfer to a family member or trust established for such holder or his family members shall be subject to the approval of the Company’s board of directors or compensation committee and any contractual transfer restrictions that are applicable to the equity grants that are the subject of the transfer. Following the approval of the Company’s board of directors of such amendments to the Stock Plan, but in no event later than twelve months after the date thereof, the Company shall solicit shareholder approval of the Stock Plan, as amended; provided , however , if such approval is sought after Closing, Purchasers shall approve the Stock Plan, as amended, at such time as the amended Stock Plan is presented to them for approval. As used herein, the “ New Reserve Amount ” means that number of shares of Common Stock equal to (x) the quotient obtained by dividing the Post Closing Fully Diluted Equity by 0.93, minus (y) the Post Closing Fully Diluted Equity, rounded to the nearest whole share.

4.14 SCS Revolving Loans .

(a) SCS Revolving Loans. If, after the Closing and before December 31, 2010, (i) the Company has borrowed all funds available to it under the credit facility provided to the Company pursuant to the Loan Agreement (the “ Existing Credit Facility ”), and (ii) the Company’s board of directors determines that the Company does not have sufficient working capital for the operation of its business in the Ordinary Course of Business (“ Working Capital Shortfall ”), then the Company shall upon the authorization of the Company’s board of directors, request that the Significant Common Shareholders provide unsecured, subordinated loans (each, an “ SCS Loan ”) to the Company in the amount of the Working Capital Shortfall; provided, however, each SCS Loan shall be in an aggregate amount of not less than $500,000, and the aggregate amount of all SCS Loans shall not exceed $5 million in the aggregate.

(b) Terms of SCS Notes. Promptly following Closing, the Company and the Significant Common Shareholders agree to use their commercially reasonable efforts (including agreeing to subordinate the SCS Loans to the Existing Credit Facility at all times that amounts are outstanding thereunder) to obtain the consent of Wells Fargo for the SCS Loans and to negotiate and execute documents for the SCS Loans having the terms set forth in this Subsection 4.14 . The SCS Loans will be due on December 31, 2010 or such later date on which no amounts are outstanding under the Existing Credit Facility (the “ Maturity Date ”), and will accrue simple interest at an annual rate of 8.0% (due on the Maturity Date). For so long as any of the SCS Loans remain outstanding, the Company shall not (i) make any distributions with respect to any class of its equity securities, (ii) incur any indebtedness for borrowed money, or (iii) make any payments of indebtedness to any party other than payments to Wells Fargo to pay down any borrowings under the Existing Credit Facility and trade debt incurred in the Ordinary Course of Business.

(c) Limitations on Lending Obligations. Each Significant Common Shareholder’s obligations under this Subsection 4.14 shall be several and not joint and several, and shall be on a pro rata basis, based on the amount of cash proceeds such Significant Common Shareholder receives in connection with the Common Dividend (to the extent the exercise price for any option or

 

32


warrant is, without duplication, received or deemed to be received by the Company in cash proceeds, net of such exercise price) and Exchange Offer as a percentage of the total cash proceeds received by all Significant Common Shareholders in connection with the Common Dividend (to the extent the exercise price for any option or warrant is, without duplication, received or deemed to be received by the Company in cash proceeds, net of such exercise price) and Exchange Offer).

5. Conditions to Purchasers’ Obligations at Closing . The obligations of each Purchaser to purchase Shares at the Closing are subject to the fulfillment, on or before such Closing, of each of the following conditions, unless otherwise waived:

5.1 Representations and Warranties . The representations and warranties of the Company contained in Section 2 shall be true and correct in all material respects as of such Closing (except those representations and warranties that specifically relate to an earlier date shall be true and correct only as of such earlier date).

5.2 Performance . The Company shall have performed and complied in all material respects with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by the Company on or before such Closing.

5.3 Compliance Certificate . The President, Chief Executive Officer or Senior Vice President, Finance of the Company shall have delivered to Purchasers at such Closing a certificate in form and substance reasonably satisfactory to Purchasers certifying that the conditions specified in Subsections 5.1 and 5.2 have been fulfilled.

5.4 Qualifications . All authorizations, approvals or permits, if any, of any Governmental Body of the United States or of any state that are required in connection with the lawful issuance and sale of the Shares pursuant to this Agreement shall be obtained and effective as of such Closing.

5.5 Opinion of Company Counsel . Purchasers shall have received from Pepper Hamilton LLP, counsel for the Company, an opinion, dated as of the Closing, in substantially the form of Exhibit I attached to this Agreement.

5.6 Indemnification Agreement . The Company shall have executed and delivered the Indemnification Agreements.

5.7 Amended and Restated Bylaws . The Board of Directors and shareholders of the Company shall have adopted the Amended and Restated Bylaws.

5.8 Amended and Restated Investor Rights Agreement . The Company and the shareholders, holding the requisite vote necessary for the amendment and restatement of the Investor Rights Agreement shall have executed and delivered the Amended and Restated Investor Rights Agreement.

5.9 Second Amended and Restated Shareholders Agreement . The Company and the shareholders, holding the requisite vote necessary for the amendment and restatement of the Amendment and Restated Shareholders Agreement shall have executed and delivered the Second Amended and Restated Shareholders Agreement.

 

33


5.10 Restated Articles . The Company shall have filed the Restated Articles with the Department of State of the Commonwealth of Pennsylvania on or prior to the Closing, which shall continue to be in full force and effect as of the Closing.

5.11 Secretary’s Certificate . The Secretary of the Company shall have delivered to Purchasers at the Closing a certificate certifying (i) the Amended and Restated Bylaws of the Company, (ii) resolutions of the Board of Directors of the Company approving the Transaction Documents and the transactions contemplated under the Transaction Documents, and (iii) resolutions of the stockholders of the Company approving the Restated Articles.

5.12 No Material Adverse Effect . There shall not have been or occurred any event, change, occurrence or circumstance that, individually or in the aggregate with any such events, changes, occurrences or circumstances, has had or would reasonably be expected to have a Material Adverse Effect since the date of this Agreement.

5.13 Conversion . All outstanding shares of the Existing Preferred Stock shall have been converted into shares of Common Stock no later than immediately prior to Closing.

5.14 Credit Agreement . With respect to the consummation of the transactions contemplated hereunder, the Company shall have delivered to the Purchasers a copy of a fully executed written amendment to, or written waiver from the lender under, that certain Amended and Restated Loan and Security Agreement (the “ Loan Agreement ”), dated January 28, 2010, between the Company, as Borrower, and Wachovia Bank, National Association, as Lender (now known as Wells Fargo, National Association “ Wells Fargo ”), in form and substance reasonably satisfactory to Purchasers.

5.15 Closing Date Capitalization Table . The Company shall have delivered a capitalization table of the Company reflecting the authorized and issued capital of the Company immediately following the Closing (after giving effect to the sale of Shares, conversion of Existing Preferred Stock, exercise of any options and Compensatory Warrants, and exchange of any Financing Warrants), including all information required to be set forth in Subsection 2.2(d) of the Disclosure Schedule with respect to the capitalization of the Company immediately after Closing.

6. Conditions of the Company’s Obligations at Closing . The obligations of the Company to sell Shares to Purchasers at the Closing are subject to the fulfillment, on or before the Closing, of each of the following conditions, unless otherwise waived:

6.1 Representations and Warranties . The representations and warranties of each Purchaser contained in Section 3 shall be true and correct in all respects as of such Closing (except those representations and warranties that specifically relate to an earlier date shall be true and correct as of such earlier date)

6.2 Performance . Purchasers shall have performed and complied in all material respects with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by them on or before such Closing.

6.3 Compliance Certificate . An authorized person of Purchasers shall deliver to the Company a certificate in form and substance reasonably satisfactory to the Company certifying that the conditions specified in Subsections 6.1 and 6.2 have been fulfilled.

6.4 Payment of Purchase Price . Purchasers shall have delivered to the Company the Purchase Price.

 

34


6.5 Qualifications . All authorizations, approvals or permits, if any, of any Governmental Body of the United States or of any state that are required in connection with the lawful issuance and sale of the Shares pursuant to this Agreement shall be obtained and effective as of the Closing.

6.6 Amended and Restated Investor Rights Agreement . Each Purchaser shall have executed and delivered the Amended and Restated Investor Rights Agreement.

6.7 Second Amended and Restated Shareholders Agreement . Each Purchaser shall have executed and delivered the Second Amended and Restated Shareholders Agreement.

6.8 Credit Agreement . With respect to the consummation of the transactions contemplated hereunder, Wells Fargo shall have delivered to the Company a written amendment to, or written waiver under, the Loan Agreement, in either case duly executed by Wells Fargo and in form and substance reasonably satisfactory to the Company.

7. Survival; Indemnification .

7.1 Survival of Representations, Warranties and Covenants .

(a) The representations and warranties of the Company and Purchasers contained in or made pursuant to this Agreement shall survive the execution and delivery of this Agreement and the Closing until the date that is twelve (12) months after the Closing; provided , however , that (i) the representations and warranties of the Company set forth in Subsection 2.2 (Capitalization) and Subsection 2.4 (Authorization) shall survive the Closing indefinitely, and (ii) the representations and warranties of the Company set forth in Subsection 2.17 (Tax Returns and Payments) solely to the extent they relate to Taxes that are imposed on net income (the representations and warranties referred to in clauses (i) – (ii) of this Subsection, collectively, the “ Fundamental Representations ”) shall survive the Closing until the expiration of the applicable statute of limitations with respect to the particular matter that is the subject thereof; provided , further , however , that, notwithstanding anything to the contrary contained herein, all representations and warranties of the Company and Purchasers contained in or made pursuant to this Agreement shall expire upon the occurrence of a Qualified Public Offering or a Change in Control, whichever occurs first (each expiration date set forth in this sentence, the “ Survival Expiration Date ”). The term “Survival Expiration Date” shall also include the date on which the Pre-Closing Covenant Survival Period expires.

(b) Subject to the limitations in the following sentence, all of the covenants or other agreements of the parties contained in this Agreement shall survive until fully performed or fulfilled, unless and to the extent only that non-compliance with such covenants or agreements is waived in writing by the party entitled to such performance. No claim for a breach of a covenant or other agreement set forth in this Agreement that by its terms is required to be performed by or prior to Closing (the “ Pre-Closing Covenants ”) may be made or brought by any party hereto after the twelve (12) month anniversary of the Closing Date (the “ Pre-Closing Covenant Survival Period ”); provided , however , notwithstanding anything to the contrary contained herein, the indemnification obligations of the Significant Common Shareholders with respect to a breach of the Pre-Closing Covenants shall terminate upon the occurrence of a Qualified Public Offering or a Change in Control, whichever occurs first.

(c) On the applicable Survival Expiration Date, the representations, warranties and covenants of the parties shall terminate and have no further force and effect; provided , however , that any representation, warranty or covenant that is the subject of a claim for indemnification under this Section 7 of which notice to the Significant Common Shareholders is given in writing setting

 

35


forth the specific claim and the basis therefor in reasonable detail prior to the applicable Survival Expiration Date shall survive with respect to such claim until the final resolution thereof. The representations and warranties of the Company and Purchasers contained in or made pursuant to this Agreement shall in no way be affected by any investigation or knowledge of the subject matter thereof made by or on behalf of Purchasers or the Company.

7.2 Indemnification .

(a) After the Closing, the Significant Common Shareholders shall, severally (on a pro rata basis based on the amount of cash proceeds such Significant Common Shareholder receives in connection with the Common Dividend (to the extent the exercise price for any option or warrant is, without duplication, received or deemed to be received by the Company in cash proceeds, net of such exercise price) and Exchange Offer as a percentage of the total cash proceeds received by all Significant Common Shareholders in connection with the Common Dividend (to the extent the exercise price for any option or warrant is, without duplication, received or deemed to be received by the Company in cash proceeds, net of such exercise price) and Exchange Offer) and not jointly, indemnify, defend, and hold harmless Purchaser and its Affiliates, successors, and assigns and their respective officers, directors, partners, managers, members, employees, agents and representatives (the “ Purchaser Indemnified Parties ”), from and against any and all Losses, whether or not involving a third party claim (except with respect to Section 7.2(a)(iv) , which shall require the involvement of a third party claim), incurred or sustained by such Purchaser Indemnified Party as a result of:

(i) a breach of any of the representations and warranties made by the Company in this Agreement or in any certificate delivered pursuant to the terms of this Agreement,

(ii) a breach of any Pre-Closing Covenant of the Company or any Significant Common Shareholder,

(iii) any payment payable to Miller Buckfire & Co., LLC pursuant to the MB Letter Agreement to the extent such payments exceed the $500,000 and expense reimbursements payable to Miller Buckfire & Co., LLC pursuant to the MB Supplemental Letter Agreement, and

(iv) any shareholder claims asserted against the Company for the calculation of the Common Dividend or the Per Share Dividend in accordance with Exhibit B , and/or the payment by the Company of such Common Dividend or Per Share Dividend.

For the avoidance of doubt, only a Loss actually incurred or sustained by the Company or the Purchaser Indemnified Parties will be deemed to be sustained by the Purchaser Indemnified Parties.

(b) Notwithstanding anything to the contrary herein, but subject to the limitations set forth in Subsection 7.3 below, with respect to any indemnifiable Loss incurred or sustained by the Company, the Significant Common Shareholder shall pay his or its several, pro rata share of 100% of the amount of such indemnifiable Loss directly to the Company.

7.3 Limitations on Indemnification .

(a) Fundamental Representations and Specific Indemnifications. In connection with Losses related to (i) the failure to be true and correct of any of the Fundamental Representations or (ii) a claim for indemnification pursuant to Subsections 7.2(a)(iii) or 7.2(a)(iv) herein, the Significant Common Shareholders shall not be required to indemnify the Purchaser Indemnified Parties, for an aggregate amount of Losses greater than the sum of (x) the aggregate amount of Common

 

36


Dividend received by all of the Significant Common Shareholders (to the extent the exercise price for any option or warrant is, without duplication, received or deemed to be received by the Company in cash proceeds, net of such exercise price), and (y) the aggregate amount of cash received by all of the Significant Common Shareholders upon exchange of their Financing Warrants pursuant to the Exchange Offer. Notwithstanding anything to the contrary in this Agreement, the Significant Common Shareholders’ obligations for claims for indemnification pursuant to Subsection 7.2(a)(iv) herein with respect to out-of-pocket expenses incurred by the Company in defending a shareholder’s claim regarding the subject matter set forth in Subsection 7.2(a)(iv) herein shall be subject to the Deductible unless such shareholder’s claim is finally rendered successful on its merits (such out-of-pocket expenses that are subject to the Deductible as provided in this sentence, the “ Deductible Dividend Defense Costs ”). Notwithstanding anything to the contrary in this Agreement, no claim for indemnification for Losses related to the failure to be true and correct of any of the Fundamental Representations, or pursuant to Subsections 7.2(a)(iii) or 7.2(a)(iv) (except with respect to any Deductible Dividend Defense Costs, which shall be subject to the Deductible) shall be subject to the limitations set forth in Subsection 7.3(b) herein.

(b) Non-Fundamental Representations and Certain Other Indemnifications. In connection with Losses related to a claim for indemnification pursuant to (i)  Subsection 7.2(a)(i) herein (excluding the Fundamental Representations), (ii)  Subsection 7.2(a)(ii) herein, or (iii)  Subsection 7.2(a)(iv) herein with respect to Deductible Dividend Dispute Costs (the matters described in the immediately preceding clauses (i) through (iii) are referred to herein as collectively, the “ Non-Fundamental Claims ”), the Significant Common Shareholders shall not have any liability for a Non-Fundamental Claim unless the aggregate amount of Losses incurred by the Purchaser Indemnified Parties and indemnifiable thereunder based upon, attributable to or resulting from the Non-Fundamental Claims exceeds $1,000,000 (One Million Dollars) (the “ Deductible ”), and then only for Losses in excess of the Deductible. In connection with Losses related to the Non-Fundamental Claims, the Significant Common Shareholders shall not be required to indemnify the Purchaser Indemnified Parties for an amount of Losses greater than $15,000,000 (Fifteen Million Dollars), in the aggregate.

(c) Additional Limitation. Notwithstanding anything to the contrary herein, no Significant Common Shareholder shall have any liability under any provision of this Agreement or as a result of the transactions contemplated hereby in excess of the aggregate amount of cash proceeds received by such Significant Common Shareholder from the Common Dividend and upon the exchange of such Significant Common Shareholder’s Financing Warrants pursuant to the Exchange Offer.

(d) Except with respect to the Fundamental Representations, for purposes of determining the failure of any representations or warranties to be true and correct, the breach of any covenants and agreements, and calculating Losses hereunder, any materiality or Material Adverse Effect qualifications in the representations, warranties, covenants and agreements shall be disregarded.

7.4 Indemnification Procedures .

(a) A claim for indemnification for any matter not involving a third party claim may be asserted by notice to each Significant Common Shareholder; provided , however , that failure to notify the Significant Common Shareholders shall not preclude any Purchaser Indemnified Party from any indemnification which it may claim under Subsection 7.2 except to the extent that the Significant Common Shareholders can demonstrate actual loss and prejudice as a result of such failure.

(b) In the event that any legal proceedings shall be instituted or that any claim or demand shall be asserted by any third party (including a shareholder other than the Significant Common Shareholders and the Purchasers) (a “ Third Party Claim ”), the Purchaser Indemnified Party

 

37


shall cause written notice of the assertion of any Third Party Claim of which it has knowledge to be forwarded to each Significant Common Shareholder. The failure of the Purchaser Indemnified Party to give reasonably prompt notice of any Third Party Claim shall not release, waive or otherwise affect a Significant Common Shareholder’s obligations with respect thereto except to the extent that such Significant Common Shareholder can demonstrate actual loss and prejudice as a result of such failure. A Significant Common Shareholder shall have the right, at its sole expense, to be represented by counsel of its choice, which must be reasonably satisfactory to the Purchaser Indemnified Party, and to defend against, negotiate, settle or otherwise deal with any Third Party Claim (including any Third Party Claim relating to Taxes) which relates to any Losses indemnified against hereunder; provided that ; such Significant Common Shareholder shall have acknowledged in writing to the Purchaser Indemnified Party its unqualified obligation to indemnify the Purchaser Indemnified Party as provided hereunder. No Significant Common Shareholder shall compromise or settle any Third Party Claim that involves any action other than the payment of money without the consent of the Purchaser Indemnified Party, which consent shall not be unreasonably conditioned, withheld or delayed, provided , however , a Significant Common Shareholder (without the written consent of the Purchaser Indemnified Parties) may compromise and settle a Third Party Claim involving the payment of money provided that such compromise or settlement does not impose injunctive relief against, and includes a complete and unqualified release of, the Purchaser Indemnified Parties and the Company from the Third Party Claim. If a Significant Common Shareholder elects to defend against, negotiate, settle or otherwise deal with any Third Party Claim which relates to any Losses indemnified by it hereunder, it shall within ten (10) Business Days of the receipt of such Third Party Claim notify the Purchaser Indemnified Party of its intent to do so; provided , that such Significant Common Shareholder must conduct the defense of the Third Party Claim actively and diligently thereafter in order to preserve its rights in this regard. If a Significant Common Shareholder elects not to defend against, negotiate, settle or otherwise deal with any Third Party Claim which relates to any Losses indemnified against hereunder, fails to notify the Purchaser Indemnified Party of its election as herein provided or contests its obligation to indemnify the Purchaser Indemnified Party for such Losses under this Agreement, the Purchaser Indemnified Party may defend against, negotiate, settle or otherwise deal with such Third Party Claim. If the Purchaser Indemnified Party defends any Third Party Claim, then the each Significant Common Shareholder shall reimburse the Purchaser Indemnified Party for the expenses of defending such Third Party Claim upon submission of periodic bills. If a Significant Common Shareholder assumes the defense of any Third Party Claim, then the Purchaser Indemnified Party may participate, at his or its own expense, in the defense of such Third Party Claim; provided , however , that the Purchaser Indemnified Party shall be entitled to participate in any such defense with separate counsel at the reasonable expense of the Significant Common Shareholders if (i) so requested by a Significant Common Shareholder to participate or (ii) in the reasonable opinion of counsel to the Purchaser Indemnified Party, a conflict or potential conflict exists between the Purchaser Indemnified Party and any Significant Common Shareholder that would make such separate representation advisable.

(c) After any final decision, judgment or award shall have been rendered and the expiration of the time in which to appeal therefrom, or a settlement shall have been consummated, or the Purchaser Indemnified Party and a Significant Common Shareholder shall have reached an agreement, the Purchaser Indemnified Party shall forward to the Significant Common Shareholders notice of any sums due and owing by the Significant Common Shareholders pursuant to this Agreement with respect to such matter (including, as applicable, instructions with respect to whether payments should be sent to such Purchaser Indemnified or the Company) and the Significant Common Shareholders shall pay all of such remaining sums so due and owing to the Purchaser Indemnified Party or the Company, as applicable, by wire transfer of immediately available funds within five (5) Business Days after the date of such notice.

 

38


7.5 Determination of Losses . As used herein, “ Losses ” means all damages, losses, actual lost profits incurred directly by the Company, expenses, costs and liabilities (including reasonable attorneys’ fees and costs of collection), but excluding all consequential damages, punitive and exemplary damages, special damages, lost profits (other than actual lost profits incurred directly by the Company), incidental damages, indirect damages, unrealized expectations, diminution in value, or other similar items. No Loss shall be calculated using a “multiplier” or any other similar method having a similar effect. In determining the amount of any Losses for which Purchasers are entitled to assert a claim for indemnification hereunder, the amount of any such Losses shall be determined after deducting therefrom the amount of any insurance proceeds (after giving effect to any applicable deductible or retention) and other third party recoveries actually received by Purchasers or the Company, as applicable, in respect of such Losses (which proceeds and recoveries Purchasers agree to use commercially reasonable efforts to obtain) and the amount of any tax benefit actually recognized in cash or credit in lieu of a refund related thereto. If an indemnification payment is received by a Purchaser, and such Purchaser later receives insurance proceeds, other third party recoveries or tax benefits in respect of the related Losses, such Purchaser shall immediately pay to the Significant Common Shareholders on a pro rata basis a sum equal to the lesser of (a) the actual amount of such insurance proceeds, other third party recoveries and tax benefits actually recognized in cash or credit in lieu of a refund or (b) the actual amount of the indemnification payment previously paid with respect to such Losses. All parties shall use commercially reasonably efforts to mitigate the amount of Losses for which they may be entitled to indemnification hereunder.

7.6 Exclusive Remedy . The remedies provided in this Section 7 shall be the sole and exclusive remedies of Purchasers and their successors and permitted assigns after the Closing with respect to this Agreement and the transactions contemplated by this Agreement, including any breach or non-performance of any representation, warranty, Pre-Closing Covenant contained herein, except for the remedies of specific performance, injunction and equitable relief; provided that Purchasers shall not be deemed to have waived any rights, claims, causes of action or remedies (a) if and to the extent such rights, claims, causes of action or remedies may not be waived under applicable law, or (b) in connection with fraud or intentional misrepresentation on the part of any Person (including the Company).

8. Termination .

8.1 Termination of Agreement . This Agreement may be terminated prior to the Closing as follows:

(a) at the election of the Company or Purchasers on or after November 12, 2010 (the “ Outside Termination Date ”), if the Closing shall not have occurred by the close of business on the Outside Termination Date, provided that the terminating party is not in material default of any of its obligations hereunder;

(b) by mutual written consent of the Company and Purchasers;

(c) by the Company or Purchasers if there shall be in effect a final nonappealable Order of a Governmental Body of competent jurisdiction restraining, enjoining or otherwise prohibiting the consummation of the transactions contemplated hereby; it being agreed that, subject to the last sentence of Subsection 4.4(b) , the parties hereto shall promptly appeal any adverse determination which is not nonappealable (and pursue such appeal with reasonable diligence); provided , however , that the right to terminate this Agreement under this Subsection 8.1(c) shall not be available to a party if such Order was primarily due to the failure of such party to perform any of its obligations under this Agreement;

 

39


(d) by Purchaser if the Company or any Founder or Significant Common Shareholder shall have breached or failed to perform in any material respect any of its representations, warranties, covenants or agreements set forth in this Agreement, or if any representation or warranty of the Company shall have become untrue, in either case such that the conditions set forth in Subsections 5.1 or 5.2 would not be satisfied and such breach is incapable of being cured or, if capable of being cured, shall not have been cured within ten (10) days following receipt by the Company of written notice of such breach from Purchasers; or

(e) by the Company if Purchasers shall have breached or failed to perform in any material respect any of their representations, warranties, covenants or agreements set forth in this Agreement, or if any representation or warranty of Purchasers shall have become untrue, in either case such that the conditions set forth in Subsections 6.1 or 6.2 would not be satisfied and such breach is incapable of being cured or, if capable of being cured, shall not have been cured within ten (10) days following receipt by Purchasers of written notice of such breach from the Company.

8.2 Procedure Upon Termination . In the event of termination and abandonment by Purchaser or the Company, or both, pursuant to Subsection 8.1 , written notice thereof shall forthwith be given to the other party or parties, and this Agreement shall terminate, and the purchase of the Shares hereunder shall be abandoned, without further action by Purchasers or the Company.

8.3 Effect of Termination . In the event that this Agreement is validly terminated as provided herein, then each of the parties shall be relieved of their duties and obligations arising under this Agreement after the date of such termination and such termination shall be without liability to Purchasers, Founders, Significant Common Shareholders or the Company; provided , however , that the obligations of the parties set forth in Subsection 4.8 , Subsection 8.3 , and Section 9 shall survive any such termination and shall be enforceable hereunder; provided further , however , that nothing in this Subsection 8.3 shall relieve Purchasers, Significant Common Shareholders or the Company of any liability for a breach of this Agreement prior to the effective date of termination.

9. Miscellaneous .

9.1 Binding Effect; Assignment; Successors and Assigns . The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. No assignment of this Agreement or of any rights or obligations hereunder may be made by the Company, any Significant Common Shareholder, any Founder or any Purchaser (by operation of law or otherwise) without the prior written consent of the other parties hereto and any attempted assignment without the required consents shall be void; provided , however , that each Purchaser may assign its rights to purchase Shares to one or more of its limited partners or Affiliates or any member of the Company’s board of directors and such assignee will thereafter be entitled to all rights, and be subject to all obligations, under this Agreement to the same extent as if such assignee had originally been a Purchaser hereunder (in the same capacity as the assignor Purchaser); provided that , no such assignment shall relieve the Purchaser of its obligation hereunder if the obligation to purchase Shares hereunder is not fulfilled by the assignee. Upon any such permitted assignment, the references in this Agreement to Purchaser shall also apply to any such assignee unless the context otherwise requires.

9.2 Governing Law . This Agreement, and all claims or causes of action (whether in contract or tort) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance of this Agreement (including any claim or cause of action based upon, arising

 

40


out of or related to any representation or warranty made in or in connection with this Agreement or as an inducement to enter this Agreement) shall be governed by and construed in accordance with the internal laws of the State of Delaware without giving effect to the choice of law principles of such state that would require or permit the application of the laws of another jurisdiction.

9.3 Counterparts . This Agreement may be executed and delivered in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

9.4 Titles and Subtitles . The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.

9.5 Notices . All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given upon the earlier of (a) actual receipt, (b) personal delivery to the party to be notified, (c) when sent, if sent by electronic mail (provided that the sender did not receive an “undeliverable” message indicating that the electronic mail message did not reach its intended recipient) or facsimile (with automatic confirmation by the transmitting machine showing the proper number of pages were transmitted without error) during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient’s next Business Day, (d) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (e) one (1) Business Day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next Business Day delivery, with written verification of receipt. All communications shall be sent to the respective parties at their address as set forth on the signature page or Exhibit A , or to such e-mail address, facsimile number or address as subsequently modified by written notice given in accordance with this Subsection 9.5 . If notice is given to (i) the Company or any Significant Common Shareholder, a copy shall also be sent to Pepper Hamilton LLP, 3000 Two Logan Square, 18th & Arch Street, Philadelphia, PA 19103-2799, Attention: Barry M. Abelson, Facsimile: (215) 981-4750, E-mail: abelsonb@pepperlaw.com, (ii) the Founders, a copy shall also be sent to Morgan Lewis, Attention: Robert Lichtenstein, Facsimile: (215) 963-5001, E-mail: rlichtenstein@morganlewis.com, and (iii) Purchaser, a copy shall also be given to Weil, Gotshal & Manges LLP, 100 Federal Street, Boston, Massachusetts 02110, Attention: Marilyn French, Facsimile: (617) 772-8333, E-mail: marilyn.french@weil.com.

9.6 No Finder’s Fees . Except as set forth in Subsection 9.6 of the Disclosure Schedule, each party represents that it neither is nor will be obligated for any finder’s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder’s or broker’s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which each Purchaser or any of its officers, employees, or representatives is responsible.

9.7 Fees and Expenses . Within five (5) Business Days after Closing, the Company shall pay the reasonable out-of-pocket transaction expenses of Purchasers, including the reasonable fees and expenses of Weil, Gotshal & Manges LLP, counsel for Purchasers, and of PricewaterhouseCoopers LLP, Purchaser’s accounting firm. The Company shall pay the reasonable fees and expenses of one counsel and one accounting firm for each of (a) itself, (b) its management and (c) the Significant Common Shareholders.

 

41


9.8 Amendments and Waivers . Any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and Purchasers; provided , however , that none of Subsection 1.1 (Sale and Issuance of Series A Preferred Stock, Subsection 1.3 (Use of Proceeds; Dividend), Subsection 4.6 (No Shop), Subsection 4.7 (Non-Competition; Non-Solicitation; Confidentiality), Section 7 (Survival and Indemnification) or Section 9 (Miscellaneous) may be amended, terminated or waived, in each case, in any way that would adversely affect the rights or obligations of the Significant Common Shareholders and/or Founders hereunder without the written consent of such Significant Common Shareholder or Founder, as applicable. Any amendment or waiver effected in accordance with this Subsection 9.8 shall be binding upon, and inure to the benefit of, Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the other parties hereto.

9.9 Severability . The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.

9.10 Delays or Omissions . No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.

9.11 Entire Agreement . This Agreement (including the Exhibits hereto and any ancillary documents executed by the Company, Purchasers, Founders and Significant Common Shareholders on the date hereof) and the other Transaction Documents constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled.

9.12 Dispute Resolution . The parties (a) hereby irrevocably and unconditionally submit to the non-exclusive jurisdiction of any federal or state court sitting in the State of Delaware for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (b) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the federal or state courts of Delaware, and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.

9.13 WAIVER OF JURY TRIAL . EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION DOCUMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING,

 

42


WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL

9.14 Non Recourse . No past, present or future director, officer, employee, incorporator, member, partner, stockholder, Affiliate, agent, attorney or representative of any Purchaser shall have any liability for any obligations or liabilities of Purchaser under this Agreement or for any claim based on, in respect of, or by reason of, the transactions contemplated hereby.

9.15 No Commitment for Additional Financing . The Company acknowledges and agrees that no Purchaser has made any representation, undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Shares as set forth herein and subject to the conditions set forth herein. In addition, the Company acknowledges and agrees that (i) no statements, whether written or oral, made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (ii) the Company shall not rely on any such statement by any Purchaser or its representatives and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right, in it sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.

[Remainder of page intentionally left blank; signature pages follow.]

 

43


IN WITNESS WHEREOF, the parties have executed this Series A Preferred Stock Purchase Agreement as of the date first written above.

 

COMPANY:
FIVE BELOW, INC.
By:  

/s/ David Schlessinger

Name:   David Schlessinger
Title:   Executive Chairman
Address:    

c/o Five Below, Inc.

1616 Walnut Street

Suite 400

Philadelphia, PA 19103
Fax:   215.546.8099
Attention:   David Schlessinger;
  Thomas Vellios
E-mail:   dschlessinger@fivebelow.com
  tvellios@fivebelow.com
With a copy to (which copy shall not constitute notice):

Pepper Hamilton LLP

3000 Two Logan Square

18th & Arch Streets

Philadelphia, PA 19103

Attention:   Barry M. Abelson
Fax:   215.689.4803
E-mail:   abelsonb@pepperlaw.com

 

FIVE BELOW, INC. - INVESTMENT AGREEMENT


FOUNDERS:

/s/ David Schlessinger

David Schlessinger
c/o Five Below, Inc.

1616 Walnut Street

Suite 400

Philadelphia, PA 19103
Fax:   215.546.8099
E-mail:   dschlessinger@fivebelow.com

/s/ Thomas Vellios

Thomas Vellios
Address:  

c/o Five Below, Inc.

1616 Walnut Street

Suite 400

Philadelphia, PA 19103
Fax:   215.546.8099
E-mail:   tvellios@fivebelow.com

 

 

FIVE BELOW, INC. - INVESTMENT AGREEMENT


SIGNIFICANT COMMON SHAREHOLDERS:

/s/ David Schlessinger

David Schlessinger

c/o Five Below, Inc.

1616 Walnut Street

Suite 400

Philadelphia, PA 19103
Fax:   215.546.8099
E-mail:   dschlessinger@fivebelow.com

/s/ Thomas Vellios

Thomas Vellios
Address:

c/o Five Below, Inc.

1616 Walnut Street

Suite 400

Philadelphia, PA 19103
Fax:   215.546.8099
E-mail:   tvellios@fivebelow.com

 

FIVE BELOW, INC. - INVESTMENT AGREEMENT


SIGNIFICANT COMMON SHAREHOLDERS:

LLR Equity Partners II, L.P.

LLR Equity Partners Parallel II, L.P.

By:   LLR Capital II, L.P., its General Partner
  By:   LLR Capital II, LLC, its General Partner
    By:  

/s/ Howard D. Ross

    Name:   Howard D. Ross
    Title:   Member
Address:

c/o LLR Partners Equity Partners, L.P.

Cira Centre

2929 Arch Street

Philadelphia, PA 19104-2868
Attention:   Howard D. Ross
Fax:   215.717.2928
E-mail:   hross@llrpartners.com
With a copy to (which copy shall not constitute notice):

Pepper Hamilton LLP

3000 Two Logan Square

18th & Arch Streets

Philadelphia, PA 19103
Attention:   Barry M. Abelson
Fax:   215.689.4803
E-mail:   abelsonb@pepperlaw.com

 

FIVE BELOW, INC. - INVESTMENT AGREEMENT


SIGNIFICANT COMMON SHAREHOLDERS:
Blue 9 Fund I, L.P.
By:   Blue 9 Capital, LLC, its General Partner
  By:  

/s/ Steven Tuttleman

  Name:   Steven Tuttleman
  Title:   Manager
Address:

#401

145 Hudson St.

New York, NY 10013

Attention:   Steven Tuttleman
Fax:   212.798.0401
E-mail:   instar@earthlink.net
With a copy to (which copy shall not constitute notice):
Blank Rome LLP
One Logan Square
130 North 18th Street
Philadelphia, PA 19103-6998
Attention:   Steven Dubow
Fax:   215.832.5755
E-mail:   Dubow@BlankRome.com

 

 

FIVE BELOW, INC. - INVESTMENT AGREEMENT


  PURCHASERS:  
  Advent International GPE VI Limited Partnership
 

Advent International GPE VI-A Limited Partnership

Advent International GPE VI-B Limited Partnership

Advent International GPE VI-F Limited Partnership

  Advent International GPE VI-G Limited Partnership
  By:   GPE VI GP Limited Partnership, General Partner
    By:   Advent International LLC, General Partner
      By:   Advent International Corporation, Manager
        By:  

/s/ Steven Collins

          Name: Steven Collins
          Title:   Managing Director
  Advent International GPE VI-C Limited Partnership
 

Advent International GPE VI-D Limited Partnership

Advent International GPE VI-E Limited Partnership

  By:   GPE VI GP (Delaware) Limited Partnership, General Partner
    By:   Advent International LLC, General Partner
      By:   Advent International Corporation, Manager
        By:  

/s/ Steven Collins

         

Name: Steven Collins

Title:   Managing Director

  Advent Partners GPE VI 2008 Limited Partnership
 

Advent Partners GPE VI 2009 Limited Partnership

Advent Partners GPE VI 2010 Limited Partnership

Advent Partners GPE VI – A Limited Partnership

  Advent Partners GPE VI – A 2010 Limited Partnership
  By:   Advent International LLC, General Partner
    By:   Advent International Corporation, Manager
      By:  

/s/ Steven Collins

        Name:   Steven Collins
        Title:   Managing Director

Address:

 

FIVE BELOW, INC. - INVESTMENT AGREEMENT


c/o Advent International Corporation

75 State Street, Floor 29

Boston Massachusetts 02109

Attn: Steven Collins, Andrew Crawford

Fax: 617.951.0568, 212.461.6503

E-mail: scollins@adventinternational.com

acrawford@adventinternational.com

with a copy to (which copy shall not constitute notice):

Weil, Gotshal & Manges LLP

100 Federal Street

Boston, Massachusetts 02110

Attention: Marilyn French

Fax: 617.772.8333

E-mail: marilyn.french@weil.com

 

FIVE BELOW, INC. - INVESTMENT AGREEMENT


EXHIBITS

 

Exhibit A    SCHEDULE OF PURCHASERS
Exhibit B    COMMON DIVIDEND FORMULA
Exhibit C    FORM OF AMENDED AND RESTATED ARTICLES OF INCORPORATION
Exhibit D    FORM OF SECOND AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS, PREFERENCES, LIMITATIONS AND SPECIAL RIGHTS OF THE SERIES A 8% CONVERTIBLE PREFERRED STOCK
Exhibit E    DISCLOSURE SCHEDULE
Exhibit F    FORM OF INDEMNIFICATION AGREEMENT
Exhibit G    FORM OF AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT
Exhibit H    FORM OF SECOND AMENDED AND RESTATED SHAREHOLDERS AGREEMENT
Exhibit I    FORM OF LEGAL OPINION OF COMPANY COUNSEL
Exhibit J    FORM OF AMENDED AND RESTATED BYLAWS

[Exhibits C through J have been omitted as certain of these exhibits have been separately filed as exhibits to the Form S-1. The Company agrees to furnish supplementally a copy of these exhibits to the Securities and Exchange Commission upon request.]


EXHIBIT A

SCHEDULE OF PURCHASERS

 

Name of Purchaser

   Ownership Percentage  

Advent International GPE VI Limited Partnership

     44.08   

Advent International GPE VI-A Limited Partnership

     28.42   

Advent International GPE VI-B Limited Partnership

     2.23   

Advent International GPE VI-C Limited Partnership

     2.27   

Advent International GPE VI-D Limited Partnership

     2.00   

Advent International GPE VI-E Limited Partnership

     5.40   

Advent International GPE VI-F Limited Partnership

     8.30   

Advent International GPE VI-G Limited Partnership

     5.23   

Advent Partners GPE VI 2008 Limited Partnership

     1.61   

Advent Partners GPE VI 2009 Limited Partnership

     0.06   

Advent Partners GPE VI 2010 Limited Partnership

     0.12   

Advent Partners GPE VI – A Limited Partnership

     0.14   

Advent Partners GPE VI – A 2010 Limited Partnership

     0.14   

TOTAL

     100.00   


EXHIBIT B

COMMON DIVIDEND FORMULA

The maximum aggregate amount of the Common Dividend (the “ Maximum Common Dividend Amount ”) shall be an amount equal to the sum of the following amounts:

 

  (i) Purchase Price,

 

  (ii) plus , Assumed Exercise Price Proceeds,

 

  (iii) plus , Assumed Exercise Tax Benefit,

 

  (iv) plus , Vellios Loan Proceeds, and

 

  (v) minus , Assumed Miller Buckfire Fee.

For purposes of the foregoing calculation, “ Assumed Exercise Price Proceeds ” means the sum of the following amounts, without duplication:

 

  (i) the aggregate exercise price of vested and unvested options that have been exercised pursuant to the Exercise Offer during the Offer Period (such exercised vested and unvested options are referred to herein as the “ Offer Period Exercised Options ”);

 

  (ii) the aggregate exercise price of Compensatory Warrants that have been exercised pursuant to the Exercise Offer during the Offer Period (such exercised Compensatory Warrants are referred to herein as the “ Offer Period Exercised Compensatory Warrants ”);

 

  (iii) the aggregate exercise price of the Financing Warrants which would have been received had they been exercised rather than exchanged pursuant to the Exchange Offer;

 

  (iv) the aggregate exercise price of options (other than Offer Period Exercised Options) that have been exercised after June 1, 2010, but on or before the Dividend Record Date; and

 

  (v) the aggregate exercise price of Compensatory Warrants (other than Offer Period Exercised Compensatory Warrants) and Financing Warrants that have been exercised after June 1, 2010 but on or before the Dividend Record Date.

Assumed Exercise Tax Benefit ” means an amount equal to 38.5% of the assumed tax deduction, as determined by the Pre-Closing Board in good faith based on an equity value of $295 million for the common equity of the Company on a fully-diluted, as-converted basis, relating to the exercise of options and Compensatory Warrants that have been exercised after June 1, 2010 but on or before the Dividend Record Date.

Vellios Loan Proceeds ” means the cash proceeds received by the Company upon repayment of the outstanding balance of the loan made by the Company to Thomas Vellios pursuant to a promissory note, dated January 18, 2010, executed and delivered by Thomas Vellios in the principal amount of $250,000.

Assumed Miller Buckfire Fee ” means $314,844, such amount representing 61.5% of the sum of $500,000 fee payable by the Company to Miller Buckfire & Co, LLC for services rendered, as set forth in the Supplemental MB Letter Agreement, plus expenses of Miller Buckfire & Co, LLC reimbursed by the Company.


The Per Share Dividend shall be an amount equal to (x) an amount up to the Maximum Common Dividend Amount, as determined by the Pre-Closing Board in good faith, divided by (y) the Assumed Common Share Number. For purposes hereof, the “ Assumed Common Share Number ” shall be an amount equal to the sum of the following, without duplication:

 

  (i) the number of shares of Common Stock which are outstanding immediately prior to the Dividend Record Date;

 

  (ii) the number of shares of Common Stock into which the Series A Preferred Stock and Series A-1 Preferred Stock are convertible as of the Dividend Record Date;

 

  (iii) the number of shares of Common Stock that are issuable upon the exercise of the Offer Period Exercised Options;

 

  (iv) the number of shares of Common Stock that are issuable upon the exercise of Offer Period Exercised Compensatory Warrants;

 

  (v) the number of shares of Common Stock that underlie the Financing Warrants that have been exchanged or exercised after June 1, 2010 but on or before the Dividend Record Date;

 

  (vi) the number of shares of Common Stock issuable upon the exercise of options (other than Offer Period Exercised Options) that have been exercised after June 1, 2010 but on or before the Dividend Record Date; and

 

  (vii) the number of shares of Common Stock issuable upon the exercise of Compensatory Warrants (other than Offer Period Exercised Compensatory Warrants) that have been exercised after June 1, 2010 but on or before the Dividend Record Date.

In furtherance of the payment of the Common Dividend, the parties hereto intend that the Common Dividend be determined in a manner that is consistent with the foregoing and the illustration set forth on the following page. The calculation of the Maximum Common Dividend Amount that follows is for illustration purposes only and will vary based on the actual figures used to determine the Maximum Common Dividend Amount on the determination date.

Exhibit 10.2

AMENDMENT NO. 1

TO

INVESTMENT AGREEMENT

This Amendment No. 1 (this “ Amendment ”), dated as of October 14, 2010 (the “ Effective Date ”), to that certain Investment Agreement dated as of September 1, 2010 (the “ Investment Agreement ”), is by and among Five Below, Inc., a Pennsylvania corporation (the “ Company ”), the Purchasers listed on Exhibit A to the Investment Agreement (“ Purchasers ”) and Sargent Family Investment, LLC, a Delaware limited liability company (“ Assignee ”).

RECITALS

WHEREAS, on September 1, 2010, the Company, Purchasers and the other parties to the Investment Agreement entered into the Investment Agreement;

WHEREAS, Section 9.1 of the Investment Agreement provides that (i) each Purchaser may assign its rights to purchase Shares to a member of the Company’s board of directors, and such assignee will thereafter be entitled to all rights, and be subject to all obligations, under the Investment Agreement to the same extent as if such assignee had originally been a Purchaser hereunder (in the same capacity as the assignor Purchaser), and (ii) no such assignment shall relieve such Purchaser of its obligations under the Investment Agreement if the obligation to purchase Shares hereunder is not fulfilled by the assignee;

WHEREAS, Assignee is affiliated with Ronald L. Sargent, a member of the Company’s board of directors;

WHEREAS, each Purchaser desires to assign to Assignee, and Assignee desires to assume, the right to purchase at the Closing a portion of such Purchaser’s Shares under the Investment Agreement, and the corresponding rights and obligations with respect thereto under the Investment Agreement;

WHEREAS, Section 9.8 of the Investment Agreement provides that the Investment Agreement may be amended with the written consent of the Company and Purchasers; and

WHEREAS, the Company and Purchasers desire to amend the Investment Agreement as set forth herein to reflect the Assignment and Assumption (as defined below) and to amend Exhibit A to the Investment Agreement.

NOW, THEREFORE, for and in consideration of the mutual covenants and agreements contained herein and in the Investment Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows:

1. Defined Terms . Capitalized terms used herein and not otherwise defined shall have their respective meanings set forth in the Investment Agreement.

2. Assignment and Assumption .

(a) Each Purchaser hereby sells, assigns, transfers and delivers to Assignee, without recourse and without any representation or warranty of any kind, the right to purchase at the Closing a portion of such Purchaser’s Shares under the Investment Agreement (as set forth in Section 1.1(c) of the Investment Agreement) and the corresponding rights and obligations with respect thereto under the Investment Agreement (the “ Assignment ”).


(b) By execution of this Amendment, Assignee hereby acquires, assumes and accepts the Assignment, and agrees to be a “Purchaser” under the Investment Agreement and to be bound by, and subject to, all of the terms, conditions and obligations thereof to the same extent as if Assignee had originally been a “Purchaser” under the Investment Agreement. Without limiting the generality of the foregoing, Assignee hereby makes each of the representations and warranties set forth in Section 3 of the Investment Agreement as if it was a “Purchaser”. Assignee acknowledges receipt of a copy of the Investment Agreement and, after review and examination thereof, agrees to assume the obligations of a “Purchaser” with respect to the Shares allocated and assigned to Assignee hereunder (together with the Assignment, the “ Assignment and Assumption ”).

(c) The Assignment and Assumption will be effective as of the Effective Date, and the Assignee will become a “Purchaser” under the Investment Agreement as of the Effective Date.

(d) After giving effect to the Assignment and Assumption, subject to the terms and conditions of the Investment Agreement, each Purchaser (including the Assignee) shall purchase that number of Shares equal to the ownership percentage set forth beside such Purchaser’s name on the Revised Schedule of Purchasers (as defined below) multiplied by the Total Number of Purchased Shares, and the consideration payable by such Purchaser for such Shares shall be equal to the ownership percentage set forth on the Revised Schedule of Purchasers, multiplied by the Purchase Price.

(e) Notwithstanding anything in this Agreement to the contrary, each Purchaser acknowledges and agrees that, pursuant to Section 9.1 of the Investment Agreement, nothing in this Amendment shall relieve such Purchaser of any of its obligations under the Investment Agreement if Assignee’s obligation to purchase the Shares under the Investment Agreement is not fulfilled by Assignee.

3. Amendment to the Investment Agreement .

(a) Exhibit A. Exhibit A of the Investment Agreement is hereby deleted and replaced with the Exhibit A attached at Schedule I hereto (the “ Revised Schedule of Purchasers ”).

4. Effect on the Investment Agreement .

(a) This Amendment shall be effective as of the Effective Date. On and after the date hereof, each reference in the Investment Agreement to “this Agreement,” “hereunder,” “herein” or words of like import shall mean and be a reference to the Investment Agreement as amended hereby. Any reference to the Investment Agreement contained in any notice, request, certificate, or other document executed concurrently with or after the execution and delivery of this Amendment shall be deemed to include this Amendment unless the context shall otherwise require.

(b) Nothing contained herein invalidates or shall release or impair any covenant, condition, agreements or stipulation in the Investment Agreement, except as herein supplemented, consolidated and modified by this Amendment. The Investment Agreement, except as herein supplemented, consolidated and modified, shall continue in full force and effect.

(c) The execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy of any party for any default under the Investment

 

2


Agreement, as the Investment Agreement shall be amended by this Amendment, nor constitute a waiver of any provision of the Investment Agreement, except as herein supplemented, consolidated and modified by this Amendment.

5. Governing Law . This Amendment, and all claims or causes of action (whether in contract or tort) that may be based upon, arise out of or relate to this Amendment or the negotiation, execution or performance of this Amendment (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with this Amendment or as an inducement to enter this Amendment) shall be governed by and construed in accordance with the internal laws of the State of Delaware without giving effect to the choice of law principles of such state that would require or permit the application of the laws of another jurisdiction.

6. Counterparts . This Amendment may be executed by the parties hereto by facsimile, electronic mail (including pdf) or other transmission methods and in separate counterparts, each of which when so executed and delivered shall be an original, but all such counterparts shall together constitute one and the same instrument. Each counterpart may consist of a number of copies hereof each signed by less than all, but together signed by all of the parties hereto. Counterparts may be delivered via facsimile, electronic mail (including pdf) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

7. Captions . Section captions used in this Amendment are for convenience only, and shall not affect the construction of this Amendment.

REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

 

3


IN WITNESS WHEREOF, each of the parties hereto has caused this Amendment to be executed on its behalf by its officers or representatives thereunto duly authorized, as of the date first above written.

 

COMPANY:
FIVE BELOW, INC.
By:  

/s/ Kenneth R. Bull

Name: Kenneth R. Bull
Title:   Senior Vice President, Finance

 

A MENDMENT N O . 1 TO I NVESTMENT A GREEMENT (F IVE B ELOW )


PURCHASERS:  

Advent International GPE VI Limited Partnership

Advent International GPE VI-A Limited Partnership

Advent International GPE VI-B Limited Partnership

Advent International GPE VI-F Limited Partnership

Advent International GPE VI-G Limited Partnership

By:   GPE VI GP Limited Partnership, General Partner
By:   Advent International LLC, General Partner
By:   Advent International Corporation, Manager
By:  

/s/ Steven Collins

  Name: Steven Collins
  Title:   Managing Director

Advent International GPE VI-C Limited Partnership

Advent International GPE VI-D Limited Partnership

Advent International GPE VI-E Limited Partnership

By:   GPE VI GP (Delaware) Limited Partnership, General Partner
By:   Advent International LLC, General Partner
By:   Advent International Corporation, Manager
By:  

/s/ Steven Collins

  Name: Steven Collins
  Title:   Managing Director
PURCHASERS: (continued)

Advent Partners GPE VI 2008 Limited Partnership

Advent Partners GPE VI 2009 Limited Partnership

Advent Partners GPE VI 2010 Limited Partnership

Advent Partners GPE VI – A Limited Partnership

Advent Partners GPE VI – A 2010 Limited Partnership

By:   Advent International LLC, General Partner
By:   Advent International Corporation, Manager
By:  

/s/ Steven Collins

  Name: Steven Collins
  Title:   Managing Director

c/o Advent International Corporation

75 State Street, Floor 29

Boston, Massachusetts 02109

Attn: Steven Collins, Andrew Crawford

Fax: 617.951.0568, 212.461.6503

E-mail: scollins@adventinternational.com

acrawford@adventinternational.com

 

A MENDMENT N O . 1 TO I NVESTMENT A GREEMENT (F IVE B ELOW )


ASSIGNEE:

SARGENT FAMILY INVESTMENT, LLC

a Delaware limited liability company

By its manager:

EDGEWOOD INVESTMENT, LLC

a Delaware limited liability company

By:  

/s/ Ronald L. Sargent

  Ronald L. Sargent, Manager
By:  

/s/ Jill L. Sargent

  Jill L. Sargent, Manager

 

A MENDMENT N O . 1 TO I NVESTMENT A GREEMENT (F IVE B ELOW )


SCHEDULE 1

EXHIBIT A

SCHEDULE OF PURCHASERS

 

Name of Purchaser

   Ownership Percentage  

Advent International GPE VI Limited Partnership

     45.0730   

Advent International GPE VI-A Limited Partnership

     26.4094   

Advent International GPE VI-B Limited Partnership

     2.2770   

Advent International GPE VI-C Limited Partnership

     2.3267   

Advent International GPE VI-D Limited Partnership

     1.8594   

Advent International GPE VI-E Limited Partnership

     5.5285   

Advent International GPE VI-F Limited Partnership

     8.4816   

Advent International GPE VI-G Limited Partnership

     5.3495   

Advent Partners GPE VI 2008 Limited Partnership

     1.6506   

Advent Partners GPE VI 2009 Limited Partnership

     0.0597   

Advent Partners GPE VI 2010 Limited Partnership

     0.1293   

Advent Partners GPE VI – A Limited Partnership

     0.1491   

Advent Partners GPE VI – A 2010 Limited Partnership

     0.1392   

Sargent Family Investment, LLC

     0.5670   

TOTAL

     100.00   

 

S CHEDULE I - A MENDMENT N O . 1 TO I NVESTMENT A GREEMENT (F IVE B ELOW )

Exhibit 10.3

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the “ Agreement ”) is entered into as of September 1, 2010, by and among Five Below, Inc., a Pennsylvania corporation (the “ Company ”), the Significant Common Shareholders (as hereinafter defined), the Series A Preferred Shareholders (as hereinafter defined) and the other Holders (as hereinafter defined) identified as such on Exhibit A hereto (the “ Schedule of Holders ”). This Agreement shall become effective on the Effective Date (as hereinafter defined).

RECITALS

WHEREAS, the Company, the Advent Funds (as hereinafter defined) and the Significant Common Shareholders are party to that certain Investment Agreement, dated September 1, 2010 (the “ Investment Agreement ”), pursuant to which the Company shall sell and issue to the Series A Preferred Shareholders shares of its Series A 8% Convertible Preferred Stock, $0.01 par value per share (the “ Series A Preferred Stock ”), subject to the terms set forth herein, and in connection therewith the Series A Preferred Shareholders desire to accept the registration and other rights created pursuant hereto;

WHEREAS, certain shareholders of the Company previously entered into that certain Investor Rights Agreement, dated April 20, 2005, which was (i) amended by the First Amendment to Investor Rights Agreement, dated September 6, 2006, (ii) further amended by the Second Amendment to Investor Rights Agreement, dated February 23, 2007, (ii) further amended by the Third Amendment to Investor Rights Agreement, dated June 30, 2008, and (iv) further amended by the Fourth Amendment to Investor Rights Agreement, dated May 14, 2010 (such Investor Rights Agreement, as amended to date, the “ Original Agreement ”);

WHEREAS, the Original Agreement provides that the provisions thereof may be waived, modified, amended or terminated only by a written agreement signed by the Company and the holders of a majority of the Preferred Shares (as defined in the Original Agreement);

WHEREAS, in furtherance of the transactions contemplated by the Investment Agreement, the parties hereto (excluding the Series A Preferred Shareholders) desire to amend and restate the Original Agreement as set forth herein, and the Series A Preferred Shareholders desire to become a party to this Agreement, by execution of a Joinder Agreement, in each case, effective as of the date on which shares of Series A Preferred Stock (the “ Series A Preferred Shares ”) are sold to the Series A Preferred Shareholders pursuant to the Investment Agreement (the “ Effective Date ”); and

WHEREAS, the Significant Common Shareholders signatory hereto constitute the requisite holders of a majority of the Preferred Shares (as defined in the Original Agreement);


NOW, THEREFORE, in consideration of the mutual promises, representations, warranties, covenants and conditions set forth in this Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound hereby, mutually agree as follows:

1. DEFINITIONS

1.1. Definitions . As used in this Agreement the following terms shall have the following respective meanings:

“Advent Funds” shall mean, collectively, Advent International GPE VI Limited Partnership, Advent International GPE VI-A Limited Partnership, Advent International GPE VI-B Limited Partnership, Advent International GPE VI-C Limited Partnership, Advent International GPE VI-D Limited Partnership, Advent International GPE VI-E Limited Partnership, Advent International GPE VI-F Limited Partnership, Advent International GPE VI-G Limited Partnership, Advent Partners GPE VI 2008 Limited Partnership, Advent Partners GPE VI 2009 Limited Partnership, Advent Partners GPE VI 2010 Limited Partnership, Advent Partners GPE VI – A Limited Partnership and Advent Partners GPE VI – A 2010 Limited Partnership.

“Affiliate” shall mean any Person who is an “affiliate” as defined in Rule 12b-2 of the General Rules and Regulations under the Exchange Act.

“Business Day” shall mean any day except a Saturday, Sunday or other day on which commercial banks in the City of Philadelphia, Pennsylvania are authorized by law to close.

“Commission” shall mean the Securities and Exchange Commission, or any other federal agency at the time administering the Securities Act.

“Common Stock” shall mean the Company’s common stock, $0.01 par value per share.

“Conversion Shares” shall mean any shares of Common Stock issued or issuable upon conversion of the Series A Shares.

“Designation” shall mean the Certificate of Designations, Preferences, Limitations and Special Rights of the Series A 8% Convertible Preferred Stock of the Company’s articles of incorporation, as such Certificate may be amended from time to time.

“Equity Securities” shall mean any securities (i) evidencing an equity ownership interest in the Company including, without limitation, the Common Stock and Series A Preferred Stock, or (ii) convertible into or exercisable for any shares of the foregoing. For purposes of this Agreement, Equity Securities shall be calculated on an as converted or exercised basis.

“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, or any similar federal statute, and the rules and regulations of the Commission promulgated thereunder, all as the same shall be in the effect at the time.

“Holder” shall mean a holder of Registrable Securities identified on the Schedule of Holders, or any assignee of record of such Registrable Securities in accordance with Section 2.12(a) herein. The term “Holder” shall include the Series A Preferred Shareholders and the Significant Common Shareholders.

“Initial Public Offering ” shall mean the Company’s first underwritten public offering of its Common Stock under the Securities Act.

“Investors” shall mean, collectively, the Series A Preferred Shareholders and the Significant Common Shareholders.

“LLR” shall mean, collectively, LLR Equity Partners II, L.P. and LLR Equity Partners Parallel II, L.P.

 

2


“Person” shall mean any individual, corporation, partnership, firm, joint venture, association, limited liability company, limited liability partnership, joint-stock company, trust, unincorporated organization or governmental entity.

“Qualified Public Offering” shall mean an underwritten public offering of shares of the Company’s Common Stock in which the Company receives aggregate gross proceeds of at least One Hundred Million Dollars ($100,000,000), and following which the shares of the Company are listed on a nationally recognized U.S. stock market.

“Register,” “registered,” and “registration” shall refer to a registration effected by preparing and filing a registration statement in compliance with the Securities Act, and the declaration or ordering of effectiveness of such registration statement or document.

“Registrable Securities” shall mean (a) the Conversion Shares, (b) shares of Common Stock held by Significant Common Shareholders, and (c) any Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right, or other security that is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of shares described in clause (a) or (c). Notwithstanding the foregoing, Registrable Securities shall not include any securities which ( x ) have been sold by a Person to the public pursuant to a registration statement declared effective pursuant to the Securities Act, or ( y ) have been sold in a private transaction in which all or a portion of the transferor’s rights under this Agreement are not assigned.

“Registration Expenses” shall mean all expenses incurred in effecting any registration pursuant to this Agreement, including, without limitation, all registration and filing fees, printing expenses, legal fees and disbursements (including one counsel for the Holders selling shares in such registration), blue sky fees and expenses, fees of the National Association of Securities Dealers, Inc., fees of transfer agents and registrars, and the expense of any accounting fees, but excluding any Selling Expenses.

“Second Amended and Restated Shareholders Agreement” shall mean the Second Amended and Restated Shareholders Agreement, dated as of the date hereof, among the Company and the parties named on the signature pages thereto, and as may be further amended from time to time.

“Securities Act” shall mean the Securities Act of 1933, as amended, or any similar federal statute, and the rules or regulations of the Commission promulgated thereunder, all as the same shall be in effect at the time.

“Selling Expenses” shall mean all discounts and commissions to underwriters, brokers and dealers applicable to the sale of Registrable Securities, and stock transfer taxes applicable to the sale of Registrable Securities by Holders.

Series A Preferred Shareholders ” shall mean the Advent Funds and any Person party hereto that holds, on the date of determination, Series A Preferred Shares, including any Person who hereafter becomes a holder of Series A Preferred Shares (whether through issuance from the Company or as a permitted transferee of a Series A Preferred Shareholder) and executes and delivers a Joinder Agreement to the Company.

Significant Common Shareholder ” shall mean (i) until the first anniversary of the closing of the transactions contemplated by the Investment Agreement, provided that if as of such date there are any outstanding indemnity claims under the Investment Agreement, until the date on which the last remaining outstanding indemnity claim is finally resolved, any Holder listed under the heading

 

3


“Significant Common Shareholders” on the Schedule of Holders and any Person who hereafter becomes a permitted transferee of such Holder and executes and delivers a Joinder Agreement to the Company, and (ii) at any time thereafter, any Holder that alone (or together with any Person who hereafter becomes a permitted transferee of such Holder) owns a number of shares of Common Stock that is at least equal to 3% of the total Equity Securities outstanding on the closing of the transactions contemplated by the Investment Agreement (but excluding any equity awards granted in connection with the transactions contemplated by the Investment Agreement), calculated on a fully diluted basis assuming the conversion of all Equity Securities held by such Holder and any Person who hereafter becomes a permitted transferee of such Holder and subject to equitable adjustment upon any reverse or forward stock split or similar transaction by the Company.

Supermajority Board Approval ” means, if there are seven (7) members of the Board of Directors of the Company, the approval of five (5) of the seven (7) members of the Board of Directors of the Company, and if there are more or less than seven (7) members of the Board of Directors of the Company, the approval of that number of members representing at least two-thirds (rounded up to the nearest whole number) of the members of the Board of Directors of the Company.

For purposes of this Agreement, the following terms have the meanings set forth in the sections indicated below:

 

Term

  

Section

Agreement    Preamble
Company    Preamble
Effective Date    Recitals
Existing Shareholder    4.10
First Offer Pro Rata Share    3.1
Initial Notice    3.2
Initiating Holder(s)    2.2(a)
Investor Offer    3.3
Investment Agreement    Recitals
Joinder Agreement    2.2(a)
Notice Period    3.3
Offer Period    3.3
Original Agreement    Recitals
Preemptive Pro Rata Share    3.4
Preferred Stock Agreements    4.2
Series A Preferred Shares    Recitals
Series A Preferred Stock    Recitals
Schedule of Holders    Preamble
Subsequent Notice    3.4
Third Party Offer    4.2
Violation    2.8(a)

2. REGISTRATION RIGHTS

2.1. Notice of Proposed Transfer . Prior to any proposed transfer of any Registrable Securities (other than under the circumstances described in Sections 2.2, 2.3, 2.4 or pursuant to Rule 144 (or any other rule permitting public sale without registration under the Securities Act)), the Holder thereof shall give written notice to the Company of its intention to effect such transfer. Each such notice shall describe the manner of the proposed transfer and shall be accompanied by an opinion of counsel in form

 

4


and substance satisfactory to the Company and its counsel to the effect that the proposed transfer may be effected without registration under the Securities Act and any applicable state securities laws, whereupon such Holder shall be entitled to transfer such stock in accordance with the terms of its notice and this Agreement; provided , however , that no such opinion of counsel shall be required for a transfer to one or more current or former partners or members of the transferor (in the case of a transferor that is a partnership or a limited liability company, respectively). Each certificate for Registrable Securities transferred as provided above shall bear the legends set forth in Section 5.2 of the Second Amended and Restated Shareholders Agreement, except that such certificate shall not bear such legend if (i) such transfer is in accordance with the provisions of Rule 144 (or any other rule permitting public sale without registration under the Securities Act) or (ii) the opinion of counsel referred to above is to the further effect that the transferee and any subsequent transferee (other than an affiliate of the Company) would be entitled to transfer such securities in a public sale without registration under the Securities Act.

2.2. Required Registration .

(a) At any time ( x ) with respect to the Series A Preferred Shareholders, after the date hereof or ( y ) with respect to the Significant Common Shareholders, commencing one hundred eighty (180) days after the closing of the Initial Public Offering, each of (i) the Series A Preferred Shareholders holding a majority of the Registrable Securities held by such Series A Preferred Shareholders, and (ii) the Significant Common Shareholders holding a majority of the Registrable Securities held by such Significant Common Shareholders, as applicable, may request that the Company register under the Securities Act all or any portion of the shares of Registrable Securities held by such Series A Preferred Shareholders or Significant Common Shareholders, as applicable (the “ Initiating Holder(s) ”), for sale in the manner specified in such notice, such Registrable Securities having an anticipated aggregate offering price, prior to underwriting discounts and commissions, of at least the lesser of $10,000,000 or the balance of the Initiating Holder’s Registrable Securities.

(b) Following receipt of any notice from the Series A Preferred Shareholders as Initiating Holders under Section 2.2(a) hereof of a request for the Company to register their Registrable Shares in connection with the Initial Public Offering, within fifteen (15) days after receipt of such notice, the Company shall notify all Investors (other than the Initiating Holders) and thereafter shall use commercially reasonable efforts to register under the Securities Act, for public sale in accordance with the method of disposition specified in the notice from the Initiating Holder(s), the number of shares of Registrable Securities specified in the notice from the Initiating Holder(s) (and in all notices received by the Company from the Significant Common Shareholders within thirty (30) days after the giving of such notice by the Company). If such method of disposition shall be an underwritten public offering, the managing underwriter shall be selected by the Board of Directors of the Company and shall be reasonably acceptable to a majority in interest of the Initiating Holders. In such event, the right of any Investor to include such Investor’s Registrable Securities in such registration shall be conditioned upon such Investor’s participation in such underwriting and the inclusion of such Investor’s Registrable Securities in the underwriting to the extent provided herein. All Investors proposing to distribute their securities through such underwriting shall enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such underwriting. Notwithstanding any other provision of this Agreement, if the underwriter determines in good faith that marketing factors require a limitation on the number of shares to be underwritten, then the Company shall so advise all Investors of Registrable Securities that otherwise would be underwritten pursuant to hereto, and the number of shares that may be included in the underwriting shall be allocated (i)  first , to the Investors selling Registrable Securities, pro rata according to the total amount of Registrable Securities requested to be included in such registration by each selling Investor, and (ii)  second , to any other shareholder of the Company whose shares may be included in such registration.

 

5


(c) Following receipt of any notice from the Initiating Holders under Section 2.2(a) hereof, except in connection with the Initial Public Offering, the Company shall, within fifteen (15) days after receipt of such notice, notify all Holders (other than the Initiating Holder(s)) and thereafter shall use commercially reasonable efforts to register under the Securities Act, for public sale in accordance with the method of disposition specified in the notice from the Initiating Holder(s), the number of shares of Registrable Securities specified in the notice from the Initiating Holder(s) (and in all notices received by the Company from other Holders within thirty (30) days after the giving of such notice by the Company). Notwithstanding the foregoing, the Company shall not be required to give the Holders (other than the Investors) prior notice of the filing of any registration statement being filed by the Company in response to a notice from the Initiating Holders under Section 2.2(a) hereof provided that the Company provides the Holders entitled to participate in such registration a thirty-day period to give notice of their desire to include their shares of Registrable Securities such registration, subject to the other provisions of this Section 2.2 . If such method of disposition shall be an underwritten public offering, the managing underwriter shall be selected by the Board of Directors of the Company and shall be reasonably acceptable to a majority in interest of the Initiating Holders. In such event, the right of any Holder to include such Holder’s Registrable Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders proposing to distribute their securities through such underwriting shall enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such underwriting. Notwithstanding any other provision of this Agreement, if the underwriter determines in good faith that marketing factors require a limitation on the number of shares to be underwritten, then the Company shall so advise all Holders of Registrable Securities that otherwise would be underwritten pursuant to hereto, and the number of shares that may be included in the underwriting shall be allocated (i)  first , to the Holders selling Registrable Securities, pro rata according to the total amount of Registrable Securities requested to be included in such registration by each selling Holder, and (ii)  second , to any other shareholder of the Company whose shares may be included in such registration.

(d) Notwithstanding the foregoing or the provisions of Section 2.5(a) below, if the Company shall furnish to Holders requesting a registration statement pursuant to this Section 2.2 , a certificate signed by the President or Chief Executive Officer of the Company stating that in the good faith judgment of the Company’s Board of Directors, it would be materially detrimental to the Company and its shareholders for such registration statement to either become effective or remain effective for as long as such registration statement otherwise would be required to remain effective, because such action would (i) materially impede, delay, interfere with or otherwise adversely affect any pending financing, registration of securities, acquisitions, corporate reorganization or other significant transaction involving the Company, (ii) would require disclosure of non-public material information that the Company has a bona fide business purpose for preserving as confidential, or (iii) render the Company unable to comply with requirements under the Securities Act or Exchange Act, then the Company shall have the right to defer taking action with respect to such filing for a period of not more than ninety (90) days after the receipt of the request of the Initiating Holders; provided , however , that the Company may not utilize this right more than once in any twelve-month period.

(e) The Series A Preferred Shareholders, as a group, and the Significant Common Shareholders, as a group, may each effect two (2) registrations pursuant to this Section 2.2 , provided , however , that such obligation shall be deemed satisfied only when a registration statement covering all shares of Registrable Securities specified in notices received as set forth above, for sale in accordance with the method of disposition specified by the requesting Investors, shall have been declared effective by the Commission. In addition, the Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to this Section 2.2 :

(i) during the period that is sixty (60) days before the Company’s good faith estimate of the date of filings of, and ending on a date that is one hundred eighty (180) days after the effective date of, a registration subject to Section 2.3 below; or

 

6


(ii) if the Initiating Holders propose to dispose of shares of Registrable Securities that may be immediately registered on Form S-3 pursuant to a request made pursuant to Section 2.4 below; or

(iii) if within fifteen (15) days of receipt of a written request from the Initiating Holders pursuant to Section 2.2(a) , the Company gives notice to the Holders of the Company’s intention to make a public offering of securities of the Company (excluding offerings relating to employee benefits plans or corporate reorganizations or other transactions under Rule 145 of the Securities Act) within ninety (90) days of the date of such notice; provided , however , in no event shall the amount of Registrable Securities of the selling Holders included in the offering be reduced below 35% of the total amount of securities included in such offering; provided , further , however , that if such offering is completed, in no event shall it reduce the number of registrations that the Series A Preferred Shareholders and the Significant Common Shareholders, as applicable, may effect pursuant to this Section 2.2(e) ; provided , further , however , that if such offering is not complete within such ninety (90) day period, the Company shall be required to effect a registration under this Section 2.2 notwithstanding any intended public offering.

(f) The Company shall be entitled to include in any registration statement referred to in this Section 2.2 , for sale in accordance with the method of disposition specified by the requesting holders, shares of Common Stock to be sold by the Company for its own account, except as and to the extent that, in the opinion of the managing underwriter (if such method of disposition shall be an underwritten public offering), such inclusion would adversely affect the marketing of the Registrable Securities to be sold.

(g) For purposes of this Section 2.2 (and Sections 2.3 and 2.4 hereof), the only securities which the Company shall be required to register pursuant hereto shall be shares of Common Stock, provided , however , that in any underwritten public offering contemplated by this Section 2.2 or Sections 2.3 and 2.4 , the holders of Series A Preferred Shares shall be entitled to sell such Series A Preferred Shares to the underwriters for conversion and sale of the shares of Common Stock issued upon conversion thereof.

2.3. Incidental Registration .

(a) If the Company at any time proposes to register (but without any obligation to do so) any of its equity securities under the Securities Act for the Initial Public Offering, whether for its own account or for the account of other security holders or both, the Company will give written notice to each Investor of its intention so to do. Such written notice of the Company shall state the intended distribution of the securities the Company proposes to register or has registered. Upon the written request of any such Investor, received by the Company within thirty (30) days after the giving of any such notice by the Company, to register any of such Investor’s Registrable Securities, the Company will use commercially reasonable efforts to cause the Registrable Securities as to which registration shall have been so requested to be included in the securities to be covered by the registration statement proposed to be filed by the Company, all to the extent requisite to permit the sale or other disposition by the Investor of such number of Registrable Securities for which such Investor requested registration. In the event that any registration pursuant to this Sections 2.3(a) shall be, in whole or in part, an underwritten public offering of Common Stock, the Company shall not be required to include any of the Investor s’ securities in such underwriting unless such Investors accept the terms of the underwriting agreement as agreed upon between the

 

7


Company and the underwriters selected by it, and then only in such quantity, if any, as the underwriters determine, in their sole discretion, will not jeopardize the success of the offering by the Company. Notwithstanding any other provision of this Agreement, if the underwriter determines in good faith that marketing factors require a limitation on the number of shares to be underwritten, the number of shares that may be included in the underwriting shall be allocated (a)  first , to the Company, (b)  second , to Investors selling Registrable Securities pro rata according to the total amount of Registrable Securities requested to be included in such registration by each selling Investor, and (c)  third , to the extent determined by the underwriters to be compatible with the offering, to other shareholders of the Company; provided, however, if the registration for the Initial Public Offering has been requested by the Series A Preferred Shareholders pursuant to Section 2.2(a) , the number of shares that may be included in the underwriting shall be allocated in the manner provided in Section 2.2(b) . Notwithstanding the foregoing provisions, the Company shall have the right to terminate or withdraw any registration statement referred to in this Section 2.3(a) whether or not any Holder has elected to include securities in such registration, without thereby incurring any liability to the Holders of Registrable Securities.

(b) If the Company at any time proposes to register (but without any obligation to do so) any of its equity securities under the Securities Act for a public offering of such equity securities, except in connection with the Initial Public Offering, whether for its own account or for the account of other security holders or both (except with respect to Rule 145 transactions or registration statements on Forms S-4, S-8 or another form not available for registering the Registrable Securities for a public offering of such equity securities), each such time it will give written notice to each Holder of its intention so to do, provided that the Company may give notice to the Holders after it has made a filing for the registration of such securities. Such written notice of the Company shall state the intended distribution of the securities the Company proposes to register or has registered. Upon the written request of any such Holder, received by the Company within thirty (30) days after the giving of any such notice by the Company, to register any of such Holder’s Registrable Securities, the Company will use commercially reasonable efforts to cause the Registrable Securities as to which registration shall have been so requested to be included in the securities to be covered by the registration statement proposed to be filed by the Company, all to the extent requisite to permit the sale or other disposition by the Holder of such number of Registrable Securities for which such Holder requested registration. In the event that any registration pursuant to this Section 2.3(b) shall be, in whole or in part, an underwritten public offering of Common Stock, the Company shall not be required to include any of the Holders’ securities in such underwriting unless such Holders accept the terms of the underwriting agreement as agreed upon between the Company and the underwriters selected by it, and then only in such quantity, if any, as the underwriters determine, in their sole discretion, will not jeopardize the success of the offering by the Company. Notwithstanding any other provision of this Agreement, if the underwriter determines in good faith that marketing factors require a limitation on the number of shares to be underwritten, the number of shares that may be included in the underwriting shall be allocated (a)  first , to the Company, (b)  second , to Holders selling Registrable Securities pro rata according to the total amount of Registrable Securities requested to be included in such registration by each selling Holder, and (c)  third , to the extent determined by the underwriters to be compatible with the offering, to other shareholders of the Company. Notwithstanding the foregoing provisions, the Company shall have the right to terminate or withdraw any registration statement referred to in this Section 2.3(b) whether or not any Holder has elected to include securities in such registration, without thereby incurring any liability to the Holders of Registrable Securities.

2.4. Registration on Form S-3 . If at any time (a) a Series A Preferred Shareholder or Significant Common Shareholder requests that the Company file a registration statement on Form S-3 or any successor to Form S-3 for a public offering of all or any portion of the shares of Registrable Securities held by such requesting Series A Preferred Shareholder(s) or Significant Common Shareholder(s), the reasonably anticipated aggregate price to the public of which would exceed the lesser

 

8


of $5,000,000 or the balance of such Holder’s Registrable Securities, and (b) the Company is a registrant entitled to use Form S-3 or any successor to Form S-3 to register such shares, then the Company shall use commercially reasonable efforts to register under the Securities Act on Form S-3 or any successor to Form S-3, for public sale in accordance with the method of disposition specified in such notice, the number of shares of Registrable Securities specified in such notice. Whenever the Company is required by this Section 2.4 to use its commercially reasonable efforts to effect the registration of Registrable Securities, each of the procedures and requirements of Section 2.2 (including but not limited to the requirement that the Company notify all Holders of Registrable Securities from whom notice has not been received and provide them with the opportunity to participate in the offering) shall apply to such registration, provided , however , there shall be no limitation on the number of registrations on Form S-3 or any successor to Form S-3 which may be requested and obtained under this Section 2.4 , provided that the Company shall not be required to effect more than two (2) registrations on Form S-3 or any successor to Form S-3 pursuant to this Section 2.4 in any twelve (12) month period. If the selling Holders intend to distribute Registrable Securities pursuant to an underwriting, they shall so advise the Company in the demand pursuant to this Section 2.4 .

2.5. Registration Procedures . If and whenever the Company is required by the provisions of Sections 2.2 , 2.3 or 2.4 to use commercially reasonable efforts to effect the registration of any shares of Registrable Securities under the Securities Act, the Company will, as expeditiously as possible:

(a) prepare and file with the Commission a registration statement (which, in the case of an underwritten public offering pursuant to Section 2.2 , shall be on Form S-1 or other form of general applicability satisfactory to the managing underwriter selected as therein provided) with respect to such securities and use commercially reasonable efforts to cause such registration statement to become and remain effective for a period of up to 90 days, in the case of a registration under Section 2.2 , or 120 days, in the case of a registration under Section 2.4 or, if earlier, until the distribution contemplated in the registration statement has been completed;

(b) prepare and file with the Commission such amendments and supplements to such registration statement and the prospectus used in connection therewith as may be necessary to keep such registration statement effective for the period specified in paragraph (a) above and comply with the provisions of the Securities Act with respect to the disposition of all Registrable Securities covered by such registration statement in accordance with the sellers’ intended method of disposition set forth in such registration statement for such period;

(c) furnish to each seller of Registrable Securities and to each underwriter such number of copies of the registration statement and the prospectus included therein (including each preliminary prospectus) as such Persons reasonably may request in order to facilitate the public sale or other disposition of the Registrable Securities covered by such registration statement;

(d) use commercially reasonable efforts to register or qualify the Registrable Securities covered by such registration statement under the securities or “blue sky” laws of such jurisdictions as the sellers of Registrable Securities or, in the case of an underwritten public offering, the managing underwriter reasonably shall request, provided , however , that the Company shall not for any such purpose be required in connection therewith or as a condition thereto to qualify generally to transact business as a foreign corporation in any jurisdiction where it is not so qualified, to consent to general service of process in any such jurisdiction or to otherwise subject itself to general taxation in any such states or jurisdictions;

(e) notify each Holder of Registrable Securities covered by such registration statement at any time when a prospectus relating thereto is required to be delivered under the Securities

 

9


Act of the happening of any event as a result of which the prospectus included in such registration statement, as the in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing. The Holders of Registrable Securities covered by such registration statement agree upon receipt of such notice forthwith to cease making offers and sales of Registrable Securities pursuant to such registration statement or deliveries of the prospectus contained therein for any purpose until the Company has prepared and furnished an amendment or supplement to the prospectus as may be necessary so that, as thereafter delivered to purchasers of such Registrable Securities, such prospectus shall not include an untrue statement of material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing. The Company shall use its commercially reasonable efforts to prepare any such amendment or supplement as promptly as possible.

(f) use commercially reasonable efforts to list the Registrable Securities covered by such registration statement with any securities exchange on which the Common Stock of the Company is then listed; and

(g) make available for inspection by each seller of Registrable Securities, any underwriter participating in any distribution pursuant to such registration statement, and any attorney, accountant or other agent retained by such seller or underwriter, all financial and other records, pertinent corporate documents and properties of the Company, and cause the Company’s officers, directors and employees to supply all information reasonably requested by any such seller, underwriter, attorney, accountant or agent in connection with such registration statement.

It shall be a condition precedent to the obligations of the Company to take any action pursuant to Sections 2.2 , 2.3 or 2.4 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information with respect to themselves, the Registrable Securities held by them and the proposed method of distribution by them as shall be necessary in order to effect the registration of such Holder’s Registrable Securities; provided , however , that this requirement shall not be deemed to limit any disclosure obligation arising out of any selling Holder’s relationship to the Company if one of such selling Holder’s agents or affiliates is an officer, director or control person of the Company. In addition, the selling Holder’s shall, if requested by the Company, execute such other agreements, which are reasonably satisfactory to them and which shall contain such provisions as may be customary and reasonable in order to accomplish the registration of the Registrable Securities.

In connection with each registration pursuant to Sections 2.2 , 2.3 or 2.4 covering an underwritten public offering, the Company and each selling Holder agree to enter into a written agreement with the managing underwriter selected in the manner herein provided in such form and containing such provisions as are customary in the securities business for such an arrangement between such underwriter and companies of the Company’s size and investment stature.

2.6. Expenses . The Company will pay all Registration Expenses in connection with each registration statement under Sections 2.2 , 2.3 or 2.4 . Nothing herein shall limit the Company’s obligation to pay all Registration Expenses with respect to any non-underwritten public offering. All Selling Expenses in connection with each registration statement under Sections 2.2 , 2.3 or 2.4 shall be borne by the participating sellers in proportion to the number of shares sold by each, or by such participating sellers other than the Company (except to the extent the Company shall be a seller) as they may agree. The Company shall not, however, be required to pay for Registration Expenses regarding any registration proceeding pursuant to Section 2.2 or 2.4 , the request of which has been subsequently withdrawn by the Initiating Holders (and such Initiating Holders hereby indemnify the Company against all such expenses) unless (a) the withdrawal is based upon material adverse information concerning the Company of which

 

10


the Initiating Holders were not aware at the time of such request or a material decline in the market price of the Common Stock, or (b) the Initiating Holders agree to forfeit their right to one (1) requested registration pursuant to Section 2.2 , in which event such right shall be forfeited by all such Initiating Holders. If the Initiating Holders are required to pay the Registration Expenses, such expenses shall be borne by the holders of securities (including Registrable Securities) requesting such registration in proportion to the number of shares for which registration was requested.

2.7. Delay of Registration . No Holder shall have any right to obtain or seek to obtain an injunction restraining or otherwise delaying any such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2 .

2.8. Indemnification and Contribution .

(a) In the event of a registration of any of the Registrable Securities under the Securities Act pursuant to Sections 2.2 , 2.3 or 2.4 , the Company will indemnify and hold harmless each selling Holder thereunder, each underwriter for such selling Holder thereunder and each other Person, if any, who controls such selling Holder or underwriter within the meaning of the Securities Act or the Exchange Act, against any losses, claims, damages or liabilities, joint or several, to which such selling Holder, underwriter or controlling person may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements or omissions (collectively, a “ Violation ”): (i) any untrue statement or alleged untrue statement of any material fact contained in any registration statement under which such Registrable Securities was registered under the Securities Act pursuant to Sections 2.2 , 2.3 or 2.4 , any preliminary prospectus or final prospectus contained therein, or any amendment or supplement thereof, (i) the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or (iii) any violation or alleged violation by the Company (or any of its agents or Affiliates) of the Securities Act, the Exchange Act, any state securities law, or any rule or regulation promulgated under the Securities Act, the Exchange Act, or any state securities law, and will reimburse each such selling Holder, each such underwriter, each such controlling person or other aforementioned Person for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action, provided , however , that the indemnity obligations contained in this Section 2.8 shall not apply to: (A) amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld), (B) any such loss, claim, damage, liability or action to the extent that it arises out of or is based upon a Violation which occurs in reliance upon and in conformity with information furnished by any such selling Holder, any such underwriter or any such controlling person in writing specifically for use in such registration statement or prospectus, or (C) any such loss, claim, damage, liability or action to the extent that it arises out of or is based upon such selling Holder’s or underwriter’s failure to deliver a copy of the registration statement or prospectus or any amendments or supplements thereto.

(b) In the event of a registration of any of the Registrable Securities under the Securities Act pursuant to Sections 2.2 , 2.3 or 2.4 , each selling Holder, severally and not jointly, will indemnify and hold harmless the Company, each other selling Holder, each Person, if any, who controls the Company within the meaning of the Securities Act, each officer of the Company who signs the registration statement, each director of the Company, each underwriter and each Person who controls any underwriter within the meaning of the Securities Act, against all losses, claims, damages or liabilities, joint or several, to which the Company or such officer, director, underwriter, other selling Holder or controlling person may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any Violation and will reimburse the Company and each such officer, director, underwriter and controlling person for

 

11


any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action, provided , however , that such selling Holder will be liable hereunder in any such case if and only to the extent that any such loss, claim, damage or liability arises out of or is based upon a Violation in reliance upon and in conformity with information pertaining to such selling Holder, as such, furnished in writing to the Company by such selling Holder specifically for use in such registration statement or prospectus, and provided , further , however , that in no event shall any indemnity under this Section 2.8(b) exceed the proceeds received by such selling Holder from the sale of Registrable Securities covered by such registration statement, net of any Selling Expenses incurred by such selling Holder.

(c) Promptly after receipt by an indemnified party hereunder of notice of the commencement of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party hereunder, notify the indemnifying party in writing thereof, but the omission so to notify the indemnifying party shall not relieve it from any liability which such indemnifying party may have to such indemnified party other than under this Section 2.8 and shall only relieve such indemnifying party from any liability which it may have to such indemnified party under this Section 2.8 if and to the extent the indemnifying party is prejudiced by such omission. In case any such action shall be brought against any indemnified party and it shall notify the indemnifying party of the commencement thereof, the indemnifying party shall be entitled to participate in and, to the extent it shall wish, to assume and undertake the defense thereof with counsel satisfactory to such indemnified party, and, after notice from the indemnifying party to such indemnified party of its election so to assume and undertake the defense thereof, the indemnifying party shall not be liable to such indemnified party under this Section 2.8 for any legal expenses subsequently incurred by such indemnified party in connection with the defense thereof other than reasonable costs of investigation and of liaison with counsel so selected, provided , however , that, if the defendants in any such action include both the indemnified party and the indemnifying party and the indemnified party shall have reasonably concluded that there may be reasonable defenses available to it which are different from or additional to those available to the indemnifying party or if the interests of the indemnified party reasonably may be deemed to conflict with the interests of the indemnifying party, the indemnified party shall have the right to select a separate counsel and to assume such legal defenses and otherwise to participate in the defense of such action, with the expenses and fees of such separate counsel and other expenses related to such participation to be reimbursed by the indemnifying party as incurred.

(d) In order to provide for just and equitable contribution to joint liability under the Securities Act in any case in which either (i) any party otherwise entitled to indemnification hereunder makes a claim for indemnification pursuant to this Section 2.8 but it is judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case, notwithstanding the fact that this Section 2.8 provides for indemnification in such case, or (ii) contribution under the Securities Act may be required on the part of any party hereto for which indemnification is provided under this Section 2.8 , then, and in each such case, such parties will contribute to the aggregate losses, claims, damages, liabilities, or expenses to which they may be subject (after contribution from others) in such proportion as is appropriate to reflect the relative fault of each of the indemnifying party and the indemnified party in connection with the statements, omissions, or other actions that resulted in such loss, claim, damage, liability, or expense, as well as to reflect any other relevant equitable considerations. The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue or allegedly untrue statement of a material fact, or the omission or alleged omission of a material fact, relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission; provided, however , that, in any such case, (A) no Holder will be required to contribute any amount in

 

12


excess of the public offering price of all such Registrable Securities offered and sold by such Holder pursuant to such registration statement, and (B) no Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation; and provided further that in no event shall a Holder’s liability pursuant to this Section 2.8 , when combined with the amounts paid or payable by such Holder pursuant to Section 2.8 , exceed the proceeds from the offering received by such Holder (net of any Selling Expenses paid by such Holder), except in the case of willful misconduct or fraud by such Holder.

(e) The obligations of the Company and Holders under this Section 2.8 shall survive the completion of any offering of Registrable Securities in a registration statement under this Section 2 , and otherwise, and the termination of this Agreement. No indemnifying party, in the defense of any such claim or litigation, shall, except with the consent of each indemnified party, consent to the entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect of such claim or litigation.

2.9. Changes in Common Stock or Series A Preferred Shares . If, and as often as, there is any change in the Common Stock or the Series A Preferred Shares by way of a stock split, stock dividend, combination or reclassification, or through a merger, consolidation, reorganization or recapitalization, or by any other means, appropriate adjustment shall be made in the provisions hereof so that the rights and privileges granted hereby shall continue with respect to the Common Stock or the Series A Preferred Shares as so changed.

2.10. Rule 144 Reporting . With a view to making available the benefits of certain rules and regulations of the Commission which may at any time permit the sale of the Registrable Securities to the public without registration, at all times after ninety (90) days after any registration statement covering a public offering of securities of the Company under the Securities Act shall have become effective, the Company agrees to:

(a) make and keep public information available, as those terms are understood and defined in Rule 144 under the Securities Act;

(b) use commercially reasonable efforts to file with the Commission in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act; and

(c) furnish to each holder of Registrable Securities forthwith upon request a written statement, to the extent accurate, by the Company as to its compliance with the reporting requirements of such Rule 144 (at any time after ninety (90) days after the effective date of the registration statement filed by the Company for the Initial Public Offering) and of the Securities Act and the Exchange Act (at any time after the Company has become subject to such reporting requirements), a copy of the most recent annual or quarterly report of the Company, and such other reports and documents so filed by the Company as such holder may reasonably request in availing itself of any rule or regulation of the Commission allowing such holder to sell any Registrable Securities without registration (at any time after the Company has become subject to the reporting requirements under the Exchange Act).

 

13


2.11. Representations and Warranties . The Company represents and warrants to the Holders and each Holder, severally as to such Holder, and not jointly, represents and warrants to the Company as follows:

(a) The execution, delivery and performance of this Agreement have been duly authorized by all requisite corporate action and will not violate any provision of law, any order of any court or other agency of government, the charter or bylaws or any provision of any indenture, agreement or other instrument to which it or any or its properties or assets is bound, conflict with, result in a breach of or constitute (with due notice or lapse of time or both) a default under any such indenture, agreement or other instrument or result in the creation or imposition of any lien, charge or encumbrance of any nature whatsoever upon any of the properties or assets.

(b) This Agreement has been duly executed and delivered and constitutes the legal, valid and binding obligation, enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium and similar laws affecting creditors’ rights and remedies generally.

2.12. Additional Provisions .

(a) All covenants and agreements contained in this Section 2 by or on behalf of any of the parties hereto shall bind and inure to the benefit of the respective successors and assigns of the parties hereto (including without limitation transferees of any Series A Preferred Shares or Registrable Securities), whether so expressed or not, provided, however, that registration rights conferred herein on the holders of Series A Preferred Shares or Registrable Securities shall only inure to the benefit of a transferee of such Series A Preferred Shares or Registrable Securities if (i) there is transferred to such transferee at least 20% of the total shares of Series A Preferred Shares or Registrable Securities originally issued to the Holder thereof (as adjusted for any stock dividends, combinations, splits and the like) to the direct or indirect transferor of such transferee, or (ii) such transfer is by a Holder who is an Investor and is to such Holder’s owners, its direct or indirect general partners or limited partners, its affiliated funds or any of such fund’s respective direct or indirect general or limited partners, any of its directors, managing partners, managing directors, principals, and, solely with respect to the Advent Funds, any fund directly or indirectly managed or advised by Advent International Corporation; provided that in each case, that (A) the Company is, within thirty (30) days after such transfer, furnished with written notice of the name and address of such transferee or assignee and the securities with respect to which such registration rights are being assigned, (B) such transferee or assignee agrees in writing to be bound by and subject to the terms and conditions of this Agreement, including, without limitation, the provisions of this Section 2.12 , by executing a joinder agreement in substantially the form attached hereto as Annex A (a “ Joinder Agreement ”), and (C) such assignment shall be effective only if immediately following such transfer the further disposition of such securities by the transferee or assignee is restricted under the Securities Act.

(b) The obligations of the Company to register shares of Registrable Securities under Sections 2.2 , 2.3 or 2.4 shall terminate with respect to the shares held by any Investor upon the earlier to occur of (i) the time at which all shares of Registrable Securities held or entitled to be held upon conversion by such Holder may be sold immediately under Rule 144 without regard to any volume limitations thereunder, and (ii) the closing of a Deemed Liquidation Event, as such term is defined in the Company’s Articles of Organization.

(c) The Company shall not grant to any third party any registration rights that are more favorable than, or that would otherwise interfere with, the rights granted to the Investors hereunder, so long as any of the registration rights under this Agreement remains in effect. Subject to this Section 2.12(c) , and subject to the cut-back limitations provided to the Holders of Registrable Securities hereunder, any registration statement filed pursuant to the request of the Holders may include other securities of the Company with respect to which registration rights have been granted, other securities of the Company with respect to which no registration rights have been granted and securities of the Company being sold for the account of the Company.

 

14


2.13. “Lock-Up”. If requested in writing by the underwriters in any registered offering, each Holder agrees not to, directly or indirectly, sell, contract to sell (including without limitation, any short sale), grant any option to purchase, dispose of or otherwise transfer any shares of Registrable Securities (other than shares of Common Stock being registered in such offering), without the consent of such underwriters, for a period of not more than (a) one hundred eighty (180) days following the effective date of the registration statement filed under the Securities Act relating to the Initial Public Offering, and (b) ninety (90) days following the effective date of registration statement filed under the Securities Act relating to any registration other than the Initial Public Offering. Each Holder agrees to execute and deliver such documents, agreements and instruments as may reasonably requested by the Company or the underwriter which are consistent with the foregoing. In order to enforce the rights and obligations under this Section 2.13 , the Company may impose stop-transfer instructions with respect to the Registrable Securities of each Holder (and the Registrable Securities of every other Person subject to the foregoing restrictions) until the end of such period.

3. RIGHT OF FIRST OFFER AND PREEMPTIVE RIGHTS ON ISSUANCES OF NEW SECURITIES BY THE COMPANY

3.1. Subsequent Offerings . Each of the Investors shall have the right to purchase its First Offer Pro Rata Share of any Equity Securities that the Company may, from time to time, propose to sell and issue after the date of this Agreement, other than the Equity Securities excluded by Section 3.7 hereof, pursuant to the terms of this Section 3 and applicable securities laws. The Company shall not issue Equity Securities except in compliance with this Section 3 . Each Investor’s “ First Offer Pro Rata Share ” is equal to the ratio of ( x ) the number of shares of Common Stock of which it is deemed to be a holder (including all shares of Common Stock issued or issuable upon conversion of any securities convertible or exercisable into shares of Common Stock) immediately prior to the issuance of such Equity Securities, to ( y ) the total number of shares of Common Stock of which all Investors are deemed to be holders (including all shares of Common Stock issued or issuable upon conversion of any securities convertible or exercisable into shares of Common Stock) immediately prior to the issuance of the Equity Securities. Each Investor shall have a right of reallotment such that, if any Investor fails to exercise the right to purchase its full First Offer Pro Rata Share of the Equity Securities being offered, the Company shall promptly notify the other Investors and each other Investor may exercise an additional right to purchase its First Offer Pro Rata Share (using as the denominator, for this purpose, the total number of shares of Common Stock deemed to be held by all Investors exercising this additional right to purchase) of the balance of such Equity Securities not previously purchased.

3.2. Notice of Issue . If the Company proposes to issue any Equity Securities, then the Company shall give each Investor written notice of its intentions, which notice shall describe the Equity Securities, the amount of Equity Securities the Company proposes to issue, and the price, terms and conditions upon which the Company proposes to issue such Equity Securities, and shall offer such Equity Securities to each Investor pursuant to the terms of this Section 3 (the “ Initial Notice ”). The Company shall include with the Initial Notice the current draft of materials, if any, relating to the proposed offering to be provided to prospective investors and shall provide to each Investor all materials, if any, subsequently provided to prospective investors prior to the closing of such offering. If any information so provided or required to be provided is materially different from the information provided with the Initial Notice, a new Notice Period shall commence. The Company shall not discuss the proposed issuance of Equity Securities with prospective investors prior to the end of the Notice Period.

3.3. Exercise of Right of First Offer . The Investors shall have ten (10) Business Days (the “ Notice Period ”) after delivery of such Initial Notice from the Company to submit a firm written bona fide offer, not subject to due diligence or investment committee approval (the “ Investor Offer ”), to purchase in the aggregate all of the Equity Securities being offered. If the Company does not accept the

 

15


Investor Offer, as determined by Supermajority Board Approval, or if the Investors fail to provide an Investor Offer to the Company within the Notice Period, the Company may seek third party offers (a “ Third Party Offer ”) for such Equity Securities for a period of 60 calendar days (the “ Offer Period ”). In the event the Company receives a Third Party Offer during the Offer Period with terms and conditions materially more favorable to the Company than those provided in the Investor Offer, as determined by Supermajority Board Approval, the Company may accept the Third Party Offer and the Investor Offer will be terminated. This right of first offer will terminate in the event the Company completes a single sale of Equity Securities resulting in gross proceeds to the Company of at least the greater of Ten Million Dollars ($10,000,000) and the amount of Equity Securities stated in the Initial Notice, and the Investors did not submit an Investor Offer with respect to such offering during the Notice Period. For the avoidance of doubt, the Company will not be obligated to (a) accept any Investor Offer or any Third Party Offer or (b) complete any Investor Offer or any Third Party Offer if accepted.

3.4. Exercise of Preemptive Rights . If the Investors do not elect to purchase all of the Equity Securities being offered pursuant to Section 3.3 hereof and the Company accepts a Third Party Offer in accordance with Section 3.3 hereof, the Company shall give each Investor written notice (the “ Subsequent Notice ”). Each Investor shall have thirty (30) calendar days from the date on which the Investor receives the Subsequent Notice to agree to purchase its Preemptive Pro Rata Share (as defined below) of all of the Equity Securities being offered, each for the price and upon the terms and conditions specified in the Initial Notice. Each Investor’s “ Preemptive Pro Rata Share ” is equal to the ratio of ( x ) the number of shares of Common Stock of which it is deemed to be a holder (including all shares of Common Stock issued or issuable upon conversion of any securities convertible or exercisable into shares of Common Stock) immediately prior to the issuance of such Equity Securities, to ( y ) the total number of shares of Common Stock issued and outstanding (including all shares of Common Stock issued or issuable upon conversion of any securities convertible or exercisable into shares of Common Stock, including all shares available for issuance under the Company’s equity incentive plans) immediately prior to the issuance of the Equity Securities. Each Investor shall have a right of reallotment such that, if any Investor fails to exercise the right to purchase its full Preemptive Pro Rata Share of the Equity Securities being offered, the Company shall promptly notify the other Investor and the other Investor may exercise an additional right to purchase the balance of such Equity Securities not previously purchased. Any Equity Securities not purchased pursuant to this Section 3.4 may be sold during the Offer Period to the purchaser pursuant to the Third Party Offer accepted by the Company in accordance with Section 3.3 hereof. The Company may in its discretion sell the full amount of Equity Securities contemplated by the Third Party Offer and sell additional Equity Securities to the extent provided in this Section 3.4 .

3.5. Termination and Waiver of First Offer and Preemptive Rights . The preemptive rights established by Section 3.4 hereof shall terminate as to a particular Investor upon the consummation of an offering of Equity Securities resulting in gross proceeds to the Company of at least Ten Million Dollars ($10,000,000) in which such Investor does not exercise its rights under Section 3.4 in full on a timely basis. The right of first offer and the preemptive rights established by this Section 3 may be amended, or any provision waived, with the written consent of the Company, a majority of the Series A Preferred Shareholder and a majority of the Significant Common Shareholders, each voting as a separate class.

3.6. Transfer of Rights of First Offer and Preemptive Rights . The rights of first offer of the Investors under this Section 3 may not be transferred. The preemptive rights of each Investor under this Section 3 may be transferred to the same parties, subject to the same restrictions, as any transfer of registration rights pursuant to clause (i) of Section 2.12(a) above, except that the transferee in clause (i) of Section 2.12(a) above must have transferred to him, her or it pursuant to this Section 3.6 at least a majority of the total Registrable Securities owned by such Investor.

 

16


3.7. Termination of First Offer and Preemptive Rights; Excluded Securities . The first offer and preemptive rights under this Section 3.7 shall also terminate upon the consummation of a Qualified Public Offering. The first offer and preemptive rights under this Section 3.7 shall have no application to any of the following Equity Securities:

(a) Shares of Common Stock, or options, warrants or other rights to purchase shares of Common Stock (and any Common Stock issued upon exercise of any such options, warrants or other rights), granted or issued to officers, employees, advisors, consultants, directors or other third party service providers of the Company, pursuant to any stock option or stock purchase agreement, plan or other compensatory arrangement approved by the Board of Directors of the Company;

(b) Shares of Common Stock issued after the Effective Date as a stock dividend or upon any subdivision or combination of shares of Common Stock or Series A Preferred Shares;

(c) Shares of Common Stock or Series A Preferred Shares issued upon conversion or exercise of any convertible securities (including, without limitation, upon the conversion of the shares of any series of the Company’s Series A Preferred Shares into shares of Common Stock), options or warrants of the Company outstanding as of the Effective Date;

(d) Shares of Common Stock issued in connection with a bona fide business acquisition by the Company, whether by merger, consolidation, sale of assets, sale or exchange of stock or otherwise, or in connection with a joint venture arrangement, in each case approved by the Board of Directors of the Company;

(e) Shares of Common Stock issued after the Effective Date in connection with a Qualified Public Offering; and

(f) Shares of Common Stock that is issued after the Effective Date in connection with a lease line of credit, equipment financing, bank financing, or other similar arrangement and that is not intended to serve primarily as an equity financing for the Company, is entered into on an arms’ length basis and is approved by the Board of Directors of the Company.

4. COVENANTS OF THE COMPANY

4.1. Financial Statements, Reports, Etc. The Company shall furnish to each Investor:

(a) as soon as practicable, but in any event within one hundred and five (105) days after the end of each fiscal year of the Company, audited financial statements of the Company, audited in accordance with generally accepted accounting principles and certified by a nationally recognized independent public accounting firm selected by the Board of Directors of the Company;

(b) as soon as practicable, but in any event within thirty (30) days after the end of each month in each fiscal year financial statements of the Company including a balance sheet and related consolidated statements of operations, shareholders’ equity and cash flows, unaudited but prepared by the Company in accordance with generally accepted accounting principles;

(c) at the time of delivery of each annual financial statement pursuant to Section 4.1(a) hereof, a certificate executed by the Chief Financial Officer of the Company stating that such officer has no knowledge of any default by the Company in the performance or observance of any of the provisions of this Agreement or the terms of the Series A Preferred Shares in the Designation or, if such officer has such knowledge, specifying such default and the nature thereof;

 

17


(d) at the time of delivery of the monthly statement pursuant to Section 4.1(b) hereof, a management narrative report explaining all significant current developments and including a comparison between the comparable figures for the prior year and the Company’s budget;

(e) as soon as practicable, but in any event no later than thirty (30) days after the commencement of each fiscal year, an annual budget to be approved by the Board of Directors of the Company containing an operating plan with a monthly forecast of results and a narrative explanation;

(f) promptly following receipt by the Company, each material communication, written or otherwise submitted to the Company by its auditors, including, but not limited to an audit response letter, accountant’s management letter and other written report submitted to the Company by its independent public accountants or any governmental agency in connection with an annual or interim audit of the books of the Company;

(g) promptly, from time to time, all such other information regarding the business, financial condition, operations, property or affairs of the Company and its subsidiaries as each Investor reasonably may request; provided, however , that the Company shall not be obligated under this Section 4.1 to provide information (i) that the Company reasonably determines in good faith to be a trade secret or confidential information (unless covered by an enforceable confidentiality agreement, in form acceptable to the Company) or (ii) the disclosure of which would adversely affect the attorney-client privilege between the Company and its counsel.

If, for any period, the Company has any subsidiary whose accounts are consolidated with those of the Company, then in respect of such period the financial statements delivered pursuant to the foregoing sections shall be the consolidated and consolidating financial statements of the Company and all such consolidated subsidiaries.

Notwithstanding anything else in this Section 4.1 to the contrary, the Company may cease providing the information set forth in this Section 4.1 during the period starting with the date thirty (30) days before the Company’s good-faith estimate of the date of filing of a registration statement if it reasonably concludes it must do so to comply with the SEC rules applicable to such registration statement and related offering; provided that the Company’s covenants under this Section 4.1 shall be reinstated at such time as the Company is no longer actively employing its commercially reasonable efforts to cause such registration statement to become effective.

4.2. Reservation of Conversion Shares . The Company shall at all times reserve and keep available out of its authorized but unissued shares of Common Stock, for the purpose of effecting the conversion of the Series A Preferred Shares and, otherwise complying with the terms of this Agreement and the Investment Agreement (collectively, the “ Preferred Stock Agreements ”), such number of its duly authorized shares of Common Stock as shall be sufficient to effect the conversion of the Series A Preferred Shares from time to time outstanding or otherwise to comply with the terms of the Preferred Stock Agreements and the Designation. If at any time the number of authorized but unissued shares of Common Stock shall not be sufficient to effect the conversion of the Series A Preferred Shares or otherwise to comply with the terms of the Preferred Stock Agreements, the Company will forthwith take such corporate action as may be necessary to increase its authorized but unissued shares of Common Stock to such number of shares as shall be sufficient for such purposes.

4.3. Properties, Business, Insurance . The Company shall maintain as to its properties and business, with financially sound and reputable insurers, insurance against such casualties and contingencies and of such types and in such amounts as is customary for companies similarly situated, which insurance shall be deemed by the Company to be sufficient, as well as directors’ and officers’

 

18


liability insurance of at least $6,000,000 on terms reasonably satisfactory to the Investors. The Company shall not cause or permit any assignment or change in beneficiary and shall not borrow against any such policy.

4.4. Inspection, Consultation and Advice . The Company shall permit each Investor and such Persons as it may designate (provided that the Board of Directors of the Company has reasonably determined that such Investor or other Person is not a competitor of the Company or an Affiliate of any competitor of the Company), at such Investor’s expense, to visit and inspect any of the properties of the Company, examine their books and records, discuss the affairs, finances and accounts of the Company with its officers, employees and public accountants (and the Company hereby authorizes said accountants to discuss with each Investor and such designees such affairs, finances and accounts), and consult with and advise the management of the Company as to its affairs, finances and accounts, all at reasonable times and upon reasonable (but in no event less than on two (2) Business Days notice); provided, however , that the Company shall not be obligated pursuant to this Section 4.4 to provide access to any information that (a) it reasonably and in good faith considers to be a trade secret or confidential information (unless covered by an enforceable confidentiality agreement, in form acceptable to the Company) or (b) the disclosure of which would adversely affect the attorney-client privilege between the Company and its counsel.

4.5. Confidentiality . Each Investor agrees that such Investor will keep confidential and will not disclose, divulge, or use for any purpose (other than to monitor its investment in the Company) any confidential information obtained from the Company pursuant to the terms of this Agreement (including notice of the Company’s intention to file a registration statement), unless such confidential information (a) is known or becomes known to the public in general (other than as a result of a breach of this Section 4.5 by such Investor), (b) is or has been independently developed or conceived by the Investor without use of the Company’s confidential information, or (c) is or has been made known or disclosed to the Investor by a third party without a breach of any obligation of confidentiality such third party may have to the Company; provided , however , that an Investor may disclose confidential information (i) to its attorneys, accountants, consultants, and other professionals to the extent necessary to obtain their services in connection with monitoring its investment in the Company; (ii) to any prospective purchaser of any Registrable Securities from such Investor, if such prospective purchaser agrees to be bound by the provisions of this Section 4.5 ; (iii) to any Affiliate, partner, member, stockholder, or wholly owned subsidiary of such Investor in the ordinary course of business, provided that such Investor informs such Person that such information is confidential and directs such Person to maintain the confidentiality of such information in a manner consistent with this Section 4.5 ; or (iv) as may otherwise be required by law, provided that the Investor promptly notifies the Company of such disclosure and takes reasonable steps to minimize the extent of any such required disclosure

4.6. Expenses of Directors . The Company shall promptly reimburse in full, each director of the Company who is not an employee of the Company, and each observer allowed to attend meeting of the Board of Directors of the Company pursuant to the Second Amended and Restated Shareholders Agreement, for all of his or her reasonable and documented out-of-pocket expenses incurred in attending each meeting of the Board of Directors of the Company or any Committee thereof.

4.7. Board of Directors Meetings . The Company shall use its commercially reasonable efforts to ensure that meetings of its Board of Directors are held at least once every calendar quarter unless otherwise determined by the Board of Directors of the Company; provided, however, that the Company shall ensure that at least four (4) meetings of its Board of Directors are held during each calendar year.

 

19


4.8. Performance of Contracts . The Company shall not amend, modify, terminate, waive or otherwise alter, in whole or in part, any of its employee nondisclosure and developments agreements or non-competition covenants without the consent of the Company’s Board of Directors.

4.9. Employee Nondisclosure and Developments Agreements . The Company shall use its commercially reasonable efforts to obtain an Employee Nondisclosure and Developments Agreement, in form and substance reasonably satisfactory to the Company’s Board of Directors, from all officers, key employees and other employees hired on a full-time basis after the Effective Date who will have access to confidential information of the Company upon their employment by the Company. Notwithstanding the foregoing, the Company shall not be required to seek Employee Nondisclosure and Development Agreements from any individual employed as a sales clerk at its store locations.

4.10. Execution of Second Amended and Restated Shareholders Agreement . The Company shall require any Person (other than an Investor or its permitted transferee) who holds shares of Equity Securities (subject to adjustment for stock splits, stock dividends or other similar events) to join the Second Amended and Restated Shareholders Agreement as a “Shareholder” upon the exercise by such Person of any stock options issued by the Company or the acquisition by such Person of Equity Securities ranking junior to the Series A Preferred Shares. Any permitted transferee of an Investor or any purchaser of Series A Preferred Shares not already party to the Company’s Amended and Restated Shareholders Agreement, dated April 20, 2005, as amended from time to time, shall be required to join the Second Amended and Restated Shareholders Agreement as an “Investor” by execution of an Adoption Agreement (as defined in the Second Amended and Restated Shareholders Agreement).

4.11. Termination of Covenants . The covenants set forth in this Section 4 shall terminate and be of no further force or effect as to the Investors upon the consummation of a Qualified Public Offering.

5. GENERAL PROVISIONS

5.1. Specific Enforcement . Each Investor and the Company expressly agrees that the Investors will be irreparably damaged if this Agreement is not specifically enforced. Upon a breach or threatened breach of the terms, covenants and/or conditions of this Agreement by any Investor or the Company, the Investors shall, in addition to all other remedies, be entitled to a temporary or permanent injunction, without showing any actual damage, and/or a decree for specific performance, in accordance with the provisions hereof.

5.2. Notices . All notices or other communications given hereunder shall be deemed effective upon delivery at the address (with respect to the Company, as set forth below and, with respect to the Investors, as set forth on the Schedule of Holders) of the party to be notified and shall be mailed by certified or registered mail, return receipt requested, delivered by courier, telecopied, or sent by other facsimile method (notices by telecopy or facsimile must be confirmed by next day courier delivery to be effective), or such other address as such party may subsequently notify the other parties of in writing. Each Investor and the Company consents to the receipt of notice by electronic transmission at the electronic mail address as set forth below with respect to the Company and as set forth across below each Investor’s name in the Schedule of Holders.

to the Company:

Five Below, Inc.

1616 Walnut Street

Suite 400

Philadelphia, PA 19103

 

20


Attn: David Schlessinger and

Thomas Vellios

Fax: 215.546.8099

E-mail: dschlessinger@fivebelow.com ;

tvellios@fivebelow.com

with copies to:

Pepper Hamilton LLP

3000 Two Logan Square

18th and Arch Streets

Philadelphia, PA 19103

Attn: Barry M. Abelson, Esquire

Fax: 215.689.4803

E-mail: abelsonb@pepperlaw.com

and

Advent International Corporation

75 State Street, Floor 29

Boston Massachusetts 02109

Attn: Steven Collins, Andrew Crawford

Fax: 617.951.0568, 212.461.6503

E-mail: scollins@adventinternational.com ,

acrawford@adventinternational.com

5.3. Entire Agreement and Amendments . This Agreement constitutes the entire agreement of the parties with respect to the subject matter hereof and neither this Agreement nor any provision hereof may be waived, modified, amended or terminated except by a written agreement signed by (a) the Company, (b) the holders of a majority of the Series A Preferred Shares and (c) holders of a majority of the shares of Common Stock held by the Significant Common Shareholders; provided , however , that if any waiver, modification or amendment adversely and disproportionately affects the rights contained herein of any Significant Common Shareholders relative to other Significant Common Shareholders or holders of Common Stock, the consent of the Significant Common Shareholders so affected to such waiver, modification or amendment shall be required. Notwithstanding the foregoing, on the Effective Date, the Company, without the consent of any other party hereto, may amend (i)  Exhibit A to update the list of Holders, Series A Preferred Shareholders and Significant Common Shareholders, as they exist on the Effective Date after giving effect to all of the transactions described in the Investment Agreement, and (ii) the definition of Significant Common Shareholders to set forth the number of shares representing 3% of the total Equity Securities outstanding as of the closing of the transactions contemplated by the Investment Agreement, assuming the conversion of all Equity Securities.

5.4. Waiver of Statutory Information Rights . Each Holder agrees that the Company shall not be required to provide, and hereby waives such Holder’s right to receive, annual financial statements under Section 1554 of the Pennsylvania Business Corporation Law of 1988, as amended. This agreement and waiver shall be binding on each Holder and any transferee of its Common Stock or Series A Preferred Stock and its respective successors and assigns. Such agreement and waiver shall not excuse the Company from providing information to the Investors as required by Section 4.1 hereof.

 

21


5.5. Governing Law; Successors and Assigns . This Agreement, and all claims or causes of action (whether in contract or tort) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance of this Agreement (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with this Agreement or as an inducement to enter this Agreement) shall be governed by and construed in accordance with the internal laws of the Commonwealth of Pennsylvania without giving effect to the choice of law principles of such state that would require or permit the application of the laws of another jurisdiction. This Agreement shall bind and inure to the benefit of the heirs, personal representatives, executors, administrators, successors and assigns of the parties hereto.

5.6. Dispute Resolution . The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the United States District Court for the Eastern District of Pennsylvania or any Pennsylvania Commonwealth court sitting in the City of Philadelphia for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (b) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state or federal courts of the Commonwealth of Pennsylvania, and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.

5.7. WAIVER OF JURY TRIAL : EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION DOCUMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.

5.8. Severability . If any provision of this Agreement shall be held to be illegal, invalid or unenforceable, such illegality, invalidity or unenforceability shall attach only to such provision and shall not in any manner affect or render illegal, invalid or unenforceable any other provision of this Agreement, and this Agreement shall be carried out as if any such illegal, invalid or unenforceable provision were not contained herein.

5.9. Captions . Captions are for convenience only and are not deemed to be part of this Agreement.

5.10. Counterparts; Facsimile Signatures; Effectiveness . This Agreement may be executed in any number of counterparts (including facsimile signature) each of which shall be an original with the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement shall become effective when each party hereto shall have received a counterpart hereof signed by the other party hereto.

 

22


5.11. Effective Date of Restatement . This Agreement shall amend and restate the Original Agreement in its entirety as of, but no earlier than, the Effective Date, and the Original Agreement shall have no further effect as of the Effective Date. If the transactions contemplated by the Investment Agreement are not consummated, this Agreement shall be null and void and of no further effect and the Original Agreement shall continue in full force and effect.

[ Signature Pages Follows ]

 

23


IN WITNESS WHEREOF, this Agreement has been executed as of the date and year first above written.

 

FIVE BELOW, INC.
By:  

/s/ David Schlessinger

Name:  

David Schlessinger

Title:  

Executive Chairman

SIGNIFICANT COMMON SHAREHOLDERS:

/s/ David Schlessinger

David Schlessinger  

/s/ Thomas Vellios

Thomas Vellios  
LLR Equity Partners II, L.P.
LLR Equity Partners Parallel II, L.P.
By:   LLR Capital II, L.P., its General Partner
  By:   LLR Capital II, LLC, its General Partner
    By:  

/s/ Howard D. Ross

    Name:   Howard D. Ross
    Title:   Member
Blue 9 Fund I, L.P.
By:   Blue 9 Capital, LLC, its General Partner
  By:  

/s/ Steven Tuttleman

  Name:   Steven Tuttleman
  Title:   Manager


ANNEX I

JOINDER AGREEMENT

The undersigned is executing and delivering this Joinder Agreement pursuant to the Amended and Restated Investor Rights Agreement dated as of September 1, 2010 (as the same may hereafter be amended, the “ Amended and Restated Investors Agreement ”), among Five Below, Inc., a Pennsylvania corporation (the “ Company ”) and the Investors named therein.

By executing and delivering this Joinder Agreement to the Company, the undersigned hereby agrees to become a party to, to be bound by, and to comply with the provisions of the Investors Agreement in the same manner as if the undersigned were an original signatory to such agreement.

Accordingly, the undersigned has executed and delivered this Joinder Agreement as of the    day of                    , 201    .

 

 

Signature of Investor

 

Print Name of Investor

 

Address of Investor


EXHIBIT A

SCHEDULE OF HOLDERS

 

SIGNIFICANT COMMON SHAREHOLDERS
1.   

David Schlessinger

c/o Five Below, Inc.

1616 Walnut Street

Suite 400

Philadelphia, PA 19103

Fax: 215.546.8099

E-mail: dschlessinger@fivebelow.com

2.   

Thomas Vellios

c/o Five Below, Inc.

1616 Walnut Street

Suite 400

Philadelphia, PA 19103

Fax: 215.546.8099

E-mail: tvellios@fivebelow.com

3.   

LLR Equity Partners II, L.P.

c/o LLR Equity Partners, L.P.

Cira Centre

2929 Arch Street

Philadelphia, PA 19104-2868

Attention: Howard D. Ross

Fax:

E-mail: hross@llrpartners.com

 

With a copy to (which copy shall not constitute notice):

 

Pepper Hamilton LLP

3000 Two Logan Square

18 th & Arch Streets

Philadelphia, PA 19103

Attention: Barry M. Abelson

Fax: 215.689.4803

E-mail: abelsonb@pepperlaw.com

4.   

LLR Equity Partners Parallel II, L.P.

c/o LLR Equity Partners, L.P.

Cira Centre

2929 Arch Street

Philadelphia, PA 19104-2868

Attention: Howard D. Ross

Fax:

E-mail: hross@llrpartners.com


  

With a copy to (which copy shall not constitute notice):

 

Pepper Hamilton LLP

3000 Two Logan Square

18 th & Arch Streets

Philadelphia, PA 19103

Attention: Barry M. Abelson

Fax: 215.689.4803

E-mail: abelsonb@pepperlaw.com

5.   

Blue 9 Fund I, L.P.

c/o Blue 9 Capital

#401

145 Hudson St.

New York, NY 10013

Attention: Steven Tuttleman

Fax: 212.798.0401

E-mail: instar@earthlink.net

 

With a copy to (which copy shall not constitute notice):

 

Blank Rome LLP

One Logan Square

130 North 18th Street

Philadelphia, PA 19103-6998

Attention: Steven Dubow

Fax: 215.832.5755

E-mail: Dubow@BlankRome.com

 

SERIES A PREFERRED SHAREHOLDERS
1.    Advent International GPE VI Limited Partnership
2.    Advent International GPE VI-A Limited Partnership
3.    Advent International GPE VI-B Limited Partnership
4.    Advent International GPE VI-C Limited Partnership
5.    Advent International GPE VI-D Limited Partnership
6.    Advent International GPE VI-E Limited Partnership
7.    Advent International GPE VI-F Limited Partnership
8.    Advent International GPE VI-G Limited Partnership
9.    Advent Partners GPE VI 2008 Limited Partnership
10.    Advent Partners GPE VI 2009 Limited Partnership
11.    Advent Partners GPE VI 2010 Limited Partnership
12.    Advent Partners GPE VI – A Limited Partnership
13.    Advent Partners GPE VI – A 2010 Limited Partnership
  

Notices to any of the above listed Series A Preferred Shareholders should be sent to:

 

c/o Advent International Corporation


 

75 State Street, Floor 29

Boston Massachusetts 02109

Attn: Steven Collins, Andrew Crawford

  Fax: 617.951.0568, 212.461.6503
  E-mail:   scollins@adventinternational.com
    acrawford@adventinternational.com
 

with a copy to (which copy shall not constitute notice):

 

Weil, Gotshal & Manges LLP

100 Federal Street

Boston, Massachusetts 02110

Attention: Marilyn French

Fax: 617.772.8333

E-mail: marilyn.french@weil.com

Exhibit 10.4

FIRST AMENDMENT

TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

THIS FIRST AMENDMENT TO AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this “ Amendment ”) is made on October 14, 2010 by Five Below, Inc., a Pennsylvania corporation (the “ Company ”), to the Amended and Restated Investor Rights Agreement, dated September 1, 2010 (the “ Agreement ”), among the Company, the Investors and certain other equity holders of the Company. Capitalized terms used and not defined herein shall have the meanings ascribed to them in the Agreement.

WHEREAS, pursuant to the terms of the Investment Agreement, dated September 1, 2010, by and among the Company, the Purchasers (as defined therein), and the other parties thereto (as amended, the “ Investment Agreement ”), the Purchasers made an equity investment in the Company in exchange for shares of Series A 8% Convertible Preferred Stock of the Company, $0.01 par value per share, on the date hereof, which is the Effective Date for purposes of the Agreement;

WHEREAS, Section 5.3 of the Agreement provides that the Company, without the consent of any other parties to the Agreement, may amend (i)  Exhibit A to the Agreement to update the list of Holders, Series A Preferred Shareholders and Significant Common Shareholders, as they exist on the Effective Date after giving effect to all of the transactions described in the Investment Agreement, and (ii) the definition of Significant Common Shareholders to set forth the actual number of shares representing 3% of the total Equity Securities outstanding as of the closing of the transactions contemplated by the Investment Agreement, assuming the conversion of all Equity Securities; and

WHEREAS, pursuant to the terms of this Amendment, the Company desires to amend the Agreement in accordance with Section 5.3 of the Agreement.

NOW, THEREFORE, intending to be legally bound hereby, the Company hereby amends the Agreement as follows:

1. Amendment to Exhibit A . The information reflected in Exhibit A to the Agreement is hereby deleted in its entirety and replaced with the information set forth in Annex 1 hereto.

2. Amendment to Definition of “Significant Common Shareholder” . Section 1.1 of the Agreement is hereby amended by deleting the definition of “Significant Common Shareholder” in its entirety and replacing it with the following:

Significant Common Shareholder ” shall mean (i) until the first anniversary of the closing of the transactions contemplated by the Investment Agreement, provided that if as of such date there are any outstanding indemnity claims under the Investment Agreement, until the date on which the last remaining outstanding indemnity claim is finally resolved, any Holder listed under the heading “Significant Common Shareholders” on the Schedule of Holders and any Person who hereafter becomes a permitted transferee of such Holder and executes and delivers a Joinder Agreement to the Company, and (ii) at any time thereafter, any Holder that alone (or together with any Person who hereafter becomes a permitted transferee of such Holder) owns at least 4,073,362 shares of Common Stock, subject to equitable adjustment upon any reverse or forward stock split or similar transaction by the Company.


3. Effectiveness and Other Provisions of the Agreement . This Amendment shall be effective as of the date hereof. Except as expressly amended hereby, the provisions of the Agreement are and shall remain in full force and effect.

4. Governing Law . This Amendment shall be governed by the laws of the Commonwealth of Pennsylvania.

[The remainder of this page is intentionally left blank.]


IN WITNESS WHEREOF , this Amendment has been executed by the Company as of the day and year first written above.

 

FIVE BELOW, INC.
By:  

/s/ Kenneth R. Bull

Name:   Kenneth R Bull
Title:   Senior Vice President, Finance

[Signature Page to the First Amendment to Amended and Restated Investor Rights Agreement]


ANNEX 1

SCHEDULE OF HOLDERS


EXHIBIT A

SCHEDULE OF HOLDERS

 

SIGNIFICANT COMMON SHAREHOLDERS
1.   

David Schlessinger

c/o Five Below, Inc.

1616 Walnut Street

Suite 400

Philadelphia, PA 19103

Fax: 215.546.8099

E-mail: dschlessinger@fivebelow.com

2.   

Thomas Vellios

c/o Five Below, Inc.

1616 Walnut Street

Suite 400

Philadelphia, PA 19103

Fax: 215.546.8099

E-mail: tvellios@fivebelow.com

3.   

LLR Equity Partners II, L.P.

c/o LLR Equity Partners, L.P.

Cira Centre

2929 Arch Street

Philadelphia, PA 19104-2868

Attention: Howard D. Ross

Fax:

E-mail: hross@llrpartners.com

 

With a copy to (which copy shall not constitute notice):

 

Pepper Hamilton LLP

3000 Two Logan Square

18 th & Arch Streets

Philadelphia, PA 19103

Attention: Barry M. Abelson

Fax: 215.689.4803

E-mail: abelsonb@pepperlaw.com

4.   

LLR Equity Partners Parallel II, L.P.

c/o LLR Equity Partners, L.P.

Cira Centre

2929 Arch Street

Philadelphia, PA 19104-2868

Attention: Howard D. Ross

Fax:

E-mail: hross@llrpartners.com

 


  

With a copy to (which copy shall not constitute notice):

 

Pepper Hamilton LLP

3000 Two Logan Square

18 th & Arch Streets

Philadelphia, PA 19103

Attention: Barry M. Abelson

Fax: 215.689.4803

E-mail: abelsonb@pepperlaw.com

5.   

Blue 9 Fund I, L.P.

#401

145 Hudson St.

New York, NY 10013

Attention: Steven Tuttleman

Fax: 212.798.0401

E-mail: instar@earthlink.net

 

With a copy to (which copy shall not constitute notice):

 

Blank Rome LLP

One Logan Square

130 North 18th Street

Philadelphia, PA 19103-6998

Attention: Steven Dubow

Fax: 215.832.5755

E-mail: Dubow@BlankRome.com

SERIES A 8% CONVERTIBLE PREFERRED SHAREHOLDERS

1.

  

Advent International GPE VI Limited Partnership

2.

  

Advent International GPE VI-A Limited Partnership

3.

  

Advent International GPE VI-B Limited Partnership

4.

  

Advent International GPE VI-C Limited Partnership

5.

  

Advent International GPE VI-D Limited Partnership

6.

  

Advent International GPE VI-E Limited Partnership

7.

  

Advent International GPE VI-F Limited Partnership

8.

  

Advent International GPE VI-G Limited Partnership

9.

  

Advent Partners GPE VI 2008 Limited Partnership

10.

  

Advent Partners GPE VI 2009 Limited Partnership

11.

  

Advent Partners GPE VI 2010 Limited Partnership

12.

  

Advent Partners GPE VI – A Limited Partnership

13.

  

Advent Partners GPE VI – A 2010 Limited Partnership

  

Notices to any of the above listed Series A 8% Convertible Preferred Shareholders should be sent to:

 

c/o Advent International Corporation

75 State Street, Floor 29


  

Boston Massachusetts 02109

Attn: Steven Collins, Andrew Crawford

Fax: 617.951.0568, 212.461.6503

E-mail: scollins@adventinternational.com

acrawford@adventinternational.com

 

with a copy to (which copy shall not constitute notice):

 

Weil, Gotshal & Manges LLP

100 Federal Street

Boston, Massachusetts 02110

Attention: Marilyn French

Fax: 617.772.8333

E-mail: marilyn.french@weil.com

14.   

Sargent Family Investment, LLC

Exhibit 10.5

SECOND AMENDED AND RESTATED

SHAREHOLDERS AGREEMENT

THIS SECOND AMENDED AND RESTATED SHAREHOLDERS AGREEMENT (this “ Agreement ”) is entered into as of September 1, 2010 by and among Five Below, Inc., a Pennsylvania corporation (the “ Company ”), and the Shareholders (as hereinafter defined). This Agreement shall become effective on the Effective Date (as hereinafter defined).

RECITALS

WHEREAS, the Company, the Advent Funds (as hereinafter defined), and the Significant Common Shareholders (as hereinafter defined) intend to enter into an Investment Agreement (the “ Investment Agreement ”) shortly after the execution of this Agreement by the Company and certain Shareholders, pursuant to which the Company shall sell and issue to Advent shares of its Series A 8% Convertible Preferred Stock, $0.01 par value per share (the “ Series A Preferred Stock ”), subject to the terms set forth therein, and in connection therewith Advent desires to accept the rights created pursuant hereto;

WHEREAS, in connection with the transactions contemplated by the Investment Agreement, the Company intends to declare and pay a dividend to Persons who hold of record shares of the Company’s Common Stock, par value $0.01 per share (the “ Common Stock ”) on the later of (i) 11:59 PM EDT on the date that is thirty (30) days after the date on which notice of the record date of the Common Dividend (as defined in the Investment Agreement) is given to equity holders, and (ii) 11:59 PM EDT on the day immediately prior to the day of closing of the transactions contemplated by the Investment Agreement (the “ Effective Date ”);

WHEREAS, the Company and certain of its shareholders entered into an Amended and Restated Shareholders Agreement dated as of April 20, 2005, as amended by (i) the First Amendment, dated September 6, 2006 and (ii) the Second Amendment, (such Amended and Restated Shareholders Agreement as amended to date, the “ Original Agreement ”) which provides, among other things, that the provisions thereof may be waived, modified or amended at any time or times by a written agreement signed by (i) the Company, (ii) holders of a majority of the shares of Preferred Stock (as defined in the Original Agreement), voting as a separate class, and (iii) the holders of a majority of the shares of the Common Stock, voting as a separate class;

WHEREAS, the Company, the requisite holders of Preferred Stock (as defined in the Original Agreement), and the requisite holders of Common Stock wish to amend and restate the Original Agreement to as set forth herein, effective as of the Effective Date, and each of the Advent Funds desires to become a party to this Agreement by execution of a joinder agreement, effective as of the date on which shares of Series A Preferred Stock are sold to it pursuant to the Investment Agreement (the “ Advent Closing Date ”); and

WHEREAS, the holders of shares of Preferred Stock (as defined in the Original Agreement) and holders of shares of the Common Stock signatory hereto constitute the requisite holders of a majority of the shares of Preferred Stock (as defined in the Original Agreement), and a majority of the shares of the Common Stock, each voting as a separate class, and have executed and delivered this Agreement which shall amend, restate and supersede in its entirety the Original Agreement, effective as of the Effective Date.


NOW, THEREFORE, in consideration of the foregoing, the agreements set forth below, and the parties’ desire to provide for continuity of ownership of the Company to further the interests of the Company and its present and future Shareholders, the parties agree hereto, intending to be legally bound hereby, as follows:

ARTICLE I

DEFINITIONS

1.1 Certain Defined Terms . As used in this Agreement, the following terms shall have the following respective meanings:

(a) “ Advent Funds ” shall mean, collectively, Advent International GPE VI Limited Partnership, Advent International GPE VI-A Limited Partnership, Advent International GPE VI-B Limited Partnership, Advent International GPE VI-C Limited Partnership, Advent International GPE VI-D Limited Partnership, Advent International GPE VI-E Limited Partnership, Advent International GPE VI-F Limited Partnership, Advent International GPE VI-G Limited Partnership, Advent Partners GPE VI 2008 Limited Partnership, Advent Partners GPE VI 2009 Limited Partnership, Advent Partners GPE VI 2010 Limited Partnership, Advent Partners GPE VI – A Limited Partnership and Advent Partners GPE VI – A 2010 Limited Partnership.

(b) “ Board of Directors ” shall mean the board of directors of the Company.

(c) “ Business Day ” means any day except a Saturday, Sunday or other day on which commercial banks in the City of Philadelphia, Pennsylvania are authorized by law to close.

(d) “ Common Shareholders ” shall mean holders of Common Stock.

(e) Conversion Shares shall mean any shares of Common Stock issued or issuable upon conversion or redemption of the Series A Preferred Stock.

(f) “ Designation ” shall mean the Certificate of Designations, Preferences, Limitations and Special Rights of the Series A 8% Convertible Preferred Stock of the Company’s Articles of Incorporation, as such Certificate may be amended from time to time.

(g) “ Equity Securities ” shall mean any securities (i) evidencing an equity ownership interest in the Company (including without limitation the Common Stock and the Series A Preferred Stock), or (ii) convertible into or exercisable for any shares of the foregoing. For purposes of this Agreement, the determination of an amount of Equity Securities shall be calculated on an as converted or exercised basis.

(h) Initial Public Offering ” shall mean the Company’s first underwritten public offering of its Common Stock under the Securities Act.

(i) “ Investors ” shall mean, collectively, the Advent Funds and the Significant Common Shareholders.

(j) “ LLR ” shall mean, collectively, LLR Equity Partners II, L.P. and LLR Equity Partners Parallel II, L.P.

(k) “ Person ” means an individual or a corporation, partnership, limited liability company, association, trust, or any other entity or organization, including a government or political subdivision or an agency or instrumentality thereof.

 

-2-


(l) “ Qualified Public Offering ” shall mean an underwritten public offering of shares of the Company’s Common Stock in which the Company receives aggregate gross proceeds of at least One Hundred Million Dollars ($100,000,000), and following which the shares of the Company are listed on a nationally recognized U.S. stock market.

(m) Registrable Securities shall mean (a) the Conversion Shares, (b) any Common Stock of the Company issued as (or issuable upon the conversion or exercise of any warrant, right or other security which is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of the Conversion Shares, (c) the shares of Common Stock held by Shareholders and (d) any Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right, or other security that is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of shares described in clause (c). Notwithstanding the foregoing, Registrable Securities shall not include any securities which (x) have been sold by a Person to the public pursuant to a registration statement declared effective pursuant to the Securities Act, or (y) have been sold in a private transaction in which all or a portion of the transferor’s rights under this Agreement are not assigned.

(n) “ Requisite Share Percentage ” shall mean an amount equal to (i) prior to the first anniversary of the Advent Closing Date, more than seventy five percent (75%) of the then outstanding Equity Securities, (ii) following the first anniversary of the Advent Closing Date but prior to the second anniversary of the Advent Closing Date, more than seventy percent (70%) of the then outstanding Equity Securities, and (iii) for all periods following the second anniversary of the Advent Closing Date, more than fifty percent (50%) of the then outstanding Equity Securities.

(o) “ Series A Preferred Shareholders ” shall mean the Advent Funds and any Person party hereto that holds, on the date of determination, shares of Series A Preferred Stock, including any Person who hereafter becomes a holder of shares of Series A Preferred Stock (whether through issuance from the Company or as a permitted transferee of a Series A Preferred Shareholder) and executes and delivers an Adoption Agreement to the Company.

(p) “ Shareholder ” shall mean those Persons identified on Exhibit A attached hereto (the “ Schedule of Shareholders ”) and shall include any Person who hereafter becomes a holder of Common Stock or Series A Preferred Stock and executes and delivers, or is obligated to execute and deliver, an Adoption Agreement to the Company. The term “Shareholder” shall include the Series A Preferred Shareholders and Significant Common Shareholders.

(q) “ Significant Common Shareholder ” shall mean (i) until the first anniversary of the Advent Closing Date, provided that if as of such date there are any outstanding indemnity claims under the Investment Agreement, until the date on which the last remaining outstanding indemnity claim is finally resolved, any Shareholder listed under the heading “Significant Common Shareholders” on the Schedule of Shareholders and any Person who hereafter becomes a Permitted Transferee of such Shareholder, and (ii) at any time thereafter, any Shareholder that alone (or together with any Person who hereafter becomes a Permitted Transferee of such Shareholder) owns a number of shares of Common Stock that is at least equal to 3% of the total Equity Securities outstanding on the Advent Closing Date (but excluding any equity awards granted in connection with the transactions contemplated by the Investment Agreement), calculated on a fully diluted basis assuming the conversion of all Equity Securities held by such Shareholder and any Person who hereafter becomes a Permitted Transferee of such Shareholder and subject to equitable adjustment upon any reverse or forward stock split or similar transaction by the Company.

(r) “ Supermajority Board Approval ” means, if there are seven (7) members of the Board of Directors, the approval of five (5) of the seven (7) members of the Board of Directors, and if

 

-3-


there are more or less than seven (7) members of the Board of Directors, the approval of that number of members representing at least two-thirds (rounded up to the nearest whole number) of the members of the Board of Directors.

For purposes of this Agreement, the following terms have means set forth in the sections indicated below:

 

Term

  

Section

Adoption Agreement

   2.1

Advent

   Recitals

Advent Closing Date

   Recitals

Advent Investment

   4.2

Agreement

   Preamble

Audit Committee

   3.3

Bring Along Holders

   2.4(a)

Bring Along Notice

   2.4(b)

Bring Along Right

   2.4(a)

Bring Along Transaction

   2.4(a)

Bylaws

   3.1

Cash Dividend

   4.2

Cash Recipients

   4.2

Common Directors

   3.1(a)(ii)

Common Stock

   Recitals

Common Dividend

   4.2

Company

   Preamble

Company Competitor

   2.1(c)

Compensation Committee

   3.3

Contribution Due Date

   4.2

Contribution Notice

   4.2

Co-Sale Holder

   2.3(a)

Co-Sale Selling Shareholder

   2.3(a)

Co-Sale Shares

   2.3(b)

Effective Date

   Recitals

Indemnity Payment

   4.2

Independent Director

   3.1

Investment Agreement

   Recitals

Net Cash Proceeds

   4.2

Observer

   3.5

Offered Shares

   2.2(a)

Original Agreement

   Recitals

Other Shareholders

   2.4(a)

Permitted Transfer

   2.1(b)

Proposed Transferee

   2.2(a)

Purchase Agreement

   Preamble

Response Date

   2.2(b)

Selling Shareholder

   2.2(a)

Series A Preferred Directors

   3.1(a)(i)

Series A Preferred Stock

   Recitals

Stock Purchase Agreement

   Recitals

Third Party Purchaser

   2.4(a)

Third Party Terms

   2.4(b)

 

-4-


Term

  

Section

Transfer

   2.1

Transfer Notice

   2.2(a)

Unsold Shares

   2.3(b)

Waiver Holder

   4.7

Warrant Exchange

   4.2

ARTICLE II

RIGHTS OF FIRST REFUSAL AND CO-SALE ON TRANSFERS OF STOCK

BY SHAREHOLDERS; BRING-ALONG RIGHTS

2.1 Prohibited Transfers by Shareholders .

(a) The Shareholders shall not sell, assign, transfer, pledge, hypothecate, mortgage, encumber or otherwise dispose of (a “ Transfer ”) all or any of their Equity Securities except as expressly provided in this Agreement. Notwithstanding the foregoing, each of the Shareholders may Transfer all or any of his, her or its Equity Securities:

(i) in connection with a Transfer pursuant to Section 2.3 or Section 2.4 ,

(ii) if a natural person, to any member of his or her family, or to a custodian, trustee or other fiduciary for the account of such Shareholder or member of his or her family; provided, that, any such transferee agrees in writing with the Company, as a condition to such transfer, to be bound, by executing an Adoption Agreement substantially in the form attached as Annex A (the “ Adoption Agreement ”), by all of the provisions of this Agreement to the same extent as if such transferee were the transferring Shareholder;

(iii) if a natural person, by will or the laws of descent and distribution, in which event each such transferee shall be bound by all of the provisions of this Agreement, by executing an Adoption Agreement, to the same extent as if such transferee were the Shareholder;

(iv) if not a natural Person, to its owners, its direct or indirect general partners or limited partners, its affiliated funds or any of such fund’s respective direct or indirect general or limited partners, or any of its directors, managing partners, managing directors, principals, and, solely with respect to the Advent Funds, any fund directly or indirectly managed or advised by Advent International Corporation, in which event each such transferee shall be bound by all of the provisions of this Agreement, by executing an Adoption Agreement, to the same extent as if such transferee were the Shareholder;

(v) in connection with a sale to the public pursuant to a registration statement filed with, and declared effective by, the Securities and Exchange Commission under the Securities Act of 1933, as amended; or

(vi) to the Company, pursuant to any stock restriction agreement or otherwise between the Company and such Shareholder.

(b) Each of (i) through (vi) above is hereinafter referred to as a “ Permitted Transfer .” As used herein, the word “ family ” shall include any spouse, parent, sibling (by blood or adoption) or lineal ancestor or descendant (by blood or adoption) of the Shareholder or of any spouse, parent or sibling of such Shareholder.

 

-5-


(c) No Equity Securities may be Transferred by a Shareholder pursuant to this Section 2.1 unless such Shareholder first delivers to the Company notice of such Transfer and, if requested by the Company, an opinion of counsel, which opinion and counsel shall be reasonably satisfactory to the Company, to the effect that such Transfer is not required to be registered under the Securities Act. Notwithstanding anything in this Agreement to the contrary, except in connection with a Transfer approved with Supermajority Board Approval as required by Section 3.6, no Shareholder shall Transfer any Equity Securities to a Person or an Affiliate of a Person, other than the Company, that is engaged or has operations in retail business that competes with the Company (“ Company Competitor ”).

2.2 Right of First Refusal on Dispositions by Shareholders .

(a) Other than in the case of a Permitted Transfer, if at any time any Shareholder, subject to the terms of this Agreement (a “ Selling Shareholder ”), desires to Transfer Equity Securities pursuant to a bona fide offer from one or more third parties (a “ Proposed Transferee ”), the Selling Shareholder shall give the Company, the Investors written notice of the Selling Shareholder’s intention to make such Transfer (the “ Transfer Notice ”), which Transfer Notice shall include (i) a description of the Equity Securities to be transferred (the “ Offered Shares ”), (ii) the identity of the Proposed Transferee(s), (iii) the consideration to be paid and the material terms and conditions upon which the proposed Transfer is to be made, (iv) the number of Offered Shares proposed to be Transferred, (v) the total number of Equity Securities owned by the Selling Shareholder, and (vi) any other material facts relating to the proposed Transfer. The Transfer Notice may, in lieu of the obligations set forth in clauses (i) – (vi) of the first sentence of this Section 2.2(a) , include a copy of any written proposal, term sheet or letter of intent or other agreement relating to the proposed Transfer if any such documentation is available.

(b) The Company and the Investors shall have the right to purchase Offered Shares pursuant to the Transfer Notice in accordance with the provisions of this Section 2.2 , which rights shall be prioritized as follows: (i) first, the Company; (ii) if the Company purchases less than all of the Offered Shares, then the balance of the Offered Shares to the Investors as set forth herein. Following receipt of a Transfer Notice with respect to any Offered Shares, the Company will have a period of ten (10) Business Days after the first (1st) Business Day on which it has received such Transfer Notice to give notice of its desire to exercise its rights hereunder; and if the Company purchases none or less than all of the Offered Shares, each of the Investors shall have a period of sixty (60) Business Days after the first (1 st ) Business Day following the earlier of the date on which ( x ) such ten-Business Day period expires and ( y ) the Company notifies the Investors that it will be purchasing none or less than all of the Offered Shares to give notice of its desire to exercise its rights hereunder (each such date, a “ Response Date ”).

(c) The Company shall have an option to elect to purchase the Offered Shares by giving notice of its acceptance to the Selling Shareholder and each Investor on or before the Company’s Response Date. Such notice shall constitute an irrevocable commitment to purchase such Offered Shares subject only to such conditions as were contained in the bona fide offer. Any such notice of acceptance shall specify the maximum amount of Offered Shares that the Company desires to purchase and shall state that such purchase will be at the same price and on the same material terms and conditions as set forth in the Transfer Notice. Settlement for any Offered Shares purchased under this Section 2.2(c) shall be held at the offices of the Company on the thirtieth (30th) Business Day after the respective Response Date. At such closing, the Selling Shareholder shall deliver a certificate or certificates representing the Offered Shares, properly endorsed for transfer, and the Company shall deliver payment of the purchase price therefore which shall, at the Company’s discretion, be by check or wire transfer.

(d) If the Company does not purchase all of the Offered Shares, each Investor shall have an option to elect to purchase its pro rata share of the Offered Shares at the same price and subject to the same material terms and conditions as described in the Transfer Notice. Each Investor may exercise

 

-6-


such purchase option and, thereby, purchase all or any portion of its pro rata share (with any reallotments as provided below) of the Offered Shares then available for purchase by such Investors, by notifying the Selling Shareholder and the Company (and the Company shall then give notice to each other Investor) in writing on or before the respective Response Date as to the number of such shares which such Investor wishes to purchase (including any reallotment). Such notice shall constitute an irrevocable commitment to purchase such Offered Shares subject only to such conditions as were contained in the bona fide offer by the Proposed Transferee. Each Investor’s “ pro rata share ” of the Offered Shares then available for purchase by the Investors shall be a fraction of the Offered Shares, of which the number of Equity Securities owned by such Investor on the date of the Transfer Notice shall be the numerator and the total number of Equity Securities held by all of the Investors on the date of the Transfer Notice shall be the denominator. Each Investor shall have a right of reallotment such that, if any other Investor fails to exercise the right to purchase its full pro rata share of the Offered Shares, the Company shall promptly notify the other participating Investors and the other participating Investors may exercise an additional right to purchase the balance of the Offered Shares not previously purchased. If an Investor gives the Selling Shareholder notice that it desires to purchase its pro rata share of the Offered Shares then available for purchase by the Investors and, as the case may be, its reallotment, then payment for the Offered Shares shall, at the applicable Investor’s discretion, be by check or wire transfer, against delivery of such Offered Shares at the offices of the Company no later than thirty (30) Business Days after the respective Response Date. At such closing, the Selling Shareholder shall deliver a certificate or certificates representing the Offered Shares free and clear of any liens or encumbrances, except for such liens or encumbrances imposed by any of the Transaction Documents (as defined in the Investment Agreement) or by any securities laws, properly endorsed for transfer, and the applicable Investors shall deliver payment of the purchase price therefor.

(e) If the Company and/or Investors do not purchase all of the Offered Shares, any Offered Shares not so purchased may be sold by the Selling Shareholder to the Proposed Transferee at any time within one hundred and eighty (180) days thereafter so long as such Proposed Transferee is approved by the Board of Directors (it being understood that a transfer to a Company Competitor shall require Supermajority Board Approval), but only after compliance with Section 2.3 . Any such sale shall be to the Proposed Transferee, at not less than the price and upon other terms and conditions, if any, not more favorable to the Proposed Transferee than those specified in the Transfer Notice. Any Offered Shares not sold within such 180-day period shall thereafter be subject to the requirements of a new offer to be made in accordance with this Section 2.2 . If Offered Shares are sold pursuant to this Section 2.2 to any purchaser who is not a party to this Agreement, prior to, or at the time of, the consummation of such sale, the Selling Shareholder shall deliver to the Company an Adoption Agreement executed by the Proposed Transferee.

(f) The foregoing rights of the Company and the Shareholders shall not apply to any Permitted Transfer.

(g) If the Company and/or Investors elect to purchase any or all of the Offered Shares mentioned in the Transfer Notice, the Company and/or Investors shall have the right to purchase the Offered Shares for cash consideration whether or not part or all of the consideration specified in the Transfer Notice is other than cash. If part or all of the consideration to be paid for the Offered Shares, as stated in the Transfer Notice, is other than cash, the price stated in such Transfer Notice shall be deemed to be the sum of the cash consideration, if any, specified in such Transfer Notice, plus the fair market value of the non-cash consideration. The fair market value of the non-cash consideration shall be determined by the Board of Directors, and its reasonable judgment as to the fair market value of such non-cash consideration shall be binding upon the Selling Shareholder, the Company, and/or the Investors.

 

-7-


2.3 Right of Participation in Sales .

(a) In the event that the Offered Shares of any Selling Shareholder that owns more than two percent (2%) of the outstanding Equity Securities of the Company on an as converted and fully diluted basis (as calculated at the time of delivery by such Selling Shareholder of the Offer Notice pursuant to Section 2.2(a) ) (“ Co-Sale Selling Shareholder ”), are not purchased by the Company and/or the Investors Section 2.2 , then each of the other Shareholders (each, a “ Co-Sale Holder ”) shall have the right to participate in such sale of Equity Securities (“ Co-Sale Transaction ”), subject to the limitations set forth in Section 2.3(b) , on the same terms and conditions as specified in the Transfer Notice.

(b) In each Co-Sale Transaction, each Co-Sale Holder may sell all or any part of that number of shares of Equity Securities owned by such Co-Sale Holder (its “ Co-Sale Shares ”) equal to the product of (i) the aggregate number of Offered Shares being sold by the Co-Sale Selling Shareholder, multiplied by (ii) a fraction, of which the numerator shall be the number of Equity Securities owned by such Co-Sale Holder on the date of the Transfer Notice and the denominator shall be the total number of Equity Securities owned by all Co-Sale Holders on the date of the Transfer Notice; provided, however, that each Co-Sale Holder shall have a right of reallotment such that, if any other Co-Sale Holder fails to exercise the right to sell any or all of its Co-Sale Shares (the number of Co-Sale Shares not sold by such Co-Sale Holder, the “ Unsold Shares ”), the other participating Co-Sale Holders may sell additional Equity Securities to the Proposed Transferee up to the number of Unsold Shares; and provided further, that if the Proposed Transferee is not willing to purchase all such shares, the Co-Sale Selling Shareholder, on the one hand, and the Co-Sale Holders, on the other hand, shall each have the right to sell fifty percent (50%) of the shares actually sold. Each Co-Sale Holder may exercise its right to sell its Co-Sale Shares (or more in the case of a reallotment) by notifying the Co-Sale Selling Shareholder, the Company and the other Co-Sale Holders in writing on or before the respective Response Date as to the number of Co-Sale Shares which the Co-Sale Holder wishes to sell under its right to participate. The delivery of such notice shall constitute an irrevocable commitment by the Co-Sale Holder to sell such Co-Sale Shares contingent only upon the closing of the proposed sale on terms communicated in the Transfer Notice.

(c) Each Co-Sale Holder shall effect its participation in the sale by promptly delivering to the Co-Sale Selling Shareholder for transfer to the Proposed Transferee one or more certificates, properly endorsed for transfer, which represent:

(i) the type and number of shares of Common Stock which such Co-Sale Holder elects to sell; or

(ii) that number of shares of Series A Preferred Stock which are at such time convertible into the number of shares of Common Stock which such Co-Sale Holder elects to sell; provided , however , that if the prospective Proposed Transferee objects to the delivery of shares of Series A Preferred Stock in lieu of Common Stock, such Co-Sale Holder shall convert such shares of Series A Preferred Stock into Common Stock and deliver a certificate or certificates representing shares of Common Stock as provided in this Section 2.3 . The Company agrees to make any such conversion concurrent with the actual transfer of such shares to the purchaser and contingent on such transfer.

(d) The certificate or certificates that the Co-Sale Holder delivers to the Co-Sale Selling Shareholder shall be transferred to the Proposed Transferee in consummation of the sale of the Equity Securities pursuant to the terms and conditions specified in the Transfer Notice, and the Co-Sale Selling Shareholder shall concurrently therewith remit to such Co-Sale Holder that portion of the sale proceeds to which such Co-Sale Holder is entitled by reason of its participation in such sale. To the extent that any Proposed Transferee(s) prohibits such assignment or otherwise refuses to purchase shares or other securities from a Co-Sale Holder exercising its rights of co-sale hereunder, the Co-Sale Selling Shareholder shall not sell to such Proposed Transferee(s) any Equity Securities unless and until, simultaneously with such sale, the Co-Sale Selling Shareholder shall purchase such shares or other securities from such Co-Sale Holder for the same consideration and on the same terms and conditions as the proposed transfer described in the Transfer Notice.

 

-8-


(e) If any proposed Co-Sale Transaction is not consummated within the one hundred and eighty (180) day period set forth in Section 2.2(e) , or the price or terms or conditions of the proposed Co-Sale Transaction as specified in the Transfer Notice related thereto change in any material respect prior to completion of such Co-Sale Transfer, the Co-Sale Selling Shareholders proposing the proposed Co-Sale Transaction may not sell any Offered Shares unless they first comply in full with each provision of Section 2.2 and Section 2.3 .

2.4 Bring-Along Rights .

(a) If holders of the then outstanding Equity Securities representing the applicable Requisite Share Percentage, and a majority of the Board of Directors, approve a sale (in a bona fide, third party sale consummated in a single Transfer or a series of related Transfers to a single purchaser or a group of purchasers as part of a single transaction or group of related transactions) of Equity Securities representing the applicable Requisite Share Percentage (a “ Bring-Along Transaction ”), then such holders (the “ Bring Along Holders ”) shall have the right (“ Bring-Along Right ”), but not the obligation, to cause each of the other Shareholders (the “ Other Shareholders ”) to tender to the third party purchaser(s) (“ Third Party Purchaser ”) for purchase at the same price per Equity Security (on an as-converted basis) and on the same terms of payment and all other terms as apply to the Bring Along Holders, a number of Equity Securities held by each Other Shareholder equal to the total number of Equity Securities held by such Other Shareholder multiplied by a fraction, the numerator of which is the number of Equity Securities that the Bring Along Holders propose to sell in the Bring-Along Transaction and the denominator of which is the aggregate number of Equity Securities held by the Bring Along Holders (all calculated on an as-converted basis).

(b) If the Bring Along Holders elect to exercise their Bring-Along Rights, then the Bring Along Holders shall notify the Company and the Other Shareholders in writing of the Bring-Along Transaction (“ Bring-Along Notice ”). Each Bring-Along Notice shall set forth (i) the name of the Third Party Purchaser to which the Bring Along Holders propose to sell their Equity Securities and the number of Equity Securities proposed to be sold in the Sale, (ii) the address of the Third Party Purchaser, (iii) the proposed amount and form of consideration and terms of payment offered by the Third Party Purchaser, and any other material terms pertaining to the Sale (“ Third Party Terms ”), and (iv) that the Third Party Purchaser has been informed of the rights provided for in this Section 2.4 and has agreed to purchase Equity Securities in accordance with the terms hereof. The Bring-Along Notice shall be given at least twenty (20) calendar days before the consummation of the proposed Sale.

(c) Upon the giving of a Bring-Along Notice, each Other Shareholder shall be obligated to sell the number of Equity Securities calculated in accordance with Section 2.4(a) to the Third Party Purchaser on the Third Party Terms.

(d) At the consummation of the Bring-Along Transaction, the Third Party Purchaser shall remit to each Shareholder the consideration for the total sales price of the Equity Securities of such Shareholder sold pursuant hereto, upon delivery by such Shareholder of certificate(s) for such Equity Securities duly endorsed in blank for transfer or accompanied by stock power(s) duly executed in blank, and the compliance by such Shareholder with all other conditions to settlement generally applicable to the Bring Along Holders and all Other Shareholders selling Equity Securities in the Bring-Along Transaction (including the provision by the Other Shareholders to the Third Party Purchaser of representations and warranties and indemnities (limited to not more than the proceeds received such Shareholder) covering the same subject matter, and subject to the same restrictions, qualifications and limitations, as those provided by the Bring Along Holders).

 

-9-


(e) Notwithstanding anything to the contrary in this Agreement, in connection with a Bring-Along Transaction, (i) if indemnification is required from any of the Shareholders, such indemnification obligation shall be several and not joint, on a pro rata basis among the Shareholders required to provide the indemnity, and shall not exceed the proceeds received by any such indemnify Shareholder, (ii) any Shareholder that is not an employee of the Company shall not be required to agree to a non-compete restrictive covenant, (iii) no Shareholder shall be obligated to make any out-of-pocket expenditure prior to the consummation of the Bring-Along Transaction, and (iv) no Shareholder shall be obligated to pay more than its pro rata share (based upon the consideration received) of reasonable expenses incurred in connection with a consummated Bring-Along Transaction to the extent that such expenses are incurred for the benefit of all Shareholders and are not otherwise paid by the Company or the acquiring party.

ARTICLE III

BOARD OF DIRECTORS

3.1 Election of Directors .

(a) On all matters relating to the election of directors to the Board of Directors, including at each annual or special meeting of Shareholders at which directors are to be elected, the Shareholders agree to vote all shares of Equity Securities held by, or controlled by, them (or the holders thereof shall consent pursuant to an action by written consent of Shareholders) so as to elect members of the Board of Directors as follows:

(i) four (4) individuals nominated by the Series A Preferred Shareholders holding a majority of the Series A Preferred Stock held by all Series A Preferred Shareholders, voting together as a separate class (the “ Series A Preferred Directors ”), one of whom shall be an Independent Director (defined below), who initially shall be David Mussafer, Steven Collins, Andrew Crawford and Howard Ross (as the Independent Director); and

(ii) three (3) individuals nominated by the Common Shareholders holding a majority of the Common Stock held by all Common Shareholders, voting together as a separate class (the “ Common Directors ”), one of whom shall be an Independent Director (as defined below), who initially shall be David Schlessinger, Thomas Vellios and Ronald Sargent (as the Independent Director).

(b) For purposes of this Section 3.1 , “ Independent Director ” means, unless otherwise approved by a majority of the Common Directors (i) with respect to the Series A Preferred Directors, any individual who is not an employee, shareholder, managing partner or manager of Advent International Corporation, and (ii) with respect to the Common Shareholders, any individual who is not an employee of the Company or an employee, shareholder, managing partner or manager any Common Shareholder. Each of the above designees shall hold office, subject to his or her resignation or earlier removal in accordance with the Company’s Bylaws, as amended (the “ Bylaws ”), Articles of Incorporation (including the Designation) and/or applicable law, until his or her successors shall have been elected and shall have qualified. Any vote taken to fill any vacancy created by the resignation of a director elected pursuant to this Section 3.1 , shall also be subject to the provisions of this Section 3.1 .

(c) If all of the then-outstanding shares of Series A Preferred Stock are converted into Common Stock by the election of the holders of at least a majority of the then-outstanding shares of Series A Preferred Stock prior to an Initial Public Offering of the Common Stock, (i) the former holders

 

-10-


of Series A Preferred Stock shall continue to be entitled to nominate four (4) individuals to serve on the Board of Directors as provided in Section 3.1(a)(i), as if the Series A Preferred Stock had not been converted, and (ii) the Common Shareholders (exclusive of the former holders of Series A Preferred Stock who hold Common Stock by reason of such conversion of the Series A Preferred Stock and the shares of Common Stock held by them) shall continue to be entitled to nominate three (3) individuals to serve on the Board of Directors as provided in Section 3.1(a)(ii) as if the Series A Preferred Stock had not been converted.

3.2 Removal of Directors . In the event of any vacancy caused by removal of any member of the Board of Directors in accordance with this Section 3.2 , each Shareholder agrees to vote all shares of Equity Securities held by, or controlled by, them to fill such vacancy so that the Board of Directors will include the director nominated as provided in Section 3.1 . Each Shareholder agrees to vote all Equity Securities held by, or controlled by, them for the removal of a Series A Preferred Director or Common Director, as applicable, whenever (but only whenever, unless for cause) there shall be presented to the Board of Directors the written direction that such director be removed, signed by the Series A Preferred Shareholders or Common Shareholders, as applicable, entitled to designate such director.

3.3 Compensation Committee and Audit Committee . The Board of Directors shall maintain a compensation committee (the “ Compensation Committee ”) which will be responsible for setting the management compensation and for approving the granting of options and other equity incentives to management. The Board shall also maintain an audit committee (the “ Audit Committee ”) which shall be responsible for reviewing with management of the Company and with the Company’s independent auditors, both jointly and separately, the financial controls, accounting and audit and reporting activities of the Company, the performance of the Company’s auditors, and the capability and performance of the Company’s finance staff. Unless a majority of the members of the Board of Directors otherwise agrees, each committee of the Board of Directors, including, but not limited to the Compensation Committee and Audit Committee, shall consist of three (3) directors, two (2) of whom shall be Series A Preferred Directors, and one (1) of whom shall be a Common Director. No member of the Company’s management shall participate in Compensation Committee discussion pertaining to his or her own compensation.

3.4 Entire Board . The Company and the Shareholders shall take all action, do all things and execute and deliver all documents, including the approval of any amendment to the Bylaws, as may be reasonably necessary to ensure that the number of directors constituting the entire Board of Directors is seven (7).

3.5 Observation Rights . To the extent that (i) an employee of LLR Partners, Inc. is not a member of the Board of Directors and (ii) LLR owns Equity Securities representing more than five percent (5%) of the total then outstanding Equity Securities on a fully diluted basis (excluding, for purposes of calculating LLR’s ownership percentage under this Section 3.5, any issuances of Equity Securities by the Company after the Effective Date), LLR shall have the right to designate one individual to attend all meetings of the Board of Directors as a non-voting observer (an “ Observer ”); provided that such non-voting observer shall not have the right to participate in any discussion conducted during a meeting of the Board of Directors unless such non-voting observer is explicitly recognized by the Chairman of the Board of Directors. The Observer shall be invited (in the same manner and at the same time as the member of the Board of Directors) to attend all meetings of the Board of Directors or any subsidiary of the Company (including telephonic or other electronic meetings to the extent that members of the Board of Directors are attending such meetings in such manner) and shall receive (in advance, to the extent members of Board of Directors receive such materials in advance) copies of all notices, minutes, consents, and other material that the Company provides to each of the members of the Board of Directors in connection with any meeting or consent or otherwise by reason of their membership; provided , however , that each Observer shall hold in confidence and trust all information provided to, or

 

-11-


obtained by, them. Notwithstanding the foregoing, the Board of Directors shall have the right, in its sole discretion, to meet in confidential sessions and to not provide access to such sessions or the information discussed in such sessions to any or all Observers, as applicable, if the Board of Directors shall determine that such confidential session is (a) necessary to preserve an attorney-client privilege, (b) in the best interest of the Company and where such Observer, or the entity it represents, has an interest in the subject matter under discussion, (c) necessary to discharge the directors’ fiduciary duties, or (d) otherwise advised by counsel.

3.6 Actions Requiring Supermajority Board Approval . The Company shall not, without Supermajority Board Approval:

(a) permit any Transfer (including any Transfer permitted or required under Article II other than Section 2.4 ) or issue any Equity Securities (other than in connection with a Transfer under Section 2.4) to a Company Competitor, or

(b) authorize or enter into any agreement with Advent International Corporation or any of its Affiliates, pursuant to which the Company or any of its subsidiaries would be required to pay Advent International Corporation or any of its Affiliates any transaction, management, advisory or other fees.

3.7 Termination of Article III . The provisions of this Article III shall terminate upon completion of the Initial Public Offering.

ARTICLE IV

GENERAL PROVISIONS

4.1 Term . This Agreement shall terminate upon the occurrence of any of the following events:

(a) excluding the consummation of the transactions contemplated by the Investment Agreement, the liquidation or dissolution of the Company, or a merger, recapitalization, reorganization or sale of all or substantially all of the assets of the Company which will result in the Shareholders immediately prior to such event not holding at least fifty percent (50%) of the voting power of the surviving, continuing or purchasing entity immediately after such event;

(b) a Qualified Public Offering; and

(c) the written agreement of (i) the Company, (ii) the Advent Funds, and (iii) the Common Shareholders holding a majority of the then outstanding shares of Common Stock (exclusive of any shares of Common Stock held by the Advent Funds), voting as a separate class.

4.2 Indemnity Contribution . Each of the Significant Common Shareholders and Common Shareholders hereby agrees as follows.

(a) Contribution Obligation . In connection with the investment pursuant to the Investment Agreement (the “ Advent Investment ”), the Significant Common Shareholders, on behalf of themselves and all other Shareholders of record immediately prior to the Advent Closing Date have undertaken certain indemnity obligations under the Investment Agreement. If the Significant Common Shareholders make a payment pursuant to their indemnity obligations under the Investment Agreement (“ Indemnity Payment ”), each Common Shareholder (other than the Significant Common Shareholders) who (i) received a dividend payment with respect to his Common Stock in September or October 2010

 

-12-


(the “ Common Dividend ”), or (ii) received a cash payment upon the exchange of his warrants in connection with the Advent Investment (“ Warrant Exchange ”) agrees to contribute his pro rata share of the Indemnity Payment. The Common Shareholders (other than the Significant Common Shareholders) who received cash by reason of the Common Dividend or Warrant Exchange are referred to herein as the “ Cash Recipients ”.

(b) Limitations on Contribution Obligation . Each Cash Recipient’s obligation under this Section 4.2 is several and shall be on a pro rata basis based on such Cash Recipient’s Net Cash Proceeds as a percentage of the total Net Cash Proceeds received by all Significant Common Shareholders and all Cash Recipients. For purposes of this Section 4.2, “ Net Cash Proceeds ” with respect to any Cash Recipient or Significant Common Shareholder means the aggregate amount of cash proceeds received by such Cash Recipient (or Significant Common Shareholder) in connection with the Common Dividend (net of the exercise price of any options or warrants exercised as of the record date for such Common Dividend) and the Warrant Exchange. In no event will a Cash Recipient be required to contribute an amount or otherwise have any liability under this Section 4.2 in excess of the amount of his Net Cash Proceeds.

(c) Notice of Contribution and Payment Thereof . If the Significant Common Shareholders make an Indemnity Payment, each of the Significant Common Shareholders may seek contribution for such Indemnity Payment from the Cash Recipients by providing written notice thereof to the Cash Recipients (“ Contribution Notice ”). Upon receipt of a Contribution Notice, each Cash Recipient shall contribute to the Significant Common Shareholders requesting contribution such Cash Recipient’s pro rata share of the Indemnity Payment set forth in such Contribution Notice by the due date set forth therein, which date shall be no earlier than ten (10) days from the date on which notice of the Indemnity Payment is given (“ Contribution Due Date ”). Notwithstanding anything to the contrary, if the Significant Common Shareholders are required to make an Indemnity Payment pursuant to Subsection 7.3(a)(iv) of the Investment Agreement, the Cash Recipient whose claim resulted in the Indemnity Payment shall not be required to contribute its pro rata share of such Indemnity Payment unless the contribution is necessary for the equitable allocation of the Net Cash Proceeds among all Cash Recipients. In no event may a Significant Common Shareholder seek contribution from the Cash Recipient if such Significant Common Shareholder’s (i) fraud or intentional misrepresentation, or (ii) intentional breach of a covenant made by it under the Investment Agreement and required to be performed by it prior to the Advent Closing Date, resulted in the Indemnity Payment.

(d) Enforcement . Each Significant Common Shareholder, at its own cost, may enforce the terms of this Section 4.2 against each of the Cash Recipients.

4.3 Legends . Each certificate representing shares of capital stock now or hereafter issued to the Shareholders or their permitted transferees, shall be endorsed with the following legends, as well as any legend required by state corporate law:

“THE SHARES REPRESENTED HEREBY MAY NOT BE VOTED, SOLD, ASSIGNED, PLEDGED, ENCUMBERED OR OTHERWISE TRANSFERRED EXCEPT IN CONFORMITY WITH THE TERMS OF A SECOND AMENDED AND RESTATED SHAREHOLDERS AGREEMENT DATED SEPTEMBER 1, 2010, AS SUCH AGREEMENT MAY BE AMENDED FROM TIME TO TIME, AMONG THE HOLDER (OR THE PREDECESSOR IN INTEREST TO THE SHARES), THE COMPANY AND CERTAIN OTHER SHAREHOLDERS OF THE COMPANY. THE COMPANY WILL UPON WRITTEN REQUEST FURNISH A COPY OF SUCH AGREEMENT TO THE HOLDER HEREOF WITHOUT CHARGE.”

 

-13-


“THE SALE AND ISSUANCE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. THE SECURITIES REPRESENTED HEREBY HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE DISTRIBUTION THEREOF, AND MAY NOT BE OFFERED, SOLD, PLEDGED, OR TRANSFERRED UNLESS (I) A REGISTRATION STATEMENT UNDER THE ACT IS IN EFFECT AS TO SUCH SECURITIES AND SUCH OFFER, SALE, PLEDGE, OR TRANSFER IS IN COMPLIANCE WITH APPLICABLE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION, OR (II) AN OPINION OF COUNSEL (INCLUDING INTERNAL LEGAL COUNSEL) ACCEPTABLE TO FIVE BELOW, INC. THAT AN EXEMPTION FROM SUCH REGISTRATION STATEMENT IS AVAILABLE AND THAT SUCH OFFER, SALE, PLEDGE, OR TRANSFER IS IN COMPLIANCE WITH APPLICABLE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION.”

4.4 Specific Enforcement . Each Shareholder and the Company expressly agrees that the Shareholders will be irreparably damaged if this Agreement is not specifically enforced. Upon a breach or threatened breach of the terms, covenants and/or conditions of this Agreement by any Shareholder or the Company, the Shareholders shall, in addition to all other remedies, be entitled to a temporary or permanent injunction, without showing any actual damage, and/or a decree for specific performance, in accordance with the provisions hereof.

4.5 Notices . All notices, requests and other communications to any party hereunder shall be in writing (including facsimile or similar writing) and shall be given to such party at the address or facsimile number (with respect to the Company, as set forth below and, with respect to the Shareholders, as set forth on the Schedule of Shareholders) of the party to be notified. Each such notice, request or other communication shall be deemed effectively given upon the earlier of (a) actual receipt, (b) personal delivery to the party to be notified, (b) when sent, if sent by electronic mail (provided that the sender did not receive an “undeliverable” message indicating that the electronic mail message did not reach its intended recipient) or facsimile (with automatic confirmation by the transmitting machine showing the proper number of pages were transmitted without error) during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient’s next Business Day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) Business Day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next Business Day delivery, with written verification of receipt.

to the Company:

Five Below, Inc.

1616 Walnut Street

Suite 400

Philadelphia, PA 19103

Attn: David Schlessinger and Thomas Vellios

 

-14-


Fax: 215.546.8099

E-mail: dschlessinger@fivebelow.com;

              tvellios@fivebelow.com

with copies to:

Pepper Hamilton LLP

3000 Two Logan Square

18th and Arch Streets

Philadelphia, PA 19103

Attn: Barry M. Abelson, Esq.

Fax: 215.689.4803

E-mail: abelsonb@pepperlaw.com

and

Advent International Corporation

75 State Street, Floor 29

Boston Massachusetts 02109

Attn: Steven Collins, Andrew Crawford

Fax: 617.951.0568, 212.461.6503

E-mail: scollins@adventinternational.com ,

acrawford@adventinternational.com

4.6 Entire Agreement and Amendments . This Agreement constitutes the entire agreement and understanding among the parties hereto and supersedes any and all prior agreements and understandings, written or oral, relating to the subject matter hereof and neither this Agreement nor any provision hereof may be terminated except in accordance with Section 4.1 or waived, modified or amended except by a written agreement signed by (a) the Company, (b) the Advent Funds, and (c) a majority of the Common Shareholders (exclusive of any shares of Common Stock held by the Advent Funds), voting together as a separate class; provided , however , that (i) if any waiver, modification or amendment adversely and disproportionately affects the rights contained herein of any Significant Common Shareholder relative to the other Significant Common Shareholders or Common Shareholders, the consent of the Significant Common Shareholder so affected to such waiver, modification or amendment shall be required, (ii) any amendment to Section 3.5 shall require the consent of LLR, and (iii) any amendment which modifies the indemnity obligations of the Significant Common Shareholders in a Bring-Along Transaction as provided in Section 2.4 shall require the consent of the Significant Common Shareholders. Notwithstanding the foregoing, on the Effective Date, the Company, without the consent of any other party hereto, may amend (i)  Exhibit A to update the list of Shareholders, Series A Preferred Shareholders and Significant Common Shareholders, as they exist on the Effective Date after giving effect to all of the transactions described in the Investment Agreement and (ii) the definition of Significant Common Shareholders to set forth the number of shares representing 3% of the total Equity Securities outstanding as of the Advent Closing Date, assuming the conversion of all Equity Securities.

4.7 Waiver of Statutory Information Rights . Each Shareholder who did not own Common Stock or Preferred Stock (as defined in the Original Agreement) as of August 1, 2010 (each, a “ Waiving Holder ”), agrees that the Company shall not be required to provide, and hereby waives such Waiving Holder’s right to receive, annual financial statements under Section 1554 of the Pennsylvania Business Corporation Law of 1988, as amended. This agreement and waiver shall be binding on each Waiving Holder and its respective successors, assigns and permitted transferees.

 

-15-


4.8 Governing Law . This Agreement, and all claims or causes of action (whether in contract or tort) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance of this Agreement (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with this Agreement or as an inducement to enter this Agreement) shall be governed by and construed in accordance with the internal laws of the Commonwealth of Pennsylvania without giving effect to the choice of law principles of such state that would require or permit the application of the laws of another jurisdiction.

4.9 Consent to Jurisdiction . By his, her or its execution hereof or of an Adoption Agreement, each party hereto agrees that any suit, action or proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement or the transactions contemplated hereby shall be brought in the United States District Court for the Eastern District of Pennsylvania or any Pennsylvania Commonwealth court sitting in the City of Philadelphia, so long as one of such courts shall have subject matter jurisdiction over such suit, action or proceeding, and that any cause of action arising out of this Agreement shall be deemed to have arisen from a transaction of business in the Commonwealth of Pennsylvania, and each of the parties hereby irrevocably consents to the jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such suit, action or proceeding and irrevocably waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of the venue of any such suit, action or proceeding in any such court or that any such suit, action or proceeding which is brought in any such court has been brought in an inconvenient forum. Process in any such suit, action or proceeding may be served on any party anywhere in the world, whether within or without the jurisdiction of any such court. Without limiting the foregoing, each party agrees that service of process on such party as provided in Section 4.5 shall be deemed effective service of process on such party.

4.10 WAIVER OF JURY TRIAL . EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION DOCUMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL

4.11 Successors and Assigns . By his, her or its execution hereof or of an Adoption Agreement, each party hereto hereby agrees that the provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns and each party hereto hereby appoints the Company as its attorney-in-fact for the sole purpose of executing Adoption Agreements with any subsequent permitted transferees. Without limiting the generality of the foregoing, all covenants and agreements of the Shareholders shall bind any and all subsequent holders of their voting securities of the Company, and the Company agrees that it shall not transfer on its records any such voting securities unless (i) the transferor Shareholder shall have first delivered to the Company the written agreement of the transferee to be bound by this Agreement to the same extent as if such transferee had originally been a Shareholder hereunder (in the same capacity as the transferor Shareholder) and (ii) the certificate or certificates evidencing the voting securities so transferred bear the legends specified in Section 4.3 .

 

-16-


4.12 Severability . If any provision of this Agreement shall be held to be illegal, invalid or unenforceable, such illegality, invalidity or unenforceability shall attach only to such provision and shall not in any manner affect or render illegal, invalid or unenforceable any other provision of this Agreement, and this Agreement shall be carried out as if any such illegal, invalid or unenforceable provision were not contained herein.

4.13 Headings . The headings in this Agreement are included for convenience of reference only and shall be ignored in the construction or interpretation hereof.

4.14 Counterparts; Facsimile Signatures . This Agreement may be executed in any number of counterparts (including facsimile signature) each of which shall be an original with the same effect as if the signatures thereto and hereto were upon the same instrument.

4.15 Effectiveness . This Agreement shall amend and restate the Original Agreement in its entirety as of, but no earlier than, the Effective Date, and the Original Agreement shall have no further effect as of the Effective Date. If the transactions contemplated by the Investment Agreement are not consummated, this Agreement shall be null and void and of no further effect and the Original Agreement shall continue in full force and effect.

4.16 No Third Party Beneficiaries . No provision of this Agreement is intended to confer upon any Person other than the parties hereto any rights or remedies hereunder.

4.17 Further Assurances . Each party hereto shall execute and deliver all such additional documents, certificates, agreements and other writings and to take such other actions as may be reasonably necessary or desirable in order to consummate or implement expeditiously the transactions contemplated by this Agreement.

4.18 No Exclusive Duty to Company . In recognition that certain of the Advent Funds currently have, and will in the future have or will consider acquiring, investments in numerous companies with respect to which such Advent Fund may serve as an advisor, a director or in some other capacity, and in recognition that such Advent Fund may have a myriad of duties to various investors and partners, and in anticipation that the Company, on the one hand, and such Advent Fund (or one or more affiliates, associated investment funds or portfolio companies), on the other hand, may engage in the same or similar activities or lines of business and have an interest in the same areas of corporate opportunities, and in recognition of the benefits to be derived by the Company hereunder and in recognition of the difficulties which may confront any Advent Fund who desires and endeavors fully to satisfy such Advent Fund’s duties, in determining the full scope of such duties in any particular situation, the provisions of this Section 4.18 are set forth to regulate, define and guide the conduct of certain affairs of the Company as they may involve such Advent holder.

(a) Such Advent Fund shall have the right, subject to any confidentiality covenant or agreement that it may have with the Company:

 

  (i) to directly or indirectly engage in or invest in any business (including, without limitation, any business activities or lines of business that are the same as or similar to those pursued by, or competitive with, the Company); provided, that no director of the Company appointed by the Advent Fund that is a Person affiliated with the Advent Fund shall also serve as a director or in a similar capacity for such other business;

 

-17-


  (ii) to directly or indirectly do business with any client or customer of the Company;

 

  (iii) to take any other action that such Advent Fund believes in good faith is necessary to or appropriate to fulfill its obligations as described in the first sentence of this Section 4.18 ; and

 

  (iv) not to present potential transactions, matters or business opportunities to the Company or any of its subsidiaries, and to pursue, directly or indirectly, any such opportunity for itself, and to direct any such opportunity to another Person.

(b) Such Advent Fund and its Affiliates shall have no duty (contractual or otherwise) to communicate or present any corporate opportunities to the Company or any of its Affiliates or to refrain from any actions specified in Section 4.18(a) , and the Company, on its own behalf and on behalf of its Affiliates, hereby renounces and waives any right to require such Advent Fund or its Affiliates to act in a manner inconsistent with the provisions of Section 4.18(a) .

(c) Such Advent Fund and its Affiliates shall not be liable to the Company or any of its Affiliates for breach of any duty (contractual or otherwise) by reason of any activities or omissions of the types referred to in Section 4.18(a) or such Advent Fund’s or its Affiliates’ participation therein.

(d) Notwithstanding anything to the contrary, this Section 4.18 shall not relieve any of the Advent Funds or its Affiliates (including, any director of the Company appointed by the Advent Funds) from any confidentiality and non-disclosure covenant or agreement made by them to or for the benefit of the Company.

4.19 Lock-Up . If requested in writing by the underwriters in any registered offering of shares of Common Stock, each Shareholder agrees not to, directly or indirectly, sell, contract to sell (including without limitation, any short sale), grant any option to purchase, dispose of or otherwise transfer any shares of Registrable Securities (other than shares of Common Stock being registered in such offering), without the consent of such underwriters, for a period of not more than (i) one hundred eighty (180) days following the effective date of the registration statement filed under the Securities Act relating to the Initial Public Offering, and (ii) ninety (90) days following the effective date of registration statement filed under the Securities Act relating to any registration other than the Initial Public Offering. Each Shareholder agrees to execute and deliver such documents, agreements and instruments as may reasonably requested by the Company or the underwriter which are consistent with the foregoing. In order to enforce the rights and obligations under this Section 4.19 , the Company may impose stop-transfer instructions with respect to the Registrable Securities of each Shareholder (and the Registrable Securities of every other Person subject to the foregoing restrictions) until the end of such period.

4.20 Interpretation . Definitions contained in this Agreement apply to singular as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such terms. Words in the singular shall be held to include the plural and vice versa, and words of one gender shall be held to include the other gender as the context requires. The terms “ hereof ,” “ herein ,” “ hereby ,” and “ herewith ” and words of similar import shall, unless otherwise stated, be construed to refer to this Agreement as a whole and not to any particular provision of this Agreement. The terms “ includes ” and the word “ including ” and words of similar import shall be deemed to be followed by the words “without limitation.” Article, Section, paragraph and Schedule references are to the Articles, Sections, paragraphs and Schedules to this Agreement unless otherwise specified. The word “ or ” shall not be exclusive.

[SIGNATURES ON FOLLOWING PAGE]

 

-18-


IN WITNESS WHEREOF, this Agreement has been executed as of the date and year first above written.

 

FIVE BELOW, INC.
By:  

/s/ David Schlessinger

Name:  

David Schlessinger

Title:  

Executive Chairman

SIGNIFICANT COMMON SHAREHOLDERS:

/s/ David Schlessinger

David Schlessinger

/s/ Thomas Vellios

Thomas Vellios
LLR Equity Partners II, L.P.
LLR Equity Partners Parallel II, L.P.
By:   LLR Capital II, L.P., its General Partner
  By:   LLR Capital II, LLC, its General Partner
    By:  

/s/ Howard D. Ross

    Name:   Howard D. Ross
    Title:   Member
Blue 9 Fund I, L.P.
By:   Blue 9 Capital, LLC, its General Partner
  By:  

/s/ Steven Tuttleman

  Name:   Steven Tuttleman
  Title:   Manager

SIGNATURE PAGE TO SECOND AMENDED AND RESTATED SHAREHOLDERS AGREEMENT


EXHIBIT A

SCHEDULE OF HOLDERS

 

SIGNIFICANT COMMON SHAREHOLDERS
1.  

David Schlessinger

c/o Five Below, Inc.

1616 Walnut Street

Suite 400

Philadelphia, PA 19103

Fax: 215.546.8099

E-mail: dschlessinger@fivebelow.com

2.  

Thomas Vellios

c/o Five Below, Inc.

1616 Walnut Street

Suite 400

Philadelphia, PA 19103

Fax: 215.546.8099

E-mail: tvellios@fivebelow.com

3.  

LLR Equity Partners II, L.P.

c/o LLR Equity Partners, L.P.

Cira Centre

2929 Arch Street

Philadelphia, PA 19104-2868

Attention: Howard D. Ross

Fax:

E-mail: hross@llrpartners.com

 

With a copy to (which copy shall not constitute notice):

 

Pepper Hamilton LLP

3000 Two Logan Square

18 th & Arch Streets

Philadelphia, PA 19103

Attention: Barry M. Abelson

Fax: 215.689.4803

E-mail: abelsonb@pepperlaw.com

4.  

LLR Equity Partners Parallel II, L.P.

c/o LLR Equity Partners, L.P.

Cira Centre

2929 Arch Street

Philadelphia, PA 19104-2868

Attention: Howard D. Ross

Fax:

E-mail: hross@llrpartners.com


 

With a copy to (which copy shall not constitute notice):

 

Pepper Hamilton LLP

3000 Two Logan Square

18 th & Arch Streets

Philadelphia, PA 19103

Attention: Barry M. Abelson

Fax: 215.689.4803

E-mail: abelsonb@pepperlaw.com

5.  

Blue 9 Fund I, L.P.

#401

145 Hudson St.

New York, NY 10013

Attention: Steven Tuttleman

Fax: 212.798.0401

E-mail: instar@earthlink.net

 

With a copy to (which copy shall not constitute notice):

 

Blank Rome LLP

One Logan Square

130 North 18th Street

Philadelphia, PA 19103-6998

Attention: Steven Dubow

Fax: 215.832.5755

E-mail: Dubow@BlankRome.com

 

SERIES A PREFERRED SHAREHOLDERS
1.  

Advent International GPE VI Limited Partnership

2.  

Advent International GPE VI-A Limited Partnership

3.  

Advent International GPE VI-B Limited Partnership

4.  

Advent International GPE VI-C Limited Partnership

5.  

Advent International GPE VI-D Limited Partnership

6.  

Advent International GPE VI-E Limited Partnership

7.  

Advent International GPE VI-F Limited Partnership

8.  

Advent International GPE VI-G Limited Partnership

9.  

Advent Partners GPE VI 2008 Limited Partnership

10.  

Advent Partners GPE VI 2009 Limited Partnership

11.  

Advent Partners GPE VI 2010 Limited Partnership

12.  

Advent Partners GPE VI – A Limited Partnership

13.  

Advent Partners GPE VI – A 2010 Limited Partnership

 

Notices to any of the above listed Series A Preferred Shareholders should be sent to:

 

c/o Advent International Corporation

75 State Street, Floor 29

Boston Massachusetts 02109


 

Attn: Steven Collins, Andrew Crawford

Fax: 617.951.0568, 212.461.6503

E-mail: scollins@adventinternational.com

              acrawford@adventinternational.com

 

with a copy to (which copy shall not constitute notice):

 

Weil, Gotshal & Manges LLP

100 Federal Street

Boston, Massachusetts 02110

Attention: Marilyn French

Fax: 617.772.8333

E-mail: marilyn.french@weil.com


ANNEX A

ADOPTION AGREEMENT

This Adoption Agreement (“ Adoption Agreement ”) is executed by the undersigned (the “ Holder ”) pursuant to the terms of that certain Second Amended and Restated Shareholders Agreement, dated as of September 1, 2010 (the “ Agreement ”), by and among Five Below, Inc. (the “ Company ”) and certain of its Shareholders. Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Agreement. By the execution of this Adoption Agreement, the Holder agrees as follows:

1. Acknowledgement . The Holder acknowledges that the Holder is acquiring certain securities of the Company (the “ Securities ”), subject to the terms and conditions of the Agreement and that the Holder has read the Agreement in its entirety and understands the Agreement.

2. Agreement . The Holder (i) agrees that the Securities acquired by the Holder shall be bound by and subject to the terms of the Agreement, and (ii) hereby adopts the Agreement with the same force and effect as if the Holder were originally a party thereto [in the same capacity as the Shareholder from which the Holder acquired such Securities] [Bracketed language applies to Transferees only].

3. Notice . Any notice required or permitted by the Agreement shall be given to the Transferee at the address listed below the Holder’s signature below.

EXECUTED AND DATED this    day of            ,         .

 

HOLDER:
By:  

 

Name:  

 

Title:  

 

Address:  

 

Fax:  

 

E-Mail:  

 

Spouse: (if applicable):

 

Name:  

 

Accepted and agreed to by the Company on behalf of itself and pursuant to Section 4.11 of the Agreement on behalf of the other parties to the Agreement.


FIVE BELOW, INC.
By:  

 

Name:  

 

Title:  

 

Exhibit 10.6

FIRST AMENDMENT

TO

SECOND AMENDED AND RESTATED SHAREHOLDERS AGREEMENT

THIS FIRST AMENDMENT TO SECOND AMENDED AND RESTATED SHAREHOLDERS AGREEMENT (this “ Amendment ”) is made on October 14, 2010 by Five Below, Inc., a Pennsylvania corporation (the “ Company ”), to the Second Amended and Restated Shareholders Agreement, dated September 1, 2010 (the “ Agreement ”), among the Company and the Shareholders. Capitalized terms used and not defined herein shall have the meanings ascribed to them in the Agreement.

WHEREAS, pursuant to the terms of the Investment Agreement, dated September 1, 2010, by and among the Company, the Purchasers (as defined therein), and the other parties thereto (as amended, the “ Investment Agreement ”), the Purchasers made an equity investment in the Company in exchange for shares of Series A Preferred Stock, on the date hereof;

WHEREAS, Section 4.6 of the Agreement provides that the Company, without the consent of any other parties to the Agreement, may amend (i)  Exhibit A to the Agreement to update the list of Shareholders, Series A Preferred Shareholders and Significant Common Shareholders, as they exist on the Effective Date after giving effect to all of the transactions described in the Investment Agreement, and (ii) the definition of Significant Common Shareholders to set forth the number of shares representing 3% of the total Equity Securities outstanding as of the Advent Closing Date, assuming the conversion of all Equity Securities; and

WHEREAS, pursuant to the terms of this Amendment, the Company desires to amend the Agreement in accordance with Section 4.6 of the Agreement.

NOW, THEREFORE, intending to be legally bound hereby, the Company hereby amends the Agreement as follows:

1. Amendment to Exhibit A . The information reflected in Exhibit A to the Agreement is hereby deleted in its entirety and replaced with the information set forth in Annex 1 hereto.

2. Amendment to Definition of “Significant Common Shareholder” . Section 1.1(q) of the Agreement is hereby amended by deleting the definition of “Significant Common Shareholder” in its entirety and replacing it with the following:

Significant Common Shareholder ” shall mean (i) until the first anniversary of the Advent Closing Date, provided that if as of such date there are any outstanding indemnity claims under the Investment Agreement, until the date on which the last remaining outstanding indemnity claim is finally resolved, any Shareholder listed under the heading “Significant Common Shareholders” on the Schedule of Shareholders and any Person who hereafter becomes a Permitted Transferee of such Shareholder, and (ii) at any time thereafter, any Shareholder that alone (or together with any Person who hereafter becomes a Permitted Transferee of such Shareholder) owns at least 4,073,362 shares of Common Stock, subject to equitable adjustment upon any reverse or forward stock split or similar transaction by the Company.


3. Effectiveness and Other Provisions of the Agreement . This Amendment shall be effective as of the date hereof. Except as expressly amended hereby, the provisions of the Agreement are and shall remain in full force and effect.

4. Governing Law . This Amendment shall be governed by the laws of the Commonwealth of Pennsylvania.

[The remainder of this page is intentionally left blank.]

 

2


IN WITNESS WHEREOF , this Amendment has been executed by the Company as of the day and year first written above.

 

FIVE BELOW, INC.
By:  

/s/ Kenneth R. Bull

Name:   Kenneth R. Bull
Title:   Senior Vice President, Finance

[Signature Page to the First Amendment to Second Amended and Restated Shareholders Agreement]


ANNEX 1

SCHEDULE OF SHAREHOLDERS


EXHIBIT A

SCHEDULE OF HOLDERS

 

SIGNIFICANT COMMON SHAREHOLDERS
1.   

David Schlessinger

c/o Five Below, Inc.

1616 Walnut Street

Suite 400

Philadelphia, PA 19103

Fax: 215.546.8099

E-mail: dschlessinger@fivebelow.com

2.   

Thomas Vellios

c/o Five Below, Inc.

1616 Walnut Street

Suite 400

Philadelphia, PA 19103

Fax: 215.546.8099

E-mail: tvellios@fivebelow.com

3.   

LLR Equity Partners II, L.P.

c/o LLR Equity Partners, L.P.

Cira Centre

2929 Arch Street

Philadelphia, PA 19104-2868

Attention: Howard D. Ross

Fax:

E-mail: hross@llrpartners.com

 

With a copy to (which copy shall not constitute notice):

 

Pepper Hamilton LLP

3000 Two Logan Square

18 th & Arch Streets

Philadelphia, PA 19103

Attention: Barry M. Abelson

Fax: 215.689.4803

E-mail: abelsonb@pepperlaw.com

4.

  

LLR Equity Partners Parallel II, L.P.

c/o LLR Equity Partners, L.P.

Cira Centre

2929 Arch Street

Philadelphia, PA 19104-2868

Attention: Howard D. Ross

Fax:

E-mail: hross@llrpartners.com


    

With a copy to (which copy shall not constitute notice):

 

Pepper Hamilton LLP

3000 Two Logan Square

18 th & Arch Streets

Philadelphia, PA 19103

Attention: Barry M. Abelson

Fax: 215.689.4803

E-mail: abelsonb@pepperlaw.com

5.   

Blue 9 Fund I, L.P.

#401

145 Hudson St.

New York, NY 10013

Attention: Steven Tuttleman

Fax: 212.798.0401

E-mail: instar@earthlink.net

 

With a copy to (which copy shall not constitute notice):

 

Blank Rome LLP

One Logan Square

130 North 18th Street

Philadelphia, PA 19103-6998

Attention: Steven Dubow

Fax: 215.832.5755

E-mail: Dubow@BlankRome.com

 

SERIES A 8% CONVERTIBLE PREFERRED SHAREHOLDERS
1.    Advent International GPE VI Limited Partnership

2.

   Advent International GPE VI-A Limited Partnership

3.

   Advent International GPE VI-B Limited Partnership

4.

   Advent International GPE VI-C Limited Partnership

5.

   Advent International GPE VI-D Limited Partnership

6.

   Advent International GPE VI-E Limited Partnership

7.

   Advent International GPE VI-F Limited Partnership

8.

   Advent International GPE VI-G Limited Partnership

9.

   Advent Partners GPE VI 2008 Limited Partnership

10.

   Advent Partners GPE VI 2009 Limited Partnership

11.

   Advent Partners GPE VI 2010 Limited Partnership

12.

   Advent Partners GPE VI – A Limited Partnership

13.

  

Advent Partners GPE VI – A 2010 Limited Partnership

 

    

Notices to any of the above listed Series A 8% Convertible Preferred Shareholders should be sent to:

 

c/o Advent International Corporation

75 State Street, Floor 29


    

Boston Massachusetts 02109

Attn: Steven Collins, Andrew Crawford

Fax: 617.951.0568, 212.461.6503

E-mail: scollins@adventinternational.com

acrawford@adventinternational.com

 

with a copy to (which copy shall not constitute notice):

 

Weil, Gotshal & Manges LLP

100 Federal Street

Boston, Massachusetts 02110

Attention: Marilyn French

Fax: 617.772.8333

E-mail: marilyn.french@weil.com

14.

  

Sargent Family Investment, LLC

Exhibit 10.7

SECOND AMENDMENT

TO

SECOND AMENDED AND RESTATED SHAREHOLDERS AGREEMENT

THIS SECOND AMENDMENT, dated November 22, 2011 (this “ Amendment ”), to the Second Amended and Restated Shareholders Agreement of Five Below, Inc., dated September 1, 2010 (the “ Original Shareholders Agreement ”), as amended by the First Amendment to Shareholders Agreement, dated October 14, 2010 (the “ First Amendment ” and together with the Original Shareholders Agreement, the “ Amended Shareholders Agreement ”), is made by and among Five Below, Inc., a Pennsylvania corporation (the “ Company ”), and the undersigned shareholders of the Company (the “ Consenting Shareholders ”).

WHEREAS, the Company and the Consenting Shareholders desire to amend the Amended Shareholders Agreement in the manner set forth in this Amendment to expand the size of the Board of Directors to eight (8) members and to make other related changes to the Amended Shareholders Agreement;

WHEREAS, the parties to this Amendment have the authority to amend the Amended Shareholders Agreement pursuant to Section 4.6 thereof; and

NOW, THEREFORE, in consideration of mutual promises and covenants set forth herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

1. Amendment of the Amended Shareholders Agreement . Effective as of the date hereof, the Amended Shareholders Agreement shall be amended as follows:

a. Section 3.1(a)(i) of the Amended Shareholders Agreement is hereby deleted and replaced in its entirety with the following:

(i) five (5) individuals nominated by the Series A Preferred Shareholders holding a majority of the Series A Preferred Stock held by all Series A Preferred Shareholders, voting together as a separate class (the “ Series A Preferred Directors ”), one of whom shall be an Independent Director (defined below), who initially shall include David Mussafer, Steven Collins, Andrew Crawford and Howard Ross (as the Independent Director); and

b. Section 3.1(c) of the Amended Shareholders Agreement is hereby deleted and replaced in its entirety with the following:

(c) If all of the then-outstanding shares of Series A Preferred Stock are converted into Common Stock by the election of the holders of at least a majority of the then-outstanding shares of Series A Preferred Stock prior to an Initial Public Offering of the Common Stock, (i) the former holders of Series A Preferred Stock


shall continue to be entitled to nominate five (5) individuals to serve on the Board of Directors as provided in Section 3.1(a)(i), as if the Series A Preferred Stock had not been converted, and (ii) the Common Shareholders (exclusive of the former holders of Series A Preferred Stock who hold Common Stock by reason of such conversion of the Series A Preferred Stock and the shares of Common Stock held by them) shall continue to be entitled to nominate three (3) individuals to serve on the Board of Directors as provided in Section 3.1(a)(ii) as if the Series A Preferred Stock had not been converted.

c. Section 3.4 of the Amended Shareholders Agreement is hereby deleted and replaced in its entirety with the following:

3.4 Entire Board . The Company and the Shareholders shall take all action, do all things and execute and deliver all documents, including the approval of any amendment to the Bylaws, as may be reasonably necessary to ensure that the number of directors constituting the entire Board of Directors is eight (8).

2. Effect of Amendment . This Amendment shall be construed in connection with and as part of the Amended Shareholders Agreement, and except as amended hereby, all of the terms and conditions of the Amended Shareholders Agreement shall continue in full force and effect and are hereby ratified and confirmed in all respects. Any and all notices, requests, certificates and other instruments executed and delivered after the execution and delivery of this Amendment may refer to the Amended Shareholders Agreement without making specific reference to this Amendment, but nevertheless all such references shall include this Amendment unless the context otherwise requires.

3. Defined Terms . Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to them set forth in the Amended Shareholders Agreement.

4. Governing Law . This Amendment shall be governed by and construed in accordance with the laws of the Commonwealth of Pennsylvania without regard to principles of conflicts of laws.

5. Counterparts . This Amendment may be executed, including by facsimile or electronic signature, in two or more counterparts, each of which when so executed shall be deemed to be an original and all of which together shall constitute one and the same instrument.

[Signature Pages Follow]

 

-2-


IN WITNESS WHEREOF, the undersigned have executed this Second Amendment to the Second Amended and Restated Shareholders Agreement of Five Below, Inc. as of the day and year first written above.

 

  FIVE BELOW, INC.
  By:   

/s/ Kenneth R. Bull

  Name:    Kenneth R. Bull
  Title:    Senior Vice President and Secretary
 

/s/ David Schlessinger

  David Schlessinger
 

/s/ Thomas Vellios

  Thomas Vellios
  LLR Equity Partners II, L.P.
  LLR Equity Partners Parallel II, L.P.
  By:    LLR Capital II, L.P., its General Partner
     By:    LLR Capital II, LLC, its General Partner
        By:   

/s/ Howard D. Ross

        Name:    Howard D. Ross
        Title:    Member

[Second Amendment to Second A&R Shareholders Agreement – Five Below, Inc.]


  Advent International GPE VI Limited Partnership
  Advent International GPE VI-A Limited Partnership
  Advent International GPE VI-B Limited Partnership
  Advent International GPE VI-F Limited Partnership
  Advent International GPE VI-G Limited Partnership
  By:    GPE VI GP Limited Partnership, General Partner
     By:    Advent International LLC, General Partner
        By:    Advent International Corporation, Manager
           By:   

/s/ Steven Collins

           Name:    Steven Collins
           Title:    Vice President & Managing Director
  Advent International GPE VI-C Limited Partnership
  Advent International GPE VI-D Limited Partnership
  Advent International GPE VI-E Limited Partnership
  By:    GPE VI GP (Delaware) Limited Partnership, General Partner
     By:    Advent International LLC, General Partner
        By:    Advent International Corporation, Manager
           By:   

/s/ Steven Collins

           Name:    Steven Collins
           Title:    Vice President & Managing Director
  Advent Partners GPE VI 2008 Limited Partnership
  Advent Partners GPE VI 2009 Limited Partnership
  Advent Partners GPE VI 2010 Limited Partnership
  Advent Partners GPE VI – A Limited Partnership
  Advent Partners GPE VI – A 2010 Limited Partnership
  By:    Advent International LLC, General Partner
     By:    Advent International Corporation, Manager
        By:   

/s/ Steven Collins

        Name:    Steven Collins
        Title:    Vice President & Managing Director

[Second Amendment to Five Below Second A&R Shareholders Agreement]

Exhibit 10.8

FIVE BELOW, INC.

EQUITY INCENTIVE PLAN

(as Amended and Restated effective May 14, 2010)

SECTION 1. Purpose; Definitions . The purposes of the Five Below, Inc. Equity Incentive Plan (the “Plan”) are to: (a) enable Five Below, Inc. (the “Company”) and its affiliated companies to recruit and retain highly qualified employees, directors and consultants; (b) provide those employees, directors and consultants with an incentive for productivity; and (c) provide those employees, directors and consultants with an opportunity to share in the growth and value of the Company.

For purposes of the Plan, the following initially capitalized words and phrases will be defined as set forth below, unless the context clearly requires a different meaning:

a. “ Affiliate ” means, with respect to a Person, a Person that directly or indirectly controls, or is controlled by, or is under common control with such Person.

b. “ Award ” means a grant of Options or Restricted Shares pursuant to the provisions of this Plan.

c. “ Award Agreement ” means, with respect to any particular Award, the written document that sets forth the terms of that particular Award.

d. “ Board ” means the Board of Directors of the Company, as constituted from time to time; provided, however , that if the Board appoints a Committee to perform some or all of the Board’s administrative functions hereunder pursuant to Section 2 , references in this Plan to the “Board” will be deemed to also refer to that Committee in connection with administrative matters to be performed by that Committee.

e. “ Cause ” means (i) alcohol abuse or use of controlled drugs (other than in accordance with a physician’s prescription); (ii) refusal, failure or inability to perform any material obligation or fulfill any duty (other than any duty or obligation of the type described in clause (iv) below) to the Company (other than due to a Disability), which failure, refusal or inability is not cured within 10 days after delivery of notice thereof; (iii) gross negligence or willful misconduct in the course of employment; (iv) any breach of any obligation or duty to the Company or any of its Affiliates (whether arising by statute, common law, contract or otherwise) relating to confidentiality, noncompetition, nonsolicitation or proprietary rights; (v) other conduct involving any type of disloyalty to the Company or any of its Affiliates, including, without limitation, fraud, embezzlement, theft or proven dishonesty; and (vi) conviction of (or the entry of a plea of guilty or nolo contendere to) a misdemeanor involving moral turpitude or a felony. Notwithstanding the foregoing, if a Participant and the Company (or any of its Affiliates) have entered into an employment agreement, consulting agreement or other similar agreement that specifically defines “cause,” then with respect to such Participant, “Cause” shall have the meaning defined in that employment agreement, consulting agreement or other agreement.


f. “ Change in Control ” means the earliest to occur of the following events:

(i) the acquisition in one or more transactions by any Person (as defined below) of “beneficial ownership” (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of fifty percent (50%) or more of the combined voting power of the Company’s then outstanding voting securities (the “Voting Securities”), provided that for purposes of this clause (i) Voting Securities acquired directly from the Company by any Person shall be excluded from the determination of such Person’s Beneficial ownership of Voting Securities (but such Voting Securities shall be included in the calculation of the total number of Voting Securities then outstanding); or

(ii) approval by shareholders of the Company of:

1. a merger, reorganization or consolidation involving the Company if the shareholders of the Company immediately before such merger, reorganization or consolidation do not or will not own directly or indirectly immediately following such merger, reorganization or consolidation, more than fifty percent (50%) of the combined voting power of the outstanding voting securities of the company resulting from or surviving such merger, reorganization or consolidation in substantially the same proportion as their ownership of the Voting Securities outstanding immediately before such merger, reorganization or consolidation;

2. a complete liquidation or dissolution of the Company; or

3. an agreement for the sale or other disposition of all or substantially all of the assets of the Company; or

(iii) acceptance by shareholders of the Company of shares in a share exchange if the shareholders of the Company immediately before such share exchange do not or will not own directly or indirectly immediately following such share exchange more than fifty percent (50%) of the combined voting power of the outstanding voting securities of the entity resulting from or surviving such share exchange in substantially the same proportion as their ownership of the Voting Securities outstanding immediately before such share exchange.

g. “ Code ” means the Internal Revenue Code of 1986, as amended from time to time, and any successor thereto.

h. “ Committee ” means a committee appointed by the Board in accordance with Section 2 of this Plan.

i. “ Company ” means Five Below, Inc.

j. “ Consultant ” means an individual performing services as an independent contractor for the Company, but who is not an Employee or Director.

k. “ Director ” means a member of the Board.

l. “ Disability ” means a condition rendering a Participant Disabled.

m. “ Disabled ” will have the same meaning as set forth in Section 22(e)(3) of the Code.

 

-2-


n. “ Employee ” means common-law employee of the Company or any Subsidiary.

o. “ Exchange Act ” means the Securities Exchange Act of 1934, as amended.

p. “ Fair Market Value ” means, as of any date: (i) if the Shares are not traded in the over-the-counter market, the value of such Shares on that date, as determined by the Board in its sole and absolute discretion; or (ii) if the Shares are traded in the over-the-counter market, the Fair Market Value per Share shall be the mean of the bid and asked prices for a Share on the relevant valuation date as reported in The Wall Street Journal (or, if not so reported, as otherwise reported by the National Association of Securities Dealers Automated Quotations (“NASDAQ”) System), as applicable or, if there is no trading on such date, on the next preceding date on which there were reported Share prices. In the event Shares are listed on a national or regional securities exchange or traded through the NASDAQ Global Market, the Fair Market Value of a Share shall be the closing price for a Share on the exchange or on the NASDAQ National Market, as reported in The Wall Street Journal on the relevant valuation date, or if there is no trading on that date, on the next preceding date on which there were reported Share prices.

q. “ Incentive Stock Option ” means any Option intended to be and designated as an “Incentive Stock Option” within the meaning of Section 422 of the Code.

r. “ Non-Employee Director ” will have the meaning set forth in Rule 16b-3(b)(3)(i) promulgated by the Securities and Exchange Commission under the Exchange Act, or any successor definition adopted by the Securities and Exchange Commission; provided, however , that the Board or the Committee may, to the extent that it deems necessary to comply with Section 162(m) of the Code or regulations thereunder, require that each “Non-Employee Director” also be an “outside director” as that term is defined in regulations under Section 162(m).

s. “ Non-Qualified Stock Option ” means any Option that is not an Incentive Stock Option.

t. “ Option ” means any option to purchase Shares (including Restricted Shares, if the Committee so determines) granted pursuant to Section 5 hereof.

u. “ Participant ” means an employee, consultant or Director of the Company or any of its Affiliates to whom an Award is granted.

v. “ Person ” means an individual, partnership, corporation, limited liability company, trust, joint venture, unincorporated association, or other entity or association.

w. “ Restricted Shares ” means Shares that are subject to restrictions pursuant to Section 7 hereof.

x. “ Share ” means a share of Company’s common stock, par value $0.01, subject to substitution or adjustment as provided in Section 3(c) hereof.

 

-3-


y. “ Stock Purchase Agreement ” means any stock purchase, stock restriction, shareholders’ or other agreement the Board may require a Participant to execute as a condition of his or her receipt of either a grant of Restricted Shares or of the issuance of Shares pursuant to the exercise of an Option.

z. “ Subsidiary ” means, in respect of the Company, a subsidiary company, whether now or hereafter existing, as defined in Sections 424(f) and (g) of the Code.

SECTION 2. Administration . The Plan will be administered by the Board; provided, however , that the Board may at any time appoint a Committee to perform some or all of the Board’s administrative functions hereunder; and provided further , that the authority of any Committee appointed pursuant to this Section 2 will be subject to such terms and conditions as the Board may prescribe and will be coextensive with, and not in lieu of, the authority of the Board hereunder.

Any Committee established under this Section 2 will be composed of not fewer than two members, each of whom will serve for such period of time as the Board determines; provided, however, that if the Company has a class of securities required to be registered under Section 12 of the Securities Exchange Act of 1934, all members of any Committee established pursuant to this Section 2 will Non-Employee Directors. From time to time the Board may increase the size of the Committee and appoint additional members thereto, remove members (with or without cause) and appoint new members in substitution therefor, fill vacancies however caused, or remove all members of the Committee and thereafter directly administer the Plan.

Members of the Board who are eligible for Awards or have received Awards may vote on any matters affecting the administration of the Plan or the grant of Awards, except that no such member will act upon the grant of an Award to himself or herself, but any such member may be counted in determining the existence of a quorum at any meeting of the Board during which action is taken with respect to the grant of Awards to himself or herself.

The Board will have full authority to grant Awards under this Plan. In particular, the Board will have the authority:

a. to select the persons to whom Awards may from time to time be granted hereunder (consistent with the eligibility conditions set forth in Section 4 );

b. to determine the type of Award to be granted to any person hereunder;

c. to determine the number of Shares, if any, to be covered by each such Award;

d. to establish the terms and conditions of each Award Agreement;

e. to determine whether and under what circumstances an Option may be exercised without a payment of cash under Section 5(d) ; and

f. to determine whether, to what extent and under what circumstances Shares and other amounts payable with respect to an Award may be deferred either automatically or at the election of the Participant.

 

-4-


The Board will have the authority to adopt, alter and repeal such administrative rules, guidelines and practices governing the Plan as it, from time to time, deems advisable; to interpret the terms and provisions of the Plan and any Award issued under the Plan (and any Award Agreement); to amend the terms of any Award Agreement, provided that the Participant consents to such amendment; and to otherwise supervise the administration of the Plan. The Board may correct any defect, supply any omission or reconcile any inconsistency in the Plan or in any Award in the manner and to the extent it deems necessary to carry out the intent of the Plan.

All decisions made by the Board pursuant to the provisions of the Plan will be final and binding on all persons, including the Company and Participants. No member of the Board will be liable for any good faith determination, act or omission in connection with the Plan or any Award.

SECTION 3. Shares Subject to the Plan .

a. Shares Subject to the Plan . The Shares to be subject to Options or Restricted Shares under the Plan will be authorized and unissued Shares of the Company, whether or not previously issued and subsequently acquired by the Company. The maximum number of Shares that may be subject to Options or Restricted Shares under the Plan is 5,150,000, all of which may be subject to Incentive Stock Options, and the Company will reserve for the purposes of the Plan, out of its authorized and unissued Shares, such number of Shares.

b. Effect of the Expiration or Termination of Awards . If and to the extent that an Option expires, terminates or is canceled or forfeited for any reason without having been exercised in full, the Shares associated with that Option will again become available for grant under the Plan. Similarly, if any Restricted Share is canceled, forfeited or repurchased for any reason, or if any Share is withheld pursuant to Section 9(d) in settlement of a tax withholding obligation associated with an Award, that Share will again become available for grant under the Plan. Finally, if any Share is received in satisfaction of the exercise price payable upon exercise of an Option, that Share will become available for grant under the Plan.

c. Other Adjustment . In the event of any recapitalization, stock split or combination, stock dividend or other similar event or transaction affecting the Shares, equitable substitutions or adjustments may be made by the Board, in its sole and absolute discretion, to the aggregate number, type and issuer of the securities reserved for issuance under the Plan, to the number, type and issuer of Shares subject to outstanding Options, to the exercise price of outstanding Options, and to the number, type and issuer of Restricted Shares.

d. Change in Control . Notwithstanding anything to the contrary set forth in this Plan, upon or in anticipation of any Change in Control, the Board may, in its sole and absolute discretion and without the need for the consent of any Participant, take one or more of the following actions contingent upon the occurrence of that Change in Control: (i) cause any or all outstanding Options to become vested and immediately exercisable, in whole or in part; (ii) cause any or all outstanding Restricted Shares to become non-forfeitable, in whole or in part; (iii) cancel any or all Options, in whole or in part, in exchange for an option to purchase common stock of any successor corporation, which new option satisfies the requirements of Treas. Reg. §

 

-5-


1.425-1(a)(4)(i) (notwithstanding the fact that the original Option may never have been intended to satisfy the requirements for treatment as an Incentive Stock Option); (iv) cancel any or all Restricted Shares, in whole or in part, in exchange for restricted shares of the common stock of any successor corporation; (v) redeem any or all Restricted Share, in whole or in part, for cash and/or other substitute consideration with a value equal to the Fair Market Value of an unrestricted Share on the date of the Change in Control; or (vi) cancel any or all outstanding Options, in whole or in part, in exchange for cash and/or other substitute consideration with a value equal to (A) the number of Shares cancelled subject to such Options, multiplied by (B) the excess (if any) of the Fair Market Value per Share on the date of the Change in Control over the exercise price of such Options; provided, that if the Fair Market Value per Share on the date of the Change in Control does not exceed the exercise price of any such Option, the Board may cancel that Option without any payment of consideration therefor.

SECTION 4. Eligibility . Employees, directors, consultants, and other individuals who provide services to the Company or its Affiliates are eligible to be granted Awards under the Plan. Persons who are not employees of the Company or a Subsidiary are eligible to be granted Awards, but are not eligible to be granted Incentive Stock Options.

SECTION 5. Options . Options granted under the Plan may be of two types: (i) Incentive Stock Options or (ii) Non-Qualified Stock Options. Any Option granted under the Plan will be in such form as the Board may from time to time approve.

The Award Agreement evidencing any Option will incorporate the following terms and conditions and will contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Board deems appropriate in its sole and absolute discretion:

a. Option Price . The exercise price per Share purchasable under a Non-Qualified Stock Option will be determined by the Board. The exercise price per Share purchasable under an Incentive Stock Option will be not less than 100% of the Fair Market Value of a Share on the date of the grant. However, any Incentive Stock Option granted to any Participant who, at the time the Option is granted, owns more than 10% of the voting power of all classes of shares of the Company or of a Subsidiary will have an exercise price per Share of not less than 110% of Fair Market Value per Share on the date of the grant.

b. Option Term . The term of each Option will be fixed by the Board, but no Option will be exercisable more than 10 years after the date the Option is granted. However, any Incentive Stock Option granted to any Participant who, at the time such Option is granted, owns more than 10% of the voting power of all classes of shares of the Company or of a Subsidiary may not have a term of more than five years. No Option may be exercised by any person after expiration of the term of the Option.

c. Exercisability . Options will vest and be exercisable at such time or times and subject to such terms and conditions as determined by the Board at the time of grant. If the Board provides, in its discretion, that any Option is exercisable only in installments, the Board may waive such installment exercise provisions at any time at or after grant, in whole or in part, based on such factors as the Board determines, in its sole and absolute discretion.

 

-6-


d. Method of Exercise . Subject to the exercise provisions under Section 5(c) and the termination provisions set forth in Section 6 , Options may be exercised in whole or in part at any time and from time to time during the term of the Option, by giving written notice of exercise to the Company specifying the number of Shares to be purchased. Such notice will be accompanied by payment in full of the purchase price, either by certified or bank check, or such other means as the Board may accept and by an executed copy of a Stock Purchase Agreement, as required by the Board. As determined by the Board, in its sole discretion, at or after grant, payment in full or in part of the exercise price of an Option may be made in the form of previously acquired Shares based on the Fair Market Value of the Shares on the date the Option is exercised; provided, however , that, in the case of an Incentive Stock Option, the right to make a payment in the form of previously acquired Shares may be authorized only at the time the Option is granted.

No Shares will be issued upon exercise of an Option until full payment therefor has been made. A Participant will not have the right to distributions or dividends or any other rights of a shareholder with respect to Shares subject to the Option until the Participant has given written notice of exercise, has paid in full for such Shares, and, if requested, has given the representation described in Section 9(a) hereof.

e. Incentive Stock Option Limitations . In the case of an Incentive Stock Option, the aggregate Fair Market Value (determined as of the time of grant) of the Shares with respect to which Incentive Stock Options are exercisable for the first time by the Participant during any calendar year under the Plan and/or any other plan of the Company or any Subsidiary will not exceed $100,000. For purposes of applying the foregoing limitation, Incentive Stock Options will be taken into account in the chronological order in which they were granted. Any Option not meeting such limitation will be treated for all purposes as a Non-Qualified Stock Option.

f. Termination of Service . Unless otherwise specified in the Award Agreement, Options will be subject to the terms of Section 6 with respect to exercise upon termination of service.

g. Transferability of Options . Except as may otherwise be specifically determined by the Board with respect to a particular Non-Qualified Stock Option, no Option will be transferable by the Participant other than by will or by the laws of descent and distribution, and all Options will be exercisable, during the Participant’s lifetime, only by the Participant or, in the event of his Disability, by his personal representative.

SECTION 6. Termination of Service . Unless otherwise specified with respect to a particular Option in the applicable Award Agreement, all Options will remain exercisable after termination of employment only to the extent specified in this Section 6 .

a. Termination by Reason of Death . If a Participant’s service with the Company or any Affiliate terminates by reason of death, any Option held by such Participant may thereafter be exercised, to the extent then exercisable or on such accelerated basis as the Board may determine, at or after grant, by the legal representative of the estate or by the legatee of the Participant under the will of the Participant, for a period expiring (i) at such time as may be specified by the Board at or after the time of grant, or (ii) if not specified by the Board, then 12 months from the date of death, or (iii) if sooner than the applicable period specified under (i) or (ii) above, then upon the expiration of the stated term of such Option.

 

-7-


b. Termination by Reason of Disability . If a Participant’s service with the Company or any Affiliate terminates by reason of Disability, any Option held by such Participant may thereafter be exercised by the Participant or his personal representative, to the extent it was exercisable at the time of termination, or on such accelerated basis as the Board may determine at or after grant, for a period expiring (i) at such time as may be specified by the Board at or after the time of grant, or (ii) if not specified by the Board, then 12 months from the date of termination of service, or (iii) if sooner than the applicable period specified under (i) or (ii) above, then upon the expiration of the stated term of such Option.

c. Cause . If a Participant’s service with the Company or any Affiliate is terminated for Cause: (i) any Option not already exercised will be immediately and automatically forfeited as of the date of such termination, and (ii) any Shares for which the Company has not yet delivered share certificates will be immediately and automatically forfeited and the Company will refund to the Participant the Option exercise price paid for such Shares, if any.

d. Other Termination . If a Participant’s service with the Company or any Affiliate terminates for any reason other than death, Disability or Cause, any Option held by such Participant may thereafter be exercised by the Participant, to the extent it was exercisable at the time of such termination, or on such accelerated basis as the Board may determine at or after grant, for a period expiring (i) at such time as may be specified by the Board at or after the time of grant, or (ii) if not specified by the Board, then 90 days from the date of termination of service, or (iii) if sooner than the applicable period specified under (i) or (ii) above, then upon the expiration of the stated term of such Option.

SECTION 7. Restricted Shares .

a. Issuance . Restricted Shares may be issued either alone or in conjunction with other Awards. The Board will determine the time or times within which Restricted Shares may be subject to forfeiture, and all other conditions of such Awards.

b. Awards and Certificates . The Award Agreement evidencing the grant of any Restricted Shares will contain such terms and conditions, not inconsistent with the terms of the Plan, as the Board deems appropriate in its sole and absolute discretion. The prospective recipient of an Award of Restricted Shares will not have any rights with respect to such Award, unless and until such recipient has executed an Award Agreement and has delivered a fully executed copy thereof to the Company, and has otherwise complied with the applicable terms and conditions of such Award. The purchase price for Restricted Shares may, but need not, be zero.

 

-8-


A share certificate will be issued in connection with each Award of Restricted Shares. Such certificate will be registered in the name of the Participant receiving the Award, and will bear the following legend and/or any other legend required by this Plan, the Award Agreement, the Company’s shareholders’ agreement, or by applicable law:

THE TRANSFERABILITY OF THIS CERTIFICATE AND THE SHARES REPRESENTED HEREBY ARE SUBJECT TO THE TERMS AND CONDITIONS OF THE FIVE BELOW, INC. EQUITY INCENTIVE PLAN AND AN AGREEMENT ENTERED INTO BETWEEN THE PARTICIPANT AND FIVE BELOW, INC. (WHICH TERMS AND CONDITIONS MAY INCLUDE, WITHOUT LIMITATION, CERTAIN TRANSFER RESTRICTIONS, REPURCHASE RIGHTS AND FORFEITURE CONDITIONS). COPIES OF THAT PLAN AND AGREEMENT ARE ON FILE IN THE PRINCIPAL OFFICES OF FIVE BELOW, INC. AND WILL BE MADE AVAILABLE TO THE HOLDER OF THIS CERTIFICATE WITHOUT CHARGE UPON REQUEST TO THE SECRETARY OF FIVE BELOW, INC.

Share certificates evidencing Restricted Shares will be held in custody by the Company or in escrow by an escrow agent until the restrictions thereon have lapsed. As a condition to any Restricted Share Award, the Participant may be required to deliver to the Company a share power, endorsed in blank, relating to the Shares covered by such Award.

c. Restrictions and Conditions . The Restricted Shares awarded pursuant to this Section 7 will be subject to the following restrictions and conditions:

(i) During a period commencing with the date of grant of an Award of Restricted Shares and ending at such time or times as specified by the Board (the “ Restriction Period ”), the Participant will not be permitted to sell, transfer, pledge, assign or otherwise encumber Restricted Shares awarded under the Plan. The Board may condition the lapse of restrictions on Restricted Shares upon the continued employment or service of the recipient, the attainment of specified individual or corporate performance goals, or such other factors as the Board may determine, in its sole and absolute discretion.

(ii) Prior to the expiration of the Restriction Period, the Participant will not be entitled to vote such Restricted Shares. Consistent with Section 3(c) , any distributions or dividends paid in the form of securities with respect to Restricted Shares will be subject to the same terms and conditions as the Restricted Shares with respect to which they were paid, including, without limitation, the same Restriction Period.

(iii) Subject to the applicable provisions of the Award Agreement, if a Participant’s service with the Company terminates prior to the expiration of the Restriction Period, all of that Participant’s Restricted Shares which then remain subject to forfeiture will be forfeited.

(iv) In the event of hardship or other special circumstances of a Participant whose service with the Company is involuntarily terminated (other than for Cause), the Board may, in its sole discretion, waive in whole or in part any or all remaining restrictions with respect to such Participant’s Restricted Shares, based on such factors as the Board may deem appropriate.

 

-9-


(v) If and when the Restriction Period expires without a prior forfeiture of the Restricted Shares (or if and when the restrictions applicable to Restricted Shares lapse pursuant to Sections 3(d) or 7(c)(iv)) , the certificates for such Shares will be replaced with new certificates, without the portion of restrictive legends described in Section 7(b) applicable to such lapsed restrictions, and such new certificates will be promptly delivered to the Participant, the Participant’s representative (if the Participant has suffered a Disability), or the Participant’s estate or heir (if the Participant has died).

SECTION 8. Amendments and Termination .

a. Amendment or Termination of the Plan . The Board may amend or terminate the Plan at any time; provided that the Board may not make any amendment to the Plan, except as otherwise provided in Section 3(d) of the Plan, that would, if such amendment were not approved by the shareholders of the company, cause the Plan to fail to comply with any requirement of applicable law or regulation, unless and until the approval of the shareholders is obtained.

b. Amendment or Termination of Outstanding Options . An amendment or termination of the Plan that occurs after an Award shall not materially impair the rights of a Participant unless the Participant consents or unless the amendment is required in order to comply with applicable law. The termination of the Plan shall not impair the power and authority of the Committee with respect to an outstanding Award. Whether or not the Plan has terminated, an outstanding Award may be amended or terminated in accordance with the Plan or may be amended by agreement of the Company and the Participant consistent with the Plan.

SECTION 9. General Provisions .

a. The Board may require each Participant to represent to and agree with the Company in writing that the Participant is acquiring securities of the Company for investment purposes and without a view to distribution thereof and as to such other matters as the Board believes are appropriate. The certificate evidencing any Award and any securities issued pursuant thereto may include any legend which the Board deems appropriate to reflect any restrictions on transfer and compliance with securities laws.

All certificates for Shares or other securities delivered under the Plan will be subject to such share-transfer orders and other restrictions as the Board may deem advisable under the rules, regulations, and other requirements of the Securities Act of 1933, as amended, the Exchange Act, any stock exchange upon which the Shares are then listed, and any other applicable Federal or state securities laws, and the Board may cause a legend or legends to be put on any such certificates to make appropriate reference to such restrictions.

b. Nothing contained in the Plan will prevent the Board from adopting other or additional compensation arrangements, subject to shareholder approval if such approval is required; and such arrangements may be either generally applicable or applicable only in specific cases.

 

-10-


c. The adoption of the Plan will not confer upon any employee of the Company or an Affiliate any right to continued employment with the Company or such Affiliate, nor will it interfere in any way with the right of the Company or such Affiliate to terminate the employment of any of its employees at any time.

d. No later than the date as of which an amount first becomes includible in the gross income of the Participant for federal income tax purposes with respect to any Award under the Plan, the Participant will pay to the Company, or make arrangements satisfactory to the Board regarding the payment of, any federal, state or local taxes of any kind required by law to be withheld with respect to such amount. Unless otherwise determined by the Board, the minimum required withholding obligations may be settled with Shares, including Shares that are part of the Award that gives rise to the withholding requirement. The obligations of the Company under the Plan will be conditioned on such payment or arrangements and the Company will, to the extent permitted by law, have the right to deduct any such taxes from any payment of any kind otherwise due to the Participant.

SECTION 10. Effective Date of Plan . This Plan will become effective on the date that it is adopted by the Board; provided, however, that if the Plan is not approved by a majority of the votes cast at a duly held shareholder meeting at which a quorum representing a majority of the Company’s outstanding voting shares is present (either in person or by proxy) within 12 months before or after the date of the Board’s adoption, any Option intended to qualify as an Incentive Stock Option will be treated for all purposes as a Non-Qualified Stock Option.

SECTION 11. Term of Plan . This Plan will continue in effect until terminated in accordance with Section 8 ; provided, however, that no Incentive Stock Option will be granted hereunder on or after the 10th anniversary of (i) the date of shareholder approval of the Plan or (ii) the date the Plan is adopted by the Board, whichever is earlier; but provided further, that Incentive Stock Options granted prior to such 10th anniversary may extend beyond that date.

SECTION 12. Invalid Provisions . In the event that any provision of this Plan is found to be invalid or otherwise unenforceable under any applicable law, such invalidity or unenforceability will not be construed as rendering any other provisions contained herein as invalid or unenforceable, and all such other provisions will be given full force and effect to the same extent as though the invalid or unenforceable provision was not contained herein.

SECTION 13. Governing Law . This Plan and all Awards granted hereunder will be governed by and construed in accordance with the laws and judicial decisions of the Commonwealth of Pennsylvania, without regard to the application of the principles of conflicts of laws.

SECTION 14. Board Action . Notwithstanding anything to the contrary set forth in this Plan, any and all actions of the Board or Committee, as the case may be, taken under or in connection with this Plan and any agreements, instruments, documents, certificates or other writings entered into, executed, granted, issued and/or delivered pursuant to the terms hereof, will be subject to and limited by any and all votes, consents, approvals, waivers or other actions of all or certain stockholders of the Company or other persons required by:

a. the Company’s Articles of Incorporation (as the same may be amended and/or restated from time to time);

 

-11-


b. the Company’s Bylaws (as the same may be amended and/or restated from time to time); and

c. any other agreement, instrument, document or writing now or hereafter existing, between or among the Company and its stockholders or other persons (as the same may be amended from time to time).

SECTION 15. Notices . Any notice to be given to the Company pursuant to the provisions of the Plan shall be addressed to the Company in care of its Secretary (or such other person as the Company may designate from time to time) at its principal executive office, and any notice to be given to a Participant shall be delivered personally or addressed to him or her at the address given beneath his or her signature on his or her Award Agreement, or at such other address as such Participant may hereafter designate in writing to the Company. Any such notice shall be deemed duly given on the date and at the time delivered via personal, courier or recognized overnight delivery service or, if sent via telecopier, on the date and at the time telecopied with confirmation of delivery or, if mailed, on the date five days after the date of the mailing (which shall be by regular, registered or certified mail). Delivery of a notice by telecopy (with confirmation) shall be permitted and shall be considered delivery of a notice notwithstanding that it is not an original that is received.

 

-12-

Exhibit 10.9

AMENDMENT 2010-1

TO THE

FIVE BELOW, INC. EQUITY INCENTIVE PLAN

WHEREAS , Five Below, Inc. (the “ Company ”) maintains the Five Below, Inc. Equity Incentive Plan (the “ Plan ”), as amended and restated effective as of May 14, 2010; and

WHEREAS , in furtherance of the transactions contemplated by the Investment Agreement, dated September 1, 2010, by and among the Company and the parties listed therein (the “ Investment Agreement ”), the Company desires to amend the Plan to: (i) increase the number of shares of the Company’s common stock that are issuable under the Plan, (ii) provide that in the event of certain corporate events or transactions affecting the Company’s common stock, equitable adjustments shall automatically be made to the equity issued or available for issuance under the Plan, and (iii) allow transfers of equity grants to a participant’s family members or trusts established for him or his family members subject to certain approval and restrictions;

WHEREAS , Section 8 of the Plan provides that the Plan may be amended by the Board at any time, subject to certain restrictions; and

WHEREAS , the Company’s Board of Directors approved this Amendment 2010-1 to the Plan on October 13, 2010.

NOW THEREFORE, effective immediately following the closing of the transactions contemplated by the Investment Agreement, including payment of the cash dividend to holders of the Company’s common stock as described therein, the Plan is hereby amended as follows:

 

1. Section 1 of the Plan is amended by adding the following definition and by renumbering the subsequent definitions:

Family Member ”, with respect to a Participant, shall mean such Participant’s spouse, parent, sibling (by blood or adoption) or lineal ancestor or descendant (by blood or adoption).

 

2. Section 3(a) of the Plan is hereby deleted in its entirety and replaced with the following:

Shares Subject to the Plan . The Shares to be subject to Options or Restricted Shares under the Plan will be authorized and unissued Shares of the Company, whether or not previously issued and subsequently acquired by the Company. The maximum number of Shares that may be subject to future grants of Options or Restricted Shares under the Plan is 10,219,904 (which number does not include the 3,412,255 Shares which were previously authorized and issued pursuant to the Plan prior to the effective date of Amendment 2010-1 to the Plan, provided that, notwithstanding Section 3(b) to the contrary, any such previously issued shares may not become available for future grant under the Plan if canceled, forfeited or repurchased for any reason), all of which may be subject to Incentive Stock Options, and the Company will reserve for the purposes of the Plan, out of its authorized and unissued Shares, such number of Shares.


3. Section 3(c) of the Plan is hereby deleted in its entirety and replaced with the following:

Other Adjustment . In the event of any corporate event or transaction such as a merger, consolidation, reorganization, recapitalization, stock split, reverse stock split, split up, spin-off, combination of Shares, exchange of Shares, stock dividend, dividend in kind, or other like change in capital structure (other than ordinary cash dividends) to shareholders of the Company, or other similar corporate event or transaction affecting the Shares, the Committee, to prevent dilution or enlargement of Participants’ rights under the Plan, shall, in such manner as it may deem equitable, substitute or adjust, in its sole discretion, the number and kind of shares that may be issued under the Plan or under any outstanding Awards, the number and kind of shares subject to outstanding Awards, the exercise price, grant price or purchase price applicable to outstanding Awards, and/or any other affected terms and conditions of this Plan or outstanding Awards. The Committee shall make such adjustments in a manner intended to be consistent with Section 409A of the Code and Section 422 of the Code, to the extent applicable.

 

4. Section 5(g) of the Plan is hereby deleted in its entirety and replaced with the following:

Transferability of Options . Except as may otherwise be specifically determined by the Board or Committee with respect to a particular Non-Qualified Stock Option, no Option will be transferable by the Participant other than by will or by the laws of descent and distribution, and all Options will be exercisable, during the Participant’s lifetime, only by the Participant or, in the event of his Disability, by such Participant’s personal representative. Notwithstanding the foregoing, subject to the approval of the Board, a Participant may transfer a Non-Qualified Stock Option to any Family Member of such Participant or to the trustee or custodian of a trust established solely for the benefit of such Participant or such Participant’s Family Members, provided that such Participant’s Family Member, trustee or custodian agrees to be bound by the terms and conditions of the applicable Award Agreement, the Plan and any contractual transfer restrictions that are applicable to the Non-Qualified Stock Option on the date of the transfer of the Non-Qualified Stock Option; provided further that such Participant’s Family Member, trustee or custodian shall not transfer such Non-Qualified Stock Option other than by will or the laws of descent and distribution.

 

5. Section 7(c) of the Plan is hereby amended by adding the following new subsection (vi)  to that Section:

(vi) Notwithstanding the foregoing, subject to the approval of the Board or Committee, a Participant may transfer such Participant’s Restricted Shares to any Family Member of such Participant or to the trustee or custodian of a trust established solely for the benefit of such Participant or such Participant’s Family


Members, provided that such Participant’s Family Member, trustee or custodian agrees to be bound by the terms and conditions of the applicable Award Agreement, the Plan and any contractual transfer restrictions that are applicable to the Restricted Shares on the date of the transfer of the Restricted Shares; provided further that such Participant’s Family Member, trustee or custodian shall not transfer such Restricted Shares other than by will or the laws of descent and distribution and subject to any contractual transfer restrictions that are applicable to the Restricted Shares on the date of the transfer of the Restricted Shares.

Except as expressly provided otherwise in this Amendment 2010-1, all terms and conditions of the Plan shall remain in full force and effect.

[Signature Page Follows]


IN WITNESS WHEREOF , this Amendment 2010-1 has been executed on this 14th day of October, 2010.

 

FIVE BELOW, INC.
By:  

/s/ Kenneth R. Bull

Name:   Kenneth R. Bull
Title:   Senior Vice President, Finance

Exhibit 10.10

FIVE BELOW, INC.

EQUITY INCENTIVE PLAN

NON-QUALIFIED STOCK OPTION AGREEMENT

Five Below, Inc. (the “Company”) hereby grants to [ ] (the “Optionee”) an option to purchase a total of [ ] shares of Common Stock of the Company (the “Option Shares”), at the price and on the terms set forth herein, and in all respects subject to the terms, definitions and provisions of the Five Below, Inc. Equity Incentive Plan (the “Plan”) applicable to non-qualified stock options, which terms and provisions are hereby incorporated by reference herein. Unless the context herein otherwise requires, the terms defined in the Plan shall have the same meanings when used herein.

1. Nature of the Option. This Option is intended to be a nonstatutory stock option and is not intended to be an Incentive Stock Option within the meaning of section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), or to otherwise qualify for any special tax benefits to the Optionee.

2. Date of Grant; Term of Option. This Option is granted this [ ] day of [ ],[ ], (the “Date of Grant”) and it may not be exercised later than the date that is ten (10) years after the Date of Grant, subject to earlier termination, as provided in the Plan or Section 5 hereof. For purposes of this Agreement, the term “Effective Date of Grant” shall mean [ ].

3. Option Exercise Price. The Option exercise price is [ ] per Share.

4. Exercise of Option. This Option shall be exercisable during its term only in accordance with the terms and provisions of the Plan and this Award Agreement as follows:

(a) Right to Exercise.

(i) In General . Subject to Section 4(a)(ii) and 4(a)(iii) of this Option, the Option will vest and become exercisable according to the following schedule:

 

If the Optionee has remained an

active employee of the Company from

the Effective Date of Grant to the:

    

Then the Option will vest and

become exercisable with

respect to:

Second Anniversary of the Effective Date of Grant (the “Second Anniversary”)      50% of the Option Shares
Ninety-first (91st) day following the Second Anniversary      An additional 6.25% of the Option Shares
One Hundred Eighty First (181 st ) day following the Second Anniversary      An additional 6.25% of the Option Shares
Two Hundred Seventy First (271 st ) day following the Second Anniversary      An additional 6.25% of the Option Shares


Third Anniversary of the Effective Date of Grant (the “Third Anniversary”)      An additional 6.25% of the Option Shares
Ninety-first (91st) day following the Third Anniversary      An additional 6.25% of the Option Shares
One Hundred Eighty First (181 st ) day following the Third Anniversary      An additional 6.25% of the Option Shares
Two Hundred Seventy First (271 st ) day following the Third Anniversary      An additional 6.25% of the Option Shares
Fourth Anniversary of the Effective Date of Grant      An additional 6.25% of the Option Shares

(ii) Accelerated Vesting on Change in Control . In the event of a Change in Control, the Option will vest and become exercisable with respect to fifty percent (50%) of the then unvested Option Shares, as of the date of such Change in Control.

(iii) Accelerated Vesting for Certain Terminations . If the Optionee ceases to be employed by the Company after the first anniversary of the Effective Date of Grant and prior to the Second Anniversary as a result of: (i) his or her Disability, (ii) his or her death or (iii) a termination by the Company without Cause, then the Option will vest and become exercisable with respect to twenty five percent (25%) of the Option Shares and will remain exercisable for the applicable time period provided in Section 5.

(b) Method of Exercise. The Optionee may exercise this Option by providing written notice stating the election to exercise this Option. Such written notice must be signed by the Optionee and must be delivered in person or by certified mail to the Secretary of the Company or such other person as may be designated by the Company. The written notice must be accompanied by payment of the option exercise price in the manner described in Section 4(c), by an executed Stock Restriction Agreement described in Section 4(f) and by any other agreements required by the Board or its Committee and/or the terms of the Plan, which other agreements may restrict the sale or other transfer of the Shares and may include certain additional representations and agreements as to the Optionee’s investment intent with respect to the Shares. This Option will be deemed to be exercised only upon the receipt by the Company of such written notice, payment of the option exercise price, and duly executed copies of the Stock Restriction Agreement and any other agreements required by the Board or its Committee, the terms of the Plan and/or this Award Agreement. The Optionee will have no right to vote or receive dividends and will have no other rights as a stockholder with respect to such Shares notwithstanding the exercise of this Option, until the issuance (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) of the stock certificate(s) evidencing Shares that are being issued upon exercise of this Option. The certificate(s) for the Shares will be registered in the name of the Optionee and will contain any legend as may be required under the Plan, this Award Agreement, and/or applicable law.

(c) Method of Payment . The method of payment of the option exercise price will be determined by the Board or its Committee and may consist entirely of cash, certified check, or such other consideration or method of payment as may be authorized under the Plan.

 

-2-


(d) Partial Exercise . This Option may be exercised in whole or in part; provided , however , that any exercise may apply only with respect to a whole number of Shares.

(e) Restrictions on Exercise . This Option may not be exercised if the issuance of these Shares upon such exercise would constitute a violation of any applicable federal or state securities laws or other laws or regulations. In addition, as a further condition to the exercise of this Option, the Company may require the Optionee to make any representation or warranty to the Company as may be required by or advisable under any applicable law or regulation.

(f) Stock Restriction Agreement. In connection with and as a condition of exercising this Option, Optionee hereby acknowledges and agrees to execute a Stock Restriction Agreement (or other agreement restricting Optionee’s rights in the Shares acquired or to be acquired by the exercise of this Option) by and between Optionee, the Company and/or one or more other holders of equity securities of the Company in the form that the Company provides at the time of exercise and as may be amended by the Company in its sole discretion from time to time.

5. Termination of Relationship with the Company.

(a) Voluntary Termination. If the Optionee terminates his or her employment with the Company for any reason other than death or Disability, the Option (to the extent exercisable at the time of such termination) may be exercised at any time within ninety (90) days after the date of such termination. To the extent that the Option is not exercisable at the time of such termination, or to the extent the Option is not exercised within the time specified herein, the Option shall terminate.

(b) Disability. If the Optionee’s employment by the Company terminates due to Disability, the Option (to the extent exercisable at the time of such termination) may be exercised by the Optionee or his or her legal guardian or representative at any time within twelve (12) months after such termination. To the extent that the Option is not exercisable on the date of termination, or to the extent the Option is not exercised within the time specified herein, the Option shall terminate.

(c) Death. If the Optionee’s employment by the Company terminates due to his or her death, the Option (to the extent exercisable at the time of such death) will remain exercisable for twelve (12) months after the date of death by the Optionee’s estate or by a person who acquired the right to exercise the Option by bequest or inheritance. To the extent that the Option is not exercisable on the date of death, or to the extent the Option is not exercised within the time specified herein, the Option shall terminate.

(d) Termination Without Cause. If the Company terminates Optionee’s employment with the Company without Cause, the Option (to the extent exercisable at the time of such termination) may be exercised at any time within ninety (90) days after the date of such termination. To the extent that the Option is not exercisable at the time of such termination, or to the extent the Option is not exercised within the time specified herein, the Option shall terminate.

 

-3-


(e) Termination for Cause. If the Company terminates Optionee’s employment with the Company for Cause, the Option will then terminate immediately and automatically, and the Optionee shall have no further rights therein.

Notwithstanding any other provision of this Section 5, the Option shall not be exercisable after the expiration of the term set forth in Section 2 hereof.

6. Non-Transferability of Option. This Option may not be sold, pledged, assigned, hypothecated, gifted, transferred or disposed of in any manner either voluntarily or involuntarily by operation of law, other than by will or by the laws of descent or distribution. During the Optionee’s lifetime, this Option is exercisable only by the Optionee (or by such Optionee’s legal guardian or representative as provided in Section 5). Subject to the foregoing and the terms of the Plan, the terms of this Option will be binding upon the executors, administrators, legal guardians, representatives and heirs of the Optionee, meaning for purposes of this Award Agreement, both testamentary heirs and heirs by intestacy.

7. No Continuation of Employment or Engagement. Neither the Plan nor this Option shall confer upon any Optionee any right to continue in the service of the Company or any of its Subsidiaries or limit, in any respect, the right of the Company to discharge the Optionee at any time, with or without Cause and with or without notice.

8. Lock-Up Agreement. Each Optionee hereby agrees that, in connection with any registration of the offering of any securities of the Company under the Securities Act of 1933, as amended (the “Securities Act”) for the account of the Company, if so requested by the Company, such Optionee shall not sell or otherwise transfer any securities of the Company during the period specified by the Board of Directors (the “Market Standoff Period”), with such period not to exceed 180 days following the effective date of a registration statement of the Company filed under the Securities Act. The Company may impose stop-transfer instructions with respect to securities subject to the foregoing restrictions until the end of such Market Standoff Period. The provisions of this Section 8 shall be binding upon any transferee or assignee of any Shares.

9. Withholding. The Company reserves the right to withhold, in accordance with any applicable laws, from any consideration payable or property transferable to Optionee any taxes required to be withheld by federal, state or local law as a result of the grant or exercise of this Option or the sale or other disposition of the Shares. If the amount of any consideration payable to the Optionee is insufficient to pay such taxes or if no consideration is payable to the Optionee, upon the request of the Company, the Optionee (or such other person entitled to exercise this Option pursuant to Section 5 hereof) will pay to the Company an amount sufficient for the Company to satisfy any federal, state or local tax withholding requirements applicable to and as a condition to the grant or exercise of this Option or the sale or other disposition of the Shares issued upon the exercise of this Option.

10. The Plan. The Optionee has received a copy of the Plan (a copy of which is attached hereto), has read the Plan and is familiar with its terms, and hereby accepts the Option subject to all of the terms and provisions of the Plan, as amended from time to time. Pursuant to the Plan, the Board or its Committee is authorized to interpret the Plan and to adopt rules and

 

-4-


regulations not inconsistent with the Plan as it deems appropriate. The Optionee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Board or its Committee upon any questions arising under the Plan.

11. Spousal Consent. As a condition to the effectiveness of the grant of the Option, the Optionee’s spouse (if any) is required to execute the attached “Consent of Spouse.”

12. Governing Law. This Award Agreement will be construed in accordance with the laws of the Commonwealth of Pennsylvania, without regard to the application of the principles of conflicts of laws.

13. Amendment. Subject to the provisions of the Plan, this Award Agreement may be amended at any time by the Company or its delegate; provided, however, that any modification or amendment of this Award Agreement which adversely affects the Optionee shall require the written consent of the Optionee.

14. Entire Agreement. This Award Agreement, together with the Plan and the other exhibits attached thereto or hereto, represents the entire agreement between the parties hereto relating to the subject matter hereof, and merges and supersedes all prior and contemporaneous discussions, agreements and understandings of every nature relating to the award of Options to Optionee by the Company.

[Signature page follows]

 

-5-


IN WITNESS WHEREOF, this Award Agreement has been executed by the parties on the [ ].

 

FIVE BELOW, INC.

By:

 

 

Name:

 

 

Title:

 

 

[ ]

 

 

Signature

 

Address

 

THIS OPTION AND THE SECURITIES WHICH MAY BE PURCHASED UPON EXERCISE OF THIS OPTION HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS. THESE SECURITIES HAVE NOT BEEN ACQUIRED WITH A VIEW TO DISTRIBUTION OR RESALE, AND MAY NOT BE SOLD, ASSIGNED, EXCHANGED, MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR DISPOSED OF, BY GIFT OR OTHERWISE, OR IN ANY WAY ENCUMBERED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS, OR A SATISFACTORY OPINION OF COUNSEL SATISFACTORY TO FIVE BELOW, INC. THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT AND UNDER APPLICABLE STATE SECURITIES LAWS.

 

-6-


ACKNOWLEDGMENT

The Optionee acknowledges receipt of a copy of the Plan, a copy of which is attached hereto, and represents that he or she has read and is familiar with the terms and provisions thereof and hereby accepts this Option subject to all of the terms and provisions of the Award Agreement and the Five Below, Inc. Equity Incentive Plan (the “Plan”). The Optionee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Board or the Committee upon any questions arising under the Plan.

 

Date:      

 

  
      Signature of Optionee   
     

 

  
      Name of Optionee   
     

 

  
      Address   
     

 

  
      City, State, Zip Code   

 

-7-


CONSENT OF SPOUSE

I,                     , spouse of [ ], have read the foregoing Non-Qualified Stock Option Agreement (the “ Agreement ”). I am aware by the terms of the Agreement, among other things, my spouse agrees to sell certain of his/her shares of the capital stock of the Company, including my community property or other interest therein (if any), upon certain events and that transfer of such shares is otherwise restricted. I hereby consent to such sale and to such restrictions, approve of the provisions of the Agreement, and agree that if I pre-decease my spouse, the successors of my community property or other interest (if any) in such shares will hold such shares subject to the provisions of the Agreement. In consideration of the grant of shares of FIVE BELOW, INC. as set forth in that Agreement, I hereby appoint my spouse as my attorney-in-fact with respect to the exercise of any rights under the Agreement and agree to be bound by the provisions of the Agreement insofar as I may have any rights in said Agreement or any shares issued pursuant thereto under the community property laws or similar laws relating to marital property.

 

 

S IGNATURE OF S POUSE

 

D ATE

 

-8-

Exhibit 10.11

FIVE BELOW, INC.

EQUITY INCENTIVE PLAN

NON-QUALIFIED STOCK OPTION AGREEMENT

Five Below, Inc. (the “Company”) hereby grants to [ ] (the “Optionee”) an option to purchase a total of [ ] shares of Common Stock of the Company (the “Option Shares”), at the price and on the terms set forth herein, and in all respects subject to the terms, definitions and provisions of the Five Below, Inc. Equity Incentive Plan (the “Plan”) applicable to non-qualified stock options, which terms and provisions are hereby incorporated by reference herein. Unless the context herein otherwise requires, the terms defined in the Plan shall have the same meanings when used herein.

1. Nature of the Option. This Option is intended to be a nonstatutory stock option and is not intended to be an Incentive Stock Option within the meaning of section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), or to otherwise qualify for any special tax benefits to the Optionee.

2. Date of Grant; Term of Option. This Option is granted this [ ] day of [ ],[ ], (the “Date of Grant”) and it may not be exercised later than the date that is ten (10) years after the Date of Grant, subject to earlier termination, as provided in the Plan or Section 5 hereof. For purposes of this Agreement, the term “Effective Date of Grant” shall mean [ ].

3. Option Exercise Price. The Option exercise price is $[ ] per Share.

4. Exercise of Option. This Option shall be exercisable during its term only in accordance with the terms and provisions of the Plan and this Award Agreement as follows:

(a) Right to Exercise.

(i) In General . Subject to Section 4(a)(ii) and 4(a)(iii) of this Option, the Option will vest and become exercisable according to the following schedule:

 

If the Optionee has remained an

active employee of the Company from

the Effective Date of Grant to the:

 

Then the Option will vest and

become exercisable with

respect to:

Second Anniversary of the Effective Date of Grant (the “Second Anniversary”)

  50% of the Option Shares

Ninety-first (91st) day following the Second Anniversary

  An additional 6.25% of the Option Shares

One Hundred Eighty First (181 st ) day following the Second Anniversary

  An additional 6.25% of the Option Shares

Two Hundred Seventy First (271 st ) day following the Second Anniversary

  An additional 6.25% of the Option Shares


Third Anniversary of the Effective Date of Grant (the “Third Anniversary”)

  An additional 6.25% of the Option Shares

Ninety-first (91st) day following the Third Anniversary

  An additional 6.25% of the Option Shares

One Hundred Eighty First (181 st ) day following the Third Anniversary

  An additional 6.25% of the Option Shares

Two Hundred Seventy First (271 st ) day following the Third Anniversary

  An additional 6.25% of the Option Shares

Fourth Anniversary of the Effective Date of Grant

  An additional 6.25% of the Option Shares

(ii) Accelerated Vesting on Change in Control . In the event of a Change in Control, the Option will vest and become fully exercisable with respect to all then unvested Option Shares, as of the date of such Change in Control.

(iii) Accelerated Vesting for Certain Terminations . If the Optionee ceases to be employed by the Company after the first anniversary of the Effective Date of Grant and prior to the Second Anniversary as a result of: (i) his or her Disability, (ii) his or her death or (iii) a termination by the Company without Cause, then the Option will vest and become exercisable with respect to twenty five percent (25%) of the Option Shares and will remain exercisable for the applicable time period provided in Section 5.

(b) Method of Exercise. The Optionee may exercise this Option by providing written notice stating the election to exercise this Option. Such written notice must be signed by the Optionee and must be delivered in person or by certified mail to the Secretary of the Company or such other person as may be designated by the Company. The written notice must be accompanied by payment of the option exercise price in the manner described in Section 4(c), by an executed Stock Restriction Agreement described in Section 4(f) and by any other agreements required by the Board or its Committee and/or the terms of the Plan, which other agreements may restrict the sale or other transfer of the Shares and may include certain additional representations and agreements as to the Optionee’s investment intent with respect to the Shares. This Option will be deemed to be exercised only upon the receipt by the Company of such written notice, payment of the option exercise price, and duly executed copies of the Stock Restriction Agreement and any other agreements required by the Board or its Committee, the terms of the Plan and/or this Award Agreement. The Optionee will have no right to vote or receive dividends and will have no other rights as a stockholder with respect to such Shares notwithstanding the exercise of this Option, until the issuance (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) of the stock certificate(s) evidencing Shares that are being issued upon exercise of this Option. The certificate(s) for the Shares will be registered in the name of the Optionee and will contain any legend as may be required under the Plan, this Award Agreement, and/or applicable law.

(c) Method of Payment . The method of payment of the option exercise price will be determined by the Board or its Committee and may consist entirely of cash, certified check, or such other consideration or method of payment as may be authorized under the Plan.

 

-2-


(d) Partial Exercise . This Option may be exercised in whole or in part; provided , however , that any exercise may apply only with respect to a whole number of Shares.

(e) Restrictions on Exercise . This Option may not be exercised if the issuance of these Shares upon such exercise would constitute a violation of any applicable federal or state securities laws or other laws or regulations. In addition, as a further condition to the exercise of this Option, the Company may require the Optionee to make any representation or warranty to the Company as may be required by or advisable under any applicable law or regulation.

(f) Stock Restriction Agreement. In connection with and as a condition of exercising this Option, Optionee hereby acknowledges and agrees to execute a Stock Restriction Agreement (or other agreement restricting Optionee’s rights in the Shares acquired or to be acquired by the exercise of this Option) by and between Optionee, the Company and/or one or more other holders of equity securities of the Company in the form that the Company provides at the time of exercise and as may be amended by the Company in its sole discretion from time to time.

5. Termination of Relationship with the Company.

(a) Voluntary Termination. If the Optionee terminates his or her employment with the Company for any reason other than death or Disability, the Option (to the extent exercisable at the time of such termination) may be exercised at any time within ninety (90) days after the date of such termination. To the extent that the Option is not exercisable at the time of such termination, or to the extent the Option is not exercised within the time specified herein, the Option shall terminate.

(b) Disability. If the Optionee’s employment by the Company terminates due to Disability, the Option (to the extent exercisable at the time of such termination) may be exercised by the Optionee or his or her legal guardian or representative at any time within twelve (12) months after such termination. To the extent that the Option is not exercisable on the date of termination, or to the extent the Option is not exercised within the time specified herein, the Option shall terminate.

(c) Death. If the Optionee’s employment by the Company terminates due to his or her death, the Option (to the extent exercisable at the time of such death) will remain exercisable for twelve (12) months after the date of death by the Optionee’s estate or by a person who acquired the right to exercise the Option by bequest or inheritance. To the extent that the Option is not exercisable on the date of death, or to the extent the Option is not exercised within the time specified herein, the Option shall terminate.

(d) Termination Without Cause. If the Company terminates Optionee’s employment with the Company without Cause, the Option (to the extent exercisable at the time of such termination) may be exercised at any time within ninety (90) days after the date of such termination. To the extent that the Option is not exercisable at the time of such termination, or to the extent the Option is not exercised within the time specified herein, the Option shall terminate.

 

-3-


(e) Termination for Cause. If the Company terminates Optionee’s employment with the Company for Cause, the Option will then terminate immediately and automatically, and the Optionee shall have no further rights therein.

Notwithstanding any other provision of this Section 5, the Option shall not be exercisable after the expiration of the term set forth in Section 2 hereof.

6. Non-Transferability of Option. This Option may not be sold, pledged, assigned, hypothecated, gifted, transferred or disposed of in any manner either voluntarily or involuntarily by operation of law, other than by will or by the laws of descent or distribution. During the Optionee’s lifetime, this Option is exercisable only by the Optionee (or by such Optionee’s legal guardian or representative as provided in Section 5). Subject to the foregoing and the terms of the Plan, the terms of this Option will be binding upon the executors, administrators, legal guardians, representatives and heirs of the Optionee, meaning for purposes of this Award Agreement, both testamentary heirs and heirs by intestacy.

7. No Continuation of Employment or Engagement. Neither the Plan nor this Option shall confer upon any Optionee any right to continue in the service of the Company or any of its Subsidiaries or limit, in any respect, the right of the Company to discharge the Optionee at any time, with or without Cause and with or without notice.

8. Lock-Up Agreement. Each Optionee hereby agrees that, in connection with any registration of the offering of any securities of the Company under the Securities Act of 1933, as amended (the “Securities Act”) for the account of the Company, if so requested by the Company, such Optionee shall not sell or otherwise transfer any securities of the Company during the period specified by the Board of Directors (the “Market Standoff Period”), with such period not to exceed 180 days following the effective date of a registration statement of the Company filed under the Securities Act. The Company may impose stop-transfer instructions with respect to securities subject to the foregoing restrictions until the end of such Market Standoff Period. The provisions of this Section 8 shall be binding upon any transferee or assignee of any Shares.

9. Withholding. The Company reserves the right to withhold, in accordance with any applicable laws, from any consideration payable or property transferable to Optionee any taxes required to be withheld by federal, state or local law as a result of the grant or exercise of this Option or the sale or other disposition of the Shares. If the amount of any consideration payable to the Optionee is insufficient to pay such taxes or if no consideration is payable to the Optionee, upon the request of the Company, the Optionee (or such other person entitled to exercise this Option pursuant to Section 5 hereof) will pay to the Company an amount sufficient for the Company to satisfy any federal, state or local tax withholding requirements applicable to and as a condition to the grant or exercise of this Option or the sale or other disposition of the Shares issued upon the exercise of this Option.

10. The Plan. The Optionee has received a copy of the Plan (a copy of which is attached hereto), has read the Plan and is familiar with its terms, and hereby accepts the Option subject to all of the terms and provisions of the Plan, as amended from time to time. Pursuant to the Plan, the Board or its Committee is authorized to interpret the Plan and to adopt rules and

 

-4-


regulations not inconsistent with the Plan as it deems appropriate. The Optionee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Board or its Committee upon any questions arising under the Plan.

11. Spousal Consent. As a condition to the effectiveness of the grant of the Option, the Grantee’s spouse (if any) is required to execute the attached “Consent of Spouse.”

12. Governing Law. This Award Agreement will be construed in accordance with the laws of the Commonwealth of Pennsylvania, without regard to the application of the principles of conflicts of laws.

13. Amendment. Subject to the provisions of the Plan, this Award Agreement may be amended at any time by the Company or its delegate; provided, however, that any modification or amendment of this Award Agreement which adversely affects the Optionee shall require the written consent of the Optionee.

14. Entire Agreement. This Award Agreement, together with the Plan and the other exhibits attached thereto or hereto, represents the entire agreement between the parties hereto relating to the subject matter hereof, and merges and supersedes all prior and contemporaneous discussions, agreements and understandings of every nature relating to the award of Options to Optionee by the Company.

[Signature page follows]

 

-5-


IN WITNESS WHEREOF, this Award Agreement has been executed by the parties on the     day of             ,         .

 

FIVE BELOW, INC.

By:

 

 

Name:

 

 

Title:

 

 

[ ]

 

 

Signature

 

Address

 

THIS OPTION AND THE SECURITIES WHICH MAY BE PURCHASED UPON EXERCISE OF THIS OPTION HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS. THESE SECURITIES HAVE NOT BEEN ACQUIRED WITH A VIEW TO DISTRIBUTION OR RESALE, AND MAY NOT BE SOLD, ASSIGNED, EXCHANGED, MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR DISPOSED OF, BY GIFT OR OTHERWISE, OR IN ANY WAY ENCUMBERED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS, OR A SATISFACTORY OPINION OF COUNSEL SATISFACTORY TO FIVE BELOW, INC. THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT AND UNDER APPLICABLE STATE SECURITIES LAWS.

 

-6-


ACKNOWLEDGMENT

The Optionee acknowledges receipt of a copy of the Plan, a copy of which is attached hereto, and represents that he or she has read and is familiar with the terms and provisions thereof and hereby accepts this Option subject to all of the terms and provisions of the Award Agreement and the Five Below, Inc. Equity Incentive Plan (the “Plan”). The Optionee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Board or the Committee upon any questions arising under the Plan.

 

Date:

      

 

  
       Signature of Optionee   
      

 

  
       Name of Optionee   
      

 

  
       Address   
      

 

  
       City, State, Zip Code   

 

-7-


CONSENT OF SPOUSE

I,                     , spouse of [ ], have read the foregoing Non-Qualified Stock Option Agreement (the “ Agreement ”). I am aware by the terms of the Agreement, among other things, my spouse agrees to sell certain of his/her shares of the capital stock of the Company, including my community property or other interest therein (if any), upon certain events and that transfer of such shares is otherwise restricted. I hereby consent to such sale and to such restrictions, approve of the provisions of the Agreement, and agree that if I pre-decease my spouse, the successors of my community property or other interest (if any) in such shares will hold such shares subject to the provisions of the Agreement. In consideration of the grant of shares of FIVE BELOW, INC. as set forth in that Agreement, I hereby appoint my spouse as my attorney-in-fact with respect to the exercise of any rights under the Agreement and agree to be bound by the provisions of the Agreement insofar as I may have any rights in said Agreement or any shares issued pursuant thereto under the community property laws or similar laws relating to marital property.

 

 

S IGNATURE OF S POUSE

 

D ATE

 

-8-

Exhibit 10.12

A WARD A GREEMENT FOR R ESTRICTED S HARES

UNDER THE

F IVE B ELOW , I NC . E QUITY I NCENTIVE P LAN

THIS AWARD AGREEMENT FOR RESTRICTED SHARES (this “ Agreement ”) is made between Five Below, Inc. (the “ Company ”) and [ insert name ] (the “ Grantee ”).

WHEREAS, the Grantee previously entered into one or more Non-Qualified Stock Option Agreements (copies of which are attached as Exhibit A and collectively, the “ Option Agreements ”) under the Five Below, Inc. Equity Incentive Plan (the “ Plan ”) pursuant to which the Grantee was awarded a stock option to purchase a number of shares of the Company’s common stock (the “ Common Stock ”); and

WHEREAS, pursuant to (a) the Company’s Notice and Information Statement for Option Holders, dated September 10, 2010 (“ Information Statement ”), and (b) the terms of the Option Agreements, as amended by the exercise notice executed by the Grantee effective as of the record date (as such term is described in such exercise notice) (which notice is incorporated by reference herein, the “ Exercise Notice ”), the Grantee is permitted to exercise the unvested portion of his or her stock options to purchase the restricted shares of Common Stock subject to the Option Agreements, provided the Grantee enters into this Agreement with the Company.

NOW, THEREFORE, in consideration of these premises and the agreements set forth herein, the parties, intending to be legally bound hereby, agree as follows:

1. Purchase of Stock . Effective on the record date declared by the Board as stated in the Information Statement (the “ Effective Date ”), pursuant to the Plan, the Option Agreements and the Exercise Notice, in exchange for an immediate, single sum cash payment equal to the Purchase Price set forth on Schedule I to this Agreement, the Company hereby sells the Grantee the number of Shares set forth on Schedule I to this Agreement (the “ Restricted Shares ”), subject to the restrictions and on the terms and conditions set forth in this Agreement and the Plan. The terms of the Plan are hereby incorporated into this Agreement by this reference, as though fully set forth herein. Capitalized terms used but not defined herein will have the same meaning as defined in the Plan.

2. Vesting of Restricted Shares .

(a) Vesting Schedule; Repurchase . The Restricted Shares continue to be subject to the vesting conditions set forth in the applicable Option Agreements. Such vesting conditions are set forth on Schedule I hereof. While unvested, the Restricted Shares are subject to repurchase by the Company pursuant to Section 2(b) below.

(b) All Unvested Shares Subject To Repurchase Upon Cessation of Employment . Except as otherwise provided on Schedule I , upon cessation of Grantee’s employment with the Company for any reason or for no reason (and whether such cessation is initiated by the Company, the Grantee or otherwise), any Restricted Shares that have not, prior to the effective date of such cessation, become vested will be subject to repurchase by the Company for a purchase price equal to the lesser of (A) a pro-rata portion of the Purchase Price attributable to those unvested Restricted Shares and (B) the Fair Market Value of those unvested Restricted Shares as of the date of such cessation of employment. The Company shall exercise its right to repurchase unvested Restricted Shares by providing written notice to the Grantee at any time during the ninety (90) day period following the effective date of Grantee’s cessation of employment with the Company. In the event the Board determines in good faith that the Company does not have sufficient proceeds to exercise its repurchase right of the unvested Restricted Shares as described herein, then the Company may assign its right to repurchase such unvested Restricted Shares to any third party identified by the Board, in its sole discretion, including any Investor, as that term is defined in the Shareholders Agreement (as defined below).


3. Escrow of Shares.

(a) The Company will cause the Restricted Shares to be issued in the Grantee’s name either by book-entry registration or issuance of a stock certificate or certificates.

(b) While the Restricted Shares remain subject to repurchase by the Company pursuant to Section 2(b) above, the Company will cause an appropriate stop-transfer order to be issued and to remain in effect with respect to the Restricted Shares. As soon as practicable following the time that any Restricted Share becomes vested (and provided that appropriate arrangements have been made with the Company for the withholding or payment of any taxes that may be due with respect to such Share), the Company will cause that stop-transfer order to be removed. The Company may also condition delivery of certificates for Restricted Shares upon receipt from the Grantee of any undertakings that it may determine are appropriate to facilitate compliance with federal and state securities laws.

(c) If any certificate is issued in respect of Restricted Shares, that certificate will be legended as described herein and held in escrow by the Company’s secretary or his or her designee. In addition, the Grantee may be required to execute and deliver to the Company a stock power with respect to those Restricted Shares. At such time as those Restricted Shares become vested, the Company will cause a new certificate to be issued without that portion of the legend referencing the previously applicable vesting conditions and will cause that new certificate to be delivered to the Grantee (again, provided that appropriate arrangements have been made with the Grantee for the withholding or payment of any taxes that may be due with respect to such Shares).

4. Stock Splits, etc . If, while any of the Restricted Shares remain subject to repurchase pursuant to Section 2(b) above, any of the events set forth in Section 3(c) of the Plan occurs, then any and all new, substituted or additional securities or other consideration to which the Grantee is entitled by reason of the Grantee’s ownership of the Restricted Shares pursuant to the adjustment provisions of the Plan will be immediately subject to the escrow contemplated by Section 3 , deposited with the escrow holder and will thereafter be included in the term “ Restricted Shares ” for all purposes of the Plan and this Agreement.

5. Rights of Grantee . The Grantee shall have the right to vote the Restricted Shares and to receive cash dividends or distributions with respect to the Restricted Shares.

6. Tax Consequences . The Grantee acknowledges that the Company has not advised the Grantee regarding the Grantee’s income tax liability in connection with the exercise of stock options, the vesting of the Restricted Shares or an election filed under Section 83(b) of the Code. The Grantee has reviewed with the Grantee’s own tax advisors the federal, state, local and foreign tax consequences of the transactions contemplated by this Agreement. The Grantee is relying solely on such advisors and not on any statements or representations of the Company or any of its agents. The Grantee understands that the Grantee (and not the Company) shall be responsible for the Grantee’s own tax liability that may arise as a result of the transactions contemplated by this Agreement. The Grantee has been advised by the Company that he or she is required to file an election under Section 83(b) of the Code in connection with the purchase of the Restricted Shares.

 

-2-


7. Additional Documents . As a condition to the effectiveness of the purchase of Restricted Shares hereunder:

(a) the Grantee is required to file timely an election under Section 83(b) of the Code, as amended, with respect to the purchase of the Restricted Shares (a form of Section 83(b) election is attached as Exhibit B );

(b) the Grantee is required to execute the “Adoption Agreement to the Second Amended and Restated Shareholders Agreement” attached as Exhibit C and thereby will become a party to, and become bound by all the terms and conditions of, the Second Amended and Restated Shareholders Agreement dated September 1, 2010 by and among the Company and its shareholders (the “ Shareholders Agreement ”); and

(c) the Grantee agrees upon request to execute any further documents or instruments necessary or desirable to carry out the purposes or intent of this Agreement.

8. Restriction on Transfer of Restricted Shares . Except for the escrow described in Section 3 hereof or the repurchase by the Company contemplated by Section 2(b) hereof, none of the Restricted Shares or any beneficial interest therein shall be transferred, encumbered, pledged or otherwise alienated or disposed of in any way until they have become vested in accordance with Section 2 of this Agreement. Even after any of the Restricted Shares become transferable pursuant to this Agreement, they will remain subject to the transfer restrictions set forth in the Shareholders Agreement.

9. Lock-Up Agreement . The Grantee hereby agrees that in connection with any registration of the offering of any securities of the Company under the Securities of 1933, as amended (the “ Securities Act ”) for the account of the Company, if so requested by the Company, such Grantee shall not sell or otherwise transfer any securities of the Company during the period specified by the Board (the “ Market Standoff Period ”), with such period not to exceed 180 days following the effective date of a registration statement of the Company filed under the Securities Act. The Company may impose stop-transfer instructions with respect to securities subject to the foregoing restrictions until the end or such Market Standoff Period. The provisions of this Section 9 shall be binding upon any transferee or assignee of any Shares and may be modified by the Company in accordance with the Shareholders Agreement.

10. Share Legends . All stock certificates representing the Shares shall have affixed thereto legends substantially in the following form (as may be modified by the Company in accordance with the Shareholders Agreement), in addition to any other legends required by applicable state law:

THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AS AMENDED, (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE TRANSFERRED WITHOUT REGISTRATION UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL, SATISFACTORY TO FIVE BELOW, INC., THAT SUCH REGISTRATION IS NOT REQUIRED. THE SHARES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, ENCUMBERED, OR IN ANY MANNER DISPOSED OF EXCEPT IN CONFORMITY WITH THE TERMS OF THE SECOND AMENDED AND RESTATED SHAREHOLDERS AGREEMENT DATED SEPTEMBER 1, 2010, BETWEEN FIVE BELOW, INC. AND THE REGISTERED HOLDER OF THE SHARES (OR THE PREDECESSOR IN INTEREST TO THE SHARES), A COPY OF WHICH IS AVAILABLE AT THE PRINCIPAL OFFICES OF FIVE BELOW, INC. SUCH AGREEMENT GRANTS CERTAIN RIGHTS TO FIVE BELOW, INC. (OR ITS ASSIGNEES) UPON THE SALE, ASSIGNMENT, TRANSFER, ENCUMBRANCE OR OTHER DISPOSITION OF FIVE BELOW, INC.’S SHARES. FIVE BELOW, INC. WILL UPON WRITTEN REQUEST FURNISH A COPY OF SUCH AGREEMENT TO THE HOLDER HEREOF WITHOUT CHARGE.

11. Withholding . By executing this Agreement, the Grantee acknowledges and agrees that the Company may withhold, in accordance with any applicable laws, from any consideration payable or

 

-3-


property transferable to the Grantee by the Company or any of its Affiliates any taxes required to be withheld by federal, state or local law as a result of the purchase or vesting of the Restricted Shares or as a result of the election made by the Grantee pursuant to Section 83(b) of the Code. If the amount of any consideration payable to the Grantee is insufficient to pay such taxes or if no consideration is payable to the Grantee, upon the request of the Company, the Grantee will pay to the Company an amount sufficient for the Company to satisfy any federal, state or local tax withholding requirements.

12. The Plan . The Grantee has received a copy of the Plan, has read the Plan and is familiar with its terms, and hereby accepts the Restricted Shares subject to all of the terms and provisions of the Plan, as amended from time to time. Pursuant to the Plan, the Board or its Committee is authorized to interpret the Plan and to adopt rules and regulations not inconsistent with the Plan as it deems appropriate. The Grantee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Board or its Committee upon any questions arising under the Plan.

13. Representations and Warranties . By executing this Agreement, the Grantee hereby represents, warrants, covenants, acknowledges and/or agrees that:

(a) The Restricted Shares are being acquired for the Grantee’s own account, for investment purposes only, and not for the account of any other person, and not with a view to the distribution thereof within the meaning of the Securities Act;

(b) No other person (other than the Grantee and the Company) has or will have a direct or indirect beneficial interest in the Restricted Shares;

(c) The Restricted Shares have not been registered or qualified under the Securities Act or any state securities laws;

(d) There is no public market for the Restricted Shares, there can be no assurance that any such market will ever develop and, therefore, the Grantee may be required to hold the Restricted Shares indefinitely;

(e) In addition to complying with other similar restrictions contained herein, the Grantee will not sell, transfer, pledge, hypothecate or otherwise dispose of any interest in the Restricted Shares unless such interest is registered in accordance with the Securities Act and applicable state securities laws or an exemption from such registration is available and, if required by the Company, an opinion of counsel is delivered to the Company, in a form satisfactory to the Company, that such registration is unnecessary; and

(f) The Company is under no obligation to register the Restricted Shares on behalf of the Grantee or to assist the Grantee in complying with any exemption from registration.

14. General Provisions :

(a) This Agreement, together with the Plan, the Exercise Notice and the Shareholders Agreement, represent the entire agreement between the parties with respect to the purchase of the Restricted Shares and may only be modified or amended in a writing signed by both parties.

(b) Neither this Agreement nor any rights or interest hereunder shall be assignable by the Grantee, his beneficiaries or legal representatives, and any purported assignment in violation hereof shall be null and void.

(c) Either party’s failure to enforce any provision or provisions of this Agreement shall not in any way be construed as a waiver of any such provision or provisions, nor prevent that party

 

-4-


thereafter from enforcing each and every other provision of this Agreement. The rights granted both parties herein are cumulative and shall not constitute a waiver of either party’s right to assert all other legal remedies available to it under the circumstances.

(d) The grant of Restricted Shares hereunder will not confer upon the Grantee any right to continue in service with the Company or any of its subsidiaries or affiliates.

(e) This Agreement and all claims or causes of action (whether in contract or tort) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance of this Agreement (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with this Agreement or as an inducement to enter this Agreement) shall be governed by, and enforced in accordance with, the laws of the Commonwealth of Pennsylvania, without regard to the application of the principles of conflicts of laws.

(f) This Agreement may be executed, including execution by facsimile signature, in one or more counterparts, each of which shall be deemed an original, and all of which together shall be deemed to be one and the same instrument.

[signature page follows]

 

-5-


IN WITNESS WHEREOF, the parties have duly executed this Award Agreement for Restricted Shares on the      day of             , 2010.

 

FIVE BELOW, INC.
By:  

 

Name:  
Title:  

 

[INSERT NAME OF GRANTEE]

 

-6-


SCHEDULE I

SCHEDULE OF RESTRICTED SHARES AND VESTING SCHEDULE

Attached

 

-7-


Exhibit A

OPTION AGREEMENTS

Attached

 

A-1


Exhibit B

SECTION 83(b) TAX ELECTION

This statement is being made under Section 83(b) of the Internal Revenue Code, pursuant to Treasury Regulation Section 1.83-2.

(1) The taxpayer who performed the services is:

 

  Name:    [Insert Grantee’s name]
  Address:    [insert Grantee’s address line 1]
     [insert Grantee’s address line 2]
  Taxpayer ID No.:    [insert grantee’s SSN]

(2) The property with respect to which the election is being made is [ insert # of shares ] shares (the “ Restricted Shares ”) of the common stock of Five Below, Inc. (the “ Company ”).

(3) The property was transferred on             , 2010.

(4) The taxable year in which the election is being made is the calendar year 2010.

(5) The shares will become vested as set forth in the attached Schedule I .

(6) The fair market value at the time of transfer (determined without regard to any restriction other than a restriction which by its terms will never lapse) is $6.67 per share.

(7) The taxpayer paid the amounts set forth as “Purchase Price” in the attached Schedule I .

(8) A copy of this statement with Schedule I was promptly furnished to the entity for whom the taxpayer rendered the services underlying the transfer of property.

(9) This statement is executed on the     day of             , 2010.

 

By:       , Taxpayer

This form and its Schedule I must be filed with the Internal Revenue Service Center with which taxpayer files his/her Federal income tax returns within 30 days the transfer of the above-described property.

 

B-1


Exhibit C

[Adoption Agreement to Second Amended and Restated Shareholders Agreement]

 

C-1

Exhibit 10.17

Five Below, Inc.

1616 Walnut Street, Suite 400

Philadelphia, PA 19103

October 14, 2010

Personal and Confidential

David Schlessinger

Five Below, Inc.

1616 Walnut Street, Suite 400

Philadelphia, PA 19103

Re: Continuing Employment Terms

Dear David:

Reference is made to that certain letter agreement dated January 18, 2010 between you and Five Below, Inc. (the “Company”) regarding your continuing employment terms (the “2010 Letter Agreement”, which letter was an amendment and restatement of your prior letter agreement dated April 20, 2005). In connection with the Investment Agreement, dated as of September 1, 2010, (the “Investment Agreement”) by and among the Company and certain parties thereto, including the “Purchasers” (as such term is defined in the Investment Agreement), you and the Purchasers have agreed to a term sheet, dated September 1, 2010, (the “Term Sheet”), which sets forth the terms and conditions of your continued employment with the Company following consummation of the transaction contemplated by the Investment Agreement. This letter agreement memorializes the terms and conditions agreed to in the Term Sheet and shall become effective upon consummation of the transaction contemplated by the Investment Agreement (the “Effective Date”) and shall supersede and replace in its entirety the 2010 Letter Agreement. The terms and conditions of your continued employment with the Company following the Effective Date shall be as follows:

 

POSITION:    Executive Chairman.
COMPENSATION:    You will be paid an annual base salary of $400,000, payable in accordance with the Company’s regular payroll practices, which annual base salary will be subject to annual review for increase by the Company’s Board of Directors (the “Board of Directors”) or the Compensation Committee of the Board of Directors (the “Compensation Committee”). The Compensation Committee may, in its sole discretion, approve payment of bonuses to you.
EQUITY:    On the Effective Date, the Company Equity Incentive Plan (the “Equity Plan”) shall provide for an initial pool for which common shares of the Company may be issued equal to 7% of the fully diluted, as converted common shares of the Company, available at Closing (as defined in the Investment Agreement), as calculated pursuant to the Investment Agreement, with 3% of the fully diluted, as converted common shares of the Company, available at Closing, as calculated pursuant to the


   Investment Agreement, held back for post-closing grants for the existing management team and new hires to be granted in the discretion of the Board of Directors.
   You will be granted, on the Effective Date, an option to purchase 2% of the fully diluted, as converted common shares of the Company, available at Closing, as calculated pursuant to the Investment Agreement, under the Equity Plan, with terms and conditions set forth in the Non-Qualified Stock Option Agreement attached hereto as Exhibit B .
   To the extent (i) you are terminated without “Cause” (as defined below) or you terminate your employment for “Good Reason” (as defined below), but excluding a termination of your employment due to your death or disability, and (ii) the Company has greater than $35.0m of EBITDA (A) in the fiscal year immediately preceding your termination of employment or (B) in the last twelve consecutive months immediately preceding the month during which your termination of employment occurs, you shall have, within sixty days following your termination of employment, the right to cause the Company to purchase, and the Company shall purchase, your “Rollover Shares” (as defined below) at a price per share equal to the per share fair market value at termination (as such fair market value is determined in good faith by the Board of Directors); provided, however, that if such valuation was not determined by an independent valuation firm and you object to the valuation determination of the Board of Directors, within ten days of such determination you may request in writing, and the Board of Directors shall retain, a valuation by an independent valuation firm selected by a majority of the Board of Directors, and such independent valuation firm shall determine the fair market value of the Rollover Shares, which determination shall be final and binding upon you, the Company and all interested persons for the purpose of this paragraph. Your put right shall expire upon an initial public offering of the Company’s common stock (an “IPO”). “Rollover Shares” shall mean the shares of common stock of the Company owned by you on the Effective Date, but does not include any of the shares of common stock of the Company acquired by you after the Effective Date, either by exercise of your options or otherwise.
BENEFITS:    You will be entitled to continue to receive the benefits which you currently enjoy, and you will participate in the most favorable health and welfare plans and tax qualified retirement plans available to other employees of the Company, subject to the terms of those plans.
SEVERANCE:    If the Company terminates your employment without “Cause”, or if you resign your employment with “Good Reason,” you will be entitled to:
  

*

   payment of an amount equal to the greater of: (a) $400,000 (or $800,000 if any such event occurs after a “Change of Control Transaction”, as such term is defined below) or (b) the greater of (i) your annual base salary on the date of such termination or (ii) except to the

 

2


      extent a reduction of annual base salary was approved by you in writing, such higher annual base salary that was in effect prior to your termination of employment, for 12 months following such termination (24 months if any such event occurs after a “Change of Control Transaction”), in each case, payable in accordance with the Company’s regular payroll practices and commencing on the first payroll date of the Company following the thirtieth (30th) day of the termination of your employment (the “First Payroll Date”). The portion of the severance pay that would have been paid to you during the period between the termination of your employment and the First Payroll Date had no thirty-day delay been required will be paid to you in a lump sum on the First Payroll Date and thereafter the remaining portion of the severance pay will be paid without delay as provided in this paragraph; and
  

*

   (a) monthly payments equal to the applicable monthly premium for COBRA continuation coverage for so long as you are receiving such continuation coverage up to 18 months after such termination, commencing on the First Payroll Date; provided that the portion of the COBRA premiums paid by you during the period between the termination of your employment and the First Payroll Date, if any, had no thirty-day delay been required will be paid to you in a lump sum on the First Payroll Date; provided, further, that each monthly payment paid to you pursuant to this clause (a) shall be grossed up for Federal, state and local ordinary income taxes and payroll taxes imposed as a result of such payments (but not additional taxes imposed under the Internal Revenue Code of 1986, as amended (the “Code”)), and (b) if you remain on COBRA coverage for the entire 18-month period, the Company will make additional monthly payments to you for the 6-month period immediately following the expiration of the 18-month COBRA period equal to the amount of premiums that you would have paid had you been eligible for continued coverage under COBRA. The monthly payments described in clauses (a) (including the gross-up payment) and (b) above shall be made on the Company’s first payroll date of the applicable month. Each gross-up payment shall be calculated based on the highest marginal tax rate for federal ordinary income taxes and payroll taxes and the highest marginal tax rate applicable to ordinary income for the taxing state and local jurisdiction in which you reside at the time such payroll is calculated (after giving effect to the tax benefit, if any, applicable for deductions of taxes paid to any other taxing jurisdiction).

 

3


   For this purpose:
      “Cause” means (a) conviction of (or the entry of a plea of guilty or nolo contendere to) a crime that prevents you from effectively managing the Company or that has a material, adverse effect on the reputation or business activities of the Company, (b) gross negligence, dishonesty, misappropriation of funds or other willful misconduct in the course of employment that has a material, adverse effect on the reputation or business activities of the Company, or (c) substance abuse, including abuse of alcohol or use of controlled drugs (other than in accordance with a physician’s prescription).
      “Change of Control Transaction” means a “Change in Control” as such term is defined in the Company Equity Incentive Plan (as it exists from time to time); provided, however, that (a) in no event shall the corporate transaction contemplated by the Investment Agreement be deemed a “Change of Control Transaction” for purposes of this letter agreement and (b) any change to the definition of “Change in Control” that is less favorable to you will not apply to this letter agreement without your consent.
      “Good Reason” means (a) a material, adverse change in your title, authority, responsibilities or duties, (b) a reduction or other material adverse change in your base salary or benefits, (c) a requirement that you report to anyone other than the Board of Directors, (d) a relocation of your principal offices by more than 25 miles, or (e) any other Company willful action or inaction that constitutes a material breach by the Company of this letter agreement; provided, that, no event described in this paragraph shall constitute “Good Reason” unless (i) you provide written notice of the event within the 60-day period following the occurrence of such Good Reason event, and (ii) the Company has not cured such event within 30 days of receipt of such notice. For the avoidance of doubt, Good Reason shall not exist hereunder unless and until the thirty-day cure period following receipt by the Company of your written notice expires and the Company shall not have cured such circumstances, and in such case your employment shall terminate for Good Reason if you provide notice to the Company within 15 days following the expiration of such thirty-day cure period that you wish to resign on account of “Good Reason,” and your termination date shall become effective on the first business day following the end of your 15 day notice period.

 

4


   Notwithstanding the foregoing, all severance benefits will be contingent upon your execution of a fully effective and non-revocable general release of claims against the Company and its affiliates, in substantially the form attached hereto as Exhibit A , within 30 days following the termination of your employment, which release will be provided to you within five days of the termination of your employment.
SECTION 280G   
OF THE CODE    To the extent the common stock of the Company is not publicly traded on the relevant date, if any payment or benefit you would receive pursuant to a contemplated Change of Control Transaction would constitute a “parachute payment” within the meaning of Section 280G of the Code, and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code, the Company shall use commercially reasonable efforts to seek to obtain the approval of the shareholders of the Company of any such “excess parachute payments” in a manner intended to be compliant with the provisions of Sections 280G(b)(5)(A)(ii) and 280G(b)(5)(B) of the Code. To the extent that you are already entitled to any such payment or benefit, the foregoing shall apply to the extent you waive and forfeit your right to such payment or benefit.
NONCOMPETE/   
NONSOLICITATION:    In consideration for entering into this letter agreement, including, without limitation, the compensation to be paid to you hereunder, you agree that during your employment by the Company and (i) for the applicable period following termination during which you are eligible to receive salary continuation if your employment is terminated without Cause, or if you resign your employment with Good Reason, or (ii) for the 18-month period from the date of the termination of your employment with the Company for any other or for no reason, you will not, either directly or indirectly, on your own behalf or in the service of, together with or on behalf of any other person; (a) own, manage, engage in, operate, control, work for, consult with, render services for, do business with, maintain any interest in (proprietary, financial or otherwise) or participate in the ownership, management, operation or control of, any business, whether in corporate, proprietorship or partnership form or otherwise, that sells at retail products (1) predominantly to children, teens and pre-teens, (2) that are the same as or substantially similar to products that are sold or are planned to be sold by the Company during the period in which you are employed by the Company and (3) at fixed price points of $10.00 or less anywhere in the United States or in any other country in which the Company sells or plans to sell such products at such fixed price points during the period in which you are employed by the Company (a “Competitive Business”); provided, however, that the restrictions contained in this clause (a) shall not restrict the acquisition by you, directly or indirectly, of less than 2% of the outstanding capital stock of any publicly traded company engaged in a Competitive Business; or (b) solicit, recruit or attempt to solicit or recruit any employee of the Company; or (c) hire or attempt to hire any

 

5


   employee of the Company; provided, however that: (A) in the event that you terminate your employment with the Company for any reason other than on account of Good Reason, the restrictions in clause (c) shall terminate on the date that is 18 months from the date of such termination and (B) in the event that your employment is terminated by the Company for any or no reason or by you for Good Reason, the restrictions in clause (c) shall terminate on the date that is one (1) year from the date of such termination. Notwithstanding the foregoing the restrictions in each of clause (b) and clause (c) of the preceding sentence shall terminate upon the earlier of the completion of (x) an IPO or (y) a Change of Control Transaction. For purposes of this letter agreement, “planned to be sold” or “plans to sell” refers only to written plans that have been approved by the Board of Directors on or before the date of the termination of your employment with the Company.
   You acknowledge that the restrictions in the immediately preceding paragraph (the “Restrictive Covenants”) are reasonable and necessary to protect the legitimate interests of the Company and its affiliates and that the duration and geographic scope of the Restrictive Covenants are reasonable given the nature of this letter agreement and the position you will hold within the Company. You further acknowledge that the Restrictive Covenants contained herein are distinct and separate from any restrictive covenants contained in the Investment Agreement. You further acknowledge that the Restrictive Covenants are included herein in order to induce the Company to enter into this letter agreement and that the Company would not have entered into this letter agreement in the absence of the Restrictive Covenants.
   If any court determines that any of the Restrictive Covenants or any part thereof, is unenforceable because of the duration or geographic scope of such provision, such court shall have the power to modify such provision and, in its modified form, such provision shall then be enforceable.
NONDISCLOSURE:    All information about the Company and its business furnished by the Company or on the Company’s behalf to you, or otherwise obtained by you in connection with your employment with the Company, is referred to in this letter agreement as “Proprietary Information.” For purposes of this letter agreement, Proprietary Information: (i) shall include all documents which are prepared by you, including all correspondence, memoranda, notes, summaries, analyses, studies, models, extracts of and documents and records reflecting, based on or derived from Proprietary Information as well as all copies and other reproductions thereof, whether in writing or stored or maintained in or by electronic, magnetic or other means, media or devices; and (ii) shall not include information which is or becomes generally available to the public other than as a result of a disclosure by you. Unless otherwise agreed to in writing by the Company, you agree that you will keep all Proprietary Information confidential and not disclose or reveal any Proprietary Information to any person. You agree that you will, upon the Company’s request, promptly deliver to the Company all Proprietary Information in your possession or control.

 

6


SPECIFIC   
ENFORCEMENT:    You acknowledge that any breach by you, willfully or otherwise, of the Restrictive Covenants will cause continuing and irreparable injury to the Company for which monetary damages would not be an adequate remedy. You shall not, in any action or proceeding to enforce any of the provisions of this letter agreement, assert the claim or defense that such an adequate remedy at law exists. In the event of any such breach by you, the Company shall have the right to enforce the Restrictive Covenants by seeking injunctive or other relief in any court, without any requirement that a bond or other security be posted, and this letter agreement shall not in any way limit remedies of law or in equity otherwise available to the Company. It is understood that any failure or delay by the Company in exercising any right, power or privilege hereunder shall not operate as a waiver thereof, nor shall any single or partial exercise of any right, power or privilege hereunder preclude any other or further exercise thereof.
SECTION 409A   
COMPLIANCE:    Notwithstanding any provision to the contrary herein, no severance shall be paid pursuant to this letter agreement unless the termination of your employment constitutes a “separation from service” (as such term is defined in Treas. Reg. Section 1.409A-1(h), including the default presumptions).
   To the maximum extent permitted under Section 409A of the Code (“Section 409A”), the severance payments and benefits payable under this letter agreement are intended to be exempt from Section 409A in reliance on the “separation pay exception” under Treas. Reg. Section 1.409A-1(b)(9)(iii). If any payment, compensation or other benefit provided to you in connection with the termination of your employment is determined by the Company, in whole or in part, not to be so exempt and to constitute “nonqualified deferred compensation” within the meaning of Section 409A and you are a specified employee as defined in Section 409A(a)(2)(B)(i), then such “nonqualified deferred compensation” will not be paid before (i) the first regularly scheduled payroll date following the sixth (6th) month after the termination of your employment or (ii) the first regularly scheduled payroll date following your death (the “New Payment Date”). The aggregate of any payments that otherwise would have been paid to you during the period between the date of termination and the New Payment Date will be paid to you in a lump sum on such New Payment Date. Thereafter, any payments that remain outstanding as of the day immediately following the New Payment Date will be paid without delay over the time period originally scheduled, in accordance with the terms of this letter agreement.
   Notwithstanding the other provisions hereof, this letter agreement is intended to comply with the requirements of Section 409A, to the extent applicable, and this letter agreement shall be interpreted to avoid any penalty sanctions under Section 409A. Accordingly, all provisions herein, or incorporated by reference, shall be construed and interpreted

 

7


   to comply with Section 409A and, if necessary, any such provision shall be deemed amended to comply with Section 409A and regulations thereunder. If any payment or benefit cannot be provided or made at the time specified herein without incurring sanctions under Section 409A, then such benefit or payment shall be provided in full at the earliest time thereafter when such sanctions will not be imposed. In no event may you designate the calendar year of payment of any severance benefits payable to you under this letter agreement.
   Notwithstanding anything to the contrary contained in this letter agreement, all reimbursements and in-kind benefits provided hereunder shall be made or provided in accordance with the requirements of section 409A of the Code, including, where applicable, the requirement that (i) any reimbursement shall be for expenses incurred during your lifetime, (ii) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during a taxable year may not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year, (iii) the reimbursement of an eligible expense will be made on or before the last day of the taxable year following the year in which the expense is incurred, and (iv) the right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.
ATTORNEYS FEES:    In connection with and promptly following the execution of this letter agreement, the Company shall reimburse you for the reasonable attorneys’ fees you incur in connection herewith, including any attorney’s fees incurred in connection with assisting the Company in explaining your obligations under this letter agreement.
MISCELLANEOUS:    You will continue to be an “at-will” employee who can resign or terminate your employment with the Company at any time. Likewise, the Company may terminate your employment at any time and for any reason whatsoever, with or without “Cause” or advance notice.
   The Company will be entitled to withhold from any amounts to be paid or benefits provided to you hereunder any federal, state, local or foreign withholding, FICA contributions, or other taxes, charges or deductions which it is from time to time required to withhold. The Company will be entitled to rely on the advice of counsel if any question as to the amount or requirement of any such withholding shall arise.
   As a Company employee, you will continue to be expected to abide by all Company rules and regulations.
   Neither this letter agreement nor any of your rights, duties or obligations shall be assignable by you, nor shall any of the payments required or permitted to be made to you by this letter agreement be encumbered, transferred or in any way anticipated, except as required by applicable laws.

 

8


   Any notice, request, instruction or other document given under this letter agreement shall be in writing and shall be addressed and delivered, in the case of the Company, to the Secretary of the Company at the principal office of the Company and, in your case, to your address as shown in the records of the Company or to such other address as may be designated in writing by either party.
   This letter agreement shall be exclusively governed by and construed in accordance with the laws of the Commonwealth of Pennsylvania, without regard to conflicts of law doctrine.
   The provisions of this letter agreement are severable and the invalidity of any one or more provisions shall not affect the validity of any other provision.
   A waiver by either party of any breach of any provision of this letter agreement by the other party shall not operate or be construed as a waiver of any other or subsequent breach by the other party.
   This letter agreement forms the complete statement of your employment terms with the Company, and supersedes any other agreements made to you by anyone, whether oral or written, including without limitation, the Term Sheet and the 2010 Letter Agreement. This letter agreement may not be amended or revised except by a writing signed by the parties.
   This letter agreement may be executed simultaneously in two or more counterparts, each of which shall be deemed an original, but which together shall constitute one and the same instrument.

[ Signature Page Follows ]

 

9


If you are in agreement with the foregoing, please execute this letter agreement at the signature line below and return an executed copy to my attention.

 

Very truly yours,

/s/ Kenneth R. Bull

Kenneth R. Bull
Senior Vice President, Finance

 

Accepted and agreed to by:

/s/ David Schlessinger

David Schlessinger
Date: October 14, 2010

 

10


EXHIBIT A

GENERAL RELEASE OF CLAIMS

A general release is required as a condition for receiving the severance payments described in the employment agreement between Five Below, Inc. (the “ Company ”) and David Schlessinger (“ you ”) dated October 14, 2010, (the “ Employment Agreement ”); thus, by executing this general release (“ General Release ”), you, on your own behalf and on behalf of your heirs, estate and beneficiaries, generally release and forever discharge the Company, its predecessors, successors or assigns, affiliates, shareholders or members, and their respective managers, members, partners, officers, directors, agents and employees and each of their heirs, executors, successors and assigns (individually a “ Released Party ” and collectively the “ Released Parties ”) from any and all claims and causes of action of every kind, nature and description whatsoever, whether known, unknown or suspected to exist, which you ever had or may now have, against any of the Released Parties, arising out of or relating to your employment relationship with the Company, and/or your separation from that employment relationship, including but not limited to:

a. All claims arising out of or relating to the statements, actions, or omissions of the Released Parties.

b. All claims for any alleged unlawful discrimination, harassment, retaliation or reprisal, or other alleged unlawful practices arising under any federal, state, or local statute, ordinance, or regulation, including without limitation, claims under Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1866, the Age Discrimination in Employment Act of 1967, as amended (including the Older Workers Benefit Protection Act); the Americans with Disabilities Act of 1990, as amended; the Civil Rights Act of 1991; the Family and Medical Leave Act of 1993; the Equal Pay Act of 1963; the Worker Adjustment and Retraining Notification Act; the Employee Retirement Income Security Act of 1974; the Fair Credit Reporting Act; and any other federal, state or local anti-discrimination acts, state wage payment statutes and non-interference or non-retaliation statutes under any applicable state or local laws or ordinances or any other legal restrictions on the Released Parties’ rights.

c. All claims for alleged wrongful discharge; breach of contract; breach of implied contract; failure to keep any promise; breach of a covenant of good faith and fair dealing; breach of fiduciary duty; promissory estoppel; your activities, if any, as a “whistleblower”; defamation; infliction of emotional distress; fraud; misrepresentation; negligence; harassment; retaliation or reprisal; constructive discharge; assault; battery; false imprisonment; invasion of privacy; interference with contractual or business relationships; any other wrongful employment practices; and violation of any other principle of common law.

d. All claims for compensation of any kind, including without limitation, commission payments, bonus payments, vacation pay, expense reimbursements, reimbursement for health and welfare benefits, and perquisites including payments, benefits, and reimbursements; except as otherwise provided in the Employment Agreement.

e. All claims for back pay, front pay, reinstatement, other equitable relief, compensatory damages, damages for alleged personal injury, liquidated damages, and punitive damages.

f. All claims for attorneys’ fees, costs, and interest.

The foregoing release shall not extend to the following: (i) your rights to receive severance under the terms of the Employment Agreement; (ii) any rights you may have to receive vested amounts under

 

11


any of the Company’s employee benefit plans and/or pension plans or programs; (iii) your rights to medical benefit continuation coverage, on a self-pay basis, pursuant to federal law (COBRA); (iv) any rights or claims that the law does not allow to be released and/or waived by private agreement; (v) any rights or claims that are based on events occurring after the date on which you sign this General Release; (vi) any rights or claims that you have relating to your outstanding equity rights to receive shares of common stock of the Company, as well as any shares of common stock of the Company that you own; (vii) any rights or claims to the “put” right set forth in the Employment Agreement with respect to your Rollover Shares and (viii) any claims to indemnification or insurance coverage, including but not limited to “D&O coverage”, that you may have with respect to any claims made or threatened against you in your capacity as a director, officer or employee of the Company. You acknowledge and agree that even though claims and facts in addition to those now known or believed by you to exist may subsequently be discovered, it is your intention to fully settle and release all claims you may have against the Released Parties, whether known, unknown or suspected.

It is further understood and agreed that you are waiving any right to initiate an action in state or federal court by you or on your behalf alleging discrimination on the basis of race, sex, religion, national origin, age, disability, marital status, or any other protected status or involving any contract or tort claims based on your termination from the Company. It is also acknowledged that your termination is not in any way related to any work-related injury.

This General Release shall be construed and enforced in accordance with, and governed by, the laws of the Commonwealth of Pennsylvania, without regard to principles of conflict of laws. If any clause of this General Release should ever be determined to be unenforceable, it is agreed that this will not affect the enforceability of any other clause or the remainder of this General Release.

You understand and agree that the compensation and benefits described in the Employment Agreement offer you consideration greater than that to which you would otherwise be entitled. You acknowledge that before entering into this agreement, you have had the opportunity to consult with any attorney or other advisor of your choice, and you have been advised to do so, and to the extent you deem appropriate, you have fully availed yourself of this right. You acknowledge that you have executed this General Release knowingly and voluntarily with full understanding of its terms and after having been advised and having had the opportunity to seek and receive advice and counsel from your attorney. You acknowledge that you have been given a period of at least 21 days within which to consider this General Release or have knowingly and voluntarily waived your right to do so. You understand that you may revoke this General Release during the seven days following the execution of this General Release by delivering notice to the Company. If no such revocation occurs, this General Release shall become effective on the eighth day following the execution of this General Release.

[ Signature Page Follows ]

 

12


I hereby state that I have carefully read this General Release and that I am signing this General Release knowingly and voluntarily with the full intent of releasing the Released Parties from any and all claims, except as set forth herein. Further, if signed prior to the completion of the 21 day review period, this is to acknowledge that I knowingly and voluntarily signed this General Release on an earlier date .

 

 

   

 

Date     David Schlessinger

 

13


EXHIBIT B

STOCK OPTION AWARD AGREEMENT

[See Exhibit 10.22 to Form S-1 filed on April 17, 2012.]

 

14

Exhibit 10.18

AMENDMENT TO EMPLOYMENT AGREEMENT

THIS AMENDMENT (this “ Amendment ”), dated September 28, 2011, is made by and between FIVE BELOW, INC. (the “ Company ”), and DAVID SCHLESSINGER (“ Executive ”).

WHEREAS , the Company and Executive are parties to an employment letter agreement, dated October 14, 2010 (the “ Agreement ”); and

WHEREAS , the Company and Executive wish to amend the Agreement.

NOW THEREFORE , intending to be legally bound hereby, the parties agree as follows:

1. The section of the Agreement next to the heading “COMPENSATION” is hereby deleted in its entirety and replaced with the following:

“You will be paid an annual base salary of $600,000, payable in accordance with the Company’s regular payroll practices, effective as of January 30, 2011 (the first day of the Company’s 2011 fiscal year), which annual base salary will be subject to annual review for increase by the Company’s Board of Directors (the “Board of Directors”) or the Compensation Committee of the Board of Directors (the “Compensation Committee”) commencing with the Company’s 2014 fiscal year.

You will be eligible to participate in the Company’s 2011 fiscal year incentive bonus program (the “Program”), with a payout potential of 40% of your annual base salary if the Company’s net EBITDA after all incentive payments under the Program (including payments to you) is $40.1 million or more (but less than $42.6 million) and 50% of your annual base salary if the Company’s net EBITDA after all incentive payments under the Program (including payments to you) is $42.6 million or more.

Commencing with the Company’s 2012 fiscal year, the Compensation Committee may, in its sole discretion, approve payments of bonuses to you.”

2. The Agreement, as modified by this Amendment, is hereby ratified and confirmed in all respects.

[ signature page follows ]


IN WITNESS WHEREOF, each Company has caused this Amendment to be executed by its duly authorized officer, and Executive has executed this Amendment, in each case on the 28 th day of September, 2011.

 

FIVE BELOW, INC.
By:  

/s/ Kenneth R. Bull

  Kenneth R. Bell
Title:  

Senior Vice President, Finance

By:  

/s/ Steven J. Collins

  Steven J. Collins
Title:  

Five Below Compensation Committee

DAVID SCHLESSINGER

/s/ David Schlessinger

Exhibit 10.19

Five Below, Inc.

1616 Walnut Street, Suite 400

Philadelphia, PA 19103

October 14, 2010

Personal and Confidential

Thomas Vellios

Five Below, Inc.

1616 Walnut Street, Suite 400

Philadelphia, PA 19103

Re: Continuing Employment Terms

Dear Tom:

Reference is made to that certain letter agreement dated January 18, 2010 between you and Five Below, Inc. (the “Company”) regarding your continuing employment terms (the “2010 Letter Agreement”, which letter was an amendment and restatement of your prior letter agreement dated April 20, 2005). In connection with the Investment Agreement, dated as of September 1, 2010, (the “Investment Agreement”) by and among the Company and certain parties thereto, including the “Purchasers” (as such term is defined in the Investment Agreement), you and the Purchasers have agreed to a term sheet, dated September 1, 2010, (the “Term Sheet”), which sets forth the terms and conditions of your continued employment with the Company following consummation of the transaction contemplated by the Investment Agreement. This letter agreement memorializes the terms and conditions agreed to in the Term Sheet and shall become effective upon consummation of the transaction contemplated by the Investment Agreement (the “Effective Date”) and shall supersede and replace in its entirety the 2010 Letter Agreement. The terms and conditions of your continued employment with the Company following the Effective Date shall be as follows:

 

POSITION:    President and Chief Executive Officer.
COMPENSATION:    You will be paid an annual base salary of $600,000, payable in accordance with the Company’s regular payroll practices, which annual base salary will be subject to annual review for increase by the Company’s Board of Directors (the “Board of Directors”) or the Compensation Committee of the Board of Directors (the “Compensation Committee”). The Compensation Committee may, in its sole discretion, approve payment of bonuses to you.
EQUITY:    On the Effective Date, the Company Equity Incentive Plan (the “Equity Plan”) shall provide for an initial pool for which common shares of the Company may be issued equal to 7% of the fully diluted, as converted common shares of the Company, available at Closing (as defined in the Investment Agreement), as calculated pursuant to the


   Investment Agreement, with 3% of the fully diluted, as converted common shares of the Company, available at Closing, as calculated pursuant to the Investment Agreement, held back for post-closing grants for the existing management team and new hires to be granted in the discretion of the Board of Directors.
   You will be granted, on the Effective Date, an option to purchase 2% of the fully diluted, as converted common shares of the Company, available at Closing, as calculated pursuant to the Investment Agreement, under the Equity Plan, with terms and conditions set forth in the Non-Qualified Stock Option Agreement attached hereto as Exhibit B .
   To the extent (i) you are terminated without “Cause” (as defined below) or you terminate your employment for “Good Reason” (as defined below), but excluding a termination of your employment due to your death or disability, and (ii) the Company has greater than $35.0m of EBITDA (A) in the fiscal year immediately preceding your termination of employment or (B) in the last twelve consecutive months immediately preceding the month during which your termination of employment occurs, you shall have, within sixty days following your termination of employment, the right to cause the Company to purchase, and the Company shall purchase, your “Rollover Shares” (as defined below) at a price per share equal to the per share fair market value at termination (as such fair market value is determined in good faith by the Board of Directors); provided, however, that if such valuation was not determined by an independent valuation firm and you object to the valuation determination of the Board of Directors, within ten days of such determination you may request in writing, and the Board of Directors shall retain, a valuation by an independent valuation firm selected by a majority of the Board of Directors, and such independent valuation firm shall determine the fair market value of the Rollover Shares, which determination shall be final and binding upon you, the Company and all interested persons for the purpose of this paragraph. Your put right shall expire upon an initial public offering of the Company’s common stock (an “IPO”). “Rollover Shares” shall mean the shares of common stock of the Company owned by you on the Effective Date, but does not include any of the shares of common stock of the Company acquired by you after the Effective Date, either by exercise of your options or otherwise.
BENEFITS:    You will be entitled to continue to receive the benefits which you currently enjoy (other than the loans offered to you by the Company), and you will participate in the most favorable health and welfare plans and tax qualified retirement plans available to other employees of the Company, subject to the terms of those plans.

 

2


SEVERANCE:    If the Company terminates your employment without “Cause”, or if you resign your employment with “Good Reason,” you will be entitled to:
  

*

   payment of an amount equal to the greater of (i) your annual base salary on the date of such termination or (ii) except to the extent a reduction of annual base salary was approved by you in writing, such higher annual base salary that was in effect prior to your termination of employment, for 12 months following such termination (24 months if any such event occurs after a “Change of Control Transaction”), in each case, payable in accordance with the Company’s regular payroll practices and commencing on the first payroll date of the Company following the thirtieth (30th) day of the termination of your employment (the “First Payroll Date”). The portion of the severance pay that would have been paid to you during the period between the termination of your employment and the First Payroll Date had no thirty-day delay been required will be paid to you in a lump sum on the First Payroll Date and thereafter the remaining portion of the severance pay will be paid without delay as provided in this paragraph; and
  

*

   (a) monthly payments equal to the applicable monthly premium for COBRA continuation coverage for so long as you are receiving such continuation coverage up to 18 months after such termination, commencing on the First Payroll Date; provided that the portion of the COBRA premiums paid by you during the period between the termination of your employment and the First Payroll Date, if any, had no thirty-day delay been required will be paid to you in a lump sum on the First Payroll Date; provided, further, that each monthly payment paid to you pursuant to this clause (a) shall be grossed up for Federal, state and local ordinary income taxes and payroll taxes imposed as a result of such payments (but not additional taxes imposed under the Internal Revenue Code of 1986, as amended (the “Code”)), and (b) if you remain on COBRA coverage for the entire 18-month period, the Company will make additional monthly payments to you for the 6-month period immediately following the expiration of the 18-month COBRA period equal to the amount of premiums that you would have paid had you been eligible for continued coverage under COBRA. The monthly payments described in clauses (a) (including the gross-up payment) and (b) above shall be made on the Company’s first payroll date of the applicable

 

3


     month. Each gross-up payment shall be calculated based on the highest marginal tax rate for federal ordinary income taxes and payroll taxes and the highest marginal tax rate applicable to ordinary income for the taxing state and local jurisdiction in which you reside at the time such payroll is calculated (after giving effect to the tax benefit, if any, applicable for deductions of taxes paid to any other taxing jurisdiction).
  For this purpose:
     “Cause” means (a) conviction of (or the entry of a plea of guilty or nolo contendere to) a crime that prevents you from effectively managing the Company or that has a material, adverse effect on the reputation or business activities of the Company, (b) gross negligence, dishonesty, misappropriation of funds or other willful misconduct in the course of employment that has a material, adverse effect on the reputation or business activities of the Company, or (c) substance abuse, including abuse of alcohol or use of controlled drugs (other than in accordance with a physician’s prescription).
     “Change of Control Transaction” means a “Change in Control” as such term is defined in the Company Equity Incentive Plan (as it exists from time to time); provided, however, that (a) in no event shall the corporate transaction contemplated by the Investment Agreement be deemed a “Change of Control Transaction” for purposes of this letter agreement and (b) any change to the definition of “Change in Control” that is less favorable to you will not apply to this letter agreement without your consent.
     “Good Reason” means (a) a material, adverse change in your title, authority, responsibilities or duties, (b) a reduction or other material adverse change in your base salary or benefits, (c) a requirement that you report to anyone other than the Board of Directors, (d) a relocation of your principal offices by more than 25 miles, or (e) any other Company willful action or inaction that constitutes a material breach by the Company of this letter agreement; provided, that, no event described in this paragraph shall constitute “Good Reason” unless (i) you provide written notice of the event within the 60-day period following the occurrence of such Good Reason event, and (ii) the

 

4


      Company has not cured such event within 30 days of receipt of such notice. For the avoidance of doubt, Good Reason shall not exist hereunder unless and until the thirty-day cure period following receipt by the Company of your written notice expires and the Company shall not have cured such circumstances, and in such case your employment shall terminate for Good Reason if you provide notice to the Company within 15 days following the expiration of such thirty-day cure period that you wish to resign on account of “Good Reason,” and your termination date shall become effective on the first business day following the end of your 15 day notice period.
   Notwithstanding the foregoing, all severance benefits will be contingent upon your execution of a fully effective and non-revocable general release of claims against the Company and its affiliates, in substantially the form attached hereto as Exhibit A , within 30 days following the termination of your employment, which release will be provided to you within five days of the termination of your employment.
SECTION 280G   

OF THE CODE

   To the extent the common stock of the Company is not publicly traded on the relevant date, if any payment or benefit you would receive pursuant to a contemplated Change of Control Transaction would constitute a “parachute payment” within the meaning of Section 280G of the Code, and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code, the Company shall use commercially reasonable efforts to seek to obtain the approval of the shareholders of the Company of any such “excess parachute payments” in a manner intended to be compliant with the provisions of Sections 280G(b)(5)(A)(ii) and 280G(b)(5)(B) of the Code. To the extent that you are already entitled to any such payment or benefit, the foregoing shall apply to the extent you waive and forfeit your right to such payment or benefit.
NONCOMPETE/      

NONSOLICITATION:

   In consideration for entering into this letter agreement, including, without limitation, the compensation to be paid to you hereunder, you agree that during your employment by the Company and (i) for the applicable period following termination during which you are eligible to receive salary continuation if your employment is terminated without Cause, or if you resign your employment with Good Reason, or (ii) for the 18-month period from the date of the termination of your employment with the Company for any other or for no reason, you will not, either directly or indirectly, on your own behalf or in the service of, together with or on behalf of any other person; (a) own, manage, engage in, operate, control, work for, consult with, render

 

5


   services for, do business with, maintain any interest in (proprietary, financial or otherwise) or participate in the ownership, management, operation or control of, any business, whether in corporate, proprietorship or partnership form or otherwise, that sells at retail products (1) predominantly to children, teens and pre-teens, (2) that are the same as or substantially similar to products that are sold or are planned to be sold by the Company during the period in which you are employed by the Company and (3) at fixed price points of $10.00 or less anywhere in the United States or in any other country in which the Company sells or plans to sell such products at such fixed price points during the period in which you are employed by the Company (a “Competitive Business”); provided, however, that the restrictions contained in this clause (a) shall not restrict the acquisition by you, directly or indirectly, of less than 2% of the outstanding capital stock of any publicly traded company engaged in a Competitive Business; or (b) solicit, recruit or attempt to solicit or recruit any employee of the Company; or (c) hire or attempt to hire any employee of the Company; provided, however that: (A) in the event that you terminate your employment with the Company for any reason other than on account of Good Reason, the restrictions in clause (c) shall terminate on the date that is 18 months from the date of such termination and (B) in the event that your employment is terminated by the Company for any or no reason or by you for Good Reason, the restrictions in clause (c) shall terminate on the date that is one (1) year from the date of such termination. Notwithstanding the foregoing the restrictions in each of clause (b) and clause (c) of the preceding sentence shall terminate upon the earlier of the completion of (x) an IPO or (y) a Change of Control Transaction. For purposes of this letter agreement, “planned to be sold” or “plans to sell” refers only to written plans that have been approved by the Board of Directors on or before the date of the termination of your employment with the Company.
   You acknowledge that the restrictions in the immediately preceding paragraph (the “Restrictive Covenants”) are reasonable and necessary to protect the legitimate interests of the Company and its affiliates and that the duration and geographic scope of the Restrictive Covenants are reasonable given the nature of this letter agreement and the position you will hold within the Company. You further acknowledge that the Restrictive Covenants contained herein are distinct and separate from any restrictive covenants contained in the Investment Agreement. You further acknowledge that the Restrictive Covenants are included herein in order to induce the Company to enter into this letter agreement and that the Company would not have entered into this letter agreement in the absence of the Restrictive Covenants.
   If any court determines that any of the Restrictive Covenants or any part thereof, is unenforceable because of the duration or geographic scope of such provision, such court shall have the power to modify such provision and, in its modified form, such provision shall then be enforceable.

 

6


NONDISCLOSURE:    All information about the Company and its business furnished by the Company or on the Company’s behalf to you, or otherwise obtained by you in connection with your employment with the Company, is referred to in this letter agreement as “Proprietary Information.” For purposes of this letter agreement, Proprietary Information: (i) shall include all documents which are prepared by you, including all correspondence, memoranda, notes, summaries, analyses, studies, models, extracts of and documents and records reflecting, based on or derived from Proprietary Information as well as all copies and other reproductions thereof, whether in writing or stored or maintained in or by electronic, magnetic or other means, media or devices; and (ii) shall not include information which is or becomes generally available to the public other than as a result of a disclosure by you. Unless otherwise agreed to in writing by the Company, you agree that you will keep all Proprietary Information confidential and not disclose or reveal any Proprietary Information to any person. You agree that you will, upon the Company’s request, promptly deliver to the Company all Proprietary Information in your possession or control.
SPECIFIC   
ENFORCEMENT:    You acknowledge that any breach by you, willfully or otherwise, of the Restrictive Covenants will cause continuing and irreparable injury to the Company for which monetary damages would not be an adequate remedy. You shall not, in any action or proceeding to enforce any of the provisions of this letter agreement, assert the claim or defense that such an adequate remedy at law exists. In the event of any such breach by you, the Company shall have the right to enforce the Restrictive Covenants by seeking injunctive or other relief in any court, without any requirement that a bond or other security be posted, and this letter agreement shall not in any way limit remedies of law or in equity otherwise available to the Company. It is understood that any failure or delay by the Company in exercising any right, power or privilege hereunder shall not operate as a waiver thereof, nor shall any single or partial exercise of any right, power or privilege hereunder preclude any other or further exercise thereof.
SECTION 409A   
COMPLIANCE:    Notwithstanding any provision to the contrary herein, no severance shall be paid pursuant to this letter agreement unless the termination of your employment constitutes a “separation from service” (as such term is defined in Treas. Reg. Section 1.409A-1(h), including the default presumptions).
   To the maximum extent permitted under Section 409A of the Code (“Section 409A”), the severance payments and benefits payable under this letter agreement are intended to be exempt from Section 409A in reliance on the “separation pay exception” under Treas. Reg. Section

 

7


   1.409A-1(b)(9)(iii). If any payment, compensation or other benefit provided to you in connection with the termination of your employment is determined by the Company, in whole or in part, not to be so exempt and to constitute “nonqualified deferred compensation” within the meaning of Section 409A and you are a specified employee as defined in Section 409A(a)(2)(B)(i), then such “nonqualified deferred compensation” will not be paid before (i) the first regularly scheduled payroll date following the sixth (6th) month after the termination of your employment or (ii) the first regularly scheduled payroll date following your death (the “New Payment Date”). The aggregate of any payments that otherwise would have been paid to you during the period between the date of termination and the New Payment Date will be paid to you in a lump sum on such New Payment Date. Thereafter, any payments that remain outstanding as of the day immediately following the New Payment Date will be paid without delay over the time period originally scheduled, in accordance with the terms of this letter agreement.
   Notwithstanding the other provisions hereof, this letter agreement is intended to comply with the requirements of Section 409A, to the extent applicable, and this letter agreement shall be interpreted to avoid any penalty sanctions under Section 409A. Accordingly, all provisions herein, or incorporated by reference, shall be construed and interpreted to comply with Section 409A and, if necessary, any such provision shall be deemed amended to comply with Section 409A and regulations thereunder. If any payment or benefit cannot be provided or made at the time specified herein without incurring sanctions under Section 409A, then such benefit or payment shall be provided in full at the earliest time thereafter when such sanctions will not be imposed. In no event may you designate the calendar year of payment of any severance benefits payable to you under this letter agreement.
   Notwithstanding anything to the contrary contained in this letter agreement, all reimbursements and in-kind benefits provided hereunder shall be made or provided in accordance with the requirements of section 409A of the Code, including, where applicable, the requirement that (i) any reimbursement shall be for expenses incurred during your lifetime, (ii) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during a taxable year may not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year, (iii) the reimbursement of an eligible expense will be made on or before the last day of the taxable year following the year in which the expense is incurred and (iv) the right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.
ATTORNEYS FEES:    In connection with and promptly following the execution of this letter agreement, the Company shall reimburse you for the reasonable attorneys’ fees you incur in connection herewith, including any attorney’s fees incurred in connection with assisting the Company in explaining your obligations under this letter agreement.

 

8


MISCELLANEOUS:    You will continue to be an “at-will” employee who can resign or terminate your employment with the Company at any time. Likewise, the Company may terminate your employment at any time and for any reason whatsoever, with or without “Cause” or advance notice.
   The Company will be entitled to withhold from any amounts to be paid or benefits provided to you hereunder any federal, state, local or foreign withholding, FICA contributions, or other taxes, charges or deductions which it is from time to time required to withhold. The Company will be entitled to rely on the advice of counsel if any question as to the amount or requirement of any such withholding shall arise.
   As a Company employee, you will continue to be expected to abide by all Company rules and regulations.
   Neither this letter agreement nor any of your rights, duties or obligations shall be assignable by you, nor shall any of the payments required or permitted to be made to you by this letter agreement be encumbered, transferred or in any way anticipated, except as required by applicable laws.
   Any notice, request, instruction or other document given under this letter agreement shall be in writing and shall be addressed and delivered, in the case of the Company, to the Secretary of the Company at the principal office of the Company and, in your case, to your address as shown in the records of the Company or to such other address as may be designated in writing by either party.
   This letter agreement shall be exclusively governed by and construed in accordance with the laws of the Commonwealth of Pennsylvania, without regard to conflicts of law doctrine.
   The provisions of this letter agreement are severable and the invalidity of any one or more provisions shall not affect the validity of any other provision.
   A waiver by either party of any breach of any provision of this letter agreement by the other party shall not operate or be construed as a waiver of any other or subsequent breach by the other party.
   This letter agreement forms the complete statement of your employment terms with the Company, and supersedes any other agreements made to you by anyone, whether oral or written, including without limitation, the Term Sheet and the 2010 Letter Agreement. This letter agreement may not be amended or revised except by a writing signed by the parties.

 

9


   This letter agreement may be executed simultaneously in two or more counterparts, each of which shall be deemed an original, but which together shall constitute one and the same instrument.

[ Signature Page Follows ]

 

10


If you are in agreement with the foregoing, please execute this letter agreement at the signature line below and return an executed copy to my attention.

 

Very truly yours,

/s/ Kenneth R. Bull

Kenneth R. Bull
Senior Vice President, Finance

 

Accepted and agreed to by:

/s/ Thomas Vellios

Thomas Vellios
Date: October 14, 2010

 

11


EXHIBIT A

GENERAL RELEASE OF CLAIMS

A general release is required as a condition for receiving the severance payments described in the employment agreement between Five Below, Inc. (the “ Company ”) and Thomas Vellios (“ you ”) dated October 14, 2010, (the “ Employment Agreement ”); thus, by executing this general release (“ General Release ”), you, on your own behalf and on behalf of your heirs, estate and beneficiaries, generally release and forever discharge the Company, its predecessors, successors or assigns, affiliates, shareholders or members, and their respective managers, members, partners, officers, directors, agents and employees and each of their heirs, executors, successors and assigns (individually a “ Released Party ” and collectively the “ Released Parties ”) from any and all claims and causes of action of every kind, nature and description whatsoever, whether known, unknown or suspected to exist, which you ever had or may now have, against any of the Released Parties, arising out of or relating to your employment relationship with the Company, and/or your separation from that employment relationship, including but not limited to:

a. All claims arising out of or relating to the statements, actions, or omissions of the Released Parties.

b. All claims for any alleged unlawful discrimination, harassment, retaliation or reprisal, or other alleged unlawful practices arising under any federal, state, or local statute, ordinance, or regulation, including without limitation, claims under Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1866, the Age Discrimination in Employment Act of 1967, as amended (including the Older Workers Benefit Protection Act); the Americans with Disabilities Act of 1990, as amended; the Civil Rights Act of 1991; the Family and Medical Leave Act of 1993; the Equal Pay Act of 1963; the Worker Adjustment and Retraining Notification Act; the Employee Retirement Income Security Act of 1974; the Fair Credit Reporting Act; and any other federal, state or local anti-discrimination acts, state wage payment statutes and non-interference or non-retaliation statutes under any applicable state or local laws or ordinances or any other legal restrictions on the Released Parties’ rights.

c. All claims for alleged wrongful discharge; breach of contract; breach of implied contract; failure to keep any promise; breach of a covenant of good faith and fair dealing; breach of fiduciary duty; promissory estoppel; your activities, if any, as a “whistleblower”; defamation; infliction of emotional distress; fraud; misrepresentation; negligence; harassment; retaliation or reprisal; constructive discharge; assault; battery; false imprisonment; invasion of privacy; interference with contractual or business relationships; any other wrongful employment practices; and violation of any other principle of common law.

d. All claims for compensation of any kind, including without limitation, commission payments, bonus payments, vacation pay, expense reimbursements, reimbursement for health and welfare benefits, and perquisites including payments, benefits, and reimbursements; except as otherwise provided in the Employment Agreement.

e. All claims for back pay, front pay, reinstatement, other equitable relief, compensatory damages, damages for alleged personal injury, liquidated damages, and punitive damages.

f. All claims for attorneys’ fees, costs, and interest.

 

12


The foregoing release shall not extend to the following: (i) your rights to receive severance under the terms of the Employment Agreement; (ii) any rights you may have to receive vested amounts under any of the Company’s employee benefit plans and/or pension plans or programs; (iii) your rights to medical benefit continuation coverage, on a self-pay basis, pursuant to federal law (COBRA); (iv) any rights or claims that the law does not allow to be released and/or waived by private agreement; (v) any rights or claims that are based on events occurring after the date on which you sign this General Release; (vi) any rights or claims that you have relating to your outstanding equity rights to receive shares of common stock of the Company, as well as any shares of common stock of the Company that you own; (vii) any rights or claims to the “put” right set forth in the Employment Agreement with respect to your Rollover Shares and (viii) any claims to indemnification or insurance coverage, including but not limited to “D&O coverage”, that you may have with respect to any claims made or threatened against you in your capacity as a director, officer or employee of the Company. You acknowledge and agree that even though claims and facts in addition to those now known or believed by you to exist may subsequently be discovered, it is your intention to fully settle and release all claims you may have against the Released Parties, whether known, unknown or suspected.

It is further understood and agreed that you are waiving any right to initiate an action in state or federal court by you or on your behalf alleging discrimination on the basis of race, sex, religion, national origin, age, disability, marital status, or any other protected status or involving any contract or tort claims based on your termination from the Company. It is also acknowledged that your termination is not in any way related to any work-related injury.

This General Release shall be construed and enforced in accordance with, and governed by, the laws of the Commonwealth of Pennsylvania, without regard to principles of conflict of laws. If any clause of this General Release should ever be determined to be unenforceable, it is agreed that this will not affect the enforceability of any other clause or the remainder of this General Release.

You understand and agree that the compensation and benefits described in the Employment Agreement offer you consideration greater than that to which you would otherwise be entitled. You acknowledge that before entering into this agreement, you have had the opportunity to consult with any attorney or other advisor of your choice, and you have been advised to do so, and to the extent you deem appropriate, you have fully availed yourself of this right. You acknowledge that you have executed this General Release knowingly and voluntarily with full understanding of its terms and after having been advised and having had the opportunity to seek and receive advice and counsel from your attorney. You acknowledge that you have been given a period of at least 21 days within which to consider this General Release or have knowingly and voluntarily waived your right to do so. You understand that you may revoke this General Release during the seven days following the execution of this General Release by delivering notice to the Company. If no such revocation occurs, this General Release shall become effective on the eighth day following the execution of this General Release.

[ Signature Page Follows ]

 

13


I hereby state that I have carefully read this General Release and that I am signing this General Release knowingly and voluntarily with the full intent of releasing the Released Parties from any and all claims, except as set forth herein. Further, if signed prior to the completion of the 21 day review period, this is to acknowledge that I knowingly and voluntarily signed this General Release on an earlier date .

 

 

   

 

Date     Thomas Vellios

 

14


EXHIBIT B

STOCK OPTION AWARD AGREEMENT

[See Exhibit 10.23 to Form S-1 filed on April 17, 2012.]

 

15

Exhibit 10.20

AMENDMENT TO EMPLOYMENT AGREEMENT

THIS AMENDMENT (this “ Amendment ”), dated September 28, 2011, is made by and between FIVE BELOW, INC. (the “ Company ”), and THOMAS VELLIOS (“ Executive ”).

WHEREAS , the Company and Executive are parties to an employment letter agreement, dated October 14, 2010 (the “ Agreement ”); and

WHEREAS , the Company and Executive wish to amend the Agreement.

NOW THEREFORE , intending to be legally bound hereby, the parties agree as follows:

1. The section of the Agreement next to the heading “COMPENSATION” is hereby deleted in its entirety and replaced with the following:

“You will be paid an annual base salary of $700,000, payable in accordance with the Company’s regular payroll practices, effective as of January 30, 2011 (the first day of the Company’s 2011 fiscal year), which annual base salary will be subject to annual review for increase by the Company’s Board of Directors (the “Board of Directors”) or the Compensation Committee of the Board of Directors (the “Compensation Committee”) commencing with the Company’s 2014 fiscal year.

You will be eligible to participate in the Company’s 2011 fiscal year incentive bonus program (the “Program”), with a payout potential of 40% of your annual base salary if the Company’s net EBITDA after all incentive payments under the Program (including payments to you) is $40.1 million or more (but less than $42.6 million) and 50% of your annual base salary if the Company’s net EBITDA after all incentive payments under the Program (including payments to you) is $42.6 million or more.

Commencing with the Company’s 2012 fiscal year, the Compensation Committee may, in its sole discretion, approve payments of bonuses to you.”

2. The Agreement, as modified by this Amendment, is hereby ratified and confirmed in all respects.

[ signature page follows ]


IN WITNESS WHEREOF, each Company has caused this Amendment to be executed by its duly authorized officer, and Executive has executed this Amendment, in each case on the 28 th day of September, 2011.

 

FIVE BELOW, INC.
By:  

/s/ Kenneth R. Bull

  Kenneth R. Bell
Title:  

Senior Vice President, Finance

By:  

/s/ Steven J. Collins

  Steven J. Collins
Title:  

Five Below Compensation Committee

THOMAS VELLIOS

/s/ Thomas Vellios

Exhibit 10.21

Five Below, Inc.

1818 Market Street, Suite 1900

Philadelphia, PA 19103

April 16, 2012

Personal and Confidential

Kenneth R. Bull

Five Below, Inc.

1818 Market Street, Suite 1900

Philadelphia, PA 19103

Re: Continuing Employment Terms

Dear Kenneth:

Reference is made to that certain letter agreement dated June 21, 2005 between you and Five Below, Inc. (the “Company”) regarding your employment (the “2005 Letter Agreement”). In connection with your promotion to the position of Chief Financial Officer and your enhanced responsibilities and performance of same, you and the Company have agreed to certain terms and conditions of your continued employment with the Company. This letter agreement (“Agreement”) memorializes the terms and conditions agreed to and shall become effective upon the date you and the Company have each executed this Agreement (the “Effective Date”) and shall supersede and replace the 2005 Letter Agreement in its entirety. The terms and conditions of your continued employment with the Company following the Effective Date shall be as follows:

 

POSITION:      Chief Financial Officer.
COMPENSATION:      Effective as of April 1, 2012, you will be paid an annual base salary of $325,000, payable in accordance with the Company’s regular payroll practices, which annual base salary will be subject to annual review for increase by the Company’s Board of Directors (the “Board of Directors”) or the Compensation Committee of the Board of Directors (the “Compensation Committee”). The Compensation Committee may, in its sole discretion, approve payment of bonuses to you.
BENEFITS:      You will be entitled to continue to participate in the health and welfare plans and tax qualified retirement plans available to other employees of the Company, subject to the terms of those plans.
SEVERANCE:      If the Company terminates your employment without “Cause”, you will be entitled to:
    

*       6 months of base salary continuation following such termination (less any amounts you earn from outside sources during such 6 month period), payable in accordance with the Company’s regular payroll practices


    

and such payments will commence on the first payroll date of the Company following the thirtieth (30th) day of the termination of your employment (the “First Payroll Date”). The portion of the severance pay that would have been paid to you during the period between the termination of your employment and the First Payroll Date had no thirty-day delay been required will be paid to you in a lump sum on the First Payroll Date and thereafter the remaining portion of the severance pay will be paid without delay as provided in this paragraph; and

    

*       monthly payments equal to the applicable monthly premium for COBRA continuation coverage for so long as you are receiving such continuation coverage up to 6 months after such termination, commencing on the First Payroll Date; provided that the portion of the COBRA premiums paid by you during the period between the termination of your employment and the First Payroll Date, if any, had no thirty-day delay been required will be paid to you in a lump sum on the First Payroll Date.

     For this purpose:
    

“Cause” means (i) alcohol abuse or use of controlled drugs (other than in accordance with a physician’s prescription); (ii) refusal, failure or inability to perform any material obligation or fulfill any duty (other than any duty or obligation of the type described in clause (iv) below) to the Company (other than due to a Disability as defined in the Company Equity Incentive Plan), which failure, refusal or inability is not cured within 10 days after delivery of notice thereof; (iii) gross negligence or willful misconduct in the course of employment; (iv) any breach of any obligation or duty to the Company or any of its affiliates (whether arising by statute, common law, contract or otherwise) relating to confidentiality, noncompetition, nonsolicitation or proprietary rights; (v) other conduct involving any type of disloyalty to the Company or any of its affiliates, including, without limitation, fraud, embezzlement, theft or proven dishonesty; and (vi) conviction of (or the entry of a plea of guilty or nolo contendere to) a misdemeanor involving moral turpitude or a felony.

     Notwithstanding the foregoing, all severance benefits will be contingent upon your execution of a fully effective and non-revocable general release of claims against the Company and its affiliates, in substantially the form attached hereto as Exhibit A (the “Release”), within 30 days following the termination of your employment, which release will be provided to you within five days of the termination of your employment.

 

2


NONDISCLOSURE:      You acknowledge that you will continue to be bound by the terms of the Non-Disclosure Agreement, which you executed on June 24, 2005 in connection with your 2005 Letter Agreement.
SECTION 409A     
COMPLIANCE:      Notwithstanding any provision to the contrary herein, no severance shall be paid pursuant to this Agreement unless the termination of your employment constitutes a “separation from service” (as such term is defined in Treas. Reg. Section 1.409A-1(h), including the default presumptions).
     To the maximum extent permitted under Section 409A of the Code (“Section 409A”), the severance payments and benefits payable under this Agreement are intended to be exempt from Section 409A in reliance on the “separation pay exception” under Treas. Reg. Section 1.409A-1(b)(9)(iii). If any payment, compensation or other benefit provided to you in connection with the termination of your employment is determined by the Company, in whole or in part, not to be so exempt and to constitute “nonqualified deferred compensation” within the meaning of Section 409A and you are a specified employee as defined in Section 409A(a)(2)(B)(i), then such “nonqualified deferred compensation” will not be paid before (i) the first regularly scheduled payroll date following the sixth (6th) month after the termination of your employment or (ii) the first regularly scheduled payroll date following your death (the “New Payment Date”). The aggregate of any payments that otherwise would have been paid to you during the period between the date of termination and the New Payment Date will be paid to you in a lump sum on such New Payment Date. Thereafter, any payments that remain outstanding as of the day immediately following the New Payment Date will be paid without delay over the time period originally scheduled, in accordance with the terms of this Agreement.
     Notwithstanding the other provisions hereof, this Agreement is intended to comply with the requirements of Section 409A, to the extent applicable, and this Agreement shall be interpreted to avoid any penalty sanctions under Section 409A. Accordingly, all provisions herein, or incorporated by reference, shall be construed and interpreted to comply with Section 409A and, if necessary, any such provision shall be deemed amended to comply with Section 409A and regulations thereunder. If any payment or benefit cannot be provided or made at the time specified herein without incurring sanctions under Section 409A, then such benefit or payment shall be provided in full at the earliest time thereafter when such sanctions will not be imposed. In no event may you designate the calendar year of payment of any severance benefits payable to you under this Agreement.
     Notwithstanding anything to the contrary contained in this Agreement, all reimbursements and in-kind benefits provided hereunder shall be made or provided in accordance with the requirements of section 409A of the Code, including, where applicable, the requirement that (i) any

 

3


     reimbursement shall be for expenses incurred during your lifetime, (ii) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during a taxable year may not affect the expenses eligible for reimbursement, or in- kind benefits to be provided, in any other taxable year, (iii) the reimbursement of an eligible expense will be made on or before the last day of the taxable year following the year in which the expense is incurred, and (iv) the right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.
MISCELLANEOUS:      You will continue to be an “at-will” employee who can resign or terminate your employment with the Company at any time. Likewise, the Company may terminate your employment at any time and for any reason whatsoever, with or without “Cause” or advance notice.
     The Company will be entitled to withhold from any amounts to be paid or benefits provided to you hereunder any federal, state, local or foreign withholding, FICA contributions, or other taxes, charges or deductions which it is from time to time required to withhold. The Company will be entitled to rely on the advice of counsel if any question as to the amount or requirement of any such withholding shall arise.
     As a Company employee, you will continue to be expected to abide by all Company rules and regulations.
     Neither this Agreement nor any of your rights, duties or obligations shall be assignable by you, nor shall any of the payments required or permitted to be made to you by this Agreement be encumbered, transferred or in any way anticipated, except as required by applicable laws.
     Any notice, request, instruction or other document given under this Agreement shall be in writing and shall be addressed and delivered, in the case of the Company, to the President of the Company at the principal office of the Company and, in your case, to your address as shown in the records of the Company or to such other address as may be designated in writing by either party.
     This Agreement shall be exclusively governed by and construed in accordance with the laws of the Commonwealth of Pennsylvania, without regard to conflicts of law doctrine.
     The provisions of this Agreement are severable and the invalidity of any one or more provisions shall not affect the validity of any other provision.
     A waiver by either party of any breach of any provision of this Agreement by the other party shall not operate or be construed as a waiver of any other or subsequent breach by the other party.

 

4


     This Agreement forms the complete statement of your employment terms with the Company, and supersedes any other agreements made to you by anyone, whether oral or written, including without limitation, the 2005 Letter Agreement. This Agreement may not be amended or revised except by a writing signed by the parties.
     This Agreement may be executed simultaneously in two or more counterparts, each of which shall be deemed an original, but which together shall constitute one and the same instrument.

[ Signature Page Follows ]

 

5


If you are in agreement with the foregoing, please execute this Agreement at the signature line below and return an executed copy to my attention.

 

Very truly yours,

/s/ Thomas G. Vellios

Thomas G. Vellios
President & Chief Executive Officer

Accepted and agreed to by:

 

/s/ Kenneth R. Bull

Kenneth R. Bull

Date: April 16, 2012

 

6


EXHIBIT A

GENERAL RELEASE OF CLAIMS

A general release is required as a condition for receiving the severance payments described in the employment agreement between Five Below, Inc. (the “ Company ”) and Kenneth R. Bull (“ you ”) dated April 16, 2012, (the “ Employment Agreement ”); thus, by executing this general release (“ General Release ”), you, on your own behalf and on behalf of your heirs, estate and beneficiaries, generally release and forever discharge the Company, its predecessors, successors or assigns, affiliates, shareholders or members, and their respective managers, members, partners, officers, directors, agents and employees and each of their heirs, executors, successors and assigns (individually a “ Released Party ” and collectively the “ Released Parties ”) from any and all claims and causes of action of every kind, nature and description whatsoever, whether known, unknown or suspected to exist, which you ever had or may now have, against any of the Released Parties, arising out of or relating to your employment relationship with the Company, and/or your separation from that employment relationship, including but not limited to:

a. All claims arising out of or relating to the statements, actions, or omissions of the Released Parties.

b. All claims for any alleged unlawful discrimination, harassment, retaliation or reprisal, or other alleged unlawful practices arising under any federal, state, or local statute, ordinance, or regulation, including without limitation, claims under Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1866, the Age Discrimination in Employment Act of 1967, as amended (including the Older Workers Benefit Protection Act); the Americans with Disabilities Act of 1990, as amended; the Civil Rights Act of 1991; the Family and Medical Leave Act of 1993; the Equal Pay Act of 1963; the Worker Adjustment and Retraining Notification Act; the Employee Retirement Income Security Act of 1974; the Fair Credit Reporting Act; and any other federal, state or local anti-discrimination acts, state wage payment statutes and non-interference or non-retaliation statutes under any applicable state or local laws or ordinances or any other legal restrictions on the Released Parties’ rights.

c. All claims for alleged wrongful discharge; breach of contract; breach of implied contract; failure to keep any promise; breach of a covenant of good faith and fair dealing; breach of fiduciary duty; promissory estoppel; your activities, if any, as a “whistleblower”; defamation; infliction of emotional distress; fraud; misrepresentation; negligence; harassment; retaliation or reprisal; constructive discharge; assault; battery; false imprisonment; invasion of privacy; interference with contractual or business relationships; any other wrongful employment practices; and violation of any other principle of common law.

d. All claims for compensation of any kind, including without limitation, commission payments, bonus payments, vacation pay, expense reimbursements, reimbursement for health and welfare benefits, and perquisites including payments, benefits, and reimbursements; except as otherwise provided in the Employment Agreement.

e. All claims for back pay, front pay, reinstatement, other equitable relief, compensatory damages, damages for alleged personal injury, liquidated damages, and punitive damages.

f. All claims for attorneys’ fees, costs, and interest.

The foregoing release shall not extend to the following: (i) your rights to receive severance under the terms of the Employment Agreement; (ii) any rights you may have to receive vested amounts under

 

7


any of the Company’s employee benefit plans and/or pension plans or programs; (iii) your rights to medical benefit continuation coverage, on a self-pay basis, pursuant to federal law (COBRA); (iv) any rights or claims that the law does not allow to be released and/or waived by private agreement; (v) any rights or claims that are based on events occurring after the date on which you sign this General Release; (vi) any rights or claims that you have relating to your outstanding equity rights to receive shares of common stock of the Company, as well as any shares of common stock of the Company that you own and (vii) any claims to indemnification or insurance coverage, including but not limited to “D&O coverage”, that you may have with respect to any claims made or threatened against you in your capacity as a director, officer or employee of the Company. You acknowledge and agree that even though claims and facts in addition to those now known or believed by you to exist may subsequently be discovered, it is your intention to fully settle and release all claims you may have against the Released Parties, whether known, unknown or suspected.

It is further understood and agreed that you are waiving any right to initiate an action in state or federal court by you or on your behalf alleging discrimination on the basis of race, sex, religion, national origin, age, disability, marital status, or any other protected status or involving any contract or tort claims based on your termination from the Company. It is also acknowledged that your termination is not in any way related to any work-related injury.

This General Release shall be construed and enforced in accordance with, and governed by, the laws of the Commonwealth of Pennsylvania, without regard to principles of conflict of laws. If any clause of this General Release should ever be determined to be unenforceable, it is agreed that this will not affect the enforceability of any other clause or the remainder of this General Release.

You understand and agree that the compensation and benefits described in the Employment Agreement offer you consideration greater than that to which you would otherwise be entitled. You acknowledge that before entering into this agreement, you have had the opportunity to consult with any attorney or other advisor of your choice, and you have been advised to do so, and to the extent you deem appropriate, you have fully availed yourself of this right. You acknowledge that you have executed this General Release knowingly and voluntarily with full understanding of its terms and after having been advised and having had the opportunity to seek and receive advice and counsel from your attorney. You acknowledge that you have been given a period of at least 21 days within which to consider this General Release or have knowingly and voluntarily waived your right to do so. You understand that you may revoke this General Release during the seven days following the execution of this General Release by delivering notice to the Company. If no such revocation occurs, this General Release shall become effective on the eighth day following the execution of this General Release.

[ Signature Page Follows ]

 

8


I hereby state that I have carefully read this General Release and that I am signing this General Release knowingly and voluntarily with the full intent of releasing the Released Parties from any and all claims, except as set forth herein. Further, if signed prior to the completion of the 21 day review period, this is to acknowledge that I knowingly and voluntarily signed this General Release on an earlier date .

 

 

 

Date

   

 

 

Kenneth R. Bull

 

9

Exhibit 10.22

FIVE BELOW, INC.

EQUITY INCENTIVE PLAN

NON-QUALIFIED STOCK OPTION AGREEMENT

THIS NON-QUALIFIED STOCK OPTION AGREEMENT (the “Award Agreement”) dated as of October 14, 2010 (hereinafter referred to as the “Date of Grant”) is made by and between Five Below, Inc. (the “Company”) and David Schlessinger (the “Optionee”).

1. Grant of Option; Term of Option . The Company hereby grants to the Optionee an option (the “Option”) to purchase a total of 2,919,973 shares of Common Stock of the Company (the “Option Shares”) on the Date of Grant, at the price and on the terms set forth herein, and in all respects subject to the terms, definitions and provisions of the Five Below, Inc. Equity Incentive Plan (the “Plan”) applicable to non-qualified stock options, which terms and provisions are hereby incorporated by reference herein. Unless the context herein otherwise requires, the terms defined in the Plan shall have the same meanings when used herein. This Option shall expire at 11:59 p.m. Eastern Standard Time on the tenth anniversary of the Date of Grant, subject to earlier termination, as provided in the Plan or Section 5 hereof.

2. Nature of the Option . This Option is intended to be a nonstatutory stock option and is not intended to be an Incentive Stock Option within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), or to otherwise qualify for any special tax benefits to the Optionee.

3. Option Exercise Price . The Option exercise price is $2.18 per Share, which the Board has determined is not less than the Fair Market Value of a Share on the Date of Grant.

4. Exercise of Option . This Option shall be exercisable during its term only in accordance with the terms and provisions of the Plan and this Award Agreement as follows:

(a) Right to Exercise . 50% of the Option shall vest and become exercisable in accordance with Section 4(a)(i) hereof (the “Time-Vesting Option) and 50% of the Option shall vest and become exercisable in accordance with Section 4(a)(ii) hereof (the “Performance-Vesting Option”).

(i) Time-Vesting Option .

(A) Except as provided in Section 4(a)(i)(B) hereof, subject to the Optionee’s continued employment with the Company, on each applicable vesting date, 25% of the Time-Vesting Option shall vest and become exercisable on the first anniversary of the Date of Grant, and an additional 6.25% of such Time-Vesting Option shall vest on each January 14, April 14, July 14 and October 14 thereafter, commencing with January 14, 2011, so that the Time-Vesting Option shall become fully vested on the fourth anniversary of the Date of Grant.


(B) In the event of a Change in Control, the Time-Vesting Option shall vest and become fully exercisable immediately prior to the Change in Control; provided that the Optionee is employed by the Company immediately prior to the occurrence of such Change in Control.

(ii) Performance-Vesting Option .

(A) Subject to the Optionee’s continued employment with the Company on each applicable vesting date:

(1) 33.3% of the Performance-Vesting Option (“Tranche 1”) shall vest on the date on which (x) the “Purchasers” (as defined below) receive “Proceeds” (as defined below) equal to at least 2.0 times the amount of “Purchasers’ Investment” (as defined below) or (y) the “IRR” (as defined below) for the Purchasers is greater than or equal to 30%;

(2) an additional 33.3% of the outstanding unvested Performance-Vesting Option (“Tranche 2”) shall vest on the date on which (x) the Purchasers receive Proceeds equal to at least 2.5 times the Purchasers’ Investment or (y) the IRR for the Purchasers is greater than or equal to 40%; and

(3) the remaining 33.3% of the outstanding unvested Performance-Vesting Option (“Tranche 3”) shall vest on the date on which (x) the Purchasers receive Proceeds equal to at least 3.0 times the Purchasers’ Investment or (y) the IRR for the Purchasers is greater than or equal to 50%.

“Purchasers” shall mean Advent International GPE VI Limited Partnership, Advent International GPE VI-A Limited Partnership, Advent International GPE VI-B Limited Partnership, Advent International GPE VI-C Limited Partnership, Advent International GPE VI-D Limited Partnership, Advent International GPE VI-E Limited Partnership, Advent International GPE VI-F Limited Partnership, Advent International GPE VI-G Limited Partnership, Advent Partners GPE VI 2008 Limited Partnership, Advent Partners GPE VI 2009 Limited Partnership, Advent Partners GPE VI 2010 Limited Partnership, Advent Partners GPE VI-A Limited Partnership, and Advent Partners GPE VI-A 2010 Limited Partnership.

“Purchasers’ Investment” shall mean the amount of the Purchasers’ investment in the Company pursuant to the Investment Agreement, dated September 1, 2010, (the “Investment Agreement”) by and among the Company and certain parties thereto, including the Purchasers.

 

2


“Proceeds” shall mean the aggregate amount of (i) cash proceeds actually received by the Purchasers as a result of a sale or disposition of any of the shares of the Company that are acquired by Purchasers pursuant to the Investment Agreement (the “Purchasers’ Shares”), (ii) any other cash dividend or distribution received by the Purchasers with respect to the Purchasers’ Shares, (iii) the value of any Purchasers’ Shares that are distributed to the Purchasers’ partners and affiliates, and (iv) any fees received by the Purchasers in connection with any transaction. For purposes of this definition, the Purchasers’ Shares that are distributed to Purchasers’ partners and affiliates shall be valued at their fair market value on the date of distribution, as determined in good faith by the Board.

“IRR” shall mean the interest rate (compounded annually), which when used to calculate the net present value of all Cash Inflows and all Cash Outflows, causes such net amount to equal zero, and shall be calculated at the times and in the manner set forth herein. “Cash Inflows” shall mean the Purchasers’ Investment. “Cash Outflows” shall include all cash payments of dividends, distributions, redemptions, premiums and proceeds received by the Purchasers as a result of a sale or disposition of any Purchasers’ Shares.

(B) Notwithstanding anything herein to the contrary, so long as the Optionee continues to be employed by the Company on the applicable vesting dates, the applicable unvested Tranche shall vest (i) on the 9th month anniversary of the consummation of an initial public offering of the Company’s Common Stock (an “IPO”) if the applicable Market Cap targets (as set forth in the schedule below) are achieved during the 9-month period immediately following the consummation of the IPO, and (ii) thereafter, any Tranche that did not become vested pursuant to clause (i) shall become vested on the last day of the first Measurement Period that the applicable Market Cap targets (as set forth in the schedule below) for such Tranche are achieved. “Measurement Period” shall mean any two consecutive fiscal quarters following the 9th month anniversary of the consummation of the IPO. “Market Cap” shall be determined by the Board based on the average daily closing price of a share of the Company’s publicly traded Common Stock during the applicable measurement period (i.e., the 9-month period immediately following the consummation of the IPO or a Measurement Period).

 

3


Tranche

   Market Cap
Targets
 

Tranche 1

   $ 608 million   

Tranche 2

   $ 768 million   

Tranche 3

   $ 930 million   

(b) Method of Exercise . The Optionee may exercise this Option, to the extent vested, by providing written notice stating the election to exercise this Option. Such written notice must be signed by the Optionee and must be delivered in person or by certified mail to the Secretary of the Company or such other person as may be designated by the Company. The written notice must be accompanied by payment of the option exercise price in the manner described in Section 4(c) hereof, by an executed Stock Restriction Agreement described in Section 4(f) hereof and a joinder agreement to the Shareholders Agreement (as defined below) described in Section 4(g) hereof and by any other agreements required by the Board or its Committee and or the terms of the Plan, which other agreements may restrict the sale or other transfer of the Shares and may include certain additional representations and agreements as to the Optionee’s investment intent with respect to the Shares. This Option will be deemed to be exercised only upon the receipt by the Company of such written notice, payment of the option exercise price, and duly executed copies of the Stock Restriction Agreement, joinder, and any other agreements required by the Board or its Committee, the terms of the Plan and/or this Award Agreement. The Optionee will have no right to vote or receive dividends and will have no other rights as a stockholder with respect to such Shares notwithstanding the exercise of this Option, until the issuance (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) of the stock certificate(s) evidencing Shares that are being issued upon exercise of this Option. The certificate(s) for the Shares will be registered in the name of the Optionee and will contain any legend as may be required under the Plan, this Award Agreement, and or applicable law.

(c) Method of Payment . The method of payment of the option exercise price may consist entirely of cash, certified check, payment through delivery of Shares (including Shares that would otherwise be obtained upon exercise of this Option) valued at their Fair Market Value at the time of exercise, or such other consideration or method of payment as may be authorized under the Plan.

(d) Partial Exercise . This Option may be exercised in whole or in part; provided, however, that any exercise may apply only with respect to a whole number of Shares.

(e) Restrictions on Exercise . This Option may not be exercised if the issuance of these Shares upon such exercise would constitute a violation of an applicable federal or state securities laws or other laws or regulations. In addition, as a further condition to the exercise of this Option, the Company may require the Optionee to make any representation or warranty to the Company as may be required by or advisable under an applicable law or regulation.

 

4


(f) Stock Restriction Agreement . In connection with and as a condition of exercising this Option, the Optionee hereby acknowledges and agrees to execute a Restriction Agreement (or other agreement restricting Optionees rights in the Shares acquired or to be acquired by the exercise of this Option) by and between Optionee, the Company and or one or more other holders of equity securities of the Company in the form that the Company provides at the time of exercise and as may be amended by the Company in it sole discretion from time to time.

(g) Shareholders Agreement . The Optionee shall not be deemed for any purpose to be the owner of any of the Option Shares underlying this Option unless, until and to the extent that (i) the Option shall have been exercised pursuant to its terms, in which case the Optionee shall execute a joinder to the Second Amended and Restated Shareholders Agreement dated September 1, 2010 between the Company and the registered holders of the Shares (the “Shareholders Agreement”) and (ii) the Company shall have issued the Option Shares for which the Optionee exercised, if applicable, and such issuance or exercise shall have been recorded on the books of the Company (which issuance and recordation shall not be unreasonably delayed). The Option Shares shall be subject to the terms and conditions set forth in the Shareholders Agreement, irrespective of whether the Optionee signs a joinder pursuant to the preceding sentence.

5. Termination of Relationship with the Company .

(a) Voluntary Termination . If the Optionee terminates his employment with the Company for any reason other than death or “Disability” (as such term is defined in the Company’s long-term disability plan in which the Optionee participates as in effect as of such termination of employment), the Option (to extent vested and exercisable at the time of such termination) may be exercised at any time within 90 days after the date of such termination. To the extent that the Option is not exercisable at the time of such termination, or to the extent the Option is not exercised within the time specified herein, the Option shall terminate.

(b) Disability . If the Optionee’s employment by the Company terminates due to Disability, the Option (to the extent vested and exercisable at the time of such termination) may be exercised by the Optionee or his legal guardian or representative at any time within 12 months after such termination. To the extent that the Option is not vested and exercisable on the date of termination, or to the extent the Option is not exercised within the time specified herein, the Option shall terminate.

(c) Death . If the Optionee’s employment by the Company terminates due to his death, the Option (to the extent vested and exercisable at the time of such death) will remain exercisable for 12 months after the date of death by the Optionee’s estate or by a person who acquired the right to exercise the Option by bequest or inheritance. To the extent that the Option is not vested and exercisable on the date of death, or to the extent the Option is not exercised within the time specified herein, the Option shall terminate.

(d) Termination Without Cause . If the Company terminates Optionee’s employment with the Company without “Cause” (as such term is defined in the Optionee’s letter agreement with the Company, dated as of October 14, 2010), the Option (to the extent vested and exercisable at the time of such termination) may be exercised at any time within ninety (90) days

 

5


after the date of such termination. To the extent that the Option is not vested and exercisable at the time of such termination, or to the extent the Option is not exercised within the time specified herein, the Option shall terminate.

(e) Termination for Cause . If the Company terminates Optionee’s employment with the Company for Cause, the Option (either vested or unvested), to the extent not exercised as of the date of termination, shall terminate immediately and automatically, and the Optionee shall have no further rights therein.

Notwithstanding any other provision of this Section 5, the Option shall not be exercisable after the expiration of the term set forth in Section 1 hereof.

6. Non-Transferability of Option; Permitted Transfer . This Option may not be sold, pledged, assigned, hypothecated, gifted, transferred or disposed of in any manner either voluntarily or involuntarily by operation of law, other than (i) by will or by the laws of descent or distribution or (ii) to the Optionee’s “family” or to a custodian, trustee or other fiduciary (a “Permitted Transferee”) for the account of the Optionee or a member of the Optionee’s family (a “Permitted Transfer”). During the Optionee’s lifetime, this Option is exercisable only by the Optionee (or by his Permitted Transferee upon a Permitted Transfer or by such Optionee’s legal guardian or representative as provided in Sections 5(b) and (c) and this Section 6). “Family” shall include the Optionee’s spouse, parent, sibling (by blood or adoption) or lineal ancestor or descendant (by blood or adoption). A Permitted Transferee may not further assign or transfer this Option otherwise than by will or the laws of descent and distribution. Subject to the foregoing and the terms of the Plan, the terms of this Option will be binding upon the executors, administrators, legal guardians, representatives, heirs of the Optionee, meaning for purposes of this Award Agreement, both testamentary heirs and heirs by intestacy and other Permitted Transferees. No transfer of the Option shall be effective unless the Company shall have been furnished with written notice thereof and a copy of such evidence as the Board or its Committee may deem necessary to establish the validity of the transfer and the acceptance by the transferee of the terms and conditions hereof. Each transferee of an Option by will or the laws of descent and distribution or Permitted Transferee shall, as a condition to the transfer thereof, execute an agreement pursuant to which it shall become a party to this Award Agreement. Any attempt to sell, transfer, assign, pledge or otherwise encumber or dispose of this Option contrary to the provisions of this Award Agreement, and any levy, attachment or similar process this Option shall be null and void and without effect.

7. No Continuation of Employment or Engagement . Neither the Plan nor this Option shall confer upon the Optionee any right to continue in the service of the Company or any of its Subsidiaries or limit, in any respect, the right of the Company to discharge the Optionee at any time, with or without Cause and with or without notice.

8. Lock-Up Agreement . The Optionee hereby agrees that in connection with any registration of the offering of any securities of the Company under the Securities of 1933, as amended (the “Securities Act”) for the account of the Company, if so requested by the Company, such Optionee shall not sell or otherwise transfer any securities of the Company during the period specified by the Board (the “Market Standoff Period”), with such period not to exceed 180 days following the effective date of a registration statement of the Company filed under the

 

6


Securities Act. The Company may impose stop-transfer instructions with respect to securities subject to the foregoing restrictions until the end or such Market Standoff Period. The provisions of this Section 8 shall be binding upon any Permitted Transferee or other transferee or assignee of any Shares. The provisions of this Section 8 may be modified by the Company in accordance with the Shareholders Agreement.

9. Withholding . The Company reserves the right to withhold, in accordance with any applicable laws, from any consideration payable or property transferable to Optionee any taxes required to be withheld by federal, state or local law as a result of the grant or exercise of this Option or the sale or other disposition of the Shares. If the amount of any consideration payable to the Optionee is insufficient to pay such taxes or if no consideration is payable to the Optionee, upon the request of the Company, the Optionee (or such other person entitled to exercise this Option pursuant to Sections 5 and 6 hereof) will pay to the Company an amount sufficient for the Company to satisfy any federal, state or local tax withholding requirements applicable to and as a condition to the grant or exercise of this Option or the sale or other disposition of the Shares issued upon the exercise of this Option. If elected by the Optionee in connection with his exercise of the Option, the Company shall deduct from the Shares deliverable to the Optionee upon exercise, or to accept from the Optionee the tender of, a number of whole Shares having a Fair Market Value, as determined by the Company, equal to all or any part of the tax withholding obligations of the Company. The Fair Market Value of any Shares withheld or tendered to satisfy any such tax withholding obligations shall not exceed the amount determined by the applicable minimum statutory withholding rates.

10. Adjustment . This Option is subject to adjustment as provided in Section 3 of the Plan.

11. The Plan . The Optionee has received a copy of the Plan (a copy of which is attached hereto), has read the Plan and is familiar with its terms, and hereby accepts the Option subject to all of the terms and provisions of the Plan, as amended from time to time. Pursuant to the Plan, the Board or its Committee is authorized to interpret the Plan and to adopt rules and regulations not inconsistent with the Plan as it deems appropriate. The Optionee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Board or its Committee upon any questions arising under the Plan.

12. Successors . The terms of this Award Agreement shall be binding upon and inure to the benefit of the Company, its successors and assigns, and of the Optionee and the beneficiaries, executors, administrators, heirs and successors of the Optionee.

13. Invalid Provision . The invalidity or unenforceability of any particular provision hereof shall not affect the other provisions hereof, and this Award Agreement shall be construed in al respects as if such invalid or unenforceable provision has been omitted.

14. Governing Law . This Award Agreement and all claims or causes of action (whether in contract or tort) that may be based upon, arise out of or relate to this Award Agreement or the negotiation, execution or performance of this Award Agreement (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with this Award Agreement or as an inducement to enter this Award Agreement) shall be governed by, and enforced in accordance with, the laws of the Commonwealth of Pennsylvania, without regard to the application of the principles of conflicts of laws.

 

7


15. Amendment . Subject to the provisions of the Plan, this Award Agreement may be amended at any time by the Company or its delegate; provided, however, that any modification or amendment of this Award Agreement which adversely affects the Optionee shall require the written consent of the Optionee.

16. Entire Agreement . This Award Agreement, together with the Plan, the Shareholders Agreement, the Stock Restriction Agreement, and the other exhibits attached thereto or hereto, represents the entire agreement between the parties hereto relating to the subject matter hereof, and merges and supersedes all prior and contemporaneous discussions, agreements and understandings of every nature relating to the award of Options to Optionee by the Company.

17. Section 409A of the Code . It is the intent that the grant, vesting and/or exercise of the Option set forth in this Award Agreement shall be exempt from the requirements of Section 409A of the Code, and any ambiguities herein shall be so interpreted.

18. Failure to Enforce Not A Waiver . Either party’s failure to enforce any provision or provisions of this Award Agreement shall not in any way be construed as a waiver of any such provision or provisions, nor prevent that party thereafter from enforcing each and every other provision of this Award Agreement. The rights granted to both parties herein are cumulative and shall not constitute a waiver of either party’s right to assert all other legal remedies available to it under the circumstances.

19. Notices . Any notice, request, instruction or other document given under this Award Agreement shall be in writing and shall be addressed and delivered, in the case of the Company, to the Secretary of the Company at the principal office of the Company and, in the case of the Optionee, to the Optionee’s address as shown in the records of the Company or to such other address as may be designated in writing by either party.

20. Headings . The headings of the Sections hereof are provided for convenience only and are not to serve as a basis for interpretation or construction, and shall not constitute a part, of this Award Agreement.

21. Counterparts . This Award Agreement may be executed, including execution by facsimile signature, in one or more counterparts, each of which shall be deemed an original, and all of which together shall be deemed to be one and the same instrument.

[Signature page follows]

 

8


IN WITNESS WHEREOF, this Award Agreement has been executed by the parties hereto on the date first written above.

 

FIVE BELOW, INC.
By:  

/s/ Kenneth R. Bull

Name:  

Kenneth R. Bull

Title:  

Senior Vice President, Finance

David Schlessinger

/s/ David Schlessinger

Signature

 

Address

 

THIS OPTION AND THE SECURITIES WHICH MAY BE PURCHASED UPON EXERCISE OF THIS OPTION HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS. THESE SECURITIES HAVE NOT BEEN ACQUIRED WITH A VIEW TO DISTRIBUTION OR RESALE, AND, EXCEPT AS OTHERWISE PROVIDED IN THE AWARD AGREEMENT, MAY NOT BE SOLD, ASSIGNED, EXCHANGED, MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR DISPOSED OF, BY GIFT OR OTHERWISE, OR IN ANY WAY ENCUMBERED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS, OR A SATISFACTORY OPINION OF COUNSEL SATISFACTORY TO FIVE BELOW, INC. THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT AND UNDER APPLICABLE STATE SECURITIES LAWS.


ACKNOWLEDGMENT

The Optionee acknowledges receipt or a copy or the Plan, a copy of which is attached hereto, and represents that he has read and is familiar with the terms and provisions thereof and hereby accepts this Option subject to all or the terms and provisions of the Award Agreement and the Five Below, Inc. Equity Incentive Plan (the “Plan”). The Optionee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Board or the Committee upon any questions arising under the Plan.

 

Date:  

October 14, 2010

   

 

      Signature of Optionee
     

/s/ David Schlessinger

      David Schlessinger
     

 

      Address
     

 

      City, State, Zip Code

Exhibit 10.23

FIVE BELOW, INC.

EQUITY INCENTIVE PLAN

NON-QUALIFIED STOCK OPTION AGREEMENT

THIS NON-QUALIFIED STOCK OPTION AGREEMENT (the “Award Agreement”) dated as of October 14, 2010 (hereinafter referred to as the “Date of Grant”) is made by and between Five Below, Inc. (the “Company”) and Thomas Vellios (the “Optionee”).

1. Grant of Option; Term of Option . The Company hereby grants to the Optionee an option (the “Option”) to purchase a total of 2,919,973 shares of Common Stock of the Company (the “Option Shares”) on the Date of Grant, at the price and on the terms set forth herein, and in all respects subject to the terms, definitions and provisions of the Five Below, Inc. Equity Incentive Plan (the “Plan”) applicable to non-qualified stock options, which terms and provisions are hereby incorporated by reference herein. Unless the context herein otherwise requires, the terms defined in the Plan shall have the same meanings when used herein. This Option shall expire at 11:59 p.m. Eastern Standard Time on the tenth anniversary of the Date of Grant, subject to earlier termination, as provided in the Plan or Section 5 hereof.

2. Nature of the Option . This Option is intended to be a nonstatutory stock option and is not intended to be an Incentive Stock Option within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), or to otherwise qualify for any special tax benefits to the Optionee.

3. Option Exercise Price . The Option exercise price is $2.18 per Share, which the Board has determined is not less than the Fair Market Value of a Share on the Date of Grant.

4. Exercise of Option . This Option shall be exercisable during its term only in accordance with the terms and provisions of the Plan and this Award Agreement as follows:

(a) Right to Exercise . 50% of the Option shall vest and become exercisable in accordance with Section 4(a)(i) hereof (the “Time-Vesting Option) and 50% of the Option shall vest and become exercisable in accordance with Section 4(a)(ii) hereof (the “Performance-Vesting Option”).

 

  (i) Time-Vesting Option .

(A) Except as provided in Section 4(a)(i)(B) hereof, subject to the Optionee’s continued employment with the Company, on each applicable vesting date, 25% of the Time-Vesting Option shall vest and become exercisable on the first anniversary of the Date of Grant, and an additional 6.25% of such Time-Vesting Option shall vest on each January 14, April 14, July 14 and October 14 thereafter, commencing with January 14, 2011, so that the Time-Vesting Option shall become fully vested on the fourth anniversary of the Date of Grant.


(B) In the event of a Change in Control, the Time-Vesting Option shall vest and become fully exercisable immediately prior to the Change in Control; provided that the Optionee is employed by the Company immediately prior to the occurrence of such Change in Control.

 

  (ii) Performance-Vesting Option .

(A) Subject to the Optionee’s continued employment with the Company on each applicable vesting date:

(1) 33.3% of the Performance-Vesting Option (“Tranche 1”) shall vest on the date on which (x) the “Purchasers” (as defined below) receive “Proceeds” (as defined below) equal to at least 2.0 times the amount of “Purchasers’ Investment” (as defined below) or (y) the “IRR” (as defined below) for the Purchasers is greater than or equal to 30%;

(2) an additional 33.3% of the outstanding unvested Performance-Vesting Option (“Tranche 2”) shall vest on the date on which (x) the Purchasers receive Proceeds equal to at least 2.5 times the Purchasers’ Investment or (y) the IRR for the Purchasers is greater than or equal to 40%; and

(3) the remaining 33.3% of the outstanding unvested Performance-Vesting Option (“Tranche 3”) shall vest on the date on which (x) the Purchasers receive Proceeds equal to at least 3.0 times the Purchasers’ Investment or (y) the IRR for the Purchasers is greater than or equal to 50%.

“Purchasers” shall mean Advent International GPE VI Limited Partnership, Advent International GPE VI-A Limited Partnership, Advent International GPE VI-B Limited Partnership, Advent International GPE VI-C Limited Partnership, Advent International GPE VI-D Limited Partnership, Advent International GPE VI-E Limited Partnership, Advent International GPE VI-F Limited Partnership, Advent International GPE VI-G Limited Partnership, Advent Partners GPE VI 2008 Limited Partnership, Advent Partners GPE VI 2009 Limited Partnership, Advent Partners GPE VI 2010 Limited Partnership, Advent Partners GPE VI-A Limited Partnership, and Advent Partners GPE VI-A 2010 Limited Partnership.

“Purchasers’ Investment” shall mean the amount of the Purchasers’ investment in the Company pursuant to the Investment Agreement, dated September 1, 2010, (the “Investment Agreement”) by and among the Company and certain parties thereto, including the Purchasers.

 

2


“Proceeds” shall mean the aggregate amount of (i) cash proceeds actually received by the Purchasers as a result of a sale or disposition of any of the shares of the Company that are acquired by Purchasers pursuant to the Investment Agreement (the “Purchasers’ Shares”), (ii) any other cash dividend or distribution received by the Purchasers with respect to the Purchasers’ Shares, (iii) the value of any Purchasers’ Shares that are distributed to the Purchasers’ partners and affiliates, and (iv) any fees received by the Purchasers in connection with any transaction. For purposes of this definition, the Purchasers’ Shares that are distributed to Purchasers’ partners and affiliates shall be valued at their fair market value on the date of distribution, as determined in good faith by the Board.

“IRR” shall mean the interest rate (compounded annually), which when used to calculate the net present value of all Cash Inflows and all Cash Outflows, causes such net amount to equal zero, and shall be calculated at the times and in the manner set forth herein. “Cash Inflows” shall mean the Purchasers’ Investment. “Cash Outflows” shall include all cash payments of dividends, distributions, redemptions, premiums and proceeds received by the Purchasers as a result of a sale or disposition of any Purchasers’ Shares.

(B) Notwithstanding anything herein to the contrary, so long as the Optionee continues to be employed by the Company on the applicable vesting dates, the applicable unvested Tranche shall vest (i) on the 9th month anniversary of the consummation of an initial public offering of the Company’s Common Stock (an “IPO”) if the applicable Market Cap targets (as set forth in the schedule below) are achieved during the 9-month period immediately following the consummation of the IPO, and (ii) thereafter, any Tranche that did not become vested pursuant to clause (i) shall become vested on the last day of the first Measurement Period that the applicable Market Cap targets (as set forth in the schedule below) for such Tranche are achieved. “Measurement Period” shall mean any two consecutive fiscal quarters following the 9th month anniversary of the consummation of the IPO. “Market Cap” shall be determined by the Board based on the average daily closing price of a share of the Company’s publicly traded Common Stock during the applicable measurement period (i.e., the 9-month period immediately following the consummation of the IPO or a Measurement Period).

 

3


Tranche

   Market Cap Targets  

Tranche 1

   $ 608 million   

Tranche 2

   $ 768 million   

Tranche 3

   $ 930 million   

(b) Method of Exercise . The Optionee may exercise this Option, to the extent vested, by providing written notice stating the election to exercise this Option. Such written notice must be signed by the Optionee and must be delivered in person or by certified mail to the Secretary of the Company or such other person as may be designated by the Company. The written notice must be accompanied by payment of the option exercise price in the manner described in Section 4(c) hereof, by an executed Stock Restriction Agreement described in Section 4(f) hereof and a joinder agreement to the Shareholders Agreement (as defined below) described in Section 4(g) hereof and by any other agreements required by the Board or its Committee and or the terms of the Plan, which other agreements may restrict the sale or other transfer of the Shares and may include certain additional representations and agreements as to the Optionee’s investment intent with respect to the Shares. This Option will be deemed to be exercised only upon the receipt by the Company of such written notice, payment of the option exercise price, and duly executed copies of the Stock Restriction Agreement, joinder, and any other agreements required by the Board or its Committee, the terms of the Plan and/or this Award Agreement. The Optionee will have no right to vote or receive dividends and will have no other rights as a stockholder with respect to such Shares notwithstanding the exercise of this Option, until the issuance (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) of the stock certificate(s) evidencing Shares that are being issued upon exercise of this Option. The certificate(s) for the Shares will be registered in the name of the Optionee and will contain any legend as may be required under the Plan, this Award Agreement, and or applicable law.

(c) Method of Payment . The method of payment of the option exercise price may consist entirely of cash, certified check, payment through delivery of Shares (including Shares that would otherwise be obtained upon exercise of this Option) valued at their Fair Market Value at the time of exercise, or such other consideration or method of payment as may be authorized under the Plan.

(d) Partial Exercise . This Option may be exercised in whole or in part; provided, however, that any exercise may apply only with respect to a whole number of Shares.

(e) Restrictions on Exercise . This Option may not be exercised if the issuance of these Shares upon such exercise would constitute a violation of an applicable federal or state securities laws or other laws or regulations. In addition, as a further condition to the exercise of this Option, the Company may require the Optionee to make any representation or warranty to the Company as may be required by or advisable under an applicable law or regulation.

 

4


(f) Stock Restriction Agreement . In connection with and as a condition of exercising this Option, the Optionee hereby acknowledges and agrees to execute a Restriction Agreement (or other agreement restricting Optionees rights in the Shares acquired or to be acquired by the exercise of this Option) by and between Optionee, the Company and or one or more other holders of equity securities of the Company in the form that the Company provides at the time of exercise and as may be amended by the Company in it sole discretion from time to time.

(g) Shareholders Agreement . The Optionee shall not be deemed for any purpose to be the owner of any of the Option Shares underlying this Option unless, until and to the extent that (i) the Option shall have been exercised pursuant to its terms, in which case the Optionee shall execute a joinder to the Second Amended and Restated Shareholders Agreement dated September 1, 2010 between the Company and the registered holders of the Shares (the “Shareholders Agreement”) and (ii) the Company shall have issued the Option Shares for which the Optionee exercised, if applicable, and such issuance or exercise shall have been recorded on the books of the Company (which issuance and recordation shall not be unreasonably delayed). The Option Shares shall be subject to the terms and conditions set forth in the Shareholders Agreement, irrespective of whether the Optionee signs a joinder pursuant to the preceding sentence.

5. Termination of Relationship with the Company .

(a) Voluntary Termination . If the Optionee terminates his employment with the Company for any reason other than death or “Disability” (as such term is defined in the Company’s long-term disability plan in which the Optionee participates as in effect as of such termination of employment), the Option (to extent vested and exercisable at the time of such termination) may be exercised at any time within 90 days after the date of such termination. To the extent that the Option is not exercisable at the time of such termination, or to the extent the Option is not exercised within the time specified herein, the Option shall terminate.

(b) Disability . If the Optionee’s employment by the Company terminates due to Disability, the Option (to the extent vested and exercisable at the time of such termination) may be exercised by the Optionee or his legal guardian or representative at any time within 12 months after such termination. To the extent that the Option is not vested and exercisable on the date of termination, or to the extent the Option is not exercised within the time specified herein, the Option shall terminate.

(c) Death . If the Optionee’s employment by the Company terminates due to his death, the Option (to the extent vested and exercisable at the time of such death) will remain exercisable for 12 months after the date of death by the Optionee’s estate or by a person who acquired the right to exercise the Option by bequest or inheritance. To the extent that the Option is not vested and exercisable on the date of death, or to the extent the Option is not exercised within the time specified herein, the Option shall terminate.

(d) Termination Without Cause . If the Company terminates Optionee’s employment with the Company without “Cause” (as such term is defined in the Optionee’s letter agreement with the Company, dated as of October 14, 2010), the Option (to the extent vested and exercisable at the time of such termination) may be exercised at any time within ninety (90) days

 

5


after the date of such termination. To the extent that the Option is not vested and exercisable at the time of such termination, or to the extent the Option is not exercised within the time specified herein, the Option shall terminate.

(e) Termination for Cause . If the Company terminates Optionee’s employment with the Company for Cause, the Option (either vested or unvested), to the extent not exercised as of the date of termination, shall terminate immediately and automatically, and the Optionee shall have no further rights therein.

Notwithstanding any other provision of this Section 5, the Option shall not be exercisable after the expiration of the term set forth in Section 1 hereof.

6. Non-Transferability of Option; Permitted Transfer . This Option may not be sold, pledged, assigned, hypothecated, gifted, transferred or disposed of in any manner either voluntarily or involuntarily by operation of law, other than (i) by will or by the laws of descent or distribution or (ii) to the Optionee’s “family” or to a custodian, trustee or other fiduciary (a “Permitted Transferee”) for the account of the Optionee or a member of the Optionee’s family (a “Permitted Transfer”). During the Optionee’s lifetime, this Option is exercisable only by the Optionee (or by his Permitted Transferee upon a Permitted Transfer or by such Optionee’s legal guardian or representative as provided in Sections 5(b) and (c) and this Section 6). “Family” shall include the Optionee’s spouse, parent, sibling (by blood or adoption) or lineal ancestor or descendant (by blood or adoption). A Permitted Transferee may not further assign or transfer this Option otherwise than by will or the laws of descent and distribution. Subject to the foregoing and the terms of the Plan, the terms of this Option will be binding upon the executors, administrators, legal guardians, representatives, heirs of the Optionee, meaning for purposes of this Award Agreement, both testamentary heirs and heirs by intestacy and other Permitted Transferees. No transfer of the Option shall be effective unless the Company shall have been furnished with written notice thereof and a copy of such evidence as the Board or its Committee may deem necessary to establish the validity of the transfer and the acceptance by the transferee of the terms and conditions hereof. Each transferee of an Option by will or the laws of descent and distribution or Permitted Transferee shall, as a condition to the transfer thereof, execute an agreement pursuant to which it shall become a party to this Award Agreement. Any attempt to sell, transfer, assign, pledge or otherwise encumber or dispose of this Option contrary to the provisions of this Award Agreement, and any levy, attachment or similar process this Option shall be null and void and without effect.

7. No Continuation of Employment or Engagement . Neither the Plan nor this Option shall confer upon the Optionee any right to continue in the service of the Company or any of its Subsidiaries or limit, in any respect, the right of the Company to discharge the Optionee at any time, with or without Cause and with or without notice.

8. Lock-Up Agreement . The Optionee hereby agrees that in connection with any registration of the offering of any securities of the Company under the Securities of 1933, as amended (the “Securities Act”) for the account of the Company, if so requested by the Company, such Optionee shall not sell or otherwise transfer any securities of the Company during the period specified by the Board (the “Market Standoff Period”), with such period not to exceed 180 days following the effective date of a registration statement of the Company filed under the

 

6


Securities Act. The Company may impose stop-transfer instructions with respect to securities subject to the foregoing restrictions until the end or such Market Standoff Period. The provisions of this Section 8 shall be binding upon any Permitted Transferee or other transferee or assignee of any Shares. The provisions of this Section 8 may be modified by the Company in accordance with the Shareholders Agreement.

9. Withholding . The Company reserves the right to withhold, in accordance with any applicable laws, from any consideration payable or property transferable to Optionee any taxes required to be withheld by federal, state or local law as a result of the grant or exercise of this Option or the sale or other disposition of the Shares. If the amount of any consideration payable to the Optionee is insufficient to pay such taxes or if no consideration is payable to the Optionee, upon the request of the Company, the Optionee (or such other person entitled to exercise this Option pursuant to Sections 5 and 6 hereof) will pay to the Company an amount sufficient for the Company to satisfy any federal, state or local tax withholding requirements applicable to and as a condition to the grant or exercise of this Option or the sale or other disposition of the Shares issued upon the exercise of this Option. If elected by the Optionee in connection with his exercise of the Option, the Company shall deduct from the Shares deliverable to the Optionee upon exercise, or to accept from the Optionee the tender of, a number of whole Shares having a Fair Market Value, as determined by the Company, equal to all or any part of the tax withholding obligations of the Company. The Fair Market Value of any Shares withheld or tendered to satisfy any such tax withholding obligations shall not exceed the amount determined by the applicable minimum statutory withholding rates.

10. Adjustment . This Option is subject to adjustment as provided in Section 3 of the Plan.

11. The Plan . The Optionee has received a copy of the Plan (a copy of which is attached hereto), has read the Plan and is familiar with its terms, and hereby accepts the Option subject to all of the terms and provisions of the Plan, as amended from time to time. Pursuant to the Plan, the Board or its Committee is authorized to interpret the Plan and to adopt rules and regulations not inconsistent with the Plan as it deems appropriate. The Optionee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Board or its Committee upon any questions arising under the Plan.

12. Successors . The terms of this Award Agreement shall be binding upon and inure to the benefit of the Company, its successors and assigns, and of the Optionee and the beneficiaries, executors, administrators, heirs and successors of the Optionee.

13. Invalid Provision . The invalidity or unenforceability of any particular provision hereof shall not affect the other provisions hereof, and this Award Agreement shall be construed in al respects as if such invalid or unenforceable provision has been omitted.

14. Governing Law . This Award Agreement and all claims or causes of action (whether in contract or tort) that may be based upon, arise out of or relate to this Award Agreement or the negotiation, execution or performance of this Award Agreement (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with this Award Agreement or as an inducement to enter this Award Agreement) shall be governed by, and enforced in accordance with, the laws of the Commonwealth of Pennsylvania, without regard to the application of the principles of conflicts of laws.

 

7


15. Amendment . Subject to the provisions of the Plan, this Award Agreement may be amended at any time by the Company or its delegate; provided, however, that any modification or amendment of this Award Agreement which adversely affects the Optionee shall require the written consent of the Optionee.

16. Entire Agreement . This Award Agreement, together with the Plan, the Shareholders Agreement, the Stock Restriction Agreement, and the other exhibits attached thereto or hereto, represents the entire agreement between the parties hereto relating to the subject matter hereof, and merges and supersedes all prior and contemporaneous discussions, agreements and understandings of every nature relating to the award of Options to Optionee by the Company.

17. Section 409A of the Code . It is the intent that the grant, vesting and/or exercise of the Option set forth in this Award Agreement shall be exempt from the requirements of Section 409A of the Code, and any ambiguities herein shall be so interpreted.

18. Failure to Enforce Not A Waiver . Either party’s failure to enforce any provision or provisions of this Award Agreement shall not in any way be construed as a waiver of any such provision or provisions, nor prevent that party thereafter from enforcing each and every other provision of this Award Agreement. The rights granted to both parties herein are cumulative and shall not constitute a waiver of either party’s right to assert all other legal remedies available to it under the circumstances.

19. Notices . Any notice, request, instruction or other document given under this Award Agreement shall be in writing and shall be addressed and delivered, in the case of the Company, to the Secretary of the Company at the principal office of the Company and, in the case of the Optionee, to the Optionee’s address as shown in the records of the Company or to such other address as may be designated in writing by either party.

20. Headings . The headings of the Sections hereof are provided for convenience only and are not to serve as a basis for interpretation or construction, and shall not constitute a part, of this Award Agreement.

21. Counterparts . This Award Agreement may be executed, including execution by facsimile signature, in one or more counterparts, each of which shall be deemed an original, and all of which together shall be deemed to be one and the same instrument.

[Signature page follows]

 

8


IN WITNESS WHEREOF, this Award Agreement has been executed by the parties hereto on the date first written above.

 

FIVE BELOW, INC.
By:  

/s/ Kenneth R. Bull

Name:  

Kenneth R. Bull

Title:  

Senior Vice President, Finance

Thomas Vellios

/s/ Thomas Vellios

Signature

 

Address

 

THIS OPTION AND THE SECURITIES WHICH MAY BE PURCHASED UPON EXERCISE OF THIS OPTION HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS. THESE SECURITIES HAVE NOT BEEN ACQUIRED WITH A VIEW TO DISTRIBUTION OR RESALE, AND, EXCEPT AS OTHERWISE PROVIDED IN THE AWARD AGREEMENT, MAY NOT BE SOLD, ASSIGNED, EXCHANGED, MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR DISPOSED OF, BY GIFT OR OTHERWISE, OR IN ANY WAY ENCUMBERED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS, OR A SATISFACTORY OPINION OF COUNSEL SATISFACTORY TO FIVE BELOW, INC. THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT AND UNDER APPLICABLE STATE SECURITIES LAWS.


ACKNOWLEDGMENT

The Optionee acknowledges receipt or a copy or the Plan, a copy of which is attached hereto, and represents that he has read and is familiar with the terms and provisions thereof and hereby accepts this Option subject to all or the terms and provisions of the Award Agreement and the Five Below, Inc. Equity Incentive Plan (the “Plan”). The Optionee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Board or the Committee upon any questions arising under the Plan.

 

Date:  

October 14, 2010

   

 

      Signature of Optionee
     

/s/ Thomas Vellios

      Thomas Vellios
     

 

Address

     

 

City, State, Zip Code

Exhibit 10.24

OPTION CANCELLATION AGREEMENT

Five Below, Inc.

1818 Market Street

Suite 1900

Philadelphia, PA 19103

March 22, 2012

David Schlessinger

Dear David,

Reference is made to the Non-Qualified Stock Option Agreement, between Five Below, Inc. and you, dated October 14, 2010 (the “ Option Agreement ”), pursuant to which 2,919,973 non-qualified stock options (the “ Options ”) were granted to you under the Five Below, Inc. Equity Incentive Plan, as amended (the “ Plan ”). Pursuant to the terms and conditions of this Option Cancellation Agreement (the “ Agreement ”), you agree to the cancellation of the Options in exchange for which Five Below, Inc. (the “ Company ”) will make two grants of restricted stock, as described herein, to you.

All capitalized terms used herein and not otherwise defined have the meanings set forth in the Plan. A copy of the Plan is attached hereto. In the event of any inconsistency between the Plan and this Agreement (other than with respect to the treatment of dividends as specified below), the terms of the Plan shall control.

Cancellation of Options . You agree that the Options shall be cancelled as of the date hereof and, as of the date hereof, you shall have no further rights pursuant to either such Options or the Option Agreement.

Restricted Shares : You are hereby awarded 973,325 Restricted Shares (the “ Vested Stock ”), which shall be made under and subject to the terms of the Plan. The Vested Stock shall be fully vested and not subject to any forfeiture restrictions on the date of grant and any dividends in cash, stock or other property made with respect to the Vested Stock will be made to you at the time or times as such dividends are otherwise paid to the shareholders of the Company. However, (i) the Vested Stock shall not be granted to you until the date on which you pay to the Company, in cash, an amount equal to the applicable withholding and other taxes that the Company is required to withhold and deposit in connection with the grant of the Vested Stock to you and (ii) the Vested Stock shall not be granted to you unless you make such payment to the Company on or prior to March 23, 2012.

In addition, as of the date hereof, you will also be granted 1,946,648 Restricted Shares (the “ Restricted Stock ”), which shall be made under and subject to terms of the Plan; provided however, that notwithstanding Section 7(c)(ii) of the Plan, any dividends in cash, stock or other property made with respect to the Restricted Stock will be made to you at the time or times as such dividends are otherwise paid to the shareholders of the


Company, regardless of whether the Restricted Stock underlying the dividend right is then subject to forfeiture. The forfeiture restrictions applicable to the Restricted Stock will, subject to your continued employment with the Company and its Affiliates as of such date, lapse according to the following schedule:

 

   

973,324 Restricted Shares shall lapse and become free from risk of forfeiture on the first anniversary of the date hereof; and

 

   

973,324 Restricted Shares shall lapse and become free from risk of forfeiture on the second anniversary of the date hereof.

Notwithstanding the foregoing, upon (i) a “Change in Control Transaction” (as such term is defined in the Employment Agreement between you and the Company, dated October 14, 2010, as amended (the “ Employment Agreement ”)), (ii) your termination of employment by the Company and its Affiliates without “Cause” (as such term is defined in the Employment Agreement), (iii) your termination of employment with the Company and its Affiliates due to your death or Disability or (iv) your voluntary termination of employment with the Company and its Affiliates due to “Good Reason” (as such term is defined in the Employment Agreement), the forfeiture restrictions underlying your Restricted Stock will immediately and fully lapse and the Restricted Stock shall become free from any forfeiture restrictions. If your employment with the Company and its Affiliates terminates or is terminated for any other reason, any Restricted Stock that are then still subject to forfeiture restrictions as of such date shall be immediately forfeited with no other compensation due to you.

As a further condition of the grant of the Restricted Stock, you are required to make a valid, timely election (in substantially the form attached hereto as Exhibit A) to include in your current year income the fair market value of the Restricted Stock, pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended. Upon making such election, you shall promptly furnish a copy of the election to the Company. THE COMPANY SHALL BEAR NO RESPONSIBILITY OR LIABILITY FOR ANY ADVERSE TAX CONSEQUENCES RESULTING FROM YOUR CODE SECTION 83(b) ELECTION OR YOUR FAILURE TO MAKE SUCH ELECTION.

The terms of the Vested Stock and the Restricted Stock, as reflected above, shall be made in the form of the Award Agreements attached hereto as Exhibits A and B, respectively.

Withholding . You agree that, no later than the date on which you make the required 83(b) election, you will pay to the Company in cash the amount of any applicable withholding and other taxes that the Company is required to withhold and deposit in connection with your making the 83(b) election with respect to the Restricted Stock.

No Right to Continued Service . Nothing in this Agreement shall confer on you the right to continue in the employ or other service of the Company or any of its Affiliates or interfere in any way with the right of the Company or any of its Affiliates to terminate your employment or other service at any time and for any reason.

No Reliance . You acknowledge that the Company has not provided any information to you concerning the tax consequences associated with the transactions set forth in this Agreement and you represent that you have consulted with your own tax advisers in regard to such tax consequences.


Entire Agreement . This Agreement contains the entire agreement between the parties, including their respective affiliates, concerning the subject matter hereof and supersedes all prior agreements, understandings, discussions, negotiations and undertakings, whether written or oral, between the parties with respect thereto; additionally, this Agreement shall supersede the Plan, solely with respect to the treatment of dividends paid with respect to unvested Restricted Stock, in each case only to the extent as specifically set forth above.

Governing Law . All issues and questions concerning the application, construction, validity, interpretation and enforcement of this Agreement and the terms and conditions of the award of the Vested Stock and the Restricted Stock shall be governed by, and construed in accordance with, the laws of the Commonwealth of Pennsylvania, without giving effect to any choice of law or conflict of law rules or provisions (whether of the Commonwealth of Pennsylvania or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the Commonwealth of Pennsylvania.

Counterparts . This Agreement may be executed in one or more counterparts each of which shall be deemed an original instrument, but all of which together shall constitute but one and the same Agreement.

[Remainder of Page Intentionally Left Blank]


Your signature will also acknowledge that this letter reflects our final agreement regarding the cancellation of the Options and the award of the Vested Stock and the Restricted Stock and that you agree to abide by the applicable terms of this Agreement (including with respect to the Vested Stock and Restricted Stock, abiding by the terms of the Plan applicable to such grant).

 

Very truly yours,
Five Below, Inc.
By:  

/s/ Kenneth R. Bull

Name:   Kenneth R. Bull
Title:   Senior Vice President, Secretary and Treasurer
Dated:   March 22, 2012

 

ACKNOWLEDGED AND ACCEPTED

/s/ David Schlessinger

David Schlessinger
Dated: March 22, 2012


EXHIBIT A

Guidelines for 83(b) Election

 

  1. The making of an 83(b) election has serious tax consequences; you are strongly urged to consult a tax professional with regard to this election. An 83(b) election is not required under the Internal Revenue Code of 1986, but it is required as a condition under the Option Cancellation Agreement.

 

  2. Under an 83(b) election, taxable compensation, if any, is based on value of the stock on the date of grant. Accordingly, you will realize compensation income in this amount as a result of this 83(b) election.

 

  3. Filing should be made by certified mail, return receipt requested to the Internal Revenue Service Center at which your federal income tax return is filed.

 

  4. The 83(b) election must be filed with the IRS within 30 days after the stock is transferred to you.

 

  5. It is recommended that three of the 83(b) election forms be stamped by the IRS as proof of filing. Accordingly, please send a self-addressed stamped envelope and four copies of the 83(b) election form and the enclosed cover letter to the IRS, requesting that three copies of each document be returned. Of these three documents:

 

  a. 1 set of copies is given to Five Below, Inc. (the “Company”)

 

  b. 1 set of copies is filed with your Federal Income Tax Return

 

  c. 1 set of copies may be required to be filed with your State Income Tax Return.

Requirements under state or local income tax laws vary. For example, in some states the filing of an 83(b) election with the Internal Revenue Service constitutes the making of the election under comparable state provisions, while in other states a separate state election is required. You are also urged to consult a tax professional regarding state or local tax implications .

 

  6. An 83(b) election may not be revoked without consent of the IRS.

 

  7. Before you submit your 83(b) election to the IRS, please deliver an executed copy of the election to the Company and keep a copy of the election form, the cover letter and the registered mail receipt with your permanent records.

YOU ARE SOLELY RESPONSIBLE FOR TIMELY FILING YOUR SECTION 83(B) ELECTION. THE COMPANY SHALL BEAR NO RESPONSIBILITY OR LIABILITY FOR ANY ADVERSE TAX CONSEQUENCES DUE TO YOUR FAILURE TO MAKE SUCH ELECTION OR YOUR MAKING SUCH ELECTION. PLEASE NOTE THAT BECAUSE THE PURCHASE PRICE FOR THE STOCK WAS $0.00, YOU WILL NOT BE ENTITLED TO RECOGNIZE A TAXABLE LOSS OR ANY OTHER INCOME TAX DEDUCTION IF THE STOCK IS FORFEITED DUE TO YOUR FAILURE TO SATISFY THE VESTING CONDITIONS.


EXHIBIT B

Restricted Share Award Agreement

(Vested Stock)


A WARD A GREEMENT FOR R ESTRICTED S HARES

UNDER THE

F IVE B ELOW , I NC . E QUITY I NCENTIVE P LAN

THIS AWARD AGREEMENT FOR RESTRICTED SHARES (this “ Agreement ”) is made between Five Below, Inc. (the “ Company ”) and David Schlessinger (the “ Grantee ”), dated March 22, 2012 (the “ Effective Date ”).

WHEREAS, pursuant to the terms of the Option Cancellation Agreement between the Grantee and the Company, dated March 22, 2012 (the “ Option Cancellation Agreement ”) the Company desires to award 973,325 Restricted Shares to the Grantee under the Five Below, Inc. Equity Incentive Plan, as amended (the “ Plan ”), pursuant to the terms of this Agreement, and 1,946,648 Restricted Shares pursuant to a separate award agreement

NOW, THEREFORE, in consideration of these premises and the agreements set forth herein, the parties, intending to be legally bound hereby, agree as follows:

1. Award of Restricted Stock . As of the Effective Date, pursuant to the Plan and the Option Cancellation Agreement, the Company hereby awards to the Grantee 973,325 Restricted Shares (the “ Award ”), subject to the restrictions and on the terms and conditions set forth in this Agreement, the Option Cancellation Agreement and the Plan. The terms of the Plan are hereby incorporated into this Agreement by this reference, as though fully set forth herein. Capitalized terms used but not defined herein will have the same meaning as defined in the Plan.

2. Vesting of Restricted Shares . The Restricted Shares subject to this Award are fully vested as of the Effective Date and are free from risk of forfeiture as of the Effective Date:

3. Issuance of Shares .

(a) The Company will cause the Restricted Shares to be issued in the Grantee’s name either by book-entry registration or issuance of a stock certificate or certificates. Any shares issued to the Grantee hereunder shall be fully paid and non-assessable.

(b) If any certificate is issued in respect of Restricted Shares, that certificate will be legended as described herein.

4. Dividend Rights . Any dividends in cash, stock or other property made with respect to the Restricted Shares will be made to the Grantee at the time or times as such dividends are otherwise paid to the common shareholders of the Company.


5. Additional Documents . As a condition to the effectiveness of the award of Restricted Shares hereunder:

(a) the Grantee agrees that the Restricted Shares shall be subject to the Second Amended and Restated Shareholders Agreement dated September 1, 2010 by and among the Company and its shareholders (the “ Shareholders Agreement ”) to which the Grantee is already a party; and

(b) the Grantee agrees upon request to execute any further documents or instruments necessary or desirable to carry out the purposes or intent of this Agreement.

6. Restriction on Transfer of Restricted Shares . The Restricted Shares or any beneficial interest therein may be transferred, encumbered, pledged or otherwise alienated or disposed of in any way by the Grantee at any time, subject to the transfer restrictions set forth in the Shareholders Agreement.

7. Share Legends . All stock certificates representing the Restricted Shares underlying the Award shall have affixed thereto legends substantially in the following form (as may be modified by the Company in accordance with the Shareholders Agreement), in addition to any other legends required by applicable state law:

THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AS AMENDED, (THE “ SECURITIES ACT ”), OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE TRANSFERRED WITHOUT REGISTRATION UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL, SATISFACTORY TO FIVE BELOW, INC., THAT SUCH REGISTRATION IS NOT REQUIRED. THE SHARES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, ENCUMBERED, OR IN ANY MANNER DISPOSED OF EXCEPT IN CONFORMITY WITH THE TERMS OF THE SECOND AMENDED AND RESTATED SHAREHOLDERS AGREEMENT DATED SEPTEMBER 1, 2010, BETWEEN FIVE BELOW, INC. AND THE REGISTERED HOLDER OF THE SHARES (OR THE PREDECESSOR IN INTEREST TO THE SHARES), A COPY OF WHICH IS AVAILABLE AT THE PRINCIPAL OFFICES OF FIVE BELOW, INC. SUCH AGREEMENT GRANTS CERTAIN RIGHTS TO FIVE BELOW, INC. (OR ITS ASSIGNEES) UPON THE SALE, ASSIGNMENT, TRANSFER, ENCUMBRANCE OR OTHER DISPOSITION OF FIVE BELOW, INC.’S SHARES. FIVE BELOW, INC. WILL UPON WRITTEN REQUEST FURNISH A COPY OF SUCH AGREEMENT TO THE HOLDER HEREOF WITHOUT CHARGE.

8. Withholding . The Company confirms that on the Effective Date the Grantee has paid to the Company, in cash, an amount equal to the applicable withholding and other taxes that the Company is required to withhold and deposit in connection with the grant of the Restricted Shares to the Grantee.

9. The Plan . The Grantee has received a copy of the Plan, has read the Plan and is familiar with its terms, and hereby accepts the Restricted Shares subject to all of the terms and provisions of the Plan, as amended from time to time. Pursuant to the Plan, the Board or its Committee is authorized to interpret the Plan and to adopt rules and regulations not inconsistent with the Plan as it deems appropriate. The Grantee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Board or its Committee upon any questions arising under the Plan.


10. Representations and Warranties . By executing this Agreement, the Grantee hereby represents, warrants, covenants, acknowledges and/or agrees that:

(a) The Restricted Shares are being acquired for the Grantee’s own account, for investment purposes only, and not for the account of any other person, and not with a view to the distribution thereof within the meaning of the Securities Act of 1933, as amended (the “ Securities Act ”);

(b) No other person (other than the Grantee and the Company) has or will have a direct or indirect beneficial interest in the Restricted Shares;

(c) The Restricted Shares have not been registered or qualified under the Securities Act or any state securities laws;

(d) There is no public market for the Restricted Shares, there can be no assurance that any such market will ever develop and, therefore, the Grantee may be required to hold the Restricted Shares indefinitely;

(e) In addition to complying with other similar restrictions contained herein, the Grantee will not sell, transfer, pledge, hypothecate or otherwise dispose of any interest in the Restricted Shares unless such interest is registered in accordance with the Securities Act and applicable state securities laws or an exemption from such registration is available and, if required by the Company, an opinion of counsel is delivered to the Company, in a form satisfactory to the Company, that such registration is unnecessary; and

(f) The Company is under no obligation to register the Restricted Shares on behalf of the Grantee or to assist the Grantee in complying with any exemption from registration.

11. General Provisions :

(a) This Agreement, together with the Plan, the Option Cancellation Agreement and the Shareholders Agreement, represent the entire agreement between the parties with respect to the award of the Restricted Shares that are subject to this Agreement and may only be modified or amended in a writing signed by both parties.

(b) Neither this Agreement nor any rights or interest hereunder shall be assignable by the Grantee, his beneficiaries or legal representatives, and any purported assignment in violation hereof shall be null and void.

(c) Either party’s failure to enforce any provision or provisions of this Agreement shall not in any way be construed as a waiver of any such provision or provisions, nor prevent that party thereafter from enforcing each and every other provision of this Agreement. The rights granted both parties herein are cumulative and shall not constitute a waiver of either party’s right to assert all other legal remedies available to it under the circumstances.


(d) The grant of Restricted Shares hereunder will not confer upon the Grantee any right to continue in service with the Company or any of its subsidiaries or affiliates.

(e) This Agreement and all claims or causes of action (whether in contract or tort) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance of this Agreement (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with this Agreement or as an inducement to enter this Agreement) shall be governed by, and enforced in accordance with, the laws of the Commonwealth of Pennsylvania, without regard to the application of the principles of conflicts of laws.

(f) This Agreement may be executed, including execution by facsimile signature, in one or more counterparts, each of which shall be deemed an original, and all of which together shall be deemed to be one and the same instrument.

[ signature page follows ]


IN WITNESS WHEREOF, the parties have duly executed this Award Agreement for Restricted Shares on the 22nd day of March, 2012.

 

FIVE BELOW, INC.
By:  

/s/ Kenneth R. Bull

Name:   Kenneth R. Bull
Title:   Senior Vice President, Finance, Secretary and Treasurer

/s/ David Schlessinger

DAVID SCHLESSINGER


EXHIBIT C

Restricted Share Award Agreement

(Restricted Stock)


A WARD A GREEMENT FOR R ESTRICTED S HARES

UNDER THE

F IVE B ELOW , I NC . E QUITY I NCENTIVE P LAN

THIS AWARD AGREEMENT FOR RESTRICTED SHARES (this “ Agreement ”) is made between Five Below, Inc. (the “ Company ”) and David Schlessinger (the “ Grantee ”), dated March 22, 2012 (the “ Effective Date ”).

WHEREAS, pursuant to the terms of the Option Cancellation Agreement between the Grantee and the Company, dated March 22, 2012 (the “ Option Cancellation Agreement ”) the Company desires to award 1,946,648 Restricted Shares to the Grantee under the Five Below, Inc. Equity Incentive Plan, as amended (the “ Plan ”), pursuant to the terms of this Agreement, and 973,325 Restricted Shares pursuant to a separate award agreement

NOW, THEREFORE, in consideration of these premises and the agreements set forth herein, the parties, intending to be legally bound hereby, agree as follows:

1. Award of Restricted Stock . As of the Effective Date, pursuant to the Plan and the Option Cancellation Agreement, the Company hereby awards to the Grantee 1,946,648 Restricted Shares (the “ Award ”), subject to the restrictions and on the terms and conditions set forth in this Agreement, the Option Cancellation Agreement and the Plan. The terms of the Plan are hereby incorporated into this Agreement by this reference, as though fully set forth herein. Capitalized terms used but not defined herein will have the same meaning as defined in the Plan.

2. Vesting of Restricted Shares .

(a) Vesting Schedule . The Award will vest and become free from forfeiture restrictions according to the following schedule:

i. 973,324 Restricted Shares shall vest and become free from risk of forfeiture on the on the first anniversary of the Effective Date; and

ii. 973,324 Restricted Shares shall vest and become free from risk of forfeiture on the on the second anniversary of the Effective Date.

(b) Vesting Upon Certain Events . Notwithstanding the foregoing, upon (i) a “Change in Control Transaction” (as such term is defined in the Employment Agreement between the Grantee and the Company, dated October 14, 2010, as amended (the “ Employment Agreement ”)), (ii) the Grantee’s termination of employment by the Company and its Affiliates without “Cause” (as such term is defined in the Employment Agreement), (iii) the Grantee’s termination of employment with the Company and its Affiliates due to death or Disability or (iv) the Grantee’s voluntary termination of employment with the Company and its Affiliates due to “Good Reason” (as such term is defined in the Employment Agreement), all of the Restricted Shares underlying the Award will immediately and fully vest and become free from any forfeiture restrictions. If the Grantee’s employment with the Company and its Affiliates terminates or is


terminated for any other reason, any Restricted Shares that are then still subject to forfeiture restrictions as of such date shall be immediately forfeited with no other compensation due to the Grantee.

3. Issuance of Shares .

(a) The Company will cause the Restricted Shares to be issued in the Grantee’s name either by book-entry registration or issuance of a stock certificate or certificates. Any shares issued to the Grantee hereunder shall be fully paid and non-assessable.

(b) While the Restricted Shares remain subject to forfeiture to the Company pursuant to Section 2 above, the Company will cause an appropriate stop-transfer order to be issued and to remain in effect with respect to the Restricted Shares. As soon as practicable following the time that any Restricted Share becomes vested (and provided that appropriate arrangements have been made with the Company for the withholding or payment of any taxes that may be due with respect to such Share), the Company will cause that stop-transfer order to be removed. The Company may also condition delivery of certificates for Restricted Shares upon receipt from the Grantee of any undertakings that it may determine are appropriate to facilitate compliance with federal and state securities laws.

(c) If any certificate is issued in respect of Restricted Shares, that certificate will be legended as described herein and held in escrow by the Company’s secretary or his or her designee. In addition, the Grantee may be required to execute and deliver to the Company a stock power with respect to those Restricted Shares. At such time as those Restricted Shares become vested, the Company will cause a new certificate to be issued without that portion of the legend referencing the previously applicable vesting conditions and will cause that new certificate to be delivered to the Grantee (again, provided that appropriate arrangements have been made with the Grantee for the withholding or payment of any taxes that may be due with respect to such Shares).

4. Dividend Rights . Notwithstanding Section 7(c)(ii) of the Plan, any dividends in cash, stock or other property made with respect to the Restricted Shares will be made to the Grantee at the time or times as such dividends are otherwise paid to the common shareholders of the Company, regardless of whether the Restricted Shares underlying the dividend right are then subject to forfeiture.

5. Tax Consequences . The Grantee acknowledges that the Company has not advised the Grantee regarding the Grantee’s income tax liability in connection with the vesting of the Restricted Shares or an election filed under Section 83(b) of the Code. The Grantee has reviewed with the Grantee’s own tax advisors the federal, state, local and foreign tax consequences of the transactions contemplated by this Agreement. The Grantee is relying solely on such advisors and not on any statements or representations of the Company or any of its agents. The Grantee understands that the Grantee (and not the Company) shall be responsible for the Grantee’s own tax liability that may arise as a result of the transactions contemplated by this Agreement. As provided under the Option Cancellation Agreement, the Grantee has been advised by the Company that he is required to file an election under Section 83(b) of the Code in connection with the grant


of the Restricted Shares. THE COMPANY SHALL BEAR NO RESPONSIBILITY OR LIABILITY FOR ANY ADVERSE TAX CONSEQUENCES RESULTING FROM THE GRANTEE’S CODE SECTION 83(b) ELECTION OR FAILURE TO MAKE SUCH ELECTION.

6. Additional Documents . As a condition to the effectiveness of the award of Restricted Shares hereunder:

(a) the Grantee is required to file timely an election under Section 83(b) of the Code, as amended, with respect to the grant of the Restricted Shares (a form of Section 83(b) election has been provided to the Grantee);

(b) the Grantee agrees that the Restricted Shares shall be subject to the Second Amended and Restated Shareholders Agreement dated September 1, 2010 by and among the Company and its shareholders (the “ Shareholders Agreement ”) to which the Grantee is already a party; and

(c) the Grantee agrees upon request to execute any further documents or instruments necessary or desirable to carry out the purposes or intent of this Agreement.

7. Restriction on Transfer of Restricted Shares . None of the Restricted Shares or any beneficial interest therein shall be transferred, encumbered, pledged or otherwise alienated or disposed of in any way until they have become vested in accordance with Section 2 of this Agreement. Even after any of the Restricted Shares become transferable pursuant to this Agreement, they will remain subject to the transfer restrictions set forth in the Shareholders Agreement.

8. Share Legends . All stock certificates representing the Restricted Shares underlying the Award shall have affixed thereto legends substantially in the following form (as may be modified by the Company in accordance with the Shareholders Agreement), in addition to any other legends required by applicable state law:

THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AS AMENDED, (THE “ SECURITIES ACT ”), OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE TRANSFERRED WITHOUT REGISTRATION UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL, SATISFACTORY TO FIVE BELOW, INC., THAT SUCH REGISTRATION IS NOT REQUIRED. THE SHARES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, ENCUMBERED, OR IN ANY MANNER DISPOSED OF EXCEPT IN CONFORMITY WITH THE TERMS OF THE SECOND AMENDED AND RESTATED SHAREHOLDERS AGREEMENT DATED SEPTEMBER 1, 2010, BETWEEN FIVE BELOW, INC. AND THE REGISTERED HOLDER OF THE SHARES (OR THE PREDECESSOR IN INTEREST TO THE SHARES), A COPY OF WHICH IS AVAILABLE AT THE PRINCIPAL OFFICES OF FIVE BELOW, INC. SUCH AGREEMENT GRANTS CERTAIN RIGHTS TO FIVE BELOW, INC. (OR ITS ASSIGNEES) UPON THE SALE, ASSIGNMENT, TRANSFER, ENCUMBRANCE OR OTHER DISPOSITION OF FIVE BELOW, INC.’S SHARES. FIVE BELOW, INC. WILL UPON WRITTEN REQUEST FURNISH A COPY OF SUCH AGREEMENT TO THE HOLDER HEREOF WITHOUT CHARGE.


9. Withholding . By executing this Agreement, the Grantee further agrees that, no later than the date on which the Grantee make the required 83(b) election, the Grantee will pay to the Company in cash the amount of any applicable withholding and other taxes that the Company is required to withhold and deposit in connection with the Grantee’s making the 83(b) election with respect to the Restricted Shares.

10. The Plan . The Grantee has received a copy of the Plan, has read the Plan and is familiar with its terms, and hereby accepts the Restricted Shares subject to all of the terms and provisions of the Plan, as amended from time to time. Pursuant to the Plan, the Board or its Committee is authorized to interpret the Plan and to adopt rules and regulations not inconsistent with the Plan as it deems appropriate. The Grantee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Board or its Committee upon any questions arising under the Plan.

11. Representations and Warranties . By executing this Agreement, the Grantee hereby represents, warrants, covenants, acknowledges and/or agrees that:

(a) The Restricted Shares are being acquired for the Grantee’s own account, for investment purposes only, and not for the account of any other person, and not with a view to the distribution thereof within the meaning of the Securities Act of 1933, as amended (the “ Securities Act ”);

(b) No other person (other than the Grantee and the Company) has or will have a direct or indirect beneficial interest in the Restricted Shares;

(c) The Restricted Shares have not been registered or qualified under the Securities Act or any state securities laws;

(d) There is no public market for the Restricted Shares, there can be no assurance that any such market will ever develop and, therefore, the Grantee may be required to hold the Restricted Shares indefinitely;

(e) In addition to complying with other similar restrictions contained herein, the Grantee will not sell, transfer, pledge, hypothecate or otherwise dispose of any interest in the Restricted Shares unless such interest is registered in accordance with the Securities Act and applicable state securities laws or an exemption from such registration is available and, if required by the Company, an opinion of counsel is delivered to the Company, in a form satisfactory to the Company, that such registration is unnecessary; and

(f) The Company is under no obligation to register the Restricted Shares on behalf of the Grantee or to assist the Grantee in complying with any exemption from registration.


12. General Provisions :

(a) This Agreement, together with the Plan, the Option Cancellation Agreement and the Shareholders Agreement, represent the entire agreement between the parties with respect to the award of the Restricted Shares that are subject to this Agreement and may only be modified or amended in a writing signed by both parties.

(b) Neither this Agreement nor any rights or interest hereunder shall be assignable by the Grantee, his beneficiaries or legal representatives, and any purported assignment in violation hereof shall be null and void.

(c) Either party’s failure to enforce any provision or provisions of this Agreement shall not in any way be construed as a waiver of any such provision or provisions, nor prevent that party thereafter from enforcing each and every other provision of this Agreement. The rights granted both parties herein are cumulative and shall not constitute a waiver of either party’s right to assert all other legal remedies available to it under the circumstances.

(d) The grant of Restricted Shares hereunder will not confer upon the Grantee any right to continue in service with the Company or any of its subsidiaries or affiliates.

(e) This Agreement and all claims or causes of action (whether in contract or tort) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance of this Agreement (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with this Agreement or as an inducement to enter this Agreement) shall be governed by, and enforced in accordance with, the laws of the Commonwealth of Pennsylvania, without regard to the application of the principles of conflicts of laws.

(f) This Agreement may be executed, including execution by facsimile signature, in one or more counterparts, each of which shall be deemed an original, and all of which together shall be deemed to be one and the same instrument.

[ signature page follows ]


IN WITNESS WHEREOF, the parties have duly executed this Award Agreement for Restricted Shares on the 22nd day of March, 2012.

 

FIVE BELOW, INC.
By:  

/s/ Kenneth R. Bull

Name:   Kenneth R. Bull
Title:   Senior Vice President, Finance, Secretary and Treasurer

/s/ David Schlessinger

DAVID SCHLESSINGER

Exhibit 10.25

OPTION CANCELLATION AGREEMENT

Five Below, Inc.

1818 Market Street

Suite 1900

Philadelphia, PA 19103

March 22, 2012

Thomas Vellios

Dear Thomas,

Reference is made to the Non-Qualified Stock Option Agreement, between Five Below, Inc. and you, dated October 14, 2010 (the “ Option Agreement ”), pursuant to which 2,919,973 non-qualified stock options (the “ Options ”) were granted to you under the Five Below, Inc. Equity Incentive Plan, as amended (the “ Plan ”). Pursuant to the terms and conditions of this Option Cancellation Agreement (the “ Agreement ”), you agree to the cancellation of the Options in exchange for which Five Below, Inc. (the “ Company ”) will make two grants of restricted stock, as described herein, to you.

All capitalized terms used herein and not otherwise defined have the meanings set forth in the Plan. A copy of the Plan is attached hereto. In the event of any inconsistency between the Plan and this Agreement (other than with respect to the treatment of dividends as specified below), the terms of the Plan shall control.

Cancellation of Options . You agree that the Options shall be cancelled as of the date hereof and, as of the date hereof, you shall have no further rights pursuant to either such Options or the Option Agreement.

Restricted Shares : You are hereby awarded 973,325 Restricted Shares (the “ Vested Stock ”), which shall be made under and subject to the terms of the Plan. The Vested Stock shall be fully vested and not subject to any forfeiture restrictions on the date of grant and any dividends in cash, stock or other property made with respect to the Vested Stock will be made to you at the time or times as such dividends are otherwise paid to the shareholders of the Company. However, (i) the Vested Stock shall not be granted to you until the date on which you pay to the Company, in cash, an amount equal to the applicable withholding and other taxes that the Company is required to withhold and deposit in connection with the grant of the Vested Stock to you and (ii) the Vested Stock shall not be granted to you unless you make such payment to the Company on or prior to March 23, 2012.

In addition, as of the date hereof, you will also be granted 1,946,648 Restricted Shares (the “ Restricted Stock ”), which shall be made under and subject to terms of the Plan; provided however, that notwithstanding Section 7(c)(ii) of the Plan, any dividends in cash, stock or other property made with respect to the Restricted Stock will be made to you at the time or times as such dividends are otherwise paid to the shareholders of the


Company, regardless of whether the Restricted Stock underlying the dividend right is then subject to forfeiture. The forfeiture restrictions applicable to the Restricted Stock will, subject to your continued employment with the Company and its Affiliates as of such date, lapse according to the following schedule:

 

   

973,324 Restricted Shares shall lapse and become free from risk of forfeiture on the first anniversary of the date hereof; and

 

   

973,324 Restricted Shares shall lapse and become free from risk of forfeiture on the second anniversary of the date hereof.

Notwithstanding the foregoing, upon (i) a “Change in Control Transaction” (as such term is defined in the Employment Agreement between you and the Company, dated October 14, 2010, as amended (the “ Employment Agreement ”)), (ii) your termination of employment by the Company and its Affiliates without “Cause” (as such term is defined in the Employment Agreement), (iii) your termination of employment with the Company and its Affiliates due to your death or Disability or (iv) your voluntary termination of employment with the Company and its Affiliates due to “Good Reason” (as such term is defined in the Employment Agreement), the forfeiture restrictions underlying your Restricted Stock will immediately and fully lapse and the Restricted Stock shall become free from any forfeiture restrictions. If your employment with the Company and its Affiliates terminates or is terminated for any other reason, any Restricted Stock that are then still subject to forfeiture restrictions as of such date shall be immediately forfeited with no other compensation due to you.

As a further condition of the grant of the Restricted Stock, you are required to make a valid, timely election (in substantially the form attached hereto as Exhibit A) to include in your current year income the fair market value of the Restricted Stock, pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended. Upon making such election, you shall promptly furnish a copy of the election to the Company. THE COMPANY SHALL BEAR NO RESPONSIBILITY OR LIABILITY FOR ANY ADVERSE TAX CONSEQUENCES RESULTING FROM YOUR CODE SECTION 83(b) ELECTION OR YOUR FAILURE TO MAKE SUCH ELECTION.

The terms of the Vested Stock and the Restricted Stock, as reflected above, shall be made in the form of the Award Agreements attached hereto as Exhibits A and B, respectively.

Withholding . You agree that, no later than the date on which you make the required 83(b) election, you will pay to the Company in cash the amount of any applicable withholding and other taxes that the Company is required to withhold and deposit in connection with your making the 83(b) election with respect to the Restricted Stock.

No Right to Continued Service . Nothing in this Agreement shall confer on you the right to continue in the employ or other service of the Company or any of its Affiliates or interfere in any way with the right of the Company or any of its Affiliates to terminate your employment or other service at any time and for any reason.

No Reliance . You acknowledge that the Company has not provided any information to you concerning the tax consequences associated with the transactions set forth in this Agreement and you represent that you have consulted with your own tax advisers in regard to such tax consequences.


Entire Agreement . This Agreement contains the entire agreement between the parties, including their respective affiliates, concerning the subject matter hereof and supersedes all prior agreements, understandings, discussions, negotiations and undertakings, whether written or oral, between the parties with respect thereto; additionally, this Agreement shall supersede the Plan, solely with respect to the treatment of dividends paid with respect to unvested Restricted Stock, in each case only to the extent as specifically set forth above.

Governing Law . All issues and questions concerning the application, construction, validity, interpretation and enforcement of this Agreement and the terms and conditions of the award of the Vested Stock and the Restricted Stock shall be governed by, and construed in accordance with, the laws of the Commonwealth of Pennsylvania, without giving effect to any choice of law or conflict of law rules or provisions (whether of the Commonwealth of Pennsylvania or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the Commonwealth of Pennsylvania.

Counterparts . This Agreement may be executed in one or more counterparts each of which shall be deemed an original instrument, but all of which together shall constitute but one and the same Agreement.

[Remainder of Page Intentionally Left Blank]


Your signature will also acknowledge that this letter reflects our final agreement regarding the cancellation of the Options and the award of the Vested Stock and the Restricted Stock and that you agree to abide by the applicable terms of this Agreement (including with respect to the Vested Stock and Restricted Stock, abiding by the terms of the Plan applicable to such grant).

 

Very truly yours,
Five Below, Inc.
By:  

/s/ Kenneth R. Bull

Name:   Kenneth R. Bull
Title:   Senior Vice President, Secretary and Treasurer
Dated: March 22, 2012

 

ACKNOWLEDGED AND ACCEPTED

/s/ Thomas Vellios

Thomas Vellios
Dated: March 22, 2012


EXHIBIT A

Guidelines for 83(b) Election

 

  1. The making of an 83(b) election has serious tax consequences; you are strongly urged to consult a tax professional with regard to this election. An 83(b) election is not required under the Internal Revenue Code of 1986, but it is required as a condition under the Option Cancellation Agreement.

 

  2. Under an 83(b) election, taxable compensation, if any, is based on value of the stock on the date of grant. Accordingly, you will realize compensation income in this amount as a result of this 83(b) election.

 

  3. Filing should be made by certified mail, return receipt requested to the Internal Revenue Service Center at which your federal income tax return is filed.

 

  4. The 83(b) election must be filed with the IRS within 30 days after the stock is transferred to you.

 

  5. It is recommended that three of the 83(b) election forms be stamped by the IRS as proof of filing. Accordingly, please send a self-addressed stamped envelope and four copies of the 83(b) election form and the enclosed cover letter to the IRS, requesting that three copies of each document be returned. Of these three documents:

 

  a. 1 set of copies is given to Five Below, Inc. (the “Company”)

 

  b. 1 set of copies is filed with your Federal Income Tax Return

 

  c. 1 set of copies may be required to be filed with your State Income Tax Return.

Requirements under state or local income tax laws vary. For example, in some states the filing of an 83(b) election with the Internal Revenue Service constitutes the making of the election under comparable state provisions, while in other states a separate state election is required. You are also urged to consult a tax professional regarding state or local tax implications .

 

  6. An 83(b) election may not be revoked without consent of the IRS.

 

  7. Before you submit your 83(b) election to the IRS, please deliver an executed copy of the election to the Company and keep a copy of the election form, the cover letter and the registered mail receipt with your permanent records.

YOU ARE SOLELY RESPONSIBLE FOR TIMELY FILING YOUR SECTION 83(B) ELECTION. THE COMPANY SHALL BEAR NO RESPONSIBILITY OR LIABILITY FOR ANY ADVERSE TAX CONSEQUENCES DUE TO YOUR FAILURE TO MAKE SUCH ELECTION OR YOUR MAKING SUCH ELECTION. PLEASE NOTE THAT BECAUSE THE PURCHASE PRICE FOR THE STOCK WAS $0.00, YOU WILL NOT BE ENTITLED TO RECOGNIZE A TAXABLE LOSS OR ANY OTHER INCOME TAX DEDUCTION IF THE STOCK IS FORFEITED DUE TO YOUR FAILURE TO SATISFY THE VESTING CONDITIONS.


EXHIBIT B

Restricted Share Award Agreement

(Vested Stock)


A WARD A GREEMENT FOR R ESTRICTED S HARES

UNDER THE

F IVE B ELOW , I NC . E QUITY I NCENTIVE P LAN

THIS AWARD AGREEMENT FOR RESTRICTED SHARES (this “ Agreement ”) is made between Five Below, Inc. (the “ Company ”) and Thomas Vellios (the “ Grantee ”), dated March 22, 2012 (the “ Effective Date ”).

WHEREAS, pursuant to the terms of the Option Cancellation Agreement between the Grantee and the Company, dated March 22, 2012 (the “ Option Cancellation Agreement ”) the Company desires to award 973,325 Restricted Shares to the Grantee under the Five Below, Inc. Equity Incentive Plan, as amended (the “ Plan ”), pursuant to the terms of this Agreement, and 1,946,648 Restricted Shares pursuant to a separate award agreement

NOW, THEREFORE, in consideration of these premises and the agreements set forth herein, the parties, intending to be legally bound hereby, agree as follows:

1. Award of Restricted Stock . As of the Effective Date, pursuant to the Plan and the Option Cancellation Agreement, the Company hereby awards to the Grantee 973,325 Restricted Shares (the “ Award ”), subject to the restrictions and on the terms and conditions set forth in this Agreement, the Option Cancellation Agreement and the Plan. The terms of the Plan are hereby incorporated into this Agreement by this reference, as though fully set forth herein. Capitalized terms used but not defined herein will have the same meaning as defined in the Plan.

2. Vesting of Restricted Shares . The Restricted Shares subject to this Award are fully vested as of the Effective Date and are free from risk of forfeiture as of the Effective Date:

3. Issuance of Shares .

(a) The Company will cause the Restricted Shares to be issued in the Grantee’s name either by book-entry registration or issuance of a stock certificate or certificates. Any shares issued to the Grantee hereunder shall be fully paid and non-assessable.

(b) If any certificate is issued in respect of Restricted Shares, that certificate will be legended as described herein.

4. Dividend Rights . Any dividends in cash, stock or other property made with respect to the Restricted Shares will be made to the Grantee at the time or times as such dividends are otherwise paid to the common shareholders of the Company.


5. Additional Documents . As a condition to the effectiveness of the award of Restricted Shares hereunder:

(a) the Grantee agrees that the Restricted Shares shall be subject to the Second Amended and Restated Shareholders Agreement dated September 1, 2010 by and among the Company and its shareholders (the “ Shareholders Agreement ”) to which the Grantee is already a party; and

(b) the Grantee agrees upon request to execute any further documents or instruments necessary or desirable to carry out the purposes or intent of this Agreement.

6. Restriction on Transfer of Restricted Shares . The Restricted Shares or any beneficial interest therein may be transferred, encumbered, pledged or otherwise alienated or disposed of in any way by the Grantee at any time, subject to the transfer restrictions set forth in the Shareholders Agreement.

7. Share Legends . All stock certificates representing the Restricted Shares underlying the Award shall have affixed thereto legends substantially in the following form (as may be modified by the Company in accordance with the Shareholders Agreement), in addition to any other legends required by applicable state law:

THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AS AMENDED, (THE “ SECURITIES ACT ”), OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE TRANSFERRED WITHOUT REGISTRATION UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL, SATISFACTORY TO FIVE BELOW, INC., THAT SUCH REGISTRATION IS NOT REQUIRED. THE SHARES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, ENCUMBERED, OR IN ANY MANNER DISPOSED OF EXCEPT IN CONFORMITY WITH THE TERMS OF THE SECOND AMENDED AND RESTATED SHAREHOLDERS AGREEMENT DATED SEPTEMBER 1, 2010, BETWEEN FIVE BELOW, INC. AND THE REGISTERED HOLDER OF THE SHARES (OR THE PREDECESSOR IN INTEREST TO THE SHARES), A COPY OF WHICH IS AVAILABLE AT THE PRINCIPAL OFFICES OF FIVE BELOW, INC. SUCH AGREEMENT GRANTS CERTAIN RIGHTS TO FIVE BELOW, INC. (OR ITS ASSIGNEES) UPON THE SALE, ASSIGNMENT, TRANSFER, ENCUMBRANCE OR OTHER DISPOSITION OF FIVE BELOW, INC.’S SHARES. FIVE BELOW, INC. WILL UPON WRITTEN REQUEST FURNISH A COPY OF SUCH AGREEMENT TO THE HOLDER HEREOF WITHOUT CHARGE.

8. Withholding . The Company confirms that on the Effective Date the Grantee has paid to the Company, in cash, an amount equal to the applicable withholding and other taxes that the Company is required to withhold and deposit in connection with the grant of the Restricted Shares to the Grantee.

9. The Plan . The Grantee has received a copy of the Plan, has read the Plan and is familiar with its terms, and hereby accepts the Restricted Shares subject to all of the terms and provisions of the Plan, as amended from time to time. Pursuant to the Plan, the Board or its Committee is authorized to interpret the Plan and to adopt rules and regulations not inconsistent with the Plan as it deems appropriate. The Grantee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Board or its Committee upon any questions arising under the Plan.


10. Representations and Warranties . By executing this Agreement, the Grantee hereby represents, warrants, covenants, acknowledges and/or agrees that:

(a) The Restricted Shares are being acquired for the Grantee’s own account, for investment purposes only, and not for the account of any other person, and not with a view to the distribution thereof within the meaning of the Securities Act of 1933, as amended (the “ Securities Act ”);

(b) No other person (other than the Grantee and the Company) has or will have a direct or indirect beneficial interest in the Restricted Shares;

(c) The Restricted Shares have not been registered or qualified under the Securities Act or any state securities laws;

(d) There is no public market for the Restricted Shares, there can be no assurance that any such market will ever develop and, therefore, the Grantee may be required to hold the Restricted Shares indefinitely;

(e) In addition to complying with other similar restrictions contained herein, the Grantee will not sell, transfer, pledge, hypothecate or otherwise dispose of any interest in the Restricted Shares unless such interest is registered in accordance with the Securities Act and applicable state securities laws or an exemption from such registration is available and, if required by the Company, an opinion of counsel is delivered to the Company, in a form satisfactory to the Company, that such registration is unnecessary; and

(f) The Company is under no obligation to register the Restricted Shares on behalf of the Grantee or to assist the Grantee in complying with any exemption from registration.

11. General Provisions :

(a) This Agreement, together with the Plan, the Option Cancellation Agreement and the Shareholders Agreement, represent the entire agreement between the parties with respect to the award of the Restricted Shares that are subject to this Agreement and may only be modified or amended in a writing signed by both parties.

(b) Neither this Agreement nor any rights or interest hereunder shall be assignable by the Grantee, his beneficiaries or legal representatives, and any purported assignment in violation hereof shall be null and void.

(c) Either party’s failure to enforce any provision or provisions of this Agreement shall not in any way be construed as a waiver of any such provision or provisions, nor prevent that party thereafter from enforcing each and every other provision of this Agreement. The rights granted both parties herein are cumulative and shall not constitute a waiver of either party’s right to assert all other legal remedies available to it under the circumstances.


(d) The grant of Restricted Shares hereunder will not confer upon the Grantee any right to continue in service with the Company or any of its subsidiaries or affiliates.

(e) This Agreement and all claims or causes of action (whether in contract or tort) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance of this Agreement (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with this Agreement or as an inducement to enter this Agreement) shall be governed by, and enforced in accordance with, the laws of the Commonwealth of Pennsylvania, without regard to the application of the principles of conflicts of laws.

(f) This Agreement may be executed, including execution by facsimile signature, in one or more counterparts, each of which shall be deemed an original, and all of which together shall be deemed to be one and the same instrument.

[ signature page follows ]


IN WITNESS WHEREOF, the parties have duly executed this Award Agreement for Restricted Shares on the 22 day of March, 2012.

 

FIVE BELOW, INC.
By:  

/s/ Kenneth R. Bull

Name:   Kenneth R. Bull
Title:   Senior Vice President, Finance, Secretary and Treasurer

/s/ Thomas Vellios

THOMAS VELLIOS


EXHIBIT C

Restricted Share Award Agreement

(Restricted Stock)


A WARD A GREEMENT FOR R ESTRICTED S HARES

UNDER THE

F IVE B ELOW , I NC . E QUITY I NCENTIVE P LAN

THIS AWARD AGREEMENT FOR RESTRICTED SHARES (this “ Agreement ”) is made between Five Below, Inc. (the “ Company ”) and Thomas Vellios (the “ Grantee ”), dated March 22, 2012 (the “ Effective Date ”).

WHEREAS, pursuant to the terms of the Option Cancellation Agreement between the Grantee and the Company, dated March 22, 2012 (the “ Option Cancellation Agreement ”) the Company desires to award 1,946,648 Restricted Shares to the Grantee under the Five Below, Inc. Equity Incentive Plan, as amended (the “ Plan ”), pursuant to the terms of this Agreement, and 973,325 Restricted Shares pursuant to a separate award agreement

NOW, THEREFORE, in consideration of these premises and the agreements set forth herein, the parties, intending to be legally bound hereby, agree as follows:

1. Award of Restricted Stock . As of the Effective Date, pursuant to the Plan and the Option Cancellation Agreement, the Company hereby awards to the Grantee 1,946,648 Restricted Shares (the “ Award ”), subject to the restrictions and on the terms and conditions set forth in this Agreement, the Option Cancellation Agreement and the Plan. The terms of the Plan are hereby incorporated into this Agreement by this reference, as though fully set forth herein. Capitalized terms used but not defined herein will have the same meaning as defined in the Plan.

2. Vesting of Restricted Shares .

(a) Vesting Schedule . The Award will vest and become free from forfeiture restrictions according to the following schedule:

i. 973,324 Restricted Shares shall vest and become free from risk of forfeiture on the on the first anniversary of the Effective Date; and

ii. 973,324 Restricted Shares shall vest and become free from risk of forfeiture on the on the second anniversary of the Effective Date.

(b) Vesting Upon Certain Events . Notwithstanding the foregoing, upon (i) a “Change in Control Transaction” (as such term is defined in the Employment Agreement between the Grantee and the Company, dated October 14, 2010, as amended (the “ Employment Agreement ”)), (ii) the Grantee’s termination of employment by the Company and its Affiliates without “Cause” (as such term is defined in the Employment Agreement), (iii) the Grantee’s termination of employment with the Company and its Affiliates due to death or Disability or (iv) the Grantee’s voluntary termination of employment with the Company and its Affiliates due to “Good Reason” (as such term is defined in the Employment Agreement), all of the Restricted Shares underlying the Award will immediately and fully vest and become free from any forfeiture restrictions. If the Grantee’s employment with the Company and its Affiliates terminates or is


terminated for any other reason, any Restricted Shares that are then still subject to forfeiture restrictions as of such date shall be immediately forfeited with no other compensation due to the Grantee.

3. Issuance of Shares .

(a) The Company will cause the Restricted Shares to be issued in the Grantee’s name either by book-entry registration or issuance of a stock certificate or certificates. Any shares issued to the Grantee hereunder shall be fully paid and non-assessable.

(b) While the Restricted Shares remain subject to forfeiture to the Company pursuant to Section 2 above, the Company will cause an appropriate stop-transfer order to be issued and to remain in effect with respect to the Restricted Shares. As soon as practicable following the time that any Restricted Share becomes vested (and provided that appropriate arrangements have been made with the Company for the withholding or payment of any taxes that may be due with respect to such Share), the Company will cause that stop-transfer order to be removed. The Company may also condition delivery of certificates for Restricted Shares upon receipt from the Grantee of any undertakings that it may determine are appropriate to facilitate compliance with federal and state securities laws.

(c) If any certificate is issued in respect of Restricted Shares, that certificate will be legended as described herein and held in escrow by the Company’s secretary or his or her designee. In addition, the Grantee may be required to execute and deliver to the Company a stock power with respect to those Restricted Shares. At such time as those Restricted Shares become vested, the Company will cause a new certificate to be issued without that portion of the legend referencing the previously applicable vesting conditions and will cause that new certificate to be delivered to the Grantee (again, provided that appropriate arrangements have been made with the Grantee for the withholding or payment of any taxes that may be due with respect to such Shares).

4. Dividend Rights . Notwithstanding Section 7(c)(ii) of the Plan, any dividends in cash, stock or other property made with respect to the Restricted Shares will be made to the Grantee at the time or times as such dividends are otherwise paid to the common shareholders of the Company, regardless of whether the Restricted Shares underlying the dividend right are then subject to forfeiture.

5. Tax Consequences . The Grantee acknowledges that the Company has not advised the Grantee regarding the Grantee’s income tax liability in connection with the vesting of the Restricted Shares or an election filed under Section 83(b) of the Code. The Grantee has reviewed with the Grantee’s own tax advisors the federal, state, local and foreign tax consequences of the transactions contemplated by this Agreement. The Grantee is relying solely on such advisors and not on any statements or representations of the Company or any of its agents. The Grantee understands that the Grantee (and not the Company) shall be responsible for the Grantee’s own tax liability that may arise as a result of the transactions contemplated by this Agreement. As provided under the Option Cancellation Agreement, the Grantee has been advised by the Company that he is required to file an election under Section 83(b) of the Code in connection with the grant


of the Restricted Shares. THE COMPANY SHALL BEAR NO RESPONSIBILITY OR LIABILITY FOR ANY ADVERSE TAX CONSEQUENCES RESULTING FROM THE GRANTEE’S CODE SECTION 83(b) ELECTION OR FAILURE TO MAKE SUCH ELECTION.

6. Additional Documents . As a condition to the effectiveness of the award of Restricted Shares hereunder:

(a) the Grantee is required to file timely an election under Section 83(b) of the Code, as amended, with respect to the grant of the Restricted Shares (a form of Section 83(b) election has been provided to the Grantee);

(b) the Grantee agrees that the Restricted Shares shall be subject to the Second Amended and Restated Shareholders Agreement dated September 1, 2010 by and among the Company and its shareholders (the “ Shareholders Agreement ”) to which the Grantee is already a party; and

(c) the Grantee agrees upon request to execute any further documents or instruments necessary or desirable to carry out the purposes or intent of this Agreement.

7. Restriction on Transfer of Restricted Shares . None of the Restricted Shares or any beneficial interest therein shall be transferred, encumbered, pledged or otherwise alienated or disposed of in any way until they have become vested in accordance with Section 2 of this Agreement. Even after any of the Restricted Shares become transferable pursuant to this Agreement, they will remain subject to the transfer restrictions set forth in the Shareholders Agreement.

8. Share Legends . All stock certificates representing the Restricted Shares underlying the Award shall have affixed thereto legends substantially in the following form (as may be modified by the Company in accordance with the Shareholders Agreement), in addition to any other legends required by applicable state law:

THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AS AMENDED, (THE “ SECURITIES ACT ”), OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE TRANSFERRED WITHOUT REGISTRATION UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL, SATISFACTORY TO FIVE BELOW, INC., THAT SUCH REGISTRATION IS NOT REQUIRED. THE SHARES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, ENCUMBERED, OR IN ANY MANNER DISPOSED OF EXCEPT IN CONFORMITY WITH THE TERMS OF THE SECOND AMENDED AND RESTATED SHAREHOLDERS AGREEMENT DATED SEPTEMBER 1, 2010, BETWEEN FIVE BELOW, INC. AND THE REGISTERED HOLDER OF THE SHARES (OR THE PREDECESSOR IN INTEREST TO THE SHARES), A COPY OF WHICH IS AVAILABLE AT THE PRINCIPAL OFFICES OF FIVE BELOW, INC. SUCH AGREEMENT GRANTS CERTAIN RIGHTS TO FIVE BELOW, INC. (OR ITS ASSIGNEES) UPON THE SALE, ASSIGNMENT, TRANSFER, ENCUMBRANCE OR OTHER DISPOSITION OF FIVE BELOW, INC.’S SHARES. FIVE BELOW, INC. WILL UPON WRITTEN REQUEST FURNISH A COPY OF SUCH AGREEMENT TO THE HOLDER HEREOF WITHOUT CHARGE.


9. Withholding . By executing this Agreement, the Grantee further agrees that, no later than the date on which the Grantee make the required 83(b) election, the Grantee will pay to the Company in cash the amount of any applicable withholding and other taxes that the Company is required to withhold and deposit in connection with the Grantee’s making the 83(b) election with respect to the Restricted Shares.

10. The Plan . The Grantee has received a copy of the Plan, has read the Plan and is familiar with its terms, and hereby accepts the Restricted Shares subject to all of the terms and provisions of the Plan, as amended from time to time. Pursuant to the Plan, the Board or its Committee is authorized to interpret the Plan and to adopt rules and regulations not inconsistent with the Plan as it deems appropriate. The Grantee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Board or its Committee upon any questions arising under the Plan.

11. Representations and Warranties . By executing this Agreement, the Grantee hereby represents, warrants, covenants, acknowledges and/or agrees that:

(a) The Restricted Shares are being acquired for the Grantee’s own account, for investment purposes only, and not for the account of any other person, and not with a view to the distribution thereof within the meaning of the Securities Act of 1933, as amended (the “ Securities Act ”);

(b) No other person (other than the Grantee and the Company) has or will have a direct or indirect beneficial interest in the Restricted Shares;

(c) The Restricted Shares have not been registered or qualified under the Securities Act or any state securities laws;

(d) There is no public market for the Restricted Shares, there can be no assurance that any such market will ever develop and, therefore, the Grantee may be required to hold the Restricted Shares indefinitely;

(e) In addition to complying with other similar restrictions contained herein, the Grantee will not sell, transfer, pledge, hypothecate or otherwise dispose of any interest in the Restricted Shares unless such interest is registered in accordance with the Securities Act and applicable state securities laws or an exemption from such registration is available and, if required by the Company, an opinion of counsel is delivered to the Company, in a form satisfactory to the Company, that such registration is unnecessary; and

(f) The Company is under no obligation to register the Restricted Shares on behalf of the Grantee or to assist the Grantee in complying with any exemption from registration.


12. General Provisions :

(a) This Agreement, together with the Plan, the Option Cancellation Agreement and the Shareholders Agreement, represent the entire agreement between the parties with respect to the award of the Restricted Shares that are subject to this Agreement and may only be modified or amended in a writing signed by both parties.

(b) Neither this Agreement nor any rights or interest hereunder shall be assignable by the Grantee, his beneficiaries or legal representatives, and any purported assignment in violation hereof shall be null and void.

(c) Either party’s failure to enforce any provision or provisions of this Agreement shall not in any way be construed as a waiver of any such provision or provisions, nor prevent that party thereafter from enforcing each and every other provision of this Agreement. The rights granted both parties herein are cumulative and shall not constitute a waiver of either party’s right to assert all other legal remedies available to it under the circumstances.

(d) The grant of Restricted Shares hereunder will not confer upon the Grantee any right to continue in service with the Company or any of its subsidiaries or affiliates.

(e) This Agreement and all claims or causes of action (whether in contract or tort) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance of this Agreement (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with this Agreement or as an inducement to enter this Agreement) shall be governed by, and enforced in accordance with, the laws of the Commonwealth of Pennsylvania, without regard to the application of the principles of conflicts of laws.

(f) This Agreement may be executed, including execution by facsimile signature, in one or more counterparts, each of which shall be deemed an original, and all of which together shall be deemed to be one and the same instrument.

[ signature page follows ]


IN WITNESS WHEREOF, the parties have duly executed this Award Agreement for Restricted Shares on the 22 day of March, 2012.

 

FIVE BELOW, INC.
By:  

/s/ Kenneth R. Bull

Name:   Kenneth R. Bull
Title:   Senior Vice President, Finance, Secretary and Treasurer

/s/ Thomas Vellios

THOMAS VELLIOS

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

The Board of Directors

Five Below, Inc.:

 

We consent to the use of our report dated April 17, 2012 included herein and to the reference to our firm under the heading “Experts” in the prospectus.

/s/ KPMG LLP

Philadelphia, Pennsylvania

April 17, 2012